Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Interneurons,0.748617346943676,2.2148722828924994,0.0,0.0,0.0,101/271,11.00%,NPY;ETV1;L1CAM;PCDH8;NRIP3;KCNMA1;SHISA6;PDE1A;NTNG1;OLFM3;CHST1;PLPPR5;SYT4;KCNC2;HTR5A;TRIM9;KCNQ5;PCSK2;GRM5;FGF12;PIANP;CTNND2;ADCY8;LMO3;SNAP25;SCRT1;RAB3C;MAP2;NRXN1;SYNPR;DLGAP1;ST8SIA3;NOL4;GRM1;GABRG2;NCALD;CACNG2;CDK5R2;RIT2;SYT1;CLVS2;TMEM196;RGS7BP;GAD1;VSTM2A;ADCYAP1R1;CACNB1;SULT4A1;PNOC;GAD2;RELN;OPCML;LRRTM1;ABAT;HIVEP2;FCHSD2;NEFM;SRGAP1;KCNIP2;GABRA4;TMEM179;NRGN;PLCB4;ASTN1;DLX1;SLC35F1;ADGRL2;CDH22;PACSIN1;CA10;SHISA9;CAMKV;SNCB;LYPD1;GDA;CACNA1B;TMEM132D;SYT13;CELF4;SH3GL2;TIMELESS;MAPK4;NOS1;NDRG4;ATP2B3;RAB15;PRKCG;VEGFD;BRINP1;EML5;SYT7;CELF3;KCNQ2;NCAN;C11ORF87;GAP43;IGSF21;CACNA1I;NRSN2;CPNE5;PSD2
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.8775801515379033,-2.2059214755760457,0.0,0.0,0.0,64/87,9.70%,RPS12;RPL18A;RPS23;RPS18;RPS13;RPS3A;RPLP1;RPS16;RPS8;RPSA;RPL23A;RPS27A;RPL29;RPL5;RPS3;RPL19;RPS2;RPL11;RPL23;RPL13;RPL3;RPL10;RPL21;RPS21;RPS5;RPS6;RPL41;RPS7;RPL10A;RPL18;RPL12;RPS14;RPS15;RPL15;RPL27A;RPS11;RPL35A;RPL32;RWDD1;RPS28;RPS27;RPL8;RPS15A;RPS25;RPL30;RPS19;RPL7A;RPS24;RPS20;RPL7;RPL14;RPL34;RPL9;RPL37;RPS9;RPL28;RPL27;RPL6;RPL35;RPL36;RPLP0;TMA7;RPL13A;RPS4X
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.8713781152966369,-2.1563506769382186,0.0,0.0,0.0,65/88,9.81%,RPS12;RPL18A;RPS23;RPS18;RPS13;RPS3A;RPLP1;RPS16;RPS8;RPSA;RPL23A;RPS27A;RPL29;RPL5;RPS3;RPL19;RPS2;RPL11;RPL23;RPL13;RPL3;RPL10;RPL21;RPS21;RPS5;RPS6;RPL41;RPS7;RPL10A;RPL18;RPL12;RPS14;SRPRA;RPS15;RPL15;RPL27A;RPS11;RPL35A;RPL32;RPS28;RPS27;RPL8;RPS15A;RPS25;RPL30;RPS19;RPL7A;RPS24;SRP14;RPS20;RPL7;RPL14;RPL34;RPL9;RPL37;RPS9;RPL28;RPL27;RPL6;RPL35;RPL36;RPLP0;RPL13A;RPS4X;SEC62
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.8353976353179898,-2.1339550358386052,0.0,0.0,0.0,75/142,9.70%,RPS12;RPL18A;RPS23;RPS18;RPS13;RPS3A;RPLP1;RPS16;RPS8;RPSA;RPL23A;RPS27A;RPL29;RPL5;RPS3;RPL19;RPS2;RPL11;RPL23;RPL13;RPL3;RPL10;RPL21;RPS21;RPS5;RPS6;RPL41;EEF1A1;RPS7;RPL10A;RPL18;RPL12;RPS14;MRPL51;RPS15;RPL15;RPL27A;RPS11;RPL35A;RPL32;MRPL52;MRPL34;RPS28;RPS27;RPL8;RPS15A;MRPL32;RPS25;RPL30;RPS19;RPL7A;RPS24;RPS20;RPL7;RPL14;MRPL24;RPL34;MRPS7;RPL9;MRPL36;SARS1;MRPS21;MRPS5;RPL37;RPS9;RPL28;RPL27;RPL6;RPL35;RPL36;HARS2;RPLP0;MRPL27;RPL13A;RPS4X
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.8164473731245843,-2.1224368463660848,0.0,0.0,0.0,85/192,9.70%,RPS12;RPL18A;RPS23;RPS18;RPS13;RPS3A;RPLP1;RPS16;RPS8;RPSA;RPL23A;RPS27A;RPL29;RPL5;RPS3;RPL19;RPS2;RPL11;RPL23;RPL13;RPL3;RPL10;RPL21;RPS21;RPS5;RPS6;EEF1B2;RPL41;EEF1A1;RPS7;RPL10A;RPL18;RPL12;RPS14;MRPL51;RPS15;RPL15;RPL27A;RPS11;RPL35A;RPL32;MRPL52;RWDD1;MRPL34;RPS28;RPS27;RPL8;RPS15A;MRPL32;RPS25;RPL30;RPS19;RPL7A;RPS24;RPS20;MRPS2;RPL7;RPL14;MRPL24;RPL34;MRPS7;RPL9;MRPL36;SARS1;MRPS21;MRPS5;RPL37;RPS9;AARS1;RPL28;TARS1;RPL27;TRMT112;RPL6;MRPL57;AIMP1;RPL35;RPL36;HARS2;RPLP0;TMA7;NARS1;MRPL27;RPL13A;RPS4X
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.8696864960097176,-2.120845288436836,0.0,0.0,0.0,64/85,9.70%,RPS12;RPL18A;RPS23;RPS18;RPS13;RPS3A;RPLP1;RPS16;RPS8;RPSA;RPL23A;RPS27A;RPL29;RPL5;RPS3;RPL19;RPS2;RPL11;RPL23;RPL13;RPL3;RPL10;RPL21;RPS21;RPS5;RPS6;RPL41;RPS7;RPL10A;RPL18;RPL12;RPS14;RPS15;RPL15;RPL27A;SEC61B;RPS11;RPL35A;RPL32;RPS28;RPS27;RPL8;RPS15A;RPS25;RPL30;RPS19;RPL7A;RPS24;SRP14;RPS20;RPL7;RPL14;RPL34;RPL9;RPL37;RPS9;RPL28;RPL27;RPL6;RPL35;RPL36;RPLP0;RPL13A;RPS4X
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.7968796495813092,2.11589409253395,0.0,0.0,0.0,62/105,15.04%,OLFM3;KCNC2;HTR5A;GRM5;SNAP25;GRIN2B;SCRT1;NRXN1;SYNPR;ST8SIA3;TMEM132B;NOL4;GRM1;CADPS;GABRG2;RIT2;CLVS2;TMEM196;SLC1A2;GABRA1;SPHKAP;SCN2A;VSTM2A;ADCYAP1R1;GAD2;OPCML;TNR;GABRA2;GRIA1;ASTN1;CDH22;CA10;GRIN1;CACNA1B;SCN3B;CNTNAP5;CELF4;MEIS2;NDRG4;ATP2B3;SCN1A;CACNG3;NEUROD6;CELF3;FUT9;NCAN;C11ORF87;KCTD16;GAP43;TRPM3;PSD2;GABRG1;SRRM4;ASIC2;ACTL6B;ATCAY;TMEM130;PTPN5;STMN2;NTRK3;PAK5;DIRAS2
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.7549530907824187,-2.0919985813144195,0.0,0.0,0.0,92/320,9.70%,RPS12;RPL18A;RPS23;RPS18;RPS13;RPS3A;RPLP1;RPS16;RPS8;RPSA;RPL23A;RPS27A;PAX8;RPL29;RPL5;RPS3;RPL19;RPS2;RPL11;PRPF4;RPL23;POLR2L;RPL13;RPL3;RPL10;RPL21;RPS21;RPS5;RPS6;RPL41;EEF1A1;RPS7;RPL10A;RPL18;RPL12;PTMA;THAP1;RPS14;MRPL51;RPS15;RPL15;POLR2G;RPL27A;RPS11;RPL35A;RPL32;MRPL52;MRPL34;RPS28;RPS27;RPL8;RPS15A;MRPL32;RPS25;RPL30;RPS19;RPL7A;RPS24;POLR2K;HOXD3;RPS20;SRSF7;POLR2I;RPL7;RPL14;MRPL24;MPHOSPH10;RPL34;MRPS7;RPL9;MRPL36;SARS1;MRPS21;MRPS5;RBM15B;RPL37;RPS9;MLF1;RPL28;RPL27;RPL6;SRSF3;POLR2A;SRSF9;RPL35;RPL36;HARS2;RPLP0;TFIP11;MRPL27;RPL13A;RPS4X
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.7600502940225785,2.0745988425462603,0.0,0.0,0.0,66/146,12.75%,PCDH8;NRIP3;KCNMA1;SHISA6;PDE1A;OLFM3;SYT4;HTR5A;GRM5;CTNND2;SNAP25;SCRT1;RAB3C;NRXN1;SYNPR;DLGAP1;ST8SIA3;CADPS;GABRG2;CACNG2;HCN1;RIT2;CLVS2;TMEM196;GABRA1;GAD1;ADGRB1;VSTM2A;ADCYAP1R1;SULT4A1;GAD2;OPCML;LRRTM1;ABAT;LRRC3B;HIVEP2;SLC24A3;TMEM179;PRKG1;ASTN1;CDH22;CLSTN3;CA10;SHANK2;PDE1B;SNCB;GRIN1;CACNA1B;CELF4;ATP2B3;BRINP1;CELF3;KCNQ2;SEZ6L;ATP2B2;CACNA2D2;NCAN;C11ORF87;GAP43;IGSF21;PSD2;DLG4;SRRM4;ASIC2;ATP1B2;ACTL6B
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.8630836674551184,-2.0580397391286116,0.0,0.0,0.0,65/105,9.91%,RPS12;RPL18A;RPS23;RPS18;RPS13;RPS3A;RPLP1;RPS16;RPS8;RPSA;RPL23A;RPS27A;RPL29;RPL5;RPS3;RPL19;RPS2;RPL11;RPL23;RPL13;RPL3;RPL10;RPL21;RPS21;RPS5;RPS6;RPL41;RPS7;RPL10A;RPL18;RPL12;RPS14;RPS15;RPL15;HELZ2;RPL27A;RPS11;RPL35A;RPL32;RPS28;RPS27;PNRC2;RPL8;RPS15A;RPS25;RPL30;RPS19;RPL7A;RPS24;RPS20;RPL7;RPL14;RPL34;RPL9;RPL37;RPS9;RPL28;RPL27;RPL6;RPL35;RPL36;RPLP0;RPL13A;RPS4X;PYM1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.8087520372637234,-2.035235780464198,0.0,0.0,0.0,68/161,9.91%,RPS12;RPL18A;RPS23;RPS18;RPS13;RPS3A;RPLP1;RPS16;RPS8;RPSA;RPL23A;RPS27A;RPL29;RPL5;RPS3;RPL19;RPS2;RPL11;RPL23;RPL13;RPL3;RPL10;RPL21;RPS21;RPS5;RPS6;RPL41;RPS7;RPL10A;RPL18;RPL12;RPS14;RPS15;RPL15;POLR2G;HELZ2;RPL27A;RPS11;RPL35A;RPL32;RPS28;RPS27;PNRC2;RPL8;RPS15A;RPS25;RPL30;RPS19;RPL7A;RPS24;RPS20;DDX5;EXOSC8;RPL7;RPL14;RPL34;RPL9;RPL37;RPS9;RPL28;RPL27;RPL6;RPL35;RPL36;RPLP0;RPL13A;RPS4X;PYM1
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.7975696896386759,2.0332172555834775,0.0,0.0,0.0,66/111,14.98%,KCNIP1;OLFM3;CHST1;KCNC2;HTR5A;GRM5;CTNND2;SNAP25;SCRT1;PLPPR4;MAP2;GFAP;SYNPR;ST8SIA3;SYN2;GABRG2;CDK5R2;LRFN5;CLVS2;TMEM196;SPHKAP;RGS7BP;GAD1;VSTM2A;ADCYAP1R1;SULT4A1;GAD2;NTRK2;OPCML;LRRC3B;TMEM179;ASTN1;DLX1;CDH22;CA10;CAMK2B;SNCB;CADM3;HS6ST3;UBE2QL1;SH3GL2;MAPK4;NDRG4;ATP2B3;NEUROD6;PTPRT;BRINP1;CELF3;PHYHIP;NCAN;C11ORF87;KCTD16;GAP43;IGSF21;PSD2;GABBR2;ASIC2;ACTL6B;TMEM59L;PTPN5;TNFAIP8L3;ABCC8;ZNF536;SEMA3C;STMN2;PAK5
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.776938268654944,2.028970250963102,0.0,0.0,0.0,61/120,13.97%,NPY;PDE10A;PRSS12;SHISA6;KCNIP1;OLFM3;SYT4;KCNC2;HTR5A;GRM5;SNAP25;SCRT1;RAB3C;PLPPR4;NRXN1;GFAP;SYNPR;ST8SIA3;GABRG2;RIT2;CLVS2;TMEM196;GABRA1;SPHKAP;RGS7BP;SCN2A;VSTM2A;ADCYAP1R1;SULT4A1;GAD2;OPCML;LRRTM1;LRRC3B;SPOCK1;TMEM179;NRGN;ASTN1;CDH22;CA10;SNCB;CADM3;SCN3B;ATXN1;CELF4;SH3GL2;ATP2B3;NEUROD6;BRINP1;CELF3;NCAN;C11ORF87;GAP43;PSD2;GABRG1;ASIC2;ACTL6B;SERPINI1;PTPN5;NEGR1;MRTFB;ZNF536
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.7228111274329356,2.026438139424597,0.0,0.0,0.0,73/155,16.34%,PCDH8;ZCCHC12;KCNH7;OLFM3;PLPPR5;SYT4;RIMS4;ATRNL1;SNAP25;SCRT1;MAP2;DCLK1;LINGO2;ST8SIA3;ELAVL2;NOL4;SLITRK5;EFNB3;DACH1;NRG1;SYT1;CLVS2;LZTFL1;DACT1;ZDBF2;PURG;FAT3;CNR1;ADCYAP1R1;SULT4A1;PNOC;RELN;OPCML;NEFM;TMEM179;ASTN1;SLC35F1;CAMKV;TMEM200C;SNCB;CACNA1B;ADAM12;SH3GL2;MAPK4;NDRG4;BRINP1;CELF3;FUT9;KCNQ2;FAM171B;CACNA2D2;NCAN;B3GALT1;GAP43;TMEM170B;PNMA2;NEFL;INSYN2A;ACTL6B;TMEM59L;RGMB;PTPN5;ZNF536;MEGF10;STMN2;PAK5;DIPK1B;CHN1;TCEAL1;GRIA2;ABCC5;NLGN1;NBEA
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.7710525083649086,-2.0239534610672294,0.0,0.0009295217038002909,0.01,75/190,13.96%,RPL18A;RPLP1;RPS16;RPL23A;RPL29;RPL5;RPL19;RPS2;RPL11;RPL23;RPL13;RPL3;RPL10;RPL21;RPS6;RPL41;RPS7;RPL10A;RPL18;RPL12;RPS14;RPS15;RPL15;RPL27A;RPL35A;POP5;RPL32;SBDS;WDR74;RPS28;RPS27;RPL8;RPS25;RPL30;RPS19;RPL7A;RPS24;ADAT1;DCAF13;EXOSC8;BYSL;RPL7;RPL14;MPHOSPH10;RPL34;IMP3;RPL9;SARS1;UTP3;RPL37;RPS9;AARS1;RPL28;RPL27;RPL6;RPL35;NOP53;RPL36;RPLP0;RPL13A;RRP36;NOP56;RPL24;RPL38;NOC4L;RPLP2;EXOSC5;UBA52;DKC1;NOL6;RRP9;POP7;POP4;PELP1;RRP1B
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.8482814462490175,-2.011298419403207,0.0,0.000836569533420262,0.01,73/97,12.13%,RPS12;RPL18A;RPS23;RPS18;RPS13;RPS3A;RPLP1;RPS16;RPS8;RPSA;RPL23A;RPS27A;RPL29;RPL5;RPS3;RPL19;RPS2;RPL11;RPL23;RPL13;RPL3;RPL10;RPL21;RPS21;RPS5;RPS6;RPL41;RPS7;RPL10A;RPL18;RPL12;RPS14;SRPRA;RPS15;RPL15;RPL27A;RPS11;RPL35A;RPL32;RPS28;RPS27;RPL8;RPS15A;RPS25;RPL30;RPS19;RPL7A;RPS24;SRP14;RPS20;RPL7;RPL14;RPL34;RPL9;RPL37;RPS9;RPL28;RPL27;RPL6;RPL35;RPL36;RPLP0;SPCS1;RPL13A;RPS4X;SEC62;SPCS2;RPL24;RPL38;RPLP2;ZFAND2A;SRP9;RPS26
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.7757417926485025,-2.0093328581627103,0.0,0.0007605177576547835,0.01,75/164,14.13%,RPL18A;RPLP1;RPS16;RPL23A;RPL29;RPL5;RPL19;RPS2;RPL11;RPL23;RPL13;RPL3;RPL10;RPL21;RPS6;RPL41;RPS7;RPL10A;RPL18;RPL12;RPS14;RPS15;RPL15;RPL27A;RPL35A;POP5;RPL32;SBDS;WDR74;RPS28;RPS27;RPL8;RPS25;RPL30;RPS19;RPL7A;RPS24;TSR3;DCAF13;EXOSC8;RIOK2;BYSL;RPL7;RPL14;MPHOSPH10;RPL34;IMP3;RPL9;UTP3;NSA2;RPL37;RPS9;RPL28;RPL27;RPL6;RPL35;NOP53;RPL36;RPLP0;RPL13A;RRP36;NOP56;RPL24;RPL38;NOC4L;RPLP2;EXOSC5;UBA52;DKC1;NOL6;RRP9;POP4;PELP1;RRP1B;RSL1D1
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.7849974460972264,-2.0089186035674995,0.0,0.0006971412778502182,0.01,73/151,13.96%,RPL18A;RPLP1;RPS16;RPL23A;RPL29;RPL5;RPL19;RPS2;RPL11;RPL23;RPL13;RPL3;RPL10;RPL21;RPS6;RPL41;RPS7;RPL10A;RPL18;RPL12;RPS14;RPS15;RPL15;RPL27A;RPL35A;POP5;RPL32;NIFK;SBDS;WDR74;RPS28;RPS27;RPL8;RPS25;RPL30;RPS19;RPL7A;RPS24;DCAF13;EXOSC8;BYSL;RPL7;RPL14;MPHOSPH10;RPL34;IMP3;RPL9;TRIR;UTP3;RPL37;RPS9;RPL28;RPL27;RPL6;RPL35;NOP53;RPL36;RPLP0;RPL13A;RRP36;NOP56;RPL24;RPL38;NOC4L;RPLP2;EXOSC5;UBA52;DKC1;NOL6;RRP9;POP4;PELP1;RRP1B
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.7643378633313082,-1.9992174934543998,0.0,0.0006435150257078937,0.01,91/278,9.70%,RPS12;RPL18A;RPS23;RPS18;RPS13;ORC1;RPS3A;RPLP1;RPS16;RPS8;RPSA;RPL23A;RPS27A;PAX8;RPL29;RPL5;RPS3;RPL19;RPS2;RPL11;RPL23;POLR2L;RPL13;RPL3;RPL10;RPL21;RPS21;RPS5;RPS6;EEF1B2;RPL41;EEF1A1;RPS7;RPL10A;PTH;RPL18;RPL12;PTMA;THAP1;RPS14;MRPL51;RPS15;RPL15;KIN;POLR2G;RPL27A;RPS11;RPL35A;RPL32;MRPL52;MRPL34;RPS28;RPS27;RPL8;RPS15A;MRPL32;RPS25;RPL30;RPS19;RPL7A;RPS24;POLR2K;HOXD3;RPS20;POLD3;POLR2I;RPL7;RPL14;MRPL24;RPL34;MRPS7;RPL9;MRPL36;SARS1;MRPS21;MRPS5;GRWD1;RPL37;RPS9;MLF1;RPL28;RPL27;RPL6;POLR2A;RPL35;RPL36;HARS2;RPLP0;MRPL27;RPL13A;RPS4X
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.7969138130778645,1.9618496512881038,0.0,0.0,0.0,10/66,6.87%,MFNG;TGFB2;DLK2;EGFR;HEY1;ENHO;KAT2B;SRC;DTX1;TSPAN14
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.7409241973934464,1.9552775195928853,0.0,0.0,0.0,54/122,14.98%,EPHA3;RND2;ROBO2;PCDH8;OLFM3;SYT4;ATRNL1;CTNND2;SNAP25;SCRT1;RAB3C;NRXN1;DCLK1;SYNPR;PAK3;ST8SIA3;NOL4;CLVS2;PURG;SLITRK3;FAT3;VSTM2A;ADCYAP1R1;SULT4A1;GAD2;OPCML;HIVEP2;TMEM179;ASTN1;SLC35F1;CAMKV;CACNA1B;SCN3B;CELF4;PCLO;MAPK4;NDRG4;ATP2B3;CELF3;FUT9;KCNQ2;NCAN;GAP43;SOX5;BCL2;ROBO1;SRRM4;ATP1B2;ACTL6B;PTPN5;ZNF536;STMN2;NTRK3;PAK5
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.7687677798796454,-1.9506035623956375,0.0,0.001195099333457517,0.02,83/182,13.96%,RPL18A;RPLP1;RPS16;RPL23A;RPL29;RPL5;RPL19;RPS2;RPL11;RPL23;RPL13;RPL3;RPL10;RPL21;RPS6;RPL41;RPS7;RPL10A;RPL18;RPL12;RPS14;RPS15;RPL15;RPL27A;RPL35A;POP5;RPL32;SBDS;WDR74;RPS28;RPS27;RPL8;RPS25;RPL30;NOC2L;RPS19;RPL7A;RPS24;DCAF13;EXOSC8;RBIS;RIOK2;SURF6;BYSL;RPL7;RPL14;MPHOSPH10;RPL34;IMP3;RPL9;MRPL36;RAN;UTP3;RPL37;RPS9;RPL28;RPL27;RPL6;LTV1;METTL17;RPL35;NOP53;RPL36;RPLP0;NIP7;RPL13A;RRP36;NOP56;RPL24;RPL38;NOC4L;RPLP2;EXOSC5;NPM1;UBA52;DKC1;NOL6;DHX29;RPF2;RRP9;POP4;PELP1;RRP1B
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.7351070356788469,1.9459599669555103,0.0,0.0,0.0,52/103,16.89%,KCNC2;HTR5A;PCSK2;SLC4A10;NRXN1;SYNPR;ST8SIA3;UNC13C;CADPS;CACNG2;SLC24A4;HCN1;SLC1A2;FGF13;GABRA1;WSCD2;VSTM2A;XKR4;GAD2;RPH3A;UNC80;TNR;FAM135B;CDH22;PDE1B;KCNJ6;SCN3B;CNTNAP5;CELF4;ADCY2;SCN1A;CACNG3;CELF3;KCNB1;SEZ6L;ATP2B2;MYT1L;PKD2L1;CACNA1E;SRRM4;ATP1B2;ACTL6B;C4ORF50;SV2B;ZNF493;KCNT1;KCNH2;CACNB2;GRIA2;CCK;DLGAP2;RUNDC3A
prerank,PanglaoDB_Augmented_2021__Neurons,0.6954614099247598,1.9456187926484632,0.0,0.0,0.0,88/264,13.19%,NPY;AQP1;ZCCHC12;KCNMA1;PDE1A;OLFM3;SYT4;IGF1;HTR5A;PCSK2;GRM5;LUZP2;DGKB;SNAP25;SCRT1;RAB3C;NRXN1;CBARP;SYNPR;DLGAP1;ST8SIA3;NOL4;CADPS;GABRG2;NCALD;CACNG2;CDK5R2;RIT2;VSNL1;CLVS2;TMEM196;GABRA1;RGS7BP;GAD1;SCN2A;VSTM2A;ADCYAP1R1;SULT4A1;GAD2;OPCML;LRRTM1;ABAT;NEFM;TMEM179;NRGN;ASTN1;GNG2;CDH22;CLSTN3;PACSIN1;CA10;OGFOD1;SNCB;CACNA1B;ADAM12;SCN3B;FBLN2;STX1A;CELF4;PCLO;TESC;SH3GL2;NDRG4;ATP2B3;SCN1A;BRINP1;EML5;TMEM191C;CELF3;MIAT;KCNQ2;CACNA2D2;NCAN;C11ORF87;GAP43;NRSN2;PNMA8A;PSD2;DLG4;NECAB2;GABBR2;SRRM4;ATP1B2;RIN1;ACTL6B;TMEM59L;PTPN11;TMEM130
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.715613176484532,1.9379327072618617,0.0,0.0,0.0,65/135,18.37%,SCN9A;SHISA6;OLFM3;SYT4;GRM5;ADCY8;SNAP25;RAB3C;PLPPR4;MAP2;NRXN1;DCLK1;SYNPR;PRKX;ST8SIA3;ADD2;LRFN5;CLVS2;TMEM196;FGF13;SPHKAP;RGS7BP;SCN2A;VSTM2A;ADCYAP1R1;SULT4A1;OPCML;LRRTM1;NEFM;TMEM179;ASTN1;CA10;CADM3;CACNA1B;SCN3B;SH3GL2;MAPK4;NDRG4;ATP2B3;BRINP1;NCAN;C11ORF87;KCTD16;GAP43;ASIC2;PIEZO2;ACTL6B;PHF24;PTPN5;ZNF536;SCN7A;ZDHHC2;STMN2;PAK5;PRUNE2;CALCB;GRIA2;ELAVL4;NFASC;RUFY3;ASXL3;GDAP1L1;AQP4;FKBP1B;TCEAL6
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.7009699628335594,1.9196246382991509,0.0,0.0,0.0,51/118,14.98%,RND2;IGFBP3;PCDH8;ZCCHC12;KCNIP1;PLPPR5;RIMS4;DCX;BTBD17;KLHDC8A;CTNND2;SCRT1;ISG15;MAP2;DCLK1;GFAP;PROM1;EFNB3;CDK5R2;CLVS2;ADCYAP1R1;PTPRZ1;SULT4A1;OPCML;NYAP1;ASTN1;DLX1;SLC35F1;CAMKV;TMEM200C;MEIS3;SOX9;MAPK4;CELF3;KCNQ2;NCAN;GAP43;NKAIN1;HOPX;FABP7;MGAT5;SEMA5B;CSPG5;CNTFR;ACTL6B;TMEM59L;ZNF536;MEGF10;SRRM3;STMN2;PAK5
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.6888161542628775,1.919301222189149,0.0,0.0,0.0,70/187,15.20%,NPY;CHRM3;KCND2;GRIK2;GLRA3;NPTX2;HTR5A;PTCHD1;KCNQ3;GRM5;ZACN;SNAP25;GRIN2B;GRIK1;GABRA6;NRXN1;DLGAP1;UNC13C;KCNMB4;GRM1;SYN2;GABRG2;RIT2;SYT1;SLC1A2;GABRA1;GAD1;CHRNA5;CACNB1;GABRB2;PNOC;GAD2;GPR176;KCNIP2;GABRA4;GABRA2;NRGN;GRIA1;SNCB;NPTX1;GRIN1;CACNA1B;GLRB;HTR3B;CHRM5;KCNQ2;GABRR2;HTR2C;GABRB3;CAMKK1;DLG4;HOMER1;CACNA1E;AMPH;CHRM1;GABRG1;GLRA2;PCDHB13;GABBR2;ASIC2;PRKAR1B;NLGN4X;HTR1E;HCRTR2;RPS6KA3;GABRD;HRH2;CAMK4;CACNB2;DOC2A
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.7122026559455638,1.918599314671347,0.0,0.0,0.0,65/149,14.98%,NMNAT2;SHISA6;KCNIP1;OLFM3;CYB561;SYT4;ATRNL1;TAFA1;KALRN;SNAP25;SCRT1;PLPPR4;MAP2;CNTN1;CASZ1;NRXN1;DCLK1;ST8SIA3;CARTPT;CDK5R2;CLVS2;TOX;DMKN;TMEM196;EFNA5;RGS7BP;VSTM2A;ADCYAP1R1;SULT4A1;NTRK2;OPCML;LRRTM1;NEFM;TMEM179;ASTN1;CA10;SCN3A;CADM3;RIMBP2;CACNA1B;PCLO;MAPK4;NDRG4;ATP2B3;BRINP1;EML5;CELF3;NCAN;KCTD16;GAP43;FSTL5;CACNA1E;CNTFR;ASIC2;GOLGA7B;TTBK2;ACTL6B;TMEM59L;RGMB;ZNF536;SCN7A;CPE;ZDHHC2;STMN2;PAK5
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.751771399093904,1.9151486593960967,0.0,0.0007854468291125223,0.01,41/108,10.72%,ETV1;SHISA6;SYT4;FGF12;KALRN;CNTN3;PLCXD3;LMO3;SNAP25;PLPPR4;MAP2;CNTN1;NRXN1;FGF14;SORBS2;ST8SIA3;CARTPT;SYBU;NOL4;RAPGEF4;FAM149A;THSD7A;PDZRN4;TMEM196;CNTN4;RGS7BP;NTRK2;CADPS2;ADGRL2;PBX1;ABCC9;RIMBP2;SYT13;SERTM1;LIFR;PCLO;MAPK4;PTPRT;SYT7;MAOB;SPARCL1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.7373236804771829,1.903569853128915,0.0,0.0007363564022929897,0.01,68/130,14.98%,ADAMTS5;KCNMA1;TRNP1;NTNG1;OLFM3;SYT4;HTR5A;PCSK2;GRM5;SNAP25;SCRT1;RAB3C;NRXN1;SYNPR;PAK3;ST8SIA3;GRM1;CADPS;GABRG2;VWC2L;HCN1;CLVS2;TMEM196;SLC1A2;GABRA1;CNTN4;SPHKAP;SCN2A;VSTM2A;ADCYAP1R1;GAD2;OPCML;NEFM;TNR;FAM135B;PCDH15;GRIA1;ASTN1;CA10;STX3;GRM6;CACNA1B;SCN3B;CNTNAP5;CELF4;CACNA2D3;ATP2B3;SCN1A;CACNG3;CELF3;LIN7A;SEZ6L;C11ORF87;TRPM3;GNB3;AMPH;SRRM4;STRIP2;ATP1B2;ACTL6B;ATCAY;TMEM130;SV2B;PTPN5;ZNF536;STMN2;NTRK3;PAK5
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.7322769498257059,1.8960298589842774,0.0,0.0020791239594155,0.03,46/100,14.74%,KCNT2;SSTR1;KCNIP1;SYT4;PCSK2;DEPP1;CNTN3;SNAP25;GPC6;FAP;RAB3C;PLPPR4;FGF14;SORBS2;LDB2;RUNX1T1;ST8SIA3;NOL4;RAPGEF4;CADPS;KCNB2;TMEM196;TMEM47;CNTN4;RGS7BP;PTGER3;DDAH1;TMEM179;RIMBP2;RGS4;SYT13;SH3GL2;PTPRT;MAFB;SYT7;CELF3;FNDC4;DNALI1;TSPAN7;ACTL6B;FRZB;ABCC8;PCSK1;PDZRN3;CPE;STMN2
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.74549002650415,1.8896386028917531,0.0,0.0026181560970417414,0.04,50/114,13.04%,NPY;SHISA6;KCNIP1;SYT4;KALRN;SNAP25;AKAP12;RAB3C;PLPPR4;MAP2;CNTN1;NRXN1;DCLK1;SYNPR;ST8SIA3;RAPGEF4;CADPS;CLVS2;TMEM196;RGS7BP;VSTM2A;ADCYAP1R1;SULT4A1;OPCML;LRRTM1;SLC26A4;TMEM179;ASTN1;CDH22;CADM3;RIMBP2;RGS4;CACNA1B;STX1A;LIFR;PCLO;UNC5D;MAPK4;NDRG4;BRINP1;CELF3;PHYHIP;FAM171B;KCTD16;GAP43;P2RY1;DPYSL3;ASIC2;ACTL6B;LRP4
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.6935106524585237,1.8712736782583559,0.0,0.0024803584077237547,0.04,59/108,21.94%,ZNF423;SHISA6;KCNIP1;PLPPR4;MAP2;DCLK1;GFAP;RUNX1T1;EFNB3;CLVS2;TMEM47;PURG;FAT3;RGS7BP;ADCYAP1R1;PTPRZ1;NTRK2;OPCML;LRRC3B;ASTN1;SLC35F1;TMEM200C;CADM3;BOC;MAPK4;NDRG4;BRINP1;NCAN;C11ORF87;GAP43;SEMA5B;CNTFR;DPYSL3;LRP4;PTPN5;ZNF536;PDZRN3;CPE;MEGF10;STMN2;NOTCH3;GRIA2;NLGN1;NFASC;ASXL3;GUCY1A2;AQP4;GJA1;ADGRL3;LRCH2;ATP1A2;PAX6;DOK5;LY6H;NOVA1;CRMP1;SLC6A1;DKK3;LRRC4C
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.7381649062322209,1.8665127570210083,0.0,0.0035345107310063508,0.06,55/108,14.98%,MYT1;PCDH8;ZCCHC12;OLFM3;SYT4;RIMS4;ATRNL1;CTNND2;SNAP25;SCRT1;NRXN1;ST8SIA3;NOL4;GABRG2;CDK5R2;CLVS2;KCNB2;TMEM196;SCN2A;VSTM2A;ADCYAP1R1;SULT4A1;GAD2;LRRTM1;CADPS2;TMEM179;ASTN1;CDH22;CAMKV;SNCB;KCNJ6;HS6ST3;RIMBP2;CACNA1B;SYT13;CELF4;TENM1;MAPK4;NEUROD6;PRKCG;CELF3;KCNQ2;CACNA2D2;NCAN;GAP43;MAPT;CNTFR;ADCY1;ACTL6B;TMEM59L;PTPN5;ABCC8;PRR36;STMN2;PAK5
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.7360170907251723,1.8623561160821174,0.0,0.003927234145562611,0.06,51/111,14.09%,KCNT2;ZNF423;ANGPT1;ROBO2;OLFM3;SYT4;RNF150;PCSK2;ASB4;PCDH18;RAB3C;PLPPR4;NRXN1;FGF14;ZNF385D;PAK3;RUNX1T1;ST8SIA3;COL11A1;CADPS;PDGFRA;CLVS2;PDZRN4;TMEM196;CNTN4;GAD2;OPCML;NEFM;PRKG1;SULF1;GRIA1;ASTN1;SCN3A;RIMBP2;CELF4;UNC5D;PTPRN;MEST;CELF3;C11ORF87;KCTD16;GAP43;TRPM3;GNB3;AMPH;NREP;TMEM130;FRZB;ZNF536;PCSK1;PDZRN3
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.7594024032150529,1.8575146146976873,0.0,0.004819787360463205,0.06,18/54,8.99%,CSF2RA;SRGN;FGL2;PTPRC;TLR2;CSF1R;ADGRE2;CLEC5A;ITGAM;BIRC3;C3AR1;TNFRSF1B;LILRB1;CIITA;WDFY4;LY86;CYSLTR1;LAPTM5
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.729096645773753,1.8385151829260291,0.0,0.008195966912478495,0.12,46/97,14.98%,RND2;ZNF423;PCDH8;RIMS4;CTNND2;SCRT1;CACNG5;NOL4;EFNB3;CDK5R2;CLVS2;PURG;ADCYAP1R1;PTPRZ1;SULT4A1;OPCML;TMEM179;ASTN1;SLC35F1;CAMKV;TMEM200C;SNCB;SOX9;CACNA1B;PCLO;UNC5D;MAPK4;NDRG4;CELF3;KCNQ2;NCAN;GAP43;NKAIN1;HES1;SEMA5B;CSPG5;CNTFR;ATP1B2;TMEM59L;LRP4;ZNF536;CPE;MEGF10;SRRM3;WNK2;PAK5
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.6659512130760741,-1.8353008930278008,0.0,0.03402049435909065,0.38,93/332,9.70%,MSRB1;RPS12;CKAP4;RPL18A;RPS23;RPS18;RPS13;RPS3A;RPLP1;RPS16;RPS8;RPSA;RPL23A;RPS27A;RPL29;RPL5;TMEM208;RPS3;RPL19;RPS2;RPL11;RPL23;RPL13;RPL3;RPL10;RPL21;RPS21;RPS5;RPS6;RPL41;TGM1;EEF1A1;RPS7;RPL10A;RPL18;RPL12;RPS14;MRPL51;RPS15;RPL15;RPL27A;RPS11;RPL35A;RPL32;MRPL52;MRPL34;RPS28;UBL5;RPS27;MSRB2;RPL8;RPS15A;MRPL32;RPS25;RPL30;RPS19;RPL7A;VWA1;RPS24;LGALS1;RPS20;F5;RPL7;RPL14;MRPL24;TF;RPL34;MRPS7;RPL9;MRPL36;SARS1;B4GALT7;MRPS21;MRPS5;ARAF;MELTF;KNG1;RPL37;RPS9;RPL28;RPL27;RPL6;RPL35;FDXR;RPL36;HARS2;RPLP0;SPCS1;AFP;MRPL27;RPL13A;SEC11C;RPS4X
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.7721107858276749,-1.8236681940711803,0.0,0.03869134092068712,0.42,25/57,10.97%,RPS16;RPL5;RPL11;RPS6;RPS7;RPS15;RPL35A;WDR74;RPS28;RPS25;NOC2L;RPS19;RPS24;RBIS;RIOK2;SURF6;BYSL;RPL7;RPL14;MRPL36;LTV1;METTL17;NIP7;RRP36;RPL38
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.7116868430308693,1.8203510740853635,0.0,0.009818085363906529,0.14,50/98,13.57%,ZNF423;ROBO2;SHISA6;KCNIP1;DCX;SNAP25;RAB3C;CNTN1;NRXN1;DCLK1;PAK3;RUNX1T1;ST8SIA3;TMEM132B;CADPS;CLVS2;PURG;FAT3;ADCYAP1R1;SULT4A1;OPCML;LRRTM1;NEFM;TMEM179;GRIA1;ASTN1;SLC35F1;TMEM200C;CADM3;CACNA1B;SCN3B;UNC5D;SH3GL2;MAPK4;NDRG4;DENND2A;BRINP1;KCNQ2;NCAN;GAP43;TRPM3;GABRB3;PNMA2;NEFL;SEMA5B;SRRM4;ATP1B2;ACTL6B;ATCAY;PTPN5
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.7102187168103986,1.8055840186944196,0.0,0.01272423863162286,0.19,32/87,13.37%,CTF1;IFNA2;PDGFB;ANGPT1;BMP6;PTPRC;CD44;IGF1;PARP14;CSF1R;GRM5;IL12A;EPHA4;CSPG4;HGF;EFNA5;SRC;TNK2;RELN;PTPRJ;LRP8;CRLF1;SOCS3;TNFRSF1A;TEC;DLG4;HES1;PARP9;CD80;PTPN11;GHR;LYN
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.7198732315957437,-1.8024473289308875,0.0,0.05117837145629838,0.54,73/188,17.96%,LSM7;RPS3;RPS2;RPS5;RPS6;EEF1B2;EIF3D;RPL18;EIF2S2;CYC1;SF3A1;LSM2;PSMD7;DDX18;ERH;PCNA;CDK4;PSMD8;USP1;SNRPB2;PPM1G;TFDP1;RANBP1;SRSF7;RACK1;CCT7;CCT2;RPL14;PHB2;RPL34;RAN;VBP1;NDUFAB1;APEX1;RPL6;SRSF3;PRDX3;HSPE1;CSTF2;RPLP0;PSMD3;KPNA2;SNRPD1;PSMB3;H2AZ1;MRPL9;ILF2;DDX21;NOP56;SNRPD2;EIF3B;EIF4G2;MCM4;PPIA;NPM1;POLE3;PSMA7;RRP9;YWHAQ;RSL1D1;COPS5;EPRS1;IMPDH2;COX5A;NHP2;SNRPG;MRPS18B;EIF3J;TRIM28;TUFM;XRCC6;VDAC1;UBE2L3
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.6628053025494278,1.7946243568047549,0.0,0.016313126450798538,0.24,46/113,13.01%,RND2;MYT1;PCDH8;ZCCHC12;EGFR;NTNG1;PLPPR5;SYT4;RIMS4;DCX;BTBD17;GRM5;SCRT1;EPHA4;ELAVL2;NOL4;EFNB3;CDK5R2;CLVS2;PURG;CNR1;ADCYAP1R1;SULT4A1;NEFM;TMEM179;NYAP1;ASTN1;SLC35F1;PBX1;CAMKV;TMEM200C;CACNA1B;LRP8;UNC5D;MAPK4;CELF3;KCNQ2;NCAN;GAP43;NKAIN1;SEMA5B;CSPG5;CNTFR;ACTL6B;DAB1;TMEM59L
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.8718781722923795,-1.7875208284400346,0.0,0.0664608018217208,0.64,6/34,5.08%,CYP1A2;CYP2E1;CBR1;GPX4;PTGIS;DAGLA
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.793197637624825,-1.7805073207815467,0.0,0.07176885997236983,0.64,6/64,5.08%,CYP1A2;CYP2E1;GPX4;GSTP1;ACOT1;DAGLA
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.6198868799894608,1.7730294323868188,0.0,0.021381608125840886,0.29,80/240,14.59%,NPY;CHRM3;KCND2;GRIK2;GLRA3;NPTX2;SHISA6;CBLN2;HTR5A;PTCHD1;KCNQ3;GRM5;ZACN;SNAP25;GRIN2B;GRIK1;GABRA6;NRXN1;DLGAP1;UNC13C;KCNMB4;GRM1;SYN2;GABRG2;RIT2;SYT1;SLC1A2;GABRA1;GAD1;CHRNA5;CACNB1;GABRB2;PNOC;GAD2;FCHSD2;GPR176;KCNIP2;GABRA4;GABRA2;NRGN;GRIA1;DNAJC5;SNCB;SNPH;RIMBP2;NPTX1;GRIN1;CACNA1B;STX1A;GLRB;HTR3B;CHRM5;SYN3;LIN7A;KCNQ2;GABRR2;HTR2C;GABRB3;GRIK5;CAMKK1;DLG4;HOMER1;TBC1D24;CACNA1E;AMPH;CHRM1;GABRG1;GLRA2;PCDHB13;GABBR2;ASIC2;RAB3A;PRKAR1B;NLGN4X;HTR1E;HCRTR2;RPS6KA3;GABRD;HRH2;CAMK4
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.9034328236795193,-1.7720990769224332,0.0,0.08198381427518567,0.68,4/21,4.59%,CYP1A2;CYP2E1;GPX4;GSTP1
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.794224455981454,-1.7714579019912515,0.022222222222222223,0.07927492245268196,0.7,21/39,12.41%,RPS16;RPSA;RPS5;RPS6;RPS7;RPS14;RPS15;RPS28;RPS27;RPS25;RPS19;RPS24;TSR3;RIOK2;SURF6;MRPS7;LTV1;METTL17;RRP36;RPS27L;NPM1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.8769398256959973,1.7704031513757064,0.0,0.021459529438252845,0.31,3/13,2.20%,PTPRC;ITGA11;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.7685829047673597,1.768880252177819,0.0,0.02193834246831528,0.33,17/53,8.81%,TGFB2;PDGFB;NCKAP1L;P2RY12;IL12A;EPHA4;SYK;CITED2;PPP3CA;NPNT;ADGRG1;TPM1;PTPRJ;STX3;FBLN2;CHRD;VIT
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.6797616901150036,1.7673398834829916,0.0,0.022385234629706884,0.33,50/128,12.53%,ALDH1L1;CHL1;SHISA6;EGFR;KCNIP1;HTR5A;BTBD17;GRM5;ADCY8;GRIN2B;PLPPR4;NRXN1;GFAP;SYNPR;ST8SIA3;RAPGEF4;GRIN3A;CLVS2;SLC1A2;SPHKAP;RGS7BP;SCN2A;VSTM2A;ADCYAP1R1;PTPRZ1;NTRK2;OPCML;LRRC3B;TNR;GRIA1;ASTN1;SLC4A4;CA10;CADM3;ADCY2;SCN1A;VIM;ATP2B2;NCAN;C11ORF87;GAP43;TRPM3;HOPX;P2RY1;SPARCL1;PSD2;FABP7;GABRG1;CDC42EP4;ATP1B2
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.787499575455373,-1.766863619043154,0.0,0.07947410567492487,0.71,15/53,12.62%,CYP1A2;CYP2E1;CYP3A43;HSD11B1;HSD17B10;AKR1D1;TSPO;SLC22A24;DHCR24;FDXR;NPC1;LIPA;SRD5A1;CYP4V2;RDH16
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.6741953496980422,1.765593202071483,0.0,0.022423240121438138,0.34,37/95,14.74%,PCDH8;RIMS4;GRM5;PIANP;SCRT1;EFNB3;CDK5R2;CLVS2;GNG3;GAD1;SULT4A1;OPCML;TMEM179;NYAP1;ASTN1;CTXN1;CAMKV;SNCB;GRIN1;NDRG4;PRKCG;BRINP1;CELF3;KCNQ2;PHYHIP;NCAN;C11ORF87;GAP43;PSD2;CSPG5;ASIC2;ACTL6B;TMEM59L;CAMK2N2;PRR36;SRRM3;STMN2
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.7002176903966183,1.7644081361959554,0.0,0.021722513867643196,0.34,52/119,11.03%,NPY;ROBO2;NPTX2;SHISA6;KCNIP1;SYT4;PCSK2;FGF12;CTNND2;SNAP25;RAB3C;CNTN1;NRXN1;PAK3;ST8SIA3;NOL4;RAPGEF4;CADPS;CLVS2;KCNB2;TMEM196;EFNA5;WSCD2;CNTN4;VSTM2A;SULT4A1;GAD2;LRRTM1;TMEM179;ASTN1;CDH22;CA10;CAMK2B;PIR;RIMBP2;CACNA1B;SYT13;SCN3B;SERTM1;UBE2QL1;CELF4;UNC5D;SH3GL2;MAPK4;PTPRT;MAFB;CELF3;SEZ6L;IGSF21;HOPX;GABRB3;HAMP
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.8668610347102313,-1.7473275330337998,0.0,0.10511678050367639,0.8,1/21,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.738132290369104,-1.7453951464380597,0.0,0.10387405039968252,0.81,33/85,15.21%,MRPL58;MRPL51;MRPS10;MRPL52;MRPL34;MRPS26;MRPL32;MRPL54;MTRF1L;MRPS2;MRPL24;MRPS7;MRPL36;MRPL40;MRPS21;MRPS5;MRPS22;TRMT112;MRPL14;MRPL57;MRPL50;MRPL27;MRPL9;GADD45GIP1;MRPL47;AURKAIP1;MRPL4;MRPS34;MRPL15;CHCHD1;MRPL35;MRPL43;MRPS18A
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.7435305537954585,-1.7413324282187097,0.0,0.10708090027779353,0.84,32/79,15.21%,MRPL58;MRPL51;MRPS10;MRPL52;MRPL34;MRPS26;MRPL32;MRPL54;MTRF1L;MRPS2;MRPL24;MRPS7;MRPL36;MRPL40;MRPS21;MRPS5;MRPS22;MRPL14;MRPL57;MRPL50;MRPL27;MRPL9;GADD45GIP1;MRPL47;AURKAIP1;MRPL4;MRPS34;MRPL15;CHCHD1;MRPL35;MRPL43;MRPS18A
prerank,PanglaoDB_Augmented_2021__Microglia,0.6982207701394845,1.740843770696183,0.0,0.03498808602410327,0.54,31/81,12.40%,SLA;CX3CR1;SLCO2B1;FGL2;PTPRC;FOS;P2RY12;CSF1R;CYFIP1;C1QB;LCP2;ITGAM;OTULINL;CD53;CSF3R;C3AR1;MERTK;TNFRSF1B;LILRB1;WDFY4;LY86;SLC2A5;APBB1IP;CD4;P2RY13;LAPTM5;MAFB;AEBP1;GPR34;AOAH;SASH3
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.8115398674189666,-1.7247939661068048,0.0,0.13545991291151163,0.89,26/44,14.64%,RPSA;RPL23A;RPL5;RPL11;RPL3;RPL10;RPS5;RPS14;RPS15;SBDS;RPS28;RPS27;RPS19;MRPS2;MRPS7;RPL6;NOP53;RPLP0;MTERF3;RPL24;RPS27L;NPM1;DHX29;RPF2;RSL24D1;NLE1
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.7662748885629477,-1.7228953883041833,0.0,0.13416096591517535,0.9,31/51,18.07%,RPL23A;RPL5;RPL11;RPL3;RPL10;RPL10A;RPL35A;WDR74;NOC2L;RPL7A;SURF6;RPL7;RPL14;NSA2;RPL6;NOP53;RPLP0;NIP7;RPL24;NPM1;RPF2;RSL24D1;RSL1D1;NLE1;ZNF622;NHP2;BRIX1;EBNA1BP2;RPL26L1;MRPL20;TRAF7
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.7412858609529935,-1.720620985087382,0.0,0.13624132401415695,0.9,36/79,18.19%,MRPL58;MRPL51;MRPS10;MRPL52;MRPL34;MRPS26;MRPL32;MRPL54;MRPS2;MRPL24;MRPS7;MRPL36;MRPL40;MRPS21;MRPS5;MRPS22;MRPL14;MRPL57;MRPL50;MRPL27;MRPL9;GADD45GIP1;MRPL47;AURKAIP1;MRPL4;MRPS34;MRPL15;CHCHD1;MRPL35;MRPL43;MRPS18A;MRPS18B;TUFM;PTCD3;MRPL20;MRPS18C
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.7115178172658093,1.7186690704418421,0.0,0.055443305584413335,0.64,9/58,7.06%,CREB3L1;CLDN5;TGFB2;PPARG;ADAMTS9;STAB1;ADGRB1;SULF1;PTPRM
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.679606641846393,-1.7184791551365797,0.0,0.13500501435885603,0.91,77/233,18.64%,LSM7;SNRNP25;PRPF4;POLR2L;CRNKL1;POLR2G;ZMAT2;SF3A3;RBM22;SF3A1;PPIL1;LSM2;UBL5;DNAJC8;PPIE;POLR2K;GEMIN6;SF3B5;DDX5;CSTF2T;SNRPB2;SRSF7;PDCD7;POLR2I;GTF2F1;RNF113A;DDX41;SNRPC;RBM15B;SF3B6;SNRNP27;GPATCH1;FRG1;PNN;SRSF3;POLR2A;SRSF9;CSTF2;TFIP11;PHF5A;SNRPD1;HSPA8;PUF60;SNRPD2;SNIP1;SF3B4;PRPF6;RBM8A;POLR2E;SNRPB;PPWD1;PRPF3;IK;DDX46;SNRPE;SRSF8;PRPF8;DHX38;WBP4;MAGOHB;HNRNPH2;POLR2C;SF3A2;POLR2D;ALYREF;DHX8;SNRPG;GPKOW;PTBP1;YBX1;POLR2J;FIP1L1;SNRNP200;EFTUD2;DDX23;SLU7;BUD13
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.8271038394499783,1.717399117628077,0.0,0.056888791765721265,0.68,2/26,0.45%,ZNF366;KANK2
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.7488521240114729,-1.7155809489688463,0.0,0.13663969045864277,0.91,18/56,14.13%,ORC1;RPS27A;UBC;UBB;PSMB6;PSMD7;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PSME1;MCM4;UBA52;MCM3;PSMA7;PSMB8;PSMD13
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.760898584639072,1.7124325959980744,0.0,0.06087212925622048,0.7,12/35,16.07%,TGFB2;ROBO2;ENHO;KAT2B;SRC;TSPAN14;TP63;NOTCH4;ROBO1;ITGB1BP1;CCN3;JAG2
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.6362857768462169,1.710914269179903,0.0,0.06081905852452369,0.71,30/121,13.37%,NPY;ETV1;TGFB2;L1CAM;FRY;GPM6A;DCX;MEF2C;MAP2;CNTN4;LGI1;NTRK2;B4GALT6;PBX1;TENM3;STX3;PTPRM;TENM1;SH3GL2;GPRIN3;TENM2;CDK5R1;UNC5A;MYT1L;TBC1D24;MAPT;SRRM4;ACTL6B;ATCAY;LYN
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.6401386342124002,-1.7095878262676782,0.0,0.1446455709397614,0.92,69/180,18.73%,CYB5A;COX7C;NDUFB3;CYC1;NDUFS6;ATP6V1F;SLC25A4;ACAA2;HCCS;SURF1;MRPL34;GRPEL1;ATP6V1G1;GPX4;NDUFA2;ECHS1;TIMM10;SLC25A11;SLC25A5;ATP1B1;COX5B;NDUFA1;UQCRFS1;ATP5F1B;HSD17B10;PHB2;COX7B;TIMM8B;IDH3B;NDUFB4;SLC25A6;MPC1;NDUFS8;NDUFAB1;MRPS22;NDUFB2;ETFB;PDHB;PRDX3;ECH1;COX6A1;UQCRQ;CYB5R3;ATP5MC3;BAX;ATP6AP1;COX4I1;MRPL15;ATP6V0E1;MGST3;MRPL35;ATP5PF;HADHA;TIMM50;UQCR10;COX6B1;NQO2;COX5A;TIMM13;ATP5PB;LRPPRC;ATP5PD;NDUFA5;UQCRB;VDAC1;TIMM17A;NDUFA3;ISCU;ETFA
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.7338997601712618,-1.7081778676927788,0.0,0.14483110047338285,0.92,42/93,18.19%,MRPL58;EEF1B2;EEF1A1;MRPL51;MRPS10;MRPL52;ZNF598;MRPL34;MRPS26;MRPL32;MRPL54;RACK1;MRPS2;MRPL24;MRPS7;MRPL36;MRPL40;MRPS21;MRPS5;MRPS22;MRPL14;MRPL57;MRPL50;MRPL27;MRPL9;GADD45GIP1;MRPL47;MTRES1;AURKAIP1;MRPL4;MRPS34;MRPL15;CHCHD1;MRPL35;MRPL43;MRPS18A;EEFSEC;MRPS18B;TUFM;PTCD3;MRPL20;MRPS18C
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.8138246491264086,1.7077955031120917,0.0,0.06293909459599027,0.74,5/24,9.99%,NPY;TGFB2;RARB;EPHB3;EDNRB
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.7096190460116838,1.7070691918879084,0.0,0.06223155646045369,0.74,12/46,11.36%,NRCAM;GPM6A;DCX;MEF2C;FGF13;RELN;NTRK2;SPOCK1;ASTN1;KIAA0319;TUBB2A;CDK5R1
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.6337787621828104,1.7051815013088059,0.0,0.061853937792611134,0.74,65/125,13.57%,KCND2;OLFM3;SYT4;KCNC2;HTR5A;KCNQ3;GRM5;ADCY8;SNAP25;GRIN2B;SCRT1;RAB3C;MAP2;NRXN1;GFAP;SYNPR;ST8SIA3;GRM1;GABRG2;RIT2;SORCS3;CLVS2;KCNB2;TMEM196;GABRA1;SPHKAP;VSTM2A;ADCYAP1R1;GAD2;OPCML;LRRTM1;LRRC3B;OXTR;NRGN;GRIA1;ASTN1;CDH22;CA10;SNCB;CACNA1B;CELF4;ATP2B3;CACNG3;NEUROD6;EMX1;BRINP1;CELF3;KCNB1;KCNQ2;SEZ6L;NCAN;C11ORF87;GAP43;IGSF21;SATB2;PSD2;DLG4;KCNN4;GABRG1;SRRM4;ASIC2;ACTL6B;DAB1;PHF24;PTPN5
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.8072521577327231,-1.701064589688928,0.0,0.15387809296548452,0.93,5/28,4.75%,CYP1A2;CYB5A;DAO;GLYAT;PTGIS
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.9383005418750151,-1.6967274042148122,0.0,0.1616547598403271,0.93,1/12,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.6386477960097234,1.6967210348062938,0.0,0.06982813883207668,0.82,38/175,13.03%,ROR1;TGFB2;PDGFC;PDGFB;ANGPT1;PTPRC;EGFR;CD44;FLT1;JCAD;IGF1;TRIM5;CHI3L1;CSF1R;LRRK2;PDGFRA;DIRAS1;RIT2;PRKCZ;NTRK2;ADRA1A;NPNT;PTPRJ;ARRB2;BMPER;TENM1;TIRAP;NDRG4;CD4;LAPTM5;HTR2C;P2RY1;ROBO1;NECAB2;CX3CL1;MTURN;GSDME;PTPN11
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.7239361152597887,-1.6938828032872157,0.0,0.16396762855037134,0.93,40/94,19.20%,MRPL58;MRPL51;MRPS10;MRPL52;MRPL34;MRPS26;MRPL32;MRPL54;MTRF1L;MRPS2;MRPL24;MRPS7;MRPL36;MRPL40;MRPS21;MRPS5;MRPS22;MRPL14;MRPL57;MRPL50;MRPL27;MRPL9;GADD45GIP1;MRPL47;AURKAIP1;MRPL4;MRPS34;MRPL15;CHCHD1;MRPL35;MRPL43;MRPS18A;EARS2;MRPS18B;TUFM;PTCD3;MRPL20;MRPS18C;NOA1;MRPL22
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.7613121575543284,-1.6912974408185195,0.0,0.16568724370240187,0.94,11/48,7.61%,RPS27A;UBC;CENPX;RNF8;UBB;FAAP100;USP1;EME1;MUS81;DCLRE1B;RAD51AP1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.6580236453246592,-1.690148212894088,0.0,0.16460070819728395,0.94,83/276,18.64%,LSM7;SNRNP25;PRPF4;POLR2L;CRNKL1;KIN;POLR2G;ZMAT2;SF3A3;RBM22;SF3A1;PPIL1;LSM2;UBL5;DNAJC8;PPIE;POLR2K;GEMIN6;SF3B5;DDX5;CSTF2T;SNRPB2;SRSF7;PDCD7;POLR2I;GTF2F1;RNF113A;DDX41;SNRPC;PRPF18;RBM15B;SF3B6;SNRNP27;GPATCH1;FRG1;PNN;SRSF3;POLR2A;SRSF9;CSTF2;TFIP11;PHF5A;SNRPD1;HSPA8;PUF60;SNRPD2;SNIP1;SF3B4;PRPF6;RBM8A;AURKAIP1;POLR2E;SNRPB;PPWD1;PRPF3;IK;DDX46;SNRPE;SRSF8;PRPF8;DHX38;WBP4;MAGOHB;HNRNPH2;POLR2C;SF3A2;POLR2D;ALYREF;DHX8;SNRPG;PRKACA;GPKOW;PTBP1;GTF2H2;SUPT5H;YBX1;POLR2J;FIP1L1;SNRNP200;EFTUD2;DDX23;SLU7;BUD13
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.7173658149481045,-1.6896282549310662,0.0,0.16114971012200835,0.94,29/76,17.31%,SMIM20;NDUFB3;NDUFS6;SDHAF1;SURF1;DMAC2;NDUFA2;NDUFA12;NDUFA1;UQCRFS1;SAMM50;NDUFB4;NDUFS8;UQCC3;NDUFAB1;NDUFB2;NDUFAF8;NDUFS5;NDUFAF3;FOXRED1;NDUFB10;NDUFB11;NDUFV3;FASTKD3;NDUFAF4;TMEM126A;LYRM7;TMEM126B;NDUFA5
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.9537651866540153,-1.6873451344311918,0.0,0.16259479649552783,0.96,1/9,0.01%,CYP1A2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.7222893344037905,-1.6828397197579408,0.0,0.17066018481773346,0.96,23/60,18.56%,PSMB6;VAMP8;PSMD7;PSME2;PSMD8;HLA-C;PSMB4;PSMD3;PSMB3;HLA-B;CHUK;PSME1;B2M;PSMA7;PSMB8;PSMD13;PSMD2;VAMP3;CALR;PDIA3;PSMC5;IKBKG;CYBA
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.7084381988617332,1.6824119464013716,0.0,0.08976535189857397,0.92,23/55,13.48%,BEGAIN;NPTX2;SHISA6;GRIN2B;MEF2C;CAPN1;CACNG5;DLGAP1;CACNG2;RELN;GRIA1;NETO1;CAMK2B;SHISA9;NPTX1;GRIN1;CACNG8;CACNG3;DAPK1;DLG4;NEFL;DLGAP3;SHANK1
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.8515877466837263,1.6794207348316945,0.041666666666666664,0.09644556413288646,0.95,4/13,8.60%,SLC2A12;SLC23A1;SLC2A9;SLC5A9
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.7789677908504912,1.6789900649350746,0.02127659574468085,0.09505691738691321,0.95,6/31,9.36%,CREB3L1;SORBS1;ADGRB1;GRIN1;VIM;TGFB3
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.9615602584312909,-1.6786678252159049,0.0,0.17690385011594317,0.97,1/12,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.8462787470135943,1.6735261118285638,0.0,0.10289353461374041,0.96,4/13,5.71%,NPY;MAP2;NTRK2;B4GALT6
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6839664146598747,1.6726861500569197,0.0,0.10373020623605593,0.96,36/88,14.82%,KCND2;AQP1;KCNMA1;KCNH7;SLC9C2;KCNC2;KCNQ3;KCNQ5;KCNJ3;KCNJ4;KCNMB4;SLC24A4;HCN1;KCNB2;KCNV1;SLC24A3;KCNK6;KCNIP2;ABCC9;KCNJ6;KCNH5;KCNS1;KCNB1;KCNK10;KCNQ2;SLC9A9;SLC9A7;KCNC3;KCNMB3;PKD2L1;KCNN4;KCNH3;ABCC8;KCNMB2;NALCN;KCNH2
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.7823239512976107,1.6708958100236797,0.018518518518518517,0.10402992577075429,0.96,11/26,14.34%,NPY;CHRM3;SSTR1;HTR5A;NPY1R;CNR1;CHRM5;HTR2C;CHRM1;HTR1E;HRH2
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.9413070477212125,1.6703825101146037,0.0,0.1028444441869209,0.96,1/9,0.33%,TGFB2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.7340685882745396,1.667384202561457,0.0,0.1062757648370617,0.96,20/47,15.92%,DPP10;KCNIP4;KCNMA1;KCNIP1;KCNJ3;NEDD4L;KCNJ4;KCNMB4;KCNIP2;GNG2;KCNJ6;KCNMB3;KCNN4;GABBR2;GABBR1;KCNIP3;KCNMB2;KCNH2;FHL1;BIN1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.6581646240912152,-1.6642679254748194,0.0,0.2125284981331951,0.98,82/256,18.98%,LSM7;SNRNP25;PRPF4;POLR2L;CRNKL1;POLR2G;ZMAT2;SF3A3;RBM22;SF3A1;PPIL1;LSM2;UBL5;DNAJC8;PPIE;POLR2K;GEMIN6;SF3B5;DDX5;CSTF2T;SNRPB2;SRSF7;PDCD7;POLR2I;GTF2F1;RNF113A;DDX41;SNRPC;SNUPN;RBM15B;SF3B6;SCNM1;SNRNP27;GPATCH1;FRG1;PNN;SRSF3;POLR2A;SRSF9;SMN1;CSTF2;TFIP11;PHF5A;SNRPD1;HSPA8;PUF60;SNRPD2;SNIP1;SF3B4;PRPF6;RBM8A;POLR2E;SNRPB;PPWD1;PRPF3;IK;DDX46;SNRPE;SRSF8;PRPF8;DHX38;WBP4;MAGOHB;HNRNPH2;POLR2C;SF3A2;POLR2D;ALYREF;DHX8;SNRPG;GPKOW;PTBP1;YBX1;POLR2J;FIP1L1;SNRNP200;EFTUD2;DDX23;SLU7;BUD13;SRPK3;WBP11
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.803758028856589,1.6634116949513587,0.0,0.1076847602713268,0.98,7/22,11.80%,TGFB2;ROBO2;HEY1;CITED2;ROBO1;BMPR2;HES1
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.9419715399377153,-1.663255661236602,0.0,0.21069879178933573,0.98,2/11,2.23%,CYP1A2;CYP2E1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.7163437203573698,1.662456193337347,0.0,0.10742140456980086,0.98,10/34,11.18%,BMP6;IGF1;MEF2C;HGF;BMPR1B;NELL1;NPNT;TP63;PRKD1;BMPR2
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.6554542705691018,1.6609783245081233,0.0,0.10898074753936246,0.98,31/76,13.01%,RND2;MYT1;PCDH8;ZCCHC12;PLPPR5;SYT4;RIMS4;BTBD17;MEX3A;OGDHL;EFNB3;CDK5R2;CLVS2;KCNB2;PURG;SULT4A1;NEFM;TMEM179;NYAP1;ASTN1;CAMKV;CACNA1B;CELF3;KCNQ2;NCAN;GAP43;NKAIN1;CSPG5;CNTFR;ACTL6B;TMEM59L
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.9553614428807656,-1.6586298848779957,0.0,0.22226131467461047,0.98,2/8,2.23%,CYP1A2;CYP2E1
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),0.9668672786504658,1.6542740881270281,0.0,0.11826161691165903,0.99,1/5,0.21%,LPL
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.7201776281980574,-1.6523462945289071,0.0,0.23721393880983424,0.99,23/62,18.56%,PSMB6;VAMP8;PSMD7;PSME2;PSMD8;HLA-C;PSMB4;PSMD3;PSMB3;HLA-B;CHUK;PSME1;B2M;PSMA7;PSMB8;PSMD13;PSMD2;VAMP3;CALR;PDIA3;PSMC5;IKBKG;CYBA
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.7043324912122507,1.6490783239466975,0.0,0.1287260081045523,1.0,11/35,17.66%,L1CAM;NRCAM;TRIM46;MAP2;TWF2;KIAA0319;MAPT;OLFM1;DIP2B;SEMA7A;RUFY3
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.7968599824208378,1.6471109765643341,0.0,0.13002715234671847,1.0,7/26,11.80%,TGFB2;ROBO2;HEY1;CITED2;ROBO1;BMPR2;HES1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.5973665605644689,1.6434941471378461,0.0,0.13633112819595924,1.0,46/146,22.23%,PDGFB;RPS6KA6;HIPK4;STK32B;CAMK1D;LRRK2;PRKX;PRKCZ;HIPK3;CAMKV;MAPKAPK3;PLK1;PRKCG;MAPK12;CAMK2D;DYRK2;PRKD1;MKNK1;CSNK1D;CDK5R1;DMPK;TTBK2;AKT3;DYRK3;RPS6KA3;CDC7;CAMK4;VRK3;PRKCE;GAS6;PRKCD;STK38;DYRK1B;CSNK2A1;STK38L;PRKCQ;TNKS;MKNK2;PAK2;MAPKAPK5;ULK1;VRK1;RPS6KA4;MASTL;MAST1;SGK1
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.7783716923648019,1.642229214061138,0.0,0.13641971242480652,1.0,12/31,12.53%,GRIN2B;GABRA6;MEF2C;LRRK2;GABRG2;GABRA1;GABRA4;GABRA2;ARRB2;GRIN1;GABRG1;INSYN2A
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.8440475653223857,1.6414445080569864,0.0,0.1367083748257054,1.0,4/19,6.75%,TGFB2;PKP2;NRG1;TPM1
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),-0.9642887850250785,-1.6411447830026493,0.0,0.26606548421605286,1.0,1/5,0.24%,BMP5
prerank,PanglaoDB_Augmented_2021__Macrophages,0.621127804332143,1.6395672274348014,0.0,0.13998260013759614,1.0,34/100,12.89%,NCEH1;SLA;CX3CR1;SLCO2B1;PPARG;FGL2;PTPRC;TLR2;STAB1;PARP14;CSF1R;MRC1;CLEC5A;NR4A3;LCP2;ITGAM;CD53;SYK;CSF3R;C3AR1;TNFRSF1B;LILRB1;WDFY4;LY86;MARCHF1;LAPTM5;RGS1;CD200;GPR34;LYVE1;AOAH;SASH3;LGALS3;CD80
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.7636973586664151,-1.6394304149633885,0.018518518518518517,0.2662783025524919,1.0,6/34,4.39%,RPL5;RPL11;RPL23;RPS7;UBXN1;PDCL3
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.87831976040294,1.6391699482781361,0.02702702702702703,0.1380422802165258,1.0,4/12,6.49%,SLC8A1;MYH11;ADRA1A;SMTN
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.9419242239885717,-1.6353240293239475,0.0,0.27362795155621067,1.0,2/12,2.23%,CYP1A2;CYP2E1
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.9543802327819123,1.6334878251527511,0.0,0.15065127705928708,1.0,1/10,0.01%,MFNG
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.6718972134572576,1.633373446682647,0.0,0.14860147266919171,1.0,19/59,17.71%,TGFB2;BMP6;RAB27B;IGF1;CADPS;CADPS2;FRMD4A;STX1A;TGFB3;KCNB1;PLA2G10;RAB3A;SYTL4;BAIAP3;GPER1;NMB;EXPH5;ACHE;EDN1
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.9624403883847323,-1.632356832289448,0.0,0.2798239725052672,1.0,1/7,0.01%,CYP1A2
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.5945964432971518,1.6315281293969564,0.0,0.1507309867296888,1.0,57/147,13.01%,DPP10;PCDH8;ZCCHC12;OLFM3;PLPPR5;SYT4;FGF12;PIANP;KLHDC8A;SNAP25;SCRT1;GALNT14;ST8SIA3;CDK5R2;NELL1;CLVS2;GRIP1;TMEM196;PURG;SYT16;ADCYAP1R1;SULT4A1;OPCML;LRRTM1;NEFM;DTX1;TMEM179;GALNTL6;NYAP1;ASTN1;SLC35F1;CA10;CAMKV;SNCB;CACNA1B;NKAIN3;SH3GL2;MAPK4;NDRG4;ATP2B3;BRINP1;CELF3;KCNQ2;NCAN;C11ORF87;GAP43;CPNE5;PSD2;CCDC184;EFNA3;MTUS2;NEFL;CNTFR;ASIC2;ACTL6B;BBC3;TMEM59L
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.9074077143991555,1.6296175252291873,0.0,0.1537143989786616,1.0,2/11,0.95%,LPL;PPARG
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.6431359849171927,1.6285314558496338,0.0,0.15279961775581302,1.0,47/111,14.98%,NPY;KCNIP1;OLFM3;SYT4;PCSK2;CTNND2;SNAP25;SCRT1;RAB3C;NRXN1;ST8SIA3;NOL4;CADPS;CDK5R2;CLVS2;KCNB2;TMEM196;VSTM2A;SULT4A1;GAD2;OPCML;LRRTM1;TMEM179;ASTN1;CDH22;CA10;SCN3A;RIMBP2;CACNA1B;SYT13;CELF4;UNC5D;SH3GL2;PTPRN;PTPRT;CELF3;NCAN;GAP43;ASIC2;ACTL6B;TMEM59L;ABCC8;PCSK1;CPE;VEGFA;STMN2;PAK5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.9050126058032578,1.6278219873112645,0.0,0.15351915296290208,1.0,3/14,3.82%,TP73;MEF2C;PIM1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.74068402084582,-1.6278199751899718,0.0,0.2926320227904076,1.0,24/54,14.46%,COX7C;NDUFB3;CYC1;NDUFS6;NDUFA2;NDUFA12;COX5B;NDUFA1;UQCRFS1;COX7B;NDUFB4;NDUFS8;UQCC3;NDUFAB1;NDUFB2;COX6A1;NDUFS5;UQCRQ;NDUFB10;COX4I1;NDUFB11;NDUFV3;UQCR10;COX6B1
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.7407878148853797,-1.626631368916839,0.0,0.2926353034552445,1.0,24/53,14.46%,COX7C;NDUFB3;CYC1;NDUFS6;NDUFA2;NDUFA12;COX5B;NDUFA1;UQCRFS1;COX7B;NDUFB4;NDUFS8;UQCC3;NDUFAB1;NDUFB2;COX6A1;NDUFS5;UQCRQ;NDUFB10;COX4I1;NDUFB11;NDUFV3;UQCR10;COX6B1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.9374214065200601,-1.6258064775443886,0.0,0.29038615535068707,1.0,4/9,1.96%,RPL5;RPL11;RPL23;RPS7
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.7605364432230604,-1.624658467819687,0.021739130434782608,0.28901109730047164,1.0,10/35,7.22%,RPS16;RPS8;RPS14;TSR1;RPS28;RPS19;TSR3;DCAF13;RIOK2;UTP3
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.68109651677532,-1.6239289913018118,0.0,0.28660252533842306,1.0,18/71,14.13%,RPS27A;UBC;UBB;ANAPC15;PSMB6;PSMD7;PSME2;PSMD8;CDC23;CDC26;PSMB4;PSMD3;PSMB3;PSME1;UBA52;PSMA7;PSMB8;PSMD13
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),0.6081496741250365,1.623482323336308,0.0,0.16230613953825182,1.0,43/158,15.77%,ROR1;PDGFC;PDGFB;ANGPT1;PTPRC;EGFR;CD44;RPS6KA6;CHI3L1;CSF1R;LMO3;SPRED3;PTPRR;PDGFRA;SYK;PRKCZ;PTPN6;NTRK2;ADRA1A;NPNT;FBLN1;EPHB1;ARRB2;BMPER;TIRAP;DUSP10;NDRG4;CD4;SEMA6A;HTR2C;P2RY1;NECAB2;CX3CL1;MTURN;PTPN11;LYN;TNFAIP8L3;ITGB1BP1;NTRK3;WNK2;TIMP3;GPER1;DUSP6
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.9364729860403587,1.6216515964424778,0.0,0.16684969774309388,1.0,1/8,0.95%,PPARG
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.7054864312645236,1.6211874297417719,0.0,0.1654560820456596,1.0,13/42,10.10%,IL1RAPL2;ROBO2;TLR2;GPC6;MEF2C;NRXN1;LRFN5;SLITRK3;CLSTN3;EPHB1;EPHB3;IL1RAP;SLIT1
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.7281617876545777,1.620828859433784,0.0,0.16393397390477074,1.0,8/22,17.81%,CHI3L1;BASP1;LOXL3;VEGFA;DNAAF1;FGF9;DISP1;CHD7
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.8400863942453678,-1.6201077599030074,0.0,0.295080889970056,1.0,2/16,3.34%,SMIM20;SURF1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.7990482566441051,1.618930006863111,0.0,0.16560759199738675,1.0,3/22,2.05%,DLK2;EGFR;HEY1
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.7810055817010695,1.6169119753091117,0.018867924528301886,0.1691983377713225,1.0,7/21,9.76%,SYT4;RIMS2;SYT1;SCIN;SYT13;SYT7;ARHGAP17
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.7551959351170292,1.6151368500193715,0.0,0.17043120237181308,1.0,6/25,11.81%,TRIM5;BIRC3;SAMHD1;LRP8;TIRAP;CX3CL1
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.6502308890591201,1.6143974977088111,0.0,0.16972019996634097,1.0,41/97,15.46%,SLCO2B1;CHL1;SSTR1;SHISA6;P2RY12;CHI3L1;CSF1R;GRM5;C1QB;SLC8A1;LRRK2;NRXN1;GFAP;PID1;SYNPR;TMIGD3;SLC1A2;RGS7BP;NTRK2;OPCML;CA10;CADM3;PTPRT;SEZ6L;EDNRB;TMEM176B;MAOB;IGSF21;SPARCL1;TGFA;MTURN;LYVE1;TNS1;RASSF4;PHF24;PDK4;PLXDC2;SLC6A7;A2M;SCN4B;IL33
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.9026297365264574,1.6136175842929728,0.025,0.16997069381994984,1.0,1/9,0.95%,PPARG
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7804125900844538,1.611895523881168,0.0,0.17424517814259377,1.0,17/40,11.37%,GRM5;GRIK1;MEF2C;LRRK2;NRXN1;CACNG5;GRM1;CACNG2;SYT1;RELN;TSHZ3;GRM6;GRM2;CACNG8;CACNG3;DGKI;HOMER1
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.850786843994196,1.6054515950433361,0.0,0.18957830284488605,1.0,4/14,9.36%,CREB3L1;VSIR;VIM;TGFB3
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.7563716877361654,1.6036738856556676,0.0,0.19213237819829393,1.0,16/40,14.16%,CHRM3;HTR5A;NPY1R;P2RY12;ADCY8;AKAP12;GNAL;ADCY2;CHRM5;ADCY7;RGS1;CHRM1;ADCY1;GABBR1;HTR1E;GRM8
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.8274052204959911,1.6035018875555613,0.0,0.1898494582519445,1.0,5/21,6.75%,TGFB2;PKP2;HEY1;MEF2C;TPM1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.7008473526083777,-1.6033635208939994,0.0,0.3573347007037976,1.0,16/47,17.32%,PSMB6;PSMD7;PSME2;PSMD8;BCKDK;PSMB4;PSMD3;PSMB3;PSME1;NQO1;BHMT;PSMA7;PSMB8;PSMD13;PSMD2;PSMC5
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.8438840750359152,-1.6011430819250234,0.03571428571428571,0.36075226546438666,1.0,3/18,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.8630745772790904,-1.6008469330810422,0.0,0.3552535794507078,1.0,1/10,0.21%,TYRP1
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.6136241295011569,1.6006734965105642,0.0,0.1941035476444321,1.0,47/120,14.74%,KCNIP1;CHST1;VCAN;CTNND2;ADCY8;SNAP25;SCRT1;PLPPR4;MAP2;DCLK1;GFAP;CSPG4;ST8SIA3;PDGFRA;CLVS2;ADCYAP1R1;OPCML;LRRTM1;LRRC3B;TMEM179;TNR;PCDH15;NYAP1;ASTN1;SLC35F1;CA10;SNCB;CADM3;MAPK4;NDRG4;BRINP1;ATP2B2;PHYHIP;NCAN;C11ORF87;GAP43;IGSF21;PSD2;CSPG5;CNTFR;ATP1B2;TMEM59L;KCNIP3;PTPN5;ZNF536;MEGF10;STMN2
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.8300180815509557,-1.5995249127840898,0.0784313725490196,0.3549039901950704,1.0,8/13,13.71%,TRMT10C;RPP25;RPP40;POP5;HSD17B10;RPP25L;POP7;POP4
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.6604775656186469,-1.5987664062469384,0.0,0.35331119961449065,1.0,43/134,18.37%,DAD1;ZNF707;POLR2G;SF3A3;POLR3GL;EDF1;NT5C;SURF1;BCAM;PCNA;GPX4;ADRM1;EIF1B;POLR2K;POLD3;POLR2I;GTF2F1;MPG;MRPL40;PRIM1;VPS28;POLR2A;GMPR2;POLD4;NME3;TAF13;TMED2;POLE4;MPC2;POLR2E;RAE1;ITPA;NELFE;IMPDH2;ERCC8;POLR2C;POLR2D;ALYREF;SNAPC5;NELFCD;SUPT5H;POLR2J;TYMS
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.9062335268844955,1.5963117921526746,0.0,0.20508889426826973,1.0,1/9,0.33%,TGFB2
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.6038366002535842,1.59624358251215,0.0,0.20273148948983577,1.0,37/147,13.64%,ROR1;EPHA3;NTNG1;PLPPR5;CAMK1D;EPHA4;LRRK2;ZNF804A;PAK3;RIT2;TOX;TWF2;RELN;NTRK2;SIPA1L1;SPOCK1;WNT5A;CAMK2B;TENM3;RTN4RL2;CSMD3;NDRG4;EPHB3;KNDC1;FUT9;PRKD1;CDK5R1;CX3CL1;TRPV4;DPYSL3;ATP1B2;SERPINI1;RAB29;KANK1;PTPRO;LYN;FES
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.7917597144135226,-1.595562476816637,0.0,0.3599991844636373,1.0,9/29,7.22%,RPS16;RPS8;RPS21;RPP40;RPS14;TSR1;RPS19;DCAF13;UTP3
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.7084029338908181,-1.5931584120338005,0.0,0.3632330941882815,1.0,14/44,17.32%,PSMB6;PSMD7;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PSME1;NQO1;PSMA7;PSMB8;PSMD13;PSMD2;PSMC5
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.7874501890405793,-1.5914338768554839,0.0,0.36384135263039963,1.0,12/25,16.06%,RPL10A;FTSJ3;NIFK;DDX18;RPL7L1;RPL7A;RPL7;NSA2;RPL35;RPF2;RSL1D1;NHP2
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.8338775398572644,1.5914209262601378,0.01818181818181818,0.21519350474721394,1.0,7/13,11.18%,TGFB2;ROBO2;HEY1;TNFRSF1B;TNFRSF1A;ROBO1;BMPR2
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.7524499252908011,1.5911510243507705,0.018518518518518517,0.2131927107591132,1.0,1/18,0.21%,LPL
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.5840859217064166,1.5900978209191636,0.0,0.21456559261167962,1.0,47/127,17.02%,ADAMTS5;AQP1;PLSCR4;ANGPT1;FSTL1;PPP1R3C;MFAP5;POSTN;SYNPO2;PCDH18;MYH11;LOX;LDB2;PDGFRA;OBSCN;KAT2B;TMEM47;CCDC80;COL12A1;PRKG1;SULF1;LMO7;SMTN;MAP3K7CL;TPM1;IRAG1;FBLN2;COL4A1;FBLN5;COL15A1;PAMR1;LAMB2;MYLK4;DMPK;PRRX1;TNS1;COL5A1;SYNPO;DAAM2;TIMP3;OGN;THY1;NOTCH3;VASN;C1R;ELN;PCP4L1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.5993353471071525,1.589739952908628,0.0,0.2124816334802655,1.0,19/123,8.99%,ROR1;PDGFB;PTPRC;EGFR;FLT1;JCAD;IGF1;TRIM5;PAK3;RIT2;SYK;PRDM15;PTPN6;NTRK2;ADRA1A;EPHB1;PTPRJ;CD4;LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.799009215747411,1.5890886117084582,0.02,0.2122060657274694,1.0,8/21,13.67%,PDGFB;FLT1;P2RY12;PDGFRA;IRS1;PRKD1;AMBRA1;TNFAIP8L3
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.767599663520809,-1.5885215069674623,0.015625,0.37318844029919496,1.0,5/21,5.89%,TINF2;PARP2;MBD4;MPG;PARP1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.6949224368074514,-1.5882930503075061,0.020833333333333332,0.36796189169977367,1.0,9/59,7.65%,CYP1A2;CYP2E1;DEGS1;ACSM6;DECR2;GPX4;ABHD1;ELOVL1;NDUFAB1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.7645064578193221,-1.5871642380020092,0.0,0.367837088785697,1.0,4/20,1.96%,RPL5;RPL11;RPL23;RPS7
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.7598455488560251,1.5865706632031011,0.02564102564102564,0.21970197384778112,1.0,7/25,11.54%,NPY;MAP2;TOX;NTRK2;SPOCK1;KNDC1;MAPT
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.8436990417458615,1.5863139902066208,0.0,0.21776292706012912,1.0,3/11,9.36%,BMP6;KIAA0319;TGFB3
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.7921414992719933,-1.5862786155278263,0.0392156862745098,0.366217677839049,1.0,8/33,6.51%,RPS27A;UBC;UBB;ANAPC15;MAD2L1BP;PHB2;CDC23;CDC26
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.5975020396094044,1.5853450561915539,0.0,0.21887784971268953,1.0,32/133,11.81%,TGFB2;CTF1;CX3CR1;NRCAM;GPM6A;DCX;TAFA1;HEY1;BHLHE40;MEF2C;MET;FGF13;RELN;NTRK2;SPOCK1;WNT5A;ASTN1;WNT8B;SNPH;KIAA0319;FZD3;NEUROD6;EMX1;FUT9;ATP2B2;TUBB2A;CDK5R1;ANOS1;MYT1L;MAPT;HES1;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.8905500675473279,-1.584192948470387,0.02,0.36421085194122704,1.0,1/7,0.21%,TYRP1
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.8905500675473279,-1.584192948470387,0.02,0.36421085194122704,1.0,1/7,0.21%,TYRP1
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),0.9450758123052796,1.5840846262332369,0.0,0.22113349188860246,1.0,1/5,4.09%,ITGAM
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.6455877121472491,1.5835407365166012,0.0,0.22001048680684457,1.0,21/93,11.54%,ROR1;EPHA3;PTPRC;EGFR;FLT1;CSF1R;EPHA4;LCP2;MET;PDGFRA;RELN;NTRK2;EPHA6;MERTK;EPHB1;AXL;CD4;EPHB3;CAMKK1;SPDYA;MAPT
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.8325248635302995,1.5831654054513318,0.04,0.21878494739956875,1.0,1/11,0.10%,CD59
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.7873347498528337,1.5831221318694515,0.0,0.21658278521911253,1.0,4/25,1.83%,TGFB2;PDGFB;PPARG;FOS
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.7678027932340709,1.5818647797072236,0.019230769230769232,0.21876761156123514,1.0,6/24,7.17%,CHRM3;KCNJ3;NEDD4L;KCNJ4;ANO6;KCNJ6
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.7750003459195687,1.5807838114807584,0.020833333333333332,0.2196796600174086,1.0,8/25,12.13%,CSGALNACT1;VCAN;CHST15;CSPG4;CHST3;NCAN;CHST11;CSPG5
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.8757973382099182,1.580582856277639,0.0,0.21753638210420528,1.0,2/12,2.05%,TGFB2;HEY1
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.6207826465163806,1.5804660297435535,0.0,0.21555706601001315,1.0,32/74,16.25%,SHISA6;FGF12;GRIN2B;MEF2C;CAPN1;FGF14;CACNG5;CACNG2;FGF13;CACNB1;RELN;GRIA1;NETO1;CAMK2B;SHISA9;GRIN1;DMD;NOS1;CACNG8;CACNG3;KCNS1;DAPK1;CAMK2D;DLG4;HOMER1;NEFL;SHANK1;JPH4;ANK3;CACNB2;GRIA2;NLGN1
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.8653561583750102,1.5804370300376422,0.02040816326530612,0.21337972190890186,1.0,7/11,11.89%,GABRA6;GABRG2;GABRA1;GABRB2;GABRA4;GABRA2;GABRG1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.8330462852149558,-1.579696696943531,0.01818181818181818,0.3784879589059957,1.0,3/10,8.14%,BUD23;RIOK2;TRMT112
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.644195620186306,1.5794125848181968,0.0,0.21525170351828674,1.0,14/80,5.66%,ROR1;TGFB2;PDGFC;PDGFB;EGFR;FLT1;IGF1;PIK3AP1;HGF;PDGFRA;PIP5K1B;SRC;PTPN6;NTRK2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.68366432811917,-1.5786861450274816,0.0,0.3773989035979013,1.0,45/123,16.31%,RPSA;RPL23A;RPL5;RPL11;RPL3;RPL10;RPS5;EIF2S2;CRNKL1;RPS14;RPS15;RPS28;RPS27;EIF2S3B;RPS19;EIF5;GEMIN6;SNRPC;MRPS7;PRPF18;SNUPN;RPL6;SRSF9;NOP53;SMN1;RPLP0;SNRPD1;RPL24;RPL38;PUF60;SNRPD2;RPS27L;PRPF6;ABT1;SNRPB;DHX29;KHDC4;RPF2;SNRPE;RSL24D1;NLE1;EIF4B;SF3A2;POLR2D;SNRPG
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.7062977737468455,1.5780704372204817,0.017543859649122806,0.217553218261612,1.0,10/38,8.19%,LPL;CDS1;PPARG;LMO3;PIM1;ID2;VSTM2A;FNDC5;ZFP36;ZBTB16
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.8464692615689859,1.5760796211256738,0.0,0.22015612592477465,1.0,2/15,4.28%,TGFB2;BMPR1B
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.8826579420372468,1.575592857114945,0.0196078431372549,0.21939131333560455,1.0,3/10,7.34%,TGFB2;HEY1;SOX9
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.7464927143511596,1.5746423486264498,0.0,0.22090692068789688,1.0,11/24,16.25%,SHISA6;MEF2C;CACNG5;CACNG2;RELN;SHISA9;CACNG8;CACNG3;SHANK1;ADRB2;NLGN1
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.9531053859086045,1.5746038439073768,0.021739130434782608,0.2189152519426473,1.0,2/5,0.33%,CD59;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.8755356504698038,1.5744665907416167,0.0,0.21751690253394426,1.0,4/11,4.71%,TGFB2;NCKAP1L;P2RY12;SYK
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.6246380548536827,1.5735809740822702,0.0,0.21779633102587417,1.0,46/106,10.87%,DACT2;ETV1;BCHE;KCNT2;SSTR1;NPTX2;SHISA6;KCNIP1;SYT4;PCSK2;KALRN;PPP1R1A;SNAP25;RAB3C;PLPPR4;CNTN1;NRXN1;SORBS2;ST8SIA3;NOL4;RAPGEF4;CADPS;FAM149A;GABRG2;SORBS1;KCNB2;TMEM196;CNTN4;RGS7BP;VSTM2A;GAD2;LRRTM1;TMEM179;ASTN1;CDH22;RIMBP2;SYT13;UNC5D;MAPK4;PTPRT;SYT7;CELF3;MAOB;IGSF21;SPARCL1;GABRB3
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.5918001414151927,1.5735204622087666,0.0,0.21599787800594367,1.0,45/122,14.18%,SCN9A;AQP1;KCNMA1;SLC23A1;KCNJ3;NEDD4L;SLC8A1;KCNJ4;KCNMB4;KCNB2;KCNV1;SLC5A4;FGF13;SCN2A;PKD1L3;SLC22A3;KCNK6;KCNIP2;SLC22A16;SLC4A4;ABCC9;SCN3A;ANO6;KCNJ6;GRIN1;SCN3B;SLC5A9;SCN1A;KCNS1;TRPM2;TRPM3;TMEM63C;KCNMB3;PKD2L1;KCNN4;SLC11A2;PANX2;PIEZO2;TRPM1;KCNH3;TRPC6;SLC7A8;ABCC8;KCNMB2;SCN7A
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.6238514954555878,-1.57326806537539,0.0,0.3969057675227242,1.0,29/116,14.88%,ORC1;RPS27A;UBC;UBB;PSMB6;PSMD7;PSME2;PSMD8;TEFM;POLD3;PRIM1;PSMB4;PSMD3;POLD4;PSMB3;PSME1;DDX21;POLE4;PNKP;MCM4;BLM;UBA52;POLE3;MCM3;POLG;PSMA7;PSMB8;PSMD13;TOPBP1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.7347431190779277,1.5700036867558251,0.02,0.2263383936002232,1.0,15/30,14.34%,NPY;GLRA3;SSTR1;GPR149;SORCS3;PNOC;CYSLTR2;NMUR2;GLRB;CYSLTR1;SORCS1;NXPH2;GLRA2;HCRTR2;CPE
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.6426722252702489,1.5691156751454192,0.0,0.22695843148492292,1.0,24/108,12.07%,ROR1;PDGFC;PDGFB;ANGPT1;PTPRC;EGFR;CD44;CHI3L1;CSF1R;PDGFRA;PRKCZ;NTRK2;ADRA1A;NPNT;ARRB2;BMPER;TIRAP;NDRG4;CD4;HTR2C;P2RY1;NECAB2;CX3CL1;MTURN
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.8827581834798035,-1.5675133423958116,0.0,0.4183993652763529,1.0,4/15,1.96%,RPL5;RPL11;RPL23;RPS7
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.8053069363083541,-1.567104095794516,0.0,0.41466716872777304,1.0,6/15,7.17%,PDE6A;GUCA1C;CNGB1;METAP2;FNTA;CALM1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.6066783953113168,-1.5663564704051511,0.0,0.41382306253188955,1.0,36/167,14.13%,TUBA1A;RPS27A;TPX2;UBC;UBB;ANAPC15;SSNA1;PSMB6;PSMD7;PLK4;MAD2L1BP;DYNLL1;PSME2;TUBB4B;PSMD8;RIOK2;TUBG1;TUBB4A;DCTN3;CDC23;CDC26;PSMB4;HMMR;NEK6;CEP131;PSMD3;PSMB3;PSME1;UBA52;TUBB;DYNC1H1;PSMA7;HAUS6;AKAP9;PSMB8;PSMD13
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.8508830997410758,1.5656438183076136,0.04081632653061224,0.23478491702660803,1.0,4/10,11.18%,TGFB2;HEY1;SOX9;BMPR2
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.9480622174767672,1.5645309775040432,0.0,0.2363704051360497,1.0,2/10,0.04%,KLRF2;CLEC2A
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),-0.9677705732982016,-1.5638416009714715,0.0,0.42136686499115295,1.0,1/6,0.24%,BMP5
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.8394163191972661,1.5630513869959513,0.0,0.2394917743103713,1.0,4/14,9.36%,CREB3L1;CIITA;VIM;TGFB3
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.7649939650925597,1.562605360978193,0.025,0.23863114847642292,1.0,9/19,20.18%,DNAH7;RSPH9;DNAH3;DNAH2;TEKT3;TEKT5;RFX3;CFAP44;DRC1
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.7991817688089808,1.5619567895329283,0.041666666666666664,0.23880998591234212,1.0,2/13,2.24%,P2RY12;CSF1R
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.643482379186874,1.5610140624426592,0.0,0.23959513834609136,1.0,26/65,15.45%,SCN9A;SLC23A1;NEDD4L;SLC8A1;SLC24A4;HCN1;SLC5A4;FGF13;SCN2A;SLC24A3;SLC6A11;SLC4A4;SCN3A;ANO6;SCN3B;SLC5A9;SCN1A;SLC6A4;SLC6A8;PKD2L1;SLC6A15;ASIC2;SCN7A;NALCN;SLC6A7;SCN4B
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.8962038346866318,1.5603983834828634,0.0,0.23875569638792185,1.0,4/12,7.34%,PDGFB;PPARG;NFATC4;SOX9
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.9490861698576984,1.5603486740455794,0.0,0.23693203290051046,1.0,2/9,0.45%,ZNF366;KANK2
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.9714995916567694,1.560107711907884,0.0,0.23593106644224465,1.0,1/7,0.01%,MFNG
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.7733044625059574,1.558856079206976,0.02,0.2380885700747333,1.0,10/29,11.24%,PDGFB;CSF1R;GRM5;EPHA4;SRC;RELN;NTRK2;LRP8;TGFA;DLG4
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.6332778082750009,1.5584101287678096,0.0,0.2375814375662671,1.0,33/97,14.82%,KCND2;KCNT2;KCNH7;SLC9C2;KCNC2;KCNQ3;KCNQ5;KCNJ3;KCNJ4;SLC24A4;HCN1;KCNB2;KCNV1;SLC24A3;KCNK6;KCNIP2;ABCC9;KCNJ6;KCNH5;KCNS1;KCNB1;KCNK10;KCNQ2;SLC9A9;SLC9A7;KCNC3;PKD2L1;KCNN4;ATP1B2;KCNH3;ABCC8;NALCN;KCNH2
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.7593573324042554,1.5572291495755077,0.04081632653061224,0.2403660439747215,1.0,7/22,14.31%,MEF2C;NRG1;CDON;BOC;MAPK12;MAPK11;OLFM2
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.7704827586961343,1.5562767113978,0.0,0.24176436544878127,1.0,11/27,15.70%,GRIK2;SHISA6;MCTP1;SLC4A10;NETO1;CAMK2B;SHISA9;DLG4;RAB3A;ZDHHC2;NSMF
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.8232877185418629,1.5557320588571997,0.0,0.2420949823280694,1.0,1/11,0.21%,LPL
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.9214753437121807,-1.5555902462252817,0.0,0.45250806580459624,1.0,1/9,0.24%,BMP5
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.8112732470204806,-1.5555525883131762,0.058823529411764705,0.4468139328498476,1.0,6/11,13.71%,RPP25;RPP40;POP5;RPP25L;POP7;POP4
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.6737709231728447,1.5547053230240724,0.0,0.24439963534665246,1.0,10/52,12.62%,CLDN5;TGFB2;PPARG;STAB1;ADGRB1;SULF1;PTPRM;SEMA6A;EFNA3;PDE3B
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.886920644849324,1.5541926934179076,0.02040816326530612,0.24376903374956496,1.0,3/10,7.34%,TGFB2;HEY1;SOX9
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.9128865465143696,1.5539376599565637,0.0,0.24240620840208907,1.0,1/5,0.95%,PPARG
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.7010670135635779,1.5529938397736571,0.02564102564102564,0.24401010280983945,1.0,11/29,17.03%,RIMS4;MCTP1;MEF2C;LRRK2;RIMS2;KCNMB4;SNCAIP;MCTP2;BAIAP3;GPER1;CPLX1
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.8028240252915989,1.552860092495573,0.02564102564102564,0.24294053086503598,1.0,3/15,4.14%,PPP1R3C;PID1;PYGL
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.9093628503948732,-1.5522924506325855,0.018867924528301886,0.4455507366882728,1.0,2/9,1.54%,CYP1A2;DPEP1
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.9093628503948732,-1.5522924506325855,0.018867924528301886,0.4455507366882728,1.0,2/9,1.54%,CYP1A2;DPEP1
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.9093628503948732,-1.5522924506325855,0.018867924528301886,0.4455507366882728,1.0,2/9,1.54%,CYP1A2;DPEP1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.6771620133682453,1.552151340313349,0.0,0.24397186891972042,1.0,7/33,5.26%,IGFBP3;PDGFB;PPARG;IGF1;IL12A;NR4A3;ID2
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.6008718342685667,1.5478168815582716,0.0,0.25919745360713237,1.0,18/76,7.70%,ADAMTS5;AQP1;PLSCR4;FSTL1;PPP1R3C;POSTN;FAP;PCDH18;GFAP;LDB2;PDGFRA;TMEM47;CCDC80;COL12A1;PRKG1;SULF1;TPM1;COL4A1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6512633157605957,1.5477194853238367,0.044444444444444446,0.25768011314180134,1.0,11/47,5.64%,EPHA3;PDGFB;EGFR;FLT1;CSF1R;EPHA4;PDGFRA;SYK;SRC;PTPN6;RELN
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.6304548499490559,1.54680483049169,0.0,0.2601718801244524,1.0,30/78,14.93%,DACT2;SYT4;ENHO;BTBD17;OGDHL;CAMSAP3;ST8SIA3;SYT1;LRRTM1;TMEM179;TMEM74B;FTCD;LRRC75B;RIMBP2;SYT13;SYT7;CELF3;CARMIL3;CACNA2D2;GRIK5;ARVCF;SEMA5B;SEMA4G;CNTFR;ACTL6B;ABCC8;PRR36;STMN2;KCNH2;WNK2
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.5818192278554266,1.5465641888781119,0.0,0.2594612230646702,1.0,30/131,13.38%,PPARG;KCNMA1;CELF2;MMP16;F3;KALRN;BHLHE40;MET;COL11A1;CITED2;CDON;IRS1;LAMC1;DDAH1;SIPA1L1;INPP4B;MAP2K5;PLCB4;ADGRL2;PTPRM;RGS4;ATXN1;ICA1;FBLN5;LTBP1;ADORA2B;AMPH;AKT3;SCAF8;APBB2
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.8423251352685241,-1.5464313961375165,0.06521739130434782,0.475008261903017,1.0,1/14,1.02%,IFNLR1
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),-0.9426757931051899,-1.5463204601558782,0.020833333333333332,0.46968843683595424,1.0,1/7,0.24%,BMP5
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.9027168958181357,1.5459797797976136,0.0,0.25937199734693517,1.0,1/12,0.55%,NCEH1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.7902025289657182,-1.54569792226599,0.015873015873015872,0.4673834309930106,1.0,1/18,0.14%,NGF
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.8184639733859009,1.5447935852164922,0.0,0.2617963585564017,1.0,3/15,9.36%,TGFB2;SRC;TGFB3
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.6830603520886029,-1.5446874693771944,0.03389830508474576,0.4684789387153467,1.0,24/64,19.65%,POLR2L;POLR2G;ADRM1;POLR2K;POLR2I;GTF2F1;ELOC;TCEA2;ELOB;POLR2A;POLR2E;ELOF1;NELFE;CTR9;POLR2C;POLR2D;EAF2;NELFCD;CCNT1;GTF2H2;SUPT5H;POLR2J;CTDP1;CCNK
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),-0.9879188601673334,-1.5444259330443382,0.0,0.46390698893967786,1.0,1/5,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.7022851872315236,1.543958720289765,0.018867924528301886,0.2625513688993282,1.0,13/32,11.18%,TGFB2;BMP6;SLC8A1;MEF2C;ISG15;BMPR1B;ADGRV1;NELL1;WNT5A;ANO6;ZBTB16;TGFB3;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.7448026925541941,1.5438266504114817,0.041666666666666664,0.2611610706799137,1.0,7/29,8.14%,LPL;TLR2;CSF1R;C5;SYK;WNT5A;TIRAP
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.6795562576815811,1.5428076783635436,0.0,0.26267263202370933,1.0,2/34,0.78%,PDGFC;PDGFB
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.7091596581302226,-1.5424043052892118,0.01818181818181818,0.4678058367919051,1.0,8/39,7.18%,RPL5;RPL11;RPL23;RAD23A;RPS7;PDCL3;PYHIN1;ARAF
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.7064538164999828,1.541847078096084,0.020833333333333332,0.26407844461661734,1.0,4/32,3.94%,KANK2;FSTL1;FAP;PRKX
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.8660737320476997,-1.5414234359383345,0.017543859649122806,0.46733816207886447,1.0,1/10,1.38%,VPS25
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.7680435605034053,1.5407987086698092,0.037037037037037035,0.2657149911253001,1.0,6/21,6.15%,PDGFC;PDGFB;AQP1;IGF1;PDGFRA;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.9440295397451925,1.540429595597279,0.04,0.26533721403188515,1.0,1/5,1.41%,EGFR
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.6417089314283416,-1.5402298528646925,0.017543859649122806,0.4688549250225018,1.0,20/74,14.13%,DDIT3;RPS27A;UBC;UBB;ATF3;PSMB6;PSMD7;PSME2;PSMD8;ELOC;ELOB;PSMB4;PSMD3;PSMB3;PSME1;UBA52;PSMA7;MAPK7;PSMB8;PSMD13
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.9594721234181439,-1.5400215302040856,0.037037037037037035,0.46457494755938544,1.0,1/7,0.09%,PM20D1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.6505323482843863,1.5398665707426442,0.0,0.26545905769935807,1.0,25/65,15.45%,SCN9A;SLC9C2;SLC8A1;SLC24A4;HCN1;SCN2A;SLC24A3;SLC6A11;SLC4A4;SCN3A;ANO6;SCN3B;SCN1A;SLC9A9;SLC9A7;SLC6A4;SLC6A8;PKD2L1;SLC6A15;ASIC2;ATP1B2;SCN7A;NALCN;SLC6A7;SCN4B
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.7324392344129653,1.5391829126532575,0.0,0.2659882959838344,1.0,19/32,23.34%,L1CAM;NRCAM;HEY1;ADGRG1;ETS2;SLIT1;CDK5R1;CNTFR;TLE3;VEGFA;THY1;ACHE;CDK6;CRMP1;RTN1;OPHN1;AMOT;RASA1;NF1
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.8261609157904557,1.5370777693335642,0.0,0.27138542164508533,1.0,4/13,6.78%,GRIK2;SHISA6;SLC4A10;SHISA9
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.8192527137033297,1.536572021855623,0.02127659574468085,0.2717054253721092,1.0,6/13,9.68%,TGFB2;WNT5A;LILRB1;LAPTM5;TGFB3;IRAK3
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),-0.9728530075170775,-1.535729867573347,0.0,0.48318785358866995,1.0,2/5,2.23%,CYP1A2;CYP2E1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.6540431379967344,-1.533795181830118,0.018518518518518517,0.4900296973480208,1.0,23/65,19.98%,POLR2L;POLR2G;WDR74;POLR2K;POLR2I;GTF2F1;RAN;POLR2A;KPNA2;POLR2E;POLG;TOPBP1;DDX24;HNRNPH2;POLR2C;POLR2D;PTBP1;POLR2J;DXO;EXD2;PDE12;LSM1;DDX1
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.6426125589967546,1.5332470186071263,0.024390243902439025,0.28099761049678607,1.0,12/83,7.34%,TGFB2;PKP2;PDGFB;HEY1;FGF12;MEF2C;KAT2B;PDLIM7;CITED2;ID2;KDM6A;SOX9
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.6402856322780062,-1.5331118060279854,0.0,0.4883587093482368,1.0,20/102,12.99%,CYP1A2;F11;AQP9;GJB1;CYP2E1;HSD11B1;SLC28A1;KNG1;AFP;TTC36;ADH6;GCK;UCP2;ANXA13;SERPINH1;SDC2;TM7SF2;AHR;HNF4A;RPP25L
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.8892084955385708,-1.5328145949059289,0.0,0.4847653455893795,1.0,2/8,5.76%,TRMT10C;HSD17B10
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.8355759976354837,1.5321846646194306,0.0,0.28236282799278206,1.0,5/15,6.76%,PDGFC;PDGFB;NR4A3;PDGFRA;PTPRJ
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.7070931075147027,-1.5308459609179985,0.015873015873015872,0.48952526697718274,1.0,21/70,16.14%,RPS27A;UBC;POLR2L;COPS6;UBB;POLR2G;PCNA;PPIE;POLR2K;POLD3;POLR2I;POLR2A;POLD4;ZNF830;POLR2E;UBA52;GPS1;COPS5;ERCC8;POLR2C;POLR2D
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),-0.9884243067215972,-1.530694897969231,0.0,0.4853846147032144,1.0,1/5,0.24%,BMP5
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.7319939654877297,1.5305592258367606,0.0,0.2868725935590837,1.0,11/28,16.25%,STON2;SYT1;PACSIN1;SNCB;STX1A;SYT7;TBC1D24;AMPH;RAB3A;NLGN4X;NLGN1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.716493893487865,1.5305524126937533,0.0,0.28503865428493436,1.0,14/37,14.70%,CTF1;IFNA2;IGF1;PARP14;CSF1R;IL12A;CRLF1;SOCS3;TNFRSF1A;HES1;PARP9;GHR;LYN;VEGFA
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.9167334179188631,1.5305137864073468,0.020833333333333332,0.2833070301166459,1.0,4/11,6.37%,TGFB2;PDGFRA;ID2;RARB
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.814902127695434,1.5303874815574816,0.023255813953488372,0.2818307240776116,1.0,5/14,12.11%,LPL;VSTM2A;C3;PLA2G10;SCARB1
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.6528184219496359,-1.5303631694527415,0.022727272727272728,0.4821917795208953,1.0,14/55,17.32%,PSMB6;PSMD7;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PSME1;PINX1;PSMA7;PSMB8;PSMD13;PSMD2;PSMC5
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.6230798544939034,-1.5302812998916884,0.0,0.4779543691449027,1.0,26/111,14.37%,ORC1;RPS27A;UBC;UBB;PSMB6;PSMD7;H2AX;PSME2;PSMD8;CHAF1B;PARP1;GRWD1;PSMB4;PSMD3;SMARCA5;PSMB3;H2BC21;PSME1;MCM4;NPM1;UBA52;MCM3;PSMA7;PSMB8;PSMD13;DAXX
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.7697348233651758,-1.530271561694201,0.0392156862745098,0.4731265472343481,1.0,13/30,12.76%,NDUFB3;NDUFS6;NDUFA2;NDUFA12;NDUFA1;NDUFB4;NDUFS8;NDUFAB1;NDUFB2;NDUFS5;NDUFB10;NDUFB11;NDUFV3
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.7798420295647053,-1.5300654275050376,0.024390243902439025,0.46981744996881913,1.0,3/21,3.32%,PDE3A;GPR62;CGAS
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.8773265953961539,1.529690016038667,0.022727272727272728,0.28237583552506074,1.0,4/9,7.18%,CX3CR1;PTPRC;LILRB1;ARRB2
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.7130311726817025,1.529429987914836,0.02,0.2816132900613501,1.0,13/27,14.82%,SCN9A;CACNA1G;CACNG2;SCN2A;SCN3A;CACNA1B;SCN3B;SCN1A;CACNA1I;YWHAH;CACNA1E;SCN7A;KCNH2
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.8177620495732484,-1.529425717122393,0.02040816326530612,0.46798196671529513,1.0,1/19,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.8186060496777859,-1.529371117989723,0.023809523809523808,0.4639680245645511,1.0,2/18,3.34%,SMIM20;SURF1
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.9040112183331027,1.5292138120844803,0.023255813953488372,0.2807085619270205,1.0,1/8,0.95%,PPARG
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.7857311616042505,1.5288387450858252,0.0,0.2802685752727472,1.0,3/18,9.36%,TGFB2;ABCB4;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),0.9412647089687679,1.528349131179019,0.058823529411764705,0.27858506521180854,1.0,1/5,0.95%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),0.9412647089687679,1.528349131179019,0.058823529411764705,0.27858506521180854,1.0,1/5,0.95%,PPARG
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.7746308608779958,1.5282996372096003,0.02127659574468085,0.2770552541558227,1.0,11/19,16.52%,PPARG;CSF1R;IKZF1;LILRB1;PDE1B;PIR;AXL;TRPM2;LYN;VEGFA;GAS6
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.9661821581272133,-1.5281529656582291,0.0,0.4650676843072252,1.0,1/7,0.14%,NGF
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.9006017528083952,1.5277250475260107,0.0,0.277827270585145,1.0,1/12,0.21%,LPL
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.6006617553294545,-1.5269996227875529,0.0,0.4657439998560881,1.0,29/132,14.13%,TUBA1A;TPX2;SSNA1;PSMB6;PSMD7;PLK4;CDK4;DYNLL1;PSME2;TUBB4B;PSMD8;TUBG1;TUBB4A;DCTN3;PSMB4;HMMR;CEP131;PSMD3;PSMB3;PSME1;DBF4B;PINX1;TUBB;DYNC1H1;PSMA7;HAUS6;AKAP9;PSMB8;PSMD13
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.576149300050436,1.5266160103397608,0.0,0.2796873708883286,1.0,26/161,13.06%,MFNG;IGFBP3;PLSCR1;TRIM5;MDFIC;RGS20;LRRK2;IGFBP4;PLCB1;TMEM204;SRC;TSPYL2;DTX1;SULF1;RGS4;LIFR;GIT1;BST1;PRKD1;HOMER1;UBASH3B;CX3CL1;CBFB;TULP3;CD80;LRIT3
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.7238490996826794,1.5243496203108704,0.0,0.2865426395095683,1.0,14/31,14.70%,CTF1;IFNA2;IGF1;PARP14;CSF1R;IL12A;CRLF1;SOCS3;TNFRSF1A;HES1;PARP9;GHR;LYN;VEGFA
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.7328491726802127,1.522599133796138,0.01818181818181818,0.29194046712749794,1.0,7/34,7.69%,TGFB2;PDGFB;PPARG;FOS;NFATC4;SOX9;TEAD1
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.665194799380347,1.5221476999336874,0.0,0.2915252956590197,1.0,24/66,13.52%,PDGFB;ANGPT1;BMP6;PTPRC;EGFR;CD44;IGF1;CSPG4;HGF;EFNA5;PRKCZ;SRC;TNK2;PTPN6;RELN;PTPRJ;LRP8;DMTN;BST1;TEC;CD80;PTPN11;GHR;SAMSN1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.7125104965370069,1.5219679471794652,0.02127659574468085,0.29061532677163326,1.0,11/21,14.21%,TGFB2;NCKAP1L;P2RY12;SYK;TESC;PDE3B;ACER2;PTPN11;LYN;RAC3;ITGB1BP1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.8105364393598209,-1.521779940025011,0.04,0.48895497396191884,1.0,15/20,18.07%,RPL23A;RPL5;RPL11;RPL3;RPL10;RPL6;NOP53;RPLP0;RPL24;RPF2;RSL24D1;NLE1;BRIX1;MRPL20;TRAF7
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.6845644813865666,-1.5209194587357815,0.034482758620689655,0.488682882163987,1.0,23/62,19.65%,POLR2L;POLR2G;ADRM1;POLR2K;POLR2I;GTF2F1;ELOC;ELOB;POLR2A;POLR2E;ELOF1;NELFE;CTR9;POLR2C;POLR2D;EAF2;NELFCD;CCNT1;GTF2H2;SUPT5H;POLR2J;CTDP1;CCNK
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.8181645435909727,1.520637400921243,0.06,0.2931230786959082,1.0,5/12,15.67%,PPARG;IRS1;GPLD1;PPM1K;PRKCE
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.8595916315801494,-1.5198234426369006,0.0,0.4903704779076526,1.0,3/10,10.73%,BMP5;SOD1;ERLIN2
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.8335543069413384,1.5197999195799672,0.02040816326530612,0.293766520636935,1.0,3/13,9.36%,CREB3L1;VIM;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.8702742309135425,1.5197419799439373,0.0,0.292438685482073,1.0,2/10,5.43%,CD53;ADGRB1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.7017191774467816,-1.5197022877430792,0.0425531914893617,0.4819868504476371,1.0,22/50,18.42%,NDUFB3;NDUFS6;DMAC2;NDUFA2;NDUFA12;NDUFA1;NDUFB4;NDUFS8;NDUFAB1;NDUFB2;NDUFAF8;NDUFS5;NDUFAF3;FOXRED1;NDUFB10;NDUFB11;NDUFV3;NDUFAF4;TMEM126A;TMEM126B;NDUFA5;NDUFA3
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.7017191774467816,-1.5197022877430792,0.0425531914893617,0.4819868504476371,1.0,22/50,18.42%,NDUFB3;NDUFS6;DMAC2;NDUFA2;NDUFA12;NDUFA1;NDUFB4;NDUFS8;NDUFAB1;NDUFB2;NDUFAF8;NDUFS5;NDUFAF3;FOXRED1;NDUFB10;NDUFB11;NDUFV3;NDUFAF4;TMEM126A;TMEM126B;NDUFA5;NDUFA3
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),-0.9551319059446272,-1.5194891593119435,0.018518518518518517,0.4787459284436862,1.0,2/6,3.84%,MSRB1;MSRB2
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.7372314739109772,1.519402062347996,0.04081632653061224,0.29217227758673797,1.0,9/24,10.65%,SYT4;CACNA1G;CBARP;SYT1;SYT13;STX1A;SYT7;KCNB1;CACNA1I
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.9729733221766547,1.5193849088614746,0.0,0.2904536171303454,1.0,1/5,0.75%,CARD18
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.8760563371031496,1.5187923250798925,0.0425531914893617,0.2911665175289052,1.0,3/9,3.40%,MX1;SHMT2;ISG15
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.8049190220237673,-1.5185331100730193,0.041666666666666664,0.47963319916095015,1.0,2/14,6.80%,PANK1;CROT
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.7269251622793023,1.51835656377456,0.0196078431372549,0.29091215260821646,1.0,13/27,15.92%,IGF1;SLC8A1;MYH11;SGCZ;DMD;NEBL;DYSF;ALPK2;HES1;ALPK3;MEGF10;VEGFA;BIN1
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.6382297433555927,-1.518285208892102,0.03508771929824561,0.47676994034120823,1.0,26/91,18.59%,SNRNP25;PRPF4;SF3A3;SRSF7;PDCD7;YJU2;RNF113A;MPHOSPH10;PRPF18;SCNM1;SNRPD1;SNRPD2;SF3B4;PRPF6;RBM8A;RP9;SNRPB;PRPF3;PRPF8;WBP4;MAGOHB;DHX8;SNRPG;PTBP1;DDX23;SLU7
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.7623470865835479,-1.5182382306049953,0.0,0.4728468681376295,1.0,5/21,11.49%,TYRP1;RAB32;GPR143;TRAPPC6A;BLOC1S4
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.5977730570459078,1.5178621090413198,0.0,0.29066072832244905,1.0,47/112,14.74%,TGFB2;KCNT2;ZNF423;FSTL1;VCAN;PCDH18;PLPPR4;MAP2;DCLK1;LDB2;RUNX1T1;COL11A1;EFNB3;LRFN5;GFRA1;TMEM47;RGS7BP;ADCYAP1R1;OPCML;PRKG1;ASTN1;ADGRL2;PBX1;CRYM;TMEM200C;CADM3;BOC;LIFR;MAPK4;MEST;BRINP1;DIO2;FNDC4;CACNA2D2;PAMR1;GAP43;SEMA5B;CNTFR;DPYSL3;PRICKLE2;LRP4;FRZB;PDZRN3;SCN7A;CPE;MEGF10;STMN2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.7954155067462275,1.5178410739018244,0.024390243902439025,0.28912568623366125,1.0,3/18,3.61%,RIMS4;LRRK2;RIMS2
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.8334479263928415,1.5176377662204392,0.038461538461538464,0.2880121315665746,1.0,7/15,8.85%,ADAMTS5;IGF1;MEF2C;ADAM12;NOS1;JAM2;ADAMTS15
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.8702947134010875,1.5173785493782548,0.02127659574468085,0.28744676285873616,1.0,3/9,7.61%,RELN;CAMK2B;LRP8
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.8009010798864367,-1.5168427487737406,0.05454545454545454,0.4746431352773907,1.0,6/23,10.52%,SELENOS;SEC61B;TMED9;TMEM129;RANGRF;LMAN1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.7181899094860769,-1.516380949591228,0.043478260869565216,0.47291639450131506,1.0,5/32,5.36%,CYB5A;EMC6;EMC4;SEC61B;EMC7
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.760025932189332,1.51545167664133,0.0,0.29154721284007185,1.0,6/17,12.70%,ADCY8;CYSLTR2;ADCY2;ADCY7;ADCY1;PRKAR1B
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.6678334883400644,1.5152848165437036,0.0,0.29024025384761887,1.0,8/42,9.45%,TGFB2;MEF2C;HGF;WNT5A;LOXL3;SOX9;LEF1;NOTCH4
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.7425315728528995,-1.514787696014187,0.06976744186046512,0.4767725159863234,1.0,10/25,19.94%,PRPF4;SF3A3;MPHOSPH10;SF3B4;PRPF6;PRPF3;PRPF8;DDX23;SLU7;LSM1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.6384640933233313,1.514734047784102,0.0,0.2909883043161839,1.0,11/44,11.18%,TGFB2;RHOJ;PTPRG;PTPRR;SRC;SOX9;BMPER;DUSP10;VIL1;CORO1C;BMPR2
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.7033487339400131,-1.5133864389961877,0.03571428571428571,0.47963319916095015,1.0,11/41,9.16%,CXCR4;P2RY10;CD38;AMPD1;PPIB;ITGAL;CD9;TMEM156;SSR4;ZNF165;REN
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.5790977505784473,1.5132348541090128,0.02,0.2933643906735271,1.0,49/100,18.30%,L1CAM;AQP1;ZNF423;CHL1;SHISA6;KCNIP1;CHST1;PLPPR4;CNTN1;NRXN1;DCLK1;GFAP;RAPGEF4;SORBS1;RGS7BP;ADCYAP1R1;PTPRZ1;NTRK2;ASTN1;CADM3;ACKR1;MAPK4;SORCS1;PTPRT;PHYHIP;EDNRB;MAOB;IGSF21;SPARCL1;CX3CL1;CNTFR;TSPAN7;INTS6;PTPN5;FRZB;ZNF536;DAAM2;MEGF10;STMN2;SCN4B;THY1;NOS2;RXRG;NFASC;CXCL14;GRIK3;ALDH1A1;AQP4;DHRS3
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.6619206529317055,1.5131140077189789,0.019230769230769232,0.2923945157215566,1.0,9/32,14.70%,TGFB2;HEY1;FLRT2;TBX19;SOX9;ALPK2;HES1;OLFM1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.6649484983219186,1.5130703905337426,0.0,0.2910468909634533,1.0,13/56,7.34%,ROR1;TGFB2;PDGFC;PDGFB;FLT1;IGF1;PIK3AP1;HGF;PDGFRA;SRC;PTPN6;NTRK2;SOX9
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.4972087219341839,1.5115213211417207,0.0,0.2954438933440463,1.0,80/420,15.08%,EPHA3;TGFB2;IGFBP3;PDGFB;EGFR;FLT1;RPS6KA6;TLR2;MAP3K21;CSF1R;HIPK4;MAP3K5;PEAK3;STK32B;CAMK1D;EPHA4;LRRK2;DCLK1;PIM1;PRKX;PAK3;BMPR1B;PDGFRA;HUNK;PRKG2;SYK;CDKL4;STK17B;PRKCZ;SRC;PTPN6;RELN;NTRK2;MERTK;PRKG1;HIPK3;CAMK2B;EPHB1;CAMKV;AURKC;MAPKAPK3;MYLK3;ACVR1C;PLK1;EPHB3;PRKCG;DAPK1;MAPK12;PICK1;IRAK3;CAMK2D;NUAK1;TEC;DYRK2;PRKD1;BMPR2;MKNK1;CSNK1D;CDK5R1;DMPK;IP6K3;PRKAR1B;TTBK2;AKT3;LYN;ZAP70;TNIK;FES;DYRK3;RPS6KA3;PDK4;CDC7;MAK;CAMK4;TSSK3;VRK3;WNK2;CDK19;PAK5;STK17A
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.879994535822034,1.5112469225537377,0.04081632653061224,0.294990777857722,1.0,1/7,1.68%,SYT4
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6461299649892749,1.511101345581465,0.0,0.29403308189290667,1.0,25/59,18.61%,GLRA3;SLC4A10;GABRA6;GABRG2;GABRA1;GABRB2;GABRA4;SLC26A9;GABRA2;ANO5;ANO6;SLC26A7;GLRB;GABRR2;GABRB3;GABRG1;ANO4;GLRA2;CLCN3;GABRD;CLCN2;ANO3;SLC12A5;SLC1A1;GLRA1
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.7116900701384763,-1.5102219921905196,0.06521739130434782,0.49003123855939407,1.0,14/35,19.08%,MRPL51;TEFM;MRPS2;MRPS7;MRPS21;MRPL57;TFB2M;MRPL47;MRPS34;MRPS18A;MRPS18B;PTCD3;TFAM;NOA1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.725679091916765,1.5099295573458509,0.021739130434782608,0.29701291787972717,1.0,11/28,16.02%,PDGFB;FLT1;P2RY12;PDGFRA;IRS1;PRKD1;PIK3R1;AMBRA1;TNFAIP8L3;WASHC1;RUBCN
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.5904609494105963,1.5096325638536325,0.0,0.296936703658341,1.0,34/91,16.64%,ADAMTS5;IGFBP3;PLSCR4;PPARG;FSTL1;PPP1R3C;POSTN;FAP;SLC8A1;PCDH18;GFAP;LDB2;HGF;PDGFRA;TMEM47;RELN;COL12A1;SULF1;COL4A1;ANTXR1;PAMR1;LAMB2;NGFR;PRRX1;FRZB;COL5A1;PDZRN3;VEGFA;TIMP3;THY1;NNMT;SEMA7A;CYGB;C1R
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.8667521480303755,1.5095869962050958,0.017857142857142856,0.29548259036693164,1.0,2/8,4.57%,TGFB2;NRG1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.8533701774923208,-1.5093205214523262,0.043478260869565216,0.4897798268352071,1.0,2/11,1.96%,LACTB2;RPP40
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.6680479329875404,-1.5077174986240767,0.05454545454545454,0.49322745407902946,1.0,25/60,23.44%,TRMT10C;RPP40;POP5;TSEN34;ADAT1;SARS1;URM1;AARS1;CSTF2;C2ORF49;TRMT10A;POP7;QTRT2;TRMT1;FAM98B;SSB;TRMT6;RTRAF;DDX1;CTU2;TRPT1;AARS2;TRDMT1;KARS1;TRMT10B
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.8366777505255255,1.5077011023207636,0.03773584905660377,0.3006515918102933,1.0,2/12,3.64%,HEY1;CACNA1G
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.8770379380937404,1.5062664241797206,0.043478260869565216,0.3053321199907942,1.0,1/10,0.21%,LPL
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.571747658617179,1.506237723122196,0.0,0.3037335225039314,1.0,31/99,11.79%,BEGAIN;CX3CR1;GRIK2;NPTX2;NRG3;GRM5;MCTP1;GRIK1;MEF2C;LRRK2;RIMS2;CACNG5;DLGAP1;KCNMB4;GRM1;SYT1;LGI1;RELN;CLSTN3;NPTX1;GRM6;CACNA1B;SNCAIP;LRP8;GRM2;SYN3;DGKI;GRIK5;DLG4;HOMER1;MCTP2
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.7227655878115506,1.5056571136171786,0.0,0.3045447353816757,1.0,10/31,9.19%,SNAP25;RIMS2;UNC13C;SYT1;STX3;DNAJC5;SNPH;STX1A;PCLO;SYT7
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.8588770066914861,1.5051616328661335,0.0,0.3045539557338633,1.0,3/13,3.82%,IGF1;MEF2C;PIM1
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.7894676873692339,1.5049003690567395,0.023255813953488372,0.30377358550676575,1.0,1/14,0.21%,LPL
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.909164449888217,-1.5048926791990267,0.0,0.503601031523404,1.0,1/7,2.11%,RNF8
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.822512742180966,1.504713692831783,0.04,0.30257828616888555,1.0,2/10,3.16%,HEY1;ASB4
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.8671819933195694,-1.5040054221811232,0.019230769230769232,0.49607224026122465,1.0,1/11,0.38%,PANK1
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.8671819933195694,-1.5040054221811232,0.019230769230769232,0.49607224026122465,1.0,1/11,0.38%,PANK1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.8671819933195694,-1.5040054221811232,0.019230769230769232,0.49607224026122465,1.0,1/11,0.38%,PANK1
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.7830325379908659,1.5028484955053487,0.05660377358490566,0.3079472529752642,1.0,5/17,11.92%,SLC2A12;SLC2A9;SLC2A5;SLC5A9;SLC45A1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.8489843177169754,1.5023492622784749,0.02040816326530612,0.30859687600664587,1.0,1/10,0.33%,TGFB2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.568088580071056,1.5022059149379512,0.0,0.30763334140240456,1.0,32/152,10.16%,FLI1;CLDN5;APOLD1;MMRN2;PLAC8;PDGFB;AQP1;PLSCR4;SRGN;GPM6A;FLT1;CHST1;STAB1;HEY1;SEMA3D;POSTN;RHOJ;CASZ1;NOSTRIN;LOX;LDB2;PDGFRA;PTPRB;ROBO4;ACKR1;COL4A1;LIFR;RASIP1;EPAS1;NOTCH4;EDNRB;COL15A1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.5983879062396639,1.5021461288783897,0.0,0.3063242633538837,1.0,25/89,16.58%,TGFB2;PDGFB;ANGPT1;IGF1;CHI3L1;ADCY8;PAK3;NRG1;WNT5A;TIRAP;ADCY2;ADCY7;KIF14;TNFRSF10B;ADCY1;PRKAR1B;GHR;TNIK;ITGB1BP1;VEGFA;NTRK3;PAK5;ADRB2;GAS6;PRKCD
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.8145822405477036,1.5018332634632907,0.02040816326530612,0.3063242633538837,1.0,2/16,2.05%,TGFB2;HEY1
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.9187505323951649,1.5015016915890949,0.0,0.30638287878889214,1.0,1/5,0.95%,PPARG
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.8232616236128038,1.5013459434112033,0.043478260869565216,0.30521608342171996,1.0,3/12,6.65%,AQP1;KLF9;ZFP36
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),0.9182447096323509,1.5011225547672913,0.0,0.30411882151844466,1.0,1/5,1.03%,CLDN16
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.7532206571291215,1.500290429440972,0.06,0.30603549613729825,1.0,8/18,16.46%,SLC8A1;MEF2C;MYH11;NRG1;ALPK2;ALPK3;VEGFA;KDM6B
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.8481155342226288,1.499932923778377,0.06818181818181818,0.3059794330386636,1.0,3/10,5.57%,DNAJB1;CITED2;BAG3
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.8326661675427179,-1.4992624138214021,0.04,0.5163976415896593,1.0,7/14,13.24%,FTSJ3;NIFK;DDX18;RPL7L1;RPL7;RPL35;RPF2
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.8097074861115622,1.499085800444219,0.022727272727272728,0.3070677688474611,1.0,4/19,10.63%,LPL;PPARG;NFKBIA;PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.9062701265931643,-1.4989229063464378,0.02127659574468085,0.5138263189793181,1.0,1/6,0.24%,BMP5
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.8799345272679995,-1.4980021230025835,0.058823529411764705,0.5140620975442303,1.0,1/9,1.40%,BUB1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.8349136733282337,1.4971951737584768,0.02127659574468085,0.3129265700333803,1.0,7/14,8.67%,NRXN1;CACNG5;CACNG2;RELN;TSHZ3;CACNG8;CACNG3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.9219004825485356,1.4970010498198452,0.017241379310344827,0.3122151145722276,1.0,3/7,4.05%,PPARG;IGF1;E2F3
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.6300496233579725,-1.4964387375186146,0.018867924528301886,0.5171698998401979,1.0,14/53,17.32%,PSMB6;PSMD7;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PSME1;NQO1;PSMA7;PSMB8;PSMD13;PSMD2;PSMC5
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.5917098018685347,1.49630590637773,0.0,0.3133143643211052,1.0,30/86,16.31%,DACT2;CDS1;ZNF423;SHISA6;KALRN;PROM1;NPNT;SPON1;PBX1;RIMBP2;SYT13;ZBTB7C;LRRN1;EPHB3;NEBL;PTPRT;MAOB;SEMA6A;APCDD1;HOPX;SPARCL1;SH3BGRL2;FRZB;PDZRN3;ANK3;WNK2;SCN4B;NOS2;PDE9A;TNFRSF19
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.7897414736309367,1.4962509510557584,0.04081632653061224,0.31187849450260796,1.0,5/16,14.29%,TGFB2;ROBO2;ROBO1;BMPR2;SEMA3C
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.9649204053888962,-1.4962307695848742,0.0,0.5139390350663238,1.0,1/7,0.24%,BMP5
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.7850818443301979,1.4957193603426946,0.02,0.3123547082029941,1.0,6/15,12.70%,ADCY8;CYSLTR2;ADCY2;ADCY7;ADCY1;PRKAR1B
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.6453252514348619,-1.4952682045688626,0.015384615384615385,0.5151337780791689,1.0,18/61,20.69%,EIF1;POLR2G;ATF3;MIF4GD;EIF5;EIF1B;EIF3B;EIF4G2;NPM1;EIF4B;EIF2AK3;POLR2D;RPS6KB2;ATF4;EIF5B;DDX1;MTIF2;TPR
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.8735040161020218,1.4936187732425237,0.057692307692307696,0.3192730212206208,1.0,2/13,0.95%,LPL;PPARG
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.8157457804703624,1.4935438603569122,0.043478260869565216,0.31849315788942983,1.0,3/12,7.55%,PKP2;NEDD4L;SCN3B
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.771550917245928,1.4933591081586812,0.02040816326530612,0.31722509084203415,1.0,6/21,10.66%,KCNJ3;NEDD4L;PIM1;KCNJ4;KCNJ6;BCL2
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.74331016271418,1.492435075596736,0.0,0.3190375422623097,1.0,7/18,12.65%,BEGAIN;NPTX2;CACNG5;DLGAP1;NPTX1;HTR2C;DLGAP3
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.7320162844957575,1.4918082323885389,0.05263157894736842,0.31963322351384593,1.0,4/26,6.94%,PLSCR4;PLSCR1;ABCB4;ANO6
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.7179324847741264,1.4918013102780119,0.0,0.31816025935018766,1.0,7/27,14.65%,MEF2C;CDON;ID2;BOC;MAPK12;MAPK11;MEGF10
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.8737952137261538,1.4916213627621653,0.0,0.31778169875102974,1.0,3/7,10.94%,EGFR;CCND1;OPN3
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.8065699578056141,1.4914075774330307,0.0,0.3170300112301434,1.0,5/18,7.22%,GRIN2B;NFATC4;PRKCZ;SHANK2;TSHZ3
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.8124232242450256,1.4914018712209185,0.13043478260869565,0.31558896572455186,1.0,7/10,10.87%,GABRG2;FGF13;GABRA1;GABRB2;WNT5A;GABRA2;GABRB3
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.6682883037539158,1.491035472173026,0.0196078431372549,0.31522717876984235,1.0,5/35,11.54%,EPHA3;CAMSAP3;EFNA5;DIAPH1;MAPT
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.6556069649332545,1.4906769817832564,0.024390243902439025,0.3151340048155512,1.0,14/43,20.42%,PPARG;PID1;NR4A3;TMEM120B;MAFB;ZNF516;BBS2;TMEM120A;UCP1;PPARGC1A;MKKS;BBS4;TRIM32;STEAP4
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.6675656910215994,1.4905238102760474,0.0,0.314143509814107,1.0,21/43,18.61%,GLRA3;GABRA6;GABRG2;GABRA1;GABRB2;GABRA4;GABRA2;ANO5;ANO6;GLRB;GABRR2;GABRB3;GABRG1;ANO4;GLRA2;CLCN3;GABRD;ANO3;SLC12A5;SLC1A1;GLRA1
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.7977165435486848,1.4904820264194278,0.02040816326530612,0.3114558493040855,1.0,2/9,5.30%,NFATC4;PPP3CA
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.7977165435486848,1.4904820264194278,0.02040816326530612,0.3114558493040855,1.0,2/9,5.30%,NFATC4;PPP3CA
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.8474604324789142,1.4903150754361847,0.019230769230769232,0.31080756605103044,1.0,1/10,0.56%,SCN9A
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.5681528587694796,1.4902842688788351,0.0,0.30959407504336095,1.0,39/165,11.18%,CREB3L1;ROR1;NCEH1;CDH9;AQP1;SLA;PLSCR4;SLCO2B1;GRIK2;GPM6A;RAB27B;ADAMTS9;CHST1;KCTD12;POSTN;C1QB;SYNPO2;STK32B;MRC1;PID1;HS3ST1;LDB2;HGF;PDGFRA;OLFML2B;TIAM2;SLC4A4;TRANK1;MEIS2;ZDHHC13;EDNRB;TMEM176B;MAOB;COL15A1;SPARCL1;DGKI;RGS1;SLC6A4;BMPR2
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.9153017043269338,1.490226216179404,0.0,0.30854625109413625,1.0,2/7,3.76%,CSGALNACT1;NDST3
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.7506649687100302,-1.4902255071765786,0.03333333333333333,0.5401301613487461,1.0,5/30,7.07%,LSM7;POLR2G;LSM2;EXOSC8;NT5C3B
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.8217401586634285,1.4897355311734082,0.05555555555555555,0.309514069253773,1.0,2/12,2.05%,ADAMTS9;HEY1
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.5762722844683271,1.4892810763536648,0.0,0.310166122844108,1.0,30/125,10.21%,CREB3L1;EPSTI1;ADAMTS5;AQP1;PLSCR4;ZNF423;PPARG;EGFR;TLR2;MPZL1;POSTN;FAP;OLFML1;LOX;PDGFRA;ROBO4;COL5A3;OLFML2B;ADAM12;PXDC1;ACVR1C;ZBTB16;FBLN5;EPAS1;STAT6;MEST;C3;MAOB;COL15A1;ARNT
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.8901146482680355,1.4890720882246853,0.06521739130434782,0.3097414670909317,1.0,2/6,10.01%,NCKAP1L;NUAK1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.7688845239815542,-1.488915482095199,0.0,0.542502667127079,1.0,1/25,0.09%,PM20D1
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.9034619156317671,1.4882135073745222,0.0425531914893617,0.3116564993704881,1.0,1/7,0.33%,TGFB2
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.8694443102623873,1.4863104462821484,0.04,0.31775200906500584,1.0,3/10,2.05%,TGFB2;ROBO2;HEY1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.7562032065369702,-1.4861869200246454,0.05084745762711865,0.5542744908646127,1.0,6/18,12.13%,RPS13;SAP18;SRSF7;SRSF9;TMBIM6;RPS26
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),-0.9477728074196541,-1.4855251577535766,0.0,0.5538839477988481,1.0,1/6,0.21%,TYRP1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.7747950732983943,-1.4832949470034535,0.05555555555555555,0.5622986626855895,1.0,4/20,5.89%,RPS27A;UBC;UBB;PARP1
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),0.8583987663353373,1.4829294302717306,0.02040816326530612,0.329384176670136,1.0,1/6,0.70%,IFNA2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.7689453097930375,1.4827383515909087,0.038461538461538464,0.32888497014754126,1.0,3/17,7.23%,CSGALNACT1;NDST3;HS6ST3
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.7561089147146312,-1.4822335302162974,0.10416666666666667,0.5635772106762088,1.0,1/18,0.24%,BMP5
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.7275808804939585,1.4817655551802615,0.03773584905660377,0.33128549732991724,1.0,9/25,12.13%,CSGALNACT1;VCAN;CHST15;CSPG4;CHST3;HEXB;NCAN;CHST11;CSPG5
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.7746041583054415,1.4817592718573254,0.020833333333333332,0.3298876682272594,1.0,1/15,0.18%,DACT2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.9397079658866334,1.480687394128975,0.0,0.3327093364578947,1.0,1/5,0.33%,TGFB2
prerank,PanglaoDB_Augmented_2021__Acinar Cells,-0.7510523498729855,-1.4800996682562657,0.04,0.5715540753878577,1.0,4/26,2.22%,CELA2A;CPA1;CLDN2;GJB1
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.8015709750490899,1.4793727756842752,0.1,0.3366904922283595,1.0,4/7,15.48%,CKMT1A;SLC6A8;CKM;CKMT2
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.6762475977009155,1.4791610605193917,0.02040816326530612,0.3357294290187837,1.0,18/35,15.39%,SCN9A;KCND2;CACNA1G;KCNMB4;SCN2A;SCN3A;SCN3B;DMD;SCN1A;KCNB1;CACNA1I;KCNMB3;YWHAH;KCNMB2;SCN7A;ANK3;KCNH2;GPER1
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.8454586978955698,-1.4787520934752547,0.020833333333333332,0.5750506227554061,1.0,10/17,11.89%,RPSA;RPS5;RPS14;RPS15;RPS28;RPS27;RPS19;MRPS7;RPS27L;ABT1
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.772036527398788,-1.478555989258278,0.057692307692307696,0.5683294880257223,1.0,11/20,18.06%,POLR2L;TINF2;POLR2G;POLR2K;POLR2I;POLR2A;POLR2E;DAXX;POLR2C;POLR2D;POLR2J
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.772036527398788,-1.478555989258278,0.057692307692307696,0.5683294880257223,1.0,11/20,18.06%,POLR2L;TINF2;POLR2G;POLR2K;POLR2I;POLR2A;POLR2E;DAXX;POLR2C;POLR2D;POLR2J
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.7959024262635683,1.4781956216963323,0.02040816326530612,0.3373184515068301,1.0,5/14,11.18%,BMPR1B;SOX9;ZBTB16;SOX5;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.6391506605666368,1.4779935034319618,0.0,0.33699563746592226,1.0,11/51,16.72%,TGFB2;BMP6;IGF1;TLR2;FRMD4A;TGFB3;WLS;SYTL4;GPER1;EXPH5;ACHE
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.7225912337656597,-1.4775445675414502,0.07017543859649122,0.5702912308677701,1.0,3/29,0.93%,LCK;CRTAM;PRELID1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.8236524571467262,1.476536427833113,0.041666666666666664,0.3421057300134541,1.0,2/8,3.38%,CSF1R;IL12A
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.6633539397256388,1.476484900337995,0.0,0.340848514346637,1.0,8/39,9.45%,TGFB2;HEY1;HGF;WNT5A;LOXL3;SOX9;LEF1;NOTCH4
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.7468411145824462,-1.4764477119031933,0.06382978723404255,0.5728144770031837,1.0,2/21,1.12%,MEIOSIN;FSHR
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.8527766878155636,1.4762458061509927,0.019230769230769232,0.340611421873714,1.0,2/10,1.79%,DCX;MYO7A
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.5239277184299861,1.4761757415787755,0.0,0.33956207429315755,1.0,48/155,22.23%,PDGFB;RPS6KA6;POGLUT2;HIPK4;GALNT3;STK32B;CAMK1D;LRRK2;PRKX;PRKCZ;HIPK3;CAMKV;MAPKAPK3;PLK1;PRKCG;MAPK12;CAMK2D;DYRK2;PRKD1;MKNK1;CSNK1D;CDK5R1;DMPK;TTBK2;AKT3;DYRK3;RPS6KA3;CDC7;CAMK4;VRK3;PRKCE;GAS6;PRKCD;STK38;DYRK1B;CSNK2A1;STK38L;PRKCQ;TNKS;MKNK2;PAK2;MAPKAPK5;ULK1;VRK1;RPS6KA4;MASTL;MAST1;SGK1
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),0.9361306515885983,1.475616953392816,0.020833333333333332,0.3403337930597883,1.0,1/5,3.35%,MEF2C
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.7780407272256732,-1.4751752815182455,0.0392156862745098,0.5764139589363526,1.0,11/20,18.91%,FTSJ3;TSR3;BUD23;METTL5;TRMT112;TFB2M;DKC1;NHP2;MTERF4;NAT10;GAR1
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.8810814338738215,-1.4749906118792278,0.023255813953488372,0.5733987010318045,1.0,1/9,0.38%,LCK
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.639199488512717,-1.474897328843605,0.02040816326530612,0.5700788661879729,1.0,17/65,14.13%,RPS27A;UBC;UBB;PSMB6;PSMD7;PSME2;PSMD8;ELOC;ELOB;PSMB4;PSMD3;PSMB3;PSME1;UBA52;PSMA7;PSMB8;PSMD13
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.7223269121586909,1.474857890326769,0.08,0.34304706973920507,1.0,8/25,15.36%,IGFBP3;MEF2C;PLCB1;SOX9;BOC;RBM24;SRA1;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7748699367036057,1.4747927835197996,0.045454545454545456,0.34176400281203306,1.0,9/16,18.67%,BMPR1B;SCIN;SOX9;ZBTB16;SOX5;BMPR2;KAT2A;MBOAT2;SCX
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.5415434115499085,1.4736160564439618,0.02564102564102564,0.3456280226826744,1.0,56/196,14.97%,SCN9A;KCND2;KCNH7;SLC9C2;KCNC2;KCNQ3;KCNQ5;RYR3;TRPC4;TRPC7;SLC8A1;CACNA1G;KCNJ4;SLC24A4;HCN1;KCNB2;KCNV1;SCN2A;SLC24A3;KCNK6;SLC6A11;SLC4A4;ABCC9;SCN3A;ANO6;SCN3B;KCNH5;SCN1A;KCNS1;SLC40A1;KCNB1;KCNK10;KCNQ2;SLC9A9;SLC9A7;KCNC3;TRPM2;TRPM3;TRPC3;SLC6A4;SLC6A8;PKD2L1;KCNN4;TRPV4;SLC11A2;SLC6A15;ASIC2;TRPM1;KCNH3;SLC30A3;TRPC6;ABCC8;SCN7A;NALCN;KCNH2;SLC6A7
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.5699397789103432,1.4728899262045274,0.024390243902439025,0.34716123992726383,1.0,50/140,13.57%,ALDH1L1;SHISA6;KCNIP1;GRM5;LUZP2;ADCY8;SNAP25;PLPPR4;NRXN1;GFAP;SYNPR;RAPGEF4;SORBS1;SLC1A2;SPHKAP;RGS7BP;ADCYAP1R1;PTPRZ1;NTRK2;OPCML;LRRC3B;SLC6A11;ASTN1;SLC4A4;CA10;CADM3;SNPH;SOX9;TEAD1;MAPK4;SOCS3;VIM;BRINP1;DIO2;ATP2B2;PHYHIP;NCAN;EDNRB;C11ORF87;SLIT1;GAP43;IGSF21;SPARCL1;PSD2;FABP7;GABRG1;CNTFR;ATP1B2;PHF24;PTPN5
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.6738974316527357,1.4727205051886165,0.023255813953488372,0.3465316605584533,1.0,3/31,5.66%,IGF1;EPHA4;NTRK2
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.6142622926804094,1.4724639495598701,0.02,0.34581392211400735,1.0,16/67,14.52%,TGFB2;L1CAM;CBLN2;GRM5;CTNND2;PAK3;SNCB;TJP2;PPFIBP1;AGRN;TGFB3;MAPT;LRP4;NLGN4X;APBB2;GRHL2
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.7484497159333752,1.4723368308355682,0.037037037037037035,0.3448699118770632,1.0,7/23,14.65%,MEF2C;TMEM204;SGCZ;DMD;NEBL;MRTFB;MEGF10
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.647923870725183,-1.4722068199679361,0.023809523809523808,0.5805563364804174,1.0,14/50,17.32%,PSMB6;PSMD7;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PSME1;PINX1;PSMA7;PSMB8;PSMD13;PSMD2;PSMC5
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.906713202901467,1.4721539654543054,0.0,0.3441181166605921,1.0,2/7,4.57%,TGFB2;NRG1
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.8853051342461489,1.4716549120794737,0.057692307692307696,0.3446608185482625,1.0,4/6,10.59%,PLSCR1;UHRF1;ITGAM;SETMAR
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.5594503680856073,1.471421430871474,0.046511627906976744,0.3442824330720842,1.0,42/108,17.96%,ZNF423;FIGN;GPC6;PCDH18;PTPRG;DCLK1;RUNX1T1;EFNB3;GFRA1;TMEM47;TUSC3;LRRTM1;CHST3;FBLN1;ADGRL2;PBX1;TENM3;MEIS3;TEAD1;COL4A1;BOC;LIFR;DENND2A;EPB41L1;NUAK1;ANTXR1;DZIP1;NGFR;CNTFR;DPYSL3;PRICKLE2;LRP4;FRZB;PDZRN3;CPE;FARP1;THY1;AGAP1;GFRA2;CAP2;NFASC;EDIL3
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.8418390706238053,-1.471226851142243,0.045454545454545456,0.5816719184413943,1.0,2/10,9.38%,BCKDK;NPL
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),-0.9422968491301321,-1.470589952768875,0.02040816326530612,0.5815854006325051,1.0,2/5,1.12%,PAX8;FSHR
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.690524818193738,1.4704215249147228,0.07547169811320754,0.34673824264252223,1.0,14/31,14.82%,KCNMA1;KCNJ3;KCNJ4;KCNMB4;GNG2;KCNJ6;NOS1;KCNMB3;KCNN4;GABBR2;GABBR1;KCNMB2;ANK3;KCNH2
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.6200702212799427,1.468842166599193,0.021739130434782608,0.35154052675955055,1.0,7/44,8.59%,LPL;CARD18;CX3CR1;IGF1;WNT5A;HSPB1;GIT1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.7757411328088406,-1.468354517991322,0.05660377358490566,0.5908202147772762,1.0,4/22,3.91%,RPS27A;UBC;UBB;PCNA
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.5752992541659432,1.468076940038656,0.018867924528301886,0.35345107310063506,1.0,31/101,14.34%,IGFBP3;AQP1;PLSCR4;EGFR;IGF1;PPP1R3C;POSTN;HSD11B2;KIAA1217;PDGFRA;TMEM47;SLC22A3;FBLN1;COL12A1;COL4A1;LIFR;NOS1;EPAS1;VIT;MAFB;MAOB;PAMR1;SPARCL1;LAMB2;PRICKLE2;ADGRF5;FRZB;TACC2;PDZRN3;SYNPO;CPE
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.7630637892473762,-1.4680753445252062,0.017543859649122806,0.5883314672033562,1.0,3/22,2.30%,RPS27A;UBC;UBB
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.6313693373166344,1.4679597161753966,0.024390243902439025,0.3524128387862909,1.0,18/51,14.87%,FGL2;PTPRC;TLR2;NCKAP1L;CSF1R;LCP2;ITGAM;CD53;LILRB1;CIITA;WDFY4;LY86;LAPTM5;AOAH;SASH3;CD80;HAVCR2;HLA-DMA
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.9366944712035659,-1.4677180700044392,0.018518518518518517,0.586263496864451,1.0,2/5,5.76%,TRMT10C;HSD17B10
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.7500163309363246,-1.4675473082809973,0.08620689655172414,0.5834522120913287,1.0,7/19,16.41%,FTSJ3;BUD23;METTL5;TRMT112;TFB2M;MRM3;MTERF4
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.7112777042158573,1.4675462646072674,0.0,0.3525517065024146,1.0,8/31,9.19%,SYT4;RIMS4;LRRK2;RIMS2;SYT1;SYT13;RAB15;SYT7
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.8741259533614902,1.4674696607940485,0.01694915254237288,0.3513903951079064,1.0,3/11,6.22%,PIM1;VSTM2A;FNDC5
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.9380476486196914,1.4673648342999501,0.0,0.35059490281295314,1.0,1/7,0.91%,VSIR
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.7554166411143761,-1.466929629920405,0.05357142857142857,0.5835209189974533,1.0,4/24,5.89%,RPS27A;UBC;UBB;PARP1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.7823761284653354,1.4668323760082478,0.02564102564102564,0.3514059473946439,1.0,4/19,11.07%,PDGFB;EGFR;CCND1;SPDYA
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.5338998530255583,1.4668255495169416,0.0,0.35008487240443853,1.0,33/194,11.19%,ROR1;EPHA3;IFNA2;ANGPT1;EGFR;FLT1;IGF1;NCKAP1L;CSF1R;EPHA4;LRRK2;MET;HGF;PDGFRA;EFNA5;NTRK2;EPHA6;MERTK;SLC4A4;EPHB1;SOX9;AXL;CCND1;CD4;PFKFB3;EPHB3;KNDC1;VEGFD;IRGM;C3;ARNT;P2RY1;CSNK1D
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.650320226187475,1.466765979478264,0.0,0.3489501980124622,1.0,9/41,9.20%,CTF1;ITGA11;UTRN;IGF1;MEF2C;SMTN;DMD;SGCA;MAPK12
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.6053286645847182,1.4667470952533987,0.0,0.34769210661106004,1.0,19/91,13.46%,EPHA3;RND2;CAMSAP3;BAIAP2;PEAK3;ARHGAP18;PAK3;SPEF1;EFNA5;TWF2;RHOQ;RHOF;DIAPH1;DMTN;ARHGAP17;BST1;MAPT;SMIM22;RAC3
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.8745530058345845,-1.4660746077554592,0.04081632653061224,0.5811729507012504,1.0,2/9,4.06%,CA6;TAS2R40
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.8745530058345845,-1.4660746077554592,0.04081632653061224,0.5811729507012504,1.0,2/9,4.06%,CA6;TAS2R40
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.7655296724681993,-1.466074470975302,0.1111111111111111,0.5774474830685501,1.0,1/20,0.25%,ABCA13
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7892874621140485,1.4659232483488505,0.043478260869565216,0.3498596247742098,1.0,8/19,12.13%,CSGALNACT1;VCAN;CHST15;CSPG4;CHST3;NCAN;CHST11;CSPG5
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.9044049440157407,1.4657897044716606,0.0,0.3490438436706148,1.0,1/8,4.37%,PDGFRA
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.7453435222603395,-1.4656984436138347,0.07407407407407407,0.5760074303358619,1.0,4/26,5.89%,RPS27A;UBC;UBB;PARP1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.8723650667981548,1.4654639198049484,0.03636363636363636,0.3484514576754723,1.0,2/10,3.82%,MEF2C;PIM1
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.8355690682200492,1.4654482376846114,0.09090909090909091,0.3472570163048764,1.0,4/8,10.87%,GABRG2;GABRB2;DIAPH1;GABRB3
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.7614937546561524,1.4650926726009983,0.02040816326530612,0.34732286157679004,1.0,4/14,7.74%,IGFBP3;MEF2C;PLCB1;BOC
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.9014018240019152,1.4643810447017636,0.019230769230769232,0.34936617627039657,1.0,2/7,5.43%,CD53;ADGRB1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.9074197320191987,1.4642636170501815,0.0,0.34835280913712285,1.0,1/6,0.33%,TGFB2
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.871815203807168,-1.4640511978318327,0.06666666666666667,0.5818923526764986,1.0,1/8,1.40%,BUB1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.8727739780787317,-1.463214587758192,0.07692307692307693,0.5841780836204509,1.0,2/5,5.17%,DSCAM;SEMA5A
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.6479834670747007,1.463126407850929,0.017543859649122806,0.352640013874921,1.0,11/42,13.98%,NUDT11;IMPA2;PLCB1;INPP5D;INPP4B;PLCB4;NUDT3;NUDT4;ITPK1;IP6K3;PLCB3
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.7070332827709948,1.4629867073245257,0.04,0.3519624103378766,1.0,8/24,9.36%,IGFBP3;PPARG;MEF2C;IL12A;PRKG1;TPM1;NDRG4;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.7531008990107769,-1.4628286650014433,0.016666666666666666,0.5823046808563411,1.0,11/33,12.44%,LCK;DDIT3;RPS3;RPS7;UBB;RACK1;SOD1;SEPTIN4;FIS1;BAX;EIF5A
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.910098284916598,-1.4626840126784817,0.0,0.5796751375674808,1.0,2/8,1.28%,DDIT3;SELENOS
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.5627083391902273,1.4626226065943384,0.021739130434782608,0.35251870815960223,1.0,33/93,15.82%,PDE10A;FIGN;ADAMTS9;FSTL1;RNF150;AKAP12;PCDH18;PTPRG;RUNX1T1;FLRT2;GPR161;TMEM47;CHST3;FBLN1;ADGRL2;TPM1;TENM3;COL4A1;LIFR;PPFIBP1;DENND2A;ANTXR1;DZIP1;AMOTL1;CSRP2;PAPPA;DPYSL3;APBB2;TACC2;RBMS3;FARP1;THY1;LAMB1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.7763229351356185,1.4617441068307855,0.0,0.35433786790769756,1.0,5/24,10.38%,CREB3L1;ADAMTS9;RHOJ;BMPER;SEMA6A
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.7767003527538804,1.4614656027522832,0.08,0.3539139256963621,1.0,3/12,4.07%,PDGFB;IGF1;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.8015628289745869,-1.4614116924891556,0.07407407407407407,0.5829133884720936,1.0,1/13,0.86%,TRMT10C
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.829759112134481,1.46132290677752,0.0,0.35311565096720626,1.0,2/10,3.38%,IL12RB2;IL12A
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.7007354175311131,1.4612048589326145,0.04081632653061224,0.3525319331942268,1.0,10/21,21.69%,CGNL1;MPP4;TJP2;PCLO;DLG4;SHANK1;NLGN1;TJP3;PAK2;JAK1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.7114986171697657,1.4610759278664738,0.05555555555555555,0.3517025518909499,1.0,2/20,3.35%,CLDN5;MEF2C
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.8090743590188056,1.4607182010716548,0.09090909090909091,0.35175019352350756,1.0,5/12,13.37%,C3AR1;SLA2;GPLD1;CR1;LYN
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.8025758606566876,-1.460557419620204,0.05084745762711865,0.5831864790340144,1.0,1/13,0.14%,NGF
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.8139042780477446,-1.4605562204472138,0.11627906976744186,0.5796304639179534,1.0,1/9,1.14%,PDZD11
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.8722807671335198,-1.4601728851142521,0.058823529411764705,0.5782977029206975,1.0,1/7,0.51%,DDIT3
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.7071217510178129,1.4598717448596576,0.05660377358490566,0.3539058054753844,1.0,4/23,2.75%,LPL;FSTL1;POSTN;VCAN
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.8843667351381554,1.4597257883256876,0.037037037037037035,0.3532862940455765,1.0,3/6,7.20%,SNAP25;UNC13C;SNPH
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.7401637181866529,1.459252522505229,0.022727272727272728,0.35361527801264464,1.0,3/19,9.68%,TLR2;BIRC3;IRAK3
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.8821787653043135,1.459211175178635,0.05454545454545454,0.3525919906312932,1.0,1/5,0.45%,KANK2
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.617455775479659,-1.4589582624710131,0.03636363636363636,0.5807102851567276,1.0,25/86,21.64%,RPS27A;UBC;COPS6;UBB;NDC80;PARP1;HMGA2;RFWD3;UBA52;RAE1;POLE3;GPS1;SOX15;TCF7L1;COPS5;HMGN4;PADI2;MSH3;CDCA8;CETN2;CENPH;CDAN1;XPC;COPS7A;EZH1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.7477100158423712,1.4589534679548484,0.0425531914893617,0.35218729187040215,1.0,7/22,11.18%,ROBO2;HEY1;TNFRSF1B;SOX9;TNFRSF1A;ROBO1;BMPR2
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.6057048319166067,1.4579274399953839,0.038461538461538464,0.355116762065822,1.0,14/57,11.75%,SYT4;KCNJ3;NEDD4L;KCNJ4;SYT1;KCNJ6;SYT13;PER1;NKAIN3;NOS1;SYT7;NKAIN1;YWHAH;CHRM1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.858003291592668,-1.4578191225472916,0.03636363636363636,0.5829436922402149,1.0,1/10,1.51%,SFRP1
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.8085629031964223,1.4576890354729697,0.025,0.35498957719889673,1.0,5/15,7.35%,GRIN2B;MEF2C;LRRK2;ARRB2;GRIN1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.5906045714214235,1.4575532627506258,0.0,0.3542580390209562,1.0,33/114,15.16%,L1CAM;CX3CR1;NRCAM;GPM6A;NTNG1;CBLN2;GRM5;CYFIP1;C1QB;CTNND2;GPC6;LRRK2;NRXN1;PAK3;UNC13C;LRFN5;SLITRK3;CACNB1;SHANK2;SNCB;PPFIBP1;AGRN;MAPT;CX3CL1;PCDHB13;LRP4;RAB29;NLGN4X;APBB2;PDZRN3;ANK3;FARP1;CACNB2
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.9341617632460818,-1.4572070614541053,0.02127659574468085,0.582909699893904,1.0,2/6,5.77%,OOEP;FBXO43
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.6896198692690815,-1.4571945829322102,0.06,0.5795100312278703,1.0,22/42,24.43%,GRPEL1;TIMM10;TIMM8B;AIP;SLC25A6;TSPO;FIS1;GRPEL2;TOMM7;TOMM20;TIMM50;TIMM13;TIMM17A;DNAJC19;TIMM9;TIMM44;PINK1;TIMM23;RALA;DNAJC15;TOMM22;TOMM40L
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.7683860862674259,-1.4566210569239093,0.038461538461538464,0.5799887365230122,1.0,5/23,5.89%,RPS27A;UBC;COPS6;UBB;PARP1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.7223015366461805,-1.4565184788831738,0.02127659574468085,0.5772329780599808,1.0,4/20,4.83%,RPS21;RPP40;FTSJ3;EXOSC8
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.8221104038599161,1.4562682301130936,0.1111111111111111,0.3577133954838737,1.0,4/11,7.34%,APOLD1;PRKX;MAFF;SOX9
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.8896074823389787,1.456173807071705,0.017241379310344827,0.3567771999790197,1.0,3/7,9.45%,APOLD1;ZEB1;NOTCH4
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.7417507727144645,1.4561136189619215,0.02040816326530612,0.355767475613611,1.0,6/22,7.21%,LPL;TLR2;CSF1R;C5;WNT5A;ACKR1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.5282209530110529,1.4558278082382834,0.029411764705882353,0.3558392560269907,1.0,36/187,11.18%,LPL;TGFB2;IGFBP3;CDS1;PPARG;NRCAM;BMP6;KITLG;IGF1;BRINP3;LMO3;ASB4;MEF2C;PLCB1;HGF;BMPR1B;NELL1;ZEB1;CDON;ID2;NPNT;DLX1;ZFP36;SOX9;LEF1;BOC;ZBTB16;TP63;BRINP1;MAPK12;TGFB3;SOX5;PLA2G10;PRKD1;MAPK11;BMPR2
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.5772092775184217,1.4557668027436363,0.0,0.3547601511491559,1.0,28/109,10.05%,CD59;FLI1;TGFB2;ANGPT1;FGL2;PTPRC;KITLG;CD44;MGST1;TLR2;STAB1;CSF1R;C1QB;MRC1;PROM1;HGF;CSF3R;MAFF;C3AR1;ROBO4;ADGRG1;WDFY4;LMO2;TAL1;P2RY13;SLC40A1;IRAK3;TMEM176B
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.7176441832778003,-1.4556538777718744,0.07692307692307693,0.5779625445135449,1.0,10/37,8.74%,PAX8;POLR2L;PTMA;THAP1;POLR2G;POLR2K;HOXD3;POLR2I;MLF1;POLR2A
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.7798140411940143,1.4551225209604706,0.10204081632653061,0.3557836920394424,1.0,5/11,6.75%,PDGFB;MEF2C;NR4A3;PRKG1;TPM1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),0.9044616040700315,1.4543415683366074,0.07142857142857142,0.3579430934276665,1.0,3/5,6.32%,PTPRC;NCKAP1L;LILRB1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.4942694051833547,1.4540364375208101,0.0,0.35824229875822144,1.0,71/303,16.46%,CLDN5;PDGFC;PDGFB;VSIR;EGFR;FLT1;NTNG1;OSGIN1;IGF1;CSF1R;SEMA3D;F3;CARMIL2;MCTP1;CAMSAP3;EPHA4;PRKX;LDB2;HGF;PDGFRA;DACH1;TMIGD3;CARMIL1;CITED2;SRC;PPP3CA;ROBO4;PLXNA4;SRGAP1;SULF1;CAMK2B;TPM1;PTPRJ;LEF1;DUSP10;CHRD;PLXNA2;PTPRT;VIL1;CORO1C;KIF14;SEMA6A;ROBO1;ZNF304;AMOTL1;MGAT5;CX3CL1;NGFR;FGF17;SEMA5B;SEMA4G;DPYSL3;SEMA4B;SMIM22;TTBK2;KANK1;ZMYND8;TMSB15B;CDH13;WASHC1;SEMA3C;VEGFA;NTRK3;GPER1;THY1;PTPRK;LAMB1;PHACTR1;CASS4;IGSF10;SEMA7A
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.7877908277897518,1.4538680804870308,0.13043478260869565,0.35775667864228183,1.0,5/11,13.17%,IGF1;PLCB1;IRS1;PIK3R1;GHR
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.5165166961693706,1.453840335612335,0.021739130434782608,0.3566110661382898,1.0,48/199,17.71%,TGFB2;PDGFC;PDGFB;VSIR;PTPRC;EGFR;FLT1;IGF1;NCKAP1L;CSF1R;SEMA3D;F3;CARMIL2;HGF;PDGFRA;CARMIL1;SRC;PPP3CA;SOX9;LEF1;VIL1;DMTN;SEMA6A;BMPR2;ZNF304;MGAT5;SEMA5B;SEMA4G;SEMA4B;SMIM22;TMSB15B;CDH13;WASHC1;SEMA3C;VEGFA;DOCK5;NTRK3;GPER1;PRKCE;NSMF;LAMB1;FERMT1;CASS4;SEMA7A;ARHGEF7;DOCK1;RUFY3;EDN1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.7311495362859509,1.4538027602130523,0.08695652173913043,0.35562854945857075,1.0,7/24,11.80%,CSF1R;MEF2C;PRKX;MET;COL4A1;RASIP1;HES1
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.794390483999586,-1.4532918431679747,0.03773584905660377,0.5856470300146123,1.0,4/18,4.33%,EIF3D;EIF2S2;EIF2S3B;EIF5
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.8258840593242954,1.4531096510894779,0.1276595744680851,0.3575204111133068,1.0,3/7,13.34%,HTR5A;HTR2C;HTR1E
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.7426408496907204,1.4525290369171653,0.05555555555555555,0.35862729646626185,1.0,8/17,16.25%,NRXN1;RIMS2;PRKCZ;RELN;GRIN1;DLG4;SHANK1;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.9209205237016866,1.4517887888339138,0.0,0.35913085147402196,1.0,2/6,2.15%,PPARG;PARP14
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.9209205237016866,1.4517887888339138,0.0,0.35913085147402196,1.0,2/6,2.15%,PPARG;PARP14
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.8706748186081951,1.4517076671948537,0.03571428571428571,0.35827086046109824,1.0,3/7,4.07%,NPAS2;MEF2C;NR4A3
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.5634829720988864,-1.4516608135113656,0.015384615384615385,0.5919450629580613,1.0,20/155,9.06%,CRYAB;RPL5;RPL11;RPL23;RPS7;USP27X;GAPDH;PPIB;PDCL3;PFN1;ATP1B1;CCT7;CCT2;PHB2;GBA3;PYHIN1;USP19;OTUD3;ZSWIM7;NOP53
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.8490270159142739,1.4515406823294381,0.11320754716981132,0.35753082119359814,1.0,4/6,10.87%,GABRG2;GABRB2;DIAPH1;GABRB3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.7875527422682659,1.4514108621653627,0.0,0.3569095728481789,1.0,5/14,11.79%,MCTP1;MEF2C;KCNMB4;SNCAIP;MCTP2
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.9645990054222005,1.4508599279827878,0.02040816326530612,0.35811071747270135,1.0,1/5,2.66%,CAMSAP3
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.788079912151513,1.450487669622864,0.07272727272727272,0.3580957827150985,1.0,4/10,14.17%,P2RY12;RYR3;P2RY1;P2RY11
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.6485844231583563,1.4503151216710675,0.03636363636363636,0.3572904777285653,1.0,11/41,13.98%,NUDT11;IMPA2;PLCB1;INPP5D;INPP4B;PLCB4;NUDT3;NUDT4;ITPK1;IP6K3;PLCB3
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.5428112284013396,1.4497880225434685,0.0,0.35814124126810637,1.0,29/146,16.02%,CREB3L1;CLDN5;TGFB2;IFNA2;PDGFB;IGF1;PARP14;MEF2C;CITED2;ID2;SLC24A3;SH3GL2;MOV10;ROBO1;DLG4;MAPT;PARP9;OLFM1;HAVCR2;RIN3;RBMS3;ZNF148;VEGFA;SFMBT2;GPER1;NOCT;TCEAL1;NOS2;TIPARP
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.6001843533912198,-1.4490624673316377,0.03333333333333333,0.6047202627295035,1.0,26/95,18.67%,ORC1;EIF3D;DDX12P;FTSJ3;TSR1;CHD4;BRPF1;USP19;DDX21;EIF3B;RFWD3;MCM3;NOL6;POLG;ILF3;PRPF8;DHX38;TOPBP1;PTBP1;YBX1;SNRNP200;NOP14;EFTUD2;DDX23;NAT10;PDCD11
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.7726104870639894,1.4490223938855407,0.058823529411764705,0.35951023435378876,1.0,1/15,0.33%,TGFB2
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.7911314948289044,-1.4489804193804714,0.09615384615384616,0.6015695463049338,1.0,2/9,4.83%,RPS21;EXOSC8
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.9235696499951601,1.4486599441533063,0.023809523809523808,0.35964019526674323,1.0,1/6,0.21%,LPL
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.8623706530016755,1.4483116489771133,0.02702702702702703,0.35969500372954216,1.0,3/8,9.45%,SPRED3;ZEB1;NOTCH4
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.7213003962341902,1.4482989897730407,0.08,0.35860093674434446,1.0,8/24,13.67%,PDGFB;FLT1;P2RY12;PDGFRA;IRS1;PRKD1;AMBRA1;TNFAIP8L3
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.7296418580669688,-1.448061535305922,0.06896551724137931,0.6035116594487754,1.0,3/16,8.88%,AMPD1;POLD3;GMPR2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.6504456330749442,-1.44799503028126,0.06666666666666667,0.6003091376616295,1.0,8/32,13.18%,TPX2;CHMP2A;NUMA1;CHMP5;ANKRD53;RAE1;CHMP3;DYNC1H1
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.9148637952906971,1.4478003429336472,0.019230769230769232,0.3595819903560902,1.0,2/6,4.76%,SLC2A9;CARMIL1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.8437876866773284,-1.44768920303039,0.057692307692307696,0.5986379415407896,1.0,3/15,9.11%,SELENOS;SEC61B;TMEM129
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.8704220440290209,1.447454970669929,0.0425531914893617,0.3596732847000108,1.0,1/9,0.46%,REP15
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.7908124835252662,-1.4471760939596672,0.058823529411764705,0.5985655011621974,1.0,3/15,5.81%,TINF2;MBD4;MPG
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.9052391341105527,1.447055469983737,0.022222222222222223,0.3586467306969384,1.0,3/5,8.57%,ZFP36;PDE1B;CD4
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.9052391341105527,1.447055469983737,0.022222222222222223,0.3586467306969384,1.0,3/5,8.57%,ZFP36;PDE1B;CD4
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.9431508555668894,1.4469268853382449,0.03278688524590164,0.35811998304458564,1.0,2/5,4.05%,PPARG;E2F3
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.7492578773089905,-1.4469086463926784,0.05172413793103448,0.5964139922240365,1.0,3/23,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.8398777549693313,-1.446443339022187,0.0847457627118644,0.5958949138055096,1.0,1/9,1.54%,DPEP1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.8625964106041947,1.4455422506821045,0.09090909090909091,0.36250552960290444,1.0,4/9,9.36%,TGFB2;WNT5A;LEF1;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.6920679500459739,1.4455262791509966,0.04918032786885246,0.36139012797335707,1.0,8/25,9.64%,PTPRC;NCKAP1L;CAMK1D;MERTK;PTPRJ;ANO6;SFTPD;C3
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.839775118209421,1.445134800368042,0.0847457627118644,0.3618717377256297,1.0,1/7,0.33%,TGFB2
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.6400357861252541,1.444738381171743,0.0851063829787234,0.3621702534972052,1.0,8/29,11.36%,EPHA4;LRRK2;RELN;SIPA1L1;CAMK2B;LRP8;NGEF;CDK5R1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.9317133043295587,-1.4447181403606018,0.01818181818181818,0.5989655996347028,1.0,1/5,1.27%,JUP
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.9317133043295587,-1.4447181403606018,0.01818181818181818,0.5989655996347028,1.0,1/5,1.27%,JUP
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.8205593168730612,1.444585734905871,0.03636363636363636,0.36178447238512157,1.0,4/10,7.02%,PPARG;CSF1R;PDE1B;PIR
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.7861560685419149,-1.4442875817088354,0.07272727272727272,0.5981246064080975,1.0,4/16,6.81%,SFRP1;FTH1;GSTP1;B4GALT7
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.6146895368514866,-1.4440569967729575,0.045454545454545456,0.5963031652734319,1.0,5/36,8.72%,DYNLRB1;KIF3B;DYNLL1;IFT81;CEP131
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.7854837904295962,-1.4437453627355323,0.09803921568627451,0.5948590955020976,1.0,5/15,8.25%,H1-4;NOC2L;CHAF1B;H1-2;BANF1
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.5598557328900793,-1.4435555048231294,0.021739130434782608,0.5926739157247058,1.0,29/153,13.01%,CYP1A2;CYB5A;F11;JUP;DCXR;AQP9;CYP2E1;SERPINE1;CBR1;SLC35B1;PMM1;ENPEP;HSD11B1;BPHL;CROT;COMT;HES6;ECH1;GSTM4;TMBIM6;NPC1;DHRS1;DDAH2;NQO1;SSR3;AP4B1;PYCR1;HNF4A;SAR1B
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),-0.9011139428989672,-1.4434785252979387,0.0625,0.590290544851461,1.0,2/5,6.89%,GBA3;GLA
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.576758155540385,1.4434713581018788,0.0,0.3652685861830271,1.0,40/104,15.46%,ADAMTS5;MMRN2;AQP1;PLSCR4;CLDN16;FSTL1;IGF1;CGNL1;POSTN;ENC1;SORBS2;LDB2;PDGFRA;DACH1;TMEM47;ROBO4;NRGN;COL4A1;PXDC1;EPAS1;PLXNA2;C3;EDNRB;MAOB;PAMR1;SPARCL1;LAMB2;CX3CL1;ARVCF;SLC11A2;CDH6;PRICKLE2;ADGRF5;TNS1;WLS;FRZB;SYNPO;KCNT1;TIMP3;IL33
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.7085354556629644,1.4433008301271455,0.019230769230769232,0.3646615414797865,1.0,8/26,12.35%,PPARG;FLT1;MEF2C;IL12A;SULF1;PTPRM;NGFR;NR2F2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.6609411257694987,1.4432374357091555,0.03278688524590164,0.3637022220485689,1.0,8/31,9.36%,PDGFB;PPARG;IGF1;MEF2C;NR4A3;PRKG1;TPM1;TGFB3
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.8870304976505984,1.4431631374955538,0.09803921568627451,0.36310355220539137,1.0,1/6,0.78%,PDGFB
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.7582389790554689,1.4427576558325748,0.09433962264150944,0.363676034074217,1.0,6/14,14.17%,P2RY12;RYR3;ABCC9;P2RY1;TRPC3;P2RY11
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.7283798610727179,-1.4426365635450094,0.05555555555555555,0.5915427200790114,1.0,8/29,12.27%,POLR2L;POLR1F;POLR2K;POLR1G;POLR1H;CAVIN1;TTF1;POLR2E
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.8066186259199438,1.4425612443274758,0.0425531914893617,0.3633984985112518,1.0,7/18,12.98%,IFNA2;PTPRC;MEF2C;BCL2;IFNK;CD70;HELLS
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.6653260424568053,-1.4418970235407558,0.0,0.5930007807841322,1.0,25/98,16.14%,RPS27A;UBC;POLR2L;RAD23A;COPS6;UBB;POLR2G;PCNA;PPIE;POLR2K;POLD3;POLR2I;PARP1;POLR2A;POLD4;ZNF830;PNKP;HUS1;POLR2E;UBA52;GPS1;COPS5;ERCC8;POLR2C;POLR2D
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.5681121771979298,1.4417452251710476,0.019230769230769232,0.36561963740837833,1.0,30/89,13.52%,FIGN;MEX3A;GPC6;PTPRG;EFNB3;NR2F1;GPR161;TUSC3;DDAH1;CHST3;ADGRL2;CTXN1;TENM3;KIAA1549;MEIS3;SOX9;TEAD1;BOC;LIFR;GLRB;EPB41L1;ADAMTS15;GTF2IRD1;ANTXR1;DZIP1;LYPD6;PCGF2;NR2F2;LRP4;KCNIP3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.717909801331941,-1.4417153798437645,0.08771929824561403,0.5907836616481943,1.0,7/34,9.25%,RPS27A;UBC;UBB;PCNA;POLD3;PARP1;POLD4
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.6594535997057374,-1.441384131579112,0.05172413793103448,0.5891963558436072,1.0,14/52,13.04%,POLR2L;H1-4;POLR1F;POLR2K;POLR1G;H1-2;SPHK2;MYBBP1A;POLR1H;MYO1C;SMARCA5;DDX21;POLR2E;ELOF1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.8983019101809044,1.4412636059931674,0.0,0.36624964866429893,1.0,4/7,9.08%,PPARG;IL12A;E2F3;CDKN2A
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.5214500495316071,1.4412550247034732,0.0,0.36516285445461255,1.0,33/152,8.97%,CD59;IGFBP3;PCOLCE;CD44;FSTL1;MFAP5;POSTN;VCAN;TNC;FAP;IGFBP4;LOX;COL11A1;CTHRC1;ID2;LAMC1;BASP1;SPOCK1;OXTR;COL5A3;FBLN1;COL12A1;WNT5A;TPM1;RGS4;ADAM12;FBLN2;COL4A1;COL7A1;CRLF1;FBLN5;MEST;VIM
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.8292015547848942,-1.4405337504304268,0.0851063829787234,0.5913770402745088,1.0,3/17,9.11%,SELENOS;SEC61B;TMEM129
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.6315704460325524,1.4402595516064958,0.043478260869565216,0.36812591548479356,1.0,15/37,25.15%,FLT1;LOX;SYK;COL4A1;RASIP1;HES1;VEGFA;EGFL7;SLC1A1;KDR;TGFBR3L;RASA1;NF1;CYP1B1;CCBE1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.7331059303728087,1.4400476482674103,0.08928571428571429,0.36763082116602924,1.0,6/20,11.20%,CSGALNACT1;NDST3;B3GALNT1;FUT9;B3GALT1;B3GNT6
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6546810321754285,1.439857528518107,0.05555555555555555,0.36720794329876766,1.0,12/26,18.82%,MEF2C;BMPR1B;SULF1;SOX9;GPLD1;CREB3L2;SOX5;BMPR2;CCN3;SNX19;SCX;RUNX2
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.9035419126744935,1.4385785910642241,0.03636363636363636,0.3708990488499821,1.0,4/8,8.06%,PTPRC;TOX;PBX1;AXL
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.6153729378688598,1.4385496849932475,0.06666666666666667,0.36991789697413446,1.0,13/57,10.72%,EPHA3;RND2;BAIAP2;PEAK3;ARHGAP18;PAK3;EFNA5;TWF2;RHOQ;RHOF;DMTN;ARHGAP17;BST1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.7896745806157622,1.438246842242561,0.06,0.37021337860822595,1.0,4/13,11.28%,TGFB2;LILRB1;LTBP1;CD200
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.9162231571758572,1.4377872176840674,0.0,0.3705413914608305,1.0,1/6,1.75%,DCX
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.6926629190891881,-1.4377287949512192,0.08620689655172414,0.6036599951157182,1.0,3/33,2.90%,BMP5;SFRP1;SERPINE1
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.7590677999558771,1.4377104532770275,0.0,0.36974055733918604,1.0,8/17,14.70%,SLC8A1;MYH11;SORBS2;PDGFRA;MYLK3;ALPK2;ALPK3;VEGFA
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.8208384806548346,1.4376737720723232,0.06666666666666667,0.36874004533783983,1.0,1/7,2.20%,P2RY12
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.5144421668407416,1.437021098508377,0.0,0.3703257304811361,1.0,45/196,13.58%,TGFB2;BMP6;PTPRC;JCAD;IGF1;TLR2;ENHO;F3;LMO3;LRRK2;NRXN1;RIMS2;SORBS1;KAT2B;CITED2;DACT1;PRKCZ;SRC;IRS1;RELN;SULF1;LOXL3;TSPAN14;GRIN1;LY86;AXL;RAB34;TP63;NOTCH4;DMTN;C3;ARNT;ROBO1;DLG4;NECAB2;HOMER1;MN1;MGAT5;PIK3R1;CD80;PTPN11;WLS;KANK1;SHANK1;CDH3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.7154150498871235,-1.4366187254757148,0.058823529411764705,0.6062141368963255,1.0,6/28,8.20%,POLR2L;POLR3K;POLR3GL;GTF3C6;POLR2K;SNAPC1
prerank,GO_Biological_Process_2021__natural killer cell activation involved in immune response (GO:0002323),0.9764051730165314,1.4364921806209572,0.0,0.3712929040895272,1.0,2/5,0.70%,KLRF2;IFNA2
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.743384253615086,1.4364486689699212,0.08888888888888889,0.3704315783317353,1.0,6/12,16.52%,LILRB1;AXL;TRPM2;LYN;CAMK4;GAS6
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.700098667768863,1.4363703827416758,0.0,0.3697098224632643,1.0,9/33,13.26%,MX1;STON2;SYT1;PACSIN1;SNCB;DNM1;STX1A;AMPH;NLGN4X
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.8711648329594814,-1.435505730182892,0.03389830508474576,0.6095916574745106,1.0,1/8,0.14%,NGF
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.7315291975697801,1.4353759144877534,0.045454545454545456,0.3724830539599,1.0,10/25,13.49%,LRRK2;NRXN1;RIMS2;PRKCZ;RELN;GRIN1;DLG4;NLGN4X;SHANK1;TMEM25
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.723178405001271,1.435375875953352,0.03773584905660377,0.37142486346569575,1.0,7/19,16.26%,PPARG;PARP14;SOCS3;IRGM;PARP9;PIAS1;NLRC5
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.62675477132685,1.435175013731195,0.0851063829787234,0.3712738184297889,1.0,14/63,12.79%,DACT2;NTNG1;ATRNL1;ACTN1;MEF2C;LAMC1;RELN;NTN4;EPHB3;ANTXR1;KIF14;LAMB4;LAMB2;PIK3R1
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.5369727010767766,1.435141694061743,0.0,0.3703248672684338,1.0,44/149,19.63%,MPPED2;FKBP5;CD44;FOS;NPY1R;BHLHE40;CA12;IGFBP4;MREG;SYBU;BCL11B;GFRA1;ABAT;SLC24A3;PEX11A;REEP1;CCND1;ABLIM1;BCL2;OPN3;MAPT;HES1;SCARB1;ITPK1;ADCY1;CCN5;SULT2B1;KAZN;OLFM1;CHPT1;FARP1;NBL1;TIPARP;SLC27A2;RBBP8;PAPSS2;PRSS23;TJP3;SLC1A1;DHRS3;GJA1;ELF1;SIAH2;WWC1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.7642041813205752,-1.4349896668272544,0.0392156862745098,0.6094282298006999,1.0,7/17,17.38%,RASL11A;POLR2L;POLR2K;DHX33;MAF1;EIF2AK3;ATF4
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.7082628217524544,-1.4347241820347227,0.09259259259259259,0.6081734391955241,1.0,9/33,13.09%,POLR2L;POLR1F;POLR2K;POLR1G;POLR1H;CAVIN1;TTF1;POLR2E;TCOF1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.58233443928364,1.4338898535774973,0.06818181818181818,0.3740607553912918,1.0,22/84,18.00%,PDGFC;PDGFB;EGFR;FLT1;CSF1R;LRRK2;DIRAS1;SRC;WNT5A;TENM1;CCND1;IRGM;ROBO1;SPDYA;VEGFA;DIRAS2;ADRB2;RPTOR;PARP16;PIK3R5;EDN1;PKD2
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.7488170982732567,-1.4338330122426062,0.07272727272727272,0.6062839996683063,1.0,12/30,18.06%,POLR2L;POLR2G;POLR2K;POLR2I;GTF2F1;POLR2A;POLR2E;POLR2C;POLR2D;GTF2H2;SUPT5H;POLR2J
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.7488170982732567,-1.4338330122426062,0.07272727272727272,0.6062839996683063,1.0,12/30,18.06%,POLR2L;POLR2G;POLR2K;POLR2I;GTF2F1;POLR2A;POLR2E;POLR2C;POLR2D;GTF2H2;SUPT5H;POLR2J
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.9094957133169599,1.4337577753072153,0.0392156862745098,0.3735064429788172,1.0,3/6,6.94%,PLSCR4;PLSCR1;ANO6
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.7379484097111255,1.4335764926097359,0.04,0.37302123989322855,1.0,3/16,10.21%,MMRN2;TMEM204;ARNT
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.8303315227796652,1.4333429149304946,0.0625,0.3728678452728301,1.0,3/9,15.02%,CX3CR1;UBAP2L;CCN3
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.8605874726576358,1.4326146538200835,0.021739130434782608,0.37448748330096066,1.0,4/7,10.63%,LPL;VSTM2A;C3;PLA2G10
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.6811227536150204,-1.431713690434926,0.06521739130434782,0.6156654793973076,1.0,9/29,12.05%,TBPL2;TCEA2;PRIM1;POLR2A;SMN1;SMARCA5;TAF13;TAF7;TTF1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.6262024185870989,1.4316120082208028,0.024390243902439025,0.37724356663250186,1.0,16/74,10.72%,EPHA3;RND2;CSF1R;BAIAP2;PEAK3;ARHGAP18;PAK3;PDGFRA;EFNA5;TWF2;RHOQ;RHOF;DMTN;ARHGAP17;TRPM2;BST1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.8268589220219514,1.431165160977424,0.12244897959183673,0.3780262031140033,1.0,3/8,8.14%,LPL;MAP2K5;TIRAP
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.8810602057169302,-1.430902084541373,0.03773584905660377,0.6163415734893318,1.0,2/7,3.45%,POLR2L;GTF3C6
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.6134139671721606,-1.430641912761989,0.019230769230769232,0.6146325572011218,1.0,20/67,13.17%,ARHGEF16;TEAD2;TEAD3;KDELR1;EPHB4;RPL8;NOC2L;TUBG1;MRPS2;LRRC59;SLC25A1;SLC52A2;TUBA1C;PSMD3;EIF3B;TMEM54;EIF5A;PYCR1;MBNL3;SAPCD2
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.8160853482709066,-1.430567416514377,0.061224489795918366,0.612124048844094,1.0,3/10,7.10%,CXCR4;DEGS1;SOD1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.8213375376522691,-1.4303623223256015,0.09836065573770492,0.6102896576815386,1.0,2/11,4.72%,PAX8;HOXD3
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.9095437970197127,-1.429796374013085,0.0,0.6098874796543562,1.0,1/6,2.11%,RNF8
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.5742440577279606,1.429743171242574,0.04081632653061224,0.3823845909631088,1.0,22/57,18.85%,GLRA3;GABRA6;GABRG2;GABRA1;GABRB2;GABRA4;GABRA2;ANO5;ANO6;GLRB;GABRR2;GABRB3;GABRG1;ANO4;GLRA2;CLCN3;GABRD;ANO3;SLC12A5;SLC1A1;GLRA1;SLC37A3
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.7035499659727943,1.429714157352253,0.04878048780487805,0.3813961028471591,1.0,8/24,17.03%,SNAP25;DNAJC5;STX1A;PCLO;SYT7;RAB3A;NLGN1;CPLX1
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),-0.7701828440624059,-1.4296699571420737,0.04,0.6077999417811056,1.0,4/14,10.32%,CENPX;EME1;MUS81;HFM1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.6222386069753973,-1.4295399018925106,0.10416666666666667,0.6053721350932078,1.0,23/51,18.54%,WDR74;DDX18;PLK4;CDK4;BYSL;MPHOSPH10;MYBBP1A;GRWD1;HSPE1;NIP7;TFB2M;NOP56;NOC4L;MCM4;EXOSC5;NPM1;TCOF1;RRP9;NDUFAF4;TMEM97;RRP12;IMP4;PUS1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.5512629306096828,1.4286770833220597,0.021739130434782608,0.3841676544534283,1.0,18/87,15.48%,ANGPT1;CHST1;MGST1;CBS;CSGALNACT1;VCAN;CHST15;CSPG4;B4GALT6;CHST3;ST3GAL6;NCAN;CHST11;CSPG5;UST;HPGDS;TPK1;OGN
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.6073601171357235,1.42773821646262,0.022222222222222223,0.38673034765467657,1.0,20/69,10.99%,ADAMTS5;PCOLCE;AQP1;ANGPT1;CPED1;ITGA11;FSTL1;POSTN;FAP;PCDH18;LDB2;PDGFRA;CCDC80;PRKG1;FBLN2;COL4A1;FAT4;COL15A1;PAMR1;AEBP1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.5970529801141394,1.427524345393382,0.04,0.3864462780121242,1.0,11/54,5.64%,EPHA3;PDGFB;EGFR;FLT1;CSF1R;EPHA4;PDGFRA;SYK;SRC;PTPN6;RELN
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.8867599838321022,-1.4270756654667194,0.07692307692307693,0.6122420253590372,1.0,2/5,5.84%,RAB32;CD63
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.8867599838321022,-1.4270756654667194,0.07692307692307693,0.6122420253590372,1.0,2/5,5.84%,RAB32;CD63
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.8083897652073032,1.4270473825768077,0.10810810810810811,0.38706263291320225,1.0,5/10,11.81%,PTPRC;IGF1;TNFRSF1B;CD200;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.7657385075482147,1.427036128656162,0.045454545454545456,0.38607486327178964,1.0,8/14,16.25%,SYT4;CACNA1G;STX1A;RAB15;KCNB1;CACNA1I;RAB3A;NLGN1
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.684633978157029,1.4268553327992084,0.04081632653061224,0.38557137838873246,1.0,5/20,16.70%,CHI3L1;LOXL3;VEGFA;DNAAF1;FGF9
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.6799912084060828,1.426751344783153,0.06382978723404255,0.38487956041147525,1.0,4/31,6.63%,MYO7A;LRRK2;CLVS2;HOOK1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.7888846988017584,-1.4266758107381392,0.08333333333333333,0.6114060542836575,1.0,1/12,3.48%,B4GALNT2
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.719280441144575,-1.4265131787016079,0.05454545454545454,0.609399665753464,1.0,3/23,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.7270968568369515,1.4261224066990938,0.08163265306122448,0.38663673090747813,1.0,7/18,19.15%,AQP1;SCN2A;YBX3;TRPV4;ZFP36L1;PKD2;CAPN3
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.8076922065937692,1.4259410548424447,0.0625,0.38651585090682344,1.0,1/10,2.24%,CSF1R
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.5483639248346719,1.4252228859454803,0.0,0.3884487307409839,1.0,34/112,15.94%,IGFBP3;CD44;FSTL1;POSTN;TNC;FAP;PCDH18;OLFML1;LOX;COL11A1;PDGFRA;CCDC80;NPNT;COL12A1;WNT5A;OLFML2B;SULF1;COL4A1;SOCS3;NOD1;PAMR1;LAMB2;CX3CL1;CCN5;PRRX1;LRP4;ALPL;COL5A1;SFRP4;TIMP3;GPER1;IL33;THY1;NNMT
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.6912474369939141,1.4251949615289266,0.046511627906976744,0.3874415996492612,1.0,3/24,3.70%,NRCAM;IGF1;PLCB1
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.9640383490903233,1.4248361712791198,0.0,0.38801073358158605,1.0,2/5,2.10%,ANGPT1;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.7314536993108984,1.4244508799430902,0.0625,0.38813815979588356,1.0,3/15,3.35%,PPARG;FLT1;MEF2C
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.681642401291155,1.424065509022226,0.06666666666666667,0.3885774220100174,1.0,4/29,6.63%,MYO7A;LRRK2;CLVS2;HOOK1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.7573456445663325,1.423196220993807,0.0784313725490196,0.39088447158333905,1.0,9/15,20.80%,NEDD4L;CBARP;SLC43A1;CAMK2D;HAMP;KCNH2;BIN1;CAV3;ATP1A2
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.9114869865511239,1.4231330984521169,0.05555555555555555,0.3900707181413165,1.0,2/7,3.74%,SYT4;CBARP
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.7017781574284644,1.4229887261945535,0.023809523809523808,0.38944727449272604,1.0,2/24,0.45%,ZNF366;KANK2
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.7213794171991093,1.4229731535338919,0.06666666666666667,0.38848694937561484,1.0,11/23,22.57%,STON2;SYT1;PACSIN1;SNCB;STX1A;AMPH;NLGN4X;NLGN1;SYT5;OPHN1;CEL
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.7659229279063107,1.4229718173856316,0.022222222222222223,0.3874699678327468,1.0,5/15,12.70%,ADCY8;ADCY2;ADCY7;ADCY1;PRKAR1B
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.7050819798722834,1.4229415834667765,0.14285714285714285,0.3864890585236187,1.0,6/18,15.36%,MAFF;ZFP36;CBFB;SULT2B1;SFRP4;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.7290793572455293,1.4227571738097415,0.13043478260869565,0.38621893300267307,1.0,6/14,16.46%,NR4A3;WNT5A;LILRB1;LAPTM5;CAMK4;SEMA7A
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.8942061659010838,1.4226897821254079,0.07017543859649122,0.3853993778899911,1.0,3/6,7.06%,ROBO2;EPHB1;PTPRM
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.81508028897473,1.4225168611759431,0.05555555555555555,0.38507242989962104,1.0,2/8,8.11%,IRS1;ABCD2
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6340057338679769,1.422393781069705,0.12,0.38465584053630697,1.0,8/37,14.70%,PDGFB;ANGPT1;JCAD;RHOJ;HSPB1;PRKD1;AKT3;VEGFA
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.5411153394875438,1.421964267624523,0.02,0.38500052885248726,1.0,37/103,16.68%,SLC2A12;AQP1;EGFR;CGNL1;SLC4A10;GPC6;KIAA1217;EFNB3;TMEM47;DDAH1;CADPS2;ADGRL2;SHANK2;SLC13A4;SOX9;TEAD1;CHRD;EPB41L1;SYT7;DIP2C;FNDC4;DNALI1;HTR2C;LAMB2;CDC42EP4;PRICKLE2;SHROOM3;CHMP1A;FRZB;PDZRN3;CPE;SHROOM2;FARP1;NOTCH3;SLC29A4;SMARCA1;AGAP1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.6540258578778929,1.4216701074121199,0.05555555555555555,0.3843251753834427,1.0,2/28,4.86%,TGFB2;PRICKLE1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.6540258578778929,1.4216701074121199,0.05555555555555555,0.3843251753834427,1.0,2/28,4.86%,TGFB2;PRICKLE1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.7121136617983833,-1.4212425825037034,0.05454545454545454,0.6345419003026959,1.0,3/16,12.42%,TINF2;PARP1;PINX1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.8548121289241983,-1.4208796332443199,0.021739130434782608,0.6334971429588504,1.0,1/9,0.32%,PDE3A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.7090371755725011,-1.420678471927599,0.09259259259259259,0.6317261879452728,1.0,7/36,9.25%,RPS27A;UBC;UBB;PCNA;POLD3;PARP1;POLD4
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.6560630465992034,1.420519400827922,0.018518518518518517,0.38765115562145525,1.0,2/18,3.63%,TEX15;ZNF93
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.7074017011185554,1.4198021442664042,0.08771929824561403,0.39005850567177225,1.0,3/19,5.89%,RHBDF2;IL12A;RSAD2
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.581472743802851,1.419591181119847,0.0784313725490196,0.38999533587499247,1.0,24/97,13.16%,CX3CR1;KCNMA1;TLR2;STAB1;CHI3L1;CSF1R;KCTD12;C1QB;MRC1;CLEC5A;LRRK2;PID1;TMIGD3;C3AR1;OLFML2B;EPHB1;IL13RA1;MAFB;IRAK3;TMEM176B;DYSF;TNS1;RASSF4;CEBPD
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.5432559519728114,1.4194989616551683,0.043478260869565216,0.3892148195835758,1.0,24/113,13.19%,TGFB2;TEX15;DLK2;CLDN16;NUDT11;MX1;KLHDC8A;CAMK1D;HSD11B2;BMPR1B;C5;RSAD2;CLSTN3;PTPRJ;SNCB;ZBTB16;NOS1;KCNQ2;TENM2;CKM;CNTFR;CPEB3;CD80;SLC30A3
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.8189320769728355,1.4192848047323037,0.045454545454545456,0.3890944513584628,1.0,5/7,17.97%,ANGPT1;TJP2;SH3GL2;VEGFA;TJP3
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.6739319048798936,-1.4191815310108649,0.041666666666666664,0.6365638772274361,1.0,6/42,5.56%,CXCR4;KLK6;TNFRSF21;MPZ;DEGS1;PMP22
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.5566148558644531,1.418766970964142,0.0,0.39004575491155935,1.0,10/89,8.74%,KLRF2;SRGN;PTPRC;ISG15;TNFRSF1B;ACKR1;PER1;SFTPD;BCL6;IGF2BP2
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),-0.9055965650221363,-1.4187538087179756,0.05454545454545454,0.635792845399399,1.0,1/5,1.93%,EIF3D
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.5805161418533462,1.4180438501496704,0.02127659574468085,0.39182321730878966,1.0,29/77,15.50%,ADAMTS5;AQP1;ITGA11;FSTL1;SEMA3D;POSTN;SYNPO2;FAP;PCDH18;RHOJ;MYH11;RUNX1T1;PDGFRA;CCDC80;COL12A1;PRKG1;SULF1;COL4A1;FAT4;COL15A1;PAMR1;PRRX1;COL5A1;ASPN;SFRP4;RBMS3;DAAM2;ECM2;THY1
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.6152607217802082,1.4170216747851492,0.0425531914893617,0.39483504296618677,1.0,15/54,13.19%,KCNMA1;PLSCR1;ZACN;NEDD4L;PAM;PPP3CA;SNCB;BCL2;TRPC3;HAMP;HOMER1;MAPT;ANXA11;SLC11A2;SLC30A3
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.7177179636717981,1.4169075905800026,0.0784313725490196,0.3943474587517946,1.0,6/21,16.25%,MEF2C;GRIN3A;CAMK2B;CPEB3;SHANK1;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.75439184968883,-1.4168217542649608,0.09090909090909091,0.6443495383439716,1.0,3/16,16.46%,POLR2G;POLR2D;RPS6KB2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.5558392468182529,1.4168021365234087,0.0,0.39398012948284117,1.0,26/79,14.77%,ROR1;EPHA3;PLPPR5;CAMK1D;ZNF804A;RIT2;TOX;TWF2;RELN;NTRK2;WNT5A;PACSIN1;CAMK2B;TENM3;LRP8;NDRG4;FUT9;PRKD1;CX3CL1;DPYSL3;ATP1B2;SERPINI1;LYN;FES;STMN2;NTRK3
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.7993237267042472,-1.416635238601777,0.11320754716981132,0.6421431686758164,1.0,1/9,1.28%,SELENOS
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.770534316542305,1.416341612176629,0.09615384615384616,0.39467234122700173,1.0,1/12,2.05%,HEY1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.5970439358962624,1.4160886624030726,0.08,0.39471633934654665,1.0,11/69,5.43%,NRCAM;NTNG1;BAIAP2;MEF2C;PLPPR4;MAP2;PAK3;SLITRK5;SLITRK3;CNTN4;ADGRB1
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.7091198304183399,-1.415876369144985,0.05084745762711865,0.6442721022087265,1.0,4/25,5.51%,RPS27A;UBC;UBB;LACC1
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.8851666640570469,1.415846600450009,0.11904761904761904,0.39484782409405933,1.0,2/5,5.19%,NPY;SRC
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.9112470625743562,1.4154276013169471,0.11538461538461539,0.39556191052285594,1.0,1/5,0.21%,LPL
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),0.8573830843483788,1.4151937648771564,0.05660377358490566,0.3955452050164062,1.0,1/8,0.70%,IFNA2
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.8463861335051932,1.4150153724459982,0.09090909090909091,0.39518035414486435,1.0,2/7,7.08%,CHRM3;LYPD1
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.5937437189329496,1.4149044592580804,0.06521739130434782,0.3947304531367944,1.0,9/60,8.19%,LPL;CDS1;PPARG;LMO3;RUNX1T1;ID2;WNT5A;ZFP36;ZBTB16
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.707011980429963,1.414403658619111,0.03636363636363636,0.39566884016543313,1.0,8/23,12.35%,ADAMTS9;PTPRG;PTPRR;ADGRB1;PTPRM;DUSP10;CORO1C;NR2F2
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.738826051276035,1.4143914506642403,0.061224489795918366,0.3947302408066831,1.0,2/15,4.55%,CSF1R;C5
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.8978217529672874,1.4140924732863822,0.037037037037037035,0.3950031260846609,1.0,1/6,0.78%,PDGFB
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.7766933028820256,1.4140418571417235,0.06521739130434782,0.39415671168967814,1.0,3/11,7.55%,ADRA1A;TPM1;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.6777347338916334,1.4137296659718692,0.08695652173913043,0.39411510432629066,1.0,13/30,15.22%,KCNMA1;KCNJ3;KCNJ4;KCNMB4;GNG2;KCNJ6;KCNMB3;KCNN4;GABBR2;GABBR1;KCNMB2;KCNH2;FHL1
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.5424468336905232,1.4137238242694228,0.044444444444444446,0.39318935759048046,1.0,18/66,13.26%,RND2;ZNF423;RIMS4;MEX3A;FBN3;EFNB3;CAMKV;TMEM200C;CACNA1B;LEF1;UNC5D;KCNQ2;SEMA6A;NKAIN1;GABRB3;SEMA5B;VASH2;NLGN4X
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.783551448770885,1.413516667569062,0.05555555555555555,0.39315028783295275,1.0,1/16,0.95%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.7283819077204627,-1.4129549863296738,0.08928571428571429,0.6575361166058626,1.0,5/16,15.75%,CCT7;CCT2;CCT6A;DKC1;CEP120
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.719730780660774,-1.412362545922853,0.07017543859649122,0.6579638137514786,1.0,4/28,7.07%,LSM7;LSM2;EXOSC8;NT5C3B
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.6520868405648006,1.4123337934901024,0.0,0.39648977405007785,1.0,10/28,11.18%,BMP6;SLC8A1;MEF2C;ISG15;BMPR1B;ADGRV1;NELL1;ANO6;TGFB3;BMPR2
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.6939482593584809,1.4121399641760248,0.06,0.39598981603309924,1.0,5/19,16.70%,CHI3L1;LOXL3;VEGFA;DNAAF1;FGF9
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.8498074940112265,-1.4121299840745107,0.0392156862745098,0.6568191242974173,1.0,2/8,3.45%,POLR2L;GTF3C6
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.6974506901886655,-1.4120720045254527,0.1111111111111111,0.6541601942664927,1.0,7/31,7.85%,KRT86;ARHGEF16;S100A16;TNS4;HR;CDSN;LAMB3
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.7547901687273995,1.4119972106485437,0.10869565217391304,0.39549225589629816,1.0,4/18,4.63%,SYT4;NEDD4L;RIMS2;SYT1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.8170571346125336,1.411938882252175,0.022222222222222223,0.394771589302033,1.0,4/10,9.19%,RIMS2;UNC13C;SYT1;SYT7
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.7346012558942007,1.411768688135376,0.022222222222222223,0.39427931161631696,1.0,5/25,6.01%,DPP10;KCNIP4;KCNIP1;FGF12;KCNIP2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.7531529187668575,1.4110854068703198,0.041666666666666664,0.39503684464675887,1.0,3/14,8.14%,NCKAP1L;CAMK1D;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.7531529187668575,1.4110854068703198,0.041666666666666664,0.39503684464675887,1.0,3/14,8.14%,NCKAP1L;CAMK1D;TIRAP
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.8977054352469506,1.4109997374466379,0.058823529411764705,0.3942682507367431,1.0,1/7,1.95%,CBS
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.9466630723565203,-1.410867013976805,0.019230769230769232,0.6576324925108129,1.0,1/5,2.75%,GREM1
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.7238681984509184,1.410770266679367,0.024390243902439025,0.39417175622696515,1.0,8/26,16.42%,NTNG1;ADGRG1;CAMK2B;SEMA6A;CX3CL1;NSMF;PHACTR1;IGSF10
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.7545384081849703,-1.4106064221530568,0.09836065573770492,0.656283270975684,1.0,10/18,12.44%,RPL23;RPS7;UBB;RPS15;RPS20;DDX5;RPL37;PLA2R1;HEXIM1;EIF5A
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.8311244989799058,1.4102188274492589,0.07547169811320754,0.3952983463781159,1.0,3/8,8.41%,CARMIL1;MAPKAPK3;RAB34
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.8736125470113995,1.4098280152173197,0.03636363636363636,0.3963364699701788,1.0,3/6,10.52%,NR4A3;PTPRN;SGPP2
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),-0.8636347861522441,-1.409742605304362,0.0392156862745098,0.6578812164133901,1.0,1/10,0.59%,KLK6
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.6106085705190955,1.4096369122262242,0.0,0.39637408291692505,1.0,7/47,6.65%,PLSCR1;MX1;TRIM5;BTBD17;ISG15;RSAD2;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.6505331699220108,1.4093071687895127,0.017543859649122806,0.3963011524546777,1.0,10/31,11.18%,BMP6;SLC8A1;MEF2C;ISG15;BMPR1B;ADGRV1;NELL1;ANO6;TGFB3;BMPR2
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.765699041788614,-1.409248796619597,0.057692307692307696,0.657967417748137,1.0,1/10,0.20%,CELA2A
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),0.8446594082765604,1.4092187836646635,0.06666666666666667,0.3955954339197217,1.0,4/7,12.58%,P2RY12;SFTPD;EDNRB;LGALS3
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.8451299142855804,1.4091495568094445,0.10204081632653061,0.39419384408518116,1.0,5/8,11.24%,CACNG5;CACNG2;CACNG8;CACNG3;DLG4
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.8451299142855804,1.4091495568094445,0.10204081632653061,0.39419384408518116,1.0,5/8,11.24%,CACNG5;CACNG2;CACNG8;CACNG3;DLG4
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.6245328431749823,1.4089260502930911,0.09090909090909091,0.39423599197659387,1.0,6/29,7.38%,IGF1;GRM5;EPHA4;CACNB1;GRIN1;CACNA1B
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.8729486769401212,1.408480761885733,0.08888888888888889,0.39495975622248436,1.0,1/7,1.80%,IGF1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.6179026149952638,1.4079110682124378,0.045454545454545456,0.3958162248187019,1.0,8/52,6.64%,EPHA3;MCTP1;NEDD4L;STON2;RIT2;SRC;LILRB1;PACSIN1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.7800656171064835,1.4077330844523501,0.09433962264150944,0.39552858180309164,1.0,2/13,4.07%,PPARG;NR4A3
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.8527845703668847,1.4075548542217864,0.1,0.39516100816385175,1.0,2/5,7.61%,RELN;LRP8
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.839208479545184,1.4069423075670264,0.019230769230769232,0.39652454485311306,1.0,2/6,11.81%,CX3CR1;CX3CL1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.5828139135247699,-1.406823338601558,0.038461538461538464,0.6682735668491511,1.0,13/91,9.04%,PM20D1;PLAAT5;PDZD11;ACSM6;ORMDL2;DBI;GLYAT;ORMDL1;ACOT1;PLPP2;SMPD2;PLAAT4;DHFR
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.8387609738994551,-1.406801117238574,0.07547169811320754,0.6655978984732032,1.0,6/12,15.33%,CRYAB;PFDN2;VBP1;PFDN1;PFDN6;CHRNA7
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6976003395044148,1.406652303760668,0.07407407407407407,0.39661470147852346,1.0,6/21,16.25%,RELN;CAMK2B;LRP8;CPEB3;SHANK1;NLGN1
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.8448618285502443,1.406629909913749,0.08928571428571429,0.39576298618947053,1.0,1/7,0.33%,TGFB2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.83802664089236,1.406514938122329,0.08163265306122448,0.3954519029717432,1.0,5/11,10.62%,PKP2;ADAMTS9;ID2;TPM1;HOPX
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.773013240566528,1.4063847879040965,0.05,0.3952761167508768,1.0,3/16,6.12%,RIMS2;CARTPT;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.8267714890957457,1.4056137091160532,0.06818181818181818,0.39699795512285996,1.0,4/10,16.02%,CLDN5;TNFRSF1A;VEGFA;ADD1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.9222592113326872,1.4053922240656256,0.0,0.3969260882007207,1.0,2/7,1.59%,CREB3L1;ADAMTS9
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.6107934297671147,1.4050876217584178,0.09523809523809523,0.3972800699757176,1.0,14/52,8.99%,SLA;PTPRC;SIGLEC10;IKZF2;NCKAP1L;LCP2;ITGAM;CD53;CSF3R;C3AR1;ARHGAP25;TNFRSF1B;LY86;LAPTM5
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.8667630127468985,1.4049550121781436,0.08928571428571429,0.39675679016521737,1.0,3/8,5.29%,LPL;PID1;IRS1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.6362102382856833,1.404415813284634,0.045454545454545456,0.3975861247005421,1.0,15/37,14.16%,GRIK2;GRM5;GRIN2B;GRIK1;PLCB1;GRM1;GRIN3A;GRIN1;GRM6;GRM2;KCNB1;CDK5R1;HOMER1;TRPM1;GRM8
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.714355754730737,-1.4041838816668006,0.06349206349206349,0.6793160965562204,1.0,7/22,19.96%,RASL11A;NCL;DHX33;PIH1D1;EIF2AK3;ATF4;DDX11
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.7633195126575725,-1.4037676168891378,0.03571428571428571,0.6785907374095687,1.0,5/17,13.18%,TPX2;NUMA1;ANKRD53;RAE1;DYNC1H1
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.8404439806740925,1.4034082827056642,0.13725490196078433,0.4002873027424456,1.0,5/7,11.81%,CX3CR1;C1QB;ITGAM;C3;CX3CL1
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.7695134996305618,1.4025529347731505,0.10344827586206896,0.40305546680498966,1.0,1/11,0.33%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),0.6321600282033513,1.401998841935872,0.0,0.40418076953003423,1.0,5/34,5.89%,PLSCR1;MX1;BTBD17;ISG15;RSAD2
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.7188925634238988,1.4015940814730155,0.058823529411764705,0.40464506297586433,1.0,7/13,23.42%,PIK3AP1;ITGAM;TIRAP;PRKCE;LBP;LY96;SCIMP
prerank,PanglaoDB_Augmented_2021__Pericytes,0.5564631233197372,1.4008973847125745,0.02,0.40591892128535156,1.0,39/104,16.80%,ADAMTS5;AQP1;PLSCR4;ANGPT1;FSTL1;POSTN;SYNPO2;FAP;PCDH18;CSPG4;LDB2;PDGFRA;ROBO4;MYO1B;INPP4B;ABCC9;FBLN2;COL4A1;VIM;COL15A1;PAMR1;SPARCL1;PDZD2;PRRX1;ADGRF5;ANGPT2;TNS1;ALPL;FRZB;ASPN;DAAM2;VEGFA;TIMP3;ECM2;THY1;NOTCH3;CYGB;C1R;ELN
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.6257109749536884,-1.4006805585547564,0.12244897959183673,0.6923864168269321,1.0,20/66,18.20%,POLR2L;POLR3K;POLR1F;POLR2K;POLR1G;CSTF2T;POLR1H;LSM10;POLR2A;CAVIN1;SMN1;CSTF2;TTF1;POLR2E;SNRPB;SNRPE;SSU72;SNRPG;GTF2H2;FIP1L1
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.7526982147913643,-1.4006466882582373,0.058823529411764705,0.6896180851666942,1.0,1/15,0.86%,TRMT10C
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.8844790677622937,-1.4004412284100582,0.04081632653061224,0.6877948583454806,1.0,1/6,7.70%,CD81
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.7342084665175266,1.4001259590316781,0.08163265306122448,0.407605106695433,1.0,3/14,10.72%,CSF1R;CAMK1D;BST1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.5315641964953185,1.3998409380645456,0.021739130434782608,0.4077198883067945,1.0,19/101,13.85%,EGFR;OSGIN1;CSF1R;CAMSAP3;ARHGAP18;PRKX;LDB2;NRG1;ROBO4;PLXNA4;FBLN1;DIAPH1;PLXNA2;KIF14;AMOTL1;FGF17;TTBK2;FES;TMSB15B
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.7027279793491107,-1.3988254431610978,0.12727272727272726,0.6940350281058729,1.0,7/31,12.27%,POLR2L;POLR1F;POLR2K;POLR1G;POLR1H;CAVIN1;POLR2E
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.7675028430348886,1.3984309363892837,0.08695652173913043,0.41196946268683293,1.0,4/10,11.81%,PTPRC;LRFN5;CD200;CX3CL1
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.723928355906222,1.3982780570400997,0.06666666666666667,0.41189246932843465,1.0,8/28,10.19%,SCN9A;TTC8;MYO7A;ADGRV1;PNOC;PCDH15;GNAL;CDH23
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.6785246871590496,1.3973690532798773,0.020833333333333332,0.4140944733351909,1.0,1/24,0.33%,TGFB2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.8265317968132404,-1.3973171220202452,0.07017543859649122,0.7001876094845217,1.0,3/8,4.69%,RPS7;UBB;PTTG1IP
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.7943159702883125,1.3970247795279476,0.05357142857142857,0.41481410662505086,1.0,2/11,5.26%,CSF1R;ID2
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.8146849939304218,1.3967466551347154,0.08695652173913043,0.41478295515070146,1.0,4/8,11.77%,PKP2;GFAP;VIM;NEFL
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.8048188185760152,-1.3966035956244056,0.12244897959183673,0.7012132829710506,1.0,2/9,12.13%,FBXO43;AURKAIP1
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.8066588093036154,1.396445383480084,0.057692307692307696,0.41482911243237564,1.0,4/13,8.03%,TGFB2;CAMSAP3;SCEL;CELF4
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.7738757003169872,1.3963997333930942,0.1,0.41420769547022135,1.0,6/14,10.63%,LPL;VSTM2A;NFKBIA;MEST;C3;PLA2G10
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.6502131621996082,1.3959342115539584,0.1111111111111111,0.4151001117204342,1.0,8/30,11.05%,TLR2;PLCB1;SYK;LILRB1;TIRAP;LAPTM5;IRAK3;MAPK11
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.6382898265739311,-1.3958609567129359,0.07407407407407407,0.7029624075202675,1.0,22/48,24.43%,GRPEL1;TIMM10;SAMM50;TIMM8B;AIP;SLC25A6;TSPO;FIS1;GRPEL2;TOMM7;TOMM20;TIMM50;TIMM13;TIMM17A;DNAJC19;TIMM9;TIMM44;TIMM23;TIMM29;DNAJC15;TOMM22;TOMM40L
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.6560004849755384,1.3957349443488842,0.022727272727272728,0.4150686101393647,1.0,7/33,7.61%,PDGFB;PTPRC;CSF1R;GRM5;EPHA4;RELN;LRP8
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.7107782008102136,1.395569146434022,0.045454545454545456,0.4145527160406871,1.0,6/18,6.67%,TP73;PRNT;TXNDC8;CAPN1;SYCP3;GCNA
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.8028186331943477,1.3955327096091419,0.11320754716981132,0.4129943752860509,1.0,4/9,13.03%,SORBS1;PRKCZ;IRS1;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.8028186331943477,1.3955327096091419,0.11320754716981132,0.4129943752860509,1.0,4/9,13.03%,SORBS1;PRKCZ;IRS1;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.7041567826100162,1.3954457741317243,0.05454545454545454,0.4124355962675368,1.0,5/22,10.21%,PDGFB;IGF1;SLC4A4;PFKFB3;ARNT
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.9007533686857938,-1.395281934430434,0.038461538461538464,0.7034820815060178,1.0,3/6,7.61%,OOEP;MEIOSIN;RAD51AP1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.7528811821252279,1.3950489671587927,0.13333333333333333,0.4132444770979885,1.0,5/15,11.24%,NTNG1;GRIP1;WNT5A;MOV10;DLG4
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.8468789527372058,-1.3949573906774326,0.10909090909090909,0.7024072871721613,1.0,1/5,6.52%,TMEM107
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),-0.920993228634245,-1.3949210285148006,0.03508771929824561,0.6968212785751395,1.0,1/5,4.56%,XG
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.920993228634245,-1.3949210285148006,0.03508771929824561,0.6968212785751395,1.0,1/5,4.56%,XG
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.8659562211330329,-1.3948341768031516,0.07017543859649122,0.694489295519784,1.0,5/9,12.71%,CRYAB;PFDN2;VBP1;PFDN1;PFDN6
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.8080753233266983,1.3948025845347263,0.08333333333333333,0.41379760892195694,1.0,4/8,13.37%,NCKAP1L;MEF2C;DOCK11;LYN
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.5312064933587503,1.3947312098235354,0.022222222222222223,0.41311482261975935,1.0,32/108,13.64%,ROR1;EPHA3;ROBO2;PLPPR5;CARMIL2;CAMK1D;ZNF804A;RIT2;CARMIL1;TOX;GRIP1;TWF2;RELN;NTRK2;PLXNA4;WNT5A;TIAM2;CAMK2B;TENM3;NDRG4;PLXNA2;FUT9;PRKD1;ROBO1;DLG4;CX3CL1;NGFR;DPYSL3;ATP1B2;SERPINI1;LYN;FES
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.6909092040063752,-1.3946209106896645,0.05660377358490566,0.6924143199174777,1.0,9/25,17.27%,ATP5F1B;SAMM50;UQCC3;ATP5MC3;ATP5PF;APOO;ATP5PB;CHCHD6;ATP5PD
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.6144549772518269,-1.3945584512688716,0.11864406779661017,0.6900513228301384,1.0,8/48,9.55%,ARHGEF16;GPRC5C;S100A16;CLDN2;GJB1;TMEM125;LAMB3;CFTR
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.5540363289382819,1.39454911430327,0.043478260869565216,0.4131634541070465,1.0,25/90,13.04%,FIGN;KITLG;EGFR;FSTL1;PTPRG;LRIG3;LAMC1;DDAH1;MYO1B;CHST3;COL12A1;WNT5A;ADGRL2;TENM3;TEAD1;COL4A1;LIFR;CCND1;ADAMTS15;NUAK1;ANTXR1;LAMB2;PCGF2;NR2F2;LRP4
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.9175682135343467,1.3945000743560432,0.04,0.41240972018806016,1.0,1/6,0.33%,TGFB2
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.6654832118927917,-1.3944724959388752,0.09433962264150944,0.6875049863160628,1.0,4/50,5.46%,CYP1A2;GPC4;GPC2;AWAT2
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.8294639947483595,1.393779210292576,0.11764705882352941,0.41431069524174224,1.0,1/9,0.04%,CLEC2A
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.7995979643879711,1.3931745897220134,0.18604651162790697,0.41557958446698257,1.0,3/9,14.26%,BMPR1B;BMPR2;SFRP4
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),0.6298519233448222,1.393147385427031,0.06382978723404255,0.41482552300338094,1.0,7/25,16.26%,ISG15;PTPN6;WNT5A;SAMHD1;PTPN11;TTLL12;NLRC5
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.8624777204687377,1.393145040809853,0.047619047619047616,0.4139503636721502,1.0,5/8,13.77%,HEY1;MEF2C;TMEM204;EDNRB;MRTFB
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.6905159639733002,1.3930984439300083,0.0784313725490196,0.41327731789493205,1.0,5/17,15.72%,NCKAP1L;RHOQ;FMNL3;FHOD1;FMNL1
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.8225861736483386,-1.3928269401704716,0.08823529411764706,0.6927400485780072,1.0,1/6,1.82%,DCXR
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.5985878464178507,1.3928244301731587,0.0196078431372549,0.4131021295552941,1.0,12/65,10.57%,EPHA3;EPHA4;EFNA5;NTRK2;SIPA1L1;PLXNA4;PRKG1;RASIP1;NOS1;PLXNA2;EPHB3;NGEF
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.7979086362202364,1.3925269490844052,0.12962962962962962,0.4133722683027413,1.0,3/13,6.22%,PIM1;VSTM2A;FNDC5
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.7916343343476512,1.3919810371156425,0.0,0.4150955036323428,1.0,4/16,11.07%,PDGFB;EGFR;CCND1;SPDYA
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.7031697798888268,-1.391833483790469,0.0784313725490196,0.6954235217415954,1.0,6/21,16.06%,LACTB2;TRIR;RNASE1;TOE1;POP7;NHP2
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.899210256423814,1.3917901925233036,0.06,0.4147700379746701,1.0,3/6,8.98%,PDGFRA;ID2;EPHB3
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.8171913780020136,1.3917226725384142,0.038461538461538464,0.41407775022275783,1.0,5/10,7.30%,BEGAIN;NPTX2;CACNG5;DLGAP1;NPTX1
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),0.8961678816576208,1.391635320085303,0.046511627906976744,0.41351081192549693,1.0,2/5,2.20%,CX3CR1;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.7053583591921634,1.3915464279089478,0.1276595744680851,0.4130928862656108,1.0,4/14,16.26%,ISG15;SAMHD1;TTLL12;NLRC5
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),0.8868806597500571,1.3915417829695165,0.041666666666666664,0.4122620142494019,1.0,2/5,2.20%,CX3CR1;P2RY12
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.8433465384985219,1.3914076555265906,0.10638297872340426,0.41184839571554027,1.0,6/11,12.96%,IFNA2;PTPRC;MEF2C;BCL2;IFNK;CD70
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.8424056868076117,-1.3913043236443716,0.08333333333333333,0.6956858912781326,1.0,3/8,6.89%,FUCA1;GBA3;GLA
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.8773683699739654,1.391230534842673,0.08333333333333333,0.4119223262245683,1.0,2/6,6.74%,ANGPT1;EPHB1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.5895059543604223,1.390944558324262,0.025,0.41231110091190676,1.0,14/60,17.89%,HIPK4;GALNT3;LRRK2;GALNTL6;HIPK3;CAMK2D;DYRK2;PRKD1;CDK5R1;DYRK3;PRKCD;DYRK1B;CSNK2A1;CDC42BPA
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.695513782049638,1.3905825926635524,0.1111111111111111,0.4127950486184898,1.0,3/13,5.64%,TGFB2;GCM1;RELN
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),0.8989015308315974,1.3901901429092998,0.07692307692307693,0.4132528700999706,1.0,1/5,6.16%,SAMHD1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.8713148605587456,1.3894713916627899,0.0392156862745098,0.4147689313856464,1.0,2/8,5.43%,CD53;ADGRB1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.6660699185941533,-1.3892362632145892,0.07017543859649122,0.7047434374991564,1.0,8/44,11.16%,LCK;DDIT3;RPS3;HYAL2;RACK1;SEPTIN4;FIS1;BAX
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.7019550902769335,-1.3892153973179329,0.10344827586206896,0.702057088283755,1.0,2/27,2.90%,BMP5;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.5436659291175573,1.3891544634423834,0.0425531914893617,0.414956368678283,1.0,15/79,13.29%,LPL;PDGFB;BMP6;PLSCR1;TLR2;P2RY12;WNT5A;STX3;NFKBIA;LY86;TNFRSF1A;CX3CL1;IFNK;PUM1;NFKBIZ
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.7753525311586152,-1.3888160293882266,0.078125,0.7019608844797655,1.0,4/15,7.06%,P2RY10;LCK;KLRB1;PYHIN1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7949916176578563,1.3886835656599756,0.11764705882352941,0.41581491145695215,1.0,1/9,0.44%,MMRN2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.7346100088365531,1.3877810337999825,0.10204081632653061,0.4187293674957795,1.0,7/16,16.90%,VSIR;DUSP10;BCL6;CBFB;CR1;TNFSF4;KAT2A
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.5071178164934552,1.3876680422213212,0.0,0.4184774672795957,1.0,42/188,14.74%,SCN9A;ACBD7;CYB561;CFAP126;FGF12;TTC9;MAP2;ABHD3;CARTPT;SYBU;EFNB3;CDK5R2;NRG1;SPEF1;EFNA5;CNTN4;MACROD1;SPOCK1;NYAP1;CTXN1;GNAL;MEIS3;PCLO;TESC;NDRG4;EPB41L1;SYT7;MORN5;MEIG1;FLRT1;NRSN2;FSTL5;CCDC184;EFNA3;CSPG5;GOLGA7B;GPC1;TMEM59L;ARL6;CPE;PRR36;SRRM3
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.5809668038506789,1.387514319184759,0.06666666666666667,0.41805963970182397,1.0,10/48,8.65%,RHBDF2;MCTP1;RAB3C;MEF2C;RIMS2;KCNMB4;SYT1;STXBP5L;SNCAIP;RAB15
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.770790869926675,1.3871717870257787,0.08163265306122448,0.41864315991697443,1.0,6/12,11.36%,EPHA3;NRCAM;EPHA4;CNTN4;EPHB3;CDK5R1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.5902909333798165,1.3871359161494903,0.025,0.41787038158510564,1.0,14/54,20.91%,HIPK4;LRRK2;HIPK3;CAMK2D;DYRK2;PRKD1;CDK5R1;DYRK3;PRKCD;DYRK1B;CSNK2A1;CDC42BPA;TNKS;ULK1
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.5747727817836921,1.3871029155426056,0.04,0.41702959610907925,1.0,8/48,10.20%,REP15;MX1;SYK;LILRB1;ARRB2;DNM1;KIF16B;MVB12A
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),0.9184052321279508,1.38666813568136,0.037037037037037035,0.41765898557688164,1.0,2/5,6.56%,AQP1;YBX3
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.7153597582879809,1.3865993824430003,0.02564102564102564,0.4171525423875765,1.0,6/21,12.53%,GRIN2B;MEF2C;LRRK2;ARRB2;GRIN1;INSYN2A
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.8171598470616075,1.386453267850633,0.0847457627118644,0.4167659419953956,1.0,1/8,1.95%,CBS
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.6865218169881773,-1.385511828479946,0.125,0.7172845599490434,1.0,2/26,3.84%,MSRB1;MSRB2
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.8078706158480863,-1.3849888084712993,0.1875,0.7172930179130761,1.0,3/7,14.76%,SFRP1;MEOX1;UFL1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.5034645558948048,1.3845398940372091,0.0,0.4226597562766277,1.0,40/155,21.96%,CDS1;PLSCR1;PLEKHA2;DGKB;ABHD3;INPP5D;PIP5K1B;INPP4B;LPCAT4;SLC44A5;ETNPPL;PLA2G10;GPAT4;PLEKHA4;TPTE2;GPAT3;PIK3R1;PIP4K2A;CHPT1;INPP5E;ABHD5;PLA2G4A;ACHE;ACP6;PIK3R5;AGK;CSNK2A1;ETNK1;CHKA;DGKD;BMX;ABHD8;PTEN;DGKE;DGKA;PTPN13;PIK3C3;CDS2;PTDSS2;MTM1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.7056671973047727,1.3842092585487482,0.08888888888888889,0.42289740280214755,1.0,3/21,7.06%,PNLDC1;ZFP36;CNOT11
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.6960721525707996,1.3841815908822246,0.11904761904761904,0.4221034982337007,1.0,2/19,1.59%,TGFB2;ADAMTS9
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.7783636617138368,1.3841776416903588,0.09615384615384616,0.4212659912927608,1.0,7/14,16.14%,LPL;PID1;IRS1;SOX9;GLDC;PDK4;UCP1
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.8062540351528349,1.3839903199834283,0.09803921568627451,0.4212016946375489,1.0,4/7,13.64%,ADGRE2;SYK;LYN;FES
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.6947768762094667,1.3836591876220037,0.08928571428571429,0.4215101960698812,1.0,6/17,11.80%,HEY1;CNTN4;DTX1;DLX1;SOX9;HES1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.5415847230099874,1.3835375065797648,0.024390243902439025,0.4211435764498888,1.0,49/116,18.04%,ZNF423;FIGN;CHST1;CBS;PPP1R3C;GPC6;PLPPR4;DCLK1;EFNB3;NR2F1;GFRA1;TMEM47;CHST3;ADGRL2;TENM3;MEIS3;TEAD1;COL4A1;BOC;LIFR;NOS1;NDRG4;EPAS1;EPB41L1;VIM;FNDC4;NUAK1;ANTXR1;GAP43;TNFRSF1A;CNTFR;DPYSL3;PRICKLE2;GPC1;TMEM59L;LRP4;FRZB;ABCC8;PDZRN3;CPE;SRRM3;THY1;SMARCA1;GFRA2;CAP2;NFASC;GUCY1A2;EDIL3;SMIM10L2B
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.7648143840708505,1.3833847019516863,0.06818181818181818,0.42087116952475223,1.0,6/17,9.79%,PKP2;FGF12;CACNA1G;SCN3B;SCN1A;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.5409643734289411,1.3830490390467056,0.0,0.4210627682235529,1.0,27/123,17.11%,TGFB2;PDGFB;PTPRC;CSF1R;GRM5;EPHA4;PAK3;LCP2;SRC;RELN;LRP8;CD4;IRGM;KIF14;CAMKK1;SPDYA;DLG4;TNIK;VEGFA;PAK5;ADRB2;RPTOR;CASS4;GAS6;PRKCD;PARP16;CDKN1A
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.6947554991434772,1.3829236119467414,0.11363636363636363,0.42062987836708254,1.0,3/21,5.01%,EPHA3;CAMSAP3;EFNA5
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.7965648313646984,1.3827604343300954,0.03773584905660377,0.420313963641525,1.0,4/10,9.68%,TGFB2;LILRB1;TGFB3;IRAK3
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.793353269348566,-1.3826211999450606,0.11320754716981132,0.7274899806384995,1.0,2/9,1.48%,CCDC78;STAC3
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.7046807280015202,1.3824629496317205,0.09090909090909091,0.42085069504801526,1.0,9/20,20.06%,EPHA3;MCTP1;LILRB1;PRKD1;LGALS3;RUBCN;PROM2;SCAMP5;SNX33
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.7575517837948876,-1.38209403525414,0.0851063829787234,0.7280424703056257,1.0,4/12,12.94%,CCT7;CCT2;CCT6A;DKC1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5822351266877027,1.3820134640674442,0.07692307692307693,0.4217527944392503,1.0,13/56,12.79%,FLT1;NCKAP1L;CYFIP1;BAIAP2;SRC;SULF1;HSPB1;MAPKAPK3;AXL;VEGFD;PRKD1;MAPK11;PIK3R1
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),0.8938080870318945,1.3816187592307003,0.1,0.42244508931548014,1.0,2/5,6.07%,ABCB4;SLC22A16
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.8535649519041145,-1.3815924928494916,0.08771929824561403,0.7279446940035692,1.0,2/9,1.02%,PRELID1;IFNLR1
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.7787784051066842,1.3812117094021663,0.05263157894736842,0.42288304765470797,1.0,3/10,8.30%,P2RY12;SRC;RASIP1
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.671849762658917,1.381116380006632,0.07407407407407407,0.4222690016746218,1.0,10/30,12.11%,PTPRC;PLSCR1;TLR2;CAMK1D;SYK;MERTK;SFTPD;SYT7;DYSF;SCARB1
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.7888549291726988,1.38109492617556,0.02,0.42149781096514155,1.0,5/10,12.13%,VCAN;CSPG4;HEXB;NCAN;CSPG5
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.8681617169979271,1.3809566776219353,0.09803921568627451,0.4202140535751994,1.0,2/7,7.72%,MX1;DNM1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.8681617169979271,1.3809566776219353,0.09803921568627451,0.4202140535751994,1.0,2/7,7.72%,MX1;DNM1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.7124818097147045,-1.380801753522429,0.058823529411764705,0.7294886331424684,1.0,6/23,8.00%,RPL5;RPL11;RPL23;RPS7;PDCL3;GABARAPL2
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.8267781878179341,-1.3806886839034165,0.1,0.7270782872070966,1.0,2/8,7.04%,CRTAM;CD274
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.5206109060207023,-1.3804480019066117,0.03636363636363636,0.7254207339608753,1.0,71/265,21.58%,RPS27A;UBC;PARP2;CENPX;RAD23A;RNF8;UBB;FAAP100;H2AX;UBXN1;PCNA;USP1;ENDOV;MBD4;POLD3;EME1;MGMT;MPG;PARP1;MUS81;DCLRE1B;RAD51AP1;APEX1;NOP53;POLD4;KPNA2;SMARCA5;ALKBH2;HMGA2;BTG2;PNKP;NUDT1;RFWD3;HUS1;NPM1;BRCC3;BLM;UBA52;TEX264;KAT5;ABRAXAS1;TOPBP1;ACTR8;ERCC8;UBE2A;MEN1;MDC1;ADPRS;PARK7;TRIM28;GTF2H2;SMC1A;REXO4;PRIMPOL;EXO1;ATR;MSH3;EXD2;CETN2;DDX1;MGME1;UBE2N;FANCF;PARP3;PRKDC;NSMCE4A;ATRIP;XPC;GTF2H2C;RAD9B;RMI2
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),0.9273781491589411,1.379817647808893,0.025,0.4231236742665376,1.0,1/5,0.78%,PDGFB
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),0.9273781491589411,1.379817647808893,0.025,0.4231236742665376,1.0,1/5,0.78%,PDGFB
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.6670408768075645,-1.3795057030888356,0.07936507936507936,0.7278791115306408,1.0,16/40,24.43%,SEC61B;GRPEL1;SEC62;SEC61A2;GRPEL2;TOMM20;TIMM50;ZFAND2B;PEX10;TIMM17A;DNAJC19;TIMM44;TIMM23;PEX16;DNAJC15;TOMM40L
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.7630370007788135,1.3793683583948193,0.08928571428571429,0.423847873675404,1.0,4/14,15.78%,PPARG;NFKBIA;ABCA1;ABHD5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.6755652603972598,1.3791594009090684,0.09302325581395349,0.4238934890079445,1.0,6/20,11.05%,TLR2;PLCB1;SYK;TIRAP;LAPTM5;MAPK11
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.9088186871026005,-1.3790399425330535,0.020833333333333332,0.7278788705554323,1.0,1/6,1.28%,SELENOS
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6320833311100152,1.3786443929939558,0.11764705882352941,0.42517555930871553,1.0,7/27,14.70%,FLT1;HSPB1;VEGFD;SEMA6A;PRKD1;ITGB1BP1;VEGFA
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.6597032953194392,1.3785224574840924,0.0851063829787234,0.4247023211701282,1.0,4/34,7.61%,SYT4;MYO7A;MYO1B;MYO5C
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.7978379109660411,-1.3785144314382285,0.0851063829787234,0.7288256912480598,1.0,3/10,11.04%,SELENOS;GSTP1;TAF7
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.7627171174682644,-1.378333016669706,0.1276595744680851,0.7270606944966022,1.0,4/21,3.91%,RPS27A;UBC;UBB;PCNA
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.5306417569690016,-1.3782913865627446,0.05172413793103448,0.7247449392338605,1.0,36/162,18.59%,SNRNP25;PRPF4;KIN;SF3A3;SF3A1;TSEN34;SRSF7;PDCD7;YJU2;MPHOSPH10;PRPF18;SCNM1;SRSF9;TFIP11;SNRPD1;SNRPD2;SF3B4;PRPF6;RBM8A;AURKAIP1;RP9;SNRPB;PRPF3;RBMS2;DKC1;PRPF8;WBP4;MAGOHB;M1AP;SF3A2;DHX8;SNRPG;PRKACA;PTBP1;DDX23;SLU7
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8680782882051482,1.378094838771309,0.07017543859649122,0.42570919488914255,1.0,3/6,10.66%,CHRM3;PIM1;BCL2
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.780714611385378,1.377654269334036,0.10204081632653061,0.4262427678517842,1.0,3/9,15.43%,ZMYND10;RSPH9;DNAAF1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.5405981640228114,1.3769999275800846,0.0196078431372549,0.427867697392972,1.0,23/82,10.99%,ADAMTS5;MMRN2;AQP1;FSTL1;TLR2;POSTN;TNC;FAP;PCDH18;RHOJ;LDB2;PDGFRA;CCDC80;ROBO4;COL5A3;OLFML2B;SULF1;FBLN2;COL4A1;FBLN5;COL15A1;PAMR1;AEBP1
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.5464682284924014,-1.3764521250020878,0.03278688524590164,0.7322792792726092,1.0,20/112,14.13%,RPS27A;UBC;UBB;PSMB6;PSMD7;PSME2;PSMD8;EXOSC8;PSMB4;APEX1;PSMD3;PSMB3;HSPA8;YWHAB;PSME1;EXOSC5;UBA52;PSMA7;PSMB8;PSMD13
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.5525374807946627,1.3761902896327873,0.0425531914893617,0.42999873146527795,1.0,25/102,12.42%,AQP1;BMP6;EGFR;SYT4;FOS;RYR3;ADCY8;MEF2C;LRRK2;ADGRV1;SYT1;MT1M;WNT5A;CPNE8;SYT13;SYT7;DMTN;CAMK2D;TRPM2;GPLD1;ADCY7;CPNE5;DLG4;GLRA2;ADCY1
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.7400916754140774,-1.3760561854334454,0.09803921568627451,0.7317650974490246,1.0,8/25,6.47%,P2RY10;LCK;STMN1;S100B;H2AX;PCNA;TUBA1B;KLRB1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.8529813883566886,-1.3759995418445283,0.08163265306122448,0.7292097766313284,1.0,1/8,0.51%,DDIT3
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.7407545236471295,-1.3758328998881524,0.16666666666666666,0.7274141876573821,1.0,3/14,11.51%,ADPRM;ENTPD2;NUDT1
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.7943149492029908,-1.3755364427406833,0.12727272727272726,0.7263084386661576,1.0,1/11,2.00%,ARPC5
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.6730193271139236,1.3754462897172817,0.025,0.4316104424730774,1.0,4/24,6.15%,PDGFB;IGF1;NRG1;WNT5A
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.7533900180989201,-1.3753665716574182,0.1346153846153846,0.72450598822913,1.0,5/13,7.90%,ORMDL2;ORMDL1;RACK1;SPHK2;SMPD2
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.8223478376914073,-1.3753113182831298,0.08196721311475409,0.7222587183426903,1.0,2/8,4.71%,CDNF;LMX1B
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.5421990908783282,-1.3749406383237601,0.017857142857142856,0.7213663034907152,1.0,52/196,18.40%,PAX8;POLR2L;PTMA;THAP1;POLR3K;POLR2G;TBPL2;POLR3GL;GTF3C6;BTF3;DRAP1;POLR2K;HOXD3;TEFM;DDX5;TFDP1;POLR2I;GTF2F1;ELOC;PARP1;TCEA2;MLF1;ELOB;NFIC;POLR2A;IRF9;SMN1;SMARCA5;TAF13;TFB2M;DDX21;TAF7;ABT1;TTF1;POLR2E;NELFE;CTR9;SNAPC3;POLR2C;POLR2D;RO60;TAF11;EAF2;ATF4;NELFCD;CCNT1;GTF2H2;SUPT5H;SNAPC2;TAF9B;POLR2J;TFAM
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.8684377106415558,1.374419004878154,0.041666666666666664,0.43439203447358654,1.0,4/8,10.59%,BMPR1B;SOX9;ZBTB16;SOX5
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),0.8627032250659563,1.3740007370439078,0.044444444444444446,0.4351921702694599,1.0,2/5,11.81%,CX3CR1;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.8269890242843204,1.3738135568166157,0.05084745762711865,0.4348177647881547,1.0,3/10,6.58%,IFNA2;TRIM5;CIITA
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.9324361206320456,1.3738004126773296,0.0,0.4340476255373779,1.0,1/5,0.55%,NCEH1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.7056681025590261,1.3729407772913806,0.12727272727272726,0.4359669517337062,1.0,3/12,13.83%,PPP1R3C;GYG1;PGM2L1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.7056681025590261,1.3729407772913806,0.12727272727272726,0.4359669517337062,1.0,3/12,13.83%,PPP1R3C;GYG1;PGM2L1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.8378572181185893,-1.372795425119081,0.10416666666666667,0.7301190913415677,1.0,1/7,3.32%,PTPRU
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.9254214479581675,1.3720691441877169,0.03636363636363636,0.4382705547025627,1.0,1/5,0.26%,CHRM3
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.8367295342071008,1.371911545773358,0.05263157894736842,0.43795960414743496,1.0,2/6,4.06%,FGF12;CARTPT
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.8743126960026881,1.371262999475026,0.125,0.4396389259909136,1.0,1/5,2.97%,LMO3
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.6866365087490964,1.3708177505181975,0.14893617021276595,0.44043930942484694,1.0,8/21,19.73%,KCNMB4;NOS1;EDNRB;KCNMB2;ITGB1BP1;GPER1;EDN1;GCLC
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),-0.8428027121407831,-1.3704714282249497,0.1346153846153846,0.7410737621323605,1.0,1/7,0.51%,DDIT3
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.7166295125979582,-1.3700333007991174,0.1206896551724138,0.7411163478084248,1.0,11/21,20.22%,ISCA2;CIAO2B;CIAPIN1;CIAO1;GLRX5;NFS1;NUBP2;ISCU;LYRM4;NFU1;ISCA1
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.91738467747156,1.369383448531774,0.01818181818181818,0.4455487063811394,1.0,3/5,6.83%,PTPRG;PTPRR;TENM3
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.9015598550858376,1.3691529668381512,0.06666666666666667,0.4456396340489619,1.0,2/5,4.76%,CARMIL2;CARMIL1
prerank,GO_Biological_Process_2021__dehydroascorbic acid transport (GO:0070837),0.8605794307034312,1.368929095937169,0.1111111111111111,0.4456434371033728,1.0,1/5,1.38%,SLC23A1
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.5589864181859142,1.368730079530563,0.09259259259259259,0.4455389384697465,1.0,18/58,18.14%,ITGA11;ITGB4;ISG15;ITGBL1;SYK;SRC;FBLN1;FYB1;TEC;PRKD1;ERBIN;ZNF304;CUL3;ITGB1BP1;THY1;SEMA7A;DOCK1;ZYX
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.5897443770377133,-1.3683592520037218,0.07352941176470588,0.7472155115710726,1.0,2/75,0.14%,PM20D1;NGF
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.777043987977636,-1.3683567165508883,0.09090909090909091,0.7445468847440331,1.0,5/15,14.71%,EMC6;EMC4;EMC7;MMGT1;UBL4A
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.7856846615554497,-1.3683024683780427,0.08888888888888889,0.7421651921221961,1.0,4/11,6.68%,EYS;CNGB1;CACNA2D4;GNA11
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.8037510746329862,1.367875614646283,0.06896551724137931,0.44746689676514034,1.0,1/8,0.78%,PDGFB
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.8076912741931674,1.36787084090655,0.07692307692307693,0.4466689385337695,1.0,2/9,4.14%,PPP1R3C;PYGL
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.832079875569119,1.3677885329882775,0.08695652173913043,0.44632621187028393,1.0,6/9,10.65%,SYT4;CACNA1G;SYT1;STX1A;KCNB1;CACNA1I
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.7592273856663811,1.367700589977045,0.10204081632653061,0.445963236577036,1.0,3/11,8.11%,NR4A3;IRS1;ABCD2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7393327159820635,1.3669768097762784,0.12244897959183673,0.447661772002383,1.0,6/14,14.03%,CSGALNACT1;VCAN;CSPG4;NCAN;CSPG5;UST
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.7388734623354805,1.366842287416227,0.1,0.4475119010997192,1.0,5/11,14.70%,SLC8A1;MYH11;ALPK2;ALPK3;VEGFA
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.6398920579126253,1.366798191768733,0.08695652173913043,0.4468493965914744,1.0,8/30,19.48%,CLDN16;SLC8A1;GRIN1;SLC7A8;ANK3;KCNH2;SLC12A5;CNNM2
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.5672106293804448,-1.366353458847957,0.06896551724137931,0.7503020084845838,1.0,23/84,21.92%,ANAPC15;PSMB6;PSMD7;PSME2;PSMD8;CDC23;CDC26;PSMB4;PSMD3;PSMB3;PSME1;DBF4B;PSMA7;PSMB8;PSMD13;PSMD2;PSMC5;ANAPC11;UBE2S;PSMA4;CDC20;XPC;SKP1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5977940057170114,-1.3662015509625747,0.10204081632653061,0.7484489051826011,1.0,17/56,21.28%,TRMT10C;FTSJ3;HENMT1;BUD23;RBM15B;METTL5;TRMT112;TFB2M;METTL2A;TRMT10A;METTL6;MTERF4;PCIF1;TRMT6;MEPCE;TRMT13;VIRMA
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.7434074937102769,1.365906048908441,0.07142857142857142,0.44896396876037786,1.0,3/8,12.49%,PKD1L3;PKD2L1;ASIC2
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.7549531671879066,1.3657085850257853,0.1702127659574468,0.448812556114405,1.0,3/10,11.62%,MGST1;SLC7A9;SLC6A8
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),-0.7750020949912837,-1.3656180673898892,0.09803921568627451,0.7490242991482543,1.0,2/11,8.88%,AMPD1;GMPR2
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.7437884168533637,-1.3654089404679486,0.022222222222222223,0.7474822164402446,1.0,9/15,23.12%,POP5;ADAT1;SARS1;AARS1;POP7;SSB;DTD1;TRPT1;KARS1
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.7383265828653485,1.365263714119695,0.1111111111111111,0.44953362113124085,1.0,2/13,5.57%,CAMSAP3;BAG3
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.5714640088845417,1.3650668312568939,0.1111111111111111,0.44929681454504145,1.0,14/64,14.70%,ANGPT1;ADAMTS9;RHOJ;ADGRB1;WNT5A;PTPRM;BMPER;GPLD1;PRKD1;BMPR2;SCARB1;NR2F2;ITGB1BP1;VEGFA
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.865264456890237,-1.364783720868699,0.09433962264150944,0.7486419803621743,1.0,1/8,2.11%,RNF8
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.7232970125571363,1.36462266646348,0.08333333333333333,0.4497601334868693,1.0,7/18,17.80%,GRIK2;GRIK1;UNC13C;GRIK5;GRID1;GRIA2;GRIK3
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.8442708957838811,1.3641840337927953,0.0851063829787234,0.45045446156499847,1.0,3/8,11.24%,GRIP1;WNT5A;DLG4
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.7192597206700246,-1.3639299848547752,0.16071428571428573,0.7510762079317034,1.0,4/21,8.93%,TUBA1A;TUBA1B;MYO10;TUBA1C
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.4943541669464651,1.3638345314418008,0.02857142857142857,0.4508929310671483,1.0,42/217,10.29%,CREB3L1;ADAMTS5;TGFB2;PDGFB;ITGA11;CD44;ADAMTS9;ST7;MMP16;ITGB4;MFAP5;POSTN;VCAN;TNC;ADAMTS7;CAPN1;LOX;ITGAM;ADAMTS10;COL11A1;FLRT2;ADAMTS17;LAMC1;COL5A3;NPNT;COL12A1;TNR;LOXL3;COL20A1;ADAMTS6;ADAM12;COL4A1;COL7A1;P3H2;FBLN5;JAM2;VIT;ADAMTS15;AGRN;NCAN;COL15A1;PAPLN
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.6368323768565566,1.3636688605754015,0.0625,0.45084507481787023,1.0,2/31,4.86%,TGFB2;PRICKLE1
prerank,PanglaoDB_Augmented_2021__Podocytes,0.5210429007933338,1.3635847547199549,0.024390243902439025,0.45029245937933887,1.0,46/163,14.71%,PLSCR4;KITLG;EGFR;FSTL1;PTPRG;LRIG3;KIAA1217;MET;THSD7A;DACH1;TMEM47;LAMC1;DDAH1;MYO1B;CADPS2;CHST3;SRGAP1;MERTK;COL12A1;SULF1;ADGRL2;TPM1;TEAD1;COL4A1;LIFR;EPB41L1;NTN4;NEBL;MAFB;FAT4;NUAK1;ANTXR1;LAMB2;MAPT;NR2F2;ADCY1;PRICKLE2;CD80;KANK1;PTPRO;APBB2;CDH13;SYNPO;CPE;VEGFA;DOCK5
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.6891101774810752,-1.3634794862002648,0.1,0.7510535366706351,1.0,2/19,5.56%,NGF;PMP22
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.7620360526825037,1.3634622161618555,0.11363636363636363,0.44988882281412973,1.0,4/17,4.63%,SYT4;NEDD4L;RIMS2;SYT1
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.7772155304044651,1.3633953873530267,0.20754716981132076,0.44933987549460336,1.0,4/6,14.26%,LAPTM5;DAPK1;DLEC1;RBMS3
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.639297261971366,1.3632165080776208,0.045454545454545456,0.449295117789854,1.0,9/38,13.03%,EGFR;SRC;SOX9;KIF16B;VIL1;TGFA;ERBIN;PIK3R1;PTPN11
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.8190305780205268,1.3631333643291146,0.1206896551724138,0.44893717565045793,1.0,3/8,14.41%,SHMT2;GDA;SHMT1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.8214864985789629,1.36313251957622,0.10714285714285714,0.4481425965785102,1.0,1/8,0.95%,PPARG
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.5483896936622874,1.3628163161021571,0.02040816326530612,0.44870384757110066,1.0,24/87,12.42%,KCNMA1;SYT4;RYR3;ADCY8;MEF2C;KCNMB4;ADGRV1;SYT1;PPP3CA;KCNIP2;WNT5A;CPNE8;SYT13;SYT7;DMTN;CAMK2D;TRPM2;GPLD1;TRPC3;CPNE5;KCNMB3;HOMER1;ANXA11;ADCY1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.7088736305021291,1.3622523144805776,0.05263157894736842,0.4504267437743954,1.0,5/19,12.83%,NDST3;SULF1;HS6ST3;HS3ST4;GPC1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.803917353756469,1.3620024406901041,0.0784313725490196,0.4505464060339726,1.0,1/8,0.99%,NRCAM
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.5549803979473857,1.3619861550948857,0.05660377358490566,0.44983740850095466,1.0,17/79,8.98%,ROR1;EPHA3;EGFR;FLT1;CSF1R;EPHA4;LDB2;MET;PDGFRA;TSPYL2;NTRK2;EPHA6;MERTK;EPHB1;AXL;CD4;EPHB3
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),-0.904224183358872,-1.3619192795669908,0.10416666666666667,0.7569651660532819,1.0,1/5,3.25%,SBDS
prerank,PanglaoDB_Augmented_2021__Monocytes,0.5493185853536202,1.36178508371873,0.046511627906976744,0.44977165793390755,1.0,28/83,13.37%,CX3CR1;FGL2;PTPRC;PLSCR1;CD44;MX1;TLR2;CSF1R;SELL;VCAN;MRC1;LCP2;ITGAM;CD53;CSF3R;C3AR1;TNFRSF1B;LILRB1;LY86;P2RY13;LAPTM5;DYSF;RGS1;AOAH;SASH3;PILRA;NFKBIZ;LYN
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.5724163967138283,1.361742593898591,0.09523809523809523,0.4490665005815658,1.0,11/43,18.33%,SLCO2B1;ABCC4;ABCB4;SLC6A11;SLC16A14;SLC6A8;NCOA1;SLCO1A2;ABCC11;RXRA;SLC16A2
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.7800097643073821,1.3613423517347425,0.08,0.44959965172731126,1.0,3/10,10.69%,CX3CR1;SYK;DYSF
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.6987099752796491,1.3611788564953327,0.0425531914893617,0.4492468002429189,1.0,2/20,0.81%,TGFB2;AQP1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.7150252375177133,1.3606686654199818,0.12,0.45033197118629115,1.0,2/17,2.05%,IGF1;HEY1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.6001752772422311,1.3604005473392413,0.09803921568627451,0.4503683818406933,1.0,11/41,11.18%,SRGN;BMP6;SLC8A1;MEF2C;ISG15;BMPR1B;ADGRV1;NELL1;ANO6;TGFB3;BMPR2
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.7269131075204377,-1.360273789072543,0.10909090909090909,0.7637591367874088,1.0,1/19,0.14%,NGF
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.8072733615975135,-1.36023998473674,0.1016949152542373,0.7613357716003023,1.0,1/9,6.73%,RAN
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.7284413615906393,-1.360013128780292,0.12727272727272726,0.7601609393917743,1.0,3/17,10.73%,RAN;SOD1;ERLIN2
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.7647303275804065,-1.3596942366887108,0.125,0.7588228153484744,1.0,3/12,3.00%,RPS21;RPP40;TSR1
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.8128219654634903,1.359362208900412,0.09259259259259259,0.45341145471190836,1.0,2/5,16.90%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.6695722986678175,1.359141032497868,0.10204081632653061,0.45338114541458696,1.0,4/19,4.71%,TGFB2;NCKAP1L;ADGRE2;SYK
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.8035083222229731,-1.3589988216260895,0.11864406779661017,0.7603392687932932,1.0,5/10,15.39%,EIF2S2;EIF2S3B;EIF5;DHX29;EIF4B
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.7496578436957289,1.3589549256982374,0.058823529411764705,0.4531878724478904,1.0,3/11,4.76%,CARMIL2;ACTN1;CARMIL1
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),0.884548836581177,1.3589356516588784,0.07692307692307693,0.4525069063679863,1.0,1/5,0.21%,LPL
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.7009121046116285,1.3588502302422427,0.14,0.45205173452767433,1.0,9/21,15.16%,LRRK2;UNC13C;CACNB1;PPFIBP1;AGRN;LRP4;PDZRN3;ANK3;CACNB2
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.7084093313834132,1.3587122730606236,0.08,0.4517806344009781,1.0,4/18,10.08%,TGFB2;CGNL1;ARHGAP25;SYNGAP1
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.7300699108416913,1.3586849015127538,0.06382978723404255,0.45102462249038655,1.0,6/21,12.70%,AQP1;ADCY8;ADCY2;ADCY7;ADCY1;PRKAR1B
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.8435177572035941,1.358257281053237,0.08163265306122448,0.4519889480256606,1.0,2/7,5.19%,MET;SRC
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.8285884976393708,-1.3577070468790422,0.037037037037037035,0.765248435910026,1.0,2/7,7.04%,PRELID1;CD274
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.6214989680386445,1.3574734132391477,0.11363636363636363,0.4537569369965459,1.0,4/32,5.18%,CD59;C1QB;C5;C3AR1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.8278511634424544,-1.3573057985919312,0.13636363636363635,0.7650089233317449,1.0,4/10,11.48%,EMC6;EMC4;EMC7;MMGT1
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.8687118569686487,1.3569094704147535,0.08695652173913043,0.45513622797727926,1.0,2/5,12.96%,SLA2;CD70
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.6222061470684326,1.3566393239393493,0.0425531914893617,0.45516375676480536,1.0,5/38,5.09%,TTC8;PTCHD1;GRM5;CYFIP1;TUSC3
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.770781991020439,1.3566344938134902,0.041666666666666664,0.4544485631541499,1.0,5/14,14.26%,FSTL1;TMEM204;SULF1;LRIT3;SFRP4
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.8826856644195814,1.3564520392778905,0.06521739130434782,0.45352553369613463,1.0,3/5,10.59%,PLSCR1;UHRF1;SETMAR
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.8826856644195814,1.3564520392778905,0.06521739130434782,0.45352553369613463,1.0,3/5,10.59%,PLSCR1;UHRF1;SETMAR
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.7041330736448612,1.3561552151638028,0.09090909090909091,0.4536155127996625,1.0,2/19,10.61%,WTIP;MOV10
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),-0.8885978801251746,-1.3560778933478739,0.09433962264150944,0.7694749668004954,1.0,1/5,3.61%,EXOC7
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.7274350391435436,1.3560561725271494,0.10638297872340426,0.4531669370402502,1.0,3/13,1.80%,IGFBP3;PDGFB;IGF1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.5631139858432639,1.356044742747757,0.045454545454545456,0.4524213538736901,1.0,13/64,11.18%,PPARG;BMP6;IGF1;MEF2C;HGF;BMPR1B;NELL1;NPNT;SOX9;CHRD;TP63;PRKD1;BMPR2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.6589165733185531,1.3554856024919577,0.07692307692307693,0.4535856098306632,1.0,8/22,19.53%,IGF1;MLIP;NR4A3;CAMK2D;PDE9A;EDN1;RGS2;CAV3
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.8525970644610151,1.3553561740519948,0.08695652173913043,0.4533376951059548,1.0,2/7,9.36%,TGFB2;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.8353365304697716,1.3552506171769871,0.08163265306122448,0.45301140898578873,1.0,4/10,13.28%,TGFB2;SOX9;SOX5;RBM24
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.8671959566284294,1.355165442149818,0.08,0.4525873779999463,1.0,2/5,7.36%,ANGPT1;TJP2
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.940189726281152,1.3551236501317223,0.0425531914893617,0.45196741910389415,1.0,2/5,2.20%,FLI1;P2RY12
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),0.8643266985773151,1.3550213922165308,0.05660377358490566,0.4507533802029634,1.0,1/5,2.05%,HEY1
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),0.8643266985773151,1.3550213922165308,0.05660377358490566,0.4507533802029634,1.0,1/5,2.05%,HEY1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7920922356674394,1.354193233629467,0.05660377358490566,0.45296718634919164,1.0,2/7,10.38%,IL12A;SEMA6A
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.8443560604997932,1.3538469192408633,0.022222222222222223,0.4534681210739817,1.0,2/7,7.72%,MX1;DNM1
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.8522457903452156,1.353416005948678,0.021739130434782608,0.45418267184088806,1.0,3/6,7.35%,SHISA6;GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.5884963749078117,-1.3532995737424638,0.07272727272727272,0.7825293873855638,1.0,25/85,19.22%,KIN;SF3A3;SF3A1;LSM2;DDX5;SRSF7;RNH1;PRPF18;PCBP3;LSM10;SRSF9;SF3B4;AURKAIP1;SNRPB;PRPF3;SNRPE;NUDT12;PRPF8;NUDT16L1;SF3A2;SNRPG;PRKACA;PTBP1;SSB;DXO
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.9155310249845692,-1.3532420759020494,0.08695652173913043,0.7776750382674754,1.0,3/6,6.89%,FUCA1;GBA3;GLA
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.9155310249845692,-1.3532420759020494,0.08695652173913043,0.7776750382674754,1.0,3/6,6.89%,FUCA1;GBA3;GLA
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.8766210583484708,-1.3530739005941845,0.0392156862745098,0.7763420856155541,1.0,1/5,1.44%,RPL23
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.6996442681817246,1.3529201493663938,0.14893617021276595,0.4550511604485235,1.0,2/17,5.66%,IGF1;NTRK2
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.8077978805166209,-1.3526503977069895,0.1320754716981132,0.7764584113168854,1.0,3/9,9.28%,DCLRE1B;APEX1;TFIP11
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.6630469270039483,1.351941982720127,0.08,0.4574577575251707,1.0,12/21,15.45%,SCN9A;SLC8A1;CACNA1G;SCN2A;SCN3A;SCN3B;SCN1A;CACNA1I;YWHAH;SCN7A;KCNH2;SCN4B
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.8307700004270169,-1.3519102522200277,0.1836734693877551,0.7781753234141943,1.0,3/7,13.40%,TRMT10C;HSD17B10;TRMT10A
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.46342341364145523,1.3516263005117242,0.03225806451612903,0.45802585340644275,1.0,44/217,9.96%,PDGFC;NPAS2;CX3CR1;NRCAM;IL1RAPL2;ROBO2;SLC23A1;RPS6KA6;DCX;VCAN;NHEJ1;GRIN2B;PCDH18;GRIK1;CHST8;DCLK1;ITGAM;TBX6;CNTN4;PTPRZ1;RELN;SPOCK1;SCIN;ADGRG1;ADGRL2;PBX1;CA10;LOXL3;MEIS3;NPTX1;SOX9;GRIN1;NMUR2;COL4A1;ATXN1;ZBTB16;MEIS2;SH3GL2;NDRG4;VIT;WWP1;EMX1;C3;NCAN
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.5453320101187069,-1.351553852703621,0.09433962264150944,0.7777895162036277,1.0,8/106,7.44%,CYP1A2;PDZD11;GLYAT;ACOT1;LDHC;CROT;AASDH;ALKBH7
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.712713489786762,-1.3510107340553947,0.1206896551724138,0.7782290941551834,1.0,11/22,20.22%,ISCA2;CIAO2B;CIAPIN1;CIAO1;GLRX5;NFS1;NUBP2;ISCU;LYRM4;NFU1;ISCA1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.5931131866060777,1.3509017540344739,0.058823529411764705,0.45968081256278415,1.0,13/52,15.57%,IFNA2;PTPRC;NHEJ1;LAT2;MEF2C;BLNK;PTPRJ;BCL2;IFNK;CD70;ZAP70;TPD52;KLF6
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.7055873633683348,-1.3508934387980656,0.15384615384615385,0.7765060280305784,1.0,5/13,20.71%,LAMTOR4;CD81;GLMP;LAMTOR5;RNF128
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.6752870884679337,-1.3503515987164159,0.1,0.7770559223131007,1.0,11/34,18.80%,MBOAT1;DOLK;SPHK2;ABCA8;IDI1;AGPAT5;DPAGT1;FADS1;GPAM;GPAT2;DOLPP1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.732824370407217,1.349596600494078,0.12244897959183673,0.4641253190544967,1.0,6/15,14.00%,PTPRC;ZFP36;SFTPD;LAPTM5;CR1;HAVCR2
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.6273204035659415,1.3493875190689988,0.1111111111111111,0.464330845045911,1.0,5/25,7.35%,IGF1;GRM5;EPHA4;CACNB1;GRIN1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.6990065126605032,1.3492169948368509,0.06382978723404255,0.46405204654980475,1.0,7/27,12.04%,IGF1;CSGALNACT1;CHST8;NDST3;BMPR1B;BMPR2;CHST11
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.6764056777085915,1.3484417741802681,0.043478260869565216,0.466400902362521,1.0,6/20,17.42%,NUDT11;NUDT3;NUDT4;NT5C1A;PDE9A;AMPD3
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.8871370734943971,1.3481409373137903,0.13559322033898305,0.4668909346964363,1.0,1/5,2.24%,CSF1R
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.5128217345711815,1.3481272996951732,0.04878048780487805,0.4661857944556088,1.0,19/90,9.94%,TGFB2;RHBDF2;BMP6;KCNC2;IGF1;SNAP25;IL12A;RAPGEF4;ITPR1;STXBP5L;RSAD2;FRMD4A;STX1A;CLOCK;SYT7;PICK1;TGFB3;KCNB1;CACNA2D2
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.5183037690605441,1.3476311191918156,0.043478260869565216,0.46713585273033903,1.0,23/108,11.44%,TGFB2;CTF1;MYO7A;MEF2C;MET;ID2;NTRK2;SPOCK1;WNT5A;PBX1;TENM3;WNT8B;SNPH;TENM1;FZD3;NEUROD6;EMX1;FUT9;ATP2B2;TENM2;CDK5R1;ANOS1;MYT1L
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.7119895220361463,1.3476068755109794,0.08196721311475409,0.46645179891440486,1.0,4/21,10.17%,MX1;PEX11A;DNM1;CORO1C
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.7444283297718063,1.347493679049384,0.15789473684210525,0.46605732825974255,1.0,6/13,9.63%,CD44;CARMIL2;CARMIL1;TWF2;VIL1;DMTN
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.5365097282131891,1.347420778988081,0.06976744186046512,0.46562588607332034,1.0,26/95,21.96%,CDS1;PLEKHA2;CSF1R;PLCB1;INPP5D;PIP5K1B;INPP4B;PLA2G10;PLEKHA4;TPTE2;IP6K3;PIK3R1;PIP4K2A;PLCB3;PGAP1;INPP5E;PLA2G4A;PIK3R5;PLCG1;BMX;PTEN;LPGAT1;PTPN13;PIK3C3;PIP4P2;MTM1
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.4563831586917875,1.347386982842017,0.0,0.46500489098577336,1.0,50/273,13.60%,TGFB2;PDGFC;PDGFB;CX3CR1;ANGPT1;BMP6;PTPRC;EGFR;CD44;IGF1;CHI3L1;CSF1R;LRRK2;CSPG4;LCP2;HGF;EFNA5;SRC;TNK2;RELN;NTRK2;INHBC;PTPRJ;SH2D3C;SOX9;LRP8;TENM1;NOS1;CCND1;CD4;PLK1;KNDC1;VEGFD;TGFB3;IRGM;C3;P2RY1;TEC;PRKD1;CAMKK1;SPDYA;BMPR2;CSNK1D;CX3CL1;FGF17;CD80;PTPN11;GHR;LYN;TNIK
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7192619020592198,1.3473057262612735,0.09523809523809523,0.46450029105161666,1.0,4/8,19.42%,NR4A3;GNB3;LEPR;SGIP1
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.8227120743108935,-1.3464057612065539,0.10526315789473684,0.7958275106887557,1.0,2/11,5.55%,DDIT3;EIF2AK1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.5819376696230709,1.3459726122695947,0.11363636363636363,0.46867954895153674,1.0,11/56,8.60%,PCOLCE;FSTL1;POSTN;PCDH18;LOX;PDGFRA;COL12A1;TPM1;BMPER;COL4A1;FBLN5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.7404115176350524,-1.345858632386207,0.15555555555555556,0.7959593618950065,1.0,6/24,9.25%,RPS27A;UBC;UBB;PCNA;POLD3;POLD4
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.6992131495868296,1.345655571378298,0.19047619047619047,0.46908278169296647,1.0,4/18,6.84%,ALDH1L1;SHMT2;GGH;FTCD
prerank,GO_Biological_Process_2021__sensory perception of sour taste (GO:0050915),0.8368042786687808,1.3454712961522548,0.08108108108108109,0.4687637742442561,1.0,3/5,12.49%,PKD1L3;PKD2L1;ASIC2
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.8100891930842997,-1.3452839986492975,0.10638297872340426,0.7963332374741454,1.0,4/9,11.53%,AKR1D1;SCARF1;SNX17;ADH4
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.6207801911412879,-1.3450593743115726,0.12280701754385964,0.7946334593816062,1.0,9/40,12.77%,TINF2;PCNA;POLD3;PARP1;DCLRE1B;APEX1;POLD4;HUS1;BLM
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.5807434446428068,1.3446810824245201,0.06976744186046512,0.4700199556363394,1.0,6/41,6.16%,IFNA2;MX1;ISG15;RSAD2;XAF1;SAMHD1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.5807434446428068,1.3446810824245201,0.06976744186046512,0.4700199556363394,1.0,6/41,6.16%,IFNA2;MX1;ISG15;RSAD2;XAF1;SAMHD1
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.7162066297582664,-1.3446116995848956,0.12280701754385964,0.7951432536403163,1.0,10/16,24.43%,GRPEL1;GRPEL2;TOMM20;TIMM50;TIMM17A;DNAJC19;TIMM44;TIMM23;DNAJC15;TOMM40L
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.729487273348619,1.34422753722727,0.08928571428571429,0.4704386656159706,1.0,4/13,15.36%,ZFP36;NANOS3;CPEB3;ZFP36L1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.729487273348619,1.34422753722727,0.08928571428571429,0.4704386656159706,1.0,4/13,15.36%,ZFP36;NANOS3;CPEB3;ZFP36L1
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.688327987161399,-1.3439481076081556,0.0967741935483871,0.7962110671114888,1.0,3/14,8.75%,SAP18;SRSF7;SRSF9
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.5188032424128093,1.343684176997127,0.04081632653061224,0.47168215090778043,1.0,47/124,15.50%,PLSCR4;ZNF423;CD44;FSTL1;TLR2;PPP1R3C;POSTN;PCDH18;PLPPR4;DCLK1;SYNPR;LDB2;COL11A1;PDGFRA;TMEM47;RGS7BP;NTRK2;OPCML;ADGRL2;CRYM;CADM3;COL4A1;BOC;LIFR;BRINP1;FNDC4;EDNRB;PAMR1;SPC25;SPARCL1;COL9A1;HES1;DPYSL3;PRICKLE2;PRRX1;LRP4;FRZB;COL5A1;PDZRN3;CPE;MEGF10;VEGFA;TIMP3;DAPL1;SCN4B;IL33;THY1
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),0.8400533381013354,1.3434452912770154,0.10909090909090909,0.47171907172346317,1.0,2/6,11.42%,AQP1;SLC14A1
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.7716150070507721,-1.3432925957578732,0.1276595744680851,0.7970589404883431,1.0,2/11,2.75%,BMP5;GREM1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.7357616712196331,1.3432807455531715,0.1276595744680851,0.47151198621222196,1.0,5/14,15.36%,ZFP36;MOV10;CPEB3;RBM24;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.7746375682420454,-1.3432496075138756,0.0625,0.7948472878011117,1.0,3/13,7.70%,LCK;RPS3;CD81
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.5884140528388875,1.343108926377458,0.11363636363636363,0.47138048254640075,1.0,13/50,16.63%,ZNF423;HEY1;SORBS2;KAT2B;DTX1;PBX1;NOTCH4;SUSD5;HES1;DTX2;NOTCH3;JAG2;GMDS
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.7744516911354323,1.3429143916642061,0.12698412698412698,0.47139900527236545,1.0,3/11,6.58%,IFNA2;TRIM5;CIITA
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.7554006171068901,1.3425641791745313,0.07142857142857142,0.47194027066516914,1.0,4/15,5.88%,CHRM3;KCNMB4;ADRA1A;OXTR
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.757510706401312,-1.3425186078630742,0.16666666666666666,0.7961971113169107,1.0,4/10,15.37%,BCKDK;PGP;GCK;MST1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.7495835831842391,1.3422109638413882,0.12962962962962962,0.472293403850453,1.0,2/16,4.44%,PPARG;SORBS1
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),0.8356426977660882,1.3421811464881714,0.1836734693877551,0.47164034714955727,1.0,2/5,2.75%,CX3CR1;C1QB
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),0.8943528638552011,1.3421576051833148,0.16,0.47091501805695024,1.0,2/6,6.40%,PDGFB;ADGRG1
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.647159750422862,1.3418999267727951,0.10638297872340426,0.47110111270856825,1.0,5/34,6.76%,IFNA2;PTPRC;NHEJ1;BLNK;PTPRJ
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.6972601700508341,-1.3416787405962602,0.11864406779661017,0.7982773443668613,1.0,3/13,8.75%,SAP18;SRSF7;SRSF9
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.8477339760401861,1.3416107627982035,0.09090909090909091,0.47126809746751336,1.0,3/5,13.37%,BTLA;LILRB1;LYN
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.6474854354592392,1.3414805199225361,0.09433962264150944,0.4711016369935257,1.0,5/25,8.77%,CLDN5;LAMC1;TJP2;DMD;JAM2
prerank,GO_Biological_Process_2021__negative regulation of meiotic cell cycle (GO:0051447),-0.8627742564671792,-1.3414665061024336,0.08333333333333333,0.7967930197557515,1.0,2/5,8.04%,FBXO43;NPPC
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.7136724547971643,1.341304597512025,0.09433962264150944,0.47108343128512015,1.0,12/16,15.39%,SCN9A;CACNA1G;KCNMB4;SCN2A;SCN3A;SCN1A;CACNA1I;KCNMB3;KCNMB2;SCN7A;ANK3;GPER1
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.6962059565844053,1.341033316743842,0.1111111111111111,0.47145247465744594,1.0,14/23,17.71%,GRIK2;RIMS2;CARTPT;SYT1;LGI1;CLSTN3;DLG4;HOMER1;CD80;WLS;ANK3;NMB;KCTD13;EDN1
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.8683165353276942,-1.3410161209906166,0.10606060606060606,0.7967603625195736,1.0,1/5,4.46%,DBI
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.819548792380877,1.340591955816561,0.1,0.47224376970055165,1.0,4/6,13.64%,ADGRE2;SYK;LYN;FES
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.5467856421216637,1.3405379432001987,0.04878048780487805,0.47169084186071747,1.0,21/80,16.25%,ANGPT1;CHST1;CSGALNACT1;VCAN;GPC6;CHST15;CSPG4;HS3ST1;B4GALT6;CHST3;ST3GAL6;GPC5;AGRN;NCAN;CHST11;CSPG5;GPC1;UST;HS3ST3A1;OGN;ABCC5
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.6595177528080284,1.3404739859502408,0.1111111111111111,0.47113963653751834,1.0,6/25,9.24%,NRXN1;CLSTN3;EPHB1;AGRN;EPHB3;IL1RAP
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.7440478446402188,1.3404723186256131,0.022727272727272728,0.47040691548536046,1.0,6/15,14.70%,CX3CR1;TAFA1;LRRK2;FZD3;CX3CL1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.6407283215741632,1.3403179541917773,0.10416666666666667,0.47018871789645045,1.0,8/22,28.68%,TAL1;MEIS2;HES1;CUL3;DUSP3;USP22;MDM2;TTL
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.5411509776831451,1.3402942017180455,0.0625,0.4695876065773192,1.0,17/79,9.68%,ADAM28;ALDH1L1;SLCO2B1;FGL2;CHL1;CSF1R;C1QB;SLC8A1;MRC1;LRRK2;FMO5;CLMN;ST3GAL6;L3MBTL4;DDO;C3;IRAK3
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.6050105863893449,1.339586111665172,0.0625,0.47137752504432473,1.0,4/25,8.16%,CHST1;B4GALT6;HEXB;ST3GAL6
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.5302226363489926,-1.3394218297143563,0.04918032786885246,0.8022701825500312,1.0,23/137,14.13%,RPS27A;UBC;UBB;PSMB6;PSMD7;PSME2;PSMD8;EXOSC8;PSMB4;APEX1;PSMD3;PSMB3;HSPA8;YWHAB;PSME1;MEX3D;EXOSC5;NPM1;UBA52;PSMA7;FASTKD3;PSMB8;PSMD13
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.6986878750165539,1.3385917163888625,0.10204081632653061,0.47425449499396904,1.0,6/12,23.93%,CD4;FES;ZFP36L1;CDK6;IL34;HLA-DRB1
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.8479178248498821,-1.338588524319504,0.11538461538461539,0.8048789243037809,1.0,1/7,0.86%,TRMT10C
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.5869278200933272,-1.3378479349584036,0.057692307692307696,0.8062763633591431,1.0,16/76,13.78%,TUBA1A;TPX2;SSNA1;PLK4;DYNLL1;TUBB4B;TUBG1;TUBB4A;DCTN3;HMMR;CEP131;NPM1;TUBB;DYNC1H1;HAUS6;AKAP9
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.5948097081985064,1.3378370485995859,0.13043478260869565,0.4762135034285923,1.0,6/36,9.24%,CX3CR1;NRXN1;CLSTN3;EPHB1;EPHB3;IL1RAP
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.7522216430587585,-1.3378111424081387,0.16326530612244897,0.8040391515634245,1.0,5/13,12.61%,VPS25;VPS28;CHMP5;TMEM50A;SNF8
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.7544725968493725,1.3377752403351832,0.09803921568627451,0.4756612746472953,1.0,4/14,9.79%,SLC9C2;SLC8A1;SLC9A9;SLC9A7
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.8794536960357482,1.3376304382984336,0.17073170731707318,0.4754370075604953,1.0,2/5,10.85%,MLIP;TRPC3
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),-0.8767739608649245,-1.3375013001490463,0.08928571428571429,0.8031067520834514,1.0,2/5,3.81%,CCDC78;PLK4
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.8788422402156402,-1.337451460256189,0.06666666666666667,0.8009960227991295,1.0,2/6,5.76%,TRMT10C;HSD17B10
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.8772011461499032,1.337381438471802,0.07272727272727272,0.47552109297077244,1.0,1/6,1.95%,CBS
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.614202193135615,-1.337160774558793,0.11475409836065574,0.7998477235330105,1.0,10/62,9.25%,RPS27A;UBC;UBB;PNRC2;PCNA;POLD3;PARP1;MUS81;RNASE1;POLD4
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),-0.8821554425427868,-1.337005852941384,0.07547169811320754,0.7983482831777583,1.0,1/6,1.93%,EIF3D
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.6091315805627822,-1.3367854757415227,0.09523809523809523,0.7971130374385196,1.0,14/56,16.85%,ZDHHC12;SELENOK;ZDHHC16;DPM3;HHAT;PGAP2;PIGO;PGAP4;ZDHHC14;PIGF;PIGW;DPM2;WDR45B;ZDHHC7
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.49060761318557095,1.3366345277329128,0.05,0.4774300001222842,1.0,57/212,14.29%,EPHA3;L1CAM;NRCAM;ROBO2;NTNG1;SEMA3D;CYFIP1;BAIAP2;EPHA4;PLPPR4;NRXN1;EMB;DOK6;PAK3;SLITRK5;EFNB3;GFRA1;DOK4;PDLIM7;EFNA5;SLITRK3;SRC;CNTN4;LGI1;ADGRB1;ROBO4;RELN;B4GALT6;EPHA6;TNR;WNT5A;EPHB1;UNC5D;NTN4;EPHB3;SLIT1;SEMA6A;SLITRK4;PLA2G10;ROBO1;DOK1;CDK5R1;UNC5A;ANOS1;EFNA3;SEMA5B;SEMA4G;SEMA4B;RAB3A;PIK3R1;GPC1;DAB1;PTPN11;PTPRO;DRAXIN;ANK3;SEMA3C
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.5816741197031119,-1.3364611515960403,0.07462686567164178,0.7965464195721316,1.0,18/61,19.21%,OST4;DAD1;DPM3;B4GALNT2;PMM1;B4GALT7;MOGS;LMAN1;DDOST;MAGT1;DPAGT1;DPM2;ST3GAL1;MGAT4B;ALG5;ALG3;DOLPP1;ALG12
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.6987974169617973,-1.3362457750463839,0.16666666666666666,0.7952734191796071,1.0,3/16,9.28%,TINF2;DCLRE1B;TFIP11
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.8499797485944429,1.3357170239278635,0.1276595744680851,0.48014496974752935,1.0,2/8,8.93%,PARP14;SOCS3
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.7653023785863308,1.334955497514347,0.21052631578947367,0.48209501362110574,1.0,4/7,16.52%,LILRB1;AXL;LYN;GAS6
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.5044370350768299,1.3346355915245547,0.0,0.48245621794937577,1.0,28/121,10.73%,ADAMTS5;PDGFB;PLSCR4;FSTL1;ACTN1;POSTN;AKAP12;FAP;PCDH18;MRC1;MEF2C;RHOJ;NOSTRIN;LDB2;PDGFRA;TMEM47;CCDC80;ROBO4;COL12A1;SULF1;TPM1;LEF1;COL4A1;FAT4;COL15A1;PAMR1;HOPX;PAWR
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.48367547844415193,1.3343075986869724,0.0,0.48285224086943973,1.0,32/161,13.98%,LPL;PTPRC;PLPPR5;NUDT11;IMPA2;PLPPR3;PLPPR4;LRRK2;PLCB1;INPP5D;PTPRB;PPP3CA;TNK2;HDHD2;INPP4B;PLCB4;LPCAT4;NUDT3;NUDT4;DUSP10;PPA2;PFKFB3;PRKCG;PLA2G10;TPTE2;ITPK1;IP6K3;ALPL;PIP4K2A;TNFAIP8L3;PGM2L1;PLCB3
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.8127214442187474,-1.3341698510132176,0.1111111111111111,0.8035111361479447,1.0,1/6,4.73%,USP1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.5313779003784348,1.3337094695741905,0.08108108108108109,0.4843050802247007,1.0,25/112,14.21%,PDGFB;CX3CR1;ANGPT1;KITLG;EGFR;P2RY12;CHI3L1;F3;PIK3AP1;MET;HGF;PDGFRA;NRG1;SRC;IRS1;PTPRJ;AXL;TGFA;CX3CL1;FGF17;PIK3R1;CD80;PTPN11;TNFAIP8L3;ITGB1BP1
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.6312058084917507,1.3335151370311673,0.1346153846153846,0.48417783524388414,1.0,9/25,13.46%,NCKAP1L;P2RY12;CYFIP1;RHOJ;RHOQ;SCIN;CSPG5;ATP1B2;RAC3
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),-0.7427833821276821,-1.3332928239933053,0.10416666666666667,0.8056265398347172,1.0,1/12,0.94%,OOEP
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.640752393604006,1.332613479529324,0.06382978723404255,0.4862142328803678,1.0,5/24,13.90%,BHLHE40;ID2;PER1;CLOCK;PPP1CB
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.8178733876895902,-1.3323551160595035,0.07547169811320754,0.8082065603502477,1.0,2/6,2.30%,UXT;UBB
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.8235928622497369,-1.331932116352505,0.14583333333333334,0.8056788912459079,1.0,2/7,6.89%,PTGIS;GLA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.8235928622497369,-1.331932116352505,0.14583333333333334,0.8056788912459079,1.0,2/7,6.89%,PTGIS;GLA
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6761477128833432,1.3317771814305772,0.08888888888888889,0.48831586387211473,1.0,2/19,5.66%,IGF1;NTRK2
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.7866383263254737,1.3308838617644598,0.1320754716981132,0.4906072005595048,1.0,3/8,11.80%,CITED2;NDRG4;HES1
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.845933602442182,1.3307871981051136,0.14893617021276595,0.4900440734051353,1.0,2/5,8.14%,LPL;TIRAP
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.7827855864252287,1.330726734283162,0.10638297872340426,0.48960703700697317,1.0,2/10,8.31%,MX1;CRLF1
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.7180896183901515,1.3306955920973509,0.1,0.48895839465031127,1.0,5/12,14.03%,VCAN;CSPG4;NCAN;CSPG5;UST
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.7810852759648951,1.3306630798438364,0.1875,0.48829398625196,1.0,2/9,7.25%,PPARG;NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),0.8454887071970023,1.330569338126123,0.08333333333333333,0.4878792364886093,1.0,2/5,11.81%,P2RY12;CX3CL1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.7452498619568971,1.330212706650143,0.12,0.4881722792245003,1.0,6/11,21.60%,SLC6A4;BBS2;MKKS;BBS4;PTEN;FBXW11
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.7592230148912358,-1.330182768923873,0.0784313725490196,0.812493261431649,1.0,4/12,9.07%,HSD17B10;AKR1D1;TSPO;FDXR
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.614656547434052,-1.3300536623988382,0.09615384615384616,0.8105787826341783,1.0,5/45,5.04%,MSRB1;CFL2;FLII;MSRB2;CFL1
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.6674886224570953,1.3299044386789232,0.11627906976744186,0.4878575798223115,1.0,2/18,1.83%,TEX15;FOS
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.6674886224570953,1.3299044386789232,0.11627906976744186,0.4878575798223115,1.0,2/18,1.83%,TEX15;FOS
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.8405060323937297,-1.3295874261569873,0.14583333333333334,0.8110764381710646,1.0,2/6,10.56%,MRPS2;MTERF3
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.6716773041266423,-1.3294001790132768,0.17307692307692307,0.8098190504046995,1.0,5/15,8.79%,PRDX1;NOX1;PRDX5;SOD1;PRDX3
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.8410384625749293,-1.3293318472278182,0.14583333333333334,0.8076340695584316,1.0,2/5,8.48%,RPS3;OTUB1
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.7005560094434959,-1.3293091685487377,0.16,0.8053883053564157,1.0,6/21,18.64%,CRYAB;TMEM109;HRAS;MEN1;XRCC6;ATR
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.8085243021913096,1.3291468925151624,0.17777777777777778,0.49004848284420394,1.0,1/6,3.54%,LRRK2
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.8229742355553913,-1.3288927080033452,0.1836734693877551,0.8054060952454838,1.0,1/9,0.51%,DDIT3
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.7009326279898453,-1.3287733911305397,0.09803921568627451,0.8037164966413379,1.0,7/22,21.28%,TRMT10C;RPUSD2;DKC1;PCIF1;PUS1;TRMT6;VIRMA
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),0.806453603321357,1.328589953227347,0.1836734693877551,0.49105644120245706,1.0,3/7,9.39%,CARTPT;STX1A;KCNB1
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.8251103867688652,1.3282673364846096,0.13043478260869565,0.49139517246352177,1.0,2/6,5.66%,SRC;NTRK2
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.7597620376868399,-1.3281950694072506,0.13725490196078433,0.8045415661087945,1.0,4/13,11.31%,FSHR;COL9A3;SOD1;ZNF830
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.67278946825553,-1.3280864266636738,0.10416666666666667,0.8027672745916287,1.0,1/22,1.56%,TINF2
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.6106085953896949,1.3278254365860191,0.10416666666666667,0.49211803446914076,1.0,11/25,12.98%,GPM6A;PLPPR5;RHOQ;TENM1;AGRN;TGFB3;TENM2;DOCK11;DPYSL3;PIK3R1;ARAP1
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.7348064095774202,1.3276930970081542,0.07692307692307693,0.4917724549723128,1.0,1/14,0.32%,CLDN5
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),-0.8080994643397656,-1.3274809500444873,0.10869565217391304,0.8034452484264539,1.0,2/6,15.13%,ACAA2;THEM4
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.8601060366796914,-1.3273135770473463,0.125,0.8019977550074476,1.0,3/6,8.71%,PRDX1;SOD1;SOD3
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.6373257710679366,1.3267112096664915,0.15555555555555556,0.4946744129750666,1.0,4/29,5.18%,CD59;C1QB;C5;C3AR1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.7224209037982275,1.326641517551365,0.11320754716981132,0.4942389315082746,1.0,4/12,13.84%,SRC;BCL2;ZNF304;PDK4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.6656820872269651,1.3266026940312658,0.14,0.4935785000137967,1.0,3/17,1.80%,CARD18;CX3CR1;IGF1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.6788667337063943,-1.3265485048352803,0.14035087719298245,0.8037798540068931,1.0,1/24,0.14%,NGF
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.7778628482566867,-1.3264469646156316,0.15,0.8020760217127617,1.0,1/12,3.32%,CGAS
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.8416182362794709,1.326297312128146,0.058823529411764705,0.4938062509489059,1.0,1/7,0.78%,PDGFB
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.7137082207935194,1.3255487736292912,0.14893617021276595,0.4960634623894971,1.0,4/18,11.04%,ROBO2;HEY1;SOX9;ROBO1
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.6044725350884342,1.3252417573258835,0.1,0.4963908453104507,1.0,4/30,3.35%,TGFB2;PTPRC;GPM6A;MEF2C
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.8406272820501519,1.3251121236854846,0.06896551724137931,0.49621554961685826,1.0,2/9,5.94%,ROBO2;NPNT
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.6312458212428812,-1.3250628221275473,0.15789473684210525,0.8065008341904707,1.0,16/44,21.77%,TMEM11;TIMM10;ATP5F1B;SAMM50;TIMM8B;UQCC3;ATP5MC3;ATP5PF;APOO;TIMM13;ATP5PB;CHCHD6;ATP5PD;TIMM9;AFG3L2;TIMM29
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.6075950296874311,1.3249081495167068,0.14583333333333334,0.4961616945514829,1.0,4/32,5.18%,CD59;C1QB;C5;C3AR1
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),0.8669865447737353,1.3246272815366837,0.17857142857142858,0.4964874956555626,1.0,2/5,8.60%,MYH11;FBLN5
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.7983665849509936,-1.3246156628294392,0.125,0.8061813238729447,1.0,2/8,5.81%,TINF2;MPG
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.5460099567348331,-1.3244950078937117,0.09090909090909091,0.8045089566991274,1.0,14/118,8.78%,TUBA1A;NES;PKMYT1;SSNA1;PLK4;DYNLL1;TUBB4B;TUBG1;TUBB4A;DCTN3;USH1C;KDM8;CEP131;CCNB2
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.5796077132759909,1.3240700237766727,0.17777777777777778,0.49800084919520277,1.0,19/71,12.84%,L1CAM;NRCAM;NTNG1;BAIAP2;PLPPR4;PAK3;SLITRK5;SLITRK3;CNTN4;ADGRB1;RTN4RL2;EPHB3;GAP43;SLITRK4;CDK5R1;MAPT;NREP;RAB3A;VASH2
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.5108931516585675,1.3239698095548296,0.05084745762711865,0.49777262805866074,1.0,23/77,12.81%,KANK2;PCOLCE;PPARG;EGFR;FSTL1;STAB1;PCDH18;LRIG3;CSPG4;LOX;LAMC1;CHST3;FBLN1;COL12A1;TEAD1;COL4A1;BOC;ADAMTS15;ANTXR1;LAMB2;NR2F2;CCN5;PRRX1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.7574453778407612,1.32393207242932,0.10416666666666667,0.4971157099561653,1.0,2/14,6.75%,PKP2;TPM1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.7962189601904226,-1.3237408827045685,0.08928571428571429,0.8064008927391291,1.0,3/10,11.32%,NDC80;CHAMP1;MIS12
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.6596345441230244,-1.323665549383137,0.13846153846153847,0.8043828751005332,1.0,13/36,16.31%,LSM2;GEMIN6;SNRPC;SNUPN;SMN1;SNRPD1;SNRPD2;PRPF6;SNRPB;PRPF3;SNRPE;PRPF8;SNRPG
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),0.7912744044498049,1.3236316081460089,0.13725490196078433,0.4976097203827281,1.0,1/6,3.41%,MYH11
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.7525760460684583,1.323615334223286,0.1568627450980392,0.4969378241427969,1.0,4/9,15.39%,PDGFB;PDGFRA;CD200;GPER1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),0.7917307239259457,1.3233764632736151,0.16666666666666666,0.4970544650647924,1.0,4/5,19.76%,HSPB1;PRKD1;VEGFA;KDR
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.7181281991420282,-1.3229375593702108,0.17307692307692307,0.805746070048045,1.0,3/13,12.11%,EXOSC8;TRIR;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.7584891779110917,1.3227446924776662,0.15217391304347827,0.4984855375893691,1.0,2/9,13.15%,TLR2;PUM1
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.7102707099701957,1.3227115193001076,0.14,0.49784939138762385,1.0,4/12,16.73%,IRS1;GPLD1;NNMT;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.7995570777220229,1.3224229139170807,0.16326530612244897,0.49825364423362645,1.0,2/6,7.67%,BMP6;LY86
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.7272733767005743,1.3222089035199482,0.13636363636363635,0.4983337111460229,1.0,3/10,13.15%,WTIP;ZFP36;PUM1
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.6577776295426063,1.322194967259153,0.07547169811320754,0.49763262755998633,1.0,3/20,6.69%,PID1;NR4A3;ACSM1
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),-0.8880604057192092,-1.322184594740431,0.12962962962962962,0.8070781074527779,1.0,1/5,4.31%,SLC39A6
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.8235082731758926,1.3219554824963982,0.11764705882352941,0.49781507015219423,1.0,2/8,7.34%,HEY1;SOX9
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.7693948394565499,-1.3218687901449577,0.14634146341463414,0.8063639836001298,1.0,3/10,14.13%,PSMG2;ADRM1;PSMD13
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.7685746360292245,1.3216115704807145,0.08695652173913043,0.4983524708851866,1.0,1/10,2.02%,MLIP
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.701470508607557,1.3215489194214565,0.18867924528301888,0.49780650898200396,1.0,9/18,16.65%,NTNG1;MYH11;FBLN5;NTN4;LAMB4;LAMB2;LAMB1;GAS6;PXDN
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.7234327885897471,-1.32129787288832,0.14035087719298245,0.806471724508382,1.0,5/13,17.69%,RNF8;HEXIM1;NELFE;NELFCD;SUPT5H
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),-0.8635347904576439,-1.3211533386400591,0.12244897959183673,0.8049243683399078,1.0,2/5,3.93%,FSHR;COL9A3
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.623149275396077,1.3211112479156952,0.058823529411764705,0.4989500344247742,1.0,14/31,17.71%,GRIK2;RIMS2;CARTPT;SYT1;LGI1;CLSTN3;DLG4;HOMER1;CD80;RAB29;WLS;NMB;KCTD13;EDN1
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.5186319130239685,1.3209397184121738,0.075,0.4989441423903195,1.0,19/96,8.93%,IGFBP3;COBLL1;PLSCR4;EGFR;FSTL1;PPP1R3C;F3;POSTN;LRIG3;KIAA1217;LOX;CDON;CCDC80;COL12A1;SULF1;COL4A1;PXDC1;EPAS1;NTN4
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6231706406892901,-1.3208550165406558,0.09803921568627451,0.8045475107243418,1.0,7/46,12.79%,RPS27A;UBC;UBB;PARP1;MCM4;BLM;UBA52
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),0.8028634969021171,1.3208246179568477,0.17391304347826086,0.49856798511366723,1.0,1/5,16.58%,PRKCD
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.7402263206757606,1.320547603582743,0.0784313725490196,0.49876433881761517,1.0,4/13,11.81%,CX3CR1;ITGAM;MAPT;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7490003578814783,1.3203716791563138,0.16279069767441862,0.4985573398636023,1.0,4/12,14.70%,JCAD;RHOJ;AKT3;VEGFA
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8083031312189938,-1.3202708561489136,0.09803921568627451,0.8056095085823265,1.0,3/7,11.87%,HLA-C;HLA-B;B2M
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.7230963869532981,1.320267918386918,0.09803921568627451,0.498233615562294,1.0,2/13,0.33%,CD59;TGFB2
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),0.8284675323158268,1.3195703764561868,0.171875,0.5004211168492041,1.0,1/5,4.28%,CBLIF
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.548897631600932,1.3193620239872528,0.07317073170731707,0.5004466115873105,1.0,18/82,14.05%,PTPRC;RAB3C;LRRK2;RIMS2;STON2;RIT2;SYT1;SYK;SRC;STXBP5L;PACSIN1;RAB15;SYT7;RNF139;SCARB1;RAB3A;FES;CDH13
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.5612158150571264,1.3192613760327738,0.02,0.5001549627903273,1.0,12/54,13.64%,MEF2C;NR4A3;KAT2B;ZBTB16;MEIS2;MAFB;MOV10;CBFB;SETD1A;LGALS3;LYN;FES
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.7052127214851968,-1.3189953640900622,0.13636363636363635,0.8102938549810675,1.0,1/17,0.94%,OOEP
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.6036794277290374,1.3183959492114086,0.18181818181818182,0.5026304227657404,1.0,4/29,3.54%,TM4SF20;TIMP4;EPHA4;LRRK2
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.849446435960503,1.318179523929819,0.044444444444444446,0.5027691747452677,1.0,2/6,7.72%,MX1;DNM1
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.7722682300785351,-1.3179009509204347,0.16326530612244897,0.8137770466832747,1.0,5/10,21.39%,COPS6;GPS1;COPS5;TOR1A;COPS7A
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.6142035129767313,1.3178688012110213,0.13725490196078433,0.5028244485638041,1.0,7/33,12.62%,EGFR;ADGRB1;BANP;GIT1;PRKCG;IRAK3;PDE3B
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),-0.7348584384975788,-1.317857429958575,0.125,0.8116792915330602,1.0,3/17,4.63%,DPM3;SDF2L1;RXYLT1
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.7703486929393323,-1.3178522655669134,0.1746031746031746,0.809478432365392,1.0,3/12,17.75%,BRCC3;BLM;XRCC6
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.8596031094102783,1.3177391873450386,0.10204081632653061,0.5025144998453771,1.0,2/5,6.75%,ADRA1A;TPM1
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.7414458962587862,-1.3176001767580785,0.09433962264150944,0.8087524535794844,1.0,1/13,0.25%,ABCA13
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.8948472448269595,1.3175538551207364,0.08163265306122448,0.502520264549923,1.0,1/5,2.30%,GRM5
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),0.8298815755494384,1.3172967939161075,0.2,0.5025922024010108,1.0,3/6,12.43%,RSPH9;TEKT3;TEKT5
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.573701829775627,-1.3171406335827058,0.05555555555555555,0.8086914805763115,1.0,21/68,19.79%,POLR2L;POLR2G;POLR2K;POLR2I;GTF2F1;PHAX;SNAPC1;INTS14;POLR2A;TAF13;POLR2E;SNAPC3;POLR2C;POLR2D;TAF11;SNAPC5;CCNT1;SNAPC2;POLR2J;CCNK;GTF2A1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.6814889600137239,1.3169395300233144,0.08888888888888889,0.5032422829022833,1.0,4/18,10.72%,NCKAP1L;CAMK1D;TIRAP;BST1
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.8274037639984166,1.3169302461283456,0.0625,0.5025374617777704,1.0,4/8,9.28%,NRCAM;KCNIP2;AGRN;PICK1
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.6679987041726143,1.316747481904771,0.13043478260869565,0.5024442946845951,1.0,9/19,24.89%,MFAP5;TENM3;COL5A1;SHROOM2;VEGFA;RARG;FBN1;NF1;STAT3
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5699029138530058,1.3163636564477594,0.061224489795918366,0.5028614894765087,1.0,9/54,8.49%,ZNF423;PPARG;FSTL1;BMPR1B;VWC2L;SULF1;DLX1;BMPER;CHRD
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.9006967503794566,1.3160498082851753,0.07317073170731707,0.5030803372407737,1.0,1/5,3.84%,SPRED3
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.8912806440947172,1.315055611228017,0.03773584905660377,0.505743524792696,1.0,1/5,0.95%,PPARG
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.5713706131411528,-1.3150184858063165,0.07547169811320754,0.8169283356790906,1.0,21/69,19.79%,POLR2L;POLR2G;POLR2K;POLR2I;GTF2F1;PHAX;SNAPC1;INTS14;POLR2A;TAF13;POLR2E;SNAPC3;POLR2C;POLR2D;TAF11;SNAPC5;CCNT1;SNAPC2;POLR2J;CCNK;GTF2A1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.8738224978112801,-1.3150094376537835,0.07142857142857142,0.8147371090114892,1.0,2/5,4.75%,SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.8456895475868097,-1.3149183880442932,0.1,0.8129647065853767,1.0,2/8,4.20%,TGM1;KRT10
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.8505546890772641,1.3146342222691696,0.0847457627118644,0.5065968185433117,1.0,3/6,11.97%,SPEF1;DACT1;PLEKHA4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.6903398276269358,1.3139933580959902,0.1346153846153846,0.5079386463017043,1.0,3/14,1.80%,CARD18;CX3CR1;IGF1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),0.5080068697274105,1.3139719104988796,0.1111111111111111,0.5072831767608005,1.0,15/72,10.66%,IFNA2;PTPRC;PLSCR1;MX1;TLR2;TRIM5;ISG15;RSAD2;SAMHD1;LILRB1;ABCC9;AGBL4;MOV10;PLA2G10;BCL2
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.47037232347276764,-1.3135951306667712,0.03225806451612903,0.8169744141603642,1.0,45/233,18.02%,RPS27A;UBC;RAD23A;COPS6;UBB;USP27X;PSMB6;PSMD7;JOSD2;ADRM1;PSME2;PSMD8;USP1;USP51;PSMB4;USP19;USP16;RHOA;OTUB1;OTUD3;PSMD3;CFTR;PSMB3;PSME1;BRCC3;UBA52;GPS1;PSMA7;TOMM20;TADA3;PSMB8;PSMD13;HGS;KEAP1;ABRAXAS1;COPS5;ACTR8;SMAD7;PSMD2;STAMBP;TOR1A;PSMC5;MCRS1;IKBKG;TAF9B
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.4894490538403208,1.3135069968323452,0.022222222222222223,0.5082450195195004,1.0,27/108,13.36%,CLDN5;IGFBP3;MCTP1;EPHA4;PTPRG;PTPRR;DACH1;TMIGD3;CITED2;SRGAP1;SULF1;ADGRG1;TPM1;PTPRJ;ACVR1C;DUSP10;NDRG4;CHRD;PTPRT;CORO1C;ROBO1;CX3CL1;NGFR;DPYSL3;ATP1B2;KANK1;ZMYND8
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.7938735856956647,1.313467080901733,0.16279069767441862,0.507705008461198,1.0,5/9,18.32%,ADCY8;ADCY2;ADCY7;ADCY1;ADCY10
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.5007565654794961,1.3133466956262758,0.0975609756097561,0.5074756774697654,1.0,16/79,10.66%,IFNA2;PTPRC;PLSCR1;MX1;TLR2;TRIM5;ZDHHC11;ISG15;RSAD2;SAMHD1;LILRB1;ABCC9;AGBL4;MOV10;PLA2G10;BCL2
prerank,GO_Biological_Process_2021__definitive hemopoiesis (GO:0060216),0.9052343212008838,1.3133239789367295,0.0851063829787234,0.5068244628902349,1.0,1/5,2.18%,MFAP5
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.7091407425564961,1.3128423001745104,0.1346153846153846,0.5079439204797923,1.0,5/14,9.36%,PPARG;MEF2C;PRKG1;TPM1;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.5556506239216984,-1.3124785772661618,0.06896551724137931,0.8198156543235389,1.0,22/84,18.87%,TRMT10C;RPL5;EIF3D;POLR2G;EIF2S3B;PASK;RPS9;METTL5;USP16;RPS4X;PYM1;RPS27L;EIF5A2;NPM1;EIF5A;FASTKD3;POLR2D;RPS6KB2;JMJD4;PCIF1;NAT10;CIRBP
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.6515702701419962,-1.3124671203031253,0.16417910447761194,0.8176401852645864,1.0,14/35,18.00%,GEMIN6;NUTF2;PHAX;SNUPN;RBM15B;SMN1;SNRPD1;NXT2;SNRPD2;NPM1;SNRPB;SNRPE;SNRPG;NXT1
prerank,GO_Biological_Process_2021__cellular response to salt stress (GO:0071472),0.856870777688722,1.312423971068318,0.1276595744680851,0.5086551504543618,1.0,1/5,0.81%,AQP1
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.840232044762301,-1.3122201831168923,0.12962962962962962,0.8103851289259408,1.0,1/5,4.83%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.840232044762301,-1.3122201831168923,0.12962962962962962,0.8103851289259408,1.0,1/5,4.83%,EXOSC8
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.840232044762301,-1.3122201831168923,0.12962962962962962,0.8103851289259408,1.0,1/5,4.83%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.840232044762301,-1.3122201831168923,0.12962962962962962,0.8103851289259408,1.0,1/5,4.83%,EXOSC8
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.6152443341873547,1.3120981709397204,0.07547169811320754,0.5090731206709513,1.0,7/35,9.68%,EGFR;TIMP4;NELL1;ADGRB1;BANP;PRKCG;IRAK3
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.7254473361141166,1.3120475318282536,0.14893617021276595,0.5085364182068853,1.0,3/12,7.55%,TGFB2;ADRA1A;SCN3B
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.7216230619975813,-1.3116349505357576,0.19607843137254902,0.8111404753805824,1.0,3/17,8.43%,ABCA13;ABCA8;TSPO
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.5220119347238226,1.3111286889680147,0.043478260869565216,0.5110353780209365,1.0,19/75,19.76%,TGFB2;ANGPT1;SRC;WNT5A;SOX9;VIL1;GPLD1;PRKD1;BMPR2;SCARB1;ITGB1BP1;VEGFA;DOCK5;PRKCE;DOCK1;EDN1;SASH1;PLCG1;KDR
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.6025175327485441,-1.3108221121449528,0.10416666666666667,0.8129734165013631,1.0,2/44,0.29%,NGF;P2RY10
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.8482334930727664,-1.3107534346323675,0.11290322580645161,0.8112522975404381,1.0,3/5,14.89%,SEC61B;SEC61A2;ZFAND2B
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6826674011345177,1.310637004549552,0.23076923076923078,0.5121253008560273,1.0,2/15,4.57%,MEF2C;NRG1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.6055726025729028,1.310549477766397,0.0851063829787234,0.5117153901224267,1.0,14/37,15.77%,PTPRC;RPS6KA6;LMO3;SPRED3;PTPRR;FBLN1;DUSP10;SEMA6A;LYN;ITGB1BP1;WNK2;TIMP3;GPER1;DUSP6
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.7465042716177162,1.3104696505952689,0.11363636363636363,0.5113226710994726,1.0,2/8,7.71%,TJP2;SLC2A5
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.7509530481143396,1.3099778812144598,0.06382978723404255,0.5125522100930735,1.0,3/11,10.97%,CHI3L1;TIRAP;TNFRSF10B
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.852399119537837,1.3091753776012702,0.057692307692307696,0.5142432596889557,1.0,3/6,9.08%,IGF1;IL12A;CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.699052371335144,1.3090887069044834,0.19230769230769232,0.5138487068174993,1.0,1/12,1.80%,IGF1
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),0.7796146636891109,1.3088088965180789,0.23636363636363636,0.5140786797272827,1.0,3/6,17.71%,PTGER3;EDNRB;EDN1
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.703775020371572,-1.3087423721715914,0.2,0.8192233409950125,1.0,8/16,22.62%,TSEN34;CSTF2;C2ORF49;FAM98B;RTRAF;DDX1;TRPT1;ERN1
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.7763255273334753,-1.3084407705864844,0.08695652173913043,0.8183489613834646,1.0,2/9,1.32%,RPL5;RPL11
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.7476568525345736,1.3082731678847537,0.1875,0.5153137844903071,1.0,7/8,25.26%,BBS2;MKKS;LEPR;BBS4;UGCG;STAT3;SIRT1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.7512079731020588,1.3081577952942767,0.08928571428571429,0.5149353274730452,1.0,6/14,11.75%,CHRM3;PLCB1;CHRM5;AGRN;CDK5R1;CHRM1
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.5490671166827644,-1.3080616027567873,0.07692307692307693,0.8185494325045515,1.0,14/119,8.78%,TUBA1A;NES;PKMYT1;SSNA1;PLK4;DYNLL1;TUBB4B;TUBG1;TUBB4A;DCTN3;USH1C;KDM8;CEP131;CCNB2
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.7402438406792844,1.3079681002050785,0.09090909090909091,0.5149400025808035,1.0,4/12,16.21%,YBX3;ZFP36;TIRAP;ELAVL4
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.4876450301590386,1.3079457345659844,0.06521739130434782,0.5142927760014908,1.0,25/136,15.51%,RGS7;EPHA3;EPHA4;LRRK2;EFNA5;NTRK2;SIPA1L1;PLXNA4;LRCH1;PRKG1;RASIP1;PLXNA2;AGRN;EPHB3;DOCK8;NGEF;RGS1;CX3CL1;DOCK11;ARAP1;GNB5;ITGB1BP1;PKP4;THY1;CHN1
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.7806016232140214,1.3079223329389753,0.1568627450980392,0.5136790505785555,1.0,1/8,2.05%,HEY1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),0.8575773330685805,1.3078350228790867,0.13953488372093023,0.5133524019991009,1.0,1/5,2.09%,NCKAP1L
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.7187376105789594,-1.3076857707336031,0.15789473684210525,0.818465645861089,1.0,3/13,9.67%,RPS3;TPT1;DDIAS
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),-0.85994512476617,-1.30761462522992,0.125,0.81463667415028,1.0,2/6,9.16%,ENPEP;REN
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),-0.85994512476617,-1.30761462522992,0.125,0.81463667415028,1.0,2/6,9.16%,ENPEP;REN
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.5786896244027142,1.3075925034014948,0.02564102564102564,0.513406686424538,1.0,18/64,8.67%,GRIK2;ADCY8;GRIN2B;NRXN1;RIMS2;CACNG5;CACNG2;SYT1;NFATC4;PRKCZ;LGI1;RELN;ADRA1A;CLSTN3;SHANK2;TSHZ3;CACNG8;CACNG3
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.7717224279721514,1.3074466389943347,0.08771929824561403,0.5131445378062375,1.0,3/10,11.80%,HEY1;TMEM65;HES1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.5599579886987314,-1.3073110183471979,0.07272727272727272,0.8142177789614363,1.0,17/82,14.34%,RPS27A;UBC;UBB;PSMB6;PSMD7;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;CHUK;PSME1;UBA52;PSMA7;PSMB8;PSMD13;SQSTM1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.5681603804552936,-1.3071499902780248,0.058823529411764705,0.8128954780672865,1.0,11/47,17.32%,RAD23A;UBB;PSME2;ARAF;GABARAPL2;USP19;PSME1;RHBDF1;UFL1;PRKACA;PSMC5
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.5536517614685151,-1.3069845498759707,0.0847457627118644,0.8113864248435235,1.0,19/75,21.12%,COPE;USE1;KIF3B;KDELR1;ARCN1;TMED9;BNIP1;TMED2;ERGIC3;KIF4A;KIF11;TMEM115;LMAN2;SURF4;GBF1;RINT1;SCYL1;RER1;NAPA
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.8009899212481011,-1.306818959815849,0.21951219512195122,0.8100996153628106,1.0,1/10,0.24%,BMP5
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.6315984082728022,1.3067631906717612,0.08333333333333333,0.5147782720158713,1.0,8/26,18.00%,MEF2C;TBX6;NDRG4;HES1;DNAAF1;MKKS;BBS4;PKD2
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.6049706496912165,-1.306622540136806,0.14285714285714285,0.8090761357106703,1.0,14/46,20.90%,TINF2;PCNA;POLD3;PARP1;DCLRE1B;APEX1;POLD4;HUS1;BLM;XRCC6;SMC6;ATR;PARP3;PRKDC
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.7405358310426293,1.3064643970748797,0.16666666666666666,0.5146304327725958,1.0,2/11,9.45%,ZFP36;NOTCH4
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.7405358310426293,1.3064643970748797,0.16666666666666666,0.5146304327725958,1.0,2/11,9.45%,ZFP36;NOTCH4
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.7625645896539204,-1.3062284442611223,0.1,0.8088901792150047,1.0,4/10,12.94%,CCT7;CCT2;CCT6A;DKC1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.6669655002912528,1.3061835491806058,0.19298245614035087,0.5152331953454072,1.0,2/13,5.75%,AQP1;MT1M
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.5284322006177651,1.306047449447034,0.07142857142857142,0.5150960305319922,1.0,22/72,21.39%,SLCO2B1;ABCC4;SLC1A2;SLC24A3;SLC22A3;SLC4A4;ABCC9;SLC15A2;ATP1B2;SLC29A2;SLC7A8;SLC2A13;SLC29A4;ABCC5;SLC28A2;LEPR;SLC1A1;SLC16A2;LRP1;SLC16A7;ATP1A2;SLC6A1
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.48610877646125294,1.3057588325464111,0.02857142857142857,0.5154926236579569,1.0,28/129,10.30%,CLDN5;TGFB2;L1CAM;CDH9;CLDN16;ROBO2;NTNG1;CDH10;SELL;GPC6;EMB;ITGAM;LRFN5;SLITRK3;CNTN4;CDH18;ROBO4;CDH22;TENM3;PTPRM;CADM3;TENM1;UNC5D;PTPRT;TENM2;FAT4;CDH23;IGSF21
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.817375851783035,1.3056334091260362,0.12727272727272726,0.5146241365804775,1.0,2/6,8.14%,TLR2;TIRAP
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.817375851783035,1.3056334091260362,0.12727272727272726,0.5146241365804775,1.0,2/6,8.14%,TLR2;TIRAP
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.608506785920149,1.3055706555176838,0.08163265306122448,0.5140509904007379,1.0,3/21,8.16%,CHST1;B4GALT6;ST3GAL6
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.7185674967288055,1.3050260909162126,0.14285714285714285,0.5151802970129963,1.0,5/11,14.03%,VCAN;CSPG4;NCAN;CSPG5;UST
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.6439220478954695,1.3048064489529458,0.16279069767441862,0.5153248075052337,1.0,2/16,8.69%,WNT8B;AMER1
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.8206590104785237,-1.304697678387241,0.21428571428571427,0.8124066875057375,1.0,3/5,12.61%,VPS25;VPS28;SNF8
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.8206590104785237,-1.304697678387241,0.21428571428571427,0.8124066875057375,1.0,3/5,12.61%,VPS25;VPS28;SNF8
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6108235544503764,-1.3046536356847254,0.14,0.8105829304454096,1.0,14/47,16.14%,POLR2L;TINF2;H1-4;POLR2G;CGAS;POLR2K;POLR2I;H1-2;POLR2A;POLR2E;BLM;DAXX;POLR2C;POLR2D
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.8660810649202241,1.3042620822760975,0.08333333333333333,0.5163716293849788,1.0,1/5,6.15%,WNT5A
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.7356065259319112,-1.304191372914923,0.19607843137254902,0.810796431633072,1.0,7/12,15.69%,COX7C;COX5B;COX7B;COX6A1;COX4I1;COX6B1;COX5A
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.6092508794916228,1.3041723505987808,0.1282051282051282,0.5159390906113667,1.0,7/51,4.48%,PDGFC;PDGFB;EGFR;FLT1;MAP3K5;LRRK2;DIRAS1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.8625553072714116,1.304168094497984,0.13725490196078433,0.5152748516282644,1.0,2/6,6.15%,ROBO2;WNT5A
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.7345200784579786,1.3037233544921152,0.14285714285714285,0.5161625846473133,1.0,1/11,0.65%,DPYS
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.7582852590357713,1.3037082584722561,0.16,0.5155462432873914,1.0,4/10,12.26%,GAS2L3;BAIAP2;BAIAP2L1;DPYSL3
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.8835292343281351,1.3036257564940876,0.04,0.5151479813458862,1.0,2/5,10.21%,CAMK2B;FRMPD4
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.896927959808693,-1.30358534070483,0.11627906976744186,0.8116620979416032,1.0,1/5,2.47%,DCTD
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),-0.8094790304596204,-1.3032001098485566,0.16666666666666666,0.8115355054226858,1.0,2/9,6.63%,AIPL1;FNTA
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.810506845421955,1.30290166482469,0.10869565217391304,0.5169743087553194,1.0,1/7,2.17%,PPP1R3C
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.5538218929696037,-1.3027812471028546,0.06451612903225806,0.8118708138621399,1.0,13/74,12.27%,POLR2L;POLR1F;POLR2K;POLR1G;SPHK2;DNMT3B;MYBBP1A;POLR1H;MYO1C;SMARCA5;DDX21;ZNF335;POLR2E
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),-0.7980292215721796,-1.3026495551103783,0.2127659574468085,0.8103430785475366,1.0,1/6,0.98%,PAX8
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),-0.8462087844860365,-1.3024492469334883,0.1282051282051282,0.8093653770217577,1.0,1/6,3.32%,PTPRU
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.5505262386442804,1.3023975871656968,0.07547169811320754,0.5180093803020694,1.0,15/56,16.82%,LPL;NPAS2;PLSCR1;TLR2;MEF2C;WNT5A;NFKBIA;TNFRSF1A;CX3CL1;IFNK;NFKBIZ;IL17RA;IL33;SLC15A4;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.828136564971442,1.3022860819418993,0.23809523809523808,0.5177326677308953,1.0,2/5,5.66%,SRC;NTRK2
prerank,GO_Biological_Process_2021__cellular water homeostasis (GO:0009992),0.8294999315282694,1.3021242073217594,0.1702127659574468,0.5174412968342718,1.0,1/5,0.81%,AQP1
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.7856814824129261,1.3018109458397642,0.21818181818181817,0.5181491350643469,1.0,2/5,12.71%,MAP2;TTBK2
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.4840087819903971,1.3016887655527318,0.02631578947368421,0.517996047496356,1.0,34/156,10.29%,ADAMTS5;PDGFB;ITGA11;CD44;ADAMTS9;ST7;MMP16;ITGB4;MFAP5;POSTN;VCAN;TNC;ADAMTS7;LOX;ITGAM;ADAMTS10;COL11A1;ADAMTS17;LAMC1;COL5A3;NPNT;TNR;ADAMTS6;ADAM12;COL4A1;COL7A1;FBLN5;JAM2;VIT;ADAMTS15;AGRN;NCAN;COL15A1;PAPLN
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.7711302602854117,1.3015748237446731,0.18181818181818182,0.5177054707907915,1.0,4/11,8.45%,KCNC2;GUCY1A1;DDAH1;NOS1
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.8524064250003769,-1.3013926346945168,0.16666666666666666,0.8125129567875798,1.0,1/8,0.51%,DDIT3
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.4689459124905139,1.3013135245540546,0.019230769230769232,0.5179511807588569,1.0,27/139,9.41%,LPL;EPHA3;AQP1;CX3CR1;SSTR1;EGFR;MGST1;BRINP3;ADCY8;MEF2C;PID1;ABCB4;IRS1;TWF2;TNFRSF1B;WNT5A;LILRB1;ZFP36;WNT8B;SOX9;AXL;TESC;ADCY2;GIT1;VIM;BRINP1;IRGM
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.7767774020795497,1.3011070130819253,0.18867924528301888,0.5181962533469795,1.0,4/10,17.20%,SYBU;MAPT;NEFL;ACTR10
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.6747665100393145,1.30095862208985,0.1,0.5180591592173643,1.0,4/18,6.99%,PDGFB;P2RY12;CSF1R;STX3
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.8047682544130721,1.3009363543768249,0.19230769230769232,0.5174194493152376,1.0,2/6,15.53%,KLF9;PTPRK
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.7297643657828642,1.3008747407699215,0.14285714285714285,0.5170401636524233,1.0,5/15,19.63%,KAT2B;PBX1;NOTCH4;NOTCH3;WWC1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.6128928869524056,-1.3005099537718596,0.14545454545454545,0.815312779022685,1.0,6/53,7.28%,RPS27A;UBC;FAM89B;UBB;IL17RD;BAMBI
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.7740301764645698,1.3004019893022425,0.1956521739130435,0.5182276830506473,1.0,4/6,21.23%,TNFRSF1B;TNFRSF1A;RIC1;RGCC
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.5230271008888062,1.3000692182337101,0.0625,0.5189111158261814,1.0,20/78,12.26%,ROR1;FSTL1;TNC;PCDH18;ADAMTS7;GPR161;TMEM47;EFNA5;CHST3;WNT5A;ADGRL2;TPM1;TENM3;COL4A1;AXL;P3H2;ADAMTS15;ANTXR1;CSRP2;DPYSL3
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.6590962824974159,1.2999350537742929,0.12962962962962962,0.5186830054720474,1.0,6/24,9.39%,SYT4;SYT1;SYT13;STX1A;SYT7;KCNB1
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.8134037530617841,-1.2998599991529807,0.10714285714285714,0.8165871175848523,1.0,2/9,0.74%,LCK;CRTAM
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6412122590152914,1.2996831095085772,0.16326530612244897,0.5188492145061678,1.0,4/22,6.15%,MMRN2;JCAD;RHOJ;MAP2K5
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.7657480666777721,-1.2996548270408614,0.18867924528301888,0.8156656231036865,1.0,3/7,20.86%,KDELR1;GPAA1;RER1
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.642616559884361,1.2994898596411395,0.15555555555555556,0.5187427623568114,1.0,2/20,0.78%,PDGFC;PDGFB
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.7882287328603413,-1.2994114616732522,0.10204081632653061,0.8145838267168278,1.0,3/9,15.30%,FUCA1;SMPD2;SGPL1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.5197802515169774,1.2993954237772458,0.061224489795918366,0.5183798024675511,1.0,19/71,17.76%,PDGFC;PDGFB;EGFR;FLT1;LRRK2;DIRAS1;PTPRJ;TENM1;IRAK3;ROBO1;LYN;VEGFA;DIRAS2;CDK12;PRKCD;STK38;PIK3R5;EDN1;RGS2
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.547378067760718,-1.2993658027393393,0.08620689655172414,0.8127673830590663,1.0,6/74,2.41%,WNT9A;RPS27A;UBC;SFRP1;UBB;GPC4
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.6051116965900115,1.2989824337346731,0.11904761904761904,0.5191340921302668,1.0,13/39,9.49%,SNAP25;NRXN1;RIMS2;SYN2;SYT1;GAD1;GAD2;DNAJC5;SNPH;STX1A;PCLO;SYN3;LIN7A
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.686370952669898,-1.2989364086163282,0.19047619047619047,0.8130512673704325,1.0,3/20,7.02%,BMP5;SFRP1;IL17RD
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.8183611177155719,1.2987283183820377,0.15555555555555556,0.5192536758061972,1.0,2/6,16.58%,GAS6;PRKCD
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.6932459310943073,1.2986100804309135,0.08333333333333333,0.5190720165497066,1.0,5/15,11.93%,MAP2K5;WNT5A;LIFR;PARP9;CBFB
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.576283278520607,-1.2985438453991975,0.13793103448275862,0.8130269531521269,1.0,22/58,19.58%,POLR2L;RAD23A;POLR2G;PPIE;POLR2K;POLR2I;GTF2F1;POLR2A;KPNA2;PPIA;POLR2E;NELFE;FKBP6;POLR2C;POLR2D;NR5A2;NELFCD;CCNT1;SUPT5H;POLR2J;CTDP1;PDE12
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.8194966458918121,1.2983759687262797,0.18518518518518517,0.5192965681150318,1.0,5/5,18.07%,GAD1;GAD2;ABAT;ALDH5A1;ALDH1A1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.778492992063649,-1.2983595470034284,0.13043478260869565,0.8097423157791938,1.0,3/7,5.86%,EYS;CNGB1;CACNA2D4
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.778492992063649,-1.2983595470034284,0.13043478260869565,0.8097423157791938,1.0,3/7,5.86%,EYS;CNGB1;CACNA2D4
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.7926100446810855,1.2983145337993929,0.1,0.5188751804346138,1.0,2/10,1.59%,ROBO2;ADAMTS9
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.8497730978799986,-1.2982831472056697,0.13725490196078433,0.806327443507515,1.0,2/5,6.28%,SELENOS;PASK
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.8497730978799986,-1.2982831472056697,0.13725490196078433,0.806327443507515,1.0,2/5,6.28%,SELENOS;PASK
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.7374672519051394,1.2982119892690684,0.07692307692307693,0.5185597910906051,1.0,4/9,15.92%,EPHA4;ID2;HES1;BIN1
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.7876976076250728,-1.298202198852267,0.19148936170212766,0.8046424835940781,1.0,1/5,12.41%,NPM1
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.530419678999293,-1.2981318837623428,0.09433962264150944,0.8031470686874718,1.0,13/94,11.43%,NGF;CXCR4;LCK;DDIT3;CDK4;PFN1;CFL1;FGF6;ITPR2;YWHAB;ARHGDIA;HRAS;PRKAA2
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.780602000993396,1.2978703673040348,0.09803921568627451,0.5190835454761297,1.0,3/11,8.29%,KITLG;TAL1;TPO
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.5832888045744604,1.2973044858244,0.04878048780487805,0.5203385890883376,1.0,11/44,12.65%,TGFB2;IGF1;PDGFRA;NRG1;PPP3CA;WNT5A;TPM1;SYT7;DYSF;SCARB1;RAB3A
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.5051689186388567,1.2972807737126786,0.047619047619047616,0.5197686925427506,1.0,14/78,12.14%,EPSTI1;PLSCR1;MX1;TRIM5;TMEM140;PARP14;SELL;ISG15;RSAD2;UBA7;MVB12A;MOV10;PARP9;NCOA7
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.6689728719862024,1.2971454253724752,0.14545454545454545,0.5196625587422627,1.0,2/19,7.34%,HEY1;SOX9
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.6896569235152601,1.2970357182734449,0.1276595744680851,0.5195715879885989,1.0,6/20,10.17%,ROBO2;TLR2;SRC;DMTN;SLIT1;CORO1C
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.5744268998975327,1.2969309061292091,0.11363636363636363,0.5192279568815052,1.0,7/38,12.15%,PLPPR5;PLPPR3;PLPPR4;PLPP4;SGPP2;PLPP6;TPTE2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.7337604637697334,1.2965284867078735,0.14545454545454545,0.5199994770290973,1.0,4/13,15.58%,NR4A3;ANO6;C3;ACSL5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.7793886688094366,1.2964925492154598,0.14583333333333334,0.5194929500106311,1.0,3/8,13.37%,MEF2C;CDKN2A;LYN
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.7052810615935486,1.296309314252453,0.19230769230769232,0.5194471095702456,1.0,3/15,7.57%,CHRM3;KCNB2;NMUR2
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.7668196290004035,1.2962395776286257,0.06818181818181818,0.5189573502954131,1.0,7/10,19.76%,F3;VEGFD;CDH13;VEGFA;NTRK3;IL16;KDR
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.7318750708535896,1.295667645754493,0.12727272727272726,0.5200209891064048,1.0,7/15,11.75%,CHRM3;PLCB1;LYPD1;CHRM5;AGRN;CDK5R1;CHRM1
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.792374389837705,-1.295551739131253,0.14035087719298245,0.8146296930125334,1.0,2/6,8.14%,BUD23;TRMT112
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.6280917841390111,-1.2954183601897395,0.14893617021276595,0.8132378699342244,1.0,9/33,13.15%,PCNA;MBD4;POLD3;MPG;PARP1;APEX1;POLD4;PNKP;POLG
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.8605422766108055,1.2953173109993303,0.23076923076923078,0.5205504567828818,1.0,3/5,13.58%,PER1;CLOCK;CDH3
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.8277318206393532,1.2948513437587816,0.16,0.5214177470134149,1.0,2/5,5.64%,FGF13;RELN
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.7562849316185942,1.2947083989955663,0.1951219512195122,0.5211783344149322,1.0,2/7,11.81%,PTPRC;CX3CL1
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.8225858899368762,1.2947019490188398,0.0851063829787234,0.520557092305642,1.0,3/7,16.81%,BIRC3;SLC15A2;SLC15A4
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.818770673532738,-1.294639498727172,0.13043478260869565,0.8135688627162013,1.0,3/8,9.17%,AKR1D1;SCARF1;SNX17
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.818770673532738,-1.294639498727172,0.13043478260869565,0.8135688627162013,1.0,3/8,9.17%,AKR1D1;SCARF1;SNX17
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.535038254763881,1.2944563007505945,0.09523809523809523,0.5208335139530306,1.0,22/70,21.39%,SLCO2B1;ABCC4;SLC1A2;SLC24A3;SLC22A3;SLC4A4;ABCC9;SLC15A2;ATP1B2;SLC29A2;SLC7A8;SLC2A13;SLC29A4;ABCC5;SLC28A2;LEPR;SLC1A1;SLC16A2;LRP1;SLC16A7;ATP1A2;SLC6A1
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.8202764515347506,1.2941995357979506,0.2222222222222222,0.5211092471280719,1.0,3/5,15.36%,ZFP36;MAFB;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.7907131118259549,-1.2941363986171928,0.11538461538461539,0.8142211758846064,1.0,2/10,5.48%,H1-4;H1-2
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.5965014430354573,1.2940588975256149,0.12,0.5208567554846174,1.0,8/24,13.03%,IGF1;NR4A3;SORBS1;IRS1;RHOQ;C3;PIK3R1;PTPN11
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),-0.7869949236706129,-1.2939551213937237,0.19298245614035087,0.8131416122824355,1.0,1/5,4.39%,PDCL3
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.5865261839776854,1.2932430292552817,0.1346153846153846,0.5229465959817304,1.0,6/31,5.81%,EGFR;FLT1;P2RY12;PDGFRA;NTRK2;ADRA1A
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.7286923333454529,-1.2932294879903692,0.12727272727272726,0.8154372319362336,1.0,1/12,1.11%,MEIOSIN
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),-0.881242604725404,-1.2931972321797467,0.14285714285714285,0.8116500211393707,1.0,1/6,2.59%,ANAPC15
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),-0.881242604725404,-1.2931972321797467,0.14285714285714285,0.8116500211393707,1.0,1/6,2.59%,ANAPC15
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.83581919334691,-1.2931447636511253,0.13333333333333333,0.8100355162190733,1.0,1/5,7.34%,NUMA1
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),-0.7934604670239842,-1.2930123110965255,0.14814814814814814,0.8086053311763546,1.0,2/6,7.86%,LIMA1;SOAT2
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.8086482249536665,1.2927859819561263,0.1111111111111111,0.5236864410630004,1.0,1/5,3.54%,LRRK2
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.8336219386863686,-1.2926236559687216,0.10869565217391304,0.808514086772538,1.0,2/6,3.34%,HCCS;SURF1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.6809486182389852,1.2924330151295877,0.16981132075471697,0.5243368562746512,1.0,8/22,12.04%,IGF1;CSGALNACT1;CHST8;BMPR1B;SULF1;HS3ST4;BMPR2;CHST11
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.7660026465346186,1.2922862657818794,0.20408163265306123,0.5242274331730211,1.0,2/10,2.87%,CBS;SHMT2
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),-0.7407416592056552,-1.2922605447571345,0.2,0.8086969129843439,1.0,6/13,18.91%,RPUSD2;PUSL1;DKC1;NHP2;PUS1;GAR1
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.6500341613799275,1.292119237881558,0.15517241379310345,0.5239580843846168,1.0,7/23,13.48%,CTNND2;PAK3;EPHB1;EPHB3;PICK1;DLG4;SHANK1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.7583322872212414,1.2920869396751746,0.21739130434782608,0.523427585045245,1.0,4/6,21.23%,ZFP36L1;MACROH2A1;PTEN;RGCC
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.5673510223247166,-1.2920141160578031,0.09615384615384616,0.8079233645485984,1.0,9/76,7.87%,POLR2L;POLR3K;GAPDH;POLR3GL;POLR3D;CGAS;POLR2K;DDX41;DHX33
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.7149356443658633,-1.291968077036796,0.2,0.8062195689519921,1.0,4/12,12.41%,RPS15;RAN;LTV1;NPM1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4463740138271661,1.2917498284939726,0.0,0.5240605840950394,1.0,76/325,13.39%,ROR1;EPHA3;PDGFC;PDGFB;SLA;ANGPT1;EGFR;FLT1;IGF1;NCKAP1L;CSF1R;MPZL1;CYFIP1;KALRN;GRIN2B;GALNT3;BAIAP2;EPHA4;PTPRG;PLCB1;PAK3;NR4A3;LCP2;MET;HGF;EFNB3;PDGFRA;SORBS1;NRG1;NFATC4;FLRT2;SYK;EFNA5;SRC;IRS1;TNK2;NTRK2;SIPA1L1;RHOQ;EPHA6;MERTK;SH2D6;SULF1;EPHB1;BLNK;PTPRJ;GRIN1;STYK1;DNM1;ATP6V0D2;MAPKAPK3;AXL;CD4;GIT1;KIF16B;EPHB3;VEGFD;PTPRT;FLRT1;GPLD1;NGEF;PRKD1;MAPK11;CDK5R1;ANOS1;EFNA3;UBASH3B;NGFR;FGF17;PIK3R1;ANGPT2;GRB14;PTPN11;GHR;LYN;ZAP70
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.7307081457332137,-1.2917390215886193,0.1568627450980392,0.8054359480001668,1.0,4/14,13.92%,OOEP;CFL1;DYNC1H1;LLGL1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.7737426887110546,-1.290831132753125,0.1864406779661017,0.8075994403184863,1.0,3/9,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.5728535308928311,-1.2906263152537958,0.16981132075471697,0.8065650880299232,1.0,1/39,0.20%,CELA2A
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.6701174338699496,1.290484314507329,0.11864406779661017,0.5276519591288052,1.0,3/17,4.07%,PDGFB;IGF1;NR4A3
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.5668792817588484,1.2903449612702007,0.13043478260869565,0.5274956564519523,1.0,14/39,12.98%,GPM6A;PLPPR5;RHOQ;TENM1;AGRN;TGFB3;DMTN;TENM2;TRPM2;GAP43;DOCK11;DPYSL3;PIK3R1;ARAP1
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.730501473969466,-1.2901718216269296,0.19298245614035087,0.8067691532666277,1.0,5/10,18.91%,TSR3;RPUSD2;DKC1;NHP2;GAR1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.5583551564078405,-1.2901370170544815,0.14285714285714285,0.8051260578537762,1.0,7/78,7.28%,RPS27A;CDKN1C;UBC;FAM89B;UBB;IL17RD;BAMBI
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.6617524163564728,1.2896778619036458,0.1509433962264151,0.5290621242853198,1.0,4/19,5.55%,TEX15;TDRD1;EXD1;MAEL
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.6110563515765036,1.2896533045321512,0.09090909090909091,0.5284707926110395,1.0,11/28,16.46%,SEMA3D;TRIM46;MAP2;KIAA0319;SEMA6A;SEMA5B;SEMA4G;SEMA4B;SEMA3C;DIP2B;SEMA7A
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.7592598482678612,1.2894075074733227,0.15384615384615385,0.5287760886505131,1.0,3/7,15.92%,ID2;HES1;BIN1
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),0.8638682935426593,1.289404789147689,0.10204081632653061,0.5281432925841558,1.0,3/5,9.68%,TGFB2;TGFB3;IRAK3
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.5832577892234149,-1.2893683763247994,0.16666666666666666,0.8070017891312568,1.0,16/51,22.85%,FTSJ3;HENMT1;TSR3;RBM15B;URM1;AARS1;QTRT2;TRMT1;JMJD6;NAT10;SSB;TRMT6;MEPCE;CTU2;AARS2;TRDMT1
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.8762559657829261,1.2893256452450241,0.10869565217391304,0.5277857018215024,1.0,2/6,7.91%,ISG15;UBA7
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.8716476006030299,1.289288437046892,0.19607843137254902,0.5273139005118794,1.0,2/5,6.76%,PTPRC;PTPRJ
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.625449275467295,1.289104906584056,0.11363636363636363,0.5272886557609839,1.0,9/22,11.91%,TRPC4;SLC8A1;CACNA1G;CACNA1B;MICU3;CACNA1I;MAIP1;CACNA1E;TRPV4
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.6819530518821865,-1.2889150660623585,0.2631578947368421,0.8071268802760888,1.0,1/16,0.24%,BMP5
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.779415084213329,-1.288767828391523,0.25,0.8059335167169264,1.0,3/6,16.64%,RFT1;NPC2;CPTP
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.724278394033624,-1.288766274668865,0.12244897959183673,0.8040976772711019,1.0,4/11,12.94%,CCT7;CCT2;CCT6A;DKC1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.5886249746549346,1.2884058969125156,0.10344827586206896,0.5287846180110516,1.0,11/36,14.65%,PTPRG;PTPRR;CITED2;EFNA5;SRC;TENM3;EPHB3;FUT9;RNASE10;ZDHHC2;MEGF10
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.7503925353600134,1.2875333994797113,0.2127659574468085,0.5310365879310027,1.0,4/8,16.46%,WNT5A;LILRB1;LAPTM5;SEMA7A
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.6705681355070269,-1.2873162778162552,0.19230769230769232,0.8069765975441711,1.0,3/19,5.76%,ECHS1;BCKDK;HSD17B10
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.6705681355070269,-1.2873162778162552,0.19230769230769232,0.8069765975441711,1.0,3/19,5.76%,ECHS1;BCKDK;HSD17B10
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.7392691100818357,-1.2872689168625138,0.14285714285714285,0.8053401277609084,1.0,3/8,8.79%,PRDX1;PRDX5;PRDX3
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.7424202990124282,1.2867374897925472,0.25,0.5329538274792849,1.0,3/10,5.89%,TGFB2;NCKAP1L;RSAD2
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.5936239541155767,-1.2864263695354543,0.11320754716981132,0.8075445362900826,1.0,20/51,21.18%,SLC25A4;TIMM10;SLC25A5;TIMM8B;AIP;SLC25A6;TSPO;TMEM14C;FIS1;BAK1;KIFBP;TOMM7;TOMM20;BAD;TIMM13;TIMM17A;DNAJC19;TIMM9;TIMM44;TIMM23
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.7778352451153238,1.2862219271512305,0.16363636363636364,0.5343087844133346,1.0,1/6,3.36%,RHOJ
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6516298526795969,1.2861486168188558,0.1951219512195122,0.5339181927278158,1.0,4/14,11.81%,BMP6;TRIM5;LY86;CX3CL1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.6577653334433026,1.2860410007040866,0.13043478260869565,0.5335713374716932,1.0,5/17,10.07%,TLR2;NCKAP1L;SRC;DMTN;ALAS1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.8421288278190997,1.2859686378103345,0.1206896551724138,0.5331255968388539,1.0,3/6,11.75%,CHRM3;CHRM5;CHRM1
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.7229771886767741,-1.2859652532992099,0.18181818181818182,0.8063966322710593,1.0,3/10,9.77%,MGMT;MPG;ALKBH2
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.7229771886767741,-1.2859652532992099,0.18181818181818182,0.8063966322710593,1.0,3/10,9.77%,MGMT;MPG;ALKBH2
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.7773495934927687,-1.2858328054891315,0.2553191489361702,0.8050574971838037,1.0,2/10,4.59%,GREM1;GSTP1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.649646279911855,1.285589856009943,0.1320754716981132,0.5338761780489464,1.0,9/25,15.22%,DPP10;KCNIP4;KCNIP1;KCNIP2;NOS1;KCNIP3;ANK3;KCNH2;FHL1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.7342726482770205,-1.2853682661196644,0.2037037037037037,0.8052964307279744,1.0,3/10,5.41%,TAX1BP3;GOPC;ACTN2
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.6364946736849414,-1.2850296819554259,0.19672131147540983,0.805123482208661,1.0,3/26,7.12%,SFRP1;DDX5;PRMT2
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.7393042347609424,-1.2849675666355833,0.14893617021276595,0.80353528436115,1.0,3/10,12.80%,XG;ICAM1;AGER
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.8257195301614578,1.2849486432195816,0.3409090909090909,0.5355203009853248,1.0,2/5,16.81%,ERBIN;SLC15A4
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.5768689811925618,1.2849033422275689,0.0392156862745098,0.5349460699144791,1.0,4/38,8.15%,CERS3;GRHL1;SCEL;COL7A1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.511418629484378,1.2847905783464324,0.0,0.5346425979392277,1.0,16/72,7.67%,ADAM28;PTPRC;SIGLEC10;NCKAP1L;SELL;IKZF1;LCP2;BIRC3;CD53;ABCB4;ARHGAP25;PNOC;BTLA;LILRB1;WDFY4;LY86
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.7173336041705088,-1.2847788085184013,0.1568627450980392,0.8027535338360073,1.0,2/15,8.82%,HENMT1;TSN
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.5073139643600421,1.2847211867200938,0.12195121951219512,0.5341416056632994,1.0,13/69,12.53%,CLDN16;KCNMA1;NEDD4L;SLC8A1;SLC24A4;VAPB;SLC24A3;ATP2B3;ATP2B2;HTR2C;TRPV4;DMPK;ATP1B2
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.5590216284969736,-1.2846651027666314,0.18181818181818182,0.8013816752185271,1.0,17/71,14.94%,LCK;FTL;FTH1;ATP6V1G1;SLC31A2;SLC39A6;TF;SOD1;HEPH;CCDC22;SLC22A17;ATP6AP1;MT1E;MT2A;CYBRD1;CYB561A3;SLC39A7
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.7191739945746973,-1.2845755293629484,0.20454545454545456,0.8000158867719208,1.0,4/12,17.37%,STX10;TMED9;LMAN1;SURF4
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.5660898954494119,-1.28457200418648,0.16981132075471697,0.7982498472867731,1.0,8/57,8.61%,VWA3A;ARMC3;SPAG6;TUBB4B;DCDC2B;CNGA4;TTC29;CFAP70
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.7008684574162394,1.284534259413362,0.20754716981132076,0.5341085583633166,1.0,7/11,25.11%,IL12A;AXL;GAS6;ZBTB1;AP1G1;TICAM1;HLA-E
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.7976016413491289,-1.2836612069770101,0.17391304347826086,0.8005085956030052,1.0,4/7,16.00%,PHB2;SPHK2;ANTKMT;DNAJC30
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.6610257879477905,-1.283637828426159,0.21052631578947367,0.7988411667701877,1.0,1/17,1.38%,VPS25
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.7774277156818721,1.2833279629152898,0.14583333333333334,0.5376072756961539,1.0,3/9,13.59%,PRICKLE1;SOX9;SRA1
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.8264198108026661,1.2831969473867804,0.16326530612244897,0.5374431686388499,1.0,1/5,3.12%,SLC8A1
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.6953063932421816,-1.2828353234785321,0.1320754716981132,0.8004832993799624,1.0,6/15,17.27%,ATP5F1B;ATP5MC3;ATP5PF;VPS9D1;ATP5PB;ATP5PD
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.6298701044629613,-1.2827653369716892,0.16363636363636364,0.7989513629349526,1.0,3/26,7.61%,OOEP;PARP1;RAD51AP1
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.7237899975836405,-1.2823480691743678,0.15555555555555556,0.7993074843334206,1.0,5/14,14.51%,SFRP1;CRHBP;LOC400499;PELP1;SFR1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.8315884985415805,1.2822648958464078,0.1568627450980392,0.5395061395709135,1.0,1/6,3.54%,LRRK2
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.7694541848180527,-1.2821846962972987,0.20408163265306123,0.7984409176486892,1.0,4/7,12.41%,RPS15;RAN;LTV1;NPM1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.6180816430213503,-1.282038963806348,0.13333333333333333,0.795630252131843,1.0,5/24,6.80%,ACSM6;DBI;GLYAT;ACOT1;CROT
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.6180816430213503,-1.282038963806348,0.13333333333333333,0.795630252131843,1.0,5/24,6.80%,ACSM6;DBI;GLYAT;ACOT1;CROT
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.6694470320043453,-1.2817694801274926,0.1111111111111111,0.7952480685876854,1.0,5/17,13.09%,NIFK;GTF3C6;POLR1G;CAVIN1;TCOF1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.6872045539436249,1.2816218815606137,0.18032786885245902,0.5408462995518001,1.0,2/15,7.72%,MX1;DNM1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.6201089774670703,1.2810466719900582,0.15555555555555556,0.5419583120876404,1.0,8/25,13.04%,TGFB2;MEF2C;WNT5A;SOX9;ZBTB16;BMPR2;PTPN11;LRP4
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.639176160952752,-1.28085696654845,0.16666666666666666,0.7978488312578511,1.0,4/22,13.15%,ATP6V1F;ATP5F1B;UCP2;ATP6V0E1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.6650475652428828,-1.2807536244625315,0.14814814814814814,0.7965800673615089,1.0,8/28,14.83%,OST4;DAD1;DPM3;B4GALNT2;LMAN1;DDOST;MAGT1;DPM2
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.8755318635994214,1.2807168821574442,0.16279069767441862,0.5423515035873154,1.0,2/6,9.36%,TGFB2;TGFB3
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.5695141805222635,1.280620271715989,0.14285714285714285,0.5418881829064697,1.0,17/51,10.24%,FGL2;TLR2;CSF1R;ADGRE2;MRC1;CLEC5A;ITGAM;CSF3R;C3AR1;TNFRSF1B;LILRB1;GDA;WDFY4;LY86;LAPTM5;OLR1;KLHDC4
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.6914631803609038,1.2805360469160616,0.13559322033898305,0.5414399732170608,1.0,2/11,5.19%,LRRK2;SRC
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.7127684775652129,-1.280203317667446,0.21739130434782608,0.7973137329487993,1.0,7/15,21.44%,TSEN34;CSTF2;C2ORF49;FAM98B;RTRAF;DDX1;TRPT1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.722914706296233,1.280187279017824,0.10714285714285714,0.5420002896497664,1.0,1/10,2.10%,CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.5244503817645535,1.2797764543976922,0.0975609756097561,0.5426990359656291,1.0,15/74,8.14%,LPL;VSIR;CX3CR1;PTPRC;IGF1;TLR2;C1QTNF4;SYK;PTPN6;WNT5A;LILRB1;ZFP36;PTPRJ;HSPB1;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.7347381226805234,-1.2797177113415845,0.2,0.797972441213104,1.0,3/11,14.85%,SELP;RHOA;ETS1
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),0.805033550471581,1.2795739604162748,0.14285714285714285,0.5426841989676259,1.0,3/6,15.76%,ABCC4;NMUR2;NOS2
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.6382591817981105,-1.2794317104698738,0.23636363636363636,0.7975535067866574,1.0,5/27,9.18%,ORC1;PCNA;TFDP1;DHFR;CDK15
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),0.8655605138714146,1.279291122991935,0.07142857142857142,0.5429343111060643,1.0,3/5,10.15%,AQP1;SCIN;GPLD1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.69219040868098,1.2791941647414147,0.2558139534883721,0.5425432193008094,1.0,3/14,10.15%,SLC23A1;SLC1A2;GPLD1
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),0.8523761483294945,1.2788791238822845,0.175,0.54283463706227,1.0,2/5,4.71%,NCKAP1L;SYK
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.6484079751580206,1.2788449980731662,0.19047619047619047,0.542263969462177,1.0,3/22,4.39%,PDGFB;HGF;DACH1
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.5147689396045115,1.278641658521958,0.15555555555555556,0.5423607495089171,1.0,16/68,15.70%,PDGFB;ANGPT1;F3;WNT5A;SULF1;PTPRM;VEGFD;ARNT;PRKD1;BMPR2;NR2F2;AKT3;VASH2;CDH13;VEGFA;EGFL7
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.8140565014024375,1.2784590617862388,0.1509433962264151,0.5425266059698808,1.0,2/6,5.57%,IGF1;BAG3
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.7962883854908681,-1.2782868644921626,0.21428571428571427,0.8013013349279932,1.0,1/8,1.59%,PRR7
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.629870892649768,1.2779438491304989,0.1509433962264151,0.5440903710479811,1.0,11/26,21.60%,DTX1;WNT5A;ST3GAL6;CCND1;HES1;DTX2;NOTCH3;KAT2A;ARRB1;NOTCH2;FBXW11
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.7254454857047333,-1.277779410701192,0.17391304347826086,0.7999918655228441,1.0,1/9,1.56%,TINF2
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.7254454857047333,-1.277779410701192,0.17391304347826086,0.7999918655228441,1.0,1/9,1.56%,TINF2
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.6974266282418148,1.2777393312054246,0.1875,0.5440602120528711,1.0,2/14,4.37%,FLT1;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.7188889978097395,-1.2777128221643874,0.16071428571428573,0.7985065077277009,1.0,4/12,17.48%,RNF8;HEXIM1;NELFE;NELFCD
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.8291547884653192,1.2776574063739956,0.1,0.5437262580570379,1.0,2/8,5.94%,ROBO2;NPNT
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.6099683317643579,1.2776490834753307,0.18867924528301888,0.5431171680650195,1.0,6/27,6.32%,RHBDF2;SYT4;IL12A;RSAD2;TNFRSF1B;LILRB1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.6537834703798577,1.2775979692848796,0.15217391304347827,0.5426886398410257,1.0,6/18,19.72%,SLC8A1;GRIN1;ANK3;TMC8;CNNM2;ATP13A2
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.8060954912361593,1.2774344025435251,0.17391304347826086,0.542811659694036,1.0,4/7,11.91%,MEF2C;BMPR1B;BMPR2;TRPV4
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.7061121292060164,1.2772468528768952,0.1590909090909091,0.5427969163450943,1.0,2/16,1.41%,RHBDF2;EGFR
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.884193216403471,-1.276951261017167,0.18181818181818182,0.7998278248867831,1.0,1/6,0.29%,CXCR4
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.6879199939675087,-1.2756311222956638,0.22641509433962265,0.8046985334366824,1.0,4/11,25.83%,KDELR1;GPAA1;RER1;HSPA5
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.6130979323536843,-1.2756186651542682,0.1509433962264151,0.8030008572058033,1.0,8/29,16.19%,VAMP8;LIX1;CALM1;GABARAPL2;SNAP29;CHMP3;MAP1LC3B;ATG14
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.8550994922089379,1.2755155476902083,0.14583333333333334,0.5476569210750826,1.0,3/6,10.59%,PDGFRA;SOX9;SOX5
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.8112397442823647,1.275224226367021,0.16666666666666666,0.5479108835166537,1.0,4/8,14.70%,JCAD;IL12A;NGFR;VEGFA
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.7700106429728156,1.2748216142322906,0.24,0.5485889446217763,1.0,4/5,18.80%,NTRK2;SH3GL2;MAPT;TMEM108
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.7696537360831643,-1.2746451326035915,0.22,0.8059070585216371,1.0,2/11,5.04%,PPIB;CFL1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.4786752883505766,1.2745283163536285,0.047619047619047616,0.5489233371053804,1.0,33/157,16.46%,PDGFC;PDGFB;VSIR;EGFR;FLT1;IGF1;CSF1R;SEMA3D;F3;CARMIL2;HGF;PDGFRA;CARMIL1;PPP3CA;LEF1;VIL1;SEMA6A;ZNF304;MGAT5;SEMA5B;SEMA4G;SEMA4B;SMIM22;TMSB15B;CDH13;WASHC1;SEMA3C;VEGFA;NTRK3;GPER1;LAMB1;CASS4;SEMA7A
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.6398846869143501,-1.2745170286504144,0.14814814814814814,0.8048115261326482,1.0,4/28,13.52%,COPE;TRAPPC3;GABARAPL2;COG2
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.8292276644358805,1.2744520627847942,0.16279069767441862,0.5485052209822732,1.0,3/5,16.02%,BMP6;VEGFA;ADD1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.8463385895474405,1.2743817808583928,0.13043478260869565,0.5481290299339705,1.0,3/6,8.41%,CARMIL1;MAPKAPK3;RAB34
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.5817953704594199,-1.2743761980183224,0.15384615384615385,0.8037732016069309,1.0,2/30,2.30%,UXT;UBB
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.591834030015215,-1.2740442617429217,0.16666666666666666,0.803544288450303,1.0,20/54,20.29%,RPS27A;UBC;UBB;DYNLL1;UFC1;PHB2;CFTR;UBA52;TEX264;DYNC1H1;MAP1LC3B;SQSTM1;ARL13B;UFL1;ATG14;DYNC1I2;PARK7;BECN1;UBE2N;ATG2A
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.8050471919828219,-1.2739922691093333,0.23214285714285715,0.8022335062239313,1.0,2/8,5.04%,PPIB;CFL1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.4706075715066742,1.273915435246976,0.025,0.5492264225028657,1.0,34/155,10.29%,ADAMTS5;PDGFB;ITGA11;CD44;ADAMTS9;ST7;MMP16;ITGB4;MFAP5;POSTN;VCAN;TNC;ADAMTS7;LOX;ITGAM;ADAMTS10;COL11A1;ADAMTS17;LAMC1;COL5A3;NPNT;TNR;ADAMTS6;ADAM12;COL4A1;COL7A1;FBLN5;JAM2;VIT;ADAMTS15;AGRN;NCAN;COL15A1;PAPLN
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),-0.8001734643827649,-1.2735420214777293,0.21568627450980393,0.8025664675931176,1.0,2/6,13.96%,SLC22A2;ABCC1
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),0.7626971176688753,1.2734454392959198,0.24444444444444444,0.5501986935606995,1.0,2/6,6.89%,AQP1;IPCEF1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.696618845288909,1.2731502753869994,0.09803921568627451,0.5506653439115206,1.0,5/14,13.42%,TRPC4;TRPC7;TRPC3;SLC11A2;TRPC6
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.5520824313927805,1.273072359089588,0.11904761904761904,0.550261218879816,1.0,6/44,6.32%,TGFB2;PTPRC;PLSCR1;ITGAM;RSAD2;LILRB1
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.7782071572195447,1.2730135100728857,0.06521739130434782,0.549790158062259,1.0,1/7,2.02%,MLIP
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.6144084081236351,-1.2730012054350626,0.16071428571428573,0.8030197905934909,1.0,7/41,11.16%,LCK;DDIT3;NOC2L;RACK1;SEPTIN4;FIS1;BAX
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.7229530758485067,1.2729543621789066,0.16326530612244897,0.549347296929982,1.0,2/8,4.07%,PDGFB;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.7134462450283834,1.272800708985198,0.14814814814814814,0.549365888217374,1.0,1/13,1.01%,RNFT1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.6662424421140017,-1.2727758027191463,0.17307692307692307,0.8024298597223852,1.0,12/28,24.43%,GRPEL1;GRPEL2;TOMM20;TIMM50;PEX10;TIMM17A;DNAJC19;TIMM44;TIMM23;PEX16;DNAJC15;TOMM40L
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6938116150583715,1.2725404716008124,0.14285714285714285,0.5495197032037237,1.0,2/10,1.03%,CLDN5;CLDN16
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.5889567066368471,1.2724678846843525,0.16666666666666666,0.5491327203375043,1.0,10/36,16.25%,RND2;NCKAP1L;RHOQ;RHOF;FMNL3;TRPV4;FHOD1;RAC3;FMNL1;NLGN1
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.85917140254178,1.2723616530541193,0.1568627450980392,0.5488950761798025,1.0,3/6,13.07%,C3AR1;GPLD1;CR1
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.77344134448227,-1.2723598362067015,0.10204081632653061,0.80241394087565,1.0,1/7,1.14%,PDZD11
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.7852679772159178,-1.27202211415311,0.1111111111111111,0.8022770963478281,1.0,4/9,17.86%,SLC25A4;SLC25A5;PARK7;VDAC1
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.7358568618130907,-1.271728296586886,0.19148936170212766,0.8018475855692312,1.0,3/11,14.32%,SLC31A2;CCDC22;MT2A
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.5497720204420274,1.271705259139149,0.11538461538461539,0.550221680043807,1.0,16/70,9.45%,TGFB2;PDGFB;PTPRC;KITLG;FLT1;MFAP5;CSF1R;PRKX;TOX;WNT5A;ETV6;TAL1;TIRAP;ZBTB16;TPO;NOTCH4
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.6908564242009977,1.2713716519971798,0.1875,0.5505623210671188,1.0,6/15,16.25%,NRXN1;CNTN4;ASTN1;CDK5R1;NLGN4X;NLGN1
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),-0.8042530823168698,-1.2713409365402377,0.125,0.8018501764468325,1.0,2/5,4.77%,SCN11A;SPX
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),0.8040409531414776,1.2712637331419778,0.23076923076923078,0.5503238587949689,1.0,1/6,1.90%,HIGD1C
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.8597802843471631,1.2712081430514255,0.11363636363636363,0.5499919016624857,1.0,2/5,11.80%,CHRM1;HES1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.800339580864767,1.27102908673101,0.14285714285714285,0.5492632356689771,1.0,2/5,3.12%,RYR3;SLC8A1
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.800339580864767,1.27102908673101,0.14285714285714285,0.5492632356689771,1.0,2/5,3.12%,RYR3;SLC8A1
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.7978608018491027,1.2709112052660243,0.10204081632653061,0.549027333549653,1.0,3/7,10.91%,TBC1D8B;SULF1;TMEM63C
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.8049095568902631,-1.2709014512880807,0.15555555555555556,0.7989666738198992,1.0,2/8,5.48%,H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.8049095568902631,-1.2709014512880807,0.15555555555555556,0.7989666738198992,1.0,2/8,5.48%,H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.8049095568902631,-1.2709014512880807,0.15555555555555556,0.7989666738198992,1.0,2/8,5.48%,H1-4;H1-2
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.6651583147421501,-1.2708009465512897,0.14545454545454545,0.7978141693209967,1.0,8/27,14.83%,OST4;DAD1;DPM3;B4GALNT2;LMAN1;DDOST;MAGT1;DPM2
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7395971141468737,1.2707921144177854,0.18421052631578946,0.5486849821508117,1.0,3/11,4.71%,LPL;PPARG;SYK
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6841286375810629,1.2706942111316242,0.18604651162790697,0.5483166911804561,1.0,8/15,22.57%,WNT5A;PCLO;LRP4;NLGN4X;NLGN1;PTEN;IL1RAPL1;CEL
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.7173915221363653,-1.2704712984562654,0.12280701754385964,0.7976375296755512,1.0,3/10,11.06%,NUMA1;PLAAT4;ETV4
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.6910846393307405,1.2704588676620021,0.10204081632653061,0.5483628615435977,1.0,1/13,0.47%,TEX15
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6794199892551791,-1.2701839207825125,0.16981132075471697,0.7976316425354569,1.0,5/14,17.27%,ATP5F1B;ATP5MC3;ATP5PF;ATP5PB;ATP5PD
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.829615762266318,-1.2694970635575136,0.21739130434782608,0.7990342026306956,1.0,3/5,11.80%,ZNF598;RACK1;MTRES1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.7749017252004111,1.2694566023846054,0.2222222222222222,0.5506248525241193,1.0,1/7,3.54%,LRRK2
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.7749017252004111,1.2694566023846054,0.2222222222222222,0.5506248525241193,1.0,1/7,3.54%,LRRK2
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.8317056410368646,1.2693515062574452,0.1956521739130435,0.5503225229597359,1.0,2/7,14.55%,CHI3L1;CTBS
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.6369740473632008,-1.2688714589629098,0.125,0.8001939998618262,1.0,11/36,15.43%,TPX2;KIF3B;BCCIP;RHOA;MAP10;KIFC1;KIF4A;GOLGA2;ABRAXAS1;KIF11;WRAP73
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.7950658602969658,-1.2687610663650062,0.2127659574468085,0.7992027609274902,1.0,3/8,13.44%,PAX8;USH1C;EPHB2
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.6425603892386137,-1.2681225889611911,0.13043478260869565,0.8003238090791299,1.0,4/18,11.38%,SELENOK;FIS1;BAX;BAK1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.7184365997006439,-1.2678490154737194,0.16981132075471697,0.7997907722427313,1.0,4/14,11.38%,ACAA2;SLC25A5;BAX;BAK1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.4292462944747065,1.267560265027332,0.0,0.5555995842437603,1.0,98/348,22.50%,TGFB2;IGFBP3;PDGFB;MAP3K21;DGKB;MAP3K5;PEAK3;LRRK2;DCLK1;PIM1;PAK3;BMPR1B;HUNK;PRKG2;SYK;CDKL4;STK17B;PRKCZ;TNK2;MERTK;PRKG1;HIPK3;CAMK2B;AURKC;MYLK3;ACVR1C;PLK1;PRKCG;DAPK1;PICK1;IRAK3;CAMK2D;NUAK1;DGKI;TEC;DYRK2;PRKD1;BMPR2;MKNK1;CSNK1D;DMPK;IP6K3;PRKAR1B;AKT3;LYN;ZAP70;TNIK;DYRK3;PDK4;MAK;CAMK4;TSSK3;WNK2;CDK19;PAK5;STK17A;ACVR2A;PRKCE;LMTK3;GAS6;CDK12;PRKCD;STK38;DYRK1B;GK;GRK4;AGK;CDKL1;PRKAG2;CSNK2A1;CDC42BPA;CDK13;CERKL;COQ8B;STK38L;DGKD;MEX3B;MKNK2;BMX;LIMK2;PAK2;DGKE;DGKA;ULK1;VRK1;CDK6;PGK1;RPS6KA4;FER;JAK1;MINK1;MAP4K3;PRRT1;TAOK3;MAST1;SGK1;MATK;MAP3K20
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),0.7459666504420764,1.2674822807848714,0.22727272727272727,0.5552392626947625,1.0,1/8,3.54%,LRRK2
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.4891326763326149,1.2674136038509218,0.075,0.554866499009276,1.0,25/115,15.16%,PKP2;DPP10;KCNIP4;RAB3C;ANK1;KCNB2;FGF13;FYB1;PACSIN1;TSPAN14;SCN3B;ZDHHC23;TESC;RAB34;RAB15;KCNB1;TNFRSF1A;P2RY1;RAB3A;KCNIP3;TNIK;ANK3;ITGB1BP1;ZDHHC2;CACNB2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.6712199915307341,-1.267333368991244,0.2127659574468085,0.80075495018227,1.0,2/17,3.83%,NGF;BEX3
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.6061016632206679,1.2672540685052216,0.12727272727272726,0.5547328546173076,1.0,10/33,15.90%,CTNND2;MAP2;PAK3;EPHB1;EPHB3;DLG4;LRP4;SHANK1;FARP1;PHACTR1
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),0.8499045766215383,1.2670975433819058,0.12,0.5547714093504356,1.0,2/5,6.56%,AQP1;YBX3
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.6724329305915169,-1.266618171592831,0.17647058823529413,0.8024026254220558,1.0,2/15,5.77%,PKMYT1;FBXO43
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.6877234203688349,1.2658354641694458,0.22641509433962265,0.5579798424191453,1.0,5/13,14.52%,DACT2;MET;COL15A1;COL22A1;GRHL2
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.7559038294681947,1.2658023044243514,0.225,0.5574473587401282,1.0,5/7,24.20%,LPCAT4;PLA2G10;PLA2G4A;LPGAT1;LPCAT1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7785343248888443,1.265664655891086,0.2,0.5571928176992861,1.0,3/8,13.37%,PTPRC;CBFB;LYN
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.7254195746974108,1.2655435369177472,0.21428571428571427,0.5569125176385649,1.0,2/12,5.95%,CHST1;CHST3
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.4657129651567587,1.2653599967109692,0.046511627906976744,0.5569089768984821,1.0,33/156,8.97%,ADAMTS5;FLI1;IGFBP3;PLSCR4;CD44;FOSL2;FSTL1;IGF1;MFAP5;POSTN;KLF9;SYNPO2;FAP;PCDH18;LOX;ADAMTS10;HGF;ITGBL1;PDGFRA;CTHRC1;CCDC80;LAMC1;COL5A3;COL12A1;TNFRSF1B;OLFML2B;SULF1;PBX1;FBLN2;COL4A1;COL7A1;FBLN5;VIM
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.8112999689076106,-1.2653069059277737,0.18181818181818182,0.8065868813424797,1.0,3/7,11.71%,SEC61B;SEC62;SEC61A2
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.6115337441668451,1.2636214410782487,0.16,0.5616864247519717,1.0,4/23,13.90%,BHLHE40;ID2;PER1;PPP1CB
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.5000517852764138,1.2633889933219549,0.15217391304347827,0.5617956551658942,1.0,34/93,16.37%,ZNF423;ADAMTS9;FSTL1;PPP1R3C;POSTN;PCDH18;RUNX1T1;PDGFRA;GFRA1;TMEM47;FBLN1;PRKG1;SULF1;ADGRL2;COL4A1;BOC;LIFR;CHRD;FNDC4;FAT4;ANTXR1;PAMR1;LAMB2;DPYSL3;PRRX1;LRP4;FRZB;PDZRN3;CPE;TIMP3;IL33;THY1;LAMB1;SMARCA1
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.6568958341745728,-1.2630890151969456,0.1875,0.8151627042417235,1.0,7/20,19.40%,CHMP2A;CEP131;CHMP5;NPM1;CHMP3;NAT10;PKHD1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.6115838725993745,1.2630233769445862,0.15217391304347827,0.5622715921508953,1.0,3/33,9.36%,TGFB2;LEF1;TGFB3
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.7204033591256277,-1.2628386472036934,0.16666666666666666,0.814538758058079,1.0,2/9,11.20%,B4GALT7;B3GALT6
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.8010996007915228,1.262837691218821,0.21951219512195122,0.5624061112055364,1.0,1/5,1.03%,SRGN
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.8009086451778769,-1.262420288709619,0.26229508196721313,0.8147821360289986,1.0,1/5,0.20%,CELA2A
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.7383462025068079,-1.2621582023260611,0.12244897959183673,0.8143606041401763,1.0,2/11,4.06%,CA6;TAS2R40
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.7574462513409861,1.262080502047836,0.18518518518518517,0.563719194858729,1.0,1/7,4.25%,HGF
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.7574462513409861,1.262080502047836,0.18518518518518517,0.563719194858729,1.0,1/7,4.25%,HGF
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.681618434774255,-1.2618926863931337,0.14285714285714285,0.8136922556845514,1.0,5/18,13.60%,PRDX1;NOX1;SOD1;SOD3;NOXA1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.7298707266337,-1.2616798687186683,0.2413793103448276,0.8113734451060066,1.0,3/8,15.78%,UQCRFS1;UQCC3;LYRM7
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.7298707266337,-1.2616798687186683,0.2413793103448276,0.8113734451060066,1.0,3/8,15.78%,UQCRFS1;UQCC3;LYRM7
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.6274045378349397,-1.2610110847490263,0.17647058823529413,0.812971026699962,1.0,3/27,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.7110737950402439,-1.2609204543100847,0.20833333333333334,0.8118011584327504,1.0,1/10,2.11%,RNF8
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.7845655877154862,-1.260899856052888,0.13333333333333333,0.8103242147247243,1.0,3/6,11.87%,ADAM15;ATP2A3;B2M
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.49363219283757453,1.2607347683870516,0.08,0.5672048173091143,1.0,39/100,21.39%,KALRN;CAMSAP3;SORBS2;PROM1;SYBU;SORBS1;PRKCZ;ABAT;HOOK1;SHANK2;SYT13;ZBTB7C;CHDH;MYO5C;MAPK4;ABLIM1;NEBL;PTPRT;SYT7;MAOB;SPARCL1;HAMP;SH3BGRL2;ANK3;WNK2;BAIAP3;USP54;PDE9A;AGAP1;PLPPR1;ZDHHC11B;AQP4;MYO5B;ATP9A;MAL2;PPP1R9A;PLEKHA6;EBF4;SLC6A1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.47437718503898657,1.2607231381134407,0.11904761904761904,0.5666034440652695,1.0,35/105,17.09%,EGFR;GFAP;EFNB3;NR2F1;DDAH1;CHST3;NYAP1;MEIS3;SLC13A4;SOX9;LEF1;TEAD1;LIFR;KIAA1549L;NDRG4;EPB41L1;PHYHIP;FNDC4;NUAK1;ANTXR1;NGEF;DZIP1;GPC1;TMEM59L;LRP4;KCNIP3;KAZN;CPE;SHROOM2;SRRM3;FARP1;TNFRSF19;AGAP1;CAP2;DOCK1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.5851100498840616,1.2606676041998606,0.14583333333333334,0.5662116951147669,1.0,8/26,8.62%,PKP2;FGF12;SLC8A1;CACNA1G;KCNIP2;SCN3B;DMD;SCN1A
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.7251893180755866,1.2606399280343905,0.18181818181818182,0.5656777659999126,1.0,5/10,17.21%,IGF1;PLCB1;SOAT1;IL33;RAMP1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.4687804604169503,1.2604349278236302,0.06666666666666667,0.5657295529466688,1.0,27/139,14.93%,EGFR;FLT1;MAP3K21;CSF1R;EPHA4;LRRK2;PIM1;PRKX;PDGFRA;STK17B;SRC;NTRK2;CAMK2B;EPHB1;MAPKAPK3;EPHB3;DAPK1;CAMK2D;TEC;PRKD1;MKNK1;LYN;TNIK;FES;MAK;CAMK4;WNK2
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.532402256795559,1.2601829055036566,0.06666666666666667,0.5659888329166558,1.0,10/66,6.32%,EPHA3;BMP6;CARMIL2;MCTP1;FAP;DNAJB1;CARMIL1;PRKCZ;SRC;LILRB1
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.621725020302583,1.2594789257052001,0.16666666666666666,0.5678676885133158,1.0,5/18,6.00%,NCKAP1L;CYFIP1;RHOJ;RHOQ;SCIN
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),-0.7716584030411651,-1.2593134186641441,0.2857142857142857,0.8158599353815802,1.0,1/6,1.95%,TGM1
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.8242780334641863,1.25924321439576,0.2127659574468085,0.5681758367407095,1.0,2/5,13.77%,PLCB1;RNASE10
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),-0.8510892226268484,-1.2588711040424445,0.1509433962264151,0.816227168789242,1.0,2/5,3.32%,GPR62;CGAS
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.7482755077203673,1.2588335380671969,0.14893617021276595,0.5690135497358851,1.0,6/9,18.53%,PRKCZ;NFKBID;CD80;NFKBIZ;TNFSF4;NLRP3
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.720210253864508,-1.2585569438753597,0.25,0.8159895967501571,1.0,3/12,12.80%,CHAMP1;MIS12;IK
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.7660010988843939,1.2585507966279754,0.24,0.5693068472394696,1.0,6/7,22.38%,ABCC9;PKD2L1;ASIC2;ABCC8;PKD2;KCNJ11
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.7690550278519612,1.2585356545769433,0.16363636363636364,0.5686961953831685,1.0,4/6,19.00%,ZBTB1;IL12RB1;PRKCQ;CLEC7A
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.573597448698115,1.258438803222262,0.17391304347826086,0.5683704655808279,1.0,9/37,12.67%,CREB3L1;REP15;HSD11B2;CDON;OTOGL;PDIA5;PLA2G10;DMBT1;SMIM22
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.7509219132989664,1.258397550321102,0.23333333333333334,0.5678780574483537,1.0,3/9,11.18%,PDGFRA;NOTCH4;BMPR2
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),0.8249594352050926,1.2583915860713184,0.13725490196078433,0.5672709653577296,1.0,4/6,5.89%,IFNA2;DENND1B;PRKCZ;RSAD2
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.838135918902827,-1.2581538969283657,0.18181818181818182,0.8163714246464382,1.0,2/5,6.89%,GBA3;GLA
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.7113854260870095,1.2581220764519194,0.1111111111111111,0.5675517158541422,1.0,3/11,9.04%,PDGFRA;MYLK3;NEBL
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.7049295815224452,-1.2580222183373717,0.1509433962264151,0.8154684882957393,1.0,6/13,20.56%,NIFK;POLR1G;CAVIN1;SNAPC3;SNAPC2;GTF3A
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.616377770289716,1.257889862584828,0.15555555555555556,0.567677845511521,1.0,2/21,1.83%,TEX15;FOS
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.5280352591323311,-1.2577221342575589,0.1206896551724138,0.8152824055640449,1.0,13/65,9.93%,CRYAB;TPX2;STMN1;MYADM;PFDN2;PFN1;KATNB1;TUBB4A;LIMA1;VBP1;PFDN1;TWF1;HSPA8
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.6235342351632203,1.2576171549627269,0.22,0.568162664406019,1.0,5/26,15.58%,TM4SF20;KLF15;KCNN4;DMBT1;ACSL5
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.7746316624395982,1.2575645421980164,0.14285714285714285,0.5677243830687446,1.0,3/8,10.91%,TBC1D8B;SULF1;TMEM63C
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.6864910958605384,-1.2574181660173527,0.25,0.814983774085975,1.0,3/13,14.37%,ATF3;GSTO2;DAXX
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.7629430412593565,1.2573914150965624,0.15217391304347827,0.5675812762360505,1.0,1/8,0.65%,DPYS
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.5160892084020924,1.2573777023381456,0.16666666666666666,0.5670167919990773,1.0,18/61,12.53%,TGFB2;CORIN;CELF2;RYR3;SLC8A1;TMIGD3;ITPR1;KCNIP2;TPM1;ABCC9;NOS1;ATP2B3;ATP2B2;TMEM65;CAMK2D;RNF207;DMPK;ATP1B2
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.8493256948363319,1.257232132129002,0.21052631578947367,0.5669768784754066,1.0,3/5,12.59%,KCNMA1;ANO6;CLCN3
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.7353779085425656,-1.2571293546734976,0.19047619047619047,0.8146055456702318,1.0,1/8,1.22%,CORO1B
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.6123496465472923,1.2568085343377065,0.1509433962264151,0.5673705771918816,1.0,2/31,2.71%,LPL;DGKB
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.5755180629182675,1.2567380153005285,0.16666666666666666,0.5671647868143488,1.0,3/33,5.01%,EPHA3;CAMSAP3;EFNA5
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.6035792015076507,-1.2567177421779356,0.171875,0.8147445787333442,1.0,9/33,18.53%,GAPDH;SLC25A11;SLC25A1;PGAM1;CRTC2;SLC25A10;SLC37A4;ATF4;FBP1
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.7142827939713847,-1.2565885680829845,0.12,0.8136443106294181,1.0,1/12,0.59%,KLK6
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.7577172981473094,1.2564796400454281,0.27906976744186046,0.5673538607524664,1.0,2/6,11.81%,PTPRC;CX3CL1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.8232244386038818,1.2564746368038373,0.12244897959183673,0.56674182854022,1.0,2/6,4.89%,GRIP2;GRIP1
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.6908649654132893,-1.2563657136671482,0.22580645161290322,0.8131423750851341,1.0,3/10,19.96%,NCL;PIH1D1;DDX11
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.5181089396244948,-1.2557701238014418,0.09090909090909091,0.8138924090947893,1.0,22/115,16.19%,PRPF4;POLR2L;POLR2G;WDR74;POLR2K;POLR2I;GTF2F1;MPHOSPH10;PCBP3;RNASE1;POLR2A;TFIP11;LAGE3;POLR2E;RBMS2;DKC1;DDX24;HNRNPH2;M1AP;POLR2C;POLR2D;DHX8
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.807812119204573,1.2552530340304457,0.18518518518518517,0.5705111663765531,1.0,4/6,11.18%,BMPR1B;SULF1;SOX9;BMPR2
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.5900411294407921,1.2551654792785893,0.16279069767441862,0.5701253315837477,1.0,11/26,16.97%,P2RY12;CYFIP1;CARMIL1;SPEF1;ARHGEF6;ABLIM1;DMTN;PTPRO;CDH13;ARHGEF4;ARHGEF7
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.6147028193343259,1.2550611996438132,0.1951219512195122,0.5699050170073537,1.0,5/16,15.46%,LRFN5;WNT5A;PLA2G10;CD200;IL33
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.5611120729157668,-1.2549337728971148,0.14545454545454545,0.815791257628428,1.0,15/49,17.59%,RPL5;RPS3;RPL11;PRR7;UBXN1;VPS28;PINX1;SVBP;SQSTM1;UFL1;SMAD7;SH3RF2;DNAJA1;COPS9;PARK7
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.6654397826525233,-1.2549024096692163,0.14634146341463414,0.8143940547576524,1.0,3/21,4.63%,DPM3;SDF2L1;RXYLT1
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.7692562192149432,1.2546815636208402,0.21052631578947367,0.5705963277849815,1.0,2/10,7.58%,DNAJB1;SNCAIP
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.7232978318385208,-1.2545872568283378,0.14814814814814814,0.8142132085557167,1.0,3/16,11.22%,CRYAB;TMEM109;HRAS
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.6409762842985162,1.254067999900718,0.25925925925925924,0.5721331229421187,1.0,8/19,14.15%,CELF2;KCNMB4;TMIGD3;KCNIP2;TPM1;CAMK2D;DMPK;KCNMB2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5131727666187161,-1.2537567947003128,0.0847457627118644,0.816370991453651,1.0,22/107,14.34%,RPS27A;UBC;SFRP1;UBB;PSMB6;PSMD7;PSME2;PSMD8;PTGIS;HYAL2;PSMB4;PSMD3;PSMB3;ADAMTS12;CHUK;PSME1;GBP3;UBA52;PSMA7;PSMB8;PSMD13;SQSTM1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.6596016249977766,-1.2536314751567796,0.16,0.8155997354383233,1.0,5/22,13.15%,ATP6V1F;ATP6V1G1;ATP6V1G2;ATP6V1E2;ATP6V0E1
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.6659826174809588,1.2534207556618624,0.19642857142857142,0.5740580844285412,1.0,3/16,7.61%,MYO7A;MYO1B;MYO5C
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.5937835030411782,1.2533749782037138,0.14545454545454545,0.5736326748483719,1.0,5/34,16.90%,HEY1;LEF1;NOTCH4;JAG2;KAT2A
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.5322156439797315,-1.2532641881522937,0.14814814814814814,0.8154176332854882,1.0,12/87,8.99%,VWA3A;CFAP61;RGS22;ARMC3;S100B;SPAG6;AK8;HDC;TMEM107;TTC29;CFAP70;TTLL9
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.8339375117917304,1.2530451381181196,0.22641509433962265,0.5740776270727925,1.0,4/5,16.52%,BCL11B;JAM2;GPLD1;GAS6
prerank,MSigDB_Hallmark_2020__Myogenesis,0.4607400948142021,1.252292034028236,0.1282051282051282,0.5760950396606077,1.0,38/142,17.11%,IGFBP3;CTF1;IGF1;ITGB4;PPP1R3C;BHLHE40;MEF2C;MYH11;SORBS1;PDLIM7;REEP1;SMTN;CAMK2B;ADAM12;DMD;SGCA;NOS1;AGRN;EPHB3;ABLIM1;PKIA;MAPK12;PICK1;COL15A1;AEBP1;SLC6A8;CKM;DMPK;GNAO1;CDH13;KCNH2;FHL1;CKMT2;AGL;BIN1;PFKM;ACHE;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.6807920921513994,1.2519339652378665,0.09803921568627451,0.5765112665124197,1.0,6/20,14.21%,PID1;LZTFL1;RHOQ;DMTN;BCL2L1;ITGB1BP1
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.678398121237556,-1.2517050780528696,0.17647058823529413,0.8190804948725326,1.0,3/23,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.678398121237556,-1.2517050780528696,0.17647058823529413,0.8190804948725326,1.0,3/23,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.7811282260149515,1.2515533314268124,0.2549019607843137,0.5771903753444735,1.0,5/6,21.47%,GAD1;GAD2;BCAT2;ALDH1A1;PAH
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.7978325489948155,-1.251395016900906,0.26,0.8187038111811173,1.0,2/6,2.75%,SFRP1;GREM1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.6178104612455944,1.2513629767424939,0.10638297872340426,0.5772657781758614,1.0,7/24,18.00%,MEF2C;TBX6;NDRG4;DNAAF1;MKKS;BBS4;PKD2
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.7642287611220346,1.25120817175739,0.1875,0.5770652786037709,1.0,1/7,0.65%,DPYS
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.6319999549451635,-1.2510444556021794,0.16666666666666666,0.8187688433482369,1.0,15/25,19.39%,POLR2L;POLR2G;POLR2K;POLR2I;GTF2F1;POLR2A;POLR2E;NELFE;POLR2C;POLR2D;NELFCD;CCNT1;SUPT5H;POLR2J;CTDP1
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.5943959888504367,-1.2499883857448386,0.14583333333333334,0.821658819409957,1.0,7/41,7.10%,FTL;SELENOS;PRDX1;PTPA;GPX4;NDUFB4;SOD1
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.8069069408295397,-1.2498599177022078,0.17391304347826086,0.8207624424236132,1.0,1/6,9.38%,NPL
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.7048914501462201,1.2496337480757083,0.14814814814814814,0.5818984085520764,1.0,4/11,19.30%,NR4A3;WNT8B;MKKS;UGDH
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.8556702341737841,1.2494736102195363,0.0784313725490196,0.58174344526291,1.0,2/5,9.08%,MEF2C;CDKN2A
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.4449864255423565,-1.2492257351879121,0.11666666666666667,0.8219334757888345,1.0,39/225,15.88%,RPS27A;UBC;RAD23A;UBB;USP27X;PSMB6;PSMD7;JOSD2;ADRM1;PSME2;PSMD8;USP1;USP51;ENY2;PSMB4;USP19;USP16;RHOA;OTUB1;OTUD3;PSMD3;CFTR;PSMB3;PSME1;BRCC3;UBA52;PSMA7;TOMM20;TADA3;PSMB8;PSMD13;HGS;KEAP1;ABRAXAS1;COPS5;ACTR8;SMAD7;SPATA2;PSMD2
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.7088544147315179,1.2491217332129687,0.2542372881355932,0.5823634294579993,1.0,6/13,13.48%,CTNND2;PAK3;EPHB1;EPHB3;DLG4;SHANK1
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.8033268581481244,-1.24908011017885,0.14,0.8210711463552186,1.0,2/5,16.47%,VAMP8;VAMP3
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.8304378006699625,1.2490127797804824,0.2558139534883721,0.5820335732361623,1.0,2/5,11.54%,BAG3;MAPT
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.7824727483969318,1.248464476372709,0.1836734693877551,0.5830508954012099,1.0,4/10,11.80%,PTPRC;PTPRT;MGAT5;HES1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.7498014728471939,-1.2481623280060947,0.18,0.8236081581538623,1.0,7/11,21.07%,CYC1;UQCRFS1;UQCC3;UQCRQ;UQCR10;UQCRB;UQCRH
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.6606183598874898,1.2481452321134303,0.22448979591836735,0.5835305348504987,1.0,4/9,15.92%,EPHA4;EFNA3;LYN;BIN1
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.785157481711759,1.2480029265068702,0.2916666666666667,0.583449312749049,1.0,1/6,5.26%,ID2
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),-0.8451974473805912,-1.2477465835293997,0.16666666666666666,0.8240831888972793,1.0,3/6,12.94%,TSR3;RPUSD2;DKC1
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.6673881922724403,1.2474657619572727,0.2222222222222222,0.5846483414863985,1.0,4/12,8.08%,PLSCR1;F3;ANO6;MYLK3
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.594395845699312,-1.2471038835561523,0.19148936170212766,0.8252704124493909,1.0,9/37,14.88%,ORC1;NOP53;HMGA2;ZNF830;HUS1;BRCC3;BLM;ABRAXAS1;TOPBP1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.7737697409013163,1.246979289233885,0.16326530612244897,0.5856958649690432,1.0,2/7,9.68%,LILRB1;IRAK3
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.8659994638381113,1.246932434195466,0.11627906976744186,0.5852777716785358,1.0,1/5,6.15%,WNT5A
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.8099013038474623,1.2465963091512002,0.20408163265306123,0.5856286602362467,1.0,1/5,11.91%,TRPV4
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.5840988698868522,1.2465108267468157,0.19230769230769232,0.5852486430997561,1.0,7/29,9.64%,TGFB2;ITGAM;BMPR1B;PBX1;MEIS3;MEIS2;C3
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.8613012137921816,-1.2463343251943277,0.14,0.8269644758143255,1.0,2/5,3.91%,RPS3;PCNA
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.5852361354313121,-1.2459595664651917,0.15789473684210525,0.8252557793981762,1.0,13/51,20.69%,POLR2L;POLR2G;POLR2K;POLR2I;POLR2A;POLR2E;RAE1;POLR2C;NUP37;POLR2D;POLR2J;NUP210;TPR
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.5852361354313121,-1.2459595664651917,0.15789473684210525,0.8252557793981762,1.0,13/51,20.69%,POLR2L;POLR2G;POLR2K;POLR2I;POLR2A;POLR2E;RAE1;POLR2C;NUP37;POLR2D;POLR2J;NUP210;TPR
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.5817717748666431,-1.2457140999712852,0.1724137931034483,0.8247527961802372,1.0,7/43,5.47%,ARHGEF16;CXCR4;CORO1B;CCR3;CCL28;SEMA5A;RHOG
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),0.7937732349245762,1.2456831298323814,0.3137254901960784,0.5874037875936892,1.0,1/5,6.07%,SLC22A16
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.708308017576947,1.2456036660072982,0.23255813953488372,0.5870227064183258,1.0,5/9,23.93%,CD4;FES;ZFP36L1;IL34;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.7062703713415366,1.2451953445453745,0.21818181818181817,0.5876170353527521,1.0,4/9,13.07%,VSIR;DUSP10;BCL6;CR1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.7971284404070352,1.2451366561973845,0.2033898305084746,0.5872365283558321,1.0,2/6,14.41%,SHMT2;SHMT1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.486217212690129,1.2449001489682625,0.06976744186046512,0.5875462369811149,1.0,19/86,11.28%,TGFB2;PLSCR1;DENND1B;PIANP;SELL;BIRC3;NCR3LG1;SYK;RSAD2;SAMHD1;LILRB1;LRP8;SFTPD;TIRAP;BCL6;SLA2;C3;ADCY7;CD200
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.7512102278383459,-1.244834048589359,0.30612244897959184,0.8271119918200145,1.0,2/5,14.96%,SPHK2;PIH1D1
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.8309306562724789,1.2447940814450467,0.25,0.5873387734565111,1.0,2/5,13.37%,PLSCR1;LYN
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.7856024089015823,-1.2442834714378612,0.2786885245901639,0.828081038888493,1.0,1/5,7.87%,DHX33
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.7847261855399352,-1.244195790468895,0.16666666666666666,0.8270393823252545,1.0,2/7,4.75%,CBR1;PTGIS
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.8317777017314397,1.2440417433638773,0.16666666666666666,0.588631035386311,1.0,1/5,4.07%,NR4A3
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.8317777017314397,1.2440417433638773,0.16666666666666666,0.588631035386311,1.0,1/5,4.07%,NR4A3
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.5345472188361788,-1.2440334053434945,0.09259259259259259,0.8262156472388082,1.0,16/84,12.68%,SELENOS;PRDX1;NOX1;PRDX5;GSTP1;CHCHD2;PARP1;ETV5;SOD1;VKORC1L1;SOD3;PRDX3;RBM11;PRKAA2;PPIA;PYCR1
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.7887618666335561,-1.2439239432579823,0.23404255319148937,0.8236628959920842,1.0,2/7,6.98%,CHAF1B;ASF1B
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.7887618666335561,-1.2439239432579823,0.23404255319148937,0.8236628959920842,1.0,2/7,6.98%,CHAF1B;ASF1B
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.7187519606231287,1.2430765704144155,0.17307692307692307,0.5912673726499281,1.0,2/14,5.95%,CHST1;CHST3
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.7088713197937351,1.2429625819159813,0.17391304347826086,0.5910079152674064,1.0,5/9,13.48%,MYO7A;NRXN1;PCDH15;CDH23;SHANK1
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.6959690282934343,-1.2429467940050163,0.2037037037037037,0.8262569126264631,1.0,4/9,14.08%,SPCS1;SEC11C;SPCS2;SPCS3
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.6136947591636801,-1.2427948817864511,0.1509433962264151,0.8254253948080936,1.0,3/27,9.06%,RPL11;UBXN1;NOP53
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.42401257262308906,1.2427273832522852,0.1,0.5910548560943157,1.0,20/228,9.51%,KLRF2;TGFB2;PLAC8;PDGFC;PDGFB;PLCB1;BMPR1B;SYK;ADRA1A;OXTR;WNT5A;ACADL;SOX9;LEF1;ZBTB16;KDM3A;EPAS1;STAT6;TGFB3;DIO2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.7022974599438729,-1.242683479335115,0.14583333333333334,0.8229090942036527,1.0,4/11,12.94%,CCT7;CCT2;CCT6A;DKC1
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.7022974599438729,-1.242683479335115,0.14583333333333334,0.8229090942036527,1.0,4/11,12.94%,CCT7;CCT2;CCT6A;DKC1
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.7807026533756055,-1.242536004326042,0.26666666666666666,0.8220730216498024,1.0,3/6,20.15%,PRPSAP2;TKT;G6PD
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.814039181258426,-1.2425215256973816,0.25,0.8206671756228138,1.0,2/5,2.89%,SF3A3;SF3A1
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8503067524617333,-1.2425184636923803,0.17647058823529413,0.8192062017374026,1.0,2/6,2.04%,RPS23;PTH
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.5818015878447776,-1.242336273732792,0.1724137931034483,0.8185464914076171,1.0,6/35,10.48%,ZDHHC12;SELENOK;ZDHHC16;HHAT;ZDHHC14;NAT9
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.5941454190565191,-1.2422491043766983,0.19298245614035087,0.817424384779085,1.0,11/43,13.14%,NDC80;CHAMP1;CHMP2A;CDC23;CHMP5;KIFC1;ANKRD53;MIS12;NUDC;PINX1;CHMP3
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.6384558273682721,-1.242119394304326,0.1956521739130435,0.8165307748290322,1.0,3/22,8.64%,USP27X;OTUB1;OTUD3
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),0.7048305265393697,1.241880563900396,0.21568627450980393,0.5930816121837661,1.0,2/9,6.32%,PTPRC;LILRB1
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.6530482393973993,-1.2417438445272244,0.14814814814814814,0.8167458232265353,1.0,11/26,17.59%,RPS27A;UBC;UBB;DYNLL1;CFTR;UBA52;DYNC1H1;SQSTM1;ARL13B;DYNC1I2;PARK7
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.6808937004683556,-1.2417344588018788,0.23636363636363636,0.8153495967704039,1.0,2/14,7.01%,RPL23;GRWD1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.5055746951759212,-1.2412397524573753,0.17857142857142858,0.8160572057146904,1.0,28/110,16.85%,ZDHHC12;RPL11;NACA;SRPRA;SRP14;TIMM10;KATNB1;TIMM8B;AIP;SLC25A6;MYO1C;NACAD;TSPO;SPCS1;ZDHHC14;FIS1;SPCS2;ZFAND2A;AP4B1;YIF1B;TOMM7;TOMM20;SPCS3;ZFAND2B;RABGEF1;CDC37;TIMM13;ZDHHC7
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.669064326790708,1.2409709222821057,0.2391304347826087,0.595067540688254,1.0,2/13,1.85%,ROBO2;TLR2
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.8026453516033877,1.2409382852398199,0.1702127659574468,0.594500314258708,1.0,6/6,19.76%,F3;ANGPT2;CDH13;VEGFA;NTRK3;KDR
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.8438317332099535,-1.2408559658475542,0.26785714285714285,0.816257090219809,1.0,2/5,11.26%,ATP6V1G1;ATP6AP1
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.772877554209822,-1.2407871222509015,0.22413793103448276,0.8150026521863424,1.0,5/6,21.88%,MRI1;APIP;BHMT;ADI1;ENOPH1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.5891869642193353,1.2407755873267794,0.17391304347826086,0.5943363252989342,1.0,3/27,7.64%,AQP1;CX3CR1;LEF1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.5213580646419578,-1.2404069956794659,0.2,0.8152036956021126,1.0,22/63,21.10%,TPX2;KIF3B;NDC80;TUBG1;CHMP2A;BCCIP;RAN;RHOA;KIFC1;SGO2;MIS12;GOLGA2;ABRAXAS1;KIF11;WRAP73;SMC1A;CTDP1;CDCA8;CHMP7;UBE2S;EPS8;FLNA
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.7477375047644242,1.2402301509141607,0.2641509433962264,0.5957792709461461,1.0,5/9,19.47%,PICK1;GAP43;CHRM1;PARD3;DGKD
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.8492914507007072,-1.2401193915543658,0.22641509433962265,0.8147980330187063,1.0,1/8,0.29%,CXCR4
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.6480662392670875,1.2399031519884838,0.21739130434782608,0.5961614384681919,1.0,1/24,0.33%,TGFB2
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.7375146123169888,-1.2396928416849342,0.2,0.8149692195414742,1.0,3/11,11.71%,SEC61B;SEC62;SEC61A2
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.8557495758833941,1.2396750212646914,0.09803921568627451,0.5965428180159653,1.0,1/5,5.57%,BAG3
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.7978366343591955,1.2396055713679097,0.17307692307692307,0.596207531031442,1.0,3/5,19.76%,TLR2;IL33;KDR
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.6865217662847333,1.2392300524703375,0.23076923076923078,0.5968426213811822,1.0,1/8,3.16%,ASB4
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.7277741432403447,1.2391928978512226,0.17307692307692307,0.5963503031930893,1.0,3/8,20.17%,TOP2A;SETMAR;TERF2IP
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.4876151724269135,1.2391109020583935,0.1111111111111111,0.5960525351850409,1.0,28/92,19.34%,SLC8A1;SLC24A4;SLC1A2;PKD1L3;SLC24A3;SLC26A4;SLC26A9;ANO6;GRIN1;SLC26A7;GLRB;SLC9A9;SLC9A7;TRPM3;TMEM63C;SLC15A2;PKD2L1;KCNN4;PANX2;PIEZO2;TRPC6;SLC25A22;SLC17A5;SLC15A4;SLC12A5;SLC1A1;GLRA1;SLC5A12
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.7213825847060032,1.2390942690617375,0.21568627450980393,0.5955378696304853,1.0,7/13,19.24%,COL11A1;ADGRV1;SCN1A;PIEZO2;TMEM120A;MKKS;WHRN
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.7483997471001407,-1.2388697129959545,0.21739130434782608,0.8169366603912266,1.0,1/7,8.21%,UBQLN2
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.635049694534055,-1.2387827850767885,0.19148936170212766,0.8158390757379672,1.0,3/17,15.69%,RNF8;PCGF1;UBE2A
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.7345212151477835,1.238210312259771,0.2857142857142857,0.5978248273304594,1.0,4/10,13.36%,PROM1;KLF15;BASP1;PTPRO
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7712746452921535,1.2381546822700003,0.22,0.5973335194461569,1.0,5/8,15.92%,CACNB1;NOS1;CAMK2D;CACNB2;BIN1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.5445059263038379,1.238122553497325,0.22,0.5968432162814541,1.0,9/60,8.49%,CREB3L1;MMRN2;PPARG;BMPR1B;VWC2L;SULF1;DLX1;BMPER;CHRD
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.7485809595053587,-1.2379950753157745,0.2391304347826087,0.817357787468558,1.0,2/12,1.44%,CRTAM;BTN3A1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.8119533161202371,-1.2379288491457545,0.19148936170212766,0.8161314511239175,1.0,4/7,14.88%,ORC1;ZNF830;HUS1;TOPBP1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),-0.60498303260517,-1.2378510294692546,0.23076923076923078,0.8149679040345674,1.0,2/25,1.59%,TEAD2;TEAD3
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.7480959475303607,1.237694528408793,0.17073170731707318,0.5974851507422653,1.0,3/9,6.71%,NRXN1;RELN;CAMK2B
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.8374930561514212,-1.237267421586477,0.14583333333333334,0.8159691911575047,1.0,2/5,2.23%,SELP;CCL28
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.7385615837454402,-1.2371875445943439,0.3090909090909091,0.8149120015968733,1.0,1/7,10.13%,FIS1
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.5903227921886465,1.237056574229518,0.2692307692307692,0.5990394581788586,1.0,10/30,17.71%,IGF1;MYO16;IRS1;NYAP1;TPTE2;PIK3R1;NYAP2;ZFP36L1;PIK3R5;EDN1
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.6561318164059815,1.23697082366593,0.20408163265306123,0.5986810242267603,1.0,6/14,14.70%,ANGPT1;MET;PTPRJ;CX3CL1;LGALS3;VEGFA
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.7378925558204708,1.2369406887843497,0.24489795918367346,0.5982273390001311,1.0,1/7,4.94%,KYNU
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.7103807079753913,-1.2368945866794485,0.24528301886792453,0.8148478236220628,1.0,5/10,17.59%,PRR7;PIH1D1;GSN;PLAUR;PARK7
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.7539581957551977,-1.2365539175449582,0.22413793103448276,0.8147548209341988,1.0,1/7,0.29%,CXCR4
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.6009309565908748,-1.2365263265068438,0.09803921568627451,0.8134877535726873,1.0,2/51,1.49%,CELA2A;USE1
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.8315345129119746,1.2364293033906149,0.1702127659574468,0.599488496925994,1.0,2/6,11.93%,NCKAP1L;CBFB
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.5492267766121844,1.2359479996453753,0.18604651162790697,0.6002322407048759,1.0,10/49,13.03%,PLSCR1;BIRC3;PTPN6;SAMHD1;LRP8;TIRAP;IRAK3;PARP9;IFNK;PTPN11
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.6100197073801684,-1.2358210690014089,0.18181818181818182,0.8150908277525168,1.0,8/29,13.15%,RAB32;ATP6V1F;ATP6V1G1;ATP6V1G2;MCOLN1;ATP6V1E2;RAB31;ATP6V0E1
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.7486031130151659,-1.2357253501230872,0.19607843137254902,0.8140298361467626,1.0,3/5,22.05%,AIF1L;RAC1;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),-0.8414823783924723,-1.2354448585459483,0.2765957446808511,0.813837919891463,1.0,2/5,4.75%,ACAA2;SLC25A5
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.6240346718412303,-1.2350856829605539,0.28846153846153844,0.8138194497231189,1.0,4/24,14.38%,EXOSC8;TRIR;EXOSC5;NUDT16L1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.6491691787762608,1.2350817737686612,0.18181818181818182,0.6023021585780872,1.0,4/20,9.19%,SYT4;SYT1;SYT13;SYT7
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.6925015379886478,-1.234954671529745,0.2653061224489796,0.8130248444899802,1.0,3/14,14.32%,SLC31A2;CCDC22;MT2A
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.609792936730366,-1.2348189583717952,0.10204081632653061,0.8120894712587702,1.0,6/29,13.15%,ATP6V1F;ATP6V1G1;ATP6V1G2;GPR89A;ATP6V1E2;ATP6V0E1
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.7511341598473781,1.234764605681199,0.18518518518518517,0.6027189174533175,1.0,4/7,20.20%,GRIN3A;NGEF;NLGN1;PTEN
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.4948305291279002,1.2347320684261154,0.07317073170731707,0.6022395656897412,1.0,27/87,15.16%,RYR3;TRPC4;TRPC7;SLC8A1;CACNA1G;SLC24A4;GRIN3A;ITPR1;SLC24A3;ANO6;CACNA1B;NMUR2;CACNG8;CACNG3;ATP2B2;TRPM2;CDH23;TRPM3;CACNA1I;TRPC3;CACNA1E;KCNN4;TRPV4;TRPM1;TRPC6;NALCN;CACNB2
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.7821565110734061,1.2347083312964604,0.21568627450980393,0.601713485073716,1.0,3/7,16.90%,KAT2B;MAPT;KAT2A
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.5902944311437194,-1.2344876038056005,0.15254237288135594,0.8119451665033196,1.0,11/47,18.53%,DCXR;GAPDH;SLC25A11;SLC25A1;APOD;PGAM1;CRTC2;SLC25A10;SLC37A4;ATF4;FBP1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),0.8059536059395762,1.2344839809823513,0.19148936170212766,0.6018913201351395,1.0,2/5,8.59%,SIGLEC10;GIT1
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.6754166173663307,1.2343866213768413,0.2549019607843137,0.601592767552532,1.0,3/13,17.87%,NR4A3;C3;PRKAG2
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),-0.7686345457364998,-1.2343358358921355,0.23255813953488372,0.8110863384022294,1.0,2/6,8.56%,PTH;P2RY6
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.7109572725713491,1.2342782975252415,0.20408163265306123,0.6013067061985846,1.0,2/10,11.63%,PKD1L3;PKD2L1
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.6759973288422323,1.2342122512134537,0.22727272727272727,0.6009024544195777,1.0,3/10,10.15%,NRG1;SCIN;GPLD1
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.6936546945838478,-1.233941115545424,0.15384615384615385,0.8113011362504007,1.0,3/11,5.49%,WNK4;MAGED2;HYAL2
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.7471744836923334,-1.2338607419860061,0.22448979591836735,0.810204054087596,1.0,2/8,8.82%,HENMT1;TSN
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.741512845441662,1.2337726883055873,0.17391304347826086,0.6019465170422161,1.0,1/8,0.18%,DACT2
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.7174677837417528,-1.2336901453664235,0.24489795918367346,0.8095375246872942,1.0,4/10,14.88%,ORC1;ZNF830;HUS1;TOPBP1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.6289051874675549,1.2336274370430345,0.18,0.6017083744451287,1.0,3/18,5.75%,EGFR;FOS;MT1M
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),0.862317441523873,1.2335150666054693,0.2127659574468085,0.6008313372155475,1.0,2/5,6.15%,EGFR;WNT5A
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),0.862317441523873,1.2335150666054693,0.2127659574468085,0.6008313372155475,1.0,2/5,6.15%,EGFR;WNT5A
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.7291279022029867,-1.2335081317441658,0.20512820512820512,0.8089726810699126,1.0,2/8,17.97%,PHB2;OAS3
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.8238776518001643,-1.2334623895324814,0.2608695652173913,0.8077007949449457,1.0,1/5,3.09%,PPIB
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.749612910815406,-1.2334268663936252,0.20408163265306123,0.8064332130031429,1.0,3/8,6.90%,CFL2;SEMA5A;LIMA1
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.7993295702430803,-1.2332853318083643,0.21568627450980393,0.8056503756647967,1.0,1/5,2.90%,SERPINE1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.7159624123418765,-1.2332714180310873,0.25,0.8043623117541834,1.0,4/10,20.14%,METAP2;NAA40;NAA11;METAP1D
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.7928383277824431,-1.2330530397112571,0.3018867924528302,0.8024881124284852,1.0,1/5,3.05%,KIF3B
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.7928383277824431,-1.2330530397112571,0.3018867924528302,0.8024881124284852,1.0,1/5,3.05%,KIF3B
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.6531659166948152,1.2330340310358963,0.23255813953488372,0.6018121965829502,1.0,3/12,10.71%,ISG15;LRRK2;MAIP1
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.6352529333513249,-1.2329729848250228,0.20689655172413793,0.8014223838953569,1.0,5/23,7.06%,P2RY10;LCK;ITGAL;KLRB1;PYHIN1
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.49264314678182164,1.2329418960043559,0.061224489795918366,0.6015043111764715,1.0,22/88,14.24%,ADAMTS5;AQP1;PLSCR4;FSTL1;POSTN;SYNPO2;MYH11;PDGFRA;TMEM47;COL12A1;TPM1;FBLN2;COL4A1;COL15A1;PAMR1;LAMB2;INTS6;PRRX1;ADGRF5;TNS1;FRZB;ASPN
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),0.8071680132358656,1.232552554035929,0.30952380952380953,0.6022938372789267,1.0,2/5,13.20%,KYNU;ALPL
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),-0.7511571346081911,-1.2325108387954593,0.20454545454545456,0.8022940044630432,1.0,1/7,2.90%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.5584938995678813,-1.2324203980346757,0.15384615384615385,0.8012881226629727,1.0,11/64,12.27%,POLR2L;POLR3K;GAPDH;POLR3GL;POLR3D;CGAS;POLR2K;DDX41;DHX33;CHUK;POLR2E
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.7284772055639555,-1.2321838282258057,0.18181818181818182,0.8008302773931759,1.0,6/11,23.10%,NOC2L;CHAF1B;HIRIP3;M1AP;CDAN1;RBBP4
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5590693878097688,1.2321485790380802,0.10526315789473684,0.6030110941145568,1.0,8/39,11.04%,PPARG;PTPRC;PARP14;ISG15;H2BC11;SAMHD1;IRAK3;ROBO1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.7834226988185311,1.2319263294460507,0.16326530612244897,0.6032090408394122,1.0,2/7,4.89%,GRIP2;GRIP1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.5803599013249997,1.2317876836398889,0.225,0.603065605065152,1.0,12/38,9.49%,SNAP25;NRXN1;SYN2;SYT1;GAD1;GAD2;DNAJC5;SNPH;STX1A;PCLO;SYN3;LIN7A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.587353587052708,1.2316841113586383,0.20930232558139536,0.6028284836000196,1.0,7/23,15.16%,PDGFB;GRIN1;GRM6;TRPC3;LGALS3;TRPC6;CACNB2
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.7507608146168976,1.231489193997976,0.21568627450980393,0.6026857125954687,1.0,4/6,22.56%,CX3CL1;ITGB1BP1;FERMT3;COL16A1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.7654088885104995,1.2314606677004813,0.26,0.6021563638412644,1.0,1/7,10.54%,TNFRSF1A
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.8009534821900145,-1.2313445807606729,0.2631578947368421,0.8027721242700833,1.0,3/7,8.71%,PRDX1;SOD1;SOD3
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.5000585849944388,1.2312579986453607,0.14893617021276595,0.6023307535002903,1.0,12/68,10.19%,ROR1;MYO7A;COL11A1;ADGRV1;SLC26A4;GRXCR2;PCDH15;MYO3B;CRYM;ATP2B2;USP53;CDH23
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.8518320373339759,1.2312444347627582,0.1875,0.601779408968261,1.0,2/5,11.54%,PLSCR1;MAPT
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.629159798186189,-1.2312255408630872,0.2222222222222222,0.8018122268487078,1.0,2/17,7.33%,FTSJ3;NSA2
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.5927110512979317,1.2308434214567763,0.2,0.6025031718317306,1.0,8/24,18.35%,TLR2;IL12A;H2BC11;TIRAP;DMBT1;LYG2;LYG1;DROSHA
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.5780189240916601,1.2307847234479135,0.12244897959183673,0.6020578387889608,1.0,6/41,8.19%,TGFB2;KANK2;ROBO2;PRKX;SULF1;ZBTB16
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.7789729059390863,-1.2305146175321442,0.14814814814814814,0.8016500389655554,1.0,2/7,5.49%,CXCR4;HYAL2
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.7789729059390863,-1.2305146175321442,0.14814814814814814,0.8016500389655554,1.0,2/7,5.49%,CXCR4;HYAL2
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.715514688515219,-1.2304521912244428,0.1956521739130435,0.8005998135809834,1.0,5/8,22.93%,ADAM15;ATP2A3;B2M;HFE;BDNF
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.46631592913078446,1.2303675990284044,0.14285714285714285,0.6028148879413042,1.0,27/119,15.16%,PKP2;DPP10;KCNIP4;RAB3C;ANK1;KCNB2;FGF13;FYB1;PACSIN1;TSPAN14;SCN3B;ZDHHC23;TESC;RAB34;RAB15;KCNB1;LIN7A;TNFRSF1A;P2RY1;RAB3A;RAB29;KCNIP3;TNIK;ANK3;ITGB1BP1;ZDHHC2;CACNB2
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.6012643371048506,1.2297802445718546,0.14285714285714285,0.6039666589379036,1.0,10/29,17.15%,VSIR;NCKAP1L;LEF1;DUSP10;BCL6;CR1;ZAP70;ZBTB1;TNFSF4;IL12RB1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.5952224680773439,1.229368190691106,0.11764705882352941,0.6047319677582143,1.0,8/31,11.81%,CX3CR1;HEY1;BHLHE40;PTPRZ1;TNFRSF1B;KIF14;HES1;CX3CL1
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.6250350178181934,1.2284657930059728,0.1875,0.6071821889533318,1.0,3/19,5.75%,EGFR;FOS;MT1M
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.4752086528946283,-1.2282550527799754,0.12698412698412698,0.8081399968795666,1.0,34/182,15.55%,CXCR4;DDIT3;BUB1;PRDX1;EIF2S2;GAPDH;SQLE;CCNG1;CD9;SDF2L1;TUBG1;GLA;PNO1;DHCR24;HSPE1;DHFR;FDXR;SLC7A11;CCT6A;BTG2;SERPINH1;MCM4;SC5D;PPIA;IDI1;SRD5A1;TM7SF2;RRP9;PSMD13;SQSTM1;COPS5;EPRS1;FADS1;SLC37A4
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.6797799693977707,1.2281875878851718,0.30434782608695654,0.6072340559627019,1.0,4/7,23.64%,PLA2G10;CHPT1;PLA2G4A;LPCAT2
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.5845783289982291,1.2280351507015994,0.18604651162790697,0.6070652765875242,1.0,10/16,29.45%,SRC;SOCS3;PTPN11;FER;JAK1;SPI1;CBL;STAT3;YAP1;IL6R
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.5903598381914507,-1.2279613403160023,0.19148936170212766,0.8079798386395134,1.0,8/27,22.91%,HLA-C;HLA-B;B2M;SAR1B;CALR;PDIA3;HFE;ERAP2
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.6847275285726353,1.2278965886677866,0.15217391304347827,0.6068504447999487,1.0,1/15,0.88%,NMNAT2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.6591264571711245,1.2277162305560716,0.19047619047619047,0.6068213916776259,1.0,7/19,19.43%,GRIN1;TRPC3;CX3CL1;GPER1;THY1;CAPN3;PLCG1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.4633592307877585,1.2275737934154254,0.08888888888888889,0.6066882352000128,1.0,34/146,13.60%,NPY;L1CAM;FRY;GPM6A;NCKAP1L;MYO16;CTNND2;EPHA4;MAP2;LRRK2;DCLK1;PAK3;ADGRV1;CNTN4;LGI1;NYAP1;PACSIN1;EPHB1;STX3;PTPRM;SH3GL2;GPRIN3;CNTNAP1;EPHB3;DLG4;CDK5R1;UNC5A;TBC1D24;MAPT;VASH2;ATCAY;LYN;SHANK1;TNIK
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.6924007775765171,1.2270854272051823,0.2765957446808511,0.6072953096045421,1.0,4/11,14.70%,CX3CR1;FZD3;CX3CL1;VEGFA
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),0.8119214681986497,1.2266746909990407,0.20930232558139536,0.6080398019310631,1.0,3/5,12.58%,SFTPD;EDNRB;LGALS3
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),-0.7320967351947494,-1.2262514630501817,0.21311475409836064,0.8136913550763141,1.0,1/8,4.77%,SPX
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.5632488488973779,1.226119599441018,0.10416666666666667,0.6093251865493285,1.0,2/33,1.03%,CLDN5;CLDN16
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.752190417224723,1.225831300369163,0.20408163265306123,0.6088364607189661,1.0,1/8,1.80%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.752190417224723,1.225831300369163,0.20408163265306123,0.6088364607189661,1.0,1/8,1.80%,IGF1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4631543511698364,1.2257707945570149,0.07894736842105263,0.608460499669726,1.0,47/177,13.36%,EPHA3;L1CAM;ROBO2;SEMA3D;CYFIP1;EPHA4;NRXN1;EMB;DOK6;EFNB3;GFRA1;DOK4;PDLIM7;EFNA5;SRC;CNTN4;LGI1;ROBO4;RELN;PLXNA4;EPHA6;TNR;WNT5A;EPHB1;PTPRM;UNC5D;PLXNA2;NTN4;EPHB3;SLIT1;GAP43;SEMA6A;PLA2G10;ROBO1;DOK1;CDK5R1;UNC5A;ANOS1;EFNA3;SEMA5B;SEMA4G;SEMA4B;PIK3R1;GPC1;DAB1;PTPN11;PTPRO
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.7490286615596784,1.2254949397461004,0.2631578947368421,0.608889876271868,1.0,1/7,6.16%,SAMHD1
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.565929549406134,1.2254929769822822,0.18181818181818182,0.6082964163534743,1.0,12/34,15.50%,PDGFB;SPOCK1;NPNT;FBLN2;VIT;DMTN;CORO1C;BST1;CX3CL1;PTPRO;ECM2;THY1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.7157262961223959,1.225247897316429,0.26666666666666666,0.6084727334390679,1.0,2/8,6.25%,GALNT3;GALNTL6
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),0.7669575070064922,1.2244668136987698,0.2857142857142857,0.6105168179011293,1.0,3/5,21.10%,ADRA1A;RGS2;CHGA
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.7403633830265024,1.2244457923908052,0.19607843137254902,0.6099578560832567,1.0,3/7,10.54%,FAP;TNFRSF1B;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.636132673731088,1.2240010998569473,0.14754098360655737,0.6103287540650443,1.0,5/19,14.66%,IGF1;SLC4A4;PFKFB3;ARNT;PFKFB2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.636132673731088,1.2240010998569473,0.14754098360655737,0.6103287540650443,1.0,5/19,14.66%,IGF1;SLC4A4;PFKFB3;ARNT;PFKFB2
prerank,PanglaoDB_Augmented_2021__Basophils,0.49729367384543804,1.2238763776233583,0.125,0.6101369234751401,1.0,24/80,12.79%,L1CAM;FGL2;CD44;TLR2;STAB1;CSF1R;CLEC5A;LCP2;ITGAM;HGF;CSF3R;C3AR1;GRM6;SNCAIP;CD4;P2RY13;IRAK3;ST6GALNAC5;P2RY1;ADORA2B;TEC;TULP3;AOAH;GABBR1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.8300950029301241,1.2234748151262649,0.24489795918367346,0.6102215415829951,1.0,1/5,3.55%,NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.8300950029301241,1.2234748151262649,0.24489795918367346,0.6102215415829951,1.0,1/5,3.55%,NRXN1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.5681253854695516,-1.223189764361593,0.19607843137254902,0.8248603118258434,1.0,12/40,19.93%,DEGS1;DECR2;GPX4;GSTP1;DAGLA;ELOVL1;FADS1;DAGLB;MGLL;CYP4Z1;ACOX1;CYP4F12
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.5549361983051875,1.223114822506161,0.15555555555555556,0.610838584014595,1.0,2/30,3.70%,RPS6KA6;PLCB1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.5785394139172844,-1.2230485316111293,0.19148936170212766,0.8239179646143495,1.0,12/47,17.12%,MSRB1;MAP7D3;MSRB2;GPX4;CHMP2A;CASQ2;CHMP3;RAC1;GSN;TPPP3;CORO7;WASF3
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.6524707363193818,1.2227077709970875,0.21739130434782608,0.611465807544239,1.0,2/12,6.74%,EPHA4;EPHB1
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.711097835481149,1.222701638940104,0.2708333333333333,0.610876158742364,1.0,1/7,3.39%,EPHA4
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.5155482304076473,1.2225582124480598,0.16666666666666666,0.6107643623489136,1.0,28/64,21.72%,SNAP25;NRXN1;SYN2;SYT1;SLC1A2;GAD1;GAD2;SLC22A3;GABRA2;DNAJC5;SNPH;STX1A;SYN3;LIN7A;SLC6A4;SLC6A15;RAB3A;SLC29A2;SLC29A4;SLC28A2;CPLX1;SLC1A1;TSPOAP1;SLC32A1;PPFIA3;ATP1A2;UNC13A;PPFIA4
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.7725838280123982,-1.2224856322076503,0.3333333333333333,0.8244324180583451,1.0,3/9,9.31%,H1-4;H1-2;SMARCA5
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.785705177927688,-1.2222249555935907,0.25,0.8242058298412358,1.0,2/7,20.90%,MSH3;PRKDC
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.4718753709419471,1.2218501683235596,0.10638297872340426,0.6122516454899772,1.0,27/111,9.07%,ROR1;EPHA3;SLA;EGFR;FLT1;CSF1R;MPZL1;EPHA4;PTPRG;LCP2;MET;PDGFRA;SYK;SRC;TNK2;NTRK2;EPHA6;MERTK;SH2D6;EPHB1;BLNK;STYK1;LIFR;AXL;CD4;EPHB3;PTPRT
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.6343796244324396,1.2218282152637225,0.26,0.6117648990250159,1.0,8/14,16.65%,NTNG1;FLRT2;COL4A1;NTN4;LAMB4;LAMB2;LAMB1;PXDN
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.7754700265651766,1.2218081597974026,0.15789473684210525,0.6112111816458468,1.0,1/6,2.24%,CSF1R
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.598123031809767,1.2213642996329024,0.21739130434782608,0.6121849472452874,1.0,10/29,11.77%,GRIN2B;MEF2C;CAPN1;RELN;GRIA1;CAMK2B;GRIN1;DAPK1;DLG4;NEFL
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.5603253534263599,1.2211505762382424,0.14545454545454545,0.612106319884219,1.0,10/42,12.79%,NTNG1;ATRNL1;LAMC1;NTN4;EPHB3;ANTXR1;KIF14;LAMB4;LAMB2;PIK3R1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",-0.7706186914630087,-1.2209906810711357,0.23214285714285715,0.8275887134291326,1.0,1/6,0.48%,ZDHHC12
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.5045458542804516,1.2209207603603913,0.16666666666666666,0.612219690795321,1.0,18/68,10.06%,CHRM3;CX3CR1;PTPRC;EGFR;P2RY12;GRM5;MCTP1;LAT2;SLC8A1;LRRK2;PPP3CA;NUDT4;PTPRJ;NMUR2;IRGM;DMTN;EDNRB;TRPM2
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.7814195836197966,1.2207798769553082,0.2641509433962264,0.6121186319570264,1.0,2/6,11.15%,KCNIP2;RNF207
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.7038035861787582,-1.2207297818436487,0.26,0.8271120670799642,1.0,3/14,7.61%,OOEP;PARP1;RAD51AP1
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.632603728508423,1.220532801987632,0.24444444444444444,0.6121867200156984,1.0,3/17,4.71%,TGFB2;NCKAP1L;SYK
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.584978524652463,1.2205042165407465,0.22641509433962265,0.6116582785564508,1.0,6/27,20.81%,SORBS1;GPLD1;SCARB1;HSD17B13;MLXIPL;LPGAT1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.7651493450699167,-1.220494380919988,0.3125,0.826827722078316,1.0,3/7,14.38%,TFIP11;HMGA2;NUDT16L1
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.504577198420225,1.2203951520349543,0.13636363636363635,0.6114793501300808,1.0,20/77,14.45%,RYR3;TRPC4;TRPC7;GRIN2B;SLC8A1;CACNA1G;SLC24A4;SLC24A3;ANO6;GRIN1;ATP2B3;TRPM2;TRPM3;MICU3;MAIP1;TRPC3;TRPV4;TRPM1;TRPC6;NALCN
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.657379143446134,1.2201562716710095,0.3111111111111111,0.611615241079383,1.0,6/15,18.00%,ROBO2;ROBO1;BMPR2;HES1;VEGFA;PKD2
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.6095555697130175,1.2199824811021112,0.13636363636363635,0.6116274458299211,1.0,5/27,5.39%,ITGB4;ACTN1;SORBS1;SRC;LAMC1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.734277793179481,-1.2199753473149053,0.2391304347826087,0.8262753823434347,1.0,5/9,24.94%,AP2S1;MYLIP;AP2A1;AP2B1;CLTA
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.734277793179481,-1.2199753473149053,0.2391304347826087,0.8262753823434347,1.0,5/9,24.94%,AP2S1;MYLIP;AP2A1;AP2B1;CLTA
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.4447429397943601,1.2198794660050474,0.11428571428571428,0.6113257475569309,1.0,21/147,8.06%,PDGFB;CX3CR1;ANGPT1;KITLG;EGFR;P2RY12;CHI3L1;F3;PIK3AP1;PHLPP2;MET;HGF;PDGFRA;NRG1;SRC;IRS1;NTRK2;PTPRJ;ARRB2;GRM2;AXL
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.6231681959927277,1.2198491685009014,0.17391304347826086,0.6109350281594659,1.0,7/22,18.00%,MEF2C;TBX6;NDRG4;DNAAF1;MKKS;BBS4;PKD2
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7271975901780635,-1.2197812140291062,0.28,0.8255463400544487,1.0,3/10,12.80%,CHAMP1;MIS12;IK
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.7398198976296332,-1.2196001929502795,0.16666666666666666,0.8249685610878805,1.0,5/9,23.69%,ATP5MC3;VPS9D1;ATP5PB;ATP5PD;ATP5MC2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.7480447004752506,1.2195377906944118,0.22807017543859648,0.61127231645163,1.0,1/6,0.91%,VSIR
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.6027942073879992,1.2194604707205565,0.2558139534883721,0.6109159234082545,1.0,11/23,16.97%,P2RY12;CYFIP1;CARMIL1;SPEF1;ARHGEF6;ABLIM1;DMTN;PTPRO;CDH13;ARHGEF4;ARHGEF7
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.6703517677768153,1.2194510588706178,0.2127659574468085,0.6103591911631978,1.0,2/11,7.41%,SLCO2B1;SLCO4A1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.4616580407710798,1.219340051923461,0.1,0.6101493777060457,1.0,39/143,17.11%,NFKBIE;CD44;FOSL2;FOS;TLR2;F3;KLF9;TNC;BHLHE40;NR4A3;BIRC3;KYNU;MAFF;ID2;ZFP36;NFKBIA;ETS2;PER1;CCND1;BCL6;PFKFB3;SOCS3;OLR1;TUBB2A;HES1;TGIF1;CD80;CEBPD;TSC22D1;VEGFA;ABCA1;TRIP10;KLF6;CD83;TIPARP;JUNB;KDM6B;PHLDA1;CDKN1A
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.6126041738974598,-1.2192206342983865,0.18867924528301888,0.8249467579963294,1.0,12/35,19.96%,OOEP;CENPX;PCNA;EME1;TONSL;RFWD3;BLM;ALYREF;PRIMPOL;ATR;EXD2;DDX11
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.5768743064758581,-1.2191742912856804,0.1320754716981132,0.8237511292791451,1.0,4/30,6.34%,ZDHHC12;SELENOK;ZDHHC16;HHAT
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.6563908826162012,1.2190056868002035,0.17307692307692307,0.6106310355620337,1.0,5/18,8.06%,IFNA2;PTPRC;TOX;PBX1;AXL
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.5042359697229206,1.2189413456502822,0.2,0.61022091694293,1.0,12/65,10.19%,ROR1;MYO7A;COL11A1;ADGRV1;SLC26A4;GRXCR2;PCDH15;MYO3B;CRYM;ATP2B2;USP53;CDH23
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.676802712232015,1.2188048299285403,0.20833333333333334,0.6100229537379295,1.0,4/12,4.25%,LRRK2;NR4A3;MET;HGF
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.4807463879731574,1.2185348170666677,0.11363636363636363,0.6102810714068103,1.0,18/71,11.91%,RYR3;TRPC4;SLC8A1;GRIN3A;ITPR1;TUSC3;CACNA1B;NMUR2;CACNG8;CACNG3;ATP2B2;NIPAL2;TRPM2;CDH23;TRPC3;CACNA1E;KCNN4;TRPV4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.5646090249973343,1.2183210977286685,0.20930232558139536,0.610127842020559,1.0,3/29,7.62%,LPL;WNT5A;HSPB1
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.8134545076395119,1.2181863135293165,0.30434782608695654,0.6100192767289586,1.0,3/5,14.70%,VEGFD;RIN3;VEGFA
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.7154383351479893,-1.2178299259668033,0.24489795918367346,0.8275168003049894,1.0,3/10,12.35%,HSD17B10;AKR1D1;SRD5A1
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.7728121913761883,-1.21728598119158,0.2857142857142857,0.8285400798599419,1.0,1/6,3.60%,MUC4
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.7819802047449846,1.2170618018242463,0.2037037037037037,0.6131029479682606,1.0,2/5,16.58%,SYK;PRKCD
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.6862656275833761,1.2170574330202952,0.2777777777777778,0.6125488694503143,1.0,2/10,15.31%,RRAGD;SESN2
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),0.6667479967540328,1.216965575874207,0.2037037037037037,0.6121838961891375,1.0,2/14,2.39%,CD44;CARMIL2
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.6974634925222991,1.2168134451536177,0.2,0.612062757262041,1.0,1/8,0.95%,PPARG
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.7687771531980054,-1.2165362753721294,0.2037037037037037,0.8299226326330544,1.0,2/6,19.28%,TRMT112;ETF1
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.7198665001620037,1.2161553727068004,0.2222222222222222,0.6132227052707551,1.0,3/11,11.24%,NETO1;CAMK2B;DLG4
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.7383143886528363,-1.2157522559095784,0.2608695652173913,0.8314616329037056,1.0,1/7,5.54%,PHAX
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.7622052872749091,1.215665645394406,0.25,0.6142922286394776,1.0,2/6,13.94%,HEY1;OLFM1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.7125933020675459,1.2155585584445807,0.2413793103448276,0.6140372025796315,1.0,5/10,20.66%,DGKB;DGKI;DGKD;DGKE;DGKA
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.660031914457202,-1.2149723919327287,0.16393442622950818,0.8332098701740461,1.0,2/15,4.41%,CELA2A;CD9
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.5662318269160594,-1.2149122425218024,0.18518518518518517,0.8320926836807125,1.0,10/32,20.20%,H1-4;H1-2;USP51;RAD51AP1;KPNA2;BLM;SIRT6;ALYREF;MSH3;H1-10
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.6001735080383923,1.214733718946807,0.10909090909090909,0.6160839390070633,1.0,10/26,14.06%,DCX;PCSK2;PAK3;SYT13;SRPRB;LMO2;MAFB;AKT3;ABCC8;PCSK1
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.6991642275245062,-1.2145757596358404,0.23636363636363636,0.8322465903767505,1.0,2/16,2.32%,CXCR4;TNFRSF21
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.49439949741847494,-1.214281437328133,0.18333333333333332,0.8321202623348739,1.0,24/133,12.62%,CA6;CBR1;ACAA2;HCCS;LGALS1;ECHS1;AADAT;HSD17B10;HMGCL;BLVRA;BPHL;IDH3B;ERP29;APEX1;PDHB;ECH1;DHCR24;EHHADH;GPD1;H2AZ1;PSME1;IDI1;KMT5A;RDH16
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.7400923834755423,-1.214064346019426,0.3050847457627119,0.8315155362390266,1.0,1/5,1.51%,SFRP1
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5643271221252548,-1.2140610417806939,0.22641509433962265,0.8302355069529371,1.0,10/44,13.15%,PCNA;MBD4;POLD3;MPG;PARP1;APEX1;POLD4;HMGA2;PNKP;POLG
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.780643779539273,1.214049419497523,0.27450980392156865,0.6176208231609728,1.0,3/9,12.89%,WNT5A;ETV6;ARIH2
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.6015992278309903,1.2140103405714098,0.19230769230769232,0.6171875594562302,1.0,3/23,6.65%,EGFR;WTIP;ZFP36
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.675451664996166,1.213908809555921,0.2727272727272727,0.6169747063536715,1.0,2/10,5.75%,AQP1;MT1M
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.6337185446552491,1.2136679157389216,0.2608695652173913,0.6170584376756897,1.0,12/16,33.84%,CX3CL1;CACNB2;GPER1;THY1;CAPN3;PLCG1;ANK2;AKAP6;SNCA;PDPK1;CEMIP;F2
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.5746946954796979,-1.2136048996467241,0.21052631578947367,0.8306035066367575,1.0,3/22,10.80%,NES;PHPT1;NOSIP
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.7245010129694832,1.2135694750911585,0.26,0.6168351409689904,1.0,3/8,12.60%,IGF1;NECAB2;NECAB1
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.7320293104680098,1.2134388788982384,0.17647058823529413,0.6166560574622542,1.0,3/9,8.49%,WNT5A;SOX9;CHRD
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.5303752453378415,1.2133896875093388,0.17391304347826086,0.6162038222434439,1.0,11/56,12.53%,SLC9C2;KCNJ3;SLC8A1;KCNJ4;ABCC9;KCNJ6;SLC9A9;SLC9A7;TRPM2;TRPV4;ATP1B2
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.5664426043349544,1.2132595862601634,0.19230769230769232,0.6160147274039639,1.0,13/42,9.34%,FGL2;TLR2;CSF1R;CLEC5A;ITGAM;CSF3R;C3AR1;MERTK;LILRB1;WDFY4;LY86;P2RY13;SLC40A1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.5737778552827147,1.2129451197020542,0.2127659574468085,0.6163500995771253,1.0,7/26,18.36%,ABHD3;SLC44A5;GPAT4;CHPT1;ACHE;CSNK2A1;CHKA
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.6145330133596404,-1.21290198054403,0.25,0.8319763431022741,1.0,3/17,11.34%,HENMT1;TSN;SNIP1
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.6913300004451879,1.21283229875823,0.24489795918367346,0.6161612194712984,1.0,3/11,11.82%,KCNK6;KCNK10;KCNN4
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.7735926719509161,-1.2126651502008858,0.21818181818181817,0.831481393288085,1.0,3/6,18.69%,CHMP2A;HGS;SNX3
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6113254274421315,1.2125748347487257,0.1896551724137931,0.6164740378597354,1.0,6/18,17.99%,SLC26A4;SLC9A7;CLCN3;PDK4;KCNH2;SLC12A5
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.5227099947071437,1.2124720266403708,0.17073170731707318,0.6161982817857343,1.0,19/63,14.05%,CLDN5;TGFB2;PKP2;CDH9;CDH10;CSF1R;CTNND2;CDH18;CDH22;CADM3;TJP2;TGFB3;ARVCF;TRPV4;CDH6;CDH7;NLGN4X;CDH3;CDH13
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.7619104044574115,-1.2122858514748243,0.19148936170212766,0.8315026138487576,1.0,2/7,4.22%,DEGS1;DECR2
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.7533103619271615,1.212190495263568,0.22950819672131148,0.6165104882636532,1.0,2/7,14.41%,SHMT2;SHMT1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.4712898530947368,-1.212044805105458,0.12727272727272726,0.83112853787219,1.0,34/142,18.64%,RPL5;TPX2;RPL11;RPL23;RPS15;CHD4;NOC2L;CCNG1;RPS20;RPL37;BRPF1;TTC5;NOP53;TAF13;HEXIM1;TAF7;PRKAA2;KMT5A;HUS1;BLM;KAT5;RPF2;SETD9;DAXX;BRD7;TOPBP1;PIP4P1;TAF11;ING2;PLK3;TAF9B;PPP1R13L;EXO1;ATR
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.6563824003572519,1.2118048992865942,0.2916666666666667,0.6165033694405085,1.0,4/16,5.17%,IL1RAPL2;GPC6;LRFN5;SLITRK3
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.6563824003572519,1.2118048992865942,0.2916666666666667,0.6165033694405085,1.0,4/16,5.17%,IL1RAPL2;GPC6;LRFN5;SLITRK3
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.7587241559906163,1.2115613961979617,0.2549019607843137,0.6166625505582043,1.0,5/6,23.34%,CRYM;SLC7A8;SLC16A2;SLC16A10;SLCO1C1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.4731078045187366,-1.2115175964985894,0.08928571428571429,0.8318342341744869,1.0,31/150,18.14%,CDKN1C;THAP1;ANAPC15;PKMYT1;PSMB6;PSMD7;PSME2;PSMD8;BTG3;FBXO43;CDC23;CDC26;PSMB4;NEK6;PSMD3;PSMB3;PSME1;CDK11A;BTG2;DYNLT3;CDK11B;PSMA7;PSMB8;PSMD13;CKS1B;GAS1;PSMD2;SCRIB;PSMC5;GBF1;ANAPC11
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.7893676743251979,1.2115088769304463,0.22448979591836735,0.6162253084962743,1.0,2/6,16.82%,SYK;TNFSF4
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.7744332997750257,-1.211366113531555,0.14583333333333334,0.8284787670407044,1.0,1/5,1.82%,DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.7744332997750257,-1.211366113531555,0.14583333333333334,0.8284787670407044,1.0,1/5,1.82%,DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.7744332997750257,-1.211366113531555,0.14583333333333334,0.8284787670407044,1.0,1/5,1.82%,DCXR
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),-0.7049590463482691,-1.2112203899896414,0.18604651162790697,0.8277071249255912,1.0,1/7,0.98%,PAX8
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.7397229136647426,1.2110599150448096,0.22641509433962265,0.6169258911034399,1.0,1/6,8.42%,DUSP10
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.787977313012297,1.2109323882541305,0.24489795918367346,0.6167380432560392,1.0,4/6,14.03%,SULT4A1;SULT2A1;SULT2B1;UST
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.7361552955492368,1.210565298077103,0.21739130434782608,0.6172423097679438,1.0,2/10,4.57%,PTPRC;NRG1
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.752089556577665,1.2104262312857923,0.28,0.6170437172593092,1.0,5/7,23.34%,CRYM;SLC7A8;SLC16A2;SLC16A10;SLCO1C1
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.7686938724017784,-1.2103995698276495,0.23636363636363636,0.829861315944786,1.0,2/9,11.26%,ATP6V1G1;ATP6AP1
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.6971677866431094,-1.2103901734087041,0.21311475409836064,0.828633850463051,1.0,8/15,20.01%,RBM22;SNRPC;PRPF39;WBP4;SNRNP200;DDX23;WBP11;DCPS
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.7097993373270651,1.2102910672570988,0.3018867924528302,0.6168778557876041,1.0,5/10,16.25%,NRXN1;WNT5A;LRP4;NLGN4X;NLGN1
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.6200989262477177,1.2099467079963482,0.2708333333333333,0.6173159349008925,1.0,2/17,2.87%,ALDH1L1;SHMT2
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.6807901133679792,1.2096084656433344,0.25,0.6179255232287703,1.0,2/10,4.69%,ZMYND10;DNAH7
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.5459825972950939,1.2094928506250147,0.17391304347826086,0.6176624749593624,1.0,10/42,15.82%,TRIM46;ADGRE2;MAP2;LRRK2;EFNA5;CAMK2D;LYN;FES;PARD6A;KIAA1614
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.4800501376409261,1.2094600156451791,0.14285714285714285,0.617163412678031,1.0,23/120,17.14%,IGF1;TRIM5;LRRK2;DACT1;IRS1;TNFRSF1B;SLC4A4;ABCD2;AMER1;PFKFB3;LAPTM5;DAPK1;IRGM;GPLD1;ARNT;MOV10;PRKD1;GTPBP1;PFKFB2;TRIM22;ABHD5;PRKCD;TP53INP1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.5146485523993889,1.2093458366674543,0.17647058823529413,0.6170626376480397,1.0,5/37,9.65%,ADAMTS5;ZNF423;PGAM5;PLCL2;PLCL1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.537513910916265,1.208969596277987,0.21428571428571427,0.6174878234281193,1.0,6/55,9.36%,TGFB2;BMP6;IGF1;FRMD4A;TENM1;TGFB3
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.6829324574728329,-1.2087931477970864,0.1956521739130435,0.8339804613028338,1.0,1/8,0.98%,PAX8
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.5318480389253417,1.208789671663927,0.1956521739130435,0.6173654958361957,1.0,7/36,7.52%,SLC4A10;SLC26A4;SLC26A9;ANO5;ANO6;SLC13A4;SLC26A7
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.462106829482746,1.2086427028601479,0.17777777777777778,0.6172112587423392,1.0,30/96,15.10%,DACT2;ANGPT1;IL12A;EPHA4;PRKX;EFNA5;SRC;PPP3CA;PLXNA4;FBLN1;ADGRG1;TPM1;PTPRJ;STX3;TESC;CHRD;PLXNA2;EPHB3;NUAK1;KIF14;PDE3B;PTPN11;LYN;FES;PPP1CB;CDH13;ITGB1BP1;ZDHHC2;VEGFA;PKP4
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.4640892311419556,1.2083561089245958,0.13333333333333333,0.617463936423035,1.0,19/123,11.44%,ROR1;EPHA3;EGFR;FLT1;CSF1R;EPHA4;MET;PDGFRA;NTRK2;EPHA6;MERTK;EPHB1;AXL;CD4;PLK1;EPHB3;RFC3;CD200;DCUN1D4
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5813729044350344,-1.2082543792771607,0.21818181818181817,0.8350107082027085,1.0,3/32,11.51%,ADPRM;ENTPD2;NUDT1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.458091972396808,1.2079292840223685,0.11363636363636363,0.618411083525712,1.0,28/127,14.39%,RND2;MYO7A;CGNL1;GAS2L3;KASH5;CARMIL2;ACTN1;BAIAP2;CARMIL1;ARHGAP25;MYO1B;SCIN;BAIAP2L1;TPM1;RHOF;MYO5C;NEBL;VIL1;DMTN;ARHGAP17;CORO1C;TRPV4;DPYSL3;FHOD1;SHROOM3;RAC3;CORO6;SHROOM2
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.7284190334884193,1.2079112398821934,0.2553191489361702,0.6179145097551718,1.0,3/9,11.98%,OGFOD1;P3H2;P4HA1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.7649021623547388,-1.2078552290600364,0.3,0.8350390651265629,1.0,3/7,19.85%,UBE2D4;RNF6;UBE2S
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.7753983368212147,-1.2078182289408577,0.2653061224489796,0.8325741704244836,1.0,2/5,14.68%,SLC25A11;SLC25A10
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.7753983368212147,-1.2078182289408577,0.2653061224489796,0.8325741704244836,1.0,2/5,14.68%,SLC25A11;SLC25A10
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.7163704888059654,1.2076453261288538,0.22,0.6180591454898333,1.0,2/9,2.20%,CX3CR1;P2RY12
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),0.6973667000651862,1.2076122869183143,0.24528301886792453,0.6175744511654595,1.0,3/11,10.07%,NCKAP1L;DMTN;ALAS1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.6897579784072339,1.2073874611561923,0.23255813953488372,0.6177510904213058,1.0,2/9,3.03%,POGLUT2;GALNT3
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.7442721065896407,-1.2073541980519042,0.30434782608695654,0.8319935367428477,1.0,2/6,10.22%,HLA-C;HLA-B
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.7442721065896407,-1.2073541980519042,0.30434782608695654,0.8319935367428477,1.0,2/6,10.22%,HLA-C;HLA-B
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.705022360905151,1.207305127555464,0.2978723404255319,0.6174484795523439,1.0,3/6,25.85%,TIRAP;LBP;NINJ1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.5780778101247088,-1.207207898421013,0.20754716981132076,0.831279839908943,1.0,4/32,9.06%,RPL11;UBXN1;GABARAPL2;NOP53
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.789441776416896,1.2071191625411433,0.24444444444444444,0.6174760473812839,1.0,2/5,9.27%,SAMHD1;NT5C1A
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.5772960328668109,1.2070661367858961,0.17647058823529413,0.6171317353897172,1.0,9/29,14.00%,IFNA2;NCKAP1L;LILRB1;SFTPD;LAPTM5;LGALS3;CD80;CR1;HAVCR2
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.6766733727566533,-1.2068005040807843,0.2391304347826087,0.8318148371473664,1.0,5/12,26.07%,ELOVL1;FADS1;ACOX1;ACAA1;ELOVL2
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.7153368462294667,1.2060928960656874,0.22,0.6193778954869206,1.0,6/11,24.71%,PGAM5;ITPK1;MLKL;IPMK;LY96;TICAM1
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5276687018795648,-1.2060493090981923,0.25,0.8335542904700508,1.0,9/70,7.70%,CXCR4;P2RY10;LCK;EEF1B2P3;ITGAL;KLRB1;EVI2B;PYHIN1;CD81
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.7499721865025888,1.2057920195855827,0.2391304347826087,0.6197536037847978,1.0,2/6,7.50%,TSHZ3;MTG1
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.6937553386208145,1.2054297042874904,0.21153846153846154,0.6202769671343998,1.0,3/13,11.92%,SLC2A9;SLC2A5;SLC45A1
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.7695519384446021,1.20458363211763,0.2978723404255319,0.6225354180607472,1.0,2/5,10.88%,C3;GNB3
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),0.8077519622751627,1.2044628031979554,0.2631578947368421,0.6207069158408288,1.0,2/5,13.77%,TAC4;RNASE10
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),0.8077519622751627,1.2044628031979554,0.2631578947368421,0.6207069158408288,1.0,2/5,13.77%,TAC4;RNASE10
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.8077519622751627,1.2044628031979554,0.2631578947368421,0.6207069158408288,1.0,2/5,13.77%,TAC4;RNASE10
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),0.8077519622751627,1.2044628031979554,0.2631578947368421,0.6207069158408288,1.0,2/5,13.77%,TAC4;RNASE10
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6976284390457705,-1.204449124112535,0.2542372881355932,0.8372219041573328,1.0,5/9,15.34%,CALM1;CASQ2;SRI;CLIC2;TRDN
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6976284390457705,-1.204449124112535,0.2542372881355932,0.8372219041573328,1.0,5/9,15.34%,CALM1;CASQ2;SRI;CLIC2;TRDN
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.8331118282068806,1.2043461321224962,0.24390243902439024,0.6204046385086639,1.0,1/5,1.99%,ABCC4
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.7567910466374002,-1.2042548929541224,0.22,0.8366333936899886,1.0,3/9,11.96%,SERPINE1;MELTF;PLGRKT
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.6418845410236452,-1.2040322588412438,0.27450980392156865,0.8363144817332434,1.0,2/17,4.16%,CDKN1C;DYNLL1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.7493175115651657,-1.2039537459952743,0.26666666666666666,0.8352707496697463,1.0,1/6,3.68%,BACE2
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.6656322739568437,1.2037908980197578,0.29411764705882354,0.6208220827732196,1.0,3/13,11.91%,SLC8A1;TRPM2;TRPV4
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.6656322739568437,1.2037908980197578,0.29411764705882354,0.6208220827732196,1.0,3/13,11.91%,SLC8A1;TRPM2;TRPV4
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.7181543238427754,1.203760686666022,0.2549019607843137,0.6203733717487715,1.0,4/6,24.71%,ITGAM;CAMK4;SPI1;TICAM1
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.6753508470924806,-1.2036832662925971,0.24561403508771928,0.8349167364697356,1.0,6/13,19.13%,FICD;BAX;BAK1;UFL1;COPS5;PTPN1
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.7422917086866728,-1.2036827617008072,0.2608695652173913,0.8336624860279517,1.0,2/7,7.04%,PRELID1;CD274
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.6402098296589986,-1.2036568139988093,0.288135593220339,0.832488088120848,1.0,3/13,10.98%,MYADM;NPC1;ANXA2
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),0.5933437643874274,1.2035070062495836,0.21153846153846154,0.6205134956249503,1.0,9/25,20.18%,DCX;SPEF1;RSPH9;CFAP74;SPAG16;DNAAF1;CFAP46;TOGARAM1;DRC1
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.5752251223511236,1.2033034623444734,0.20930232558139536,0.6206114048461878,1.0,7/30,13.12%,CAMSAP3;MAP2;ARHGAP18;PAK3;FCHSD2;MAPT;ARHGAP28
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.5182441641866002,-1.2029400803000092,0.26,0.8338611237356637,1.0,20/88,18.14%,TUBA1A;SSNA1;PLK4;DYNLL1;TUBB4B;TUBG1;TUBB4A;DCTN3;FBF1;CEP131;MKS1;TUBB;DYNC1H1;HAUS6;AKAP9;HAUS1;PRKACA;DYNC1I2;TCTN3;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7083138763988315,1.2029244547282771,0.2549019607843137,0.6213170924685689,1.0,2/6,21.60%,NLGN1;FBXW11
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.579646912335045,1.2029041145624002,0.2558139534883721,0.6208276463549257,1.0,6/25,8.62%,PKP2;FGF12;NEDD4L;CACNA1G;SCN3B;SCN1A
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.8094914237475498,1.202692228407373,0.3333333333333333,0.6207680658648453,1.0,1/5,10.61%,MOV10
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.5975238978787637,-1.2026800267300704,0.19148936170212766,0.8335113789325324,1.0,7/27,14.37%,VPS25;CHMP2A;VPS28;CHMP5;SNF8;CHMP3;HGS
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.65598173459784,1.2022733810451498,0.24,0.6213985577099926,1.0,5/9,21.27%,GPLD1;GRAMD1B;GRAMD1A;GRAMD1C;MLC1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.6216956478287368,-1.2022366320893063,0.18867924528301888,0.8339071477256665,1.0,14/38,19.96%,OOEP;CENPX;PCNA;EME1;TONSL;ZNF830;RFWD3;BLM;ALYREF;PRIMPOL;ATR;MSH3;EXD2;DDX11
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.5334660419898382,1.2022277227340306,0.2857142857142857,0.6209416754087694,1.0,11/57,13.03%,EGFR;PTPRR;NRG1;SRC;SOX9;KIF16B;VIL1;TGFA;ERBIN;PIK3R1;PTPN11
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.7404140357918195,1.2021012209802477,0.17391304347826086,0.6206838773510355,1.0,2/7,9.28%,SHANK2;PICK1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.7248694898819266,1.2016097421490841,0.275,0.6215838532460343,1.0,3/10,6.71%,NRXN1;RELN;CAMK2B
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.5907716835360364,1.2013234516257185,0.19148936170212766,0.6219405502033692,1.0,11/31,15.45%,PKP2;FGF12;SCN3B;PER1;NKAIN3;NOS1;NKAIN1;YWHAH;ANK3;WNK2;SCN4B
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.5873993098927061,1.2012882686225808,0.17777777777777778,0.62150561926397,1.0,2/20,1.99%,SLCO2B1;ABCC4
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),0.7450006977950552,1.2012290634925558,0.30434782608695654,0.6211858415361176,1.0,2/6,7.18%,LILRB1;ARRB2
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.76931445907436,1.201078066296466,0.2727272727272727,0.6199602346460288,1.0,2/8,7.62%,RAB27B;HSPB1
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.76931445907436,1.201078066296466,0.2727272727272727,0.6199602346460288,1.0,2/8,7.62%,RAB27B;HSPB1
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.76931445907436,1.201078066296466,0.2727272727272727,0.6199602346460288,1.0,2/8,7.62%,RAB27B;HSPB1
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.5068205898792832,-1.2009120699940719,0.14285714285714285,0.8372120792968347,1.0,32/94,29.30%,SRSF7;ENY2;RBM15B;SRSF3;SRSF9;RBM8A;RAE1;DHX38;MAGOHB;NUP37;POLR2D;ALYREF;NXT1;FIP1L1;SLU7;NUP210;TPR;CASC3;CDC40;POM121C;SRSF2;NXF1;NUP93;UPF2;NUP42;NUP85;CPSF4;MAGOH;DDX39A;NXF5;MCM3AP;THOC5
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),-0.5783868005754693,-1.2008714989343672,0.2653061224489796,0.836192133630749,1.0,5/39,5.08%,DPEP1;CPA1;GPX4;PTGIS;DAGLA
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.7154438273897759,1.200807886885488,0.2542372881355932,0.6201195974701701,1.0,2/9,6.15%,MEF2C;MAP2K5
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.7462448654841954,1.2007942991478153,0.2553191489361702,0.6196160888693587,1.0,1/8,2.18%,MFAP5
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.8017414562050493,1.2007506319974521,0.2545454545454545,0.6191444960934039,1.0,2/5,7.70%,MEF2C;COL4A1
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.8342994770020123,-1.2003612642503945,0.26,0.8369714887516352,1.0,3/5,13.84%,RACK1;CALM1;MAPK7
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.830019779683102,1.2003584023512481,0.3181818181818182,0.6196762088629847,1.0,3/5,8.47%,LMO3;PER1;CLOCK
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.5994137074063416,1.1999633516202057,0.24528301886792453,0.6202379669277197,1.0,6/30,10.61%,CD44;NTNG1;WTIP;EFNA5;VIL1;MOV10
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.49913291732529796,1.199668611405891,0.18,0.620509872817011,1.0,17/61,16.44%,CDS1;KCNMA1;DNAH7;VWA3B;SHANK2;ZBTB7C;MYO5C;DNAH3;NEBL;MORN5;SLC9A7;SHROOM3;TACC2;GRHL2;MUC16;EXPH5;CFAP47
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.8232356473881082,1.1995310023588888,0.22916666666666666,0.6203277640790119,1.0,3/5,16.81%,BIRC3;SLC15A2;SLC15A4
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.602725008252814,-1.1994380223542023,0.21311475409836064,0.8395671363960857,1.0,9/31,16.63%,TMEM11;SLC25A4;SLC25A5;SAMM50;BAK1;TIMM50;APOO;BAD;CHCHD6
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.5347817000523634,-1.1992502677144106,0.1935483870967742,0.8390366621340911,1.0,7/71,10.73%,SELENOS;SEC61B;UBXN4;UBQLN2;USP19;TMEM129;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.6391874313883212,1.1990865480465465,0.2553191489361702,0.6212479336436366,1.0,5/16,15.36%,ZFP36;ZBTB16;MEIS2;MAFB;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.6479463230986776,1.1982006734969588,0.25,0.6231954655703046,1.0,2/18,4.37%,FLT1;PDGFRA
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.7652726237136744,-1.1980314319968575,0.20408163265306123,0.8419465872225147,1.0,1/6,5.21%,PDCD7
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.6143858736771477,1.1978220265049242,0.19230769230769232,0.6238956318262112,1.0,2/23,1.80%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.5085057702139639,-1.197756739849417,0.21568627450980393,0.8417138117451747,1.0,14/61,23.39%,CSTF2T;SRSF7;SRSF3;SRSF9;CSTF2;RBM8A;DHX38;MAGOHB;ALYREF;FIP1L1;SLU7;CASC3;CDC40;SRSF2
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.7971894127197838,1.1976534005010013,0.23255813953488372,0.6238036521186157,1.0,1/5,3.54%,LRRK2
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.6522732446511281,-1.1975882073609447,0.22950819672131148,0.8411575749746383,1.0,3/15,19.58%,CGAS;NPM1;PDE12
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.4675930400922444,1.1974384085902257,0.13953488372093023,0.6237734094964169,1.0,20/106,13.60%,WTIP;NEDD4L;MEF2C;EPHA4;LRRK2;PID1;PAK3;EFNA5;SIPA1L1;BMPER;BCL6;EPHB3;KNDC1;CDK5R1;MAPT;SARM1;LZTS1;VASH2;HECW1;TNIK
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.6460352640677711,1.1972960914065145,0.2857142857142857,0.6235894113900529,1.0,4/13,15.43%,ZMYND10;ODAD3;DNAI2;DNAAF1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.5304377086380082,1.197270437912669,0.27906976744186046,0.6230778946038963,1.0,14/48,19.46%,FOS;GRIN2B;MAP3K5;LRRK2;ITGAM;WNT5A;MAPT;SARM1;ACER2;DDIT4;ACOX2;CIDEB;LRP1;RARG
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5069720280441845,1.1972064139962277,0.18421052631578946,0.6226900993319123,1.0,11/50,11.04%,L1CAM;ROBO2;EMB;CNTN4;ROBO4;TENM3;PTPRM;CADM3;PTPRT;IGSF21;ROBO1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.5442808752507307,-1.196924553191598,0.21052631578947367,0.8427566622611826,1.0,7/46,7.06%,CXCR4;P2RY10;CD38;CCR3;ITGAL;KLRB1;PYHIN1
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.5373213170664737,1.1968090737333825,0.23684210526315788,0.6233972847467942,1.0,8/44,8.65%,RAB27B;RAB3C;RIMS2;CADPS;SYT1;STXBP5L;CADPS2;RAB15
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.7163241514217353,1.1966610876038735,0.30357142857142855,0.6232755609958467,1.0,3/6,21.83%,PCLO;RAB3A;ERC2
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.6201898278737921,1.196503727320458,0.2222222222222222,0.6231744670996436,1.0,7/33,11.98%,GLRA3;KYNU;GLRB;IRAK3;TRPM2;RNF139;GLRA2
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.6873584330396018,-1.1963963697727642,0.2830188679245283,0.8435927397558108,1.0,1/9,3.22%,TRARG1
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.6957991841383588,1.1959912585409758,0.2916666666666667,0.6242670194137306,1.0,5/10,11.36%,NRCAM;EPHA4;CNTN4;EPHB3;CDK5R1
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.5454776234190395,1.1953011502464397,0.26,0.6255411336129665,1.0,11/44,14.74%,GRIN2B;EPHA4;SPOCK1;RTN4RL2;YWHAH;TRPV4;DPYSL3;RAB29;KANK1;PTPRO;STMN2
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.48576342645581405,1.1952617095426723,0.20408163265306123,0.6250921225397749,1.0,22/64,15.48%,CMYA5;PTCHD1;PPP1R1A;SORBS1;FGF13;ADCYAP1R1;LRRC2;ADRA1A;WIPF3;ANO5;SLC35F1;MYLK3;ADCY2;NT5C1A;SYCP2L;MAPT;COL9A1;CNTFR;ATP1B2;ACACB;CACNB2;CKMT2
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),-0.6966351742836705,-1.1952440700208553,0.2553191489361702,0.8462881379405596,1.0,1/7,0.24%,BMP5
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.6896217213596662,-1.1952425162832798,0.27450980392156865,0.8450343777362033,1.0,5/11,20.66%,CRTAM;BTN3A2;CD46;CTSH;JAG1
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.4915597001562646,1.1952360944458387,0.16326530612244897,0.6246235385972161,1.0,18/63,15.04%,CREB3L1;AQP1;POSTN;SYNPO2;MYH11;PDGFRA;COL12A1;SULF1;TPM1;COL4A1;COL15A1;PAMR1;LAMB2;TRPV4;TNS1;FRZB;ASPN;TIMP3
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),0.7534236266760159,1.1952345207706665,0.3137254901960784,0.6240846054319036,1.0,2/6,13.73%,SLC22A16;SLC25A20
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.6649766590535862,1.1949899487364966,0.2564102564102564,0.6243083494640758,1.0,2/10,13.48%,NRXN1;SHANK1
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.7589708587196556,1.1949023556202867,0.1836734693877551,0.6241562360645324,1.0,2/8,15.43%,MET;DNAAF1
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.6344274039534011,-1.194160234015167,0.3076923076923077,0.8482765567725632,1.0,1/18,0.29%,P2RY10
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),0.7947895871729029,1.1938162554841583,0.22857142857142856,0.6268940447142617,1.0,4/5,19.40%,CACNA1G;CACNB2;SCN4B;CACNA1C
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.44426886664793036,1.1934916551810895,0.13157894736842105,0.6273883178043975,1.0,23/137,12.84%,CLDN5;TGFB2;AQP1;PPARG;FLT1;STAB1;CHI3L1;F3;RHOJ;ADGRB1;WNT5A;SULF1;PTPRM;BMPER;ADAM12;HSPB1;VEGFD;SEMA6A;PRKD1;ZNF304;EFNA3;PDE3B;VASH2
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.6285452349266833,-1.1934005151999176,0.24193548387096775,0.8500139595998962,1.0,4/14,19.96%,NCL;NOP53;PIH1D1;DDX11
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.7227510160667079,1.1930174361498975,0.2619047619047619,0.6280234459528953,1.0,1/6,8.14%,TIRAP
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.5608038314264785,1.192905831242843,0.2,0.6277675354140749,1.0,8/32,13.46%,PID1;SORBS1;PRKCZ;IRS1;GRB14;PTPN11;KANK1;PIP4K2A
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.8295709642938178,-1.1928738919599278,0.20408163265306123,0.8507097795161265,1.0,2/5,7.30%,CORO1B;SYAP1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.6845132793875134,1.1928026406495815,0.26,0.6275524813339377,1.0,4/7,24.71%,CAMK4;CLEC7A;SCIMP;TICAM1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.582810510349602,1.192682397063963,0.2558139534883721,0.6274791358590052,1.0,2/19,7.25%,PPARG;NFKBIA
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.7666918137001535,-1.192382806426565,0.16666666666666666,0.8515021147826384,1.0,1/6,3.45%,GTF3C6
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.5652114323370288,1.1921364579682268,0.2641509433962264,0.628636539004129,1.0,7/24,12.92%,PPARG;ADAMTS9;MEF2C;ADGRB1;PTPRM;NR2F2;ANGPT2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.7308754595913123,1.1921217014791206,0.3125,0.628118940086994,1.0,5/7,19.00%,NFKBID;NFKBIZ;IL12RB1;PRKCQ;CLEC7A
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.4678995834791494,1.1920491142254903,0.13157894736842105,0.6277935527460397,1.0,43/149,17.97%,FKBP5;CD44;FOS;NPY1R;IMPA2;CA12;IGFBP4;CHST8;ID2;HSPA4L;PTPN6;PTGER3;SLC24A3;ZFP36;CCND1;MEST;TOP2A;TRIM29;CACNA2D2;BCL2;OPN3;MAPT;SCARB1;ITPK1;CCN5;TSPAN13;PLAC1;SULT2B1;OLFM1;ISG20;CHPT1;CPE;SORD;FARP1;GPER1;NBL1;SLC27A2;RBBP8;PAPSS2;ACOX2;CXCL14;PRSS23;TJP3
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.49708708532179613,1.1917917534883329,0.1702127659574468,0.6278611091879314,1.0,11/86,12.07%,EGFR;MAP3K5;PLCB1;SH3RF3;DACT1;EPHB1;PER1;TIRAP;DUSP10;ANKRD6;MTURN
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.7649446541330774,-1.1916489404921853,0.2,0.8531286891847277,1.0,2/7,9.28%,DCLRE1B;TFIP11
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),0.7436657588356888,1.1914898063383124,0.23214285714285715,0.628230129759701,1.0,4/7,25.01%,TPO;DIO2;CTSK;CPQ
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.6781117632332283,1.1913734156801763,0.25,0.6281465376709467,1.0,5/14,12.42%,GUCY1A1;ADCY8;ADCY2;ADCY7;ADCY1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.6686979242003225,1.1911172383787587,0.16666666666666666,0.6282939049861289,1.0,7/15,19.28%,NCKAP1L;SYK;AXL;ZAP70;GAS6;ZBTB1;PPP2R3C
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.5629173488502589,1.1911141394624205,0.11764705882352941,0.6277692137499166,1.0,11/40,15.95%,PPARG;FSTL1;BMPR1B;VWC2L;DLX1;BMPER;CHRD;BMPR2;CHRDL1;ACVR2A;NBL1
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.715194757244686,-1.1905220958696952,0.2619047619047619,0.8560649203444609,1.0,1/8,3.68%,BACE2
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.7971676869187243,1.190406405591086,0.2777777777777778,0.6292290688274259,1.0,3/6,12.98%,UHRF1;UHRF2;HELLS
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.49255580317664904,1.1901926619529986,0.20454545454545456,0.629285051304008,1.0,14/56,19.47%,RHBDF2;EGFR;PTPRJ;SH3GL2;MVB12A;TGFA;DOK1;ARAP1;CDH13;GPER1;ARHGEF7;TSG101;EPS15;DGKD
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5474987333299904,1.1899472270514437,0.2,0.6294409531858649,1.0,10/31,13.98%,PLCB1;PPP3CA;WNT5A;GNG2;LEF1;FZD3;MOV10;FZD6;GNAO1;PLCB3
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.7505288807462688,1.189890363292424,0.3111111111111111,0.6290369847197845,1.0,2/6,15.43%,CITED2;DNAAF1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.5566287690398113,-1.1898801727483679,0.265625,0.8571771113696173,1.0,9/45,14.29%,RPL23;VAMP8;LIX1;GABARAPL2;PYM1;HSPA8;SNAP29;CHMP3;MAP1LC3B
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.7877158076531694,-1.189821577758569,0.17777777777777778,0.8561425658420128,1.0,1/5,2.83%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),-0.7614520433412852,-1.1897170801358818,0.2692307692307692,0.8552700424348757,1.0,2/6,8.20%,SPX;NMU
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.7818797482973237,-1.1894182777608886,0.25,0.8551206154825303,1.0,1/5,8.20%,NMU
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.5752875491165462,-1.1893487886623555,0.2,0.8542033460343391,1.0,3/37,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.48792000128975616,1.1892912544238257,0.20454545454545456,0.6299416696063634,1.0,12/70,9.14%,L1CAM;ITGA11;CD44;ADAMTS9;ITGB4;ACTN1;ITGBL1;SORBS1;SRC;NPNT;FBLN5;MKLN1
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.5298039192888601,1.1887154050796016,0.225,0.630984486977566,1.0,7/44,9.24%,CLDN5;NRXN1;CLSTN3;EPHB1;PTPRJ;EPHB3;IL1RAP
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.48531705542789,1.1880792668068687,0.20408163265306123,0.6323744058297684,1.0,17/74,7.70%,ADAMTS5;PCOLCE;FSTL1;POSTN;TNC;FAP;PCDH18;CSPG4;LOX;PDGFRA;TMEM47;CCDC80;COL12A1;OLFML2B;SULF1;FBLN2;COL4A1
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.5201312448400196,1.187810927513491,0.23529411764705882,0.632726220801058,1.0,16/59,12.42%,SYT4;RYR3;ADCY8;MEF2C;ADGRV1;SYT1;WNT5A;CPNE8;SYT13;SYT7;DMTN;CAMK2D;TRPM2;GPLD1;CPNE5;ADCY1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.638720237549599,1.187766717867562,0.2916666666666667,0.6323510358502015,1.0,6/16,17.71%,IGF1;NR4A3;CAMK2D;TRPC3;PDE9A;EDN1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.45821826903660917,-1.1875608195181386,0.1791044776119403,0.8598887569500987,1.0,22/251,7.30%,NGF;ARHGEF16;TNFRSF8;DDIT3;RPS27A;RPS3;UBC;SFRP1;PRR7;SAP18;RPS6;UBB;USP27X;PTPA;PTGIS;RACK1;TNFAIP8;SPHK2;MYBBP1A;SOD1;PRMT2;KNG1
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.4653283749683716,-1.187362459637228,0.15789473684210525,0.8593684850941427,1.0,54/180,21.45%,JPT1;STMN1;H2AX;PLK4;PCNA;CDK4;USP1;EXOSC8;RANBP1;POLD3;TUBG1;PSMC3IP;RAN;ASF1B;DCLRE1B;RAD51AP1;HMMR;PNN;CCNB2;KPNA2;PHF5A;H2AZ1;NOP56;POLE4;MCM4;HUS1;CDKN2C;SNRPB;WDR90;MCM3;TUBB;KIF4A;POP7;ILF3;CKS1B;CBX5;TCF19;SMC1A;XRCC6;MTHFD2;SMC6;RFC1;DUT;MELK;CDCA8;UBE2S;PA2G4;DNMT1;PRKDC;DSCC1;PAN2;CDC20;IPO7;SSRP1
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.7455750316736135,1.1873269474471162,0.3018867924528302,0.6326158301628624,1.0,1/5,4.83%,TOX
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.7455750316736135,1.1873269474471162,0.3018867924528302,0.6326158301628624,1.0,1/5,4.83%,TOX
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),0.7805175308783168,1.1872406977668752,0.3142857142857143,0.6323310169621498,1.0,1/5,3.52%,PIK3AP1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.40989861374599257,1.1871302493914397,0.05555555555555555,0.6320764350187703,1.0,62/312,14.77%,CLDN5;TGFB2;PDGFC;CTF1;PDGFB;AQP1;BMP6;PTPRC;KITLG;EGFR;FLT1;IGF1;CSF1R;IL12RB2;MEF2C;CAPN1;PID1;PIM1;NR4A3;PDGFRA;NRG1;TOX;TBX6;ID2;IRS1;LAMC1;PTPN6;NTRK2;WNT5A;SHANK2;STX3;MEIS3;SOX9;IL13RA1;LEF1;LIFR;MEIS2;CRLF1;CHRD;VEGFD;TGFB3;KIF14;BCL2;BST1;TGFA;SPDYA;ZNF304;HES1;CX3CL1;FGF17;ACER2;CR1;LYN;CUL3;CDC7;CDH13;ITGB1BP1;FZD9;MEGF10;VEGFA;RPRD1B;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.45444403156671964,1.1868398855418854,0.12,0.6323672717447808,1.0,26/104,14.34%,RHBDF2;ADCY8;RXFP1;SYK;SRC;MAPKBP1;ADCYAP1R1;GPR176;LILRB1;GNG2;CYSLTR2;VIPR2;ADCY2;CYSLTR1;IRAK3;ADCY7;ADORA2B;ADCY1;LGALS3;PRKAR1B;CR1;LYN;SAMSN1;HAVCR2;P2RY11;HRH2
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.6924792833056497,1.1867138823933139,0.32075471698113206,0.632212093106839,1.0,2/6,15.04%,TIMP4;TIMP3
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.725200544448457,-1.1866346346378824,0.2682926829268293,0.8607317013666527,1.0,2/6,10.80%,GLA;NOSIP
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.643390801283167,1.1866026423249634,0.18,0.6319483600024592,1.0,5/12,21.27%,GPLD1;GRAMD1B;GRAMD1A;GRAMD1C;MLC1
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.7989863031411713,1.1865916120513782,0.24489795918367346,0.6314379699394315,1.0,3/6,13.28%,NRG1;DMPK;RBM24
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),-0.7640904146973111,-1.186434733158823,0.30434782608695654,0.860175343298077,1.0,2/6,11.05%,AMPD1;PFAS
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.7589187342949998,1.1863913311725909,0.22916666666666666,0.6316197340681005,1.0,1/6,10.41%,HTR2C
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.5502647630062821,1.1861652096498128,0.23529411764705882,0.6316729172420507,1.0,10/28,24.62%,ZNF423;CSNK1D;TULP3;RAB29;ARL6;BBS4;SNX10;IFT140;ODAD4;TUB
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.7530376725792056,1.185838865358134,0.18421052631578946,0.6320020680326363,1.0,3/8,17.71%,SLC8A1;EDNRB;EDN1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.4629572897689362,-1.1857805590231358,0.10909090909090909,0.8617634726250023,1.0,79/244,24.05%,ORC1;RPS27A;UBC;TINF2;PARP2;UBB;PCNA;ENDOV;MBD4;POLD3;MGMT;MPG;PARP1;RAN;MUS81;PRIM1;DCLRE1B;RAD51AP1;APEX1;TSN;NOP53;POLD4;KPNA2;DDX21;POLE4;BTG2;PNKP;NUDT1;MCM4;HUS1;NPM1;BLM;UBA52;POLE3;MCM3;POLG;KAT5;TOP3B;TOPBP1;UBE2A;MEN1;ADPRS;HMGB1;PARK7;TRIM28;SMC1A;XRCC6;REXO4;PRIMPOL;TYMS;EXO1;DDX23;ATR;RFC1;MSH3;EXD2;UBE2N;DNMT1;PARP3;PRKDC;NSMCE4A;ATRIP;XPC;RAD9B;RMI2;OGG1;NT5E;MCM6;ENDOG;TERF1;ORC6;THAP9;WDHD1;CHRNA4;SP100;CNBP;SUMO1;RFC2;DDB2
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.7643224671531077,-1.1854182230507266,0.32,0.860604308904241,1.0,1/6,1.22%,CORO1B
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.7643224671531077,-1.1854182230507266,0.32,0.860604308904241,1.0,1/6,1.22%,CORO1B
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.452662698141156,1.18541236320793,0.15789473684210525,0.6328626181794091,1.0,10/85,5.56%,TGFB2;L1CAM;EGFR;SYT4;IGF1;NEDD4L;RIMS2;SYT1;LGI1;TWF2
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),-0.7755264428828543,-1.1852826929126705,0.2916666666666667,0.8598705263323853,1.0,3/7,18.54%,RPUSD2;DKC1;PUS1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.5106679242365308,1.185165480787615,0.19148936170212766,0.633013056650547,1.0,9/46,8.14%,LPL;PTPRC;TLR2;C1QTNF4;SYK;WNT5A;PTPRJ;HSPB1;TIRAP
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),-0.7193152636463761,-1.184902892466649,0.22916666666666666,0.8603184785920341,1.0,2/7,7.86%,LIMA1;SOAT2
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.6055723506443107,-1.1848246713352144,0.16666666666666666,0.8594309594628674,1.0,5/17,16.39%,SERPINE1;KNG1;AJAP1;TFPI;CRK
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.4327452165182349,1.1847096405613,0.12195121951219512,0.633802484922555,1.0,31/119,16.97%,ARHGAP31;CGNL1;ARHGAP10;KALRN;RHOJ;ARHGAP18;OBSCN;SRC;FAM13B;ARHGAP25;RELN;RHOQ;SRGAP1;TIAM2;RHOF;ARHGEF6;FAM13A;ARHGAP17;NGEF;MCF2;ARAP1;ARHGAP28;RAC3;ARAP2;A2M;CHN1;TRIP10;RHOT1;ARAP3;ARHGEF4;ARHGEF7
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.7622966662016151,-1.1846788314427497,0.2692307692307692,0.858726023501952,1.0,4/8,17.69%,NELFE;CTR9;CCNT1;SUPT5H
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.706771685361689,1.1845549978117893,0.2982456140350877,0.6337651893736909,1.0,4/7,15.39%,LRFN5;CD200;HAVCR2;GPER1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.4541119845631828,1.1843747183548454,0.13157894736842105,0.6336886836426192,1.0,19/126,8.93%,MMRN2;AQP1;PLSCR4;BMP6;FSTL1;STAB1;ITGB4;POSTN;LOX;ITGBL1;TMEM47;ROBO4;COL12A1;SULF1;PTPRJ;COL4A1;PXDC1;EPAS1;NTN4
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),0.7953688343593868,1.1841407826953414,0.3333333333333333,0.6339752720011558,1.0,2/5,10.15%,IRGM;GPLD1
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),-0.7249333787978647,-1.184138469650117,0.3125,0.8594493506022,1.0,2/6,21.58%,MSH3;RMI2
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.4541373296848723,1.1839405807506074,0.17391304347826086,0.6340457450266439,1.0,35/124,16.54%,NRCAM;GPM6A;NTNG1;NCKAP1L;MYO16;CTNND2;BAIAP2;PLPPR4;MAP2;LRRK2;DCLK1;PAK3;SLITRK5;SLITRK3;CNTN4;ADGRB1;NYAP1;PACSIN1;EPHB1;CNTNAP1;EPHB3;FLRT1;SLITRK4;DLG4;RAB3A;LRP4;SHANK1;TNIK;ANK3;NYAP2;FARP1;NBL1;CCK;NLGN1;PARD3
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.45931577093344705,1.1838997627749646,0.11904761904761904,0.6336166272206092,1.0,19/73,14.22%,GPM6A;PLPPR5;P2RY12;CARMIL2;CYFIP1;TWF2;RHOQ;TENM1;AGRN;TGFB3;TENM2;CCP110;DOCK11;DPYSL3;CDC42EP4;PIK3R1;ARAP1;CDC42EP3;WASHC1
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.6581796119092951,1.1838563703141567,0.22,0.6331882222348503,1.0,4/12,16.58%,IRS1;ABCD2;ABHD5;PRKCD
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.6079667003309253,-1.1837835797412672,0.14285714285714285,0.8595602354760605,1.0,7/30,14.88%,ORC1;PRIM1;POLE4;MCM4;POLE3;MCM3;TOPBP1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),-0.7258595956103256,-1.1828744905650632,0.35294117647058826,0.8618697863095574,1.0,1/9,5.41%,ACTN2
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.7803153861752811,1.182870730153956,0.35714285714285715,0.6351853102069919,1.0,1/5,7.25%,NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6932227279965457,1.1826131768860575,0.2830188679245283,0.63546946940437,1.0,4/8,15.67%,NEDD4L;CAMK2D;HECW1;PRKCE
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.3969248664335231,1.1819757531841466,0.09090909090909091,0.6368756894649001,1.0,71/305,13.17%,CTF1;IFNA2;CSF2RA;SLA;FOS;TLR2;CHI3L1;CSF1R;F3;IL12RB2;ADAMTS7;IL12A;PID1;PIM1;ITGAM;HGF;INPP5D;SYK;ZEB1;CSF3R;PTPN6;PTPRZ1;LRCH1;NPNT;TNFRSF1B;WNT5A;YBX3;ZFP36;PTPRJ;STX3;PDE1B;SOX9;LRP8;IL13RA1;LEF1;STX1A;LIFR;AXL;MYLK3;ST3GAL6;CRLF1;CCND1;CD4;BCL6;STAT6;SOCS3;VIM;DAPK1;PTPRT;SLA2;IL1RAP;IRGM;IRAK3;TNFRSF1A;ZFAND6;DOCK8;BCL2;TEC;ERBIN;MAPK11;CX3CL1;CNTFR;DPYSL3;IFNK;PIK3R1;CD80;GSDME;PTPN11;SYNCRIP;CEBPD;GHR
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),0.7811186137125389,1.1815552344440656,0.2826086956521739,0.6374993361520395,1.0,2/5,10.41%,PDGFB;HTR2C
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.6674392785524113,-1.181523327424082,0.24489795918367346,0.8646220217631578,1.0,4/9,25.59%,GABARAPL2;MAP1LC3B;BECN1;MAP1LC3B2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.6674392785524113,-1.181523327424082,0.24489795918367346,0.8646220217631578,1.0,4/9,25.59%,GABARAPL2;MAP1LC3B;BECN1;MAP1LC3B2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.7575266500564689,1.1813624279164272,0.23076923076923078,0.6375177612970373,1.0,3/6,17.71%,SLC8A1;EDNRB;EDN1
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6030130120373993,1.1812792184465586,0.19148936170212766,0.6371953629415609,1.0,9/15,23.77%,SLC8A1;CACNA1G;SCN3B;CACNB2;SCN4B;CACNA1C;ATP1A2;SCN1B;CACNA2D1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.7717208568501233,-1.1804248005324154,0.20408163265306123,0.8675571161375644,1.0,3/5,21.47%,GSTM4;GSTM3;ACAA1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.5613712899999965,1.1802104539141516,0.25925925925925924,0.6397337947372793,1.0,12/38,15.92%,NCKAP1L;CARMIL2;BAIAP2;CARMIL1;FCHSD2;SCIN;BAIAP2L1;TENM1;CDC42EP4;CDC42EP3;PRKCE;BIN1
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.6893273867866261,-1.1800395379955226,0.3409090909090909,0.8674299180550975,1.0,1/10,0.21%,TYRP1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.5100048699938531,1.1797066054678746,0.24390243902439024,0.6408682314715504,1.0,6/30,7.52%,SLCO2B1;SLC22A3;SLC26A4;SLC26A9;SLC13A4;SLC26A7
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.4551422844981091,-1.1796036242493784,0.08064516129032258,0.8675760042121363,1.0,33/166,11.85%,TAX1BP3;DDIT3;RPS12;FUCA1;DCXR;RPL18;ATF3;VAMP8;PMM1;PCNA;CCNG1;CLCA2;H1-2;RACK1;H2AJ;NHLH2;PRMT2;BLCAP;CD81;SLC3A2;FDXR;RPL36;ACVR1B;TXNIP;HEXIM1;SLC7A11;BAX;HRAS;TRIAP1;BAK1;BTG2;RPS27L;PDGFA
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),0.6814124616859328,1.1795860529341184,0.2857142857142857,0.6407381255922696,1.0,1/13,0.21%,LPL
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",-0.7770605121237004,-1.1794572720812408,0.26,0.8670344097718695,1.0,3/5,19.58%,TRIR;TOE1;PDE12
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.6893282351508092,1.1791772542809045,0.2391304347826087,0.6412778695316793,1.0,2/12,12.14%,MOV10;GTPBP1
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.7739519491368032,-1.1791586938190606,0.2857142857142857,0.8668256620900725,1.0,2/5,5.76%,AQP9;SLC28A1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.5611804428218041,1.1791139440394314,0.26666666666666666,0.6409149156813847,1.0,7/28,16.73%,IGF1;PID1;SLC4A4;PFKFB3;ARNT;PFKFB2;PPARGC1A
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.5375231604994974,-1.1789429225435055,0.21818181818181817,0.8663221052444456,1.0,7/38,9.44%,RPS27A;UBC;UBB;CNPY3;LACC1;TLR1;S100A1
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.7174845655576086,1.1784960500960044,0.3333333333333333,0.6420543382993361,1.0,5/6,24.25%,IRGM;FYCO1;ADRB2;CALCOCO2;UVRAG
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.6712122826859429,1.1781699071058418,0.2978723404255319,0.6424561370632003,1.0,3/14,9.41%,PLSCR1;XAF1;IRGM
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.6070890939782421,1.178068886707221,0.2857142857142857,0.6421511477520185,1.0,4/19,11.18%,ZNF423;BMPR1B;SULF1;BMPR2
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),-0.7651539626732726,-1.1777123536851422,0.22916666666666666,0.8700441140452729,1.0,2/5,8.27%,CBR1;VKORC1L1
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),-0.7245394564209584,-1.1775534387967619,0.3877551020408163,0.8695374426387111,1.0,3/6,22.92%,PLCE1;GPAM;MOGAT1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.5242760110220309,1.1775193412324216,0.16666666666666666,0.6434703881274537,1.0,2/36,1.03%,CLDN5;CLDN16
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.7766845592609968,1.1773455916457163,0.3269230769230769,0.6433002673094453,1.0,2/5,15.39%,BAIAP3;GPER1
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.592471921042705,-1.1772665714429058,0.2,0.8693498811011177,1.0,3/23,7.04%,CRTAM;TNFRSF21;CD274
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.6489501501188188,-1.1770948468251556,0.2777777777777778,0.8686458652494375,1.0,5/14,12.41%,NUTF2;RBM15B;BANF1;NXT2;NPM1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.5569483730930748,1.1769854362267342,0.19230769230769232,0.6439023630652055,1.0,16/37,14.93%,KCNMA1;KCNJ3;KCNJ4;KCNMB4;KCNIP2;GNG2;ANO6;KCNJ6;KCNMB3;KCNN4;GABBR2;ATP1B2;GABBR1;KCNMB2;KCNH2;WNK2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.7370650719370191,-1.1769465662827023,0.3333333333333333,0.8680259558480279,1.0,2/13,3.59%,ANAPC15;NDC80
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.570556680470725,-1.176858847649236,0.2653061224489796,0.8672085996652756,1.0,5/30,9.66%,TAX1BP3;GOPC;ACTN2;RIC3;RANGRF
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.5644253962329285,1.176838824725885,0.25,0.6438382217836145,1.0,5/25,9.79%,SLC9C2;SLC4A10;SLC4A4;SLC9A9;SLC9A7
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.7595959337864808,1.1765470238165603,0.3125,0.6442365907224031,1.0,3/5,16.25%,NRXN1;LRRC4;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.5008905326535599,1.176490098419622,0.2553191489361702,0.6438450116728861,1.0,7/52,13.68%,VSIR;NEDD4L;DACT1;WNT5A;WWP1;HECW1;APC2
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),-0.743402409590401,-1.176214283567045,0.30357142857142855,0.8685580803345416,1.0,2/6,18.54%,PUSL1;PUS1
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.6908613340978187,-1.1759162915251782,0.3469387755102041,0.8684900357289792,1.0,1/11,4.51%,AADAT
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.566393729569709,-1.175712479719276,0.30303030303030304,0.8680604841971278,1.0,7/24,12.60%,SMYD1;TRMT112;VCPKMT;ANTKMT;CSKMT;KMT5A;METTL18
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.6379840140760856,1.1754539104751902,0.3333333333333333,0.6463201513860075,1.0,2/13,4.57%,MEF2C;NRG1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.641833801859166,1.1752896118072738,0.16666666666666666,0.6462061979222161,1.0,7/13,28.25%,YBX3;CPEB3;RBM24;CPEB4;FMR1;ZNF385A;PKM
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.4679568348419285,1.1752431215777033,0.11363636363636363,0.645823573096322,1.0,29/102,19.34%,RND2;ARHGAP10;WTIP;ANK1;PACSIN1;TPM1;RHOF;FMNL3;PCLO;DIAPH1;CNTNAP1;BRWD3;DMTN;SEMA6A;CSPG5;STRIP2;RAC3;TNIK;PAK5;THY1;BIN1;ARAP3;WDPCP;PALLD;SPRYD3;SH3D19;FGD1;PPP2R3C;ABI2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.7399765481126122,1.1746125860678014,0.2857142857142857,0.6469958351143981,1.0,2/7,14.59%,UBASH3B;CAMK4
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.6508879518965639,1.1744457055659503,0.24528301886792453,0.6469391285108858,1.0,3/16,5.71%,PID1;LZTFL1;RHOQ
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.6614599503265833,-1.1742924182340737,0.2807017543859649,0.8723276378501614,1.0,5/19,14.94%,LCK;SLC39A6;MT1E;MT2A;SLC39A7
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.7413595223614567,1.1741986656202084,0.2608695652173913,0.6470357720311083,1.0,4/6,23.32%,DAPK1;PRKD1;PRKCD;XRCC1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.6337440297903866,-1.1740193600496294,0.3269230769230769,0.8720452011170404,1.0,4/13,18.95%,CDK11A;CDK11B;PTCD2;SRPK3
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.54702699498088,1.1737796522211776,0.2826086956521739,0.6476682255021141,1.0,19/53,17.66%,EPHA4;EFNB3;SPOCK1;RTN4RL2;KIAA0319;NGEF;MCF2;NGFR;TRPV4;DPYSL3;LRP4;RAB29;KANK1;PTPRO;STMN2;BCL11A;THY1;NLGN1;RUFY3
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.6240466239027276,1.1736727388404593,0.2619047619047619,0.6474676651590502,1.0,7/16,14.05%,LRRK2;RIT2;ITPR1;SLA2;BST1;MAPT;CDH13
prerank,"GO_Biological_Process_2021__complement activation, classical pathway (GO:0006958)",0.7758414065245324,1.173666407921188,0.35185185185185186,0.6469521047675479,1.0,4/5,22.29%,C1QB;C1R;C1QA;C1QC
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.713479928816393,1.1735531828744201,0.33962264150943394,0.6466856168105163,1.0,4/8,15.67%,NEDD4L;CAMK2D;HECW1;PRKCE
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.6579610938593778,1.173377261558135,0.20754716981132076,0.6467343751339096,1.0,6/13,18.90%,SYK;PRKCZ;HAVCR2;TNFSF4;NLRP3;PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.3792159556104875,1.173278690708065,0.034482758620689655,0.6464970909089636,1.0,43/401,8.57%,ROR1;TGFB2;PDGFC;PDGFB;CX3CR1;ANGPT1;PTPRC;KITLG;EGFR;FLT1;JCAD;IGF1;TLR2;TRIM5;P2RY12;CHI3L1;F3;PIK3AP1;BIRC3;MET;HGF;PDGFRA;C1QTNF4;RIT2;NRG1;ADGRV1;SRC;IRS1;PTPN6;RELN;NTRK2;ADRA1A;WNT5A;CASP10;PTPRJ;RRAGD;SOX9;C18ORF32;AXL;TIRAP;NR3C2;ZDHHC13;CD4
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.5316575641318728,1.173244138406724,0.26,0.6460411287635698,1.0,8/41,12.92%,PDGFB;PPARG;ANGPT1;MEF2C;HSPB1;PRKD1;AKT3;ANGPT2
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.5850126468172909,-1.1731511704242097,0.3,0.8739711629769262,1.0,6/21,21.29%,SELENOS;PGP;GCK;MST1;FBP1;DGKQ
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.5393464220640635,1.173112945577646,0.25925925925925924,0.6458428547361739,1.0,10/32,16.46%,SEMA3D;MET;PLXNA4;PLXNA2;SEMA6A;SEMA5B;SEMA4G;SEMA4B;SEMA3C;SEMA7A
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.7446256689727621,1.173086200366783,0.3090909090909091,0.6453596295182648,1.0,4/7,13.36%,PTPRB;DUSP10;PTPRT;PTPRO
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.5318631677032395,1.1729628521576039,0.20833333333333334,0.6451242193921215,1.0,12/41,28.81%,ADAMTS9;FBXO17;ISG20;DENND3;SIAH2;MANBA;HNRNPD;OGA;DAB2IP;EXOSC7;RAB12;FBXO2
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.6063983431922766,1.1721819797471187,0.25925925925925924,0.64662653881164,1.0,2/18,2.39%,CD44;CARMIL2
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.6557154863948941,1.1720095215615793,0.3404255319148936,0.6465232927314487,1.0,7/12,12.69%,ADAMTS5;ADAM12;NOS1;JAM2;ADAMTS15;PTGFRN;ERVW-1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.7146180012399023,1.171923405373688,0.35294117647058826,0.6463064714806384,1.0,5/10,15.45%,PKP2;SCN3B;NOS1;ANK3;SCN4B
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.8097863368825912,-1.171870348683502,0.30612244897959184,0.8751928958346027,1.0,2/5,10.73%,SOD1;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.8097863368825912,-1.171870348683502,0.30612244897959184,0.8751928958346027,1.0,2/5,10.73%,SOD1;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.8097863368825912,-1.171870348683502,0.30612244897959184,0.8751928958346027,1.0,2/5,10.73%,SOD1;ERLIN2
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.5305772643995456,1.171792457730984,0.18181818181818182,0.6461562945703089,1.0,8/36,18.42%,YBX3;ZFP36;TIRAP;SYNCRIP;RBM24;NOCT;ELAVL4;E2F1
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.6015638169271658,-1.1716042193456537,0.25862068965517243,0.874873787609325,1.0,4/18,12.11%,EXOSC8;INTS14;TOE1;EXOSC5
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.7813564560038428,1.1714495871756698,0.2653061224489796,0.6464889828632661,1.0,1/5,14.52%,GRHL2
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.574618051270082,1.1713801868626017,0.27906976744186046,0.6461686993707356,1.0,5/22,10.42%,MEF2C;EPHA4;WNT5A;CAMK2B;SLITRK4
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.6572681392700124,-1.1713662907679772,0.2727272727272727,0.8746824874738773,1.0,4/12,27.34%,USP19;EIF2AK3;ALOX5;NR1H2
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.739878653432903,1.171318803967479,0.40816326530612246,0.6458016893784471,1.0,3/6,16.25%,BAIAP3;GPER1;NLGN1
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.6834569366823069,1.171215194980565,0.23529411764705882,0.6456146364104229,1.0,4/9,12.41%,IFNA2;IRAK3;RFTN1;IFNK
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.6167542007098018,1.1711968508291288,0.24074074074074073,0.6451260299019358,1.0,2/12,8.11%,IRS1;ABCD2
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6784502287898537,-1.1710499256766294,0.3137254901960784,0.8744917143360482,1.0,1/8,1.51%,SFRP1
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.7272781536992647,1.1709433868598595,0.29411764705882354,0.6452979805003167,1.0,3/6,18.61%,PLCB1;PLA2G10;GLRA1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.7257955465594887,1.170880805221452,0.2765957446808511,0.644989346985614,1.0,5/8,20.20%,NRXN1;LRRC4;NLGN1;TMEM108;PTEN
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.7383797045217091,-1.1708628259070126,0.32653061224489793,0.8738641944631103,1.0,3/6,15.37%,PGP;GCK;MST1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.7031237054366556,-1.1708078924207277,0.3023255813953488,0.8728476929945443,1.0,2/11,14.96%,SPHK2;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5070574110398649,1.1707446623029272,0.20833333333333334,0.6448600022994467,1.0,9/48,8.14%,LPL;PTPRC;TLR2;C1QTNF4;SYK;WNT5A;PTPRJ;HSPB1;TIRAP
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.4946339764798151,-1.1706510404070471,0.2037037037037037,0.8723274300750978,1.0,30/89,29.30%,SRSF7;RBM15B;SRSF3;SRSF9;RBM8A;RAE1;DHX38;MAGOHB;NUP37;ALYREF;NXT1;FIP1L1;SLU7;NUP210;TPR;CASC3;CDC40;POM121C;SRSF2;NXF1;NUP93;UPF2;NUP42;NUP85;CPSF4;MAGOH;DDX39A;NXF5;MCM3AP;THOC5
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.6882291284583135,-1.1697714464785627,0.20930232558139536,0.8743526807036399,1.0,5/11,24.04%,TALDO1;TKT;PGLS;G6PD;RPIA
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.7085231691545171,-1.16969877276643,0.32,0.8734197919375429,1.0,4/7,16.19%,VAMP8;CALM1;SNAP29;ATG14
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.40939163617054986,1.1696337159435544,0.10256410256410256,0.647777369727293,1.0,18/220,6.32%,KLRF2;LPL;PTPRC;TLR2;CHI3L1;CSF1R;F3;IL12RB2;IL12A;ISG15;PLCB1;C1QTNF4;C5;SYK;PRKCZ;WNT5A;SULF1;LILRB1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.6556895949558648,1.1696228206734092,0.21568627450980393,0.6468013820581024,1.0,8/14,19.64%,SORBS1;SRC;FHDC1;CUL3;PHACTR1;KCTD13;ZYX;ARRB1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.6556895949558648,1.1696228206734092,0.21568627450980393,0.6468013820581024,1.0,8/14,19.64%,SORBS1;SRC;FHDC1;CUL3;PHACTR1;KCTD13;ZYX;ARRB1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.6588363249397106,-1.1694577159421446,0.35294117647058826,0.8731523076890907,1.0,7/15,22.16%,CHMP2A;RHOA;CHMP5;CHMP3;CHMP7;CNTROB;CEP55
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.6126313809234609,-1.169368978341428,0.27419354838709675,0.8722806667091022,1.0,3/20,15.45%,PTPA;PPP1R35;SH3RF2
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.613401462662339,-1.1691472779557839,0.25862068965517243,0.8719242840015923,1.0,6/16,16.27%,SLC25A4;SLC25A5;ALKBH7;BAK1;THEM4;BAD
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),0.7472795487792635,1.1691372522288694,0.2826086956521739,0.6476184205644333,1.0,4/5,21.85%,MYLK3;EDN1;CAV3;AKAP13
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.6363632448167457,1.1689664437485239,0.2619047619047619,0.6476843291805909,1.0,1/18,1.32%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.7441685119005526,1.1688265891004956,0.25,0.6475909208184847,1.0,2/8,15.94%,SPRED3;NNMT
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.5104469190113974,-1.1687861802469621,0.25,0.8721493478620544,1.0,5/75,7.50%,ARHGEF16;TAX1BP3;RHOG;TBC1D16;RASGRF1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.4391850486086164,-1.1686121082540026,0.15254237288135594,0.8715326840289674,1.0,41/294,15.96%,DDIT3;RPS27A;UBC;SELENOS;RAD23A;UBB;ANAPC15;SEC61B;UBXN4;PSMB6;PSMD7;DMAC2;UBXN1;PSME2;PSMD8;HECTD3;CDC23;CDC26;PSMB4;FBXO48;UBQLN2;USP19;TMEM129;PSMD3;PSMB3;PSME1;ERLIN2;ZFAND2A;UBA52;KAT5;PSMA7;KLHL20;SPSB3;PSMB8;PSMD13;FEM1A;ZFAND2B;ERCC8;UBE2A;PSMD2;RNF126
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.6449955115460034,1.1685653982865005,0.25,0.6477877583596839,1.0,3/16,13.89%,PID1;RHOQ;BCL2L1
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.6907594697836619,1.168415850510806,0.3076923076923077,0.6476850656206795,1.0,6/8,16.65%,NTNG1;NTN4;LAMB4;LAMB2;LAMB1;PXDN
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.46468257214380126,1.1683801674994938,0.23809523809523808,0.6473022414878429,1.0,15/104,8.48%,TGFB2;PKP2;PDGFB;FGF12;MEF2C;FLRT2;KAT2B;PDLIM7;CITED2;ID2;SGCZ;TBX19;KDM6A;SOX9;NDRG4
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),0.5564367472966679,1.1683223849736468,0.2786885245901639,0.646864009616215,1.0,2/27,4.93%,ZNF366;CITED2
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.5721141872088457,-1.168317206166217,0.21739130434782608,0.8713717340914495,1.0,8/27,18.02%,DPM3;PGAP2;PIGO;PGAP4;PIGF;PIGW;DPM2;GPAA1
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),0.8131716019592101,1.1680404919537937,0.3148148148148148,0.647098112692477,1.0,4/5,16.00%,SLC22A3;PICK1;SLC6A4;SLC29A4
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.5602860921581246,-1.1679595568797525,0.22,0.8715512892486484,1.0,5/43,5.33%,RPS27A;UBC;UBB;PCNA;POLD3
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.7702355385595954,1.1679035638972166,0.2391304347826087,0.6469496857006559,1.0,1/6,4.07%,NR4A3
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.410676550022883,1.1676786274598578,0.1111111111111111,0.6471554101290546,1.0,42/226,10.88%,LPL;EPHA3;PDGFB;AQP1;CX3CR1;SSTR1;EGFR;KCNC2;FOS;TLR2;P2RY12;RYR3;BRINP3;MEF2C;PID1;NR4A3;PDGFRA;HCN1;ABCB4;IRS1;TWF2;TNFRSF1B;WNT5A;LILRB1;GNG2;ZFP36;TPM1;WNT8B;RRAGD;SOX9;AXL;TIRAP;TESC;GIT1;VIM;DAPK1;BRINP1;IRGM;DMTN;GPLD1;P2RY1;PRKD1
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.7696510990022275,-1.167645237776039,0.28205128205128205,0.8714926323458575,1.0,2/5,17.97%,PHB2;OAS3
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.5590363305136758,-1.1675079130391004,0.26,0.8706880043913747,1.0,5/42,5.33%,RPS27A;UBC;UBB;PCNA;POLD3
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.7204666855395625,1.167239824801011,0.3191489361702128,0.6477795904506557,1.0,3/6,20.39%,FZD3;BCL2L1;PAK2
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.7016319398221385,-1.167147708970829,0.38461538461538464,0.8709129142659359,1.0,4/6,25.30%,DKC1;NHP2;MEPCE;NOP10
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.6959703854214598,1.166203246614603,0.3541666666666667,0.6501788748012735,1.0,3/9,5.89%,DENND1B;PRKCZ;RSAD2
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.6073247938861164,-1.1661081152679396,0.29411764705882354,0.8734033968391837,1.0,4/21,21.70%,FIS1;BAX;VPS11;AFG3L2
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),-0.7287934931576562,-1.1660643927861345,0.2978723404255319,0.8724755932059578,1.0,3/8,13.28%,SERPINE1;KNG1;TFPI
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.6606151739195143,1.1660524013874485,0.32608695652173914,0.6501306936080818,1.0,3/7,24.66%,BCL2L1;TRIM27;SERPINB9
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.6421850531816812,-1.166039678574175,0.25862068965517243,0.871415353098614,1.0,5/21,14.94%,LCK;SLC39A6;MT1E;MT2A;SLC39A7
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.5519555383032021,1.166019962109415,0.25,0.6497297871743799,1.0,3/21,5.56%,CARMIL2;CYFIP1;TWF2
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.5035335449406804,1.1659334935748282,0.21739130434782608,0.64946866605518,1.0,8/34,12.34%,CERS3;CERS6;ST8SIA3;B4GALT6;ST8SIA4;ST8SIA6;ST6GALNAC5;PNPLA1
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.752166122586243,1.1656812152427232,0.3220338983050847,0.6496528981690245,1.0,3/6,24.00%,ATCAY;PRUNE2;PRUNE1
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.7493488643978893,1.165646376483995,0.28846153846153844,0.6492347882053436,1.0,4/5,24.61%,TOX;OPHN1;CHD5;ASCL1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.44835542397069555,1.1655654617558726,0.16666666666666666,0.6489191408863846,1.0,20/85,13.36%,CLDN5;MCTP1;EPHA4;DACH1;TMIGD3;CITED2;SRGAP1;FBLN1;SULF1;TPM1;PTPRJ;DUSP10;CHRD;PTPRT;ROBO1;CX3CL1;NGFR;DPYSL3;KANK1;ZMYND8
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.7353701369961608,1.1653489031258166,0.21212121212121213,0.6490201402740887,1.0,1/9,3.53%,DNAJB1
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.5351096457412381,-1.165213258942994,0.2631578947368421,0.8736368626795946,1.0,7/44,11.13%,TAX1BP3;CFL1;RHOG;CDC42EP5;CDC42EP1;RHOA;ARHGDIA
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.7198145604437023,-1.1652129274636944,0.3018867924528302,0.8724657676894074,1.0,2/7,4.77%,SCN11A;SPX
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.669481130633643,-1.1651429040834196,0.2682926829268293,0.8716449789178825,1.0,1/15,1.40%,BUB1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.5626108390107941,-1.1649523076382744,0.14634146341463414,0.8711954595628973,1.0,4/29,4.80%,ACSM6;DBI;GLYAT;ACOT1
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.5786528846542711,-1.164949669163717,0.32608695652173914,0.8700323147570724,1.0,1/20,0.32%,PDE3A
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.6094223356426136,1.1648185578234884,0.2608695652173913,0.6498509847549087,1.0,6/18,16.97%,ACTN1;SORBS1;SRC;THY1;PTPRK;ARHGEF7
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.7886105133778769,1.1646211471933765,0.34,0.6498495291508829,1.0,2/5,16.46%,KDM6A;KDM6B
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.4292124112889461,1.1645576290975272,0.11904761904761904,0.6494421283659594,1.0,11/111,8.12%,MX1;STAB1;MRC1;ITGAM;SYK;PDLIM7;FCHSD2;LILRB1;ARRB2;DNM1;SFTPD
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.47281992608192136,1.1640275247182996,0.14893617021276595,0.6504181940654437,1.0,9/73,10.99%,PCSK4;SRGN;MMP16;PCSK2;F3;TSPAN14;TESC;TASP1;AEBP1
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.633899737470992,-1.1638814521716272,0.25,0.8727651085662453,1.0,5/12,19.80%,NOC2L;SPHK2;TAF7;THAP7;SET
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.7504513139105494,-1.163832146531981,0.27450980392156865,0.8717366441660378,1.0,1/6,5.55%,EIF2AK1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.6696989231225542,1.163723319435395,0.2692307692307692,0.6506926479458602,1.0,3/11,8.81%,RELN;LOXL3;VIT
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.6598572688830987,1.163717962699428,0.2708333333333333,0.6496859316355909,1.0,7/13,17.86%,RAB27B;MREG;BBS2;ARL6;SHROOM2;MKKS;BBS4
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.6598572688830987,1.163717962699428,0.2708333333333333,0.6496859316355909,1.0,7/13,17.86%,RAB27B;MREG;BBS2;ARL6;SHROOM2;MKKS;BBS4
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.627433669503911,1.163542196323787,0.2545454545454545,0.6496754214951428,1.0,6/16,11.77%,CBARP;CACNB1;NOS1;DIAPH1;CAMK2D;UBASH3B
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.3904712502138866,1.1633240623719072,0.05405405405405406,0.6496649277383898,1.0,81/363,12.49%,CHRM3;L1CAM;PDGFC;NAGLU;NPAS2;NRCAM;IL1RAPL2;ROBO2;GPM6A;RPS6KA6;DCX;FGF12;KALRN;PCDHB12;VCAN;NHEJ1;GRIK1;MEF2C;NRXN1;CHST8;DCLK1;LDB2;MET;EFNB3;NRG1;ADGRV1;NELL1;GFRA1;EFNA5;DACT1;FGF13;TBX6;CNTN4;LGI1;ADGRB1;SCN2A;PTPRZ1;RELN;SPOCK1;SCIN;MERTK;NRGN;EPHB1;WNT8B;SHANK2;NPTX1;GDA;ST8SIA4;NMUR2;TEAD1;ATXN1;TENM1;AXL;GLRB;ACVR1C;ZBTB16;SH3GL2;IGF2BP2;NRSN1;WWP1;EMX1;KCNQ2;FAT4;NCAN;EDNRB;SEMA6A;NRSN2;NAIP;ROBO1;FABP7;DLG4;MYT1L;CHRM1;HES1;FGF17;PCDHB13;NPAS1;CSPG5;CNTFR;SRRM4;ASIC2
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.6778816770572105,-1.1632913030220757,0.3148148148148148,0.8725909715747143,1.0,1/10,4.77%,SPX
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),0.5767984089524923,1.1630648432038295,0.2765957446808511,0.6498930206256147,1.0,1/22,0.21%,LPL
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5037913114021614,1.162875700409194,0.2708333333333333,0.6499465543439124,1.0,21/61,15.90%,ADGRE2;ADCY8;RXFP1;GPR161;CNR1;ADGRB1;PTGER3;ADRA1A;ADGRG1;GNG2;ADGRL2;GNAL;ADCY2;GPR26;ADCY7;GPR12;ADCY1;ABCA1;GPER1;CALCB;ADRB2
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),-0.74820676858223,-1.162657254222576,0.18867924528301888,0.8737096655613501,1.0,2/6,10.84%,SPX;SRI
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.6446556926720738,1.1624269569987102,0.32653061224489793,0.6508153792359489,1.0,4/12,12.14%,LRRK2;RHOQ;AK4;GTPBP1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.5130300682569486,1.1620671310331403,0.21052631578947367,0.6514997661337995,1.0,4/31,5.26%,PDGFB;IGF1;NR4A3;ID2
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.6550593163779579,-1.1619529661928274,0.3125,0.8749696283163829,1.0,4/10,18.72%,SMPD2;ABCA8;SMPDL3A;SMPD1
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),0.7805309921979621,1.1617658139389977,0.2830188679245283,0.6518720826460574,1.0,1/6,0.47%,TEX15
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.5949760778164527,1.1616844751987687,0.2682926829268293,0.6516222886860739,1.0,5/13,10.68%,ST8SIA3;B4GALT6;ST8SIA4;ST8SIA6;ST6GALNAC5
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5478298752949582,1.1615907189822592,0.1951219512195122,0.6513637489008834,1.0,9/33,17.87%,CHI3L1;SPRED3;PLK1;IRGM;DMTN;RPTOR;PARD3;DDIT4;PRKAG2
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.7194538247910487,-1.1614765225906527,0.33962264150943394,0.8734360586975406,1.0,3/6,17.62%,TMED9;TMED2;GBF1
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.7194538247910487,-1.1614765225906527,0.33962264150943394,0.8734360586975406,1.0,3/6,17.62%,TMED9;TMED2;GBF1
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.7194538247910487,-1.1614765225906527,0.33962264150943394,0.8734360586975406,1.0,3/6,17.62%,TMED9;TMED2;GBF1
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.7454856200167899,1.161225196900508,0.35294117647058826,0.6513038182163741,1.0,3/6,23.34%,CNTNAP1;PARD3;NF1
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.7454856200167899,1.161225196900508,0.35294117647058826,0.6513038182163741,1.0,3/6,23.34%,CNTNAP1;PARD3;NF1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.5505848064717717,-1.1612103643842728,0.2962962962962963,0.8732770567468555,1.0,6/26,17.61%,SLC25A1;ELOVL1;HSD17B12;FASN;ACSF3;HSD17B8
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.6356948434232259,1.1612040995194925,0.2765957446808511,0.6508821101759361,1.0,8/16,14.70%,ADCY8;CAMK1D;RELN;LRP8;PRKD1;CD200;ADCY1;VEGFA
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.7724422977163367,1.1611868370375105,0.27906976744186046,0.6503973198318074,1.0,2/6,15.03%,RIT2;ABCA1
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.6122193155678716,-1.161122420280056,0.2962962962962963,0.8723800000089632,1.0,1/15,0.29%,CXCR4
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7738896367788827,1.1610727751289303,0.3333333333333333,0.6502317025888157,1.0,1/5,5.19%,SRC
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.6824559782523703,1.161012008272269,0.41509433962264153,0.6499663419103937,1.0,2/5,8.14%,TLR2;TIRAP
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),0.7852036471683075,1.1608530105375392,0.23255813953488372,0.6498194799621441,1.0,4/5,16.88%,EPHB1;SCN1A;TMEM120A;MMP24
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.5994931445043026,-1.1607820710542576,0.24489795918367346,0.8723769109494213,1.0,3/15,15.23%,AMPD1;PFAS;IMPDH2
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),0.7799115795916047,1.1606055458015618,0.2916666666666667,0.6499179182370742,1.0,1/6,3.54%,LRRK2
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.6286102334180751,-1.160312195676893,0.28,0.8729344745050744,1.0,1/16,0.59%,KLK6
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,0.466824280053722,1.160302988076164,0.20512820512820512,0.650170391973801,1.0,25/75,12.97%,LAMP5;SLA;PTPRC;NCKAP1L;SELL;TNFSF13B;IKZF1;LCP2;ITGAM;CD53;ARHGAP25;LILRB1;PACSIN1;BLNK;WDFY4;LY86;ETV6;CD4;LAPTM5;DOCK8;MCTP2;AOAH;SASH3;CD80;CCR9
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.6308662382430115,-1.1602727663681816,0.29411764705882354,0.8719096558360077,1.0,3/16,8.27%,CBR1;LRAT;VKORC1L1
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.7491720326400795,-1.1602456799699026,0.25806451612903225,0.8708984876684773,1.0,1/7,6.14%,USH1C
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.5173106994542576,1.1602265753756982,0.22448979591836735,0.6498062036234753,1.0,6/38,6.15%,PDGFC;PDGFB;AQP1;IGF1;PDGFRA;WNT5A
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.6049475881767146,1.1601902959694572,0.3269230769230769,0.6493610721945718,1.0,4/13,9.79%,NEDD4L;LRRK2;SCN3B;CAMK2D
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.6092104226247248,1.160183634019705,0.3,0.6488804288248935,1.0,5/15,20.20%,IGF1;ZFP36L1;GAS6;KDR;PTEN
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),0.7726769830119582,1.159963831057156,0.34,0.6490515459020155,1.0,2/5,17.99%,TRPV4;SLC12A5
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),0.7704956217227743,1.1598869176895434,0.3018867924528302,0.6482193371296449,1.0,3/5,18.53%,PRKCZ;TNFSF4;NLRP3
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.7704956217227743,1.1598869176895434,0.3018867924528302,0.6482193371296449,1.0,3/5,18.53%,PRKCZ;TNFSF4;NLRP3
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.6819586476934597,-1.159666591677458,0.36538461538461536,0.8717295435225192,1.0,1/10,8.34%,PRPSAP2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.7113899036819803,1.1596160720125712,0.2727272727272727,0.6484266521778317,1.0,2/5,23.90%,AMER1;GSK3B
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.6393655031232689,1.159462915785621,0.2962962962962963,0.6482911062293158,1.0,6/15,17.87%,NR4A3;ACADL;SOX9;PDK4;PPARGC1A;PRKAG2
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.7357642285427195,1.1593769336366986,0.2962962962962963,0.6479936340178309,1.0,2/5,22.86%,TSG101;SDCBP
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.6517188796576894,1.1593315931358004,0.28846153846153844,0.6476606141628596,1.0,3/10,13.67%,SULT4A1;SULT2A1;SULT2B1
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.6072295202362391,-1.1592344265368006,0.27450980392156865,0.8719460359119555,1.0,2/19,1.20%,LCK;RPS3
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.6093912025829449,-1.1592301007353438,0.2553191489361702,0.8708186464333945,1.0,4/28,7.70%,LCK;RPS3;PHPT1;CD81
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.7628687367244883,-1.1590604478897089,0.3541666666666667,0.870239548409419,1.0,3/6,22.84%,TXNIP;BLM;ORC6
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.7106228740818822,1.159006382026043,0.27450980392156865,0.648083570677653,1.0,4/7,25.21%,CPEB3;RBM24;CPEB4;FMR1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.5457136962175198,1.1587166424433695,0.32653061224489793,0.6484789215323856,1.0,6/19,13.03%,IGF1;SORBS1;IRS1;RHOQ;PIK3R1;PTPN11
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.7102371123870458,1.1585111755722168,0.3958333333333333,0.6480564458358483,1.0,1/6,0.95%,PPARG
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.7102371123870458,1.1585111755722168,0.3958333333333333,0.6480564458358483,1.0,1/6,0.95%,PPARG
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.6577736168690651,1.1584937497333931,0.2641509433962264,0.6476170499216811,1.0,4/8,10.69%,RYR3;SLC8A1;TRPM2;P2RY1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.4821588157819019,-1.1584427280061493,0.2857142857142857,0.8711978478309782,1.0,18/105,10.42%,RPS27A;UBC;SFRP1;UBB;ACAA2;PSMB6;PSMD7;PSME2;PSMD8;PTGIS;ELOC;OPRD1;ELOB;PSMB4;NOP53;PSMD3;PSMB3;PSME1
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.6413011872640916,-1.1582839328966474,0.3392857142857143,0.8707394281468294,1.0,3/12,20.87%,BACE2;NCSTN;BACE1
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.6137797340293394,-1.158273562899347,0.203125,0.86966292041764,1.0,4/20,12.46%,PTPA;PPP1R1B;YWHAB;PPP1R11
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.45770908364143775,-1.1576317765669466,0.1694915254237288,0.8708569487977978,1.0,20/186,9.46%,TUBA1A;NES;PKMYT1;SSNA1;PLK4;CDK4;DYNLL1;CCNG1;TUBB4B;TUBG1;TUBB4A;DCTN3;USH1C;KDM8;CHMP2A;CDC23;CCNB3;CEP131;CCNB2;ACVR1B
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.6507230681453484,1.157603706473137,0.32653061224489793,0.6489068054832885,1.0,6/12,17.86%,RAB27B;MREG;BBS2;ARL6;MKKS;BBS4
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.6507230681453484,1.157603706473137,0.32653061224489793,0.6489068054832885,1.0,6/12,17.86%,RAB27B;MREG;BBS2;ARL6;MKKS;BBS4
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.6128606607290699,-1.1575313784826402,0.2542372881355932,0.8700864967216723,1.0,5/13,18.73%,UQCRFS1;ETFRF1;ETFB;NDUFA5;ETFA
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.7067227854739568,1.1574404042526238,0.30434782608695654,0.6488703286562482,1.0,2/10,13.55%,PID1;ZDHHC6
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.7161709808451279,1.157335665390267,0.32075471698113206,0.6487623945713629,1.0,1/7,0.33%,TGFB2
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),-0.7226681814164088,-1.1571580453312915,0.35294117647058826,0.8700647818799735,1.0,1/6,0.48%,ZDHHC12
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.4875662241064142,-1.1571513835577962,0.21153846153846154,0.868951475566607,1.0,18/72,17.48%,PSMB6;PSMD7;AP2S1;PSME2;PSMD8;PFN1;PSMB4;RHOA;PSMD3;PSMB3;PSME1;PSMA7;RAC1;PSMB8;PSMD13;PSMD2;PSMC5;CDC42
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.7338220551343813,1.1570116840289177,0.29411764705882354,0.6491994943885305,1.0,5/9,19.46%,PPARG;RARB;RXRG;RXRA;RARG
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.39374859971170373,1.1567147222182468,0.16666666666666666,0.6493503149044798,1.0,42/261,16.02%,CREB3L1;CLDN5;TGFB2;IFNA2;PDGFB;SRGN;IGF1;PARP14;ENC1;MEF2C;KAT2B;CITED2;ID2;SLC24A3;ZFP36;AEBP2;SH3GL2;IGF2BP2;DAPK1;ZNF540;MOV10;ROBO1;RNF139;MAPT;PHF19;PARP9;NANOS3;CPEB3;HELLS;SYNCRIP;OLFM1;HAVCR2;RBMS3;SHMT1;ZNF148;VEGFA;SFMBT2;GPER1;NOCT;TCEAL1;NOS2;TIPARP
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.7204367473608607,-1.1565541275772964,0.30357142857142855,0.8698596036275922,1.0,4/9,17.69%,NELFE;CTR9;CCNT1;SUPT5H
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.576825779094494,-1.1560610955248816,0.24489795918367346,0.8703233892081335,1.0,7/24,14.83%,DPM3;PGAP2;PIGO;PGAP4;PIGF;PIGW;DPM2
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.6996004945406087,1.1557551384513975,0.37254901960784315,0.651445200136679,1.0,1/9,2.17%,PPP1R3C
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.6522462846735129,1.1556761061526966,0.3023255813953488,0.651130668252108,1.0,2/12,7.89%,SLC8A1;DMD
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.6881149716576889,1.1556333819780262,0.3617021276595745,0.6507186536290376,1.0,3/9,16.25%,WNT5A;NLGN4X;NLGN1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.7382055365047753,1.1548008583087899,0.3269230769230769,0.6512011714082112,1.0,3/5,22.49%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.7382055365047753,1.1548008583087899,0.3269230769230769,0.6512011714082112,1.0,3/5,22.49%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.7382055365047753,1.1548008583087899,0.3269230769230769,0.6512011714082112,1.0,3/5,22.49%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.6541552044059594,-1.1547780872741786,0.3508771929824561,0.8733053795982533,1.0,2/14,0.93%,CRTAM;PRELID1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.620183733574432,-1.1547311110795049,0.3333333333333333,0.8723119129715339,1.0,5/13,22.16%,CHMP2A;CHMP5;CHMP3;CHMP7;CEP55
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.41291713353149034,1.1546737977152823,0.13157894736842105,0.6510922128802304,1.0,35/206,15.52%,IGFBP3;ANGPT1;EGFR;CSF1R;GRM5;LRRK2;PID1;HGF;EFNA5;TSPYL2;NTRK2;FBLN1;KDM4D;SOX9;BMPER;HSPB1;SH3GL2;CCND1;CD4;KNDC1;VEGFD;IRGM;C3;CORO1C;P2RY1;BST1;CSNK1D;FGF17;LYN;TNIK;VEGFA;NTRK3;SESN2;GPER1;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),0.6059692349625265,1.1544767179367996,0.3076923076923077,0.6510455207935995,1.0,3/11,8.45%,CBARP;LILRB1;NOS1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.7500726408974236,-1.1543767199292654,0.34545454545454546,0.8723089866580365,1.0,2/7,1.96%,RPS21;RPP40
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),-0.7954734990515364,-1.1543580623279446,0.3090909090909091,0.8700858723456396,1.0,2/5,12.94%,CCT2;DKC1
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),-0.7954734990515364,-1.1543580623279446,0.3090909090909091,0.8700858723456396,1.0,2/5,12.94%,CCT2;DKC1
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.49011768619997753,1.1541964371408036,0.17647058823529413,0.6513623675964174,1.0,10/47,14.70%,EGFR;ACTN1;ARHGAP18;NRG1;DIAPH1;ZSWIM6;ARAP1;LYN;FES;VEGFA
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.6854020758038277,1.1536045275639806,0.2545454545454545,0.6523076859626934,1.0,2/12,6.71%,IMPA2;NUDT3
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.7726439148168758,1.1533096014731334,0.2765957446808511,0.6525168871697072,1.0,3/6,16.25%,SLC25A19;ABCC11;ABCC5
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5512677015571035,-1.153154059933789,0.2641509433962264,0.8730277043908022,1.0,16/38,18.06%,POLR2L;POLR2G;POLR2K;POLR2I;GTF2F1;POLR2A;HEXIM1;POLR2E;NELFE;POLR2C;POLR2D;TRIM14;NELFCD;CCNT1;SUPT5H;POLR2J
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.6599269645224227,1.1525305228321399,0.3148148148148148,0.6543355864555976,1.0,2/10,8.17%,ALDH8A1;RDH13
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.5716793323839726,-1.1525078119804664,0.2833333333333333,0.8740922946127518,1.0,4/24,6.73%,JUP;RBM22;HYAL2;RAN
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),0.7398487950227794,1.1519534979518242,0.32608695652173914,0.6555240244724883,1.0,2/5,15.90%,ADGRV1;ADRB2
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.5692662645402612,1.1517763448638725,0.20634920634920634,0.6554477246149557,1.0,8/23,17.87%,CX3CR1;TNFRSF1B;C3;PRKAB2;PDK4;ADIPOR2;SIRT5;PRKAG2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.6928612411684646,1.1517496399805442,0.3409090909090909,0.655009704008218,1.0,3/7,12.58%,PDGFB;GRM6;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.75685041909789,1.1517410759133024,0.28846153846153844,0.6545370645627578,1.0,1/5,14.70%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.7105085026058499,1.1516864948383123,0.32,0.6541620646129553,1.0,4/8,21.23%,ANO6;GPER1;PLCG1;RGCC
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.6060714857455278,-1.1516505052822044,0.32142857142857145,0.8759651293053079,1.0,4/23,8.40%,ANAPC15;RIOK2;CDC23;NEK6
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.763522695418474,1.1515800782726395,0.3191489361702128,0.6538844852361749,1.0,1/5,5.13%,FGF13
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.7337919578231368,1.1512835330468933,0.3125,0.6541968455322931,1.0,2/5,13.89%,RSAD2;CDH26
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.654435487454,1.151203690802576,0.3488372093023256,0.6539108621819287,1.0,3/12,17.65%,MCTP1;ACOX2;MACROH2A1
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.6073021358215297,1.150982013188197,0.3392857142857143,0.6539415926678217,1.0,5/14,18.67%,ITGB4;TBX19;BMPR2;KDM6B;SCX
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.5750213988981886,1.150854290871127,0.2777777777777778,0.6538581476003253,1.0,6/24,13.54%,MGST1;SLC26A4;SLC13A4;SLC26A7;SLC35F3;SLC25A19
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.662345090987515,-1.1507427038884381,0.3333333333333333,0.8781742144199141,1.0,3/12,5.89%,PARP2;PARP12;PARP1
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.6934774698585745,-1.150680801010023,0.2962962962962963,0.8772272384796181,1.0,6/13,20.22%,ISCA2;CIAO2B;CIAO1;GLRX5;NFU1;ISCA1
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.7960463186728403,1.1502721448727076,0.3333333333333333,0.6549503652406853,1.0,4/5,20.20%,LRRK2;NLGN4X;TMEM25;PTEN
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.6598222035445035,-1.1501393232882526,0.2826086956521739,0.8781003741708714,1.0,3/14,9.18%,DECR2;CROT;EHHADH
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.6950110896192128,1.1500417151561497,0.3584905660377358,0.6552344719737119,1.0,3/10,7.83%,SNAP25;STX3;STX1A
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.5230852479814365,1.1499550312863418,0.3023255813953488,0.6549312610288769,1.0,3/25,3.54%,VSIR;PRSS12;TBC1D10A
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.5953184646321958,1.1496478699355517,0.2962962962962963,0.6551887004390474,1.0,3/18,7.61%,MYO7A;MYO1B;MYO5C
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.5441065981564364,1.149453148882396,0.28,0.6553320514969557,1.0,5/25,15.43%,ZMYND10;DNAH7;ODAD3;DNAI2;DNAAF1
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.4601936182640338,1.149385533985286,0.25,0.6549682620181847,1.0,11/86,6.93%,CLDN5;PKP2;CDH9;NRCAM;GPM6A;CDH10;CTNND2;NRXN1;CDH18;CDH22;SHANK2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.7409748218714614,1.1493810603078516,0.375,0.6545002080099231,1.0,1/6,10.21%,ARNT
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.7415267263131978,1.1491569564787942,0.37254901960784315,0.6546350233173268,1.0,1/5,6.56%,YBX3
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.7022118943853234,1.149147144510359,0.30612244897959184,0.6541940710514986,1.0,2/8,6.65%,CX3CR1;ZFP36
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.5828282828182392,-1.1487036874856127,0.32142857142857145,0.8820394231618734,1.0,2/18,3.66%,GREM1;EPHB4
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.7216146405065452,-1.148650034407575,0.28,0.8810911490201564,1.0,2/10,3.88%,DCTD;ERH
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.550758497041141,-1.1484318906527953,0.29411764705882354,0.8807065184240043,1.0,16/39,26.11%,SARS1;AARS1;TARS1;AIMP1;HARS2;NARS1;EPRS1;EARS2;VARS1;TARS2;AARS2;KARS1;FARSB;RARS1;FARSA;QARS1
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.7481002997488817,-1.1483190141091262,0.32075471698113206,0.879899816333319,1.0,4/8,5.39%,NES;CFL2;SEMA5A;KATNB1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.5834993328276573,-1.1482221570923021,0.22916666666666666,0.8792113415821003,1.0,7/28,14.37%,VPS25;CHMP2A;VPS28;CHMP5;SNF8;CHMP3;HGS
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5676045817695892,-1.1481565876399127,0.33962264150943394,0.8783347135313693,1.0,12/26,28.76%,UBL5;ABLIM3;TOMM7;VPS11;UBE2L3;PINK1;CSNK2A2;HPS4;PDCD5;BAP1;UBE2J2;HTRA2
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.7744429192671098,-1.1480978860107813,0.3333333333333333,0.8774286851910903,1.0,3/6,19.98%,YBX1;SSB;DDX1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.6399831859408955,-1.1479312943869835,0.28,0.8768932372198399,1.0,4/12,8.48%,SFRP1;GREM1;ATRAID;RHOA
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.49171543656401684,1.1478598103456936,0.18,0.6570303392152017,1.0,7/73,2.38%,VSIR;PRSS12;PCSK4;SRGN;MMP16;PCSK2;F3
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.6895395361249383,-1.1477916813867814,0.37254901960784315,0.8762960765902191,1.0,1/10,3.69%,FLII
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.5926519526921035,1.147762939780344,0.2692307692307692,0.6567624251144641,1.0,2/17,3.11%,NEDD4L;FAP
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.6691674544320847,-1.1477477433964196,0.29411764705882354,0.8752490657998563,1.0,4/11,19.80%,NOC2L;TAF7;THAP7;SET
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.5544221593352542,-1.1477043613383218,0.2777777777777778,0.8743619290089844,1.0,14/35,26.11%,SARS1;AARS1;TARS1;AIMP1;HARS2;NARS1;EPRS1;VARS1;KARS1;QRSL1;FARSB;RARS1;FARSA;QARS1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.6904615836037316,1.1476945920192851,0.20833333333333334,0.6559843237147431,1.0,3/10,16.08%,RRAGD;SESN2;RPTOR
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.6904615836037316,1.1476945920192851,0.20833333333333334,0.6559843237147431,1.0,3/10,16.08%,RRAGD;SESN2;RPTOR
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.5304149185053487,1.1475489165693327,0.19047619047619047,0.6558220365956006,1.0,8/43,15.50%,IGFBP3;MCTP1;DDAH1;MAP2K5;UBASH3B;AKT3;LYN;THY1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.6061070405821034,1.1474760793920977,0.3076923076923077,0.6556078956515636,1.0,3/18,6.32%,PTPRC;IL12A;LILRB1
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.6987879417403293,1.1468824503701591,0.4222222222222222,0.6564958935082242,1.0,2/6,20.33%,CAV3;TCAP
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.694610489707445,-1.1468811957406253,0.28205128205128205,0.8761155049813173,1.0,2/8,6.63%,GSTP1;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),0.7293342911783306,1.1468547409208827,0.375,0.6560561676941514,1.0,2/6,13.42%,ANO6;TRPC6
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.6931630046426525,-1.1467122503346896,0.3617021276595745,0.8747843639169504,1.0,2/6,12.98%,MCM4;MCM3
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.6931630046426525,-1.1467122503346896,0.3617021276595745,0.8747843639169504,1.0,2/6,12.98%,MCM4;MCM3
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.759246125941144,-1.1464482760862678,0.2962962962962963,0.874788869710185,1.0,1/6,3.87%,UBXN1
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.6866210096449522,-1.1462923640061415,0.26,0.8742099533984363,1.0,4/12,16.86%,ACTG1;FUZ;ZDHHC7;SCRIB
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.6771604635731497,1.1462493117687056,0.2916666666666667,0.6570204972082933,1.0,3/7,13.37%,EPHA4;EFNA3;LYN
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.5031053334860428,1.1459613173586005,0.23404255319148937,0.657412070646131,1.0,8/39,14.87%,TGFB2;BMPR1B;PBX1;MEIS3;MEIS2;COL5A1;SHROOM2;CHRDL1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.4726943193875842,-1.1453954746744095,0.1590909090909091,0.8763898270073185,1.0,16/81,17.32%,PSMB6;PSMD7;DMAC2;PSME2;PSMD8;PSMB4;FBXO48;PSMD3;PSMB3;PSME1;PSMA7;PSMB8;PSMD13;PSMD2;FBXL15;PSMC5
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.661501406497739,-1.1449951769060522,0.3488372093023256,0.876485851157743,1.0,3/11,18.20%,CSTF2T;CSTF2;FIP1L1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.5049695513694169,1.1448981972226075,0.30952380952380953,0.6600261950232882,1.0,4/37,8.14%,TLR2;ISG15;LILRB1;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.7705940551511227,-1.1448407226509847,0.2692307692307692,0.8760003976567826,1.0,2/5,15.34%,CALM1;TRDN
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.5970918700446863,1.1447392214581957,0.24074074074074073,0.6599568593827436,1.0,5/20,13.19%,ZACN;PAM;MT1M;GLRA2;SLC30A3
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.6387682633211222,-1.1447011963878766,0.3076923076923077,0.8754539487840711,1.0,2/14,1.02%,PRELID1;IFNLR1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.7187501057103152,-1.1446971145902154,0.2982456140350877,0.8744118805075275,1.0,2/6,11.91%,GSTP1;PPIA
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.6192982802573732,1.1443194400827195,0.3333333333333333,0.6606736480772574,1.0,2/14,3.54%,CREB3L1;LRRK2
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.4322032742880874,1.144269168342801,0.19047619047619047,0.6603363699038848,1.0,23/108,12.42%,IFNA2;CARD18;CD44;FOS;TLR2;CHI3L1;CSF1R;ADCY8;TMIGD3;NFATC4;C3AR1;PTGER3;CIITA;LOXL3;BLNK;ACKR1;NOD1;OLR1;TNFRSF1A;NAIP;TAC4;CX3CL1;ADCY1
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.4858793902309299,1.1439546996672358,0.18181818181818182,0.6607327075895644,1.0,20/71,17.76%,PTPRC;RPS6KA6;LMO3;SPRED3;PTPRR;PRDM15;FBLN1;PTPRJ;DUSP10;IRAK3;SEMA6A;LYN;ITGB1BP1;WNK2;TIMP3;GPER1;DUSP6;PRKCD;STK38;RGS2
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.5486491923747503,-1.1437857349533453,0.2708333333333333,0.8764746240193818,1.0,7/31,16.21%,TRMT10C;HSD17B10;TRMT112;METTL2A;TRMT10A;METTL6;TRMT1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.5762380251207314,-1.143777111628138,0.30952380952380953,0.8753925565823207,1.0,5/26,17.48%,RNF8;HEXIM1;NELFE;EAF2;NELFCD
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.5819455588567878,1.143745299335349,0.32727272727272727,0.6608095751468396,1.0,2/12,2.22%,ABCC4;SLC25A41
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.5087878637001645,-1.1436707811044293,0.23728813559322035,0.874736084266809,1.0,16/64,16.40%,TPX2;RPS3;KIF3B;BCCIP;NUMA1;GOLGA8M;NEK6;RHOA;KIFC1;GOLGA8H;GOLGA2;HAUS6;ABRAXAS1;KIF11;WRAP73;HAUS1
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.5514674575003071,-1.143410409166193,0.2826086956521739,0.8746066604816856,1.0,5/44,5.33%,RPS27A;UBC;UBB;PCNA;POLD3
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.6084749000422882,-1.1431587779251846,0.2978723404255319,0.8744981348985779,1.0,1/19,0.62%,RPS23
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.6456036781828428,-1.1429076083134124,0.3111111111111111,0.8742665487591504,1.0,6/13,25.83%,RACK1;UFL1;ATF6B;PTPN1;NCK1;HSPA5
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.49340911267123083,1.1425008596264223,0.29545454545454547,0.6637714694447404,1.0,18/60,16.58%,NCKAP1L;BAIAP2;ARHGAP18;PAK3;CARMIL1;TWF2;FCHSD2;BAIAP2L1;TENM1;VIL1;CDC42EP4;ARHGAP28;KANK1;CDC42EP3;PRKCE;BIN1;SSH2;PRKCD
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.5342118994977693,-1.142499421046733,0.35294117647058826,0.8745590284287084,1.0,10/51,13.14%,ARHGEF16;UXT;CD9;TMEM125;LAMB3;ATP2C2;DDR1;EPCAM;C6ORF132;EHF
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.614170168451422,-1.1423222447124963,0.24528301886792453,0.8739793646390184,1.0,2/18,5.49%,SFRP1;HYAL2
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.6107161232257619,1.142087656093163,0.28,0.6644914598550337,1.0,4/14,9.20%,IGF1;NRG1;EPAS1;MAPK12
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.6833911976783902,1.1420527768277036,0.375,0.6636080419882625,1.0,3/8,24.40%,DYRK2;GSK3B;FHL2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.6833911976783902,1.1420527768277036,0.375,0.6636080419882625,1.0,3/8,24.40%,DYRK2;GSK3B;FHL2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.48459184433708535,1.141955827860209,0.24444444444444444,0.6634249162909563,1.0,12/42,16.82%,LPL;TLR2;C1QTNF4;SYK;WNT5A;TIRAP;POU2F2;PTPN11;IL17RA;IL33;NOS2;TNFSF4
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.664056617783635,-1.1417726594063937,0.375,0.8746708214723646,1.0,2/8,9.07%,TSPO;FDXR
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.621197991092425,1.1416593726896158,0.29310344827586204,0.6637225929154631,1.0,6/10,22.57%,LRP4;NLGN4X;NLGN1;PTEN;IL1RAPL1;CEL
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",-0.774768357639772,-1.1416306608100932,0.2962962962962963,0.8739697141503097,1.0,3/7,12.80%,TARM1;HLA-DRA;AGER
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.46993617977677676,1.1416160710818817,0.23404255319148937,0.6634196039476719,1.0,6/54,6.75%,AQP1;EGFR;FOS;MAP3K5;PDGFRA;TPM1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.6065484250401716,1.1415616059329379,0.3137254901960784,0.6631341927128327,1.0,2/15,14.01%,EPHA4;SLC2A13
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.6958975907507386,1.1413204087484734,0.34545454545454546,0.6633286842097699,1.0,2/7,11.77%,ITGA11;UBASH3B
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),-0.728180287950064,-1.1411881707477118,0.4186046511627907,0.873276572215946,1.0,1/6,6.45%,CDC23
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),-0.728180287950064,-1.1411881707477118,0.4186046511627907,0.873276572215946,1.0,1/6,6.45%,CDC23
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.5118112948977578,1.1411552096310014,0.26,0.6633089915789574,1.0,4/43,7.64%,TGFB2;EGFR;EPHB1;PER1
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.5978689087396907,-1.1407789743036743,0.25,0.8735477409328336,1.0,3/18,21.70%,FIS1;BAX;AFG3L2
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.42605062510941805,1.1407002277560714,0.1276595744680851,0.6642383616155862,1.0,34/125,15.52%,PDGFB;BMP6;EGFR;CD44;FLT1;ADAMTS7;MEF2C;HGF;BMPR1B;VSTM2A;TWF2;NTRK2;MAP2K5;WNT5A;DLX1;ZFP36;SOX9;HSPB1;ACVR1C;NOS1;VIL1;SEMA6A;SOX5;PRKD1;BMPR2;MAPT;PTPN11;ITGB1BP1;VEGFA;STMN2;NTRK3;ZFP36L1;WWOX;ACVR2A
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.5563755302496143,1.1406268886745883,0.25925925925925924,0.6639104662437552,1.0,7/22,23.93%,ADCY8;EFNA5;GPLD1;BAIAP3;EPHA5;KLF7;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.5656155729869367,-1.1405934017488846,0.288135593220339,0.8730447792569799,1.0,4/25,6.73%,JUP;RBM22;HYAL2;RAN
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.5467454988294455,1.1405666342029603,0.3,0.6636171959447431,1.0,5/26,6.32%,VSIR;ISG15;SYK;PRKCZ;LILRB1
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.42688475096590317,1.1405510361262203,0.13953488372093023,0.6631707872653817,1.0,7/99,5.06%,CLDN5;CARD18;PDGFB;LRRK2;PRMT8;ADD2;DACT1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.5483650157034823,1.1404428016099804,0.28,0.6629211021557763,1.0,9/20,21.97%,LRRK2;SHANK2;PICK1;NLGN4X;TMEM25;ACHE;GRIK3;PTEN;PRRT1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.6572934136027877,-1.1404366001378152,0.3877551020408163,0.8725227100874243,1.0,2/8,18.94%,GBA3;NEU4
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.7657872529064673,-1.1400902794941883,0.3620689655172414,0.8726212131918074,1.0,3/5,23.18%,CTR9;RTF1;PAF1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.6278837727138844,1.1397119720855027,0.36585365853658536,0.6644181620712902,1.0,3/19,4.71%,TGFB2;NCKAP1L;SYK
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.628422948976289,-1.1396925976042942,0.28846153846153844,0.8728208798684731,1.0,1/16,1.14%,PDZD11
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),0.6885333076945831,1.139430950508795,0.375,0.6646361399887304,1.0,1/5,6.06%,SLC6A11
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.6800019859180795,1.1393921609399567,0.42857142857142855,0.6642072981653595,1.0,2/5,25.51%,VPS41;VPS39
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6968655119190161,1.1393454645396088,0.30952380952380953,0.6638215776954015,1.0,2/8,7.34%,ACADL;SOX9
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.6347340496095658,1.1391382042549705,0.32075471698113206,0.6638696267028846,1.0,2/13,8.61%,RIMS2;PTPRN
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.6005903663764718,1.139124196240983,0.35185185185185186,0.6634167992393452,1.0,3/15,7.83%,SNAP25;STX3;STX1A
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.45340904803476906,-1.1390949697311545,0.22641509433962265,0.8734960772320086,1.0,28/115,17.32%,HELZ2;EDF1;PSMB6;SQLE;PSMD7;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PSME1;OPA3;ADIPOR1;CERS2;SC5D;IDI1;NQO1;TM7SF2;HNF4A;PSMA7;PSMB8;PSMD13;CARM1;PMVK;FASN;PSMD2;GPAM;PSMC5
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.6509808704409099,1.1389260356909479,0.35294117647058826,0.6634141775958716,1.0,5/9,21.23%,BMP6;NOTCH4;VEGFA;MAD2L2;RGCC
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.6395531284030879,-1.1389050461998231,0.26,0.8729861031942999,1.0,5/15,16.06%,CCT7;CCT2;CCT6A;DKC1;NHP2
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.5236259091937675,-1.1387293377913685,0.3275862068965517,0.872447050487597,1.0,8/34,20.75%,PTPA;CALM1;YWHAB;PPIA;PPP1R16A;PTBP1;SMPD1;DLC1
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.49660494211568373,1.1387270787463746,0.21428571428571427,0.6634793680838947,1.0,20/59,17.24%,NRCAM;GPM6A;NRXN1;GABRG2;FGF13;GABRA1;GABRB2;WNT5A;GABRA2;SHANK2;GABRB3;PCDHB13;RAB29;NLGN4X;FARP1;LRRC4;NLGN1;CBLN4;ACHE;DNER
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.7396254835088212,1.138608094704468,0.40384615384615385,0.6632903662972401,1.0,2/5,16.21%,RBM24;ELAVL4
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.4211462032483566,-1.138558504346389,0.16129032258064516,0.8720404852896493,1.0,36/175,18.51%,TPX2;BUB1;JPT1;NCL;STMN1;SQLE;NDC80;H2AX;PLK4;CDK4;TFDP1;NUMA1;HMMR;CCNB2;KPNA2;SNRPD1;HSPA8;H2AZ1;KMT5A;HUS1;CDKN2C;DKC1;MCM3;KIF4A;ILF3;MT2A;KIF11;CKS1B;SAP30;CCNT1;SMC1A;STIL;DTYMK;SMC2;EXO1;CENPF
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.5367558998138723,1.138341950716858,0.21428571428571427,0.663541757132914,1.0,3/33,7.62%,LPL;WNT5A;HSPB1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.5317155045677652,-1.1381336685035532,0.23404255319148937,0.8725722608103484,1.0,10/54,13.14%,ARHGEF16;BTN3A1;S100A16;TMEM125;LAMB3;ATP2C2;EPCAM;C6ORF132;FFAR1;EHF
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6195763825197915,-1.1381172906823966,0.27586206896551724,0.8716128372209351,1.0,3/14,12.13%,RPS13;TMBIM6;RPS26
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.440329509781814,-1.1380072967648491,0.2413793103448276,0.8709875323733575,1.0,18/152,10.42%,TAX1BP3;DDIT3;TRABD2B;SHISA2;SFRP1;GREM1;PTPRU;PSMB6;PSMD7;PSME2;PSMD8;RACK1;LZTS2;PSMB4;PSMD3;PSMB3;DACT3;PSME1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.6301136863072815,-1.1379579919185596,0.28888888888888886,0.8690793878305145,1.0,4/11,24.46%,BLOC1S4;AP3S2;SNAPIN;BLOC1S2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.6301136863072815,-1.1379579919185596,0.28888888888888886,0.8690793878305145,1.0,4/11,24.46%,BLOC1S4;AP3S2;SNAPIN;BLOC1S2
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.46351647634207377,1.1378518809041465,0.2558139534883721,0.6643340856385638,1.0,10/58,10.29%,KANK2;EGFR;MYO16;PLCB1;DACT1;ID2;PTPN6;CCND1;CDKN2A;KIF14
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.48398518837321286,-1.1377663466624484,0.26,0.86863970200084,1.0,23/73,24.22%,NUTF2;SRSF7;PHAX;RAN;SRSF3;SRSF9;RBM8A;RAE1;DHX38;MAGOHB;ALYREF;CALR;SLU7;WASHC4;RANBP17;TPR;MALT1;CASC3;CDC40;POM121C;SRSF2;NXF1;CSE1L
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.49965738288266726,1.137557140549823,0.24444444444444444,0.6645674636292691,1.0,6/48,5.89%,PLSCR1;MX1;BTBD17;ISG15;VAPB;RSAD2
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6262790475536851,1.1374479352741276,0.3111111111111111,0.6643866694512439,1.0,7/15,14.16%,GRM5;GRM1;GRM6;GRM2;HOMER1;TRPM1;GRM8
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.5891224269514863,-1.1374129449536685,0.3269230769230769,0.868791469994583,1.0,6/22,18.99%,VPS25;VPS28;SNF8;RNF126;NEDD4;VPS36
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.6385812061491234,1.1373001856465295,0.41509433962264153,0.6642652115951476,1.0,4/14,5.17%,NTNG1;GPC6;LRFN5;SLITRK3
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5306859987352504,1.1371005519493953,0.2553191489361702,0.6643969348334056,1.0,10/29,14.05%,CDH9;CDH10;SELL;CDH18;CDH22;CDH23;PCDHB13;CDH6;CDH7;CDH13
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.6643489003162962,-1.1369611229230108,0.36585365853658536,0.8694026387641753,1.0,3/7,23.60%,GSN;ASAP1;IL5
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.7243567897601257,1.1367707221366958,0.41304347826086957,0.6643903278307196,1.0,1/6,10.03%,B3GALT1
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.7243567897601257,1.1367707221366958,0.41304347826086957,0.6643903278307196,1.0,1/6,10.03%,B3GALT1
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.5872181541794899,-1.1367388390247926,0.28846153846153844,0.8692037315676466,1.0,5/16,20.16%,TSPO;FDXR;SRD5A1;HSD17B8;STAR
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.7461595094515018,-1.1366818404210508,0.35294117647058826,0.868367152515342,1.0,1/6,12.81%,RAE1
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.7109008491064588,-1.1363293616387038,0.28888888888888886,0.8674559591190718,1.0,1/7,0.98%,PAX8
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.7109008491064588,-1.1363293616387038,0.28888888888888886,0.8674559591190718,1.0,1/7,0.98%,PAX8
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.6076749772926572,-1.1361325941557978,0.34545454545454546,0.8671708892745897,1.0,4/19,13.78%,TPX2;TUBG1;GOLGA2;AKAP9
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),0.7526159615377659,1.1359140866977306,0.3076923076923077,0.6663983363242854,1.0,3/5,24.00%,ATCAY;PRUNE2;PRUNE1
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.6386140232071658,1.1358218968339928,0.375,0.6661665526228863,1.0,1/11,1.17%,PTPRC
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.6779630740566741,1.1357700249749494,0.3137254901960784,0.6658090471175301,1.0,1/8,2.09%,NCKAP1L
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.7575203691158547,1.1355870286464533,0.33962264150943394,0.6657963490326407,1.0,3/5,21.07%,NTRK3;TMEM108;DOK5
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.45658257445204264,-1.1354339825049327,0.21052631578947367,0.8682857401677253,1.0,10/104,6.68%,ARHGEF16;GPRC5C;JUP;PTPRU;BCAM;VWA1;COL18A1;ATP1B1;TMEM125;GNA11
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.7470673066346848,-1.1351553296866288,0.42,0.867151347488134,1.0,1/5,2.70%,DPM3
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.7470673066346848,-1.1351553296866288,0.42,0.867151347488134,1.0,1/5,2.70%,DPM3
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.6787119707893439,1.135018628399142,0.3793103448275862,0.6668829589359109,1.0,3/8,21.85%,ADRA1A;ADRB2;AKAP13
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.5794688922965794,1.134904013487097,0.30952380952380953,0.6666095624231313,1.0,3/18,7.61%,RELN;CAMK2B;LRP8
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.5322324836462319,1.1347334859689324,0.3125,0.6666130812541897,1.0,6/35,17.34%,ISG15;LILRB1;UBA7;HAVCR2;NLRC5;ILRUN
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.670505813607815,1.1345049277260397,0.32727272727272727,0.666817562289099,1.0,4/9,16.25%,NRXN1;LRP4;NLGN4X;NLGN1
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.6769305128017402,-1.1344146051239126,0.3620689655172414,0.8686083666150805,1.0,2/12,5.89%,SLC25A4;PARP1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),0.38044971257073945,1.1342326069555795,0.1724137931034483,0.667239312714125,1.0,67/391,13.17%,CTF1;IFNA2;PDGFB;CSF2RA;SLA;CD44;FOS;MX1;TRIM5;CSF1R;F3;TNFRSF25;IL12RB2;IL12A;ISG15;TNFSF13B;PLCB1;PIM1;ITGAM;BIRC3;HGF;INPP5D;SYK;ZEB1;CSF3R;SRC;IRS1;PTPN6;PTPRZ1;GPR35;RSAD2;TNFRSF1B;XAF1;SAMHD1;CIITA;CAMK2B;PTPRJ;STX3;NFKBIA;LRP8;IL13RA1;STX1A;LIFR;CRLF1;CCND1;CD4;BCL6;STAT6;SOCS3;VIM;SLA2;IL1RAP;NOD1;IRAK3;CAMK2D;TNFRSF1A;BCL2;TEC;CX3CL1;CNTFR;IFNK;PIK3R1;CD80;CD70;PTPN11;CEBPD;GHR
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.5326081497900887,-1.1338110137755157,0.2916666666666667,0.8697952702611801,1.0,4/26,11.33%,GREM1;DDX5;MYBBP1A;TRIAP1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.5954025158569981,1.133740749818962,0.3333333333333333,0.6680952753647419,1.0,3/16,7.34%,SRGN;HEY1;SOX9
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.7272828827597053,1.133671987041049,0.39622641509433965,0.6678554118135805,1.0,1/6,2.10%,CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.5290469948884735,1.1336371085690131,0.35,0.667482289926569,1.0,6/30,11.81%,CX3CR1;HEY1;BHLHE40;CLOCK;HES1;CX3CL1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.7477747647083739,-1.1335458732550316,0.2692307692307692,0.8695291892122088,1.0,1/7,3.91%,PIK3C2G
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.7105162394485015,1.1334736457458994,0.37254901960784315,0.6665244022067939,1.0,4/5,27.50%,SLF1;MACROH2A1;SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.7105162394485015,1.1334736457458994,0.37254901960784315,0.6665244022067939,1.0,4/5,27.50%,SLF1;MACROH2A1;SMC5;NSMCE2
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.7105162394485015,1.1334736457458994,0.37254901960784315,0.6665244022067939,1.0,4/5,27.50%,SLF1;MACROH2A1;SMC5;NSMCE2
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.6413092921899322,-1.1329808364058496,0.2727272727272727,0.8702195329094279,1.0,1/12,0.48%,ZDHHC12
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.6336779812282294,-1.1329408622088997,0.3469387755102041,0.8692843231742495,1.0,4/16,8.56%,STAC3;ATP1B1;CALM1;P2RY6
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.6293127797121435,-1.1329288119849128,0.3584905660377358,0.8682824983416928,1.0,4/13,14.18%,LSM2;PRPF6;PRPF3;PRPF8
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.6067441931209805,1.1329251238366889,0.3673469387755102,0.6676769870640006,1.0,5/18,5.54%,TAFA1;LRRK2;TOX;ID2;PTPRZ1
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.712605341896769,1.1329019032068017,0.375,0.6672553862360034,1.0,2/5,14.19%,CNTNAP1;ANK3
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.560653554650088,-1.1326775189273837,0.2909090909090909,0.8681274498570309,1.0,11/40,22.16%,SUN3;RPS19;CHMP2A;NUMA1;CHMP5;CHMP3;REEP4;TOR1A;CHMP7;TPR;CEP55
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.7334599463885996,-1.1324646816890604,0.4166666666666667,0.8676785435024316,1.0,4/5,17.29%,RAN;PINX1;RPF2;NOL8
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6156304701916367,1.1316470069233793,0.21739130434782608,0.6702433416540883,1.0,6/17,20.06%,TIMP4;TNFRSF1B;GPLD1;TIMP3;SH3D19;SNX33
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.6255761811838828,1.1315092898365782,0.32653061224489793,0.6701694900146714,1.0,6/16,14.70%,NRG1;OXTR;TGFB3;NOTCH4;GPAT4;VEGFA
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.5431001955117026,-1.1314012074988027,0.30612244897959184,0.8703261916423488,1.0,12/36,20.36%,PHB2;GABARAPL2;FIS1;ATG9A;CISD2;MAP1LC3B;SQSTM1;WDR45B;ATG14;BECN1;ATG2A;PINK1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.5822543854309266,1.1311606613833847,0.35555555555555557,0.6706935455484191,1.0,4/24,8.57%,IFNA2;TRIM5;CIITA;CD4
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.5907066855110517,1.1310709071852096,0.32653061224489793,0.6703871656210848,1.0,3/17,8.14%,NCKAP1L;CAMK1D;TIRAP
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),0.6703160505038465,1.130640789885748,0.35714285714285715,0.6709600771913884,1.0,3/9,7.71%,AQP1;SLC23A1;SLC2A5
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5867070561894037,1.1305101925497274,0.2978723404255319,0.6708445027382143,1.0,4/14,11.04%,JCAD;IL12A;SEMA6A;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.6223678341569966,1.12977840105956,0.2857142857142857,0.6723518691328946,1.0,3/13,6.08%,PDGFB;PDGFRA;PRKG1
prerank,MSigDB_Hallmark_2020__Hypoxia,0.4025493506832942,1.128883899616601,0.1111111111111111,0.6740474127910965,1.0,39/166,13.99%,PLAC8;IGFBP3;PDGFB;EGFR;FOSL2;FOS;PPP1R3C;F3;NEDD4L;AKAP12;BHLHE40;PAM;CA12;PIM1;HS3ST1;LOX;CITED2;MAFF;CHST3;ZFP36;AK4;RRAGD;SLC2A5;KDM3A;PFKFB3;TGFB3;NCAN;XPNPEP1;BCL2;ADORA2B;CSRP2;EFNA3;P4HA1;SCARB1;CCN5;GPC1;SULT2B1;COL5A1;ISG20
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.5954270553317034,-1.1288537717787828,0.35714285714285715,0.8782805968234265,1.0,1/18,0.24%,BMP5
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.6315091464169074,1.1288133664282465,0.37254901960784315,0.6737562900127216,1.0,5/14,17.71%,IGF1;NR4A3;CAMK2D;PDE9A;EDN1
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.6132943413107689,-1.128769377641618,0.3541666666666667,0.8775868503801315,1.0,3/15,10.47%,NPC2;ABCA8;NPC1
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.7081402556920346,-1.1287240646668948,0.38461538461538464,0.8767385372711881,1.0,4/7,19.96%,RPS3;NPM1;HMGB1;DDX11
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.5871363423319884,1.1285337023466198,0.2682926829268293,0.6740604441074173,1.0,3/17,10.88%,FMO5;ACADL;GNB3
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.7338172262576368,-1.128526458904061,0.3888888888888889,0.8763212115992177,1.0,2/5,20.36%,PARK7;PINK1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.6769776972884447,-1.1284562324937373,0.3018867924528302,0.8754860858713372,1.0,2/10,13.01%,CD81;SAR1B
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.6659468148996077,1.1283056427176066,0.3953488372093023,0.6742238152661542,1.0,2/6,26.48%,PRKCD;RELA
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.6765403712282685,-1.1282568305930285,0.3392857142857143,0.8749739115358804,1.0,4/8,22.80%,HMGA2;RESF1;INPP5K;SETDB1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6153727636270668,1.1281286069690977,0.32558139534883723,0.6742054467918907,1.0,6/19,24.40%,IGF1;DYRK2;SPPL3;CLEC7A;GSK3B;FHL2
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.5662407379447144,1.1279861701768947,0.3333333333333333,0.6740964121245864,1.0,7/18,16.46%,SEMA3D;SEMA6A;SEMA5B;SEMA4G;SEMA4B;SEMA3C;SEMA7A
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.5472124836360089,-1.1277640841171288,0.2962962962962963,0.8755414311966694,1.0,8/27,15.45%,ACAA2;SQLE;DHCR24;SC5D;IDI1;TM7SF2;PMVK;MSMO1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.48552341875998983,1.1275195926311037,0.20930232558139536,0.6747125577955783,1.0,4/48,5.06%,CLDN5;LRRK2;ADD2;DACT1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.6038544264011481,1.1271894746714692,0.2777777777777778,0.6752208107880103,1.0,6/11,22.57%,LRP4;NLGN4X;NLGN1;PTEN;IL1RAPL1;CEL
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5588037197317127,1.1271613878467996,0.2978723404255319,0.6747821976587915,1.0,3/18,8.14%,TLR2;RSAD2;TIRAP
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.5540862251444243,1.1268479591541534,0.2916666666666667,0.675141702019187,1.0,12/37,12.18%,FGL2;PTPRC;DCLK1;ITGAM;CSF3R;CAMK2B;SOX9;IL13RA1;P2RY13;TMEM176B;NREP;AOAH
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.6632419480794669,-1.126204717328859,0.3492063492063492,0.8790288339853854,1.0,5/10,21.77%,TIMM10;TIMM8B;TIMM13;TIMM9;TIMM29
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.49720459922422344,-1.1260902659580685,0.23728813559322035,0.8785046412021398,1.0,7/42,19.58%,LSM2;DDX5;RNH1;NUDT12;NUDT16L1;DXO;PDE12
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),0.6173851074139498,1.1258399228684943,0.2826086956521739,0.6772589227761866,1.0,2/14,6.97%,SHMT2;AK4
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 cell differentiation (GO:2000321),0.7304472348345573,1.125684136751187,0.44,0.6772221083555373,1.0,3/5,17.15%,NFKBID;NFKBIZ;IL12RB1
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),-0.700043594462243,-1.1253055992575818,0.3673469387755102,0.8800053080374298,1.0,1/7,5.54%,RACK1
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.6750992206275194,-1.1252664740837097,0.3269230769230769,0.8791813873422235,1.0,3/7,11.43%,FNTA;BEX4;PRKAA2
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.6732752590413084,1.125116037393196,0.41304347826086957,0.6780714342496538,1.0,4/8,24.61%,ID2;MYT1L;PAX6;ASCL1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.46587312622852184,1.1250186037367982,0.2830188679245283,0.6778619304526631,1.0,7/74,12.07%,TGFB2;MAP3K5;PLCB1;SH3RF3;TIRAP;ANKRD6;MTURN
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.5210048745651751,1.1247407929415685,0.3148148148148148,0.6780377945430982,1.0,10/32,15.45%,CHRM3;UTRN;FGF12;NEDD4L;SCN3B;HOMER1;YWHAH;TRPC6;FHL1;SCN4B
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),0.7352267757228899,1.1246189398319764,0.4423076923076923,0.677844980149981,1.0,4/6,19.24%,DDAH1;NOS1;NOS2;ARG1
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.75269245496859,1.1245329170555947,0.3333333333333333,0.6775542527009929,1.0,2/6,3.46%,OLAH;ABHD3
prerank,PanglaoDB_Augmented_2021__Neutrophils,0.4656018453815584,1.1241651240987642,0.20930232558139536,0.6780570065783453,1.0,12/51,13.13%,TLR2;SELL;ITGAM;CSF3R;LY86;P2RY13;NR1I3;DOCK8;BST1;AOAH;CR1;PILRA
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.5528880525492901,-1.1240543266455183,0.3220338983050847,0.881759744474996,1.0,8/28,20.71%,LAMTOR4;CD81;ZFYVE16;GLMP;HGS;NEDD4;LAMTOR5;RNF128
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5800683844735305,1.1240272370997648,0.3404255319148936,0.6780034766322237,1.0,4/19,14.01%,EPHA4;EFNA3;LYN;SLC2A13
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.6980679940345438,1.1238370376556182,0.3333333333333333,0.677933691422775,1.0,2/9,4.59%,COL11A1;ADGRV1
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),-0.7156888149789107,-1.1237081101657522,0.4107142857142857,0.881736569013575,1.0,1/5,4.27%,SLC22A2
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.5288029601256864,-1.1232602076928884,0.2857142857142857,0.8822049797422081,1.0,13/37,26.08%,PHAX;RAN;NPM1;RAE1;NOL6;NUP37;SSB;NUP210;TPR;POM121C;NUP93;NUP42;NUP85
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.7038277850742347,1.1230972997637223,0.4,0.6793081589153434,1.0,2/6,16.21%,RBM24;ELAVL4
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.589980275313267,-1.1228237773463787,0.32608695652173914,0.8825856711619059,1.0,6/18,11.87%,PRDX1;CNGB1;TF;SOD1;ACTG1;B2M
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.5285638313306955,-1.1226702678643121,0.2553191489361702,0.8823116169889997,1.0,4/41,2.22%,ARHGEF16;GPRC5C;CLDN2;GJB1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.5571610031947744,1.1226006255915102,0.2857142857142857,0.6799713758563705,1.0,3/20,6.48%,LRRK2;NR4A3;GNG2
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.5158291837189493,1.122497377725516,0.28888888888888886,0.6798351921938863,1.0,7/42,6.61%,DACT2;CERS3;ITGB4;MET;COL5A3;WNT5A;SCEL
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.5861217343322934,-1.122441476238157,0.3076923076923077,0.8821342391211312,1.0,2/16,3.66%,GREM1;EPHB4
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),-0.6422517585287115,-1.1223951449550855,0.3333333333333333,0.8812569289096148,1.0,2/15,1.89%,DPEP1;CPA1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.6363647712341376,-1.122384637554186,0.35294117647058826,0.8802858015928077,1.0,5/11,20.64%,CHMP2A;CTDP1;CHMP7;UBE2S;EPS8
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.7460610165938084,-1.1222727393697296,0.36,0.8795849050814823,1.0,1/5,0.97%,GJC1
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.5338733817986377,1.1221550666929334,0.3157894736842105,0.6801551576010493,1.0,10/27,19.56%,SORBS1;C3;PRKAB2;PDK4;GPER1;ADIPOR2;HSD17B13;ASXL3;PRKAG2;MLXIPL
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.42449229229938673,1.1220336304769556,0.23636363636363636,0.6799864889771241,1.0,33/127,15.90%,RHBDF2;PPARG;SIGLEC10;IGF1;ADCY8;RXFP1;LRFN5;SYK;SRC;ADCYAP1R1;GPR176;TNFRSF1B;GNG2;CYSLTR2;VIPR2;ADCY2;GIT1;CYSLTR1;FNDC4;ADCY7;TNFRSF1A;ADORA2B;CD200;AOAH;ADCY1;PRKAR1B;LYN;P2RY11;HRH2;CCN3;GPER1;CALCB;ADRB2
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),0.7145789417917361,1.1219303222241281,0.35185185185185186,0.6798587077579135,1.0,2/5,15.36%,ZFP36;ZFP36L1
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.6935568436121452,1.1216963314539548,0.38461538461538464,0.6800073633975207,1.0,3/9,15.51%,ABCC4;ABCC6;ABCC11
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.5495579306830449,-1.1216004386218452,0.3125,0.8806161144541722,1.0,8/22,17.58%,CRTAM;RPS3;CD274;AGER;ICOSLG;SCRIB;FADD;HMGB1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.6228014222280257,-1.1213416147506095,0.35555555555555557,0.8805371833274181,1.0,2/14,12.42%,TINF2;PINX1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.5171679034754221,1.121041708271287,0.3333333333333333,0.6812438555741622,1.0,6/30,9.79%,SLC9C2;SLC4A10;LRRK2;SLC4A4;SLC9A9;SLC9A7
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.48012165096523274,-1.1206009427126797,0.25862068965517243,0.8820514437434981,1.0,21/59,21.15%,JUP;RBM22;HYAL2;CCT7;CCT2;RAN;PYHIN1;CCT6A;PINX1;DKC1;EIF2AK3;PARK7;TRIM28;MCRS1;LAMTOR5;ZPR1;IPO5;MEPCE;TPR;FLNA;DMAP1
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.6424745603325993,1.1205799835461436,0.4444444444444444,0.6818944279437825,1.0,3/12,19.22%,SPEF1;ARHGEF4;FGD1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.532662999055447,1.1205044939223388,0.2857142857142857,0.6816683829645375,1.0,5/24,11.81%,ITGAM;SYK;DYSF;MAPT;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.6847930546611196,1.1203330609506679,0.3541666666666667,0.6816452228896084,1.0,4/7,26.85%,PUM1;PUM2;USP15;DDX60
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.4733898168477991,1.1202677712373463,0.20512820512820512,0.6813872703400995,1.0,6/53,10.66%,TGFB2;EGFR;PLCB1;LGI1;RFTN1;BCL2
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.6607749072149335,-1.1200512787386816,0.4230769230769231,0.8830000953377669,1.0,2/8,5.02%,WNK4;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.5579814274303514,1.119752726735349,0.32727272727272727,0.6822463444673499,1.0,10/26,15.50%,TRIM46;MAP2;EFNB3;FGF13;KIAA0319;MCF2;NGFR;LRP4;DIP2B;THY1
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.7619330839680893,-1.119110081339555,0.40476190476190477,0.8851457666236409,1.0,3/6,17.71%,EME1;MUS81;SMC1A
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),0.7331843028071796,1.1189552574552748,0.3877551020408163,0.6836298472220061,1.0,2/5,15.94%,PNPO;NNMT
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.618038850016441,-1.118682329361339,0.41818181818181815,0.8853852669897282,1.0,2/13,4.75%,CBR1;PTGIS
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.7174030155549057,1.1183962405588235,0.3333333333333333,0.6846801422911936,1.0,1/6,4.89%,VAPB
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.6214971366138626,1.117940411126665,0.3508771929824561,0.6854140651978251,1.0,3/13,12.11%,C3;GPLD1;SCARB1
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.7494932769041389,1.1178502333386096,0.32608695652173914,0.685194762944633,1.0,2/5,23.34%,CDK6;NF1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.6499192093133536,-1.117789194443233,0.391304347826087,0.8878082303820749,1.0,2/9,7.10%,WWC2;SOD1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.7617836642977576,-1.1177365250726363,0.43103448275862066,0.8849561852797393,1.0,2/5,14.76%,UFC1;UFL1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.7617836642977576,-1.1177365250726363,0.43103448275862066,0.8849561852797393,1.0,2/5,14.76%,UFC1;UFL1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.7617836642977576,-1.1177365250726363,0.43103448275862066,0.8849561852797393,1.0,2/5,14.76%,UFC1;UFL1
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.6745830293250983,1.1176502230397884,0.38461538461538464,0.6851854284312493,1.0,4/8,15.39%,SOX9;CD200;LYN;GPER1
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.6159355021563111,-1.1174010425287877,0.28,0.8850811135955476,1.0,7/16,29.72%,FOLH1B;FOLH1;ADI1;ASPA;NAALAD2;NIT2;GOT2
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.5979487731772717,1.1173372380897555,0.3333333333333333,0.6855951549272601,1.0,3/13,10.14%,TGFB2;SNCAIP;MAOB
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.5701933889260782,1.1172825336894077,0.2826086956521739,0.6852634350273944,1.0,3/19,8.26%,PRKX;SOX9;TIMELESS
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.6273377269800144,1.1172593188703825,0.3,0.6848275493543885,1.0,2/11,15.39%,NR3C2;GPER1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.5647941188551244,1.1172400817646386,0.2777777777777778,0.6844083429825562,1.0,3/19,5.26%,MFAP5;PDGFRA;ID2
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.6620401486222711,1.1169896559616965,0.3877551020408163,0.6841097320803976,1.0,6/9,25.34%,PLCB1;CD4;JAK1;STAT5A;STAT3;STAT5B
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.6620401486222711,1.1169896559616965,0.3877551020408163,0.6841097320803976,1.0,6/9,25.34%,PLCB1;CD4;JAK1;STAT5A;STAT3;STAT5B
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.6800880267267935,1.1169274209002031,0.29545454545454547,0.6837801538851274,1.0,2/7,23.73%,LAPTM5;UBE2K
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.644177538542547,-1.1162093333064655,0.32075471698113206,0.8879722934647304,1.0,1/11,0.29%,CXCR4
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.5869268933373232,1.1157309931708534,0.2978723404255319,0.6865468291254949,1.0,3/19,5.60%,EGFR;NOSTRIN;DDAH1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.4650124444448918,1.1156694603227293,0.27906976744186046,0.6862481005010357,1.0,12/60,13.95%,PTPRC;BIRC3;SYK;PTPN6;LIFR;AXL;SOCS3;IRAK3;TNFRSF1A;CBFB;PTPN11;PIAS1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.4852707137685293,1.1156015920562683,0.2391304347826087,0.685973805978928,1.0,11/40,23.15%,SRGN;HOOK1;DNM1;ALS2CL;EPS15;SAR1A;SNX10;SNX33;SORT1;WASL;ARFGEF2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.3926238096637835,1.1152503110400718,0.23255813953488372,0.686380213424322,1.0,34/191,13.76%,CREB3L1;MMRN2;KANK2;DLK2;IGFBP3;CX3CR1;PTPRC;EGFR;HEY1;IL12A;LRRK2;PID1;DACT1;PRKCZ;IRS1;SULF1;PTPRJ;NDRG4;PTPRT;IRAK3;SEMA6A;APCDD1;BCL2;UBASH3B;CX3CL1;TULP3;GPC1;GRB14;NLGN4X;KANK1;LYN;PIP4K2A;TMEM25;FRZB
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.5802539151616526,1.1148199006813582,0.3333333333333333,0.6869220425442122,1.0,6/20,16.88%,PTPRZ1;RELN;SOX9;PICK1;GPC1;MMP24
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.43769803249481265,1.11466218540439,0.2222222222222222,0.6867917233174801,1.0,11/96,11.21%,ARHGAP31;IGF1;ARHGAP18;RIT2;TNK2;TIAM2;CDKN2A;RERG;PRKD1;MAPK11;ZNF304
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.6109380859395859,1.114178694363339,0.40384615384615385,0.6873485139538045,1.0,3/12,15.30%,KLF9;LMO2;THRB
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.6130565959616996,1.1140237940153894,0.26,0.6872819398399024,1.0,2/16,4.93%,MET;CITED2
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),-0.6922083263506211,-1.1138638193264794,0.43636363636363634,0.8943088646896965,1.0,3/6,16.64%,PLEKHA3;GLTP;CPTP
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.722359267547376,1.1137680894435265,0.39622641509433965,0.687359037893968,1.0,1/6,1.85%,TLR2
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),0.5968948678744364,1.1136823969222716,0.2857142857142857,0.6871889187818324,1.0,5/13,22.38%,ABCC9;RFC3;TRPC3;VGF;KCNJ11
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5852827757465442,1.1136289716229428,0.36363636363636365,0.686859709872192,1.0,2/14,21.11%,LAPTM5;DUSP3
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.424009251078121,1.1134821038828793,0.27906976744186046,0.6867777247418465,1.0,22/119,11.81%,IFNA2;VSIR;SRGN;PTPRC;NCKAP1L;IL12A;ISG15;MAPKBP1;PTPN6;MAP2K5;LILRB1;ZFP36;LEF1;UBA7;AXL;ABCD2;SFTPD;LAPTM5;IRAK3;ADCY7;CD200;CX3CL1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.7171098128848639,-1.1134548434905047,0.3695652173913043,0.8944699427941463,1.0,2/9,7.04%,CRTAM;CD274
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.5252943277133174,1.1134325055908367,0.38636363636363635,0.6864492380549335,1.0,9/35,11.95%,TGFB2;FOS;GRIN2B;MAP3K5;ITGAM;WNT5A;CDK5R1;MAPT;SARM1
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.43465775605199236,1.1132868053830876,0.30434782608695654,0.6864073898707835,1.0,18/70,13.35%,PDE10A;UNC13C;HCN1;GNGT1;MGAT4C;XKR4;TNR;KCNJ6;GRM6;SCN3B;KCNB1;FAM227A;MYT1L;ASMT;SRRM4;CDH7;ATCAY;SV2B
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.4445481099419059,1.113195105776511,0.28,0.686111373930999,1.0,11/88,13.68%,NEDD4L;UHRF1;DACT1;MAP2K5;WNT5A;NFKBIA;WWP1;PLA2G10;CD80;HECW1;APC2
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.7328206329561818,-1.1131553069828686,0.42,0.8944895050535769,1.0,1/5,14.43%,CTR9
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.5855568964629019,-1.113134916702639,0.32608695652173914,0.8935596579273074,1.0,3/13,14.37%,CHMP2A;SNF8;HGS
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.4720469782307944,1.1131042284185348,0.3170731707317073,0.685911026765554,1.0,16/42,13.39%,SLA;PTPRC;NCKAP1L;SELL;IKZF1;LCP2;CD53;ARHGAP25;TNFRSF1B;CD4;BCL6;LAPTM5;CD200;AOAH;SASH3;ZAP70
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.6025142286938977,-1.1130907961241554,0.34545454545454546,0.8927163999730472,1.0,4/22,6.75%,RPS27A;UBC;UBB;TLR1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.4799996525555754,1.1128262475887127,0.23404255319148937,0.686155242583803,1.0,7/66,7.76%,LAMP5;E2F3;SYK;PRICKLE1;NUP62CL;SPRN;HEATR3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.7138959353639528,1.112742358010881,0.29545454545454547,0.6859234216740319,1.0,3/7,16.97%,DMTN;PRKCE;ARHGEF7
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.4879607050027508,1.112710736945126,0.3076923076923077,0.6855334498517428,1.0,13/58,15.70%,PDGFB;JCAD;F3;WNT5A;VEGFD;ARNT;PRKD1;BMPR2;AKT3;VASH2;CDH13;VEGFA;EGFL7
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.6937161606613166,1.1121431365255077,0.375,0.6862920847478438,1.0,2/7,26.22%,RIN3;PICALM
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),0.6468255011407902,1.11210089194156,0.3333333333333333,0.6859261266178857,1.0,1/7,3.38%,IL12A
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5177738567389036,1.1120949986429514,0.2564102564102564,0.6854815878784598,1.0,8/44,9.57%,GRIN2B;MAP3K5;TBC1D10A;SYK;GRIN1;ACVR1C;DAPK1;NOD1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.438046008570472,1.1117793428773468,0.26666666666666666,0.6857093051984553,1.0,30/105,15.50%,ADAMTS5;FSTL1;POSTN;TNC;FAP;PCDH18;RHOJ;CSPG4;COL11A1;PDGFRA;TMEM47;CCDC80;COL12A1;OLFML2B;SULF1;COL4A1;BOC;COL15A1;PAMR1;CREB3L2;AEBP1;COL9A1;PRRX1;FRZB;COL5A1;PDZRN3;DAAM2;VEGFA;TIMP3;THY1
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.6482206951650863,-1.111618151944652,0.36585365853658536,0.8960297446521506,1.0,7/13,23.28%,HDC;PYCR3;PYCR1;MOCS1;NFS1;MOCOS;ALOX5
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.7027036674487993,-1.111396707882496,0.4166666666666667,0.8956914855525717,1.0,1/5,1.68%,WWC2
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.7196662771008673,1.1113893092325822,0.38461538461538464,0.6863394430208846,1.0,3/6,24.89%,PIK3R1;GHR;STAT3
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.7075831322212188,-1.1113288981090346,0.425531914893617,0.8939423132653298,1.0,3/6,27.19%,NPHS1;JAG1;PODXL
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.7075831322212188,-1.1113288981090346,0.425531914893617,0.8939423132653298,1.0,3/6,27.19%,NPHS1;JAG1;PODXL
prerank,"GO_Biological_Process_2021__negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",0.7311243349138461,1.11112462821986,0.39215686274509803,0.6865583894150804,1.0,2/5,6.32%,VSIR;LILRB1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.5152113515574293,-1.1111002337993232,0.3333333333333333,0.8936075164522304,1.0,10/38,13.00%,DPEP1;GPT;AADAT;PYCR3;FOLH1B;DDAH2;PYCR1;RIMKLA;HNF4A;THAP4
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6076654663590216,-1.1108786180334715,0.3125,0.8931802030731157,1.0,1/18,1.40%,BUB1
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.7249604912362033,1.1108720827981007,0.36363636363636365,0.6867139546096229,1.0,1/6,8.61%,PTPRN
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.5984489420904364,1.1106651054640655,0.3333333333333333,0.686908715377272,1.0,2/17,7.34%,IGF1;SOX9
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.652078823993529,1.1102690358325313,0.358974358974359,0.6875048647162687,1.0,1/8,4.09%,ITGAM
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.6569873723338697,1.1101245896988086,0.35714285714285715,0.6873761583953766,1.0,4/8,21.62%,SOX9;BBS4;NRL;RPGRIP1L
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.6368502072710134,1.1100599267418496,0.3728813559322034,0.686608379896048,1.0,1/9,3.57%,CA12
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.6368502072710134,1.1100599267418496,0.3728813559322034,0.686608379896048,1.0,1/9,3.57%,CA12
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.7086369647241787,-1.1099181971501777,0.38181818181818183,0.895446142008414,1.0,1/6,1.78%,SELP
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.5204002745130052,1.1097511788562935,0.3,0.6869989235515588,1.0,10/29,14.77%,PDGFB;P2RY12;F3;MET;STX3;HSPB1;PRKD1;CDH13;VEGFA;NTRK3
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.43714032590724683,1.1096953025565834,0.2682926829268293,0.6867060633434435,1.0,10/102,6.58%,TGFB2;PDGFB;PRR16;EGFR;IGF1;TLR2;HGF;SORBS1;IRS1;CIITA
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.6465195820606162,1.109580840976318,0.36363636363636365,0.686444969134105,1.0,2/8,12.62%,GPLD1;PDE3B
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.45893676085274465,-1.1095539848037823,0.2545454545454545,0.8956877341523968,1.0,11/65,11.10%,KLK6;PDE6A;GUCA1C;CNGB1;METAP2;FNTA;CALM1;DYNLT1;RGS11;YWHAB;PLCE1
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.6896338838734415,-1.1094837666846886,0.36666666666666664,0.8949620868529963,1.0,1/8,5.04%,MBD4
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.625025585002672,-1.1091915873139768,0.3114754098360656,0.894822999043777,1.0,1/16,1.51%,SFRP1
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.6780008559310896,-1.1091264756639247,0.35,0.894044271764002,1.0,1/7,12.13%,AURKAIP1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),0.5014748794676004,1.1089431029311174,0.3111111111111111,0.6874070737062318,1.0,8/33,21.11%,EGFR;PTPRJ;SH3GL2;TGFA;ARHGEF7;TSG101;EPS15;DUSP3
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.6764565131089226,1.108483901541477,0.3728813559322034,0.6879605527890951,1.0,2/5,5.88%,CORIN;OXTR
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.4683652691859934,1.1080502365035636,0.21212121212121213,0.6885680949675671,1.0,14/56,18.43%,TIMP4;MET;HGF;NELL1;RASIP1;GPLD1;BCL2;WDR6;WASHC1;TIMP3;DAPL1;RUBCN;LEPR;RIC1
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.7183740235004252,1.1080175914580537,0.3090909090909091,0.6881734638417544,1.0,2/6,12.65%,CBLN2;RAB3A
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.45665370337054906,1.1077797863829595,0.24489795918367346,0.6883266153521856,1.0,3/42,3.10%,CX3CR1;HEY1;BHLHE40
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.4194298604786856,1.1077782735725095,0.20930232558139536,0.6878701653420052,1.0,32/132,17.04%,PTPRC;PLPPR5;PLPPR3;PLPPR4;PTPRG;PTPRR;PTPRB;PPP3CA;HDHD2;PTPN6;PTPRZ1;PTPRJ;PTPRM;DUSP10;PTPRT;PLPP4;SGPP2;PLPP6;PPM1L;PPM1H;TPTE2;ALPL;PTPRO;PTPN5;PPP1CB;PTPRK;PTPN4;DUSP6;PPEF1;SSH2;ACP6;PLPPR1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.6956970761376875,1.1077451375529714,0.3958333333333333,0.6874767812824634,1.0,2/6,13.58%,LILRB1;CDH3
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.5692649119416524,-1.107237262706765,0.36,0.8991501225482118,1.0,9/26,19.08%,TINF2;PPIA;PINX1;DKC1;NHP2;TELO2;RFC1;GAR1;PPP6C
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.6171015184658611,-1.1069565425685495,0.42857142857142855,0.8990253717062504,1.0,3/14,4.71%,SFRP1;GREM1;LMX1B
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.5281069801696338,1.1066764977530583,0.3111111111111111,0.690009837740721,1.0,10/35,20.81%,LPL;FABP7;GPAT4;PNPLA1;GPAT3;DGAT1;GK;AGMO;CAV3;LPGAT1
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.6708528280374508,1.1066439767832388,0.37254901960784315,0.6896233555992183,1.0,2/7,8.49%,SOX9;CHRD
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.5416835766606148,1.1065327651666834,0.3269230769230769,0.6894321879585096,1.0,3/28,10.69%,MX1;DNM1;DYSF
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.5964007031826388,1.1064006001080604,0.41304347826086957,0.6893580777347416,1.0,5/12,11.98%,GRIN2B;GRIN3A;GRIN1;ADCY7;GLRA2
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6432001849651404,1.1063699364604742,0.4067796610169492,0.6885102476779917,1.0,6/11,14.21%,EFNA5;FBLN1;DMTN;CORO1C;KANK1;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6432001849651404,1.1063699364604742,0.4067796610169492,0.6885102476779917,1.0,6/11,14.21%,EFNA5;FBLN1;DMTN;CORO1C;KANK1;ITGB1BP1
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),-0.7090504908007618,-1.1063409153042496,0.37777777777777777,0.8999177214040084,1.0,1/6,0.24%,BMP5
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.602208936149747,-1.1063032911157948,0.3333333333333333,0.8990167713288847,1.0,6/12,26.07%,GSTP1;ELOVL1;FADS1;ALOX5;CYP2J2;ELOVL2
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.5865319127364346,-1.1058018169136494,0.3392857142857143,0.8997134697575841,1.0,1/15,1.09%,ENPP6
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.6080658836752182,1.1056337203208555,0.29310344827586204,0.690092236985864,1.0,2/12,10.83%,EGFR;TEC
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5536166077513754,-1.1053937547578392,0.3541666666666667,0.8999571808864668,1.0,9/30,19.08%,TINF2;DCLRE1B;PINX1;DKC1;NHP2;TELO2;RFC1;GAR1;PPP6C
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.6420388644098953,1.1053384964471165,0.3541666666666667,0.690281946323543,1.0,3/13,18.36%,ETNPPL;ETNK1;CHKA
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.5768388864385421,1.105292955665815,0.38461538461538464,0.689912589788945,1.0,3/21,10.90%,SLC23A1;CBLIF;SLC35F3
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.4892039544004774,1.1050074066931939,0.3076923076923077,0.6901564611711127,1.0,8/34,10.68%,ST6GAL2;ST8SIA3;ST8SIA4;ST3GAL6;FUT9;ST8SIA6;B3GALT1;ST6GALNAC5
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.6943885416744682,-1.1046958818530521,0.42592592592592593,0.9013875666862565,1.0,2/6,12.76%,NDUFA12;NDUFV3
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.3542209955209836,1.1045676960500672,0.12903225806451613,0.6906945542308002,1.0,148/686,18.84%,ETV1;TGFB2;PLAC8;PDGFB;NPAS2;PPARG;BMP6;PLSCR1;EGFR;TP73;FOSL2;GRHL1;IGF1;FOS;TLR2;MLIP;HNF4G;HEY1;MEF2C;CASZ1;PID1;GCM1;UHRF1;LDB2;E2F3;NR4A3;MET;HGF;BMPR1B;BCL11B;NR2F1;ATF1;KAT2B;CITED2;MAFF;PPP3CA;PRDM15;KLF15;RHOQ;MACC1;PLAGL1;MAP2K5;WNT5A;LILRB1;LMO7;RARB;DLX1;PBX1;CIITA;MEIS3;NFKBIA;SOX9;GRIN1;PER1;LEF1;TEAD1;LMO2;TAL1;MEIS2;NOS1;CLOCK;PTPRN;EPAS1;STAT6;TP63;AGRN;ZGLP1;GLIS3;TGFB3;NOTCH4;TBL1XR1;NR1I3;BCL9;ARNT;TNFRSF1A;SATB2;PRKD1;BMPR2;ZNF304;ELK3;ZBTB18;HES1;CX3CL1;NGFR;NCOA7;NR2F2;POU2F2;FHOD1;PIK3R1;MRTFB;RPS6KA3;CDH13;KAT6B;RFX3;ITGB1BP1;NCOA1;GRHL2;ONECUT2;MED14;VEGFA;GLIS1;RPRD1B;RFXANK;TOX2;CSRNP2;THRB;WWOX;GPER1;IL33;ACVR2A;KLF6;CRX;NOTCH3;JUNB;NLRC5;CKAP2;SSBP4;SMARCA2;SMARCA1;NFIA;RXRG;KDM6B;CDK12;PFKM;PPARGC1A;CRLF3;KAT2A;NCOA6;PCGF5;CSRNP1;GLIS2;EDN1;ASXL3;HCLS1;PKD2;WWTR1;RXRA;CDK13;E2F1;NLRP3;DR1;SCX;NRF1;HMGA1;RFX5;RUNX2;ZNF827;CCDC62
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),-0.7746680652172614,-1.104482911945993,0.4444444444444444,0.9011140904987637,1.0,1/5,3.80%,PNRC2
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.4657316195744446,1.1042519993671087,0.21739130434782608,0.691061527211772,1.0,11/55,8.45%,CHRM3;CX3CR1;GUCY1A1;P2RY12;MCTP1;LAT2;LRRK2;DDAH1;NUDT4;NMUR2;NOS1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.5798136857223847,1.1042285624513117,0.2608695652173913,0.690653924509675,1.0,3/16,5.89%,DENND1B;PRKCZ;RSAD2
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.6571642190324243,1.1041510504962833,0.38,0.6903242155894369,1.0,4/8,25.51%,PIP4K2A;RUBCNL;ATP13A2;VPS39
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.48946196655128593,-1.1041143466971026,0.29310344827586204,0.9012819977672717,1.0,5/49,9.38%,USE1;ENPEP;BCKDK;SMPD2;NPL
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.6477596840397053,-1.104083089281628,0.40816326530612246,0.8994909242855076,1.0,3/9,7.90%,RACK1;SPHK2;SMPD2
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6477596840397053,-1.104083089281628,0.40816326530612246,0.8994909242855076,1.0,3/9,7.90%,RACK1;SPHK2;SMPD2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.5918036573164968,1.1038591203758819,0.3695652173913043,0.6904974397900814,1.0,2/12,3.11%,CARMIL2;FAP
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),0.7052114661852108,1.103830681425985,0.39215686274509803,0.6900910088227569,1.0,1/5,18.27%,ATPAF1
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.5529216044554532,1.1037138588510516,0.2972972972972973,0.6899476124195095,1.0,5/13,10.68%,ST8SIA3;B4GALT6;ST8SIA4;ST8SIA6;ST6GALNAC5
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),-0.7078017073603149,-1.1030813896043863,0.375,0.9014082486800993,1.0,2/8,16.47%,VAMP8;VAMP3
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.5848957986225664,-1.1029614359986373,0.3559322033898305,0.900706530982482,1.0,2/22,7.30%,RPS6;SYAP1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.6933244034414725,-1.1029428598835676,0.4339622641509434,0.8988059277168053,1.0,2/6,16.04%,DPH1;DPH2
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.6933244034414725,-1.1029428598835676,0.4339622641509434,0.8988059277168053,1.0,2/6,16.04%,DPH1;DPH2
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),0.6232533953843468,1.10285616341977,0.3793103448275862,0.6915635578292103,1.0,6/12,20.39%,IKZF1;TBX6;MEST;VEGFA;BMX;TIE1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),0.7455128295209348,1.1027795686193471,0.4166666666666667,0.6912574641043855,1.0,3/5,5.89%,DENND1B;PRKCZ;RSAD2
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.494311516925226,1.1027492856538956,0.34146341463414637,0.6908515993238202,1.0,9/45,12.16%,MEF2C;NR4A3;KAT2B;SCIN;TESC;MOV10;CBFB;MTURN;SETD1A
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.5087420742928147,1.1025988832470577,0.30612244897959184,0.6908851912546619,1.0,9/34,15.52%,NCKAP1L;ZFP36;TAL1;MAFB;ARNT;MAPK11;LYN;ZFP36L1;ACVR2A
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.6178157278488638,-1.1024350048296667,0.35294117647058826,0.8996494278683561,1.0,2/13,5.04%,NT5C;MBD4
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.5241325602453225,1.1023947633786473,0.36,0.6908956530149143,1.0,6/29,11.28%,RHBDF2;IL12A;IRS1;RSAD2;KCNB1;CD200
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.7545300342969764,-1.1020183282956029,0.42,0.8999813219926835,1.0,4/5,22.93%,ANXA2;B2M;HFE;BDNF
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.6703540958498627,-1.1017877304752528,0.38,0.8995668565456486,1.0,3/8,6.68%,PDE6A;CNGB1;GNA11
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.5515264679462366,-1.1016126238579584,0.2982456140350877,0.8990987914882868,1.0,12/30,23.84%,DDX5;PRMT2;RNF6;UFL1;CARM1;CALR;GPAM;PARK7;KCTD6;KDM5D;UFSP2;PKN1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.5268279169336051,1.1013443391859326,0.4,0.6929517491907272,1.0,6/36,11.67%,DCX;SPEF1;RSPH9;CFAP74;PLK1;SPAG16
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.6403675981906598,1.1011773997258545,0.40384615384615385,0.6928071414596618,1.0,4/11,14.26%,SOX9;SULT2B1;RFX3;SFRP4
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.45176573517846264,1.1010206606278905,0.3333333333333333,0.6926396811263488,1.0,19/63,16.82%,LPL;TLR2;NCKAP1L;C1QTNF4;SYK;PTPN6;WNT5A;TIRAP;IRAK3;CD200;CX3CL1;POU2F2;EOLA1;PTPN11;IL17RA;IL33;NOS2;GAS6;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.6626652387516977,-1.1009811510732546,0.35714285714285715,0.8997568461180786,1.0,3/9,11.33%,PRELID1;DBI;TRIAP1
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),0.6100490793783248,1.1009496441491564,0.4166666666666667,0.6923573083396913,1.0,3/12,8.16%,IGF1;SULF1;ACVR1C
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.7044143789135177,1.1007785237132648,0.46808510638297873,0.6923591072559836,1.0,2/6,15.90%,BMPR2;ADRB2
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.6278281353014842,-1.100745530014542,0.3958333333333333,0.8995161792447876,1.0,3/10,26.41%,PSMC5;HMGB1;PSMC4
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.4605767051977526,1.1007365494028971,0.26666666666666666,0.6919929651737112,1.0,1/46,0.01%,MFNG
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.47666562759222636,-1.1007317143638138,0.2631578947368421,0.8985969995832728,1.0,14/92,11.44%,NGF;LCK;RPS3;PRR7;BEX3;SLC22A2;RACK1;NLRP1;HSPE1;NLRP2;FIS1;ATP2A3;BAX;RPS27L
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5459824029156581,1.100722341022671,0.3090909090909091,0.6915813367907528,1.0,4/23,6.15%,MMRN2;PPARG;MEF2C;MAP2K5
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.5581822989232159,-1.1006188692570795,0.3191489361702128,0.8970446571428886,1.0,1/17,1.14%,CDKN1C
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.5581822989232159,-1.1006188692570795,0.3191489361702128,0.8970446571428886,1.0,1/17,1.14%,CDKN1C
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6061430799152986,1.1006023873262574,0.3333333333333333,0.6913692844442593,1.0,5/14,17.87%,PPARG;PRKAB2;PDK4;ADIPOR2;PRKAG2
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.5532555050383721,1.1005456885001783,0.2727272727272727,0.691065702016891,1.0,5/16,10.68%,ST8SIA3;HEXB;ST8SIA4;ST8SIA6;ST6GALNAC5
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.5579189126853836,1.1005150437830076,0.33962264150943394,0.6907089951559069,1.0,8/22,15.22%,SLC4A10;NEDD4L;UNC80;SLC4A4;CAMK2D;SLC30A3;WNK2;FHL1
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.7405991608963272,-1.1003870717604547,0.3673469387755102,0.8967086852078846,1.0,1/6,7.17%,CALM1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.5488549721409737,-1.100382409374834,0.3684210526315789,0.8957514190550034,1.0,5/22,13.18%,CHMP2A;NUMA1;CHMP5;CHMP3;DYNC1H1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.5896416036772463,1.1002170008364824,0.32558139534883723,0.6910480394852343,1.0,4/16,12.58%,PDGFB;GRM6;PLPP4;LGALS3
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),0.6817446950702759,1.1000956747561184,0.3953488372093023,0.6909285094562598,1.0,1/5,10.47%,RFTN1
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.4396315745709184,-1.099866907362079,0.22580645161290322,0.8963000578032179,1.0,18/233,7.30%,NGF;ARHGEF16;TNFRSF8;RPS27A;UBC;SFRP1;PRR7;SAP18;RPS6;UBB;USP27X;PTPA;RACK1;TNFAIP8;SPHK2;SOD1;PRMT2;KNG1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.6500211663113649,-1.0997616955604312,0.4117647058823529,0.8956781184106333,1.0,4/17,15.45%,PTPA;YWHAB;PPP1R35;SH3RF2
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.6366088317049453,-1.099690510015428,0.36,0.8939894401293759,1.0,4/11,20.28%,SLC25A11;SLC25A10;SLC37A4;SLC25A3
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.6366088317049453,-1.099690510015428,0.36,0.8939894401293759,1.0,4/11,20.28%,SLC25A11;SLC25A10;SLC37A4;SLC25A3
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.64761308941328,1.0991804766835573,0.32558139534883723,0.6927930996951589,1.0,2/7,15.86%,PLA2G10;PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.6952408967990881,-1.0991587781606396,0.32727272727272727,0.8948873066824847,1.0,3/8,11.33%,PRELID1;DBI;TRIAP1
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.46866039611007143,-1.0991516618038593,0.2878787878787879,0.8939381400750455,1.0,1/69,0.09%,PM20D1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.5121029692046255,-1.0990920262102972,0.2727272727272727,0.893089423715618,1.0,10/64,11.44%,NGF;LCK;BEX3;SLC22A2;RACK1;NLRP1;HSPE1;ATP2A3;BAX;RPS27L
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.5156960135203023,1.099059408006679,0.34782608695652173,0.6926039636324741,1.0,5/29,13.15%,BMP6;PLSCR1;LY86;IFNK;PUM1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.6244370805088642,1.0988076604866246,0.3829787234042553,0.6929332842566073,1.0,3/8,13.37%,EPHA4;EFNA3;LYN
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.6607832711186005,-1.0986590186207705,0.4423076923076923,0.8934759246519586,1.0,2/7,5.02%,WNK4;ATP1B1
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.5425314726221986,1.0979039036218752,0.3541666666666667,0.694983358668357,1.0,9/19,16.21%,GRIN2B;SLC8A1;ADRA1A;GRIN1;TRPM2;TRPV4;TRPM1;JPH4;ITPR3
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),0.7481581412203411,1.097552993561065,0.37735849056603776,0.695341160412298,1.0,2/5,8.86%,LEF1;STAT6
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.7264067873909608,-1.0974394718102543,0.36538461538461536,0.8965221952870395,1.0,2/6,12.30%,CROT;BHMT
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.6945943297502808,1.0973387051006858,0.3953488372093023,0.6954703200151231,1.0,3/5,24.71%,SARM1;LY96;TICAM1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.5890978653516109,1.0971642068971703,0.34782608695652173,0.695447290993471,1.0,3/14,3.12%,KCNMA1;NEDD4L;SLC8A1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.4623411004988515,-1.0970816140836268,0.3114754098360656,0.8967436767250221,1.0,29/139,17.75%,TPX2;BUB1;STMN1;KIF3B;PTPA;SBDS;NDC80;RPS27;DYNLL1;TUBG1;BCCIP;RAN;NEK6;RHOA;KIFC1;SGO2;MIS12;NUDC;DYNC1H1;KIF4A;GOLGA2;ABRAXAS1;KIF11;WRAP73;NUP37;DYNC1I2;KNTC1;SMC1A;STIL
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.7124074230393163,1.0967935481354871,0.40816326530612246,0.6958344863365027,1.0,2/8,3.35%,TGFB2;MEF2C
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.6036232413818059,1.0963157740687315,0.4,0.696661478297216,1.0,4/18,9.82%,ST8SIA3;MAN1A1;ST8SIA4;ST8SIA6
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.6462093313067514,1.0962790567366691,0.4186046511627907,0.6963115109136873,1.0,3/9,20.81%,ABCD2;MLXIPL;LPGAT1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.4785889354326855,-1.0956718752403687,0.2807017543859649,0.9001719817598492,1.0,8/84,12.97%,SELENOS;SEC61B;UBXN4;UBQLN2;USP19;TMEM129;ERLIN2;ERLEC1
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.4555548330983064,1.0956128834421965,0.36,0.6975237897571371,1.0,20/63,14.74%,RIMS4;MEX3A;CBARP;EFNB3;CDK5R2;NR2F1;DLX1;TENM3;MEIS3;TEAD1;NKAIN1;LYPD6;PCGF2;NGFR;CSPG5;NR2F2;TMEM59L;RAC3;ONECUT2;SRRM3
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.5750091554924756,-1.0955795506360804,0.35555555555555557,0.8994724425927557,1.0,4/17,14.37%,CHMP2A;SNF8;CHMP3;HGS
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.4931108980825425,1.095379464629851,0.26666666666666666,0.6976358940597465,1.0,2/40,1.03%,CLDN5;CLDN16
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.5078153619198151,-1.095331580686129,0.32727272727272727,0.8993166935358857,1.0,6/48,11.83%,CDKN1C;SERPINE1;FNTA;RHOA;RAB31;ID3
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.6943563778284016,1.0952597230282675,0.43636363636363634,0.6975055570470737,1.0,4/5,26.99%,ZNF304;PHF19;OGT;MTF2
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.6522330613810319,1.0951065115371785,0.42857142857142855,0.6974132220807778,1.0,2/7,20.78%,B3GALT1;UGCG
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),-0.6813832684714936,-1.095106431688932,0.42,0.8990280634472758,1.0,1/6,11.22%,HRAS
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.6041671638220085,1.094978620876916,0.3617021276595745,0.6972453849614432,1.0,2/14,13.45%,SGO1;PDS5B
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.513068677616102,-1.094910613130366,0.2727272727272727,0.8986868173333975,1.0,5/37,8.48%,OOEP;MGMT;USP51;RAD51AP1;OTUB1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.5488722959887522,1.094839446707897,0.3333333333333333,0.6970626487204699,1.0,8/22,18.90%,PID1;PRKCZ;IRS1;GRB14;KANK1;PIP4K2A;PRKCD;PRKCQ
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.5749577736625616,-1.0946104864810282,0.35555555555555557,0.8986121531604659,1.0,2/14,3.81%,SFRP1;CRHBP
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.7279564755207835,1.0945998625158444,0.391304347826087,0.6972275559311438,1.0,3/5,18.61%,PLCB1;PLA2G10;GLRA1
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),0.6941195581180614,1.094451315730361,0.41935483870967744,0.6970601603092516,1.0,4/6,24.77%,BMPR2;NR2F2;TIE1;ACVR2B
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.7027679964831334,-1.0941968060644944,0.42,0.8988917505131576,1.0,1/5,10.15%,LAGE3
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.7358352848128492,1.0941802349808856,0.4772727272727273,0.6972625714803437,1.0,2/5,16.50%,SETMAR;SETD5
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.639484261741047,-1.0940491229427927,0.35714285714285715,0.8983306499256225,1.0,3/8,6.18%,SIGIRR;GSTP1;APOD
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.677773444454647,1.0939370392277359,0.3191489361702128,0.6974345721382632,1.0,4/7,23.61%,RFX3;DNAAF1;CFAP53;ODAD4
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.7520449961732283,-1.093895538864641,0.4107142857142857,0.8979120766100221,1.0,1/6,0.74%,CRTAM
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.5988219192860117,1.0937353969088552,0.36363636363636365,0.6974255594587168,1.0,1/13,0.55%,IGFBP3
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),-0.6939179280465662,-1.0935962364023952,0.4489795918367347,0.8978914921516691,1.0,1/5,6.14%,USH1C
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.39386991336158955,1.0934446222452725,0.2857142857142857,0.6976725186055006,1.0,40/166,17.21%,PKP2;DPP10;KCNIP4;RAB3C;NRXN1;ANK1;KCNB2;FGF13;FYB1;PACSIN1;TSPAN14;SCN3B;ZDHHC23;TESC;RAB34;RAB15;AGRN;PICK1;KCNB1;LIN7A;RFTN1;TNFRSF1A;P2RY1;DLG4;HPS6;RAB3A;RAB29;KCNIP3;TNIK;ANK3;ITGB1BP1;CPE;ZDHHC2;CACNB2;THY1;LRRC4;NLGN1;GAS6;ATP1B3;RAMP1
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.6904708485105174,1.0934413213051664,0.4117647058823529,0.6972345295785729,1.0,2/8,21.41%,PRKCD;RPS6KA4
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.46673379107976737,1.0934264669408282,0.35555555555555557,0.6968196554752979,1.0,12/68,14.70%,PDGFB;ANGPT1;MET;WNT5A;HSPB1;GPLD1;PRKD1;BMPR2;SCARB1;AKT3;ITGB1BP1;VEGFA
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.4345465518693843,1.0931010477656204,0.225,0.6971491807913078,1.0,22/115,10.87%,PDGFB;AQP1;SSTR1;EGFR;P2RY12;RYR3;ADCY8;MEF2C;LRRK2;NR4A3;GABRG2;HCN1;ABCB4;GABRB2;GNG2;ADCY2;CASP7;DIAPH1;DMTN;TRPM2;P2RY1;GABRB3
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.6259715601679959,1.092842319213836,0.38181818181818183,0.69735063217994,1.0,1/11,1.41%,EGFR
prerank,MSigDB_Hallmark_2020__Apical Junction,0.4005062181465591,1.0923836602652761,0.1875,0.6979645617413368,1.0,26/162,13.63%,ADAMTS5;CLDN5;PTPRC;EGFR;ITGB4;MPZL1;ACTN1;VCAN;BAIAP2;CNTN1;SYK;SRC;IRS1;FYB1;RHOF;CADM3;ARHGEF6;MAPK11;YWHAH;COL9A1;CX3CL1;CDH6;AKT3;SLC30A3;CDH3;NEGR1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.716641583720712,1.0922986451199679,0.32075471698113206,0.6976627716614869,1.0,3/6,9.64%,NCKAP1L;ANO6;C3
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.4799217827395576,-1.0920975359881726,0.28,0.9016174426627078,1.0,15/88,14.95%,BUB1;SFRP1;PKMYT1;PLK4;USP51;FBXO43;ANKK1;CALM1;NUMA1;USP19;DBF4B;HMGA2;DYNC1H1;E4F1;KIF11
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.5290877136917638,1.0919462763573593,0.32558139534883723,0.6979459538273248,1.0,3/27,10.63%,PPARG;NFKBIA;PLA2G10
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.6343603499955903,-1.0917703619542996,0.375,0.9017338970761559,1.0,2/8,14.95%,RANBP1;KIF11
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),-0.7200775431459425,-1.0913082592938572,0.4186046511627907,0.9019996510814597,1.0,1/6,0.24%,BMP5
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5107382098967292,1.0911427048371292,0.32608695652173914,0.6994346590242975,1.0,7/23,17.92%,ID2;LEF1;TESC;CD4;FES;ZFP36L1;HCLS1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.46439205648030596,-1.0911222783430898,0.26666666666666666,0.9016409346280039,1.0,27/104,19.94%,RPS14;SRPRA;ATF3;H2AX;IMP3;TARS1;BANF1;SPCS1;NOP56;EXOSC5;NPM1;DKC1;RRP9;POP4;SPCS3;CKS1B;EIF2AK3;NHP2;FKBP14;CALR;ATF4;DCTN1;NOP14;MTHFD2;PSAT1;YIF1A;LSM1
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.4756686695956651,-1.0907317460587385,0.3620689655172414,0.9018974501853573,1.0,11/49,15.56%,RPS3;PRR7;UBXN1;VPS28;PINX1;SVBP;SQSTM1;UFL1;SMAD7;SH3RF2;DNAJA1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.686763206710796,1.0904312740824218,0.4107142857142857,0.700614579462504,1.0,2/9,8.82%,PLXNA4;PLXNA2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.6825332760774763,-1.0898976882499785,0.45454545454545453,0.9035301723845922,1.0,2/7,22.91%,B2M;ERAP2
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),0.6932532717172005,1.08988189839742,0.35294117647058826,0.7015985099932627,1.0,1/5,4.95%,LZTFL1
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),0.6907200948729045,1.0898054454895378,0.41509433962264153,0.7013103229635528,1.0,2/5,17.71%,EDNRB;EDN1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.5024271024608804,1.0897294843893846,0.35555555555555557,0.7010673271758718,1.0,8/27,17.99%,KCNJ3;KCNJ4;ABCC9;KCNJ6;ATP1B2;KCNH2;ATP1B3;SLC12A5
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.6339434898813313,1.0895845702833247,0.35294117647058826,0.7010635585552055,1.0,1/11,1.88%,TRIM5
prerank,GO_Biological_Process_2021__DNA protection (GO:0042262),0.7542497659438653,1.0892438270367855,0.46511627906976744,0.7015000229814082,1.0,2/5,7.96%,CBS;DCTPP1
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,0.4480069099019334,1.0892125487921984,0.2765957446808511,0.7011455169094201,1.0,13/68,13.07%,AQP1;CD44;LOX;CSF3R;TMCC2;RSAD2;TAL1;NR1I3;PNPO;KCNN4;RBM38;TUBB1;CR1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.5831407669033354,1.0891266122104175,0.30434782608695654,0.7008957880962919,1.0,2/13,7.25%,NFKBIE;NFKBIA
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.6599450338445734,-1.0890654764274832,0.43333333333333335,0.9052383142839419,1.0,4/8,21.33%,SNAPC1;SNAPC3;SNAPC5;ZC3H8
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.5223279903379444,-1.0890491463919114,0.3617021276595745,0.9043614181002491,1.0,13/46,15.64%,H1-4;H2AX;NOC2L;CHAF1B;H1-2;GRWD1;SMARCA5;H2BC21;HMGA2;NPM1;POLE3;DAXX;M1AP
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.6907506137532736,1.088968767997075,0.4883720930232558,0.7008400060094472,1.0,1/5,10.63%,PLA2G10
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.4401758517426108,1.088750774386556,0.29545454545454547,0.7009331472409267,1.0,29/73,25.75%,PPARG;IL12A;WNT8B;SOX9;MAPKAPK3;TIRAP;NOS1;IRAK3;ERBIN;ACER2;ALPL;RPS6KA3;NOCT;NOS2;RXRG;RXRA;GGT5;RARG;FER;LBP;LY96;FOXO3;HMGB2;ASCL1;SRR;STAT3;STAT5B;PELI1;LGALS9
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.6893674762256243,-1.0885423033349366,0.44,0.9039753813166188,1.0,1/5,2.90%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.6893674762256243,-1.0885423033349366,0.44,0.9039753813166188,1.0,1/5,2.90%,SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.6155287441165114,-1.08851969751973,0.36666666666666664,0.9030938218651308,1.0,2/9,10.84%,SPX;SRI
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6269143874582658,1.0882331480162903,0.32653061224489793,0.7013643743934894,1.0,3/10,11.20%,B3GALNT1;B3GALT1;B3GNT6
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.6269143874582658,1.0882331480162903,0.32653061224489793,0.7013643743934894,1.0,3/10,11.20%,B3GALNT1;B3GALT1;B3GNT6
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.6958250898008419,1.0881656404253264,0.35714285714285715,0.7010707234945867,1.0,3/6,19.23%,VEGFD;VEGFA;IL16
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.6281980859428822,1.0881213251166504,0.40425531914893614,0.7007328993676927,1.0,2/9,1.70%,AQP1;KCNC2
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),0.7075488226380158,1.0877111865994782,0.41304347826086957,0.7012932248901014,1.0,2/6,22.23%,ATPAF1;ATPAF2
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5144427332949617,-1.0875766738250268,0.3392857142857143,0.9051246638308579,1.0,5/29,9.32%,CRTAM;SELP;ITGAL;PVR;ICAM1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.44834289438129815,-1.0874838274424041,0.2708333333333333,0.9044961938706084,1.0,17/88,14.59%,TNFRSF8;PSMB6;PSMD7;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;CHUK;PSME1;TMSB4X;TXNDC17;EIF5A;PSMA7;PSMB8;PSMD13;ILK
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.530330191753932,-1.086894605984888,0.33962264150943394,0.905512602660967,1.0,2/42,3.15%,PM20D1;DEGS1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.5247328952025722,1.0867219214471633,0.38461538461538464,0.7031578040171748,1.0,8/28,16.46%,SEMA3D;SLIT1;SEMA6A;ROBO1;SEMA4G;SEMA4B;SEMA3C;SEMA7A
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),-0.6796437995811,-1.0863990244358952,0.4117647058823529,0.9061186059494688,1.0,1/7,5.41%,ACTN2
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.6315852986535592,1.0863764008470822,0.3333333333333333,0.7030440274272196,1.0,4/6,25.34%,JAK1;STAT5A;STAT3;STAT5B
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.6315852986535592,1.0863764008470822,0.3333333333333333,0.7030440274272196,1.0,4/6,25.34%,JAK1;STAT5A;STAT3;STAT5B
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.5111041331139342,-1.086216350525872,0.2978723404255319,0.9057340477497173,1.0,10/26,21.92%,RPS2;GORASP1;GOLGA2;UBE2L3;UBE2S;UBE2N;PINK1;BMI1;CDC20;SKP1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.6006153859526037,-1.0861269803951896,0.375,0.9050815440173638,1.0,6/19,16.35%,PSMG2;CCT2;PSMG3;PFDN6;BBS10;BBS12
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.6738024211228981,1.0859762826676131,0.45098039215686275,0.7035274877143796,1.0,4/6,28.81%,DENND3;DENND4A;MADD;DENND1A
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.49926289625277215,1.0858319514613117,0.38181818181818183,0.7034186673263926,1.0,5/28,16.88%,PTPRC;SOCS3;HES1;GHR;CRLF3
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.6626215334177247,1.0854690953166921,0.4716981132075472,0.7035412216817133,1.0,1/7,6.15%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.6626215334177247,1.0854690953166921,0.4716981132075472,0.7035412216817133,1.0,1/7,6.15%,WNT5A
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.5445559850323802,1.0854378760148002,0.40384615384615385,0.7031520805134021,1.0,6/27,12.79%,EGFR;PTPRR;NRG1;SRC;ERBIN;PIK3R1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.5967711413236212,1.0854183838201679,0.40816326530612246,0.7027855588752389,1.0,3/13,15.30%,KLF9;LMO2;THRB
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.6659744666246988,1.0853110764316574,0.39215686274509803,0.7025669515624889,1.0,3/6,10.72%,SYK;FBLN5;BST1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5151754145005225,-1.0852819987603473,0.2962962962962963,0.9067080080700621,1.0,13/41,21.15%,JUP;RBM22;HYAL2;RAN;ANP32B;EMD;TRIM28;NEDD4;ZPR1;IPO5;TPR;FLNA;DMAP1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.4245221075003836,-1.0852523269505117,0.3333333333333333,0.9058222647028803,1.0,26/164,13.09%,RPL5;RPS3;EIF1;RPL10;EIF3D;NCL;GAPDH;ZNF598;MIF4GD;EIF5;EIF1B;RACK1;PASK;METTL5;DHFR;RPL13A;RPS4X;PYM1;EIF3B;EIF4G2;BTG2;RPS27L;MTRES1;NPM1;METTL18;TCOF1
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.4680343977002031,1.0849796728447005,0.3333333333333333,0.702945439379193,1.0,22/75,14.70%,KCNIP1;OGDHL;CAMSAP3;TRPC7;CTNND2;NOL4;CDK5R2;NTRK2;NPNT;SH3GL2;EPB41L1;SYT7;GLIS3;PCGF2;CYS1;RAB3A;SLC7A8;ABCC8;PDZRN3;CPE;PRR36;VEGFA
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.6764768324562057,1.084633966816017,0.37254901960784315,0.7034118168544014,1.0,5/9,13.36%,PDGFB;FLT1;CX3CL1;LGALS3;PTPRO
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6932282425759231,1.0846276825505867,0.4444444444444444,0.7029871769968242,1.0,3/7,29.11%,PICK1;FYN;ITGA3
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.5275291143264192,1.0845585938188977,0.3157894736842105,0.7026366109869886,1.0,7/21,11.60%,UTRN;FGF12;NEDD4L;SCN3B;NOS1;CAMK2D;YWHAH
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.6265238028103398,-1.084446858972728,0.3953488372093023,0.9071248399372352,1.0,4/12,22.62%,CSTF2T;CSTF2;FIP1L1;ERN1
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.3835793637407937,1.0844138728555384,0.28205128205128205,0.7025804736917427,1.0,21/137,9.76%,TGFB2;PDGFB;SRGN;RAB27B;SYT4;IGF1;ABCC4;ACTN1;SNAP25;RIMS2;HGF;SYT1;SCIN;DNAJC5;SYT13;STX1A;PCLO;VEGFD;SYT7;TGFB3;ARHGAP17
prerank,GO_Biological_Process_2021__type B pancreatic cell development (GO:0003323),-0.720394048333342,-1.0843616054163594,0.4090909090909091,0.9065253944037953,1.0,1/5,0.24%,BMP5
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.4124857637119591,1.0843358344112524,0.32608695652173914,0.702304050362513,1.0,24/110,10.12%,ZNF423;KITLG;EGFR;FSTL1;LRIG3;CSPG4;KIAA1217;MET;TMEM47;LAMC1;DDAH1;CHST3;COL12A1;SOX9;TEAD1;COL4A1;BOC;DMD;LIFR;EPB41L1;ADAMTS15;NTN4;NUAK1;ANTXR1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.7032688294033731,1.0838142345847654,0.4489795918367347,0.7029382089328517,1.0,1/5,7.23%,HS6ST3
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.7082705015781222,-1.0836593283771878,0.39622641509433965,0.9068034658244017,1.0,2/7,12.11%,EXOSC8;EXOSC5
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.7082705015781222,-1.0836593283771878,0.39622641509433965,0.9068034658244017,1.0,2/7,12.11%,EXOSC8;EXOSC5
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.6347031818112467,-1.083636379350543,0.38095238095238093,0.9059221805426948,1.0,6/9,28.48%,HMGA2;ZNF639;JUN;INPP5K;TARDBP;HDAC1
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.6070468009946971,-1.0834648567755178,0.37037037037037035,0.9054038158926424,1.0,5/14,21.53%,EME1;MUS81;HUS1;MDC1;RAD9B
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.5441671190744478,1.0832476605992691,0.3170731707317073,0.7039237083499031,1.0,7/24,17.87%,PPP1R3C;PYGL;GYG1;PGM2L1;PHKA2;AGL;PRKAG2
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.6818812644818285,1.0830362170995416,0.33962264150943394,0.7040062081412255,1.0,2/7,12.31%,IMPA2;ITPK1
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),-0.6897743248680162,-1.0828093834316146,0.3877551020408163,0.9065012494480624,1.0,2/5,16.27%,DUSP12;BAD
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.6495229833051328,1.0827178360336178,0.4444444444444444,0.7039585511860132,1.0,2/7,1.70%,AQP1;KCNC2
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.6495229833051328,1.0827178360336178,0.4444444444444444,0.7039585511860132,1.0,2/7,1.70%,AQP1;KCNC2
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.508850105234662,1.082013530170955,0.37209302325581395,0.7050287823355608,1.0,7/24,15.49%,PID1;SRC;ST3GAL6;SOCS3;PTPRT;PTPN11;SELPLG
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.48658008397302766,-1.0815166312202877,0.3,0.9095441373355371,1.0,11/63,14.37%,H1-4;RNF8;H2AX;CHAF1B;H1-2;GRWD1;SMARCA5;H2BC21;NPM1;POLE3;DAXX
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5520635410096372,1.0814659254823833,0.3584905660377358,0.7059806722676744,1.0,5/15,17.92%,BAIAP2;BAIAP2L1;FES;NTRK3;HCLS1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.6704081796050464,1.0808319075846304,0.4393939393939394,0.7073406711058615,1.0,1/7,10.17%,CORO1C
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.6886424025096255,1.0804834552640112,0.42857142857142855,0.707712914316876,1.0,3/7,11.54%,ADCY8;KCNB1;MAPT
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),-0.773435029186401,-1.0799446338758352,0.46938775510204084,0.9135150733947874,1.0,1/5,6.63%,FNTA
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.6241637982802077,1.0797664867695813,0.35555555555555557,0.7091942494014684,1.0,4/9,13.64%,ADGRE2;SYK;LYN;FES
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.6382264734398546,1.0795606486832918,0.375,0.7093241432346945,1.0,2/7,4.59%,CAPN1;ADGRV1
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.7505028536833228,1.0793535402522756,0.3877551020408163,0.7094392949933291,1.0,2/6,11.37%,GRIN2B;HOMER1
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.6255002220195964,1.0793458759938703,0.40384615384615385,0.7090078431735661,1.0,1/12,1.17%,PTPRC
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.6426778229543553,-1.0792430649633784,0.35185185185185186,0.914720711839164,1.0,1/11,3.09%,PPIB
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.5475143258364803,1.0791580579015274,0.36363636363636365,0.7089191620077983,1.0,4/25,14.26%,FSTL1;BCL9;NREP;SFRP4
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.7236432488954072,-1.079086945906353,0.5192307692307693,0.9141960008618659,1.0,2/5,15.24%,GREM1;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.721948765467644,-1.079057013574101,0.4807692307692308,0.9133732818000506,1.0,2/5,25.83%,UFL1;HSPA5
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.7228324489871527,1.0790138750555611,0.48,0.7088524218362499,1.0,2/5,25.08%,BMPR2;SOX4
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.7182990059456924,1.0786487688032222,0.41509433962264153,0.7093748491818096,1.0,1/8,6.69%,ACSM1
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.5115468375668347,-1.0785365970097724,0.3389830508474576,0.9139266059902048,1.0,3/35,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.5049611761078918,1.0783179366771527,0.43902439024390244,0.7096713187048963,1.0,6/25,11.37%,EPHA4;LRRK2;SIPA1L1;WNT5A;CDK5R1;HOMER1
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.6350600583634661,-1.0782505430595697,0.34615384615384615,0.9140012496634421,1.0,3/11,6.63%,PLPP2;KDSR;SPHK2
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.6445769691376813,-1.0781419309304399,0.47058823529411764,0.9134027373094405,1.0,2/10,5.02%,KCND3;ATP1B1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.4032952030183149,1.0779156732324153,0.26666666666666666,0.7101998606934133,1.0,24/118,16.82%,LPL;PPARG;TLR2;PIK3AP1;BIRC3;LRFN5;TNFRSF1B;WNT5A;NFKBIA;BCL6;FNDC4;TNFRSF1A;BST1;CD200;CX3CL1;AOAH;NFKBIZ;CCN3;IL17RA;GPER1;IL33;SEMA7A;PRKCD;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),-0.7492405914075781,-1.0776819545663991,0.47619047619047616,0.9139458324828968,1.0,3/6,13.28%,SERPINE1;KNG1;TFPI
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.6519372039465751,1.0770314646838743,0.42,0.712215889998963,1.0,2/7,13.17%,ARL13A;RAB29
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),0.7238444352036751,1.0770183956620412,0.3898305084745763,0.7113683177095775,1.0,3/5,9.64%,NCKAP1L;ANO6;C3
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",0.7238444352036751,1.0770183956620412,0.3898305084745763,0.7113683177095775,1.0,3/5,9.64%,NCKAP1L;ANO6;C3
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.5942318267282118,1.076838007734293,0.36,0.7113800626255464,1.0,4/14,12.14%,LRRK2;RHOQ;AK4;GTPBP1
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.705794341349567,-1.0767779201915122,0.42592592592592593,0.915907611528777,1.0,3/6,23.18%,CTR9;RTF1;PAF1
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.5489237074312293,-1.0762732322576007,0.3673469387755102,0.9164385678596949,1.0,3/22,7.06%,NGF;EDF1;PYHIN1
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.6539331857998546,-1.0762305081351566,0.4807692307692308,0.9156363841499112,1.0,2/9,11.31%,SOD1;ZNF830
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.6540544120172486,1.076193151021158,0.4791666666666667,0.7126228253192685,1.0,3/7,23.76%,TCAP;CAMTA2;HDAC4
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.5097243002572184,1.0752613860750413,0.40816326530612246,0.714609463827236,1.0,9/31,9.08%,EPHA3;AQP1;BRINP3;TWF2;WNT5A;WNT8B;SOX9;TESC;BRINP1
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.6019312515074831,1.0750288305092128,0.4230769230769231,0.7146047325088654,1.0,3/11,6.00%,CYFIP1;FCHSD2;SCIN
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.4544427217618461,1.0750176792059187,0.36,0.714195236850729,1.0,3/41,2.72%,ADAMTS5;ZNF423;PGAM5
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.6263349108479339,-1.0749571951040253,0.4406779661016949,0.9183278892396322,1.0,3/14,18.51%,DDX5;TADA3;PADI2
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.6337940256658376,1.0747765905248663,0.38,0.7144869331776786,1.0,4/9,19.32%,KAT2B;CCNF;KAT2A;TMEM67
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.6441777962617596,1.0745721380596398,0.375,0.7145328198995415,1.0,4/9,19.76%,COL4A1;NOTCH4;VEGFA;KDR
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.7141597845780464,1.0744873173640521,0.49019607843137253,0.7142612009994462,1.0,3/7,15.51%,ABCC4;ABCC6;ABCC11
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.6245582012339126,-1.0744343900694113,0.4074074074074074,0.9191003354672993,1.0,4/12,14.88%,ORC1;ZNF830;HUS1;TOPBP1
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.4068376452107769,1.0744191854620997,0.2608695652173913,0.7140403869676845,1.0,28/97,16.21%,CX3CR1;TRPC4;TRPC7;ADCY8;SLC8A1;PDGFRA;C3AR1;PTGER3;ADRA1A;GPR35;WNT5A;NMUR2;ATP2B3;CYSLTR1;ATP2B2;CDH23;P2RY1;TRPC3;TAC4;DLG4;TRPV4;CCR9;TRPC6;HCRTR2;FZD9;GPER1;CALCB;ITPR3
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.4894864282952162,-1.074339638674576,0.391304347826087,0.9183401874098845,1.0,12/37,20.43%,MBOAT1;MOCS1;TKT;AGPAT5;FADS1;GPAM;NFS1;GPAT2;PPIP5K1;GK5;G6PD;MOCOS
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.5628907700748543,-1.0742747371512862,0.3673469387755102,0.9175562244131891,1.0,7/24,19.85%,UBE2D4;CDC23;CDC26;UBE2A;UBE2L3;ANAPC11;UBE2S
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),-0.6997989459129452,-1.0741915990434814,0.47058823529411764,0.9159930401314718,1.0,1/5,3.81%,CRHBP
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),-0.6997989459129452,-1.0741915990434814,0.47058823529411764,0.9159930401314718,1.0,1/5,3.81%,CRHBP
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.4542769963993666,1.0740953459030722,0.3333333333333333,0.714540436466034,1.0,4/66,1.95%,LPL;PPARG;PLSCR1;CBS
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.43286993341796864,1.0740107336975329,0.3333333333333333,0.714247706400183,1.0,30/94,16.27%,NPY1R;P2RY12;ADGRE2;ADCY8;AKAP12;RXFP1;GPR161;CNR1;ADGRB1;PTGER3;ADCYAP1R1;ADGRG1;ADGRL2;GNAL;VIPR2;ADCY2;GPR26;ADCY7;GPR12;RGS1;ADCY1;GABBR1;GNAO1;HTR1E;GRM8;ABCA1;GPER1;CALCB;ADRB2;GNAZ
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.7179522088144963,1.0733902886777495,0.48,0.7152796059668808,1.0,4/7,24.89%,IL17RA;CLEC7A;TICAM1;STAT3
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.45754547662112766,1.0729933321369136,0.26,0.7157779830797029,1.0,15/61,14.21%,DACT2;ANGPT1;PTPRC;PLXNA4;SPOCK1;FBLN1;PLXNA2;DMTN;SEMA6A;CX3CL1;PDE3B;ACER2;PTPRO;CDH13;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.4922074381307965,1.072936672647061,0.37209302325581395,0.7155065988045131,1.0,9/37,13.07%,PTPRC;NCKAP1L;TNFRSF1B;LILRB1;SFTPD;LGALS3;CD80;CD70;CR1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.3958873642409249,1.0728572443641053,0.3333333333333333,0.7152858332400596,1.0,25/121,14.52%,CX3CR1;ROBO2;SLC23A1;GRIN2B;PCDH18;CNTN4;RELN;ADGRG1;ADGRL2;PBX1;CA10;MEIS3;GRIN1;COL4A1;ATXN1;MEIS2;NDRG4;EMX1;SLC6A4;CDK5R1;SETD1A;PTPN11;BBS2;SHROOM2;GRHL2
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.4735222171731349,-1.0723817137833829,0.27586206896551724,0.920344432114432,1.0,14/76,16.85%,ZDHHC12;NACA;SRPRA;SRP14;MYO1C;NACAD;SEC62;ZDHHC14;FIS1;YIF1B;SSR2;RABGEF1;PXMP4;ZDHHC7
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.6344358587428579,1.0721899764080347,0.38181818181818183,0.7165371520940398,1.0,3/8,7.64%,IFNA2;PRKCZ;LEF1
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.4000105518937395,1.0719859648962022,0.37209302325581395,0.7165743355341905,1.0,21/118,16.50%,NRG3;CAMSAP3;GFAP;STON2;RIT2;SPOCK1;WNT5A;PACSIN1;SNCAIP;IRGM;IRAK3;CAMK2D;KIF14;SLITRK4;SETD1A;PTPN11;CDH13;CHPT1;PAK5;RPTOR;SETD5
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.5911401655974021,-1.0717047403313191,0.38,0.9214720832506805,1.0,5/18,16.06%,CCT7;CCT2;CCT6A;DKC1;NHP2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6048102487804146,1.071695664218335,0.4,0.7168122574413812,1.0,2/9,10.38%,IL12A;SEMA6A
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.6536118718480175,-1.0714732139833432,0.4166666666666667,0.9211933761727739,1.0,5/9,14.82%,RACK1;FICD;BAX;BAK1;COPS5
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.42689244870438137,1.0714138659600148,0.36538461538461536,0.716913726678188,1.0,15/88,16.02%,EGFR;NEDD4L;GFAP;DACT1;ADGRB1;WNT5A;BANP;WWP1;PRKCG;IRAK3;HECW1;APC2;ZDHHC2;EEF1A2;TIPARP
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.5252877334164977,1.0713317188663263,0.3148148148148148,0.7166999388659443,1.0,2/25,5.76%,RHBDF2;STXBP5L
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.6561988940077673,1.0711812999387722,0.5283018867924528,0.7166080930446168,1.0,1/8,6.15%,WNT5A
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.6422002006840607,1.0710745544954798,0.4339622641509434,0.7163947504110362,1.0,1/9,1.56%,RPS6KA6
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.5727073000899418,-1.0709272511178298,0.41818181818181815,0.9219567410181573,1.0,3/18,3.81%,DPEP1;RBM22;CRHBP
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.5166681271227718,1.0709200239080763,0.36,0.7162817539664003,1.0,9/20,30.84%,RASIP1;VEGFA;EGFL7;KDR;TGFBR3L;RASA1;ITGB8;CAV1;PDGFRB
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.6301556382025161,1.070713924581469,0.4594594594594595,0.7162760659083256,1.0,2/7,4.94%,NMNAT2;KYNU
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),0.7268201793943307,1.0705376671602442,0.4727272727272727,0.716248963467709,1.0,1/5,11.18%,BMPR2
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.649817712438358,1.0701556030673833,0.42592592592592593,0.7168570068306944,1.0,4/9,9.07%,CHI3L1;PID1;ST3GAL6;PTPRT
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.48514431847034506,1.0701195886146282,0.46511627906976744,0.716522918953747,1.0,9/41,14.05%,CDH9;CDH10;CDH18;CDH22;CADM3;CDH6;CDH7;CDH3;CDH13
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.6216395585002337,1.0693606776245004,0.4230769230769231,0.7179497195690051,1.0,6/8,31.68%,RGS2;LRP1;FGFR3;FGFR1;SNCA;PDPK1
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.68351274444793,1.068923349967075,0.46296296296296297,0.7184630307567383,1.0,3/6,19.72%,UNC80;SLC7A8;ATP13A2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.589027619648266,-1.068686388559776,0.34,0.9279209126614494,1.0,2/13,7.34%,BUB1;NUMA1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.3926124506005291,1.0686075259150147,0.3333333333333333,0.7188831765341678,1.0,16/139,9.03%,KANK2;IGFBP3;TP73;OSGIN1;ACTN1;TNFRSF25;LRRK2;BIRC3;PTPN6;CASP10;SOX9;LRP8;TP53I3;BCL6;TP63;DAPK1
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.4895675099496853,-1.068581321662263,0.3469387755102041,0.9273431955185387,1.0,8/49,11.57%,ARHGEF16;GPRC5C;GJB1;TMEM125;ATP2C2;CFTR;CCKBR;EPCAM
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.5929410915862268,1.068570572665827,0.46808510638297873,0.7185344429911159,1.0,4/9,15.46%,IGF1;TNFRSF1B;CD200;IL33
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.6848707415901228,1.0684407326564298,0.48936170212765956,0.718292784284296,1.0,3/6,11.54%,SIAH3;LRRK2;MAPT
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.4518889760320158,1.0682443959000643,0.35555555555555557,0.7182717022318494,1.0,17/59,20.35%,OBSCN;SORBS1;SRC;FHDC1;TPM1;MYLK3;EPB41L1;CSRP2;CUL3;PHACTR1;KCTD13;CDC42BPA;ZYX;CAPN3;ARRB1;TCAP;FHOD3
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.7063047178346924,1.068167838991984,0.41509433962264153,0.7179949847824072,1.0,1/5,15.15%,BCAT2
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.5292158671594707,-1.068165065743923,0.35294117647058826,0.9276877826009012,1.0,7/26,15.45%,ACAA2;SQLE;DHCR24;IDI1;TM7SF2;PMVK;MSMO1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.6811184543242705,-1.0681537651949404,0.38,0.9267851919043029,1.0,3/6,15.03%,PRELID1;BAX;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.6237819208756554,1.0681323139978038,0.4230769230769231,0.7176263343830986,1.0,2/9,14.70%,ZSWIM6;VEGFA
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.45758480625088677,-1.0680118376894931,0.3,0.9262688421335453,1.0,17/70,23.39%,CSTF2T;SRSF7;SRSF3;SRSF9;CSTF2;RBM8A;DHX38;MAGOHB;SSU72;POLR2D;ALYREF;FIP1L1;SLU7;CASC3;CDC40;PAF1;SRSF2
prerank,GO_Biological_Process_2021__positive regulation of calcium-mediated signaling (GO:0050850),0.6565438936700623,1.0678553420887755,0.4807692307692308,0.7178397652002902,1.0,3/5,27.12%,CDH13;CLEC7A;NEUROD2
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),0.7384078359593185,1.0677249537647657,0.46296296296296297,0.7177268511476133,1.0,3/5,16.73%,ZNF516;UCP1;PPARGC1A
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.6285820837051201,1.0675513902281561,0.3559322033898305,0.7177274266121294,1.0,2/12,1.85%,PLSCR1;TLR2
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.4272797201144185,1.0674813993565768,0.34782608695652173,0.717522671234342,1.0,12/64,12.70%,CERS3;CERS6;ST8SIA3;VAPB;B4GALT6;ELOVL4;SGPP2;ST6GALNAC5;PRKD1;PPM1L;PNPLA1;ACER2
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),0.6981992738437325,1.067335453979625,0.5116279069767442,0.7174384554674733,1.0,1/5,4.06%,ST8SIA3
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.5258135682620608,-1.0672692484786266,0.3584905660377358,0.9275652554237295,1.0,8/29,15.45%,ACAA2;SQLE;DHCR24;SC5D;IDI1;TM7SF2;PMVK;MSMO1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.459284121123332,1.0669518493918355,0.37254901960784315,0.718012022868759,1.0,13/32,23.80%,RAB27B;CADPS;CADPS2;RAB15;RAB3A;SYTL4;EXPH5;TSG101;ATP13A2;CLASP1;RAB27A;SDCBP;STXBP5
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5264567137018382,1.066226901866847,0.45454545454545453,0.7193835418240601,1.0,16/31,16.49%,UTRN;FGF12;NEDD4L;FGF14;FGF13;NETO1;SCN3B;DMD;CAMK2D;YWHAH;HECW1;ANK3;WNK2;SCN4B;PRKCE;GLRX
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.5083093133455765,1.0659459625210184,0.32608695652173914,0.7197504176235334,1.0,9/27,29.30%,EDNRB;DLG4;RIN3;SIRT5;EDN1;SDCBP;AP1AR;ATXN2;PLIN5
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.6330355020623116,-1.0657856090617674,0.4444444444444444,0.9312445162104254,1.0,4/9,24.69%,EXOSC8;EXOSC5;DXO;EXOSC4
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.6353533215727841,-1.0655958313635596,0.37254901960784315,0.930841920881585,1.0,2/8,8.93%,PLAAT5;PLAAT4
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.6572638072745933,-1.065555737794817,0.3617021276595745,0.9299906266896708,1.0,5/7,25.42%,BYSL;PINX1;MCRS1;NVL;GLUL
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.5024939636883127,-1.0653524018893359,0.3541666666666667,0.9296316571628677,1.0,11/30,13.14%,TGM1;TNS4;KRT10;CLCA2;ENTPD2;CDSN;DUOXA1;LAMB3;ICAM1;C6ORF132;EHF
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.40540156524646886,1.0653439551899304,0.2727272727272727,0.720872181625,1.0,30/116,12.83%,PPARG;EGFR;FSTL1;POSTN;TNC;FAP;SLC45A2;CSPG4;LOX;CCDC80;LAMC1;CHST3;COL12A1;SOX9;HSPB1;TEAD1;COL4A1;PXDC1;PPFIBP1;CCND1;EPAS1;TP63;ANTXR1;BNC2;LAMB2;CCN5;PRICKLE2;TRPM1;PRRX1;GPC1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.6016324104805295,-1.065209648246011,0.375,0.929115557276287,1.0,3/13,15.28%,MELTF;PLGRKT;GSN
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.5753317790160319,1.0649859857843134,0.43137254901960786,0.7213012208559287,1.0,6/14,15.62%,PYGL;MGAM;AOAH;PGM2L1;PHKA2;AGL
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.5519060374386927,-1.0647559142684142,0.4666666666666667,0.9294636086938035,1.0,4/16,12.60%,BUD23;RIOK2;TRMT112;METTL18
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.47691992836073543,-1.0646590558383144,0.2962962962962963,0.928832623290437,1.0,10/69,10.82%,CELA2A;SELENOS;TRARG1;RAB8A;PARP1;SYAP1;USF1;CAPN10;RAB31;GCK
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.6238886074728547,-1.0645088431047527,0.425531914893617,0.9283685446964673,1.0,3/13,6.99%,AK8;CMPK1;ENTPD2
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.5114864361670027,-1.0642753697506404,0.375,0.9281039763351476,1.0,3/22,8.88%,AMPD1;PRPSAP2;GMPR2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.45070418978900223,1.064019345537676,0.34,0.7232949996814012,1.0,18/64,9.34%,FGL2;TLR2;CSF1R;C1QB;CLEC5A;LCP2;ITGAM;CD53;CSF3R;C3AR1;TNFRSF1B;LILRB1;WDFY4;LY86;CD4;P2RY13;LAPTM5;SLC40A1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.5617358065323118,1.0638827562916906,0.34545454545454546,0.723172451779208,1.0,4/13,27.07%,UBA7;UBA3;UBA5;ATG7
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.6650080781846336,-1.0637965954782265,0.43859649122807015,0.9285095171228327,1.0,3/7,18.56%,NOX1;NOXA1;CYBA
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated immunity (GO:0002705),0.6908371540279681,1.0629704920461565,0.43137254901960786,0.7248317423780826,1.0,3/5,23.42%,NOS2;CLEC7A;SCIMP
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),0.6693851435691613,1.0628996980174004,0.4666666666666667,0.7245746998563019,1.0,3/7,18.86%,F3;A2M;F8
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.6544284216883011,1.062773268678365,0.4666666666666667,0.724381268920774,1.0,1/6,6.12%,TNFRSF1B
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.6870968708844404,1.0626692816735444,0.3958333333333333,0.7242513357082783,1.0,4/7,20.20%,WNT5A;LRRC4;NLGN1;PTEN
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.6288357765556396,1.062496092662075,0.45098039215686275,0.7241918120907684,1.0,4/8,31.97%,ATP9A;IL1RAPL1;SNCA;RAB33B
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.522322147836906,1.0622199172600586,0.4117647058823529,0.7242657636779859,1.0,5/30,13.15%,WTIP;ZFP36;NOTCH4;MOV10;PUM1
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.6509673937383454,1.0622043632874727,0.36,0.7238694818128908,1.0,1/7,3.47%,CLEC5A
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.5915588217556481,1.0621470590516966,0.38181818181818183,0.723578865483677,1.0,2/12,9.27%,DPYS;NT5C1A
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.5337828669475057,1.0610760264823946,0.44680851063829785,0.7257977260759343,1.0,1/15,0.08%,CREB3L1
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.6471369096320528,1.060901657421121,0.37777777777777777,0.7257164462874434,1.0,2/6,13.62%,ST8SIA3;ST6GAL1
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),-0.7076804703900701,-1.0608507250352384,0.42857142857142855,0.9362724354635277,1.0,1/5,1.51%,SFRP1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.6130381473255577,1.0607463071734473,0.4,0.7256492639228684,1.0,2/12,8.93%,PARP14;SOCS3
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.5262228032983219,1.0605598236704135,0.38095238095238093,0.725624138909451,1.0,8/23,18.90%,PID1;PRKCZ;IRS1;GRB14;KANK1;PIP4K2A;PRKCD;PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.6429387019300915,-1.0604925933616312,0.421875,0.9364463654871819,1.0,1/13,10.34%,CHUK
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.5996888459428358,1.0604560388430406,0.41818181818181815,0.7254452173360453,1.0,4/11,25.20%,ADRA1A;ADRB2;AKAP13;LMBRD2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.40934925497760893,1.0603884487779873,0.2777777777777778,0.7251826524731415,1.0,16/105,8.29%,NPY;L1CAM;FRY;GPM6A;CFAP126;CSF1R;CYFIP1;MAP2;CARMIL1;CNTN4;LGI1;TPM1;STX3;PTPRM;SH3GL2;GPRIN3
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.6994029872862457,-1.0598032488867548,0.44,0.9374111909709704,1.0,3/6,20.48%,DNMT3B;PIH1D1;DNMT1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.5927058072792608,1.0596154248900378,0.34615384615384615,0.7266454021517839,1.0,2/11,9.27%,DPYS;NT5C1A
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.5763280909819651,1.0593859106228374,0.43902439024390244,0.726724441770105,1.0,6/14,24.20%,LPCAT4;PLA2G10;PLA2G4A;LPGAT1;CDS2;LPCAT1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.43468207869348197,1.0592974156625827,0.29545454545454547,0.7265731946746034,1.0,12/62,9.41%,CX3CR1;TLR2;MEF2C;TNFRSF1B;WNT5A;LILRB1;ZFP36;AXL;TIRAP;GIT1;VIM;IRGM
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.6120707842940432,1.0591796545002043,0.3958333333333333,0.7264081837266266,1.0,3/9,8.48%,F3;PTPRJ;NDRG4
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.7047763547763124,-1.0591726993433797,0.5087719298245614,0.9384399888088001,1.0,4/5,27.43%,IDH3B;IDH3G;IDH2;IDH1
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.6394441655503654,1.0591021328871888,0.42105263157894735,0.7258141460937312,1.0,1/11,2.83%,IMPA2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.6394441655503654,1.0591021328871888,0.42105263157894735,0.7258141460937312,1.0,1/11,2.83%,IMPA2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.642959896957668,1.058827234685256,0.37254901960784315,0.7259769520955178,1.0,4/8,20.80%,CBARP;BIN1;FKBP1B;ATP1A2
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.5479103374220113,-1.0587794146024263,0.37209302325581395,0.9386441778667912,1.0,3/24,7.50%,NGF;LRRC59;RASGRF1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.6307923083512662,-1.0587490366624914,0.43103448275862066,0.9378371793960761,1.0,6/11,29.63%,POLD3;XPC;DDB2;ACTR5;DDB1;CUL4B
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.6805359093678527,-1.058263746538892,0.423728813559322,0.9374007671836805,1.0,3/6,18.80%,DOLK;DPAGT1;DOLPP1
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.6805359093678527,-1.058263746538892,0.423728813559322,0.9374007671836805,1.0,3/6,18.80%,DOLK;DPAGT1;DOLPP1
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.6455405825349976,-1.0577627894340167,0.3684210526315789,0.9380558237331253,1.0,1/8,4.56%,XG
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.6676553391548948,1.05653820294627,0.48148148148148145,0.7308619838012639,1.0,1/7,14.34%,CPE
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.5835818573809379,1.0565342366278208,0.375,0.7304307967901719,1.0,4/16,7.37%,KCNC2;GRIN2B;GRIN1;TMEM120B
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.5545391500597691,1.056501506109863,0.3888888888888889,0.7300765325979627,1.0,5/11,16.08%,BMP6;BCL2;HAMP;SLC11A2;ACO1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.40495244917929946,1.0562465482854704,0.29545454545454547,0.7303197551104911,1.0,25/123,16.11%,PTPRC;PTPRG;PTPRR;PTPRB;PPP3CA;PTPN6;PTPRZ1;PTPRJ;PTPRM;DUSP10;PTPRT;PPM1L;PPM1H;UBASH3B;TPTE2;PTPN11;PTPRO;PTPN5;PPP1CB;RPRD1B;PTPRK;PTPN4;DUSP6;PPEF1;SSH2
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.5762632606649414,-1.0561300808206429,0.3877551020408163,0.9415827481389365,1.0,7/17,14.89%,SRPRA;SRP14;SPCS1;SPCS2;ZFAND2A;SPCS3;ZFAND2B
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.4677245263163786,1.056029306408959,0.4117647058823529,0.7304239196172723,1.0,9/43,9.08%,EPHA3;AQP1;BRINP3;TWF2;WNT5A;WNT8B;SOX9;TESC;BRINP1
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.6363860448925271,1.0557887675501052,0.46,0.7305765029516246,1.0,2/8,5.39%,ITGB4;LAMC1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.5513247232799702,-1.0556361437853528,0.42857142857142855,0.941995285373869,1.0,8/25,19.08%,TINF2;PINX1;DKC1;NHP2;TELO2;RFC1;GAR1;PPP6C
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.5929867666280891,1.0555869543880605,0.40425531914893614,0.7305972289254088,1.0,3/11,15.39%,ZFP36;ZFP36L1;GPER1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.4509954664868251,-1.0554110466715472,0.35384615384615387,0.941679920304882,1.0,14/70,17.52%,RPS13;RBM22;SRSF3;POLR2A;TMBIM6;C9ORF78;RPS26;MBNL3;RRP1B;FASTK;RBM23;HNRNPH2;JMJD6;PTBP1
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.5474634283218044,-1.0552924544590354,0.37254901960784315,0.9410876743468949,1.0,10/21,20.43%,HDC;PYCR3;FDXR;SRD5A1;PYCR1;MOCS1;NFS1;PRLR;STAR;MOCOS
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.6175435187985051,1.0552734425626393,0.47058823529411764,0.7307772363242936,1.0,2/12,10.69%,SYK;DYSF
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.5699509033420567,1.0551776894089522,0.44,0.7305624628455702,1.0,3/16,5.14%,ISG15;SYK;PRKCZ
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.5922496268305558,-1.055089051058192,0.4915254237288136,0.940708579042519,1.0,4/14,9.69%,GAPDH;RPL30;RPS19;H2BC21
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),-0.669455290039036,-1.0550492300917074,0.45454545454545453,0.939914788245022,1.0,1/5,3.05%,KIF3B
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.5854348734168151,1.054558544056881,0.4186046511627907,0.7316001366293239,1.0,6/14,19.95%,SLC24A4;GNAL;UBR3;MKKS;BBS4;OR3A2
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.4140277274610135,1.054448931799132,0.3333333333333333,0.7314197030325466,1.0,23/94,19.19%,GLRA3;KCNC2;RYR3;SHMT2;ADCY8;PRMT8;HCN1;SLC1A2;SAMHD1;TRPM2;PKD2L1;ACACB;MLKL;SHMT1;ATL2;TMEM120A;ZBTB1;DISP1;CBR4;PKD2;AQP4;TDO2;SYCP1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.4933368218094246,-1.0543456874747326,0.34782608695652173,0.941108173754082,1.0,4/33,12.41%,CENPX;RNF8;SMARCA5;NPM1
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.691615456744041,1.0542186205370776,0.5319148936170213,0.7315435250219321,1.0,1/5,0.40%,PDE10A
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),-0.6583214508141093,-1.0541407651067736,0.5,0.940827722891413,1.0,4/5,18.86%,GPD1;GPAM;GPAT2;GK5
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.5993912890660305,1.0539389431308999,0.4375,0.7317984165906368,1.0,4/15,11.81%,GPR35;LRCH1;DOCK8;CX3CL1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.5192582751660462,-1.0538538693666093,0.35714285714285715,0.940726501348237,1.0,4/31,7.06%,RAD23A;SERF2;KDM8;PYHIN1
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),0.7019890559347662,1.0534946481059075,0.3469387755102041,0.7323497952253287,1.0,1/5,4.00%,ARL13A
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.6191928667229069,-1.0530795301049602,0.46296296296296297,0.9422077366753384,1.0,3/10,19.22%,EXOSC8;EXOSC5;DXO
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),0.607352023940083,1.0529539801514654,0.46,0.7333695889703399,1.0,1/11,0.55%,IGFBP3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.4594448316750129,-1.0529421902436962,0.3333333333333333,0.941708165672789,1.0,4/56,6.31%,UXT;TFDP1;FBXO43;CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.5641638468072115,-1.052667125905674,0.3673469387755102,0.9417440593692352,1.0,1/13,1.56%,TINF2
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.5692348344346752,1.0520532996562888,0.4423076923076923,0.7351327322037492,1.0,6/19,16.25%,NRXN1;DLG4;LRP4;NLGN4X;LRRC4;NLGN1
prerank,GO_Biological_Process_2021__regulation of urine volume (GO:0035809),-0.6959895354723028,-1.0519436351625573,0.5,0.9428963884319552,1.0,1/5,5.49%,HYAL2
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.4756646516242755,1.0513386697193932,0.37777777777777777,0.7364597505599781,1.0,3/45,6.23%,ALDH1L1;SHMT2;ME3
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),0.7042381783414111,1.051338084236075,0.5185185185185185,0.7360293240546831,1.0,1/5,14.31%,OLFM2
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.5193711317169563,-1.0512597985290635,0.3157894736842105,0.9440222423795755,1.0,4/23,13.74%,PRELID1;NPC2;TRIAP1;PRELID2
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),0.7025332520642706,1.0507999247452076,0.47619047619047616,0.7368106034383293,1.0,1/5,9.45%,NOTCH4
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.7086908097113522,1.0507577039634646,0.4090909090909091,0.7360470810504862,1.0,2/5,13.66%,GDPD3;GDPD1
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.7086908097113522,1.0507577039634646,0.4090909090909091,0.7360470810504862,1.0,2/5,13.66%,GDPD3;GDPD1
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.564968583557621,1.0507088825467326,0.48717948717948717,0.7357072064444374,1.0,4/21,9.63%,MDFIC;SIAH3;LRRK2;DMTN
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.6667432718554049,-1.0501683977675613,0.45614035087719296,0.9462360472559818,1.0,1/6,4.98%,CDHR2
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.4559829559837225,1.0501413637836627,0.39215686274509803,0.7368438736642046,1.0,7/53,12.68%,FIGN;CAMSAP3;HOOK1;FIGNL1;MAPT;TRPV4;TUBGCP6
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),-0.7334559935148984,-1.0500566171205439,0.4807692307692308,0.9456543283181287,1.0,1/5,5.54%,RACK1
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),0.6841791209831058,1.049924915987624,0.48214285714285715,0.7370254273294353,1.0,2/6,11.77%,CARTPT;UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),0.4947337410482411,1.0498131711588492,0.4146341463414634,0.7369324575925716,1.0,2/26,3.40%,TLR2;ISG15
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),-0.6544319791460154,-1.0497843333768395,0.4411764705882353,0.9454525237527065,1.0,3/7,10.10%,F11;SERPINE1;USF1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.46443743206535826,1.049655487463233,0.3269230769230769,0.7368601574582581,1.0,12/44,12.83%,NAGLU;CD44;VCAN;GPC6;CSPG4;HEXB;GPC5;AGRN;NCAN;CSPG5;LYVE1;GPC1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.3510249315936552,1.0493369200658156,0.25,0.7373633268617067,1.0,69/538,11.99%,ZNF366;KANK2;PDGFB;PPARG;BMP6;MLIP;HEY1;NEDD4L;BHLHE40;SCRT1;ZIM2;MEF2C;DNAJB1;UHRF1;LDB2;NR4A3;DACH1;NFATC4;ZNF20;NR2F1;ZEB1;CITED2;DACT1;TBX6;ID2;BAG3;ZNF608;ZNF239;MAP2K5;RARB;DLX1;CIITA;ZFP36;CRYM;SOX9;ETS2;PER1;ETV6;PHF21A;ATXN1;ZBTB16;MEIS2;CCND1;BCL6;ZNF343;PLK1;ZGLP1;SLA2;GLIS3;NOTCH4;SMYD2;ZNF764;TENM2;GTF2IRD1;TBL1XR1;NR1I3;EDNRB;ZNF568;ZHX2;AEBP1;HAMP;MYT1L;ZNF550;ZBTB18;PCGF2;HES1;PARP9;CBFB;TGIF1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.5583002890727734,-1.0489200056831924,0.3770491803278688,0.9471513040843031,1.0,3/19,6.61%,TNFRSF21;GAPDH;NLRP1
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),-0.6644027438520255,-1.0487593267129989,0.4666666666666667,0.9467312618836319,1.0,1/5,9.04%,DHFR
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.4358677602188001,1.0484432819437064,0.36,0.7391529307330751,1.0,11/42,12.96%,PTPRC;NCKAP1L;MEF2C;IL12A;TNFSF13B;TIRAP;BCL2;BST1;SASH3;CD80;CD70
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.6727575957522571,-1.0484091655507957,0.44680851063829785,0.9467781269008141,1.0,3/7,21.60%,EARS2;TARS2;AARS2
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.6673879208584597,1.0481690047633958,0.4,0.7393189325804961,1.0,4/8,20.90%,FERMT1;PHLDB2;PTEN;CLASP1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.3371145833082184,1.0481456291366584,0.22580645161290322,0.7389718992065318,1.0,95/744,12.10%,ZNF366;CREB3L1;KANK2;IFNA2;PDGFB;ZNF423;PPARG;BMP6;MDFIC;MLIP;HEY1;NEDD4L;MIDEAS;BHLHE40;SCRT1;ZIM2;MEF2C;DNAJB1;ZNF93;PLCB1;IKZF1;UHRF1;LDB2;RUNX1T1;NR4A3;DACH1;NRG1;ZNF20;NR2F1;ZEB1;PRICKLE1;CITED2;DACT1;TBX6;ID2;MAEL;BASP1;ZNF608;ZNF239;MAP2K5;WNT5A;RARB;DLX1;CIITA;ZFP36;CRYM;LOXL3;TSHZ3;SOX9;ETS2;PER1;LEF1;ETV6;PHF21A;ATXN1;ZBTB16;MEIS2;TIMELESS;SPINDOC;CLOCK;CCND1;BCL6;ZNF343;PLK1;WWP1;TP63;ZGLP1;CDKN2A;SLA2;GLIS3;L3MBTL4;NOTCH4;SMYD2;ZNF764;TENM2;GTF2IRD1;TBL1XR1;NR1I3;EDNRB;ZNF540;ZNF568;ZHX2;AEBP1;HAMP;CDK5R1;ELK3;MYT1L;ZNF550;ZBTB18;PCGF2;HES1;PARP9;CBFB;TGIF1;NPAS1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.49030042406130064,1.0480906254911526,0.37037037037037035,0.7386252684234887,1.0,4/27,9.08%,KANK2;MYO16;DACT1;CDKN2A
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.5520899869161581,-1.04777930143603,0.35555555555555557,0.947667894298089,1.0,5/13,22.82%,TEFM;TFB2M;EARS2;TFAM;MTERF2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.6594591078449042,1.0476733252554065,0.4489795918367347,0.7390713163327483,1.0,3/5,6.15%,ADGRV1;ADRA1A;WNT5A
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.48355188611967753,-1.0472131602725245,0.35714285714285715,0.9485158515213798,1.0,10/44,14.77%,FTL;FTH1;ATP6V1G1;TF;SOD1;HEPH;SLC22A17;ATP6AP1;CYBRD1;CYB561A3
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.5686125708837324,-1.0470974505103274,0.4117647058823529,0.9479198230410277,1.0,2/14,2.95%,LCK;MYADM
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.5735373843789977,-1.0470855959144163,0.42,0.9470367390821395,1.0,1/8,0.24%,BMP5
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.5419371086062443,1.0469923018139882,0.42592592592592593,0.7402677090694799,1.0,2/22,4.93%,MET;CITED2
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.4389538731155103,-1.0469520897341282,0.3508771929824561,0.946515244471202,1.0,14/81,14.37%,FTL;FTH1;VAMP8;GOPC;CHMP2A;SCAMP2;HSPA8;CCDC22;BLOC1S4;AP4B1;AP1B1;KLHL20;LLGL1;HGS
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.412066172509567,1.0468456846787781,0.3888888888888889,0.7401597022978845,1.0,21/76,15.90%,RHBDF2;ADCY8;RXFP1;SYK;SRC;ADCYAP1R1;GPR176;GNG2;CYSLTR2;VIPR2;ADCY2;CYSLTR1;ADCY7;ADORA2B;ADCY1;PRKAR1B;LYN;P2RY11;HRH2;CALCB;ADRB2
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.4733741373374991,1.0467961890891784,0.32075471698113206,0.7398609133187175,1.0,4/30,9.08%,KANK2;MYO16;DACT1;CDKN2A
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3736685298711854,1.0463999424018227,0.3695652173913043,0.7403665421911914,1.0,22/133,16.72%,CERS3;MGST1;CERS6;PAM;ABHD3;VAPB;SLC44A5;DMD;ELOVL4;ALAS1;SGPP2;PRKD1;B3GNT6;GPAT4;PPM1L;ACER2;CHPT1;PCSK1;HPGDS;PLA2G4A;MOCS3;ACHE
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.6131890057598571,1.0463656243779862,0.41509433962264153,0.7399930665133314,1.0,3/10,18.19%,SLC1A2;SLC25A22;SLC1A1
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.48871973178418315,1.0461554732774367,0.3829787234042553,0.7400964632340411,1.0,5/28,12.79%,CARMIL2;CYFIP1;TWF2;DMTN;PIK3R1
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.4467453220232613,1.0458879489713586,0.3902439024390244,0.7402609618765109,1.0,12/57,13.03%,PDGFC;CSF2RA;CD44;TLR2;PIM1;CSF3R;TNFRSF1B;IL13RA1;SOCS3;TNFRSF1A;CNTFR;PTPN11
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.5018190913307528,1.045869312747135,0.43137254901960786,0.7398609998729739,1.0,10/42,12.58%,EPHA3;PLSCR1;TLR2;MCTP1;NRG1;LILRB1;DYSF;PRKD1;HAMP;LGALS3
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),-0.6718324052275125,-1.0447721204598734,0.5555555555555556,0.9521711380957572,1.0,1/5,11.22%,HRAS
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.7277684626971817,-1.044699231231238,0.46153846153846156,0.9514461761249469,1.0,1/5,15.63%,PIP4P1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.47440440207687834,-1.0443174427647435,0.3148148148148148,0.9515838881484507,1.0,12/44,13.15%,FTH1;ATP6V1F;ATP6V1G1;ATP6V1G2;TF;MELTF;MCOLN1;ATP6V1E2;HEPH;ATP6AP1;TTYH1;ATP6V0E1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.48139745891650343,-1.0437390016886947,0.4166666666666667,0.9523826261611851,1.0,1/41,0.13%,CFAP61
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.47189519480509107,1.0434621970775564,0.3191489361702128,0.7451553092454181,1.0,7/35,9.16%,TGFB2;MYO7A;BMPR1B;PBX1;MEIS3;MEIS2;MAFB
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.6390510986966371,-1.0432357163620396,0.4791666666666667,0.9531957637121142,1.0,4/8,20.07%,TEFM;POLG;PRIMPOL;MGME1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.6453893009256394,-1.043226683235865,0.48148148148148145,0.9523055884525669,1.0,5/8,19.63%,PHB2;MAP1LC3B;SQSTM1;ATG14;BECN1
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.48712918584091824,1.0431674377563935,0.358974358974359,0.7454931634621905,1.0,13/43,15.90%,IGF1;GRM5;EPHA4;SRC;CACNB1;GRIN1;TIMELESS;VIM;NOD1;NGFR;ZFP36L1;GPER1;ADRB2
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.6193389339512098,1.0430344116984365,0.475,0.7453555597993539,1.0,7/13,19.16%,IRGM;FYCO1;UBQLN4;ADRB2;RUBCN;TBC1D25;CALCOCO2
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.46060412533171136,1.042050937994895,0.34285714285714286,0.7473411271612775,1.0,17/49,24.48%,ADAMTS9;ST8SIA3;MAN1A1;ST8SIA4;FBXO17;ST8SIA6;B3GNT6;ENGASE;GCNT1;MGAT4A;MAN1A2;MANBA;CNMD;B4GALT5;OGA;GAL3ST2;GOLPH3
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.4746376392214605,1.0417537820720744,0.43478260869565216,0.7477313716190899,1.0,20/32,24.87%,ABCC9;TRPM2;TRPM3;PKD2L1;ASIC2;TRPM1;SLC25A19;SLC25A20;SLC7A8;ABCC8;SLC29A4;PKD2;ATP13A2;ATP1A2;KCNJ11;SFXN3;SLC7A1;SLC7A2;SFXN1;SLC6A9
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.44135716658955504,-1.040903274743884,0.3148148148148148,0.9580429253100605,1.0,31/92,29.30%,SRSF7;RAN;RBM15B;SRSF3;SRSF9;RBM8A;RAE1;DHX38;MAGOHB;NUP37;ALYREF;NXT1;FIP1L1;SLU7;NUP210;TPR;CASC3;CDC40;POM121C;SRSF2;NXF1;NUP93;UPF2;NUP42;NUP85;CPSF4;MAGOH;DDX39A;NXF5;MCM3AP;THOC5
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.6715862677877684,-1.0400746208309488,0.5348837209302325,0.9597532066525434,1.0,1/7,5.15%,CMPK1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.4631470481174042,1.0399108799171637,0.3617021276595745,0.7514951108006257,1.0,8/29,12.79%,CARMIL2;CYFIP1;CARMIL1;SRC;TWF2;VIL1;CORO1C;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.6670717299863335,-1.0396755732822274,0.44,0.9599853459146027,1.0,3/7,15.03%,PRELID1;BAX;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.48862320139113097,-1.0395958689253215,0.3877551020408163,0.9592822424418515,1.0,9/46,12.77%,CDKN1C;PKMYT1;CCNG1;CNPPD1;BCCIP;CCNB3;CCNB2;CDKN2C;BLM
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.5935056056718885,1.0392908586677063,0.42857142857142855,0.7526205685303025,1.0,3/9,20.27%,SHMT2;SHMT1;MTHFS
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.5860441317211866,1.0390724905128186,0.4883720930232558,0.7527567215665755,1.0,3/10,16.52%,WNT5A;AXL;GAS6
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.5454984328721234,1.0389875339834453,0.3829787234042553,0.7524869191193391,1.0,5/16,21.39%,SLC1A2;SLC25A22;SLC1A1;GJA1;SLC6A1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.5912537002226257,1.0387403686334562,0.43902439024390244,0.7527176247531175,1.0,5/12,22.71%,B4GALT6;EPHB1;EPHB6;PTEN;B4GALT5
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.5080668656529939,-1.0384883995677354,0.4107142857142857,0.9615880040910894,1.0,6/26,20.85%,AIMP1;CAPN10;GCK;BAD;MYRIP;HFE
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.4464954678317453,-1.0382760895672174,0.3333333333333333,0.9613196045806728,1.0,4/87,1.51%,TAX1BP3;TRABD2B;SHISA2;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.4726122652062847,1.0378430566090195,0.4,0.7543937563675062,1.0,9/36,12.40%,PTPRC;NCKAP1L;MEF2C;TNFSF13B;SYK;TIRAP;BCL2;BST1;SASH3
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.5307852940405235,1.0376364454643996,0.4489795918367347,0.7544205540805876,1.0,4/24,5.61%,ITGAM;ADGRB1;ARHGAP25;XKR4
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.5356711891725983,1.0374590767590788,0.4523809523809524,0.7543798428476249,1.0,6/25,17.70%,ADCY8;EPHA4;RELN;ADCY1;ZDHHC2;NSG1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.6212274302780982,1.0374262182833027,0.43478260869565216,0.7540289559480216,1.0,3/8,21.23%,PHLDB2;CLASP1;RGCC
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.4211723114043023,-1.0371961113371397,0.3508771929824561,0.9631135122291304,1.0,37/155,20.36%,RAB32;TMEM11;SLC25A4;MSTO1;TIMM10;CHCHD2;ATP5F1B;HSD17B10;PARP1;PHB2;SAMM50;TIMM8B;AIP;SLC25A6;TSPO;PRDX3;CLUH;TFB2M;FIS1;BAX;DNAJA3;TOMM7;TOMM20;IFIT2;TIMM50;PTCD2;TIMM13;PARK7;TIMM17A;TFAM;DNAJC19;RAB5IF;TIMM9;MGME1;TIMM44;COX7A2;PINK1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.5984838762517294,-1.0370940562243633,0.41304347826086957,0.9624495717037824,1.0,1/13,0.29%,P2RY10
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.49900659196672703,-1.036639108226646,0.3829787234042553,0.9625753554145051,1.0,7/27,22.64%,PTPA;CALM1;PPIA;PTBP1;SMPD1;DLC1;ITGA1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6771415120093377,1.0366220515715394,0.5254237288135594,0.755464598178579,1.0,2/5,21.10%,CAMK2D;CHGA
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.4247328547191708,-1.0365079902815324,0.37735849056603776,0.9602701769287297,1.0,18/84,17.95%,PSMB6;PSMD7;MUC4;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;CHUK;PSME1;HRAS;PSMA7;PSMB8;PSMD13;PSMD2;PRKACA;PSMC5;IKBKG
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.4247328547191708,-1.0365079902815324,0.37735849056603776,0.9602701769287297,1.0,18/84,17.95%,PSMB6;PSMD7;MUC4;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;CHUK;PSME1;HRAS;PSMA7;PSMB8;PSMD13;PSMD2;PRKACA;PSMC5;IKBKG
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.4247328547191708,-1.0365079902815324,0.37735849056603776,0.9602701769287297,1.0,18/84,17.95%,PSMB6;PSMD7;MUC4;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;CHUK;PSME1;HRAS;PSMA7;PSMB8;PSMD13;PSMD2;PRKACA;PSMC5;IKBKG
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.6410842786068998,1.0364156473693567,0.41818181818181815,0.7555850298547537,1.0,3/6,21.62%,BBS4;NRL;RPGRIP1L
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.6831130766291488,1.0363532544554344,0.45454545454545453,0.7553148446139686,1.0,1/5,6.58%,CIITA
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.35118544883269276,1.0361876034092206,0.25,0.7553073816835844,1.0,26/338,6.32%,KLRF2;CLDN5;PDGFB;VSIR;ANGPT1;BMP6;PRR16;PLSCR1;EGFR;IGF1;TLR2;HEY1;F3;MEF2C;RIMS2;PID1;ZNF804A;KAT2B;CITED2;ID2;VSTM2A;NTRK2;SLC24A3;WNT5A;SLC26A9;LILRB1
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.6524252975330402,1.0361793823303982,0.5192307692307693,0.7548829948803611,1.0,1/6,3.43%,MAP2
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),0.6099222987216338,1.0360259567526622,0.5,0.7548421824139879,1.0,1/6,1.32%,PLSCR1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.4606303509508689,1.0359101668081772,0.3684210526315789,0.7546872266656927,1.0,9/36,16.46%,SEMA3D;NRG1;CORO1C;SEMA6A;SEMA5B;SEMA4G;SEMA4B;SEMA3C;SEMA7A
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.5415501819948134,-1.0357432823806816,0.48214285714285715,0.9615600913149399,1.0,1/16,2.00%,ARPC5
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.7292026681774163,-1.035729378738012,0.5208333333333334,0.9606973036839419,1.0,1/5,5.15%,CMPK1
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.6506838439416883,1.0357076859711902,0.48,0.7547338441279943,1.0,1/7,2.12%,ITGB4
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.7172759507315924,1.0355520578349728,0.49122807017543857,0.7547535709042643,1.0,2/5,25.29%,XRCC1;LIG3
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.561614307603056,-1.0355264001799125,0.42,0.9602908758511123,1.0,3/14,8.09%,GREM1;SERPINE1;CREB3
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.6499501746867313,1.035413225239989,0.47619047619047616,0.7546525748020977,1.0,4/7,32.20%,MVD;PDSS1;PHYH;IDI2
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.5501680770272844,-1.035262676258061,0.5,0.9600967014168681,1.0,4/14,23.72%,NPC2;NPC1;STAR;OSBP
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.5411848304153646,1.0352078010979202,0.3958333333333333,0.7547125359528806,1.0,6/16,24.12%,MGAT5;HES1;GHR;CRLF3;ERBB4;CYP1B1
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.603158855247064,1.0351932569109736,0.3584905660377358,0.7543303639125757,1.0,2/12,6.03%,PTPRC;FBLN1
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.6171787398199652,-1.0350390998979446,0.5471698113207547,0.9599341931474556,1.0,2/10,8.69%,SERPINE1;PLA2R1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.43998389599767734,1.0348545489557504,0.3333333333333333,0.7546515118154146,1.0,6/53,11.18%,LPL;LRRK2;CARTPT;RRAGD;KCNB1;BMPR2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.6511466525339209,1.03472821355312,0.4375,0.7545106609880223,1.0,2/5,30.23%,SNCA;PLAA
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.534123504268438,-1.0345985288456345,0.4576271186440678,0.9603740059596063,1.0,3/20,5.49%,VPS25;PTK6;HYAL2
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.6306172006639571,-1.0345186517388987,0.45614035087719296,0.9596803869798954,1.0,2/8,16.64%,DHX33;CPTP
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.48333299635592475,-1.034163029807637,0.39622641509433965,0.9597918555537128,1.0,7/44,5.89%,OOEP;RPS3;RNF8;H2AX;PCNA;MGMT;PARP1
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.3736354377467498,1.0341452852104414,0.2558139534883721,0.7553595795489867,1.0,18/102,10.59%,TGFB2;BMP6;CD44;IGF1;MMP16;CHI3L1;VCAN;KIAA1217;BMPR1B;WNT5A;SULF1;SOX9;ETS2;ZBTB16;CHRD;NCAN;CREB3L2;SOX5
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.5929188915002118,1.0340450441046183,0.39215686274509803,0.7551717075740416,1.0,4/14,18.35%,RIMS2;PTPRN;EDN1;SNX19
prerank,PanglaoDB_Augmented_2021__B Cells,0.3938196272966855,1.0337796795666871,0.40476190476190477,0.7553714288447189,1.0,18/91,7.67%,FLI1;PTPRC;DOK3;NCKAP1L;SELL;IKZF1;LCP2;BIRC3;CD53;EBF1;FCRLA;ARHGAP25;BTLA;FCHSD2;LILRB1;BLNK;WDFY4;LY86
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.5800126074978237,-1.0336334810916568,0.42,0.9595078662505412,1.0,1/8,4.83%,EXOSC8
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.5800126074978237,-1.0336334810916568,0.42,0.9595078662505412,1.0,1/8,4.83%,EXOSC8
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.41902844700353203,1.0335264158375232,0.40476190476190477,0.7555041719471761,1.0,15/65,11.21%,TGFB2;ANGPT1;BMP6;EGFR;IGF1;UHRF1;NR4A3;LAMC1;ZFP36;SOX9;DUSP10;SGPP2;TGFA;PRKD1;ZNF304
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.4952445483911861,1.0334010336179962,0.4444444444444444,0.7553298800562629,1.0,8/41,15.31%,GRM5;SPRED3;KAT2B;KDM4D;HSPB1;CORO1C;LYN;SESN2
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.6131596134724995,-1.0333899487489118,0.44,0.9593156845889855,1.0,5/9,35.74%,GPATCH3;TKFC;C1QBP;RIOK3;NPLOC4
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.6441736527759131,1.0333373452008239,0.5555555555555556,0.7550824415082913,1.0,1/7,2.92%,ADCY8
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.4816144023040065,-1.033126506669311,0.3898305084745763,0.959263806718637,1.0,5/28,14.33%,FTL;TF;HEPH;B2M;CYBRD1
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.6755004803176916,1.0329489846978577,0.5111111111111111,0.7555216603291403,1.0,2/5,18.80%,SH3GL2;TMEM108
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.6711327113601917,1.032920073386018,0.4791666666666667,0.7551545114662805,1.0,3/5,26.63%,GRHL2;ASCL1;PKD1
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.41780629257292057,1.0328340043074533,0.4230769230769231,0.7549741546745806,1.0,22/84,17.55%,PLAC8;PDGFC;CAMK1D;SYK;OXTR;ACADL;KDM3A;EPAS1;STAT6;DIO2;PRKAB2;ZNF516;ACACB;VEGFA;ADRB2;ADIPOR2;UCP1;KDM6B;ACHE;PPARGC1A;EBF2;LEPR
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.39775361991628233,-1.0327791789674878,0.391304347826087,0.9593440742302959,1.0,41/283,12.41%,NGF;CRYAB;CD38;RPS3A;PRELID1;RPS27A;UBC;SFRP1;DPEP1;RPL10;PTMA;MIEN1;UBB;GREM1;PRDX5;GPX4;GSTP1;CFL1;MGMT;TNFAIP8;TPT1;PHB2;EVI2B;CDSN;ARAF;ANXA5;PRDX3;DHCR24;BNIP1;MYDGF;TMBIM6;CIAPIN1;HMGA2;DDAH2;ARHGDIA;ZNF830;TRIAP1;PRKAA2;GATA1;APIP;NPM1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.3987937649518451,1.0325292018950152,0.35,0.7551998083640898,1.0,17/84,12.79%,PPARG;ADCY8;NR4A3;SORBS1;KAT2B;SRC;IRS1;RHOQ;CYSLTR2;ADCY2;RAB15;GPLD1;ADCY7;ADCY1;PDE3B;PRKAR1B;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.5904883074525537,1.0321904600495473,0.47058823529411764,0.7556446183024883,1.0,4/11,20.06%,TNFRSF1B;GPLD1;SH3D19;SNX33
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.45545308577024207,1.0320656972694089,0.4,0.7554510001225567,1.0,16/38,26.22%,KAT2B;PER1;LEF1;TAF5L;KAT6B;TADA2A;KAT2A;TAF10;JADE2;DR1;SUPT3H;SPI1;MBIP;ING5;PHF14;TAF6L
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.4796946386623646,1.0320108764852463,0.44642857142857145,0.7551446977796806,1.0,10/29,15.77%,PTPRB;PTPN6;PTPRZ1;PTPRJ;DUSP10;PTPRT;UBASH3B;PTPN11;PTPRO;DUSP6
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.5256456691670901,1.031968904978101,0.4,0.7548055526720172,1.0,4/21,5.81%,EGFR;P2RY12;NTRK2;ADRA1A
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.5967294749817235,1.0318092304759603,0.45454545454545453,0.7543206807129141,1.0,2/10,10.66%,CD44;BCL2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.5967294749817235,1.0318092304759603,0.45454545454545453,0.7543206807129141,1.0,2/10,10.66%,CD44;BCL2
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.6285548429916619,1.031740474716237,0.5272727272727272,0.7540422087066679,1.0,3/9,14.19%,KCNS1;RNF207;ANK3
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.6325242159153751,-1.0310013422963968,0.40816326530612246,0.963343187390145,1.0,1/8,1.43%,AMPD1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),0.6726438029238524,1.0308653301868511,0.5555555555555556,0.7555322985298809,1.0,1/5,2.49%,DLAT
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.5959160664933288,-1.0307799919221206,0.40425531914893614,0.9630241125684035,1.0,1/15,0.98%,PAX8
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.6148825754113146,1.0307609408048566,0.4772727272727273,0.755299791267035,1.0,1/10,3.43%,BDH2
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.6166484078127541,-1.0305959781188594,0.4166666666666667,0.9626126764555814,1.0,5/9,27.49%,FIS1;BAX;VPS35;BNIP3;ATG3
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.7037918830902983,-1.0305309785284842,0.42592592592592593,0.9618924476127478,1.0,3/5,11.33%,PRELID1;DBI;TRIAP1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5333427287336032,1.0305153990990377,0.46511627906976744,0.755351999455791,1.0,5/20,17.87%,CHI3L1;PLK1;IRGM;RPTOR;PRKAG2
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.5284492661893955,-1.0303950711367453,0.475,0.961467354518884,1.0,3/25,2.70%,CYB5A;GRIN3B;SEC61B
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.5741261391357412,1.0302702784009947,0.4482758620689655,0.7556289402295469,1.0,1/10,3.16%,ALDH8A1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.5036490600906017,1.0299199139136337,0.4864864864864865,0.7559980795184831,1.0,7/28,17.87%,PPARG;ABCD2;PRKAB2;SLC25A20;ACACB;SLC27A2;PRKAG2
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.6210163131428437,1.0297234919658274,0.46938775510204084,0.7560630166826066,1.0,2/11,11.81%,GPR35;CX3CL1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.4481379241182101,-1.0296265804512768,0.3275862068965517,0.9627192753434964,1.0,8/56,8.74%,POLR2L;POLR2G;POLR2K;FRS3;POLR2I;GTF2F1;FGF6;POLR2A
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.4145020761309998,-1.0295928843040834,0.39215686274509803,0.9619083322420191,1.0,30/149,20.90%,PARP2;RNF8;H2AX;UBXN1;EME1;PARP1;TONSL;DCLRE1B;RAD51AP1;ZSWIM7;KPNA2;SMARCA5;RFWD3;HUS1;BRCC3;BLM;KAT5;SFR1;ABRAXAS1;ACTR8;MDC1;HMGB1;XRCC6;SMC6;EXD2;DDX1;UBE2N;PAXX;PARP3;PRKDC
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),-0.6759070632866403,-1.0295667828856647,0.5,0.9610911736482549,1.0,1/5,16.58%,CALR
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.6259325497178911,1.0295314707228833,0.48936170212765956,0.7562268869908321,1.0,2/5,29.99%,ACSL5;IRS2
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.5163296243104168,-1.0294040147151524,0.4166666666666667,0.9606991969702997,1.0,3/25,3.25%,RPL13;PPIB;SBDS
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.4653245289623916,1.0291772490800577,0.38,0.7565950714283527,1.0,10/53,8.57%,IFNA2;PTPRC;NHEJ1;IKZF1;TOX;PBX1;BLNK;PTPRJ;AXL;CD4
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.6248367452083009,-1.029177044744615,0.5777777777777777,0.9604772564015519,1.0,1/8,0.38%,LCK
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.470594774258403,-1.0291755965115763,0.3137254901960784,0.9595944648055946,1.0,9/46,18.64%,TINF2;CCT7;CCT2;CCT6A;PNKP;PINX1;PKIB;NAT10;ATR
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.6313827694973966,1.0290085355080976,0.54,0.7566068214503969,1.0,2/8,6.70%,LOX;LOXL3
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.3431340995796998,1.0286275307416304,0.30303030303030304,0.7571522931711703,1.0,95/535,14.26%,CLDN5;TGFB2;KANK2;IGFBP3;PDGFC;CTF1;PDGFB;BMP6;SSTR1;KITLG;TRNP1;EGFR;FLT1;OSGIN1;IGF1;CSF1R;MYO16;IL12RB2;CAPN1;UHRF1;NR4A3;PDGFRA;TMIGD3;TP53I11;NRG1;KAT2B;TBX6;ID2;IRS1;ADGRB1;PTPN6;DDAH1;NTRK2;ADRA1A;SCIN;CDKN3;ADGRG1;PTPRJ;SHANK2;STX3;MEIS3;SOX9;ZBTB7C;IL13RA1;LEF1;CLMN;LIFR;TENM1;P3H2;TESC;MEIS2;TIMELESS;CRLF1;GNRH1;BCL6;STAT6;VEGFD;CDKN2A;RERG;TGFB3;SMYD2;NUAK1;UTP20;GPLD1;KIF14;BCL2;BST1;TGFA;SPDYA;FABP7;BMPR2;RNF139;CD200;WDR6;CHRM1;HES1;CX3CL1;FGF17;TPTE2;IFNK;SMIM22;ACER2;GSDME;CR1;LYN;PDS5B;FES;SULT2B1;FRZB;CUL3;CDC7;PIAS1;CDH13;ITGB1BP1;SFRP4
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.6423995023438048,1.0285822674504033,0.44,0.7568146798891724,1.0,1/5,1.32%,PLSCR1
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.4967141753211554,1.028548464009336,0.4528301886792453,0.7565235175253983,1.0,10/25,16.99%,ADCY8;RXFP1;TMIGD3;ADCY2;ADCY7;ADORA2B;ADCY1;P2RY11;ADRB2;CAP2
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.5157739507794378,1.028515833222892,0.46,0.7561997888928048,1.0,4/22,11.54%,CAMSAP3;MAP2;AEBP1;MAPT
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.4943530636255592,1.0282944125956324,0.4772727272727273,0.7562248759334309,1.0,7/30,14.77%,CSF1R;BAIAP2;PDGFRA;BAIAP2L1;TRPM2;FES;NTRK3
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.5847039639270102,1.027926213832848,0.48,0.7565521984107587,1.0,2/12,13.37%,CAMK1D;LYN
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.4718355479715898,1.0276864561534818,0.46,0.7566821375446892,1.0,7/32,11.18%,PDGFB;BMPR1B;TWF2;MAP2K5;ACVR1C;NOS1;BMPR2
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.568934628408803,1.0276667426453545,0.38095238095238093,0.756286842097448,1.0,4/12,15.01%,SYT7;DYSF;RAB3A;SYTL4
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),-0.609533179732652,-1.0274741796709963,0.38,0.9637757308849646,1.0,2/7,20.96%,GLYATL2;ADO
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.6686309498807282,1.027453526595433,0.4888888888888889,0.7563118247943285,1.0,1/5,2.09%,NCKAP1L
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.4276537656803028,1.0272298146047172,0.40425531914893614,0.7564744623525205,1.0,14/67,11.03%,AQP1;TLR2;STAB1;IL12A;ISG15;SYK;H2BC11;ADGRB1;SFTPD;TIRAP;IRGM;NOD1;NAIP;HAMP
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.5403492644431938,1.0268868496411345,0.4375,0.7568990258408297,1.0,3/13,13.33%,OGFOD1;P3H2;P3H4
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.544400767976216,-1.026836303024158,0.43859649122807015,0.9646951461809762,1.0,5/24,9.67%,RPS3;PTTG1IP;TPT1;YJU2;DDIAS
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.593695752751627,1.026799936459043,0.4117647058823529,0.7566485673847503,1.0,5/9,25.39%,TENM3;SHROOM2;VEGFA;NF1;KDM2B
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.46723918350892457,1.0265934535319767,0.4418604651162791,0.756666748215791,1.0,8/30,15.70%,NEDD4L;KNDC1;YWHAH;SARM1;LZTS1;HECW1;TNIK;NSMF
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.6141671595949754,-1.0263598899471476,0.45614035087719296,0.9651988086093077,1.0,1/6,17.59%,PARK7
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.5764021224152551,1.0263260966270131,0.44642857142857145,0.7568353692436012,1.0,2/10,12.11%,GPLD1;SCARB1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.4314904338503262,-1.0257843986270738,0.4230769230769231,0.9659237144807117,1.0,14/59,17.32%,PSMB6;PSMD7;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PSME1;GATA1;PSMA7;PSMB8;PSMD13;PSMD2;PSMC5
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.35997777021139366,1.0256958529489137,0.3448275862068966,0.7579910600970963,1.0,61/421,11.96%,CLDN5;TGFB2;PDGFC;CTF1;PDGFB;BMP6;KITLG;EGFR;FLT1;IGF1;TLR2;CSF1R;IL12RB2;CAMK1D;IL12A;EPHA4;CAPN1;BMPR1B;PDGFRA;NRG1;CITED2;TBX6;IRS1;PPP3CA;LGI1;PTPN6;NTRK2;MERTK;TNFRSF1B;WNT5A;ADGRG1;DLX1;ZFP36;TPM1;PTPRJ;SHANK2;STX3;MEIS3;SOX9;GRIN1;IL13RA1;LEF1;LIFR;TAL1;SFTPD;MEIS2;CRLF1;CHRD;CCND1;VEGFD;TGFB3;KIF14;BCL2;BST1;TGFA;TRPC3;SPDYA;MAPT;HES1;CX3CL1;FGF17
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.5361345068893582,-1.025633194794912,0.43103448275862066,0.9654379802107189,1.0,1/19,1.09%,ENPP6
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.641023709376565,-1.0254795216295474,0.5238095238095238,0.9649913683769337,1.0,3/10,20.99%,WASHC2A;RAB35;VPS35
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),0.6619815224852424,1.0254448836454402,0.5263157894736842,0.7580999490806096,1.0,1/8,3.43%,MAP2
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.5780338639033543,1.025339012361889,0.4583333333333333,0.7579278896257945,1.0,2/10,3.12%,NEDD4L;SLC8A1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.5820720838202345,-1.0253321017981125,0.46551724137931033,0.9645990516034286,1.0,3/12,8.40%,RIOK2;CDC23;NEK6
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.3863300539298007,1.0253039289982444,0.37209302325581395,0.7575667303085116,1.0,17/137,7.97%,ROR1;CD59;KITLG;FSTL1;PTPRG;LRIG3;PROM1;LAMC1;MYO1B;FBLN1;ADGRL2;TENM3;ANO6;LEF1;TEAD1;COL4A1;LIFR
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.5265341775591785,-1.0249316208206318,0.43478260869565216,0.9648333512997699,1.0,3/30,5.41%,TAX1BP3;GOPC;ACTN2
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.6183761005251511,-1.0248548484520408,0.5106382978723404,0.9641368547972368,1.0,3/10,12.98%,ZNF830;MCM4;MCM3
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.6599196001367822,-1.0243867238101032,0.48936170212765956,0.9645311482999823,1.0,1/6,3.53%,PMM1
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.6041308900181416,1.024266782350457,0.4166666666666667,0.7595349121255212,1.0,2/7,21.44%,KNDC1;OPHN1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.4648172908705541,-1.024258836632351,0.3617021276595745,0.9640112725332921,1.0,7/41,11.22%,RBM22;DDX5;BUD23;RIOK2;TRMT112;POLR2A;HRAS
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.4270219637058747,1.0239088569734505,0.375,0.7599817474946158,1.0,9/52,12.70%,CERS3;CERS6;VAPB;ELOVL4;ST8SIA6;SGPP2;PRKD1;PPM1L;ACER2
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.43369778263054926,-1.0233620891356692,0.38636363636363635,0.9655153192306305,1.0,9/59,8.88%,AMPD1;PTH;ACSM6;DBI;GLYAT;ACOT1;RAN;CROT;GMPR2
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.5213924248133459,-1.0233263977346607,0.4444444444444444,0.9647827423842356,1.0,4/30,12.46%,PTPA;PPP1R1B;CALM1;PPP1R11
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.6766969798348014,-1.0232551643999057,0.5,0.9641729570796194,1.0,2/7,14.34%,MAP1LC3B;SQSTM1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.4686126635537257,1.0229233578495438,0.42105263157894735,0.7621419092299221,1.0,7/49,10.17%,EPHA3;CAMSAP3;EFNA5;SRC;PTPRJ;DMTN;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.636918738943661,1.0226327255139849,0.45,0.7620418154505424,1.0,1/7,1.98%,MDFIC
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.636918738943661,1.0226327255139849,0.45,0.7620418154505424,1.0,1/7,1.98%,MDFIC
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.48945569170833214,-1.0225942766865133,0.4461538461538462,0.9651721898905607,1.0,8/25,20.79%,RPS2;FEM1A;SMAD7;PARK7;UBE2L3;UBE2N;PINK1;BMI1
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.6172779246389608,1.0214329340163413,0.5319148936170213,0.7643403851927206,1.0,3/9,6.99%,GRIP2;GRIP1;STX3
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6286103852632238,1.0214134394907115,0.4745762711864407,0.7639900862642497,1.0,1/8,1.41%,EGFR
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.5537614308082981,-1.0213688842784128,0.47368421052631576,0.966756408503473,1.0,3/20,10.82%,GAPDH;PGAM1;GCK
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.5537614308082981,-1.0213688842784128,0.47368421052631576,0.966756408503473,1.0,3/20,10.82%,GAPDH;PGAM1;GCK
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),-0.6646355158677321,-1.0206792124540915,0.4888888888888889,0.9678791817039486,1.0,1/6,2.75%,GREM1
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.5819259665588187,-1.020451351439102,0.4444444444444444,0.967662322004194,1.0,1/11,4.00%,ARCN1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.6291357135097646,1.0199953999327578,0.42592592592592593,0.7667334392705393,1.0,1/7,0.91%,VSIR
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),-0.6613346132868773,-1.0199383945897091,0.52,0.9682688328015763,1.0,3/5,14.24%,ICAM1;AGER;PIK3R6
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.6155124196113373,1.019849075718438,0.48,0.7662196100395364,1.0,4/8,20.42%,SLC1A2;MLKL;DISP1;STEAP4
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.6155124196113373,1.019849075718438,0.48,0.7662196100395364,1.0,4/8,20.42%,SLC1A2;MLKL;DISP1;STEAP4
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.3516051051919852,1.0197965874563293,0.4,0.7658885110439826,1.0,47/363,12.35%,CREB3L1;IFNA2;PDGFB;ZNF423;PPARG;MDFIC;HEY1;MIDEAS;BHLHE40;ZNF93;PLCB1;IKZF1;RUNX1T1;DACH1;NRG1;ZEB1;PRICKLE1;CITED2;ID2;MAEL;BASP1;WNT5A;CIITA;LOXL3;TSHZ3;SOX9;PER1;LEF1;ATXN1;ZBTB16;TIMELESS;SPINDOC;CLOCK;BCL6;WWP1;TP63;CDKN2A;L3MBTL4;ZNF540;ZNF568;ZHX2;CDK5R1;ELK3;ZBTB18;HES1;NPAS1;NR2F2
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.6589387411629442,-1.0197282872579303,0.48333333333333334,0.9679614913383333,1.0,1/7,1.51%,SFRP1
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),0.6888529425757648,1.0197112877953292,0.5348837209302325,0.7657069119680956,1.0,5/5,31.13%,SLC32A1;SLC17A7;SLC17A8;SLC18A2;SLC17A6
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.5403013869192761,-1.019662276113643,0.39285714285714285,0.9672854071827937,1.0,1/13,5.55%,EIF2AK1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.4339853528908284,1.019589635600654,0.4222222222222222,0.7655579155931631,1.0,20/70,13.37%,EPHA3;KALRN;GRIN2B;EPHA4;PAK3;EFNB3;EFNA5;SRC;SIPA1L1;EPHA6;EPHB1;GRIN1;DNM1;GIT1;EPHB3;NGEF;CDK5R1;EFNA3;PTPN11;LYN
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.4821176223666072,1.0195358656262032,0.325,0.7652601115418733,1.0,6/32,8.24%,AQP1;KLF9;ADCY8;SRC;GNG2;ADCY2
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.6520945956193448,-1.0194378753701179,0.4883720930232558,0.9670999822217042,1.0,3/6,22.80%,PRDM5;BEND3;SETDB1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.4407956305411137,1.0191378579502994,0.45652173913043476,0.765868919550605,1.0,7/56,8.55%,TGFB2;PDGFB;EGFR;CITED2;TAL1;MEIS2;CCND1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.5451261967485819,-1.0189739407524767,0.49056603773584906,0.9675618779878302,1.0,5/16,20.48%,DNMT3B;ZNF335;CTR9;PIH1D1;DNMT1
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),0.542641913503529,1.0189379280963569,0.44680851063829785,0.7659335866363827,1.0,2/13,6.97%,SHMT2;AK4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.5348161656809007,-1.018852117078355,0.46551724137931033,0.9669932040753237,1.0,2/24,0.84%,DDIT3;SELENOK
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.629638046762958,1.0186182214537711,0.5535714285714286,0.7662180388751108,1.0,3/5,29.30%,RGS2;SORT1;PLIN5
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.5474857206691054,-1.0184786185843961,0.47368421052631576,0.967266626415291,1.0,3/21,10.82%,GAPDH;PGAM1;GCK
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.46752537897025326,-1.0183582390355126,0.38,0.9666992373452936,1.0,6/38,11.87%,ABCA13;SERPINE1;TF;VPS28;RAB31;B2M
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.36944242514278136,1.0182720227840494,0.4473684210526316,0.7665280302829387,1.0,20/138,15.36%,PTPRC;TP73;IGF1;TRIM5;SLC8A1;NELL1;NFKBID;YBX3;KDM6A;KIF16B;IGF2BP2;MKLN1;FUBP1;GNB3;ALPK2;EOLA1;NFKBIZ;TRIM22;RFXANK;ZFP36L1
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.4332129683222332,-1.018052130572715,0.38333333333333336,0.9665901298107139,1.0,7/52,7.06%,CXCR4;P2RY10;TNFRSF8;ITGAL;KLRB1;EVI2B;PYHIN1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.4119305111880863,1.0180165235714713,0.3673469387755102,0.7667472520542925,1.0,15/60,17.72%,CSF1R;ABHD3;PLCB1;PIGP;PLAAT1;GDPD3;GPLD1;PLA2G10;IP6K3;GDPD1;PLCB3;PLA2G4A;ACP6;PIGB;AGK
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.6132679448751759,1.0179541403535068,0.45454545454545453,0.7664820540304165,1.0,1/10,1.56%,RPS6KA6
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.45526728306733044,-1.0178689671969967,0.453125,0.9662490452481208,1.0,12/63,17.59%,BMP5;SERPINE1;GSTP1;ICAM1;UNC5B;GATA1;ITGA6;MAPK7;IFI6;FAIM;FADD;PARK7
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.5857169395131678,-1.0174470736244032,0.5,0.9664323621546863,1.0,1/12,8.39%,VCPKMT
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.47826770358698634,-1.0174468179691851,0.373134328358209,0.9655687049945839,1.0,13/45,16.50%,DDIT3;DNAJB4;HSPE1;HSPA8;TMBIM6;BAX;BAK1;SERPINH1;HSPB8;DAXX;DNAJA1;HSPA2;HSPA14
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.6390125999101914,1.0172838874526275,0.46808510638297873,0.7674301585553601,1.0,1/6,11.23%,TAC4
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.6399918387158601,-1.0169575748419102,0.5,0.9660809543128862,1.0,3/6,21.64%,HMGA2;POLE3;EZH1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.6374066993798997,1.0169222854644508,0.4878048780487805,0.7677452564859717,1.0,2/6,17.42%,NT5C1A;AMPD3
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.5113050807087273,-1.0168828515071284,0.44680851063829785,0.9655101970994348,1.0,3/17,10.39%,STMN1;APLP1;YWHAB
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.6390118604332099,-1.0168414141797701,0.5686274509803921,0.9647764240366736,1.0,3/7,28.74%,TOMM7;PINK1;HDAC6
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.4220515564503476,1.0167355304359054,0.5185185185185185,0.7676733017130478,1.0,17/59,19.19%,RYR3;SHMT2;GRIN2B;HCN1;SAMHD1;GRIN1;KCNC3;TRPM2;HOMER1;PKD2L1;ACACB;SHMT1;CBR4;PKD2;AQP4;TDO2;SYCP1
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.6636474868423621,1.0165938195240112,0.5581395348837209,0.7671175904036425,1.0,1/5,24.82%,CPSF6
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.6636474868423621,1.0165938195240112,0.5581395348837209,0.7671175904036425,1.0,1/5,24.82%,CPSF6
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.4846736051328975,-1.0165724037707202,0.4107142857142857,0.9647591018182661,1.0,8/29,16.38%,CLDN2;LAMB3;HNF4A;EHF;PTPRH;TSPAN8;LIPH;B3GNT3
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.6638721544344031,1.0165616603182308,0.4807692307692308,0.7668080171382246,1.0,2/6,14.19%,RYR3;ANK3
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.6582423794664194,1.0163594142959478,0.5555555555555556,0.7668331969695529,1.0,3/5,16.82%,RSAD2;CDH26;TNFSF4
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.51158236426441,1.016321766044654,0.35294117647058826,0.766479123771188,1.0,4/19,12.41%,IFNA2;IRAK3;RFTN1;IFNK
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.5060879259572728,1.0162230082289192,0.46296296296296297,0.7662796138252098,1.0,5/28,12.71%,PTCHD1;CC2D2A;DYRK2;PKD2L1;TTBK2
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.6360715585674621,1.015935735364175,0.46153846153846156,0.7664976568374208,1.0,3/5,33.88%,CHD7;PROX1;GLI3
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.357590743355507,1.015823837898141,0.4634146341463415,0.7663111882267908,1.0,23/247,7.35%,PDGFB;CSF2RA;ANGPT1;KITLG;EGFR;IGF1;GRIN2B;MAP3K5;MEF2C;LRRK2;MET;HGF;PDGFRA;RIT2;NRG1;PRKG2;GFRA1;FGF13;IRS1;ZFP36;CAMK2B;SOX9;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.634129836498958,-1.0155530748470771,0.5,0.9666769356775538,1.0,2/8,2.75%,SFRP1;GREM1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.43144527230656504,1.0155159179756135,0.42,0.7666187664451461,1.0,5/54,4.83%,PDGFB;NPAS2;EGFR;HGF;TOX
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.6501768583976112,-1.0154046382360504,0.46,0.9663307632707826,1.0,2/8,17.74%,GSTP1;CREB3L3
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.42987136149491145,1.0153829852092828,0.3953488372093023,0.7664965355124164,1.0,4/61,4.13%,RNFT1;ASB4;UHRF1;SH3RF3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.4353952022564582,-1.0148995696190521,0.4647887323943662,0.9668544653745933,1.0,16/96,15.28%,CRYAB;TRABD2B;RPS3;SELP;RACK1;OPRD1;NOP53;TFIP11;HSPA8;BAX;BAK1;SAR1B;BBS10;BRK1;PIH1D1;GSN
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.488224357928554,-1.0147415096562458,0.42857142857142855,0.966412251065224,1.0,10/33,20.36%,GABARAPL2;FIS1;ATG9A;CISD2;MAP1LC3B;SQSTM1;WDR45B;BECN1;ATG2A;PINK1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.6793406554890014,-1.0143726948484353,0.5263157894736842,0.966630880118765,1.0,1/7,8.48%,RHOA
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.5020159430625172,-1.0143678842315293,0.45,0.9657895165320064,1.0,5/32,9.06%,DDIT3;HYAL2;RACK1;OTUD3;NOP53
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.5080772063742294,-1.0139479727505056,0.38181818181818183,0.9662304078301952,1.0,2/19,6.02%,SMDT1;PHB2
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.4057488608473442,-1.013491105274066,0.42857142857142855,0.9667962637951261,1.0,21/126,14.21%,LCK;BTN3A1;BTN2A1;TNFRSF21;PSMB6;PSMD7;MOG;PSME2;PSMD8;EIF2B1;PSMB4;PSMD3;PSMB3;BTN3A2;CHUK;PSME1;HLA-DRA;PSMA7;PSMB8;PSMD13;HLA-DPA1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5043345303384669,1.0127000439561933,0.49056603773584906,0.7726016342318485,1.0,2/23,13.82%,KLHL15;CUL3
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.588849961798453,1.0123533161410474,0.5686274509803921,0.7730333542263308,1.0,1/7,2.39%,CARMIL2
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.5701587928027757,-1.012271176379639,0.5172413793103449,0.9694229830871882,1.0,2/13,1.78%,CELA2A;SELP
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.5957038387189306,1.0119852220765058,0.5294117647058824,0.7734646052148444,1.0,3/8,25.24%,BMPR2;SOX4;DCHS1
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.6786398012958963,1.0119677652594807,0.5357142857142857,0.7730958696091325,1.0,3/6,23.25%,ZSWIM6;LHX6;ERBB4
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.6797465605868197,1.011918979926864,0.6,0.7728234242952067,1.0,1/6,3.39%,EPHA4
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.4242001918685085,-1.0116875742284637,0.4,0.9703320547569032,1.0,19/74,17.48%,PSMB6;PSMD7;AP2S1;PSME2;PSMD8;PFN1;PSMB4;RHOA;PSMD3;PSMB3;PSME1;SAPCD2;PSMA7;RAC1;PSMB8;PSMD13;PSMD2;PSMC5;CDC42
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.553371416865681,-1.0114643837390584,0.4791666666666667,0.9702067212325022,1.0,2/12,2.30%,UXT;UBB
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.596006073406302,-1.0109907346738825,0.4642857142857143,0.9704059174541395,1.0,4/10,18.10%,TPH2;HDC;SAT2;MOXD1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.468859547425939,1.0109566542014166,0.46153846153846156,0.7746852704696114,1.0,5/37,5.39%,ADAMTS5;CD44;MMP16;CAPN1;LAMC1
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.5373526576827553,-1.010875805331604,0.48214285714285715,0.9698683461354042,1.0,5/15,18.72%,GLA;SMPD2;SMPDL3A;SGPL1;SMPD1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.43782718662664694,1.010730821390972,0.43137254901960786,0.7747634750872764,1.0,9/32,15.52%,NCKAP1L;SCIN;TAL1;TESC;ARNT;MAPK11;MTURN;FES;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.6543399567919953,-1.0105221043580612,0.4716981132075472,0.9698688318984932,1.0,2/7,13.67%,RAB7B;BPIFB1
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.6030553289404306,1.0104328821440798,0.5,0.7746517193361165,1.0,4/10,12.44%,ADGRV1;GRM2;EDNRB;GABBR2
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.6030553289404306,1.0104328821440798,0.5,0.7746517193361165,1.0,4/10,12.44%,ADGRV1;GRM2;EDNRB;GABBR2
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.5288263168856819,-1.010341359790354,0.4791666666666667,0.9694502969185453,1.0,1/19,3.53%,PMM1
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6005094088418217,-1.0098906583781124,0.48214285714285715,0.9697596292854334,1.0,2/9,10.84%,CALM1;SRI
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.6408503530480741,-1.00985310769909,0.5185185185185185,0.9690116995533223,1.0,2/6,9.13%,CRTAM;PVR
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),-0.6408551651402905,-1.009710792483826,0.453125,0.9685216972499241,1.0,3/5,17.78%,GPD1;GPAM;GPAT2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.6591755184708985,1.009693857161762,0.5217391304347826,0.7758837589528731,1.0,2/7,18.90%,RFTN1;PRKCQ
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.5028138516382356,-1.0094937863700253,0.3617021276595745,0.9683255721951903,1.0,17/42,19.98%,CRNKL1;SF3A3;SF3A1;SRSF9;SMN1;SNRPD1;PUF60;SNRPD2;PRPF6;KHDC4;SNRPE;SF3A2;SNRPG;SNRNP200;DDX23;SRPK3;DDX1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),-0.6608973367504374,-1.009320968788955,0.5686274509803921,0.9679541326715928,1.0,2/5,13.89%,HYAL2;RAC1
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.5404157646314659,1.0085855445892777,0.4791666666666667,0.7780893715245133,1.0,6/12,21.69%,CGNL1;TJP2;TJP3;MPP7;PAK2;JAK1
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.6227891206096111,1.0081300202569625,0.5217391304347826,0.7782097704034384,1.0,1/9,0.95%,SLCO2B1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.6227891206096111,1.0081300202569625,0.5217391304347826,0.7782097704034384,1.0,1/9,0.95%,SLCO2B1
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.6118834416685401,1.0079592788038885,0.4807692307692308,0.7782603299120301,1.0,1/7,6.23%,ME3
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.578603949062552,1.0078792654242823,0.5,0.7780946568238246,1.0,6/11,34.87%,MAD2L2;PAXIP1;HMCES;TFRC;SHLD2;SHLD1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5772025324101344,-1.00764903481135,0.45098039215686275,0.9714590580135326,1.0,3/12,11.82%,DDIT3;TMSB4X;GATA1
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.40989639343519435,1.0076323220176309,0.391304347826087,0.7782468998456575,1.0,15/61,11.80%,NRCAM;HEY1;BRINP3;MEF2C;CASZ1;LRRK2;ZEB1;CNTN4;ID2;DTX1;BRINP1;CDK5R1;YWHAH;HES1;NREP
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.4215616661184804,1.0075828840861505,0.44,0.7779162782468801,1.0,20/73,17.55%,PLAC8;PDGFC;SYK;OXTR;ACADL;KDM3A;EPAS1;STAT6;DIO2;PRKAB2;ZNF516;VEGFA;ADRB2;ADIPOR2;UCP1;KDM6B;ACHE;PPARGC1A;EBF2;LEPR
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.4134098924484656,1.007414681882897,0.37209302325581395,0.7779287995224448,1.0,14/61,17.09%,NCKAP1L;CYFIP1;BAIAP2;NR4A3;SYK;SRC;WIPF3;PLPP4;PIK3R1;LYN;PRKCE;WIPF2;PRKCD;DOCK1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.4416508387946141,1.007323537720539,0.4523809523809524,0.7776494611563084,1.0,13/52,13.16%,SLCO2B1;CSF1R;C1QB;MRC1;DDX3Y;SCEL;SFTPD;CRLF1;C3;TMEM176B;ADGRF5;SOAT1;CEBPD
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.4457422484485485,-1.0073230827832698,0.4230769230769231,0.9716188893655905,1.0,2/39,1.43%,PANK1;AMPD1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.4865446508884324,-1.0070797955645923,0.42592592592592593,0.9713988465290947,1.0,7/44,16.85%,SFRP1;RACK1;IFT81;INTU;GAS1;FUZ;PDCL
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.5575177227014,-1.0068781208310804,0.4375,0.9711135454778345,1.0,3/11,20.98%,UCK1;UCKL1;TK2
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.5412859184762208,1.0068360609934721,0.5102040816326531,0.7783152424563715,1.0,4/10,22.90%,FBLN1;DUSP3;SPINT2;CCDC125
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.5039208375052315,-1.0067735175931605,0.4727272727272727,0.9705153922512535,1.0,1/22,0.32%,PDE3A
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),0.5472351603145886,1.006772675034104,0.4230769230769231,0.77804867205079,1.0,3/12,13.95%,SOCS3;PARP9;PIAS1
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.6768965686823545,-1.0067254270959862,0.4909090909090909,0.969765382370569,1.0,1/5,8.14%,TRMT112
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.4532794259794862,1.0067167022902606,0.5,0.7777633855341878,1.0,10/38,12.89%,PTPRC;LCP2;ITGAM;CD53;CSF3R;TNFRSF1B;LY86;AOAH;SASH3;CD80
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.46219998403835927,1.0066991280044322,0.4727272727272727,0.777377112093376,1.0,5/37,5.39%,ADAMTS5;CD44;MMP16;CAPN1;LAMC1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.44843399489488955,-1.006565935746719,0.391304347826087,0.96938040273899,1.0,3/42,3.83%,NGF;DPEP1;BEX3
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.6797823846543676,-1.0063983246914032,0.5178571428571429,0.9691123832156736,1.0,3/5,18.55%,DDX21;PRIMPOL;DDX23
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.6773150906390253,1.0062797807089134,0.5686274509803921,0.7774405836563513,1.0,3/5,31.16%,PHLDB2;CLASP1;CLASP2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.6773150906390253,1.0062797807089134,0.5686274509803921,0.7774405836563513,1.0,3/5,31.16%,PHLDB2;CLASP1;CLASP2
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.4235612223898099,1.006271488112539,0.40425531914893614,0.7770614257330485,1.0,31/96,14.93%,MFNG;HNF4G;CAMSAP3;LRIG3;KIAA1217;CKMT1A;EFNB3;NR2F1;DDAH1;CADPS2;NPNT;SOX9;TEAD1;PCLO;MAPK4;EPAS1;EPB41L1;SYT7;NKAIN1;LYPD6;PCGF2;HES1;CNTFR;NR2F2;LRP4;SHROOM3;ABCC8;CPE;PRR36;ONECUT2;WNK2
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.6587811464933028,1.0061326985596153,0.5357142857142857,0.7770111722829655,1.0,3/5,17.81%,WNT5A;PTPN11;CHD7
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.42182494558864,1.0060932450057942,0.42,0.7767021035633195,1.0,4/41,11.26%,TM4SF20;TBC1D10A;PLK1;RNF139
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.4041943388363131,-1.0056047662039598,0.4225352112676056,0.9702754210012849,1.0,28/136,15.56%,CDKN1C;PARP2;ATF3;ATP6V1F;SLC25A4;H2AX;GRPEL1;AP2S1;EIF5;BTG3;CYB5R1;HYAL2;CREG1;TARS1;ICAM1;TMBIM6;DDX21;BAK1;BTG2;EPCAM;PRPF3;POLE3;CLTB;SQSTM1;SELENOW;SIGMAR1;CNP;DNAJA1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.33989481524943543,1.0051712675392939,0.38461538461538464,0.7782549632615965,1.0,49/275,14.07%,TGFB2;RND2;FIGN;MYO7A;CGNL1;ITGB4;KASH5;ACTN1;CAMSAP3;MYH11;GFAP;LOX;COL11A1;CARMIL1;FGF13;ARHGAP25;MYO1B;COL5A3;COL12A1;HOOK1;LOXL3;TPM1;COL20A1;TSPAN14;RHOF;SNCAIP;MYO5C;COL4A1;COL7A1;FIGNL1;P3H2;FBLN5;VIM;ARHGAP17;COL15A1;CORO1C;KIF14;MAPT;COL9A1;NEFL;TRPV4;P4HA1;TUBGCP6;COL22A1;SHROOM3;P3H4;RAC3;COL5A1;CORO6
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.4950329966128221,1.00512203918839,0.5263157894736842,0.7779329453672115,1.0,4/27,11.19%,TTC8;ARL13A;CEP89;CSNK1D
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.4948076292972782,-1.0049356777954568,0.4230769230769231,0.9710954286426824,1.0,13/35,26.08%,RAN;RAE1;NOL6;TOMM20;NUP37;YBX1;SSB;NUP210;TPR;POM121C;NUP93;NUP42;NUP85
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.4928385141710431,-1.0048273364572855,0.4423076923076923,0.9704859024919473,1.0,6/28,15.53%,TPX2;MAP7D3;TUBG1;GOLGA2;AKAP9;TPPP3
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.5230893084234369,-1.0047285521722527,0.5,0.9699715911391744,1.0,7/29,12.82%,AADAT;PYCR3;GLYATL1;ART4;DDAH2;PYCR1;RIMKLA
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.6170891315674868,-1.0047262631840612,0.5227272727272727,0.9691397521289624,1.0,3/7,17.62%,GOLGA2;PLK3;GBF1
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.6555983592393637,1.0044279951688961,0.5,0.7791556899836756,1.0,3/7,18.67%,TBX19;BMPR2;SCX
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.5686428766747617,1.0040517738086847,0.4166666666666667,0.779633682527005,1.0,3/11,15.14%,ADCY8;GPLD1;BAIAP3
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.4766614061701709,1.0040038210518878,0.48717948717948717,0.7793681171480386,1.0,8/32,16.60%,ISG15;SAMHD1;IRAK3;CR1;TTLL12;A2M;NLRC5;SUSD4
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.3824095593135613,1.0039427257690083,0.4523809523809524,0.779052486337055,1.0,22/144,11.24%,ADAMTS5;ZNF423;SRGN;EGFR;RPS6KA6;HEY1;PGAM5;MEF2C;PTPRG;SPRED3;PTPRR;DLX1;SOX9;PLCL2;ACVR1C;DUSP10;PLCL1;CORO1C;SLC6A4;ROBO1;BMPR2;ALPK2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.5235726566535609,-1.0038312248921337,0.4666666666666667,0.9707026484978704,1.0,4/19,15.23%,AMPD1;GMPR2;PFAS;IMPDH2
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.5098880024400826,1.0036152284369468,0.5217391304347826,0.7793347695640359,1.0,3/20,7.35%,GRIN2B;GRIN3A;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6095551114401765,1.0034944670492356,0.5106382978723404,0.7791703796643047,1.0,2/10,6.15%,MMRN2;MAP2K5
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.6120217123785952,1.003401847666598,0.5510204081632653,0.7790187322630654,1.0,1/8,6.32%,LILRB1
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.5972530312032795,-1.0033132957026676,0.5102040816326531,0.9713598128205664,1.0,4/6,21.94%,ADH4;CYP4F12;LDHD;CYP3A4
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.5871699924837924,1.0024536404631594,0.47058823529411764,0.7805189457550308,1.0,4/13,14.63%,ADCY8;RELN;ADCY1;ZDHHC2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.45816469513043323,-1.0023068943147715,0.4230769230769231,0.9734522308471977,1.0,5/42,7.61%,OOEP;CGAS;USP51;PARP1;RAD51AP1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.5098684337287271,1.0021848172470977,0.5098039215686274,0.7806492010380551,1.0,4/16,13.84%,SRC;BCL2;ZNF304;PDK4
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.5411040787304415,1.0021765738055795,0.3877551020408163,0.780271161109185,1.0,6/16,12.75%,B4GALT6;PICK1;C3;CX3CL1;SRRM4;ACTL6B
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.622318218637369,-1.0018917889585541,0.5333333333333333,0.973745301482217,1.0,3/7,17.17%,AWAT2;PNPLA3;MGLL
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.5789002560209104,-1.0011755312492039,0.4375,0.9748232770699997,1.0,3/14,12.80%,CHAMP1;MIS12;IK
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4755756370928234,1.0010883268553254,0.5142857142857142,0.7823451710646167,1.0,3/21,8.55%,EGFR;PLCB1;CCND1
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.4389619326481396,1.0009470111349341,0.391304347826087,0.7823113086590705,1.0,11/47,18.35%,RAB3C;RIMS2;PTPRN;RAB15;RAB3A;WLS;OLFM2;ABCA1;PORCN;TVP23A;SNX19
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.6921832941819097,-1.0008399245224175,0.5510204081632653,0.9749202797519071,1.0,3/5,19.85%,UBE2D4;RNF6;UBE2S
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.6471375012706636,-1.000767417945408,0.44,0.9742186700628254,1.0,3/7,7.96%,SFRP1;GREM1;ATRAID
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.5465409264827729,1.0007334111996848,0.4375,0.7823589081655329,1.0,4/14,21.11%,LAPTM5;LGALS3;SAMSN1;DUSP3
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.46813327902383506,-1.0006983477165245,0.5476190476190477,0.9735398269591223,1.0,11/40,14.73%,F11;GLOD5;TPH2;GBA3;ADH6;ANXA13;ADH4;HNF4A;TFPI;ESM1;SCTR
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.4669771255209356,-1.0006878165141717,0.5,0.972775978998936,1.0,14/37,23.16%,SURF1;UQCRFS1;ETFRF1;NDUFS8;ETFB;UQCR10;LYRM7;NDUFA5;UQCRB;ETFA;COQ10B;UQCRH;NDUFS7;COX10
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.5795350623417572,-1.000663494279454,0.5294117647058824,0.9711948619346794,1.0,1/8,1.14%,PDZD11
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.5795350623417572,-1.000663494279454,0.5294117647058824,0.9711948619346794,1.0,1/8,1.14%,PDZD11
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.669931385038619,1.0006154005878136,0.5106382978723404,0.7822499520078455,1.0,2/8,7.50%,SHMT2;MTG1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.5163571269472086,1.000344607868033,0.46938775510204084,0.7825978637153697,1.0,3/17,12.26%,DPYS;NT5C1A;DPYSL3
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),0.6901776731469189,1.0001650511648137,0.5652173913043478,0.7825764461940299,1.0,1/5,12.65%,RAB3A
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.6430487047656882,-1.0000645239959305,0.5294117647058824,0.9718244912037227,1.0,2/5,11.39%,SNRPC;PRPF39
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.5938234282880289,-0.9998677146085899,0.5384615384615384,0.9715513515500563,1.0,2/7,8.09%,SERPINE1;CREB3
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),0.6477167527320693,0.9997872569506192,0.5116279069767442,0.7829988184382327,1.0,1/5,5.47%,MAPKBP1
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.583797622784991,-0.9997433433170885,0.47540983606557374,0.9710212727914979,1.0,2/10,13.01%,CD81;SAR1B
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.554895362226901,0.9997287256299947,0.48,0.7827023462896955,1.0,5/13,20.39%,FAP;AEBP1;RIC1;LRP1;TIE1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.3813858249265953,0.9996347413150548,0.4782608695652174,0.7824686245220083,1.0,12/74,15.51%,SLCO2B1;SLC23A1;ABCC4;SLC25A48;SLC43A1;SLC26A7;SLC7A9;SLC6A15;SLC7A8;NCOA1;SLCO1A2;ABCC11
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.5926827274841533,-0.9996254416162705,0.52,0.9704920993766772,1.0,2/7,4.59%,GREM1;GSTP1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.5905243346875684,-0.9993321708284864,0.47058823529411764,0.9704492106287127,1.0,4/14,11.08%,DDX5;SCNM1;SRSF9;PUF60
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.6138970202792803,-0.9987933015186213,0.6136363636363636,0.9708770990926436,1.0,2/7,26.41%,PSMC5;PSMC4
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.4622216185972517,0.9987488664869628,0.358974358974359,0.7842570102929981,1.0,5/38,7.72%,MX1;SYK;LILRB1;ARRB2;DNM1
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.5828269364535904,0.998464832018335,0.5106382978723404,0.7844530663165568,1.0,3/9,14.50%,LRRK2;RNF139;PGAP1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.5600227428461747,0.9982417090771121,0.44680851063829785,0.7845678767085155,1.0,2/12,7.34%,ACADL;SOX9
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5137628395734777,0.9980288831795454,0.4772727272727273,0.7846264919959188,1.0,2/24,3.54%,CREB3L1;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.6400229771414645,-0.9976714714642412,0.5423728813559322,0.9731997228052712,1.0,4/6,31.69%,BAD;STOML2;VCP;MTLN
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.473504504941308,-0.9975637473171185,0.4583333333333333,0.9726420178690113,1.0,5/26,9.89%,STMN1;MYADM;PFN1;TUBB4A;TWF1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.47219678917664754,0.9975283833028709,0.4807692307692308,0.7853264382137682,1.0,11/32,14.21%,EFNA5;SPOCK1;FBLN1;CDKN2A;DMTN;CORO1C;CX3CL1;ACER2;KANK1;PTPRO;ITGB1BP1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.5429500108053035,0.9974383288467971,0.4090909090909091,0.7851107425136945,1.0,2/12,4.71%,IL12A;SYK
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.5644102905024397,-0.9971398360260574,0.49056603773584906,0.9731452007003266,1.0,1/10,4.21%,SLC31A2
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.41149201189585827,0.9970677449044211,0.36,0.7854613437054573,1.0,7/64,12.15%,CD59;VAPB;GRIA1;COL7A1;TGFA;CSNK1D;ANKRD28
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.43165829962817664,0.9969533400932591,0.43478260869565216,0.7853266288062202,1.0,5/37,8.96%,LPL;GPC6;LRP8;GPC5;AGRN
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.4160988209029279,-0.9969505777113756,0.35384615384615387,0.9728372572497713,1.0,3/56,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.418695806546933,0.9968437679104244,0.45454545454545453,0.7851734140770718,1.0,11/52,17.55%,LRRK2;MET;HGF;RASIP1;BCL2;WDR6;LZTS1;WASHC1;DAPL1;RUBCN;LEPR
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),0.607247311786765,0.9968251384735647,0.5217391304347826,0.7848154077027192,1.0,1/5,1.15%,BMP6
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.48826955136641953,-0.9965921248142423,0.375,0.9728423074168783,1.0,6/19,22.88%,SURF1;NDUFS8;UQCR10;UQCRB;UQCRH;NDUFS7
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.47258996864001823,0.9965420042364851,0.45454545454545453,0.7850040324280385,1.0,6/29,12.89%,TGFB2;RSAD2;WNT5A;CDKN2A;HOMER1;CD80
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.44647035753822023,-0.9964836915004446,0.4406779661016949,0.9723435624448312,1.0,3/63,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.4795787311287265,-0.996482514603033,0.3877551020408163,0.9715195424766576,1.0,8/31,18.20%,CSTF2T;LSM10;CSTF2;SNRPB;SNRPE;SSU72;SNRPG;FIP1L1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.6008969568989506,-0.9964182319272649,0.5,0.9708810907715031,1.0,4/8,21.73%,PARK7;P4HB;PINK1;LANCL1
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5134670626833997,-0.9961310199762725,0.5208333333333334,0.9708453133529963,1.0,3/24,5.48%,RPS3;H1-4;H1-2
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.5058838880240257,0.9957382802722641,0.43478260869565216,0.7863960658017342,1.0,4/15,19.00%,DDAH1;EDN1;PKD2;CLEC7A
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.48648229755837924,0.9956215669559323,0.48936170212765956,0.7862240080802757,1.0,3/26,7.64%,HEY1;NFKBIA;LEF1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.3735193826181323,-0.9955310090635613,0.46153846153846156,0.9715379705703813,1.0,24/195,12.89%,CFAP61;KIF3B;EXOC7;PLK4;RAB8A;ABLIM3;DYNLL1;CNGB1;CNGA4;FBF1;TMEM107;PTPDC1;TTC29;IFT81;INTU;CFAP70;CEP131;TMEM138;TTC36;MKS1;SNAP29;CFAP43;TTLL3;WDR90
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.49818345354531113,-0.9954458998701988,0.4523809523809524,0.9708940553784764,1.0,3/22,12.42%,TINF2;PARP1;PINX1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5106253295381902,0.9950396038919905,0.5294117647058824,0.7870065670293555,1.0,4/19,16.84%,TP73;DYRK2;AEN;DDIT4
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.5867103419529497,-0.9949375405773103,0.5111111111111111,0.9714513689099458,1.0,2/12,2.75%,WNT9A;GREM1
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),0.6538251444322044,0.9947044618188896,0.574468085106383,0.7872865586728253,1.0,3/5,27.07%,IRGM;ULK1;ATG7
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),-0.6338483647016593,-0.9945386023720727,0.5333333333333333,0.9706461872011134,1.0,2/5,29.68%,HSBP1L1;HSBP1
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),-0.6338483647016593,-0.9945386023720727,0.5333333333333333,0.9706461872011134,1.0,2/5,29.68%,HSBP1L1;HSBP1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.541938834152544,-0.993771931509707,0.5238095238095238,0.9719769034382605,1.0,4/12,23.72%,NPC2;NPC1;STAR;OSBP
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.48151865641025715,-0.9934275628204127,0.46296296296296297,0.9722218513709991,1.0,5/27,16.55%,RAD23A;PPIE;PPIA;FKBP6;NR5A2
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.53435219234174,-0.993380873726124,0.48148148148148145,0.971552488136249,1.0,2/13,9.44%,DHFR;S100A1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.45855830257692876,0.9932840570440442,0.42105263157894735,0.7901293799671105,1.0,8/29,14.70%,ANGPT1;ARRB2;MKLN1;PICK1;DLG4;RIN3;SFRP4;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.617626292562167,0.9931031163647401,0.4827586206896552,0.7901599226117927,1.0,3/6,25.26%,NNMT;PPARGC1A;SIRT1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.48147852765111554,-0.9930479868297634,0.4,0.9716147546590356,1.0,2/37,3.10%,NGF;EDF1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.40814914172855765,0.9930109750208115,0.47619047619047616,0.7899987099489539,1.0,21/91,20.74%,PTPRC;LCP2;TSPYL2;RELN;HSPB1;CD4;CAMKK1;SPDYA;UBASH3B;CAMK2N2;ITGB1BP1;THY1;GAS6;CDKN1A;PRKAG2;WWTR1;YWHAG;CAV3;PAK2;CEP85;CENPE
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.3932251354492918,0.9927102548438346,0.5106382978723404,0.7902765441372855,1.0,22/97,13.12%,IGFBP3;EGFR;ITGB4;F3;LRIG3;KIAA1217;MET;NPNT;FBLN1;COL12A1;TEAD1;PXDC1;CRLF1;EPAS1;EPB41L1;NTN4;TRIM29;ANTXR1;HOPX;LAMB2;GPC1;SHROOM3
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.6041202004890041,0.9926103346081572,0.54,0.790072192453337,1.0,4/6,26.99%,PHF19;MACROH2A1;OGT;MTF2
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.47710143028138086,0.9925540530186284,0.4318181818181818,0.7898310055957761,1.0,3/22,12.13%,TLR2;PICK1;CSPG5
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.4566750411816347,-0.9918440169295336,0.5106382978723404,0.974013977568772,1.0,2/32,3.32%,LCK;PTPRU
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.6216426694900399,0.9917443786654613,0.5,0.7913243083968975,1.0,2/8,4.71%,ITGAM;SYK
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.5561610014268618,0.9916395986324723,0.5416666666666666,0.791206087144837,1.0,2/15,9.66%,ADAMTS9;FBXO17
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.4480753749319819,-0.9915023856969033,0.4772727272727273,0.9741301749718567,1.0,10/49,20.29%,EMC6;GABARAPL2;UBQLN2;ATG9A;MAP1LC3B;ATG16L1;WDR45B;ATG14;BECN1;ATG2A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.5588382553073721,0.9914319869815437,0.46938775510204084,0.7913037717157946,1.0,5/10,26.49%,WNT5A;IL33;CLEC7A;LBP;NECTIN2
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.5029407889743744,0.9913998844976347,0.4727272727272727,0.7909330437583372,1.0,3/17,8.15%,COL11A1;COL12A1;COL7A1
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.6324007868938613,-0.9913141556999202,0.52,0.973832797484218,1.0,3/7,28.12%,DYNLT1;TBC1D20;DDB1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.43229129005608075,0.9910318370325211,0.425531914893617,0.7913079130046192,1.0,8/35,16.73%,ADCY8;CARTPT;KCNB1;NGFR;PIK3R1;GPER1;GAS6;PPARGC1A
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.5873612940398075,0.990966095291453,0.5714285714285714,0.7910360588996239,1.0,1/10,3.52%,PIK3AP1
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.5637256474425903,0.990900484893495,0.5272727272727272,0.7908137073156228,1.0,4/8,14.41%,CBS;SHMT2;GLDC;SHMT1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5803322837554309,0.9907550970224875,0.48936170212765956,0.7907945085936147,1.0,2/12,8.82%,PLXNA4;PLXNA2
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.6391775936995258,0.9905837281088485,0.5370370370370371,0.7907077249319301,1.0,1/5,7.01%,HEXB
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.43930041461138164,0.9901341812537161,0.4339622641509434,0.791481010044208,1.0,11/40,12.53%,CORIN;RYR3;SLC8A1;ITPR1;ABCC9;NOS1;ATP2B3;ATP2B2;TMEM65;DMPK;ATP1B2
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.5946648937391774,0.9899714487961111,0.48214285714285715,0.7914492145992004,1.0,1/9,5.26%,ID2
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.45936031047834325,0.9895254890353312,0.5,0.7919206291493481,1.0,10/39,11.91%,CD44;CHI3L1;MEF2C;SULF1;SOX9;ZBTB16;GPLD1;CREB3L2;SOX5;TRPV4
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5116288296395013,0.9894917675826486,0.5490196078431373,0.7916126480521458,1.0,4/14,8.77%,CX3CR1;SELL;ADD2;JAM2
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.5676533756741997,-0.9893698173812348,0.5,0.9780582935872654,1.0,12/16,34.80%,SPHK2;NAA40;MSL3;DMAP1;EPC1;YEATS4;RUVBL1;TRRAP;MORF4L1;MEAF6;ACTL6A;ING3
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.6446684342754924,-0.9893606689863665,0.5102040816326531,0.9772615032799205,1.0,1/6,13.86%,GPATCH3
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.5624118899909765,-0.9891366476486805,0.4897959183673469,0.9769971995440156,1.0,4/12,20.29%,UFC1;TEX264;UFL1;ATG2A
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.5509177291004124,0.9884000564453204,0.5094339622641509,0.7935853169386283,1.0,7/13,25.34%,STAT6;PIK3R1;GHR;LYN;STAT5A;STAT3;STAT5B
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),0.634246731473363,0.9882725646065925,0.5098039215686274,0.7934605923923911,1.0,3/5,15.36%,ZFP36;SFRP4;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.6095079580973854,0.9882234416963412,0.5227272727272727,0.7931951559402539,1.0,1/6,5.50%,PTGER3
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.45120488984918605,-0.9881649370738199,0.5294117647058824,0.9786606591801574,1.0,3/38,4.84%,CDKN1C;BUB1;BTG3
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.6162230381182351,0.9879056299417291,0.5434782608695652,0.7934563466478359,1.0,2/7,16.86%,ABCD2;SLC27A2
prerank,MSigDB_Hallmark_2020__Androgen Response,0.4001049662814689,0.987763227988518,0.45652173913043476,0.7934052895850722,1.0,16/94,15.19%,FKBP5;GUCY1A1;ABCC4;ACTN1;AKAP12;BMPR1B;MERTK;INPP4B;LIFR;CCND1;TSC22D1;RPS6KA3;PIAS1;MAK;SORD;TPD52
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5298712978301829,0.987519445161192,0.4583333333333333,0.7935010218179004,1.0,5/17,17.87%,ABCD2;PRKAB2;SLC25A20;ACACB;PRKAG2
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.5635353044883741,0.9874435581712495,0.5,0.7932483367772032,1.0,1/13,5.30%,PPP3CA
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.5194682440322524,0.9873799045531735,0.47058823529411764,0.7929470523329748,1.0,6/14,28.34%,TNFSF4;MAD2L2;PAXIP1;HMCES;NECTIN2;TFRC
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.49622515657464483,-0.987311135916409,0.4782608695652174,0.9800003916231003,1.0,6/45,12.77%,CRYAB;RAD51AP1;TMEM109;HRAS;HUS1;BLM
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.6069011874518713,-0.9872721878554814,0.509090909090909,0.9792743529962015,1.0,1/7,2.90%,SERPINE1
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.6119514083074719,-0.9871866066080621,0.4782608695652174,0.9786540075477098,1.0,1/8,14.99%,PMVK
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.42875739603058965,-0.987135184974888,0.55,0.9779720559701742,1.0,17/114,13.31%,BUB1;STMN1;KIF3B;PTPA;SBDS;NDC80;RPS27;DYNLL1;TUBG1;BCCIP;RAN;NEK6;SGO2;MIS12;NUDC;DYNC1H1;KIF4A
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.6532571471090205,-0.98709008579838,0.5,0.9772773300888038,1.0,5/6,34.14%,TEX264;FAM111A;VCP;SPRTN;VCPIP1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.5206745968774931,-0.9869039671893275,0.5208333333333334,0.9770909806286622,1.0,2/24,3.32%,IFNLR1;CGAS
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.5142791790722382,-0.9868120986753753,0.4918032786885246,0.9765092187742224,1.0,1/24,0.25%,ABCA13
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),0.5116524205293008,0.9867765969104279,0.5098039215686274,0.7938303548533089,1.0,4/13,8.77%,CX3CR1;SELL;ADD2;JAM2
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.6035812000218991,0.9866662731517908,0.4888888888888889,0.7936450066582307,1.0,2/9,16.54%,TNFRSF1B;PARD3
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.4062086397585641,-0.9866320625006767,0.4489795918367347,0.9760810297398996,1.0,24/125,14.59%,TNFRSF8;RPS3;SFRP1;TNFRSF21;PSMB6;PSMD7;CRHBP;PSME2;PSMD8;HYAL2;PSMB4;PSMD3;PSMB3;ADAMTS12;CHUK;PSME1;GBP3;TMSB4X;TXNDC17;EIF5A;PSMA7;PSMB8;PSMD13;ILK
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.6273904267903427,-0.9865809458883998,0.5272727272727272,0.9754109658434159,1.0,2/6,17.75%,ERCC8;XRCC6
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.5043556985368051,-0.9865674000812222,0.5,0.974631207412533,1.0,1/20,0.32%,PDE3A
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.5383810212949581,-0.9865571645180865,0.44,0.973859658421018,1.0,4/17,17.45%,SUN3;REEP4;TOR1A;EMD
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.6127146538198749,0.9862849876732114,0.47058823529411764,0.7942526149917032,1.0,2/7,9.28%,WNT5A;PICK1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.6553053325133166,-0.9862664791251995,0.5964912280701754,0.9737531093055911,1.0,1/6,1.51%,SFRP1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.4018475540506806,-0.9862073886353983,0.4482758620689655,0.9730802728910944,1.0,14/79,14.57%,SAP18;NCL;DDX5;SRSF7;RBM15B;SRSF3;SRSF9;RBM11;C9ORF78;PUF60;SF3B4;RBM8A;MBNL3;RBM23
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.40697826339841153,0.986189295309764,0.42857142857142855,0.794024574876912,1.0,6/61,7.18%,CARD18;PDGFB;MAP2;LRRK2;DACT1;ARRB2
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.6242839663234443,-0.9861223440642837,0.52,0.9724706682677169,1.0,1/6,10.84%,SRI
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.4195167225633109,0.9859923891073282,0.40540540540540543,0.7940160783856735,1.0,14/67,12.04%,IGF1;CSGALNACT1;CHST8;ST8SIA3;B3GALNT1;BMPR1B;ST8SIA4;ST3GAL6;FUT9;ST8SIA6;B3GALT1;BMPR2;B3GNT6;CHST11
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.3606386942513595,-0.9859158574122677,0.4520547945205479,0.9721379367050278,1.0,86/562,15.60%,NGF;ARHGEF16;TNFRSF8;CRYAB;CD38;RPS3A;PRELID1;RPS27A;PAX8;RPS3;UBC;SFRP1;DPEP1;PRR7;RPL10;SAP18;RPS6;PTMA;MIEN1;UBB;USP27X;GREM1;PTPA;PRDX5;LGALS1;GSTP1;CFL1;ACTN2;RACK1;MGMT;TMEM219;TNFAIP8;TPT1;PHB2;SPHK2;EVI2B;SOD1;PRMT2;ARAF;KNG1;ANXA5;APEX1;SEPTIN4;PRDX3;DHCR24;NOP53;BNIP1;MYDGF;TMBIM6;IKZF3;CIAPIN1;HMGA2;DDAH2;ARHGDIA;BAX;ZNF830;TRIAP1;BAK1;PRKAA2;GATA1;PPIA;APIP;NPM1;UBA52;DNAJA3;VAV1;KLHL20;ITGA6;RRP1B;RSL1D1;IFIT2;SQSTM1;DAXX;NCSTN;ZNF622;COPS5;FANK1;ARL6IP5;GAS1;MTCH1;ARHGEF1;SIGMAR1;SH3RF2;BCL2A1;DNAJA1;IFI6
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.5794207738544557,-0.985824068652002,0.4444444444444444,0.9716128048077156,1.0,4/7,31.84%,NCSTN;BACE1;APH1A;APH1B
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.5828108028133433,0.985627795066503,0.5416666666666666,0.7943607373126831,1.0,2/6,13.29%,NFKBID;NFKBIZ
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.5847373459803241,0.9854358796494488,0.46511627906976744,0.7939602293072654,1.0,3/9,12.42%,ADCY8;ADCY2;ADCY1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.5847373459803241,0.9854358796494488,0.46511627906976744,0.7939602293072654,1.0,3/9,12.42%,ADCY8;ADCY2;ADCY1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.5545951240107619,0.9852677836447131,0.5283018867924528,0.7939213870055786,1.0,1/9,1.26%,KCNMA1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.5167341537142457,-0.9847299830464871,0.43137254901960786,0.9735879179063788,1.0,8/25,19.81%,DCTD;AK8;CMPK1;NME3;DTYMK;TYMS;DUT;GUK1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4079400268884538,0.9844104384856852,0.5416666666666666,0.7954259331017883,1.0,9/58,9.36%,TGFB2;ZNF423;BMP6;BMPR1B;CITED2;INHBC;SULF1;KIAA0319;TGFB3
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.5941564815794895,0.9844001788606968,0.5319148936170213,0.7950705771166484,1.0,5/10,14.15%,KCNMB4;SYT1;KCNIP2;KCNMB3;KCNMB2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.5522513039265063,-0.9843656330552456,0.49056603773584906,0.9737229069257417,1.0,3/12,20.48%,DNMT3B;CTR9;DNMT1
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.35780373435231,-0.9840377901873887,0.49206349206349204,0.9737820597686748,1.0,51/356,14.45%,RPS23;RAB32;RPS3;VPS25;EMC6;KIF3B;SQLE;EXOC7;FLII;PLK4;RAB8A;ABLIM3;DYNLL1;CNGB1;CNGA4;FBF1;CHMP2A;TMEM107;PTPDC1;GOLGA8M;IFT81;GABARAPL2;VPS28;UBQLN2;NEK6;INTU;CFAP70;CEP131;TMEM138;CHMP5;TTC36;TRAPPC6A;MKS1;GOLGA8H;ATG9A;MIS12;SNAP29;CFAP43;NPM1;SNF8;TTLL3;WDR90;DHX29;CHMP3;DYNC1H1;GOLGA2;HAUS6;GORASP2;MAP1LC3B;HGS;ARL13B
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.6305294923262648,-0.9834827229577954,0.5217391304347826,0.9746309799825007,1.0,1/6,6.14%,USH1C
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.47159677945627876,-0.9833385619192746,0.4146341463414634,0.9741951726590635,1.0,2/35,1.79%,TNFRSF8;CNN2
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.44359778832556856,0.9831352419056061,0.5357142857142857,0.7975016776644347,1.0,10/42,16.46%,SEMA3D;CORO1C;SEMA6A;AMOTL1;SEMA5B;SEMA4G;SEMA4B;SEMA3C;CCN3;SEMA7A
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.4153272561326289,-0.9831188420694041,0.3888888888888889,0.9740480791214329,1.0,14/64,17.32%,PSMB6;PSMD7;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;CHUK;PSME1;PSMA7;PSMB8;PSMD13;PSMD2;PSMC5
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.38286894563539425,0.9828555697841875,0.45454545454545453,0.7976370286127548,1.0,13/112,13.46%,CDS1;PLEKHA2;INPP5D;PIP5K1B;INPP4B;SOCS3;SLA2;PIGP;PLEKHA4;TPTE2;IP6K3;PIK3R1;PIP4K2A
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.5171680150011875,0.9827019662254919,0.4418604651162791,0.7975660756059827,1.0,3/15,7.57%,KCNB2;TPM1;NMUR2
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.48110034400441215,0.9825493062939865,0.4423076923076923,0.7975376194217775,1.0,8/30,16.46%,SEMA3D;CORO1C;SEMA6A;SEMA5B;SEMA4G;SEMA4B;SEMA3C;SEMA7A
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.42844647844388406,0.98226377862648,0.5098039215686274,0.797787834304131,1.0,11/44,13.29%,FOSL2;SMAGP;BHLHE40;GCM1;MAFF;SCEL;CD4;TRIM29;HOPX;LGALS3;NFKBIZ
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5237077717885325,0.9822348665958947,0.4888888888888889,0.7974686861552338,1.0,2/15,9.68%,OGFOD1;IRAK3
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.3495608032252872,0.9820365457781813,0.4,0.7974826822951478,1.0,31/171,17.89%,TGFB2;EGFR;OSGIN1;NRG3;LGI1;TSPYL2;SPOCK1;PTPRJ;BCL6;CDKN2A;RERG;CAMK2D;KIF14;BCL2;BMPR2;APBB2;FRZB;RPS6KA3;CHPT1;GNG4;OSGIN2;PAK5;CCN3;FHL1;SESN2;RPTOR;SMARCA2;CRLF3;CDKN1A;TMC8;CSNK2A1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.473936121625233,-0.9819527724138235,0.423728813559322,0.9762924039775052,1.0,1/22,1.49%,USE1
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.5139037423840266,-0.9818752597726158,0.4318181818181818,0.9757056970637432,1.0,4/19,12.69%,USP51;ENY2;USP16;BRCC3
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.5169876406858978,0.9816131078396614,0.5106382978723404,0.7980954261501301,1.0,3/12,7.52%,SLC26A4;SLC13A4;SLC26A7
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.5221809201363397,-0.9815289964597863,0.52,0.9758381818293914,1.0,6/16,23.42%,DOLK;DPAGT1;ALG3;DOLPP1;ALG12;ALG1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.4163683767320695,0.9810111919225569,0.5283018867924528,0.7989795661682424,1.0,13/47,22.68%,THSD7A;SIPA1L1;MKLN1;DMTN;ANTXR1;TRPV4;TNIK;PHACTR1;CASS4;CDC42BPA;FER;MINK1;ATP2C1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.41073694687668155,0.9808738230150751,0.5,0.798884011789032,1.0,13/71,7.52%,AQP1;SLCO2B1;SLC23A1;MGST1;ABCC4;SLC25A41;SLC4A10;CA12;SLC22A3;SLC26A9;SLC4A4;SLCO4A1;SLC26A7
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.5405721956136735,-0.9807917438468504,0.49056603773584906,0.9770366661886707,1.0,6/24,11.01%,STMN1;CFL2;CFL1;KATNB1;TWF1;STMN3
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.418611722999938,0.9801976162939855,0.4358974358974359,0.7999238501145144,1.0,7/39,19.72%,LRRK2;PID1;MAPT;RHOT1;PPARGC1A;PRMT6;ATP13A2
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.6445709286585534,0.9799464338811715,0.5531914893617021,0.7997984267043708,1.0,4/5,35.49%,SLC11A2;SLC30A1;SLC39A14;SLC11A1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.6445709286585534,0.9799464338811715,0.5531914893617021,0.7997984267043708,1.0,4/5,35.49%,SLC11A2;SLC30A1;SLC39A14;SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.377847846555354,0.9797492747668944,0.5121951219512195,0.799877505246166,1.0,23/100,17.11%,TGFB2;OSGIN1;TRIM46;MAP2;FGF13;TSPYL2;PTPRJ;KIAA0319;BCL6;CDKN2A;RERG;BMPR2;APBB2;FRZB;GNG4;OSGIN2;CCN3;FHL1;SESN2;DIP2B;SMARCA2;CRLF3;CDKN1A
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.5249364350995402,0.9797086324145574,0.4772727272727273,0.7995587574360913,1.0,2/17,2.29%,SGO1;KASH5
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.5842105295944073,0.9796914161278844,0.5161290322580645,0.7991921486219916,1.0,2/10,2.64%,MX1;ZDHHC11
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.5724017747930339,0.9796754724247733,0.46296296296296297,0.7988379550467786,1.0,2/9,15.03%,SCARB1;ABCA1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4911817949585353,0.97954759954816,0.5,0.7986526052179279,1.0,10/21,29.92%,CCP110;KANK1;PRKCD;ARHGAP44;LIMK2;ARHGAP24;SRGAP2C;YAP1;CEP97;ODF2L
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.6057027953538676,0.9794552578980981,0.54,0.7980059636147603,1.0,4/6,27.71%,JAK1;IL21R;STAT3;STAT4
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.6057027953538676,0.9794552578980981,0.54,0.7980059636147603,1.0,4/6,27.71%,JAK1;IL21R;STAT3;STAT4
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.5623968153047996,0.9791796977665863,0.5510204081632653,0.7982719221610604,1.0,1/8,1.03%,SRGN
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.39137204498542405,-0.979126366011828,0.4166666666666667,0.9808419249552534,1.0,17/78,14.53%,PSMB6;PSMD7;CDK4;PSME2;PSMD8;GFI1B;PRMT2;PSMB4;PSMD3;PSMB3;PSME1;CDKN2C;PINX1;PSMA7;PSMB8;PSMD13;BRD7
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.4296720449340665,-0.9786210937259779,0.42592592592592593,0.9815089580481556,1.0,10/40,23.60%,PLK4;NUMA1;DYNC1H1;SAXO1;CEP120;FUZ;CROCC;G3BP2;ASAP1;IL5
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.41510750454901363,0.9784068812774039,0.4318181818181818,0.7996485244554208,1.0,6/51,9.28%,KCND2;AQP1;SCN2A;AK4;EPAS1;PICK1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3693263282135726,0.9783315041104274,0.48717948717948717,0.7994392262669109,1.0,12/114,9.68%,ROR1;CX3CR1;TLR2;TRIM5;PRKCZ;WNT5A;NFKBIA;TIRAP;CLOCK;IL1RAP;NOD1;IRAK3
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.6164428649291495,-0.9782790578798484,0.49019607843137253,0.9816499172967881,1.0,1/5,5.49%,HYAL2
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.5581903727570873,0.9779500716784648,0.45098039215686275,0.7998540195497823,1.0,6/11,23.97%,LAPTM5;AP1G1;CCDC91;SORT1;EHD3;GAK
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.4190116060529384,-0.9778433724681322,0.40350877192982454,0.9820358953675166,1.0,2/46,2.30%,NGF;UBB
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.4226343674266661,-0.9778080726803202,0.4727272727272727,0.9813389462500596,1.0,10/67,8.74%,SFRP1;POLR2L;POLR2G;POLR2K;FRS3;POLR2I;GTF2F1;HYAL2;FGF6;POLR2A
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.5844454484653099,0.9776225472112827,0.4418604651162791,0.8001784539913732,1.0,3/6,19.76%,VEGFA;ADIPOR2;KDR
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),0.6244757267667543,0.9776155085839542,0.6,0.799789423804862,1.0,1/7,3.38%,IL12A
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.5153348685508043,0.9774203384417051,0.5526315789473685,0.7997841287562871,1.0,1/16,1.98%,MDFIC
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6079275846042814,0.9772502174975007,0.48,0.799772852451442,1.0,3/8,16.82%,NCKAP1L;CBFB;TNFSF4
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.42683369056351106,0.9769802627248123,0.4909090909090909,0.7999111775247215,1.0,14/48,11.75%,CX3CR1;P2RY12;GRM5;GRM1;GRPR;C3AR1;PTGER3;ADRA1A;GPR35;NMUR2;HTR2C;P2RY1;HOMER1;CHRM1
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.5818997044071493,0.9769732670525881,0.5,0.7995170923609392,1.0,2/7,29.00%,VEGFA;LRP2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.539980920370148,0.9768963009494303,0.49019607843137253,0.7992369800620094,1.0,2/14,3.12%,NEDD4L;SLC8A1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.49016339809953097,-0.9765983014390535,0.4482758620689655,0.9834657023862035,1.0,5/31,6.73%,JUP;RBM22;HYAL2;APOD;RAN
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.5759884212897446,0.9765759905253043,0.5,0.799524728795576,1.0,1/7,8.59%,GIT1
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),-0.6428846197361493,-0.9764729514682579,0.5172413793103449,0.9830677416407378,1.0,3/5,16.10%,AGBL1;FOLH1B;FOLH1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.5171914570523766,0.9762607303255803,0.4318181818181818,0.7998599575707175,1.0,4/15,10.85%,ABCC9;TRPM2;P2RY1;TRPC3
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.5615630039631488,0.9761192561570633,0.5,0.7998606140084702,1.0,2/8,8.55%,NR4A3;CCND1
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.646108955769735,-0.9760590473491293,0.6229508196721312,0.9833358799733914,1.0,3/5,32.14%,FABP5;MFSD2A;SLC27A1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.489073593269962,-0.975568662788797,0.45652173913043476,0.9838139130981737,1.0,9/27,19.40%,CHMP2A;CEP131;CHMP5;NPM1;CHMP3;CEP120;STIL;NAT10;PKHD1
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),0.6209064230388648,0.9755606525095152,0.5094339622641509,0.80057712005611,1.0,2/7,2.24%,CBLN2;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),-0.6166532444290712,-0.9753692696674562,0.5,0.9835115483058712,1.0,2/7,18.59%,NUMA1;SMC6
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.4883882642720505,0.9751473225994836,0.5319148936170213,0.8009947808942716,1.0,6/20,14.70%,CX3CR1;TOX;FZD3;CX3CL1;FZD9;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.47892331696336643,0.9747585234380594,0.5,0.8014060598284808,1.0,3/18,11.85%,ZDHHC11;LILRB1;PARP9
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.5868104015114712,-0.9747013581424875,0.5,0.9844221909584323,1.0,2/11,2.75%,WNT9A;GREM1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.6570678994606695,0.9743698208625374,0.5777777777777777,0.8018883993650017,1.0,2/5,16.81%,RSAD2;SLC15A4
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.3601604349501103,0.9740661278840386,0.5238095238095238,0.8021976039597655,1.0,21/99,16.93%,L1CAM;AQP1;PPARG;SLC23A1;SLC35F1;COL20A1;SLC2A5;GIPC2;VIL1;SLC40A1;NR1I3;SLC11A2;DMBT1;DAB1;RGMB;ASPN;DGAT1;ACSL5;FERMT1;SLC28A2;GFRA2
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.6397466865602041,0.9740574901134705,0.6,0.8018162550737993,1.0,4/8,15.90%,KCNMA1;NOS1;GPER1;ADRB2
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),-0.5440118652483236,-0.9740301040122845,0.5,0.9853787386126394,1.0,3/10,15.27%,RGN;CARNS1;FADS1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.46076798514225653,-0.9739546261089399,0.5178571428571429,0.9839625436218998,1.0,13/48,26.08%,CHMP2A;RAN;BANF1;CCNB2;CHMP3;REEP4;NUP37;EMD;CHMP7;CC2D1B;SUMO1;NUP93;NUP85
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.46076798514225653,-0.9739546261089399,0.5178571428571429,0.9839625436218998,1.0,13/48,26.08%,CHMP2A;RAN;BANF1;CCNB2;CHMP3;REEP4;NUP37;EMD;CHMP7;CC2D1B;SUMO1;NUP93;NUP85
prerank,MSigDB_Hallmark_2020__Apical Surface,0.4662177781615522,0.9738821667288544,0.42,0.8017802375553746,1.0,9/33,17.10%,NTNG1;EFNA5;HSPB1;CX3CL1;LYN;SHROOM2;THY1;ADIPOR2;NCOA6
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.47173943858854167,0.973856166832398,0.43478260869565216,0.8014470388629855,1.0,3/22,5.84%,ARHGAP18;PAK3;FCHSD2
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.5500979147292477,0.973517662650816,0.5094339622641509,0.8016845460865354,1.0,2/6,24.66%,TRIM27;SERPINB9
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.5273692405215064,0.9735023677911722,0.44680851063829785,0.8013279780791801,1.0,3/16,8.26%,AQP1;KCNC2;TIMELESS
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.4465198305338673,-0.9733394819609603,0.48214285714285715,0.9848091145844415,1.0,2/70,2.30%,PM20D1;UBB
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.5219251517852894,0.9732407100840827,0.5319148936170213,0.801529693782184,1.0,2/12,7.25%,NFKBIE;NFKBIA
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.673196259509915,-0.97321163359867,0.5740740740740741,0.9842982678823867,1.0,1/5,17.75%,XRCC6
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.584902982459466,-0.9729249950324029,0.54,0.9843342729252752,1.0,1/7,9.38%,NPL
prerank,GO_Biological_Process_2021__aspartate metabolic process (GO:0006531),0.6192662113406439,0.9728726643606487,0.54,0.8019922309735104,1.0,1/5,9.41%,DDO
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.6092199533454286,-0.9728126159926579,0.559322033898305,0.9838785164790471,1.0,2/8,6.95%,AGBL1;FOLH1B
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.6337849022509143,-0.9726889020059525,0.5531914893617021,0.9833898421214928,1.0,1/7,8.22%,BRPF1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),0.6299032169398395,0.972311572724469,0.6744186046511628,0.8029345833751987,1.0,1/6,3.38%,IL12A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.6160664219203236,0.9723075661406458,0.56,0.8025306927396981,1.0,5/6,38.19%,PARD6A;GSK3B;CEP250;APC;BICD1
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.44903199404252014,0.9723030043993038,0.47058823529411764,0.8021272082285168,1.0,12/32,23.97%,NRXN1;DMKN;RFTN1;LRP4;NLGN4X;ANK3;NLGN1;PTEN;UGCG;IL1RAPL1;CEL;GAK
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.5884969190183724,-0.9720800980299164,0.5576923076923077,0.984307444028861,1.0,3/10,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.6027124340664546,0.9718543440500466,0.5333333333333333,0.802689163147588,1.0,3/7,16.02%,IRAK3;UBQLN4;RUBCN
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.5789571835580143,-0.9718191014777299,0.5178571428571429,0.9842962899844743,1.0,1/9,5.50%,ABHD17A
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.4486707386148264,-0.970986185786901,0.5102040816326531,0.9856078199600933,1.0,8/35,20.16%,NPC2;LIMA1;SOAT2;ABCA8;NPC1;STARD5;ABCA5;STAR
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.4535417180492598,-0.9707776884155018,0.484375,0.9852333735212484,1.0,9/36,18.53%,GAPDH;SLC25A11;SLC25A1;PGAM1;CRTC2;SLC25A10;SLC37A4;ATF4;FBP1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.4443223196404503,0.9706737455389293,0.4782608695652174,0.8048778605379052,1.0,4/34,4.71%,PTPRC;IGF1;NCKAP1L;SYK
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.5951182390451579,0.9705318487082032,0.48717948717948717,0.8048464194701208,1.0,2/7,8.90%,B4GALT6;CNTNAP1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.6525250258317513,-0.970408516809512,0.6346153846153846,0.9855298553086037,1.0,3/6,27.25%,OAS3;MUL1;SIRPA
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4324454763386447,0.9702891026942045,0.43137254901960786,0.8050337369935522,1.0,6/39,9.57%,EGFR;TLR2;C1QTNF4;NR3C2;LAPTM5;NOD1
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.6199925226693209,0.9700443893653682,0.5849056603773585,0.8052326837897148,1.0,1/6,1.87%,GUCY1A1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.45777935724801466,-0.9700131709481731,0.5,0.9857990706869028,1.0,14/52,16.79%,EME1;MUS81;SDE2;NOP53;HMGA2;ZNF830;RPS27L;RFWD3;HUS1;BRCC3;BLM;ABRAXAS1;TOPBP1;MDC1
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.4600807734101623,0.9700129769536254,0.48,0.8048703976911019,1.0,12/28,20.91%,TRIM46;MAP2;FGF13;KIAA0319;DUSP10;SLC6A4;BBS2;DIP2B;CDKN1A;WWC1;PTEN;ULK1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.5511850480538122,-0.9699606952930397,0.5555555555555556,0.9851777453370373,1.0,9/20,23.59%,TIMM10;SAMM50;TIMM8B;BAX;BAD;TIMM13;TIMM9;TIMM29;TOMM22
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.4341990817255499,0.9699334925213485,0.4888888888888889,0.8046324303917712,1.0,4/30,9.04%,CSF1R;IL12A;ANO6;VEGFD
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.5690295837606195,0.9698755883565854,0.5818181818181818,0.8043829020156883,1.0,3/10,29.11%,PICK1;FYN;ITGA3
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),-0.5893806721891574,-0.9696019231778116,0.5370370370370371,0.9844926670533111,1.0,1/8,5.50%,ABHD17A
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),-0.5893806721891574,-0.9696019231778116,0.5370370370370371,0.9844926670533111,1.0,1/8,5.50%,ABHD17A
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.5575487572060246,-0.9694501692645154,0.5079365079365079,0.9832427213132274,1.0,3/10,20.98%,UCK1;UCKL1;TK2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.5575487572060246,-0.9694501692645154,0.5079365079365079,0.9832427213132274,1.0,3/10,20.98%,UCK1;UCKL1;TK2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.5330235374020648,0.96944166724549,0.5294117647058824,0.8049060974013461,1.0,5/11,8.48%,IGFBP3;MEF2C;PRKG1;TPM1;NDRG4
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.6157971192676759,0.9694343582386657,0.54,0.804527018217927,1.0,3/7,9.68%,PTPRC;MAP2K5;IRAK3
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.6408966530351138,-0.969419621720396,0.56,0.982519254011789,1.0,2/5,20.64%,BRK1;EPS8
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.43967892268787917,-0.9693803679558837,0.559322033898305,0.981863544582918,1.0,9/38,11.91%,CNN2;PSME2;CFL1;AIP;SOD1;RPLP0;TALDO1;ANXA2;PPIA
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.41204903973605034,0.969305677235844,0.5,0.8043957338648621,1.0,5/54,7.62%,CREB3L1;LRRK2;SRC;YBX3;HSPB1
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.6164987887446473,-0.9688989782921784,0.54,0.9821672397260302,1.0,1/5,0.98%,PAX8
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.5661537372625304,0.9688925949929358,0.5217391304347826,0.8048003802916293,1.0,2/11,6.32%,IFNA2;LILRB1
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.3611564261491027,0.9685384476786562,0.5116279069767442,0.8052281623412203,1.0,18/136,9.45%,PKP2;PPARG;EGFR;HEY1;ADAMTS7;SPRED3;RUNX1T1;ADGRV1;CNTN4;ID2;DTX1;WNT5A;NFKBIA;SOX9;ZBTB16;MEIS2;CHRD;NOTCH4
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.48566523403610445,0.9681834726417172,0.5094339622641509,0.8056790453621783,1.0,1/22,0.08%,CREB3L1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.3938099042225493,-0.967986506544494,0.4827586206896552,0.98358765142388,1.0,18/104,12.68%,RPS3;SELENOS;PRDX1;PRDX5;GSTP1;CHCHD2;PARP1;ETV5;SOD1;VKORC1L1;PLA2R1;SOD3;PRDX3;RBM11;CHUK;PRKAA2;PPIA;PYCR1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.40126222831028974,-0.9678343295505974,0.4915254237288136,0.9832648915562359,1.0,18/104,14.13%,SFRP1;PDE6A;PSMB6;PSMD7;AP2S1;PSME2;PSMD8;PFN1;CALM1;PSMB4;RHOA;PSMD3;PSMB3;PSME1;PSMA7;RAC1;PSMB8;PSMD13
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.4171939575036328,0.9677757304470205,0.5,0.806276455725888,1.0,12/52,12.61%,CLDN5;PKP2;CDH9;CDH10;CTNND2;CDH18;CDH22;CNTNAP1;ARVCF;TRPV4;CDH6;CDH7
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.46549568826682075,0.967685266209387,0.4807692307692308,0.8060212268506718,1.0,9/26,14.29%,ROBO2;SEMA3D;SEMA6A;ROBO1;SEMA5B;SEMA4G;SEMA4B;ANGPT2;SEMA3C
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.5208989051598282,0.9676339315168287,0.5517241379310345,0.8057310130517917,1.0,4/20,8.08%,IGF1;MEF2C;NRG1;MYLK3
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.5697044472650561,0.9674800269368073,0.5319148936170213,0.8055819757781124,1.0,3/9,23.64%,CHPT1;PLA2G4A;LPCAT2
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.49798734487892105,0.9672536700583915,0.4772727272727273,0.8056149757803717,1.0,4/16,19.00%,DDAH1;EDN1;PKD2;CLEC7A
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.6416372711776168,-0.9670277536360448,0.6037735849056604,0.9844232392911811,1.0,1/5,14.43%,CTR9
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.3513174680120461,0.9669979324840958,0.5,0.8058004189201868,1.0,37/162,20.32%,ANGPT1;EGFR;CSF1R;LRRK2;HGF;EFNA5;NTRK2;SOX9;CCND1;CD4;KNDC1;VEGFD;IRGM;C3;P2RY1;CSNK1D;FGF17;LYN;TNIK;VEGFA;NTRK3;GPER1;ACVR2A;NSMF;NNMT;GAS6;PRKCD;FGF9;RAMP1;LEPR;SPPL3;PROM2;FGF22;ARRB1;KDR;TERF2IP;LIMK2
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.4570053646282142,-0.9669319804613019,0.5384615384615384,0.9839411084828924,1.0,4/28,9.89%,MYADM;PFN1;LIMA1;TWF1
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.5282453697865725,-0.9666670559085861,0.5,0.9837248984947183,1.0,3/17,9.32%,SELP;ITGAL;ICAM1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5937828967704286,0.9665577933544902,0.56,0.8064252933020276,1.0,4/9,16.73%,PID1;NOS1;NOS2;PPARGC1A
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.5726507845962809,-0.9665072331784134,0.509090909090909,0.9833633101396592,1.0,2/12,2.32%,SFRP1;TNFRSF21
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.6580351198979615,-0.9663562344558656,0.6170212765957447,0.9829294911896898,1.0,3/5,31.84%,NCSTN;APH1A;APH1B
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.5277968080727063,0.966159083638237,0.5660377358490566,0.8067859079332895,1.0,2/13,12.13%,PID1;CSPG5
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5079484821316432,0.9661317671373769,0.5217391304347826,0.8064259109199313,1.0,4/21,5.19%,IFNA2;EGFR;NCKAP1L;SRC
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),-0.65761218621933,-0.9661311673999962,0.5576923076923077,0.982747659639404,1.0,2/6,9.55%,NOX1;CFTR
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.6164303280901694,-0.966018281597919,0.5102040816326531,0.9815264989822857,1.0,3/7,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.6164303280901694,-0.966018281597919,0.5102040816326531,0.9815264989822857,1.0,3/7,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.45120169257757287,-0.9657931694375615,0.5272727272727272,0.9811218873416967,1.0,6/34,15.37%,PTGIS;GLA;PGP;ERLIN2;GCK;MST1
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.5035327653201704,0.9657489474299514,0.5833333333333334,0.8068329894223372,1.0,2/17,6.32%,IGF1;LILRB1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.45687805725960373,-0.9656190506691079,0.5555555555555556,0.9808036139695282,1.0,13/51,26.08%,CHMP2A;RAN;BANF1;CCNB2;CHMP3;REEP4;NUP37;EMD;CHMP7;CC2D1B;SUMO1;NUP93;NUP85
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.5097019349963999,0.9654530993391434,0.5818181818181818,0.8071051159321668,1.0,1/14,1.41%,EGFR
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.6593005632128132,-0.9654270825752137,0.6037735849056604,0.9805912364021563,1.0,3/6,8.40%,RIOK2;CDC23;NEK6
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.4028018567939984,-0.9651812404688813,0.509090909090909,0.9804581767727432,1.0,30/93,29.30%,SRSF7;RBM15B;SRSF3;SRSF9;RBM8A;RAE1;DHX38;MAGOHB;NUP37;ALYREF;NXT1;FIP1L1;SLU7;NUP210;TPR;CASC3;CDC40;POM121C;SRSF2;NXF1;NUP93;UPF2;NUP42;NUP85;CPSF4;MAGOH;DDX39A;NXF5;MCM3AP;THOC5
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.3051597585429691,0.9650651200162511,0.696969696969697,0.8074412893272489,1.0,139/852,16.65%,CHRM3;TGFB2;IGFBP3;PDGFB;PTPRC;FSTL1;MAP3K21;PARP14;VCAN;TNC;ASB4;MAP3K5;PEAK3;ISG15;PTPRG;LRRK2;IGFBP4;DCLK1;PIM1;PTPRR;PAK3;LOX;ST8SIA3;B3GALNT1;BMPR1B;HUNK;PRKG2;SYK;CDKL4;STK17B;PTPRB;PRKCZ;MACROD1;PPP3CA;LAMC1;GAD1;PTPN6;PTPRZ1;MERTK;PRKG1;LMO7;HIPK3;OGFOD1;CCNF;CAMK2B;PTPRJ;PTPRM;AURKC;ST8SIA4;FBXW9;UBA7;FBXL16;MYLK3;ST3GAL6;ACVR1C;ZBTB16;DUSP10;FBXO41;EPAS1;PLK1;SOCS3;LTBP1;PRKCG;DAPK1;PTPRT;PICK1;FUT9;C3;FBXO17;IRAK3;CAMK2D;ST8SIA6;NUAK1;B3GALT1;SPARCL1;TEC;DYRK2;PRKD1;BMPR2;MKNK1;CSNK1D;B3GNT6;FEM1B;LAMB2;PARP8;PPM1L;GAN;PPM1H;PARP9;TPTE2;DMPK;IP6K3;RAB3A;PRKAR1B;AKT3;PTPRO;LYN;ZAP70;ZDHHC6;PTPN5;TNIK;DYRK3;CUL3;PDK4;PPP1CB;UST;MAK;UBA3;PHKA2;CPE;FBXL5;FBXO31;PGAP1;CAMK4;TSSK3;PTP4A2;CHRDL1;WNK2;CDK19;PAK5;STK17A;ACVR2A;PTPRK;PRKCE;PTPN4;DUSP6;LAMB1;FBXL18;ENGASE;TIPARP;PPEF1;SSH2;PORCN;LMTK3;GLRX;GAS6;CDK12;PRKCD;SIRT5
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.5380272083410159,-0.9648756346881103,0.48,0.9803976712061717,1.0,4/15,10.47%,NPC2;SOAT2;ABCA8;NPC1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.4420571732719117,-0.9646451719359143,0.48214285714285715,0.9801401115556307,1.0,11/47,14.77%,FTL;FTH1;ATP6V1G1;TF;SOD1;HEPH;SLC22A17;ATP6AP1;B2M;CYBRD1;CYB561A3
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.456874488648428,0.9644825365357614,0.47058823529411764,0.808098554630678,1.0,9/26,17.34%,VSIR;IGF1;PTPN6;LILRB1;IRAK3;CX3CL1;HAVCR2;GAS6;ILRUN
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),-0.6207388290999885,-0.9644725449660143,0.5961538461538461,0.9798107249589558,1.0,2/7,5.15%,AK8;CMPK1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.48471341345860053,-0.9643927972990528,0.5098039215686274,0.9792390858492045,1.0,6/29,18.64%,CCT7;CCT2;CCT6A;PNKP;PKIB;ATR
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.5229118300938724,-0.9640228006901054,0.48,0.9792846243567217,1.0,6/17,21.16%,BUB1;IK;KNTC1;CENPF;TPR;CDC20
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.5210164500812049,0.9633204139801619,0.6041666666666666,0.810168738852834,1.0,1/15,2.39%,CARMIL2
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.41872578507159847,0.9632538918431717,0.48717948717948717,0.8098957104656953,1.0,5/51,6.59%,LPL;PLPPR5;PLPPR3;PLPPR4;LPCAT4
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.3631586689930327,-0.9630548637077935,0.4852941176470588,0.9807320169946258,1.0,44/347,12.41%,NGF;CRYAB;CD38;RPS3A;PRELID1;RPS27A;UBC;SFRP1;DPEP1;RPL10;PTMA;MIEN1;UBB;GREM1;BEX3;PRDX5;GSTP1;CFL1;MGMT;TNFAIP8;TPT1;NRBP2;PHB2;EVI2B;SOD1;ARAF;ANXA5;PRDX3;DHCR24;BNIP1;MYDGF;TMBIM6;CIAPIN1;HMGA2;UNC5B;DDAH2;ARHGDIA;ZNF830;TRIAP1;PRKAA2;GATA1;MAG;APIP;NPM1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.41425855981667464,-0.9629766157451065,0.4444444444444444,0.9801479070199491,1.0,14/66,17.38%,ATP6V1F;ATP6V1G1;ATP6V1G2;LAMTOR4;RRAGA;ATP6V1E2;CASTOR2;ATP6V0E1;MIOS;SLC38A9;LAMTOR2;DAP;EIF2AK3;ATF4
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.48125493393609786,-0.9628379494762327,0.5230769230769231,0.97963665933505,1.0,9/26,19.13%,HSPA8;TMBIM6;BAX;BAK1;HSPB8;DAXX;HSPA2;HSPA14;PTPN1
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.5564862198641678,-0.9626153382757741,0.5740740740740741,0.9795967808372075,1.0,2/14,9.04%,SPHK2;DHFR
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.38780884569894936,0.9625673244458971,0.4878048780487805,0.8109826041808461,1.0,6/75,7.64%,CARD18;PDGFB;LRRK2;DACT1;NFKBIA;LEF1
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.4392740915640443,-0.9625307205801444,0.41818181818181815,0.9790932921818842,1.0,5/41,4.73%,RPS3;RNF8;H2AX;PCNA;USP1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.4943289693108041,0.9622279035311617,0.5416666666666666,0.8113451885447202,1.0,8/20,12.40%,PTPRC;NCKAP1L;MEF2C;TNFSF13B;TIRAP;BCL2;BST1;SASH3
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),0.6124043946639619,0.9622216152344307,0.6590909090909091,0.8109495608920194,1.0,2/7,2.99%,AQP1;NEDD4L
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),-0.6272138728246657,-0.9621403472410133,0.5294117647058824,0.979190935311317,1.0,1/5,17.17%,MGLL
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.5466593393360901,0.9620767037196716,0.49056603773584906,0.8108631426777213,1.0,2/8,23.11%,MAPK12;CRY1
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.6079451846761645,0.9620239025010188,0.5192307692307693,0.8105555025869201,1.0,2/8,4.93%,LMO3;CITED2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5337745212785521,0.9620187172230313,0.6,0.8101550305006617,1.0,5/15,20.52%,SULT4A1;SULT2A1;SULT2B1;PAPSS2;TPST2
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.5189484687244998,0.9615032876774509,0.5272727272727272,0.8108138526305267,1.0,2/15,1.80%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.430303607631386,0.9613074159676689,0.5348837209302325,0.8108846838470822,1.0,7/51,15.03%,LPL;ACSM1;PLA2G10;SCARB1;GRAMD1B;SOAT1;ABCA1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.40198063624957353,0.9611116436905373,0.5581395348837209,0.8109147584876681,1.0,6/68,7.18%,CLDN5;TGFB2;FOS;PRKCZ;SRC;ARRB2
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.40967210889351263,0.9609725899291256,0.4807692307692308,0.8108460416634096,1.0,8/35,10.82%,PLPPR5;DGKB;PLPPR3;PLPPR4;PLPP4;SGPP2;PLPP6;DGKI
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.5140044477112934,0.9609497427807653,0.5652173913043478,0.8104870598375807,1.0,4/13,10.85%,IGF1;SORBS1;IRS1;DYRK2
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),-0.6344141260006162,-0.9608883463114668,0.5961538461538461,0.9815379701820132,1.0,2/5,5.16%,PDE6A;CNGB1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.5758491059786531,0.9606868459018717,0.6458333333333334,0.8106797921472875,1.0,3/11,22.23%,TRPC6;RXRA;SGK1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.6424013329059939,0.9603432697793037,0.5740740740740741,0.8109883534004281,1.0,1/5,6.15%,MAP2K5
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.5851607680501452,-0.9601009405650771,0.5370370370370371,0.9827085882069946,1.0,3/8,20.14%,METAP2;NAA20;METAP1D
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.5912279701731582,-0.9598185490366486,0.5227272727272727,0.9826860050785059,1.0,2/7,28.74%,DNAJC18;HDAC6
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.5240379394668662,0.9598087550113645,0.5,0.8117546594222655,1.0,4/12,10.85%,IGF1;SORBS1;IRS1;DYRK2
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.6308149246593787,0.9595710579028633,0.5555555555555556,0.8115588815139918,1.0,1/5,12.89%,CD80
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6308149246593787,0.9595710579028633,0.5555555555555556,0.8115588815139918,1.0,1/5,12.89%,CD80
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.43004621505073515,0.959527893106171,0.5185185185185185,0.8112816613025207,1.0,9/37,23.15%,HOOK1;DNM1;CORO1C;ALS2CL;CLCN3;SNX10;SNX33;RAB27A;ARFGEF2
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.5525914042475184,0.9594951634489415,0.5192307692307693,0.8109179130477652,1.0,1/11,3.77%,PID1
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.5718150287558259,-0.9594389592595624,0.509090909090909,0.9828651184676046,1.0,3/10,20.01%,PNRC2;LSM1;DCPS
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.34920619488768856,-0.959416327355625,0.5223880597014925,0.9821404324175171,1.0,41/316,15.96%,DDIT3;RAD23A;RNF8;ANAPC15;PSMB6;PSMD7;UBXN1;ADRM1;PSME2;PSMD8;HECTD3;UBE2D4;RNF167;ELOC;CDC23;CDC26;PSMB4;VPS28;UBQLN2;PSMD3;PSMB3;PSME1;ZFAND2A;PPP1R11;KAT5;PSMA7;KLHL20;SPSB3;PSMB8;RNF6;PSMD13;FEM1A;SQSTM1;MYLIP;KEAP1;ZFAND2B;ERCC8;UBE2A;WDR91;PSMD2;RNF126
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.45565012651412784,0.9593122067014579,0.4888888888888889,0.8108899852337741,1.0,9/36,11.91%,PTPRC;RYR3;GRIN2B;SLC8A1;ITPR1;GRIN1;TRPM2;HTR2C;TRPV4
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.36055864320906733,0.9590992602609492,0.5869565217391305,0.8108852088748246,1.0,19/91,13.83%,CX3CR1;MEF2C;IL12A;TNFRSF1B;WNT5A;LILRB1;ZFP36;MAPKAPK3;AXL;TIRAP;NOS1;GIT1;VIM;IRGM;IRAK3;ERBIN;SCARB1;CD80;RPS6KA3
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.5487372535436115,0.9590877931491147,0.5555555555555556,0.8105221902410559,1.0,5/13,15.62%,PYGL;MGAM;PGM2L1;PHKA2;AGL
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.4399773798497844,-0.9590388206596556,0.509090909090909,0.9823196912614938,1.0,3/40,9.31%,RNF8;CHD4;SMARCA5
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.49412658772231655,0.9589832323475189,0.5531914893617021,0.8103212371491961,1.0,3/14,11.63%,PKD1L3;GPLD1;PKD2L1
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.43590382836587094,-0.9584644676672875,0.5555555555555556,0.9830373474639275,1.0,10/51,20.29%,EMC6;GABARAPL2;UBQLN2;ATG9A;MAP1LC3B;ATG16L1;WDR45B;ATG14;BECN1;ATG2A
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.6511298779776453,0.9583112214164894,0.58,0.8114019792298638,1.0,2/5,11.04%,JCAD;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.41257287581591423,0.958247383122188,0.4222222222222222,0.8111373255456396,1.0,13/58,16.52%,RPS6KA6;HEY1;GRIN3A;SOX9;KIAA0319;NOTCH4;HOPX;ALPK2;MAPT;KANK1;BCL11A;THY1;GAS6
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.6285701099306447,-0.958240904778966,0.5961538461538461,0.9828005908550951,1.0,3/7,16.41%,NOP53;PIK3IP1;STAMBP
prerank,MSigDB_Hallmark_2020__Complement,0.3598371760778864,0.958230928759457,0.575,0.8107633605354589,1.0,27/151,13.52%,CD59;PDGFB;PLSCR1;F3;PIM1;LCP2;ITGAM;ZEB1;KYNU;MAFF;SRC;KCNIP2;GNG2;CASP10;PCLO;CASP7;L3MBTL4;NOTCH4;C3;OLR1;XPNPEP1;DYRK2;CDK5R1;LGALS3;CR1;LYN;KCNIP3
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.3719054482620578,-0.9582243278320303,0.5,0.9820846801474921,1.0,7/142,7.50%,ARHGEF16;TAX1BP3;SFRP1;RHOG;RACK1;TBC1D16;RASGRF1
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.4703134658471202,0.9581024067225604,0.5555555555555556,0.8105857388779535,1.0,9/37,15.45%,PKP2;ANO6;SCN3B;CHRM1;TRPC6;ANK3;CACNB2;FHL1;SCN4B
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.4451392725312881,0.9581017795460177,0.4146341463414634,0.8101893644335143,1.0,8/33,14.00%,PTPRC;ZFP36;SFTPD;CD4;LAPTM5;CD80;CR1;HAVCR2
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.4098366248770252,0.9580711436915809,0.4888888888888889,0.8099027872007986,1.0,6/59,8.35%,LPL;OLAH;PAM;LSS;ACSM1;ELOVL4
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.39932323393173486,0.9580022235869556,0.46,0.8088722345430086,1.0,7/57,13.82%,CD59;GRIA1;COL7A1;TGFA;CSNK1D;ANKRD28;CUL3
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.39932323393173486,0.9580022235869556,0.46,0.8088722345430086,1.0,7/57,13.82%,CD59;GRIA1;COL7A1;TGFA;CSNK1D;ANKRD28;CUL3
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.39932323393173486,0.9580022235869556,0.46,0.8088722345430086,1.0,7/57,13.82%,CD59;GRIA1;COL7A1;TGFA;CSNK1D;ANKRD28;CUL3
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.37151768108477085,-0.9576687066777753,0.532258064516129,0.982703726916871,1.0,24/178,15.96%,RPS27A;UBC;RNF8;UBB;ANAPC15;ADRM1;UBE2D4;RNF167;ELOC;CDC23;CDC26;UBQLN2;PSMD3;PPP1R11;UBA52;RNF6;PSMD13;FEM1A;SQSTM1;MYLIP;KEAP1;UBE2A;WDR91;RNF126
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.42877437303725185,-0.9574273253727899,0.4423076923076923,0.9825712974663688,1.0,12/54,15.63%,ACAA2;SQLE;AKR1D1;SCARF1;SOAT2;DHCR24;SNX17;IDI1;TM7SF2;PMVK;MSMO1;PIP4P1
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.4136663980793634,-0.957088130063021,0.45454545454545453,0.9827364621768206,1.0,14/67,17.38%,ATP6V1F;ATP6V1G1;ATP6V1G2;LAMTOR4;RRAGA;ATP6V1E2;CASTOR2;ATP6V0E1;MIOS;SLC38A9;LAMTOR2;DAP;EIF2AK3;ATF4
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.566661049335508,0.9570039414308025,0.5777777777777777,0.8106845767386891,1.0,1/7,5.19%,SRC
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.5153739871249047,0.956931509313003,0.5111111111111111,0.8104099454244188,1.0,5/13,16.90%,NFATC4;CPEB3;SHANK1;CAMK4;KAT2A
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.427889448904409,0.9568797931770076,0.5094339622641509,0.8100781660781124,1.0,13/42,19.19%,RYR3;SHMT2;HCN1;SAMHD1;TRPM2;PKD2L1;ACACB;SHMT1;CBR4;PKD2;AQP4;TDO2;SYCP1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.5578585235780135,-0.9566455407056937,0.5192307692307693,0.9830951716985505,1.0,2/10,5.56%,CD9;PMP22
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.49194976880563124,0.9557979499102404,0.5471698113207547,0.8120766520742259,1.0,2/13,2.22%,ABCC4;SLC25A41
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.6074426552502321,-0.9552536248447464,0.5892857142857143,0.9858804121050154,1.0,2/6,17.58%,AHR;HMGB1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.5769766422666388,0.9552121416625533,0.58,0.8130349797874605,1.0,2/11,20.06%,PACSIN1;SNX33
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.5793053207357454,-0.9550119177720299,0.64,0.9855975910122061,1.0,4/9,37.66%,HDAC6;ABL1;SIRT4;SLAMF8
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.4231733015446896,0.9547151901008213,0.5416666666666666,0.8136770494523039,1.0,7/42,12.67%,GRM5;CYFIP1;UHRF1;NFKBIA;EDNRB;PLA2G10;NANOS3
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.4777343487094384,-0.9544014660180447,0.5306122448979592,0.9864559823356828,1.0,6/31,18.64%,CCT7;CCT2;CCT6A;PNKP;PKIB;ATR
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.37808515663863174,0.9542380422585829,0.5531914893617021,0.8141866953353506,1.0,18/86,14.21%,EPHA3;DPP10;EGFR;TP73;ITGAM;SORBS1;STAC2;STX3;TP63;KCNB1;BCL2;NECAB2;YWHAH;LGALS3;PIK3R1;BBC3;ANK3;ITGB1BP1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.5538021909040236,-0.9539608280671619,0.6,0.9866819218305228,1.0,1/10,6.97%,RBM15B
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.3742965024548994,0.9539045648913653,0.5111111111111111,0.8145927486390944,1.0,23/85,15.82%,PDGFB;BMP6;EGFR;IGF1;F3;NR4A3;LAMC1;WNT5A;SOX9;PTPRN;VEGFD;ARNT;TGFA;PRKD1;BMPR2;ZNF304;AKT3;VASH2;CDH3;CDH13;VEGFA;EGFL7;LAMB1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.505096602740361,0.9537825576698373,0.5098039215686274,0.8145003470261233,1.0,3/16,9.64%,C3AR1;ANO6;C3
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.453562363528886,0.9537554435984027,0.52,0.814179153138144,1.0,5/28,7.34%,TGFB2;KITLG;BASP1;WNT5A;SOX9
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.4664988778612618,-0.9536263679757919,0.5833333333333334,0.9867530701199703,1.0,7/30,16.50%,SDF2L1;CCT2;DNAJB4;HSPE1;HSPA8;HSPA2;HSPA14
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.5156189304449997,-0.9535784846760236,0.5348837209302325,0.986142507416332,1.0,1/15,1.09%,ENPP6
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.5491406279101398,0.9532744512906755,0.5365853658536586,0.8148705824147617,1.0,2/11,6.84%,PRKG2;FTCD
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.5471148849997828,0.9532084621464315,0.56,0.8146066855557754,1.0,1/11,0.08%,CREB3L1
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.44556187072928766,0.9530472307098747,0.4878048780487805,0.8141995894298164,1.0,9/22,21.00%,TP73;TP63;BCL2;YWHAH;BBC3;E2F1;YWHAG;TFDP2;NMT1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.44556187072928766,0.9530472307098747,0.4878048780487805,0.8141995894298164,1.0,9/22,21.00%,TP73;TP63;BCL2;YWHAH;BBC3;E2F1;YWHAG;TFDP2;NMT1
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.541722276171827,0.9529702114071092,0.5740740740740741,0.8139364012353465,1.0,2/12,3.46%,OLAH;ABHD3
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.4303113349373472,0.9526726150746921,0.5348837209302325,0.8141184910875837,1.0,7/50,15.03%,LPL;ACSM1;PLA2G10;SCARB1;GRAMD1B;SOAT1;ABCA1
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.5988263859367634,0.9524794683696152,0.5490196078431373,0.814209162053717,1.0,4/7,25.39%,WNT5A;SLC16A2;NF1;KDM2B
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.584444659560695,-0.9523035473479182,0.5510204081632653,0.9884756540740394,1.0,1/9,6.14%,KDM8
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.41815008035001444,-0.9523006480933838,0.5370370370370371,0.987723459170939,1.0,26/94,23.02%,ORC1;KIN;GRWD1;POLD4;PNKP;MCM4;HUS1;BLM;POLE3;MCM3;POLG;KAT5;TOPBP1;EXO1;ATR;RFC1;DUT;SET;ATRIP;RAD9B;RMI2;MCMBP;MCM6;FAM111A;ORC6;WDHD1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.43602230637826184,-0.9519864600465755,0.5740740740740741,0.9877101901522247,1.0,9/40,11.91%,CNN2;PSME2;CFL1;AIP;SOD1;RPLP0;TALDO1;ANXA2;PPIA
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.4168938683438087,0.9518073569030494,0.46153846153846156,0.8153884270321746,1.0,16/42,26.17%,TBC1D10A;TNFRSF1B;PLK1;MAPK12;GPLD1;WDR48;SH3D19;CAPN3;SNX33;TRIM32;OGT;FBXW11;BAG2;CCBE1;TANK;FURIN
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.6228524690474084,-0.9516295665726342,0.625,0.987761046414261,1.0,3/5,20.07%,PARP1;PRIMPOL;MGME1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.41385619230701215,0.951507625505172,0.4634146341463415,0.8156436135170635,1.0,10/55,12.70%,EPHA3;UTRN;PLEKHA2;CAMSAP3;EFNA5;CDKN2A;CORO1C;BST1;CX3CL1;ACER2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),-0.6439138738170789,-0.95144486900486,0.6086956521739131,0.9867232035388995,1.0,2/5,9.13%,CRTAM;PVR
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),-0.6439138738170789,-0.95144486900486,0.6086956521739131,0.9867232035388995,1.0,2/5,9.13%,CRTAM;PVR
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.3687400328111374,0.9514095987998383,0.5135135135135135,0.8154543905466448,1.0,26/127,11.00%,NPY;BCHE;AQP1;SHISA6;CHST1;ITGB4;PLPPR4;DCLK1;GFAP;SORBS1;CTHRC1;LAMC1;ADCYAP1R1;BAG3;NTRK2;OPCML;ASTN1;CADM3;MAPK4;NDRG4;EPB41L1;PHYHIP;EDNRB;GAP43;SPARCL1;PSD2
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3804975708345942,0.9510561610528646,0.5094339622641509,0.8157605234013142,1.0,21/75,15.90%,RHBDF2;ADCY8;RXFP1;SYK;SRC;ADCYAP1R1;GPR176;GNG2;CYSLTR2;VIPR2;ADCY2;CYSLTR1;ADCY7;ADORA2B;ADCY1;PRKAR1B;LYN;P2RY11;HRH2;CALCB;ADRB2
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.6032581561963816,-0.9510539283005591,0.6170212765957447,0.9870305293966508,1.0,3/7,11.46%,AK8;CMPK1;PNKP
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.46456157454523217,-0.9510329802754217,0.5238095238095238,0.9863340135285157,1.0,8/25,15.34%,STAC3;ACTN2;CALM1;P2RY6;ANTKMT;TMSB4X;EPHB2;TRDN
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.44498748469046046,0.9509660584773068,0.4791666666666667,0.8155429822386567,1.0,7/33,12.53%,PLSCR1;DNAJB1;UHRF1;TPM1;DYNLL2;SETMAR;ATP1B2
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.5751976675066376,0.950866075541351,0.5384615384615384,0.8153768264062382,1.0,1/8,4.71%,SYK
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.34767891045919236,-0.9507612763817757,0.5535714285714286,0.9862196894978987,1.0,34/283,13.05%,RAB32;RPL11;VPS25;SRPRA;TRARG1;ARCN1;PTTG1IP;NUTF2;KATNB1;PHB2;ARL17A;STX10;TMED4;RAN;TMED9;TBC1D16;ERP29;MYO1C;VPS28;SNX17;RANGRF;ARFIP2;DNAJC27;NXT2;LMAN1;TMED2;RAB31;TMED1;VPS29;AP4B1;NPM1;SNF8;SAR1B;USP6NL
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.5800979960503014,0.9502955636265606,0.5849056603773585,0.8162906781833882,1.0,2/8,5.84%,CYFIP1;FCHSD2
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.43323934427645006,-0.9501573657559479,0.5490196078431373,0.9868776597338719,1.0,11/71,12.41%,RPL5;EIF3D;RACK1;PASK;SPHK2;METTL5;SMPD2;RPS4X;PYM1;RPS27L;NPM1
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.4353590077888463,0.9499482545899893,0.5283018867924528,0.8167151113910543,1.0,8/32,11.82%,CD44;CHI3L1;SULF1;SOX9;ZBTB16;CREB3L2;SOX5;ZNF516
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.5098473858177822,-0.9499153930858949,0.5,0.9866929563992759,1.0,7/16,20.36%,CSTB;SVBP;PSMB8;ECM1;CTSH;NRDC;PINK1
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.43620054344073944,-0.9497871442504177,0.48484848484848486,0.9862727912819715,1.0,3/46,0.53%,CXCR4;P2RY10;CD38
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.5777272394223811,-0.9492350329782356,0.5106382978723404,0.9869801515865759,1.0,1/9,8.21%,UBQLN2
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.4336207119788033,0.9489913712473166,0.5306122448979592,0.8181498068480291,1.0,7/36,18.85%,ZFP36;MOV10;CPEB3;PUM1;RBM24;ZFP36L1;FTO
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.44575781782986534,-0.9487274365514606,0.5576923076923077,0.9875910098754984,1.0,3/44,3.32%,ARHGEF16;TEAD3;PTPRU
prerank,MSigDB_Hallmark_2020__Glycolysis,0.3483291587370032,0.9484329442720574,0.5833333333333334,0.8188964216760282,1.0,28/170,14.70%,PKP2;IGFBP3;EGFR;CD44;CHST1;VCAN;PAM;NDST3;PYGL;MET;CITED2;MERTK;AK4;RRAGD;SOX9;IL13RA1;AGRN;TGFA;ADORA2B;HOMER1;EFNA3;P4HA1;CENPA;GPC1;COL5A1;ISG20;PHKA2;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.6035616327200617,-0.9484141958806723,0.543859649122807,0.9876224608756743,1.0,2/5,14.96%,TAF7;PIH1D1
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.36215589427050926,-0.9483946917000577,0.5873015873015873,0.986923374392605,1.0,62/308,21.58%,DDIT3;RPS3;PARP2;ZDHHC16;RNF8;KIN;CGAS;H2AX;ENDOV;MBD4;MGMT;PARP1;MUS81;ALKBH7;MACROD2;RAD51AP1;APEX1;USP16;OTUB1;NOP53;BAX;BAK1;BTG2;PNKP;NUDT1;RFWD3;HUS1;NPM1;CDKN2AIP;BLM;POLE3;UFL1;TOPBP1;ERCC8;BCL2A1;UBE2A;MEN1;CBX5;CHCHD6;ADPRS;PLK3;PARK7;TRIM28;SMC1A;REXO4;IKBKG;EXO1;SMC6;ATR;MSH3;CASP9;CCNK;DDX11;FANCF;PAXX;PARP3;PRKDC;NSMCE4A;ATRIP;XPC;RAD9B;RMI2
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.5669661949284084,0.948239705831823,0.52,0.8188935526565074,1.0,5/7,36.13%,ADARB2;NUDT16;ADARB1;APOBEC2;APOBEC3H
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.38927613813205564,-0.948236569034368,0.5490196078431373,0.9865998373766712,1.0,17/148,9.97%,TEAD2;POLR2L;TEAD3;POLR2G;TBPL2;POLR1F;POLR2K;POLR1G;POLR2I;GTF2F1;POLR1H;NR2C2AP;POLR2A;CAVIN1;SMARCA5;TAF13;TFB2M
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.513006186488529,0.9481979715042979,0.5769230769230769,0.818595860350813,1.0,7/15,25.15%,LRRK2;RNF139;NLRP7;BAG2;SERPINE2;SNX12;CCBE1
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.57375044954429,-0.9481948361867725,0.5490196078431373,0.9859469833908002,1.0,3/9,11.87%,CGAS;HMGA2;B2M
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.632870800398661,0.948064364758851,0.66,0.8184911325797309,1.0,3/5,15.90%,KCNMA1;DOCK5;ADRB2
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5231922872983767,-0.947793631171465,0.6037735849056604,0.9861063375191337,1.0,3/16,16.64%,ELOVL1;HSD17B12;ACSF3
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.384175588574393,0.947736576612741,0.5217391304347826,0.8188169907897692,1.0,17/60,22.69%,NEDD4L;CAMK1D;SCIN;MERTK;SFTPD;GPLD1;CHRM1;CDH3;GAS6;RXRA;CLEC7A;LRP1;CALY;MLC1;RAB27A;SGK1;TFR2
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.5602961716576458,0.947614932139954,0.6274509803921569,0.8186726265016504,1.0,5/10,30.37%,TJP2;TJP3;RAB1A;RAB1B;RAP2C
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.40742123583190865,0.9473471128699106,0.5555555555555556,0.8188735900604162,1.0,7/59,5.14%,CHRM3;CDS1;EGFR;ITGB4;CAMSAP3;HSD11B2;PRKCZ
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.5284496848528826,-0.9473464987979291,0.5714285714285714,0.9864934329977886,1.0,3/12,11.06%,NUMA1;PLAAT4;ETV4
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.6028918811701134,0.9472329880080268,0.6481481481481481,0.8187293372121943,1.0,3/5,11.04%,ROBO2;GAP43;ROBO1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),0.5691461037695639,0.9471078653487722,0.5306122448979592,0.8185682625781693,1.0,3/7,22.85%,WNT5A;IL33;LBP
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.5569524727574604,-0.9470991465393562,0.5777777777777777,0.9862471368543727,1.0,2/12,5.02%,KCND3;ATP1B1
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.48475590892239817,-0.9469118186068373,0.5283018867924528,0.9860328294252109,1.0,1/20,0.86%,TRMT10C
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.4011733041671304,-0.9467634500220002,0.4727272727272727,0.9856672016990983,1.0,7/83,7.28%,RPS27A;UBC;FAM89B;UBB;GREM1;IL17RD;BAMBI
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.6142783466394867,-0.9465312754708857,0.58,0.9854852241013963,1.0,2/7,19.50%,GTF2H2;MSH3
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.44764091022608704,0.9464193370695714,0.5681818181818182,0.819701351976408,1.0,6/32,7.35%,PDGFB;PID1;ITGAM;SYK;ADGRB1;GRIN1
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.5817087726278938,0.94622623139335,0.5471698113207547,0.819675517511599,1.0,1/8,0.76%,CDS1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.5586834821858176,0.9460251292978583,0.5769230769230769,0.8196722889301997,1.0,1/9,2.49%,DLAT
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4997532356877541,0.9459642142205504,0.5882352941176471,0.8194320751739069,1.0,5/15,10.06%,PTPRC;GRM5;PTPRJ;DMTN;TRPM2
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.37762519593712823,0.9459177989550092,0.5142857142857142,0.8191356926302256,1.0,16/114,7.97%,PLSCR1;MX1;CHI3L1;CSF1R;SHMT2;TIMP4;ISG15;PID1;KYNU;SRC;PTPN6;XAF1;CIITA;LEF1;MAPKAPK3;LIFR
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.5882212373574228,0.9457358052872271,0.5882352941176471,0.8191440013289694,1.0,2/6,21.23%,TIE1;RGCC
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5046535869633989,0.9452020942072457,0.5116279069767442,0.8198735158117871,1.0,6/15,23.61%,RFX3;DNAAF1;AQP4;ADCY10;CFAP53;ODAD4
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.5789757827781916,-0.9451123171231726,0.6274509803921569,0.9882119565370749,1.0,4/10,20.80%,NDC80;MIS12;CENPF;CENPH
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5591492549796895,0.9451012914911237,0.6153846153846154,0.8196730876889552,1.0,1/9,0.38%,PKP2
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.5992709791494593,-0.9447090390066946,0.5517241379310345,0.9885515855053837,1.0,3/6,19.13%,BAX;BAK1;PTPN1
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.5235052718698653,-0.9446164363330092,0.5384615384615384,0.9879646809856923,1.0,4/13,23.38%,EXOG;HMGB1;ENDOG;DICER1
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.47387625308478665,-0.944452347391186,0.6,0.9876052699506287,1.0,7/26,17.59%,CDKN1C;PHPT1;PRDX3;PINX1;SMAD7;MEN1;PARK7
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.48230221240732846,-0.9442602438683866,0.4897959183673469,0.9873910693026005,1.0,3/26,4.98%,F11;DAO;CDHR2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.3856442108922339,0.9441328023515686,0.5777777777777777,0.8209213438514511,1.0,13/60,17.09%,NCKAP1L;CYFIP1;BAIAP2;SYK;SRC;WIPF3;PLPP4;PIK3R1;LYN;PRKCE;WIPF2;PRKCD;DOCK1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3856442108922339,0.9441328023515686,0.5777777777777777,0.8209213438514511,1.0,13/60,17.09%,NCKAP1L;CYFIP1;BAIAP2;SYK;SRC;WIPF3;PLPP4;PIK3R1;LYN;PRKCE;WIPF2;PRKCD;DOCK1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.3989665431946058,-0.9440927632755344,0.5306122448979592,0.987076626187216,1.0,8/89,11.33%,ABCA13;PRELID1;SLC10A3;NPC2;PLEKHA3;ABCA8;ABCA9;TRIAP1
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.3451638623172364,0.9438468186115994,0.6046511627906976,0.8210749972130297,1.0,21/148,9.89%,SLA;CX3CR1;PPARG;MX1;TLR2;TRIM5;ZDHHC11;SHMT2;ISG15;CLEC5A;SYK;KYNU;H2BC11;SRC;TNK2;CIITA;STYK1;SFTPD;IRGM;C3;COLEC10
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.541129917276866,-0.9437740791730475,0.5686274509803921,0.9870515606030659,1.0,3/11,19.52%,CHMP2A;CHMP3;ZNF502
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.4915982245002266,-0.9435038181800091,0.45454545454545453,0.9868947399770176,1.0,5/18,13.96%,PSMB6;PSMB4;PSMB3;PSMA7;PSMB8
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),0.6239776413058691,0.9434315244327367,0.5660377358490566,0.8215489033094213,1.0,2/5,4.05%,PID1;E2F3
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.4063214689737014,0.9433186866107649,0.5348837209302325,0.8213818642985287,1.0,8/54,10.72%,PIK3AP1;BIRC3;WNT5A;SAMHD1;LRP8;TIRAP;BCL6;BST1
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),0.6381172920487596,0.9433063527033694,0.6607142857142857,0.8210184356273584,1.0,3/5,16.24%,ALOX12;PTGR1;LTC4S
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.5928992307170784,-0.9432600279839398,0.5777777777777777,0.986832221503342,1.0,1/6,14.41%,BRK1
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.5368104153775459,-0.9430499569538894,0.5625,0.986531672029103,1.0,4/11,26.69%,RAG2;HMGB1;PRKDC;RAG1
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.3583660822709949,0.9428371445466156,0.5319148936170213,0.8216320165232803,1.0,13/92,10.21%,TGFB2;NEDD4L;NRXN1;NRG1;SYK;ABCB4;RELN;CAMK2B;TAL1;TIRAP;SLF1;TGFB3;FRMPD4
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.39798744814679554,0.9426425618543307,0.5681818181818182,0.8215829935861919,1.0,14/66,8.99%,ADAM28;PTPRC;NCKAP1L;SELL;IKZF1;CD53;ARHGAP25;PNOC;BTLA;NPIPB15;LILRB1;WDFY4;LY86;LAPTM5
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.6690225402369863,-0.9424683265494197,0.6226415094339622,0.9872146669159555,1.0,1/5,1.51%,SFRP1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.5431893996942984,-0.9423747773345986,0.5681818181818182,0.9867641114323783,1.0,2/14,12.42%,PARP1;PINX1
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.5766385671500603,-0.9420379688287865,0.5740740740740741,0.9868894491339386,1.0,1/7,2.04%,PTH
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.45892439104726057,-0.9419263707055658,0.5,0.9857099034491922,1.0,11/33,26.08%,RAN;RAE1;NOL6;NUP37;SSB;NUP210;TPR;POM121C;NUP93;NUP42;NUP85
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.45892439104726057,-0.9419263707055658,0.5,0.9857099034491922,1.0,11/33,26.08%,RAN;RAE1;NOL6;NUP37;SSB;NUP210;TPR;POM121C;NUP93;NUP42;NUP85
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.5559451706060932,0.9417780501494462,0.5510204081632653,0.8229864023373362,1.0,2/7,17.20%,PCGF3;PCGF5
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.47695589943592615,-0.9417476324840622,0.4727272727272727,0.9854115356415448,1.0,5/33,14.00%,VAMP5;TRARG1;RAB31;GORASP1;GORASP2
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.5910621306764533,-0.9413550997295731,0.64,0.985593611407928,1.0,2/6,23.54%,SKP1;CAND2
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.5908529673469358,0.9407397818597699,0.6078431372549019,0.8248761104674003,1.0,3/8,14.03%,CBARP;GPR35;GNB5
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5568969877412367,0.9405373109829136,0.5897435897435898,0.8248480241849072,1.0,3/8,20.81%,PLA2G10;PLA2G4A;LPGAT1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.4241185337572592,-0.9401716552077591,0.5416666666666666,0.9877998769226977,1.0,14/38,20.15%,DYNLL1;CALM1;RHOA;S100A1;YWHAQ;ATP5PF;COX6B1;PLP1;CNP;ATP5PB;MBP;CDC42;PADI2;G6PD
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.42809896490989074,-0.9401307023793912,0.6,0.9871333760088237,1.0,13/79,12.98%,ORC1;BUB1;NCL;NDC80;PLK4;PARP1;DNMT3B;PFAS;MCM4;RFWD3;NPM1;BLM;MCM3
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.35476465009512226,-0.9400794859026097,0.631578947368421,0.9865549440440256,1.0,58/357,17.67%,CFAP61;RAB32;CNN2;TMEM11;MSTO1;CFL1;CHCHD2;ATP5F1B;HSD17B10;PARP1;PHB2;CHMP2A;TMED4;TMED9;NUMA1;GOLGA8M;MCOLN1;TTC29;PRDX3;CLUH;BNIP1;CHMP5;TFB2M;LMAN1;GOLGA8H;TMED2;RAB31;PLCE1;TMED1;ZFYVE16;PPIA;ZNF135;GORASP1;DNAJA3;SAR1B;USP6NL;CHMP3;KIF4A;KLHL20;GOLGA2;COG2;SYNE3;ZMYM6;GORASP2;FBXW8;PTCD2;TMED5;EIF2AK3;VPS11;LMAN2;PNPLA3;TOR1A;WASF3;SURF4;CDC42;PARK7;GBF1;PEX10
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.3654350921793855,-0.9398402077525339,0.5714285714285714,0.9863440699459787,1.0,18/142,11.17%,LCK;CD38;BTN3A1;BTN2A1;TNFRSF21;PSMB6;PSMD7;MOG;PSME2;PSMD8;EIF2B1;PSMB4;PSMD3;PSMB3;BTN3A2;CHUK;PSME1;HLA-DRA
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.45809970248806076,-0.9398227270783629,0.625,0.9856366599321633,1.0,3/50,2.30%,RPS27A;UBC;UBB
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.5741345927422301,-0.9394996419730226,0.5510204081632653,0.9857246681845243,1.0,3/8,11.87%,CGAS;HMGA2;B2M
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.5377833559762871,0.9393956552622583,0.54,0.826757449887043,1.0,4/9,17.86%,SLC24A4;UBR3;MKKS;BBS4
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.5079495964520618,0.939269117666909,0.5454545454545454,0.8266221533845257,1.0,3/13,8.32%,RYR3;SLC8A1;CASP7
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.5415735308661916,0.939180409309198,0.6170212765957447,0.8264198531610987,1.0,4/8,27.53%,ZFP36;ZFP36L1;TEK;YAP1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.4319290415054513,0.9391197244115378,0.5,0.8261786030959014,1.0,7/30,21.10%,NR4A3;RAB34;HPS6;RAB3A;SYTL4;KLC2;CHGA
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.46300966094939017,-0.9388658463179519,0.52,0.9866249300115895,1.0,2/36,5.18%,UXT;TFDP1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.45854277640465063,0.9388538432253469,0.5106382978723404,0.82634558205253,1.0,6/31,13.82%,TGFB2;MET;RASIP1;SYNGAP1;KANK1;CUL3
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.41933784043035305,0.9384738959039675,0.62,0.8267023400157654,1.0,13/64,11.90%,EGFR;F3;POSTN;TNC;MYH11;LRIG3;COL12A1;COL4A1;TP63;NTN4;TRIM29;LAMB2;NGFR
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.5680158873605072,0.9381303686061784,0.6153846153846154,0.8267506910262037,1.0,1/8,4.71%,SYK
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.5680158873605072,0.9381303686061784,0.6153846153846154,0.8267506910262037,1.0,1/8,4.71%,SYK
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.5316013103867492,-0.9378943027461111,0.627906976744186,0.9880815711397095,1.0,5/10,26.25%,TEFM;TFB2M;TFAM;MTERF2;TWNK
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.4563384029164034,-0.9377585225678549,0.5254237288135594,0.9876660040715411,1.0,3/25,7.06%,P2RY10;KLRB1;PYHIN1
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.6261591852910552,0.9374372525943335,0.6111111111111112,0.8278765775658593,1.0,1/5,11.80%,HES1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.4864044105714863,-0.9373328921093643,0.4090909090909091,0.9879440679290881,1.0,1/17,1.56%,TINF2
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.45496885439166684,0.9371977924860391,0.5490196078431373,0.827930841464283,1.0,3/23,8.49%,PPARG;SOX9;CHRD
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.5402633527943947,-0.9371845270973134,0.55,0.9875786813487397,1.0,3/7,15.34%,CALM1;SRI;TRDN
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.44634188736948316,0.9367998104963848,0.5636363636363636,0.8283918961621775,1.0,4/25,11.05%,NCKAP1L;TAL1;ARNT;MAPK11
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.3728594286633438,0.9367940087734243,0.5714285714285714,0.8280002215067815,1.0,35/130,20.91%,IGFBP3;PTPRC;LRRK2;PID1;SPRED3;PRKCZ;PTPN6;FBLN1;HSPB1;DMD;SH3GL2;DMTN;CORO1C;UBASH3B;LYN;SAMSN1;CAMK2N2;ITGB1BP1;NTRK3;THY1;PARD3;PRKCD;DDIT4;MACROH2A1;PRKAG2;WWTR1;SNX25;YWHAG;CAV3;MLXIPL;TERF2IP;PTEN;PAK2;CEP85;PTPN13
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.3519374504789991,0.936722123069136,0.6363636363636364,0.8278037939849372,1.0,19/144,9.57%,EPSTI1;FGL2;PLSCR1;MX1;PARP14;ISG15;PIM1;LCP2;PTPN6;RSAD2;XAF1;SAMHD1;CIITA;NFKBIA;ST8SIA4;CASP7;MARCHF1;SOCS3;NOD1
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.39033493631748656,-0.936646012754502,0.55,0.9882209307452274,1.0,20/107,16.19%,VPS25;VAMP8;LIX1;DYNLL1;CHMP2A;GABARAPL2;VPS28;MTERF3;PRKAA2;SNAP29;SNF8;CHMP3;TOMM7;TOMM20;MAP1LC3B;SQSTM1;HGS;EI24;ATG16L1;ATG14
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.5815106387058788,-0.9366127804736342,0.5777777777777777,0.9875471819092588,1.0,4/7,22.36%,GLYCTK;TKT;TKFC;KHK
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.43327901902957866,-0.9359767784871036,0.5106382978723404,0.9883859278037855,1.0,2/41,4.71%,BMP5;LMX1B
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.33106690386112314,0.9358721071542465,0.5882352941176471,0.8289877420225366,1.0,39/184,18.00%,IFNA2;PLSCR1;MX1;TLR2;TNFRSF25;FAP;EFNA5;SCN2A;ADRA1A;PLAGL1;CASP10;PDE1B;NFKBIA;ZBTB16;CASP7;ARHGEF6;TP63;DAPK1;SEMA6A;BCL2;PAWR;TNFRSF10B;FEM1B;NGFR;DMPK;BBC3;ATCAY;BCL2L1;PAK5;PRKCE;PRUNE2;TNFRSF19;PRKCD;ATN1;DDIT4;CSRNP1;RFK;NSG1;CIDEB
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.4717929508353268,-0.9355449671014159,0.5333333333333333,0.9886870959637031,1.0,2/25,0.93%,CRTAM;PRELID1
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.4626624054903028,0.9354933306385885,0.575,0.82938067512053,1.0,1/23,0.33%,TGFB2
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.4757967813893367,-0.9354661385380044,0.43137254901960786,0.9881315380648769,1.0,7/20,23.34%,TSPO;NFE2L1;PGRMC1;SUCLA2;RSAD1;COX10;UROD
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.4396696899222342,-0.9351456608226486,0.48148148148148145,0.9881985308242935,1.0,12/41,26.08%,LACC1;PGAM1;GCK;RAE1;NUP37;NUP210;TPR;POM121C;SLC2A6;NUP93;NUP42;NUP85
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.5359665201621282,0.9350220383172213,0.58,0.8297319515105505,1.0,5/11,25.34%,IRS1;JAK1;STAT5A;STAT3;STAT5B
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.5359665201621282,0.9350220383172213,0.58,0.8297319515105505,1.0,5/11,25.34%,IRS1;JAK1;STAT5A;STAT3;STAT5B
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.4036576395153979,-0.9349994969766845,0.6140350877192983,0.9878532915448055,1.0,17/72,12.90%,F11;CLDN2;GJB1;CYP2E1;SLC22A6;DAO;GLYAT;ENPEP;HSD11B1;SLC28A1;GBA3;KNG1;SOD3;TTC36;ADH6;BHMT;HNF4A
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.35751474516479154,-0.9349378211773979,0.6037735849056604,0.987207369978163,1.0,55/280,18.20%,TEAD2;POLR2L;TEAD3;POLR2G;BTF3;DRAP1;ADRM1;POLR2K;DDX5;CSTF2T;TFDP1;POLR2I;GTF2F1;PHAX;ELOC;PARP1;NR2C2AP;ELOB;LSM10;SNAPC1;NFIC;INTS14;POLR2A;IRF9;CSTF2;TAF13;DDX21;TAF7;ABT1;POLR2E;SNRPB;HNF4A;ELOF1;NELFE;SNRPE;CTR9;SSU72;SNAPC3;POLR2C;POLR2D;SNRPG;TAF11;NR5A2;SNAPC5;EAF2;ATF4;RXRB;NELFCD;CCNT1;GTF2H2;SUPT5H;SNAPC2;TAF9B;POLR2J;FIP1L1
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),-0.6382851443746284,-0.9344855664127887,0.6041666666666666,0.987004744455703,1.0,1/5,6.14%,USH1C
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),-0.6382851443746284,-0.9344855664127887,0.6041666666666666,0.987004744455703,1.0,1/5,6.14%,USH1C
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.3553920881260878,0.9341607287691897,0.5277777777777778,0.8311516134826626,1.0,17/107,13.86%,AQP1;SLC23A1;SLC25A48;CBLIF;SLC22A3;SLC43A1;SLC7A9;ARRDC2;PICK1;SLC35F3;SLC6A4;SLC15A2;SLC6A8;SLC6A15;CHMP1A;SLC7A8;ARRDC5
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.5032743621998447,-0.9340068941497156,0.5178571428571429,0.9873728449139377,1.0,3/22,10.82%,GAPDH;PGAM1;GCK
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.37013699943649353,-0.9337567463671742,0.5901639344262295,0.987286881155581,1.0,31/154,17.08%,COPE;USE1;TRAPPC1;KDELR1;ARCN1;DYNLL1;GOPC;F5;DCTN3;NRBP2;TMED4;TMED9;TRAPPC3;RANGRF;TRAPPC6A;LMAN1;TMED2;ERGIC3;TMED1;GORASP1;SAR1B;DYNC1H1;GOLGA2;YIF1B;COG2;TMED5;TMEM115;TRAPPC2L;LMAN2;TRAPPC4;DYNC1I2
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.61946031736834,0.9336156551760363,0.6808510638297872,0.8318314989476947,1.0,5/6,36.82%,KLF7;SPI1;SIRT1;SORL1;TRPM4
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.5407859890750893,0.9334877667391815,0.6382978723404256,0.8316727613138714,1.0,6/12,21.62%,MYO7A;VEGFA;THY1;BBS4;NRL;RPGRIP1L
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.349644605103362,0.9334628429860448,0.65,0.8313255771604721,1.0,26/148,14.70%,PDGFB;NRXN1;PLCB1;BMPR1B;GRIP1;SRC;RELN;BASP1;WNT5A;DLX1;PACSIN1;CAMK2B;SOX9;LRP8;ZBTB16;VIL1;CORO1C;SOX5;BMPR2;DLG4;CPEB3;SHANK1;ZDHHC6;RPS6KA3;TMEM79;VEGFA
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),0.37499867400060144,0.9333898430162564,0.5094339622641509,0.8310896063797976,1.0,10/63,13.06%,CD44;TLR2;TRIM5;WNT5A;CIITA;CAMK2B;DAPK1;CAMK2D;CX3CL1;SYNCRIP
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.5247465579918749,-0.9329904583290703,0.5,0.9868768620893892,1.0,6/16,21.16%,BUB1;IK;KNTC1;CENPF;TPR;CDC20
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.5247465579918749,-0.9329904583290703,0.5,0.9868768620893892,1.0,6/16,21.16%,BUB1;IK;KNTC1;CENPF;TPR;CDC20
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.5247465579918749,-0.9329904583290703,0.5,0.9868768620893892,1.0,6/16,21.16%,BUB1;IK;KNTC1;CENPF;TPR;CDC20
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.5412958441226826,0.9328058891815404,0.5294117647058824,0.8318569093915039,1.0,5/11,24.25%,IRGM;FYCO1;ADRB2;CALCOCO2;UVRAG
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.5203225970524415,-0.9327114358033933,0.5555555555555556,0.986870952295388,1.0,6/12,33.40%,NCSTN;BACE1;APH1A;CLN3;APH1B;ADAM17
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),0.4009860373139173,0.9324663235209261,0.6382978723404256,0.8321415877120891,1.0,5/45,9.79%,CD44;TRIM5;CIITA;CAMK2B;CAMK2D
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3305853961404902,0.9324138309471477,0.65,0.8318391279617483,1.0,18/176,11.81%,ROR1;TRIM5;BIRC3;MAPKBP1;WNT5A;CASP10;C18ORF32;HSPB1;PER1;TIRAP;ZDHHC13;CD4;NOD1;TNFRSF1A;ZFAND6;PRKD1;TNFRSF10B;CX3CL1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.4358557089060942,0.9319441423479276,0.65,0.8323615054977238,1.0,4/30,12.03%,CYFIP1;SH3GL2;FLRT1;SEMA5B
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.5049520336206292,0.9318045523987153,0.6222222222222222,0.8322915417586769,1.0,6/15,12.26%,P2RY12;RTN4RL2;GAP43;NREP;SARM1;DPYSL3
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.47732379481847215,0.93175935185442,0.6458333333333334,0.8319949661602091,1.0,7/16,20.35%,OBSCN;TPM1;MYLK3;CSRP2;CAPN3;TCAP;FHOD3
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.5284389601358269,-0.9315533912014974,0.5769230769230769,0.9888374011966681,1.0,2/18,6.46%,SFRP1;RNH1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.49670427048044075,0.9314168374817162,0.625,0.8323396994894396,1.0,1/14,5.19%,SRC
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.5953058275982447,-0.9313226124705467,0.6111111111111112,0.9886592170125306,1.0,3/8,17.59%,AGA;MAN2A2;PARK7
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.4702477726215434,-0.9312099418027578,0.5471698113207547,0.9882008100754739,1.0,5/29,8.83%,FUCA1;DCXR;PMM1;APOD;GALT
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.33972010840169276,0.9309832769691027,0.675,0.8328056273742015,1.0,13/134,11.81%,ROR1;TRIM5;BIRC3;CASP10;C18ORF32;TIRAP;ZDHHC13;CD4;NOD1;TNFRSF1A;PRKD1;TNFRSF10B;CX3CL1
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.5911158972585607,0.9305679904977118,0.6222222222222222,0.8331275739472841,1.0,3/8,30.17%,CLMP;PKD1;COBL
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.5660309257921718,0.9303789983685644,0.5952380952380952,0.8331125988614516,1.0,2/6,18.61%,INSYN2A;GLRA1
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.5402189840076164,-0.9297950439333671,0.6181818181818182,0.990746922157817,1.0,3/11,12.60%,CSKMT;KMT5A;METTL18
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.509208829086544,-0.9297527291110476,0.5517241379310345,0.9901354487909011,1.0,1/17,1.20%,RPS3
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.5454232870662932,0.929654334464767,0.5813953488372093,0.8343000774653988,1.0,2/7,14.20%,CLOCK;RFX3
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),-0.6133200182706376,-0.9294257313317976,0.6415094339622641,0.9901211107617934,1.0,3/5,17.58%,LGALS1;AGER;HMGB1
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.5653804160027758,-0.9292870268111916,0.5471698113207547,0.9897602495074012,1.0,2/8,6.14%,CDHR2;USH1C
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.6291887512566845,-0.9289841136656739,0.6274509803921569,0.9899041627157884,1.0,3/5,21.73%,ATF4;PINK1;LANCL1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.5165373963490871,0.928930488507388,0.47058823529411764,0.8354864447182894,1.0,1/9,2.66%,CAMSAP3
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.5829452513326563,-0.9287065033133767,0.6346153846153846,0.9898535983645884,1.0,2/7,11.46%,TINF2;PNKP
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.4238381141424394,0.9286683480460493,0.5625,0.8356026421829561,1.0,7/29,15.02%,FSTL1;FAP;PRKX;CDH13;LGALS8;VEGFA;CCN3
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.46401399003546007,-0.9282901733040722,0.5737704918032787,0.9900033016527874,1.0,5/38,9.66%,CRYAB;OPRD1;NOP53;TFIP11;RPL13A
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.40213703384362987,-0.9282867863941241,0.5625,0.9892919700540058,1.0,4/33,12.41%,CENPX;ASF1B;SMARCA5;NPM1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5433361182980272,0.9281733711176887,0.5454545454545454,0.836104293960684,1.0,1/9,3.54%,LRRK2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.5574371578993081,-0.9277711182762117,0.575,0.9891496467298937,1.0,2/13,9.13%,CRTAM;PVR
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.5574371578993081,-0.9277711182762117,0.575,0.9891496467298937,1.0,2/13,9.13%,CRTAM;PVR
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.6178138238968816,0.9277568824115896,0.5714285714285714,0.8365834550312615,1.0,1/5,1.17%,PTPRC
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.5364310413365269,0.9276514256912107,0.5531914893617021,0.8364073237561563,1.0,5/7,25.26%,NR4A3;LEPR;UGCG;STAT3;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.48698033719557343,0.9275889871286509,0.6829268292682927,0.836110349721454,1.0,2/13,6.03%,ACTN1;FBLN1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),0.6257615385904229,0.9274657716865431,0.62,0.8360280655342087,1.0,4/5,35.49%,IL12RB1;IL1R1;IL18;SLC11A1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.5039839535212813,0.9270710286281,0.5490196078431373,0.8364514162315481,1.0,4/16,17.72%,LDB2;FEM1B;NLRC5;HMBOX1
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.49419465670915,0.9267874693399607,0.5740740740740741,0.836693115235738,1.0,3/19,2.24%,PTPRC;FLT1;CSF1R
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.2849142316517878,0.9262053838043365,1.0,0.8376537889003184,1.0,259/1642,16.59%,ZNF366;CREB3L1;FLI1;ETV1;KANK2;PLAC8;NPAS2;PPARG;MYT1;BMP6;PLSCR1;EGFR;TP73;FOSL2;GRHL1;IGF1;IKZF2;FOS;TLR2;MLIP;HNF4G;HEY1;CSF1R;KLF9;NEDD4L;MIDEAS;BHLHE40;SCRT1;ZIM2;MEF2C;CASZ1;DNAJB1;ZNF93;IKZF1;ZNF157;PID1;GCM1;UHRF1;ZSCAN22;LDB2;E2F3;NR4A3;MET;HGF;BMPR1B;DACH1;NFATC4;ZNF20;BCL11B;NR2F1;ZEB1;ATF1;TOX;KAT2B;CITED2;DACT1;MAFF;EBF1;PURG;TBX6;ID2;PPP3CA;PRDM15;KLF15;RHOQ;MACC1;ZNF652;HIVEP2;ZNF608;ZNF239;TBX19;PLAGL1;MAP2K5;WNT5A;LILRB1;LMO7;RARB;DLX1;PBX1;CIITA;ZFP36;CRYM;AEBP2;ZNF215;MEIS3;TSHZ3;NFKBIA;ZNF442;SOX9;GRIN1;ZBTB7C;ETS2;PER1;LEF1;HIRA;TEAD1;ETV6;PHF21A;ZNF600;LMO2;ATXN1;TAL1;ZBTB16;MEIS2;NR3C2;NOS1;CLOCK;HES4;CCND1;PTPRN;BCL6;KDM3A;ZNF343;EPAS1;PLK1;STAT6;TP63;NEUROD6;EMX1;AGRN;ZGLP1;CDKN2A;MAFB;SLA2;GLIS3;ZNF697;TGFB3;BRWD3;NOTCH4;SMYD2;ZNF764;TENM2;GTF2IRD1;TBL1XR1;NR1I3;CAMK2D;BCL9;EDNRB;ZNF768;ARNT;ZNF540;ZNF568;ZHX2;CREB3L2;ZNF615;TNFRSF1A;SOX5;MOV10;HOPX;TGFA;SATB2;PRKD1;AEBP1;HAMP;ZNF644;BMPR2;ZNF304;ZNF587;ZSCAN1;ELK3;ZNF616;MYT1L;ZNF550;ZNF473;ZBTB18;PCGF2;HES1;CX3CL1;PARP9;ZNF433;CBFB;TGIF1;NPAS1;NCOA7;PROX2;NR2F2;ZFP30;POU2F2;ZNF467;FHOD1;CPEB3;ACTL6B;MED12L;PIK3R1;PRRX1;ZNF571;ZXDA;FOXP2;ARID3A;BACH1;CEBPD;ZNF384;ZNF584;KCNIP3;SRA1;ZNF775;MRTFB;ZNF493;RPS6KA3;PIAS1;ZNF536;CDH13;ZNF235;KAT6B;ZKSCAN7;RFX3;ITGB1BP1;CREB5;NCOA1;ZNF549;ZNF33B;ZNF383;KLF3;GRHL2;ONECUT2;ZNF148;MED14;ZNF248;VEGFA;GLIS1;MAFK;ZBTB34;RPRD1B;CCNQ;RFXANK;ZNF654;TOX2;CSRNP2;ZNF438;PCGF3;THRB;WWOX;GPER1;ZNF577;BCL11A;ZNF439;IL33;ACVR2A;ZNF415;KLF6;CRX;CBX7;ALX3;ETV3;JUNB;NLRC5;CKAP2;SSBP4;SMARCA2;SMARCA1;NFIA;RXRG;KDM6B;MYNN;CDK12;ZNF274;PFKM;ZBTB1;TADA2A
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.6104184592444726,0.9260801074942266,0.66,0.8375380140204554,1.0,2/5,11.54%,LRRK2;MAPT
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.3930121592437147,0.926038072888525,0.6046511627906976,0.8372194032744853,1.0,8/75,11.37%,GLRA3;KCNC2;SHMT2;ADCY8;PRMT8;TMEM120B;KCNC3;HOMER1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.5397649490477414,0.9258314294401198,0.5952380952380952,0.8372245513304031,1.0,2/10,7.18%,LILRB1;ARRB2
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.6190214853884317,-0.9255563060611927,0.6341463414634146,0.993624423989486,1.0,4/7,33.40%,NCSTN;APH1A;APH1B;ADAM17
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.5309866808949865,0.9255380860700431,0.6041666666666666,0.8374324494765744,1.0,7/13,30.08%,REEP1;ATL2;TMEM33;RAB18;REEP2;ZFYVE27;ATL1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.3931457956314574,-0.925506863825786,0.5272727272727272,0.9930636462833442,1.0,23/86,19.84%,NDC80;TUBG1;CHMP2A;CDC23;RAN;CHMP5;KIFC1;ANKRD53;SGO2;MIS12;NUDC;KMT5A;PHF13;PINX1;CHMP3;WRAP73;SMC1A;SMC2;REC8;CDCA8;BECN1;SET;CHMP7
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.6376135257427701,0.9248580674799437,0.625,0.8384672287346229,1.0,2/5,4.93%,LMO3;CITED2
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.5759605491783876,0.9245807770431309,0.5952380952380952,0.8385977094515145,1.0,1/7,5.19%,SRC
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.61330112530905,-0.9245543563414591,0.5769230769230769,0.9944788280932289,1.0,4/6,28.74%,SAT2;AMD1;SRM;HDAC6
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),-0.5731547989218315,-0.9244303695073198,0.5686274509803921,0.9940872470830944,1.0,3/7,13.67%,IFNLR1;H2BC21;BPIFB1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.5132516770836458,0.9242059371942044,0.5918367346938775,0.8389633746753006,1.0,1/17,2.66%,CAMSAP3
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.5377163816889234,-0.9237013049467983,0.5319148936170213,0.9950895080226506,1.0,2/6,12.41%,RAN;NPM1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.5602109859870172,0.9236202645285194,0.6829268292682927,0.8398428508083723,1.0,2/9,4.60%,EPHA4;NELL1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.4279132096820523,-0.9234898938784823,0.5510204081632653,0.9948306487556311,1.0,5/38,9.73%,CRYAB;PFDN2;EIF2AK1;VBP1;PFDN1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.4682870320988575,0.9234761826687833,0.6037735849056604,0.8397920956808855,1.0,1/15,0.65%,DPYS
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),0.5935519804824219,0.9233704339547965,0.5660377358490566,0.8395446616213645,1.0,2/5,14.21%,DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),0.6084113330239805,0.9232072023333465,0.6538461538461539,0.8394449330944863,1.0,2/5,2.16%,HORMAD2;SGO1
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),-0.5683472883145543,-0.9231754731949817,0.5294117647058824,0.994187659396832,1.0,2/9,9.40%,CHMP2A;CHMP5
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),-0.5683472883145543,-0.9231754731949817,0.5294117647058824,0.994187659396832,1.0,2/9,9.40%,CHMP2A;CHMP5
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.3940497118961718,-0.9228869306871355,0.5901639344262295,0.994098403218083,1.0,23/79,24.94%,KIF3B;AP2S1;DYNLL1;DCTN3;HLA-DRA;AP1B1;SAR1B;DYNC1H1;KIF4A;HLA-DPA1;KIF11;DYNC1I2;DCTN1;AP1S1;DCTN2;AP2A1;AP2B1;CTSF;DCTN6;KIF18A;CTSL;RILP;CLTA
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.6079607691643222,-0.9228483267410086,0.6538461538461539,0.9927792256944503,1.0,3/5,36.06%,BEND3;SETD4;KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.6079607691643222,-0.9228483267410086,0.6538461538461539,0.9927792256944503,1.0,3/5,36.06%,BEND3;SETD4;KMT5B
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.4886886434773456,-0.9228251740864245,0.5714285714285714,0.9920910503398178,1.0,1/16,1.51%,SFRP1
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.42981096048785067,0.922559985155642,0.5625,0.8403553131903329,1.0,9/30,16.08%,GLRA3;RRAGD;GRIN1;GLRB;GLRA2;CPEB3;SESN2;NSMF;RPTOR
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.4720066820581819,-0.9224821164810156,0.5740740740740741,0.9920695190947235,1.0,11/30,22.62%,HSPA8;TMBIM6;BAX;BAK1;HSPB8;DAXX;HSPA2;HSPA14;PTPN1;DNAJC18;ERN1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.5360577832968532,0.9220597789562645,0.5818181818181818,0.8406026508902018,1.0,2/7,19.73%,ITGB1BP1;GCLC
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.5360577832968532,0.9220597789562645,0.5818181818181818,0.8406026508902018,1.0,2/7,19.73%,ITGB1BP1;GCLC
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.44253028704261765,-0.9219790457617157,0.5666666666666667,0.9924854798423849,1.0,7/36,11.43%,GAPDH;SERPINE1;UBXN1;CSTB;KNG1;SERPINB8;SERPINH1
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.5215614412809677,-0.9219231739282454,0.5714285714285714,0.9919067825034515,1.0,1/9,5.02%,BHLHE41
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.44653719856666685,-0.9217816341595123,0.5957446808510638,0.991562290824541,1.0,9/32,19.13%,CRYAB;NUMA1;ANTKMT;CAPN10;DYNC1H1;GAS1;DNAJC30;RINT1;PTPN1
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),-0.47842068967101575,-0.9217201959069306,0.5961538461538461,0.9909671413753095,1.0,4/16,6.69%,SEPHS2;DAO;GLYAT;SARS1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.3901285641772772,0.9217126056659559,0.5581395348837209,0.8410260062868589,1.0,7/57,9.57%,EGFR;TLR2;C1QTNF4;NFKBIA;NR3C2;LAPTM5;NOD1
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),-0.4738784129108867,-0.9215860401249177,0.4888888888888889,0.990540156046261,1.0,2/14,3.48%,B3GALT4;B4GALNT2
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.4904258218171393,0.9211787309296499,0.5952380952380952,0.8416505995555623,1.0,5/16,19.03%,TRIM5;AXL;TRIM22;TRIM62;TSG101
prerank,MSigDB_Hallmark_2020__Coagulation,-0.36770966893838625,-0.9211008739120454,0.6349206349206349,0.9909915512916495,1.0,14/86,15.37%,MMP11;F11;SERPINE1;MSRB2;CD9;TF;S100A1;SPARC;RGN;CFH;HNF4A;RAC1;GSN;MST1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.5054020541532867,-0.9210665623304081,0.515625,0.990380181515655,1.0,3/13,20.98%,UCK1;UCKL1;TK2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.5355465666834831,-0.9206841274264153,0.5740740740740741,0.9905090604645306,1.0,2/8,4.59%,SELENOS;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.5925715812169179,0.9204942234331576,0.6078431372549019,0.8426395593877061,1.0,3/5,23.73%,WNT5A;NLRC5;UBE2K
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.39914943719340856,0.9199137509145172,0.5319148936170213,0.8434316064622779,1.0,13/55,18.42%,E2F3;CDKN3;CCND1;CDKN2A;SPDYA;CUL3;CDC7;DBF4;RCC1;CRLF3;CDKN1A;CUL4A;E2F1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5194797069323036,0.9199102451418926,0.5660377358490566,0.8430583563471961,1.0,2/8,7.35%,ADGRB1;GRIN1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.5696630109390104,-0.9198613524061058,0.5957446808510638,0.9918592426795131,1.0,3/8,22.41%,MCM4;MCM3;MCM6
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.5054249589165128,-0.9198170323848834,0.5625,0.9912842861347962,1.0,1/17,4.64%,GFI1B
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.5789349316785457,-0.9193981644239184,0.6271186440677966,0.9916561969238119,1.0,1/5,8.17%,LRAT
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.4706936003688852,-0.9189660923076383,0.5686274509803921,0.9919621756088799,1.0,5/19,12.60%,PPIL1;PPIB;PPIE;PPIA;PPWD1
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.4073030396026898,0.9187499757024132,0.5319148936170213,0.845149491137031,1.0,8/66,6.99%,EPHA3;DPP10;EGFR;PID1;SORBS1;STAC2;RHOQ;STX3
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.4035651239839265,0.9186793802315214,0.6111111111111112,0.8449171514413811,1.0,3/25,6.91%,SSTR1;EGFR;WNT8B
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.45436604421513027,-0.9184051982236066,0.5454545454545454,0.9927371017186862,1.0,2/33,4.72%,NGF;HOXD3
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.4123956753843318,0.918348414264565,0.6181818181818182,0.8452067250821307,1.0,2/28,1.99%,SLCO2B1;ABCC4
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.5346720971852204,0.9175506828081629,0.5833333333333334,0.8463325380165491,1.0,1/11,5.26%,ID2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.4580788323336398,0.9175124017099762,0.5714285714285714,0.8459968165816875,1.0,7/21,15.45%,SLC8A1;TPM1;SCN3B;DMD;CAMK2D;KCNH2;SCN4B
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.595393197265268,-0.9173432980523482,0.5909090909090909,0.9943243418161197,1.0,2/8,18.65%,ENTPD2;NUDT5
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.4489887560376713,0.9171581408396539,0.5686274509803921,0.8463343344582119,1.0,2/21,4.33%,SGO1;SYCP3
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.5833358714401591,0.9168763465098173,0.6923076923076923,0.8467203607537864,1.0,3/9,11.80%,RTN4RL2;GAP43;NREP
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),0.6406086944051261,0.9166151217181038,0.6666666666666666,0.8468512043217424,1.0,1/5,8.99%,LAPTM5
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.3690807898154782,-0.916410278602435,0.5737704918032787,0.9958796649228681,1.0,11/106,10.10%,ABCA13;AQP9;SLC22A6;SLC22A2;CHMP2A;ABCA8;SLC22A25;SLC22A24;SCAMP2;TXNIP;ABCA9
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.5135076589507661,0.9162464588329547,0.5238095238095238,0.8471445085088174,1.0,2/11,8.90%,B4GALT6;CNTNAP1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.33142754090780285,0.9160915192629348,0.7804878048780488,0.8470800292617795,1.0,37/215,14.52%,PKP2;DCX;NCKAP1L;CYFIP1;BAIAP2;RHOJ;ADD2;SPEF1;LAMC1;RHOQ;MYO1B;SCIN;WNT5A;BAIAP2L1;RSPH9;CFAP74;SOX9;TEAD1;PCLO;SLC7A9;IL1RAP;VIL1;LIN7A;DMTN;PAWR;DLG4;SPAG16;HES1;DPYSL3;NLGN4X;P3H4;RAC3;SHANK1;ANK3;SHROOM2;FANCC;GRHL2
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.5863505501519977,-0.915979875707162,0.5116279069767442,0.9962292142528221,1.0,1/6,1.28%,SELENOS
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.5184752392919386,0.9159754915805265,0.6041666666666666,0.8468910784166027,1.0,4/11,22.10%,CX3CL1;GAS6;MSMP;CXCL13
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.4188429600989267,0.9159492329675766,0.5813953488372093,0.8465561799076228,1.0,9/43,9.57%,PTPRC;TLR2;CHI3L1;F3;SYK;MAPKBP1;MAP2K5;TIRAP;NOD1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.5004700354406337,-0.915941363623312,0.6086956521739131,0.9956006907578446,1.0,7/17,24.04%,TALDO1;GCK;TKT;PGLS;G6PD;G6PC3;RPIA
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.5098018370713309,-0.9159363958731922,0.5178571428571429,0.9949138516886618,1.0,2/14,3.26%,DSCAM;ROBO3
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.46334205202292694,0.9159133837997149,0.5370370370370371,0.8462432265808119,1.0,2/18,2.39%,P2RY12;CARMIL2
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.5970809069009082,0.9158931546720157,0.6382978723404256,0.8458981189134933,1.0,3/6,19.53%,DYSF;BIN1;CAV3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.4877851625481482,0.9156659940225694,0.56,0.8459154260528684,1.0,3/15,11.85%,KDM4D;SETMAR;PARP9
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.4683327993789711,0.9154422014208751,0.5128205128205128,0.846019148884453,1.0,6/25,9.63%,PTPRC;PARP14;PRKCZ;PTPN6;SOCS3;DMTN
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.40865278237555686,0.9151577930777509,0.5471698113207547,0.8462091685965708,1.0,12/39,20.66%,DGKB;LPCAT4;PLA2G10;GPAT4;GPAT3;ABHD5;PLA2G4A;ACP6;DGKD;ABHD8;DGKE;DGKA
prerank,PanglaoDB_Augmented_2021__T Memory Cells,0.39586079060701646,0.9151198605061291,0.5384615384615384,0.8458755029327001,1.0,11/58,8.57%,EPSTI1;SLA;PTPRC;SELL;IKZF1;LCP2;CD53;ARHGAP25;LEF1;APBB1IP;CD4
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.6228289582263573,-0.9150981801246032,0.5849056603773585,0.9961152944368404,1.0,1/6,1.84%,EYS
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.5525355019579501,-0.9149781984640174,0.625,0.9957010214876807,1.0,4/9,11.89%,CYB5A;RGN;CYB5R3;GSTO2
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.6182244669131416,-0.914926547978456,0.6612903225806451,0.995116002338808,1.0,4/6,35.88%,PIH1D1;ZNHIT6;NOP58;ZNHIT3
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.5000788644064429,0.9146771901849484,0.6304347826086957,0.8463836929975157,1.0,6/17,20.80%,KCNMA1;ATP1B2;KCNH2;ATP1B3;SLC12A5;ATP1A2
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),0.5085569784248735,0.914214718231199,0.6190476190476191,0.8468482812318404,1.0,5/14,15.50%,PTPRJ;LAPTM5;SLA2;LGALS3;THY1
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.4007512409221283,-0.9140526674232734,0.603448275862069,0.9963619892533798,1.0,8/75,7.28%,NGF;RPL11;STMN1;EDF1;RAN;PYHIN1;ZNF618;BAMBI
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.3499463056950278,-0.9139177471472912,0.5573770491803278,0.9960074152304352,1.0,25/187,15.96%,DDIT3;RAD23A;PSMB6;PSMD7;UBXN1;PSME2;PSMD8;HECTD3;PSMB4;PSMD3;PSMB3;PSME1;ZFAND2A;ERLEC1;KAT5;PSMA7;KLHL20;SPSB3;PSMB8;PSMD13;ZFAND2B;ERCC8;UBE2A;PSMD2;RNF126
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),-0.592216608802773,-0.9138846712024101,0.660377358490566,0.9953998350402428,1.0,1/7,8.48%,RHOA
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.4777801050749999,0.9137312845055916,0.6086956521739131,0.8476358214193821,1.0,5/13,29.49%,SYT7;LEPR;CST3;DDR2;IL18
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.48875976676036065,-0.9132403350283496,0.6545454545454545,0.9963366402993048,1.0,2/17,4.75%,GSTP1;PTGIS
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4173672221228281,-0.9131347913549859,0.5869565217391305,0.9958179914006848,1.0,3/38,3.83%,NGF;DPEP1;BEX3
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.5159387698722285,0.9129701995219514,0.6046511627906976,0.8487350962484201,1.0,5/10,26.82%,FZD3;NF1;ASCL1;SOX4;NRP2
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.46993354719950375,0.912817300167228,0.6153846153846154,0.8486756578354356,1.0,5/18,7.89%,CBARP;STAC2;CACNB1;GPR35;DMD
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.37338426184279394,0.9127574960282407,0.7,0.8484440423547724,1.0,17/86,10.76%,COBLL1;ALDH1L1;CLDN16;CMYA5;SLC8A1;TRHDE;STON2;MACC1;SCIN;GDA;ZBTB7C;CLMN;EMX1;NEBL;LPP;PDZD2;RSPH3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.3993351345539322,-0.9127492505182175,0.5423728813559322,0.9961236987922094,1.0,23/75,24.94%,KIF3B;AP2S1;DYNLL1;DCTN3;HLA-DRA;AP1B1;SAR1B;DYNC1H1;KIF4A;HLA-DPA1;KIF11;DYNC1I2;DCTN1;AP1S1;DCTN2;AP2A1;AP2B1;CTSF;DCTN6;KIF18A;CTSL;RILP;CLTA
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.5032795948828153,-0.9122062120227897,0.5208333333333334,0.9967288011572134,1.0,3/11,17.62%,GOLGA2;PLK3;GBF1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.3155561534712503,0.9121327215110916,0.8,0.849229415454701,1.0,80/426,15.53%,DACT2;TGFB2;KANK2;TEX15;IGFBP3;NPAS2;ANGPT1;SSTR1;PLSCR1;OSGIN1;TLR2;ACTN1;MYO16;TMIGD3;TP53I11;KAT2B;SPEF1;ADGRB1;PTPN6;TSPYL2;DDAH1;PLXNA4;ADRA1A;SCIN;FBLN1;TNFRSF1B;CDKN3;LILRB1;ADGRG1;PTPRJ;ZBTB7C;CLMN;TENM1;P3H2;TESC;GNRH1;NOS1;BCL6;JAM2;PLXNA2;CDKN2A;BRINP1;RERG;TGFB3;NOTCH4;SMYD2;UTP20;GPLD1;HOPX;BCL2;DYSF;PRKD1;FABP7;BMPR2;RNF139;CD200;WDR6;TPTE2;IFNK;CCN5;PDE3B;GSDME;CR1;LYN;APBB2;PDS5B;SULT2B1;CHMP1A;FRZB;CDH13;ITGB1BP1;SFRP4;GNG4;OSGIN2;WNK2;CCN3;FHL1;SESN2;GPER1;PTPRK
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.590181764972111,-0.9120672049485244,0.6222222222222222,0.9963754635333094,1.0,4/7,37.96%,AP2A1;ABCA2;HSP90AB1;TGFB1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.4108054969370347,0.91175661769937,0.5660377358490566,0.8495569996667616,1.0,12/38,20.66%,DGKB;LPCAT4;PLA2G10;GPAT4;GPAT3;ABHD5;PLA2G4A;ACP6;DGKD;ABHD8;DGKE;DGKA
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.5405746444081116,-0.9116996766344281,0.6078431372549019,0.9964629215762917,1.0,3/8,23.43%,TAF7;TAF11;GTF2A2
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.48820789246594964,0.9116717202144808,0.5833333333333334,0.8493145493775844,1.0,5/15,21.27%,GPLD1;GRAMD1B;GRAMD1A;GRAMD1C;MLC1
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.5498008063951285,0.9116424829521974,0.5490196078431373,0.8490024788279885,1.0,1/6,0.92%,CX3CR1
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.6007635339213865,-0.9114736272517683,0.6571428571428571,0.9963038620034799,1.0,2/7,12.41%,RAN;NPM1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.3303771552258496,0.9113829343523807,0.6304347826086957,0.8492330591841375,1.0,38/206,14.93%,BICC1;SHISA6;EGFR;CTNND2;LRRK2;IGFBP4;PRICKLE1;DACT1;PRDM15;WNT5A;SCEL;SOX9;GPC5;AMER1;TBL1XR1;TMEM170B;ANKRD6;CSNK1D;LYPD6;PLEKHA4;FZD6;HECW1;LRP4;WLS;KANK1;PTPRO;CDH3;APC2;FRZB;CUL3;DRAXIN;SFRP4;RBMS3;TLE3;LRRK1;DAAM2;FZD9;WNK2
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.516401216313382,0.911188703597451,0.5918367346938775,0.8491896860163762,1.0,2/11,2.39%,P2RY12;CARMIL2
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.5292043115473613,0.9111116153484181,0.5918367346938775,0.8489478446137233,1.0,1/11,1.01%,RNFT1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.6010252297642384,-0.9108412935173172,0.625,0.9971299145086581,1.0,3/5,21.10%,NOP53;MAF1;FLNA
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.6027604345671682,0.9106918964745977,0.55,0.8494838050026612,1.0,1/5,15.03%,ABCA1
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3060033499232741,0.9106550971317842,0.7857142857142857,0.8491723673452958,1.0,57/431,13.06%,CREB3L1;IFNA2;PDGFB;ZNF423;PPARG;MDFIC;HEY1;MIDEAS;BHLHE40;ENC1;ZNF93;PLCB1;IKZF1;RUNX1T1;DACH1;NRG1;ZEB1;PRICKLE1;CITED2;ID2;MAEL;TSPYL2;BASP1;WNT5A;CIITA;LOXL3;TSHZ3;SOX9;PER1;LEF1;ATXN1;ZBTB16;TIMELESS;SPINDOC;CLOCK;BCL6;IGF2BP2;WWP1;TP63;DAPK1;CDKN2A;L3MBTL4;ZNF540;ZNF568;ZHX2;BMPR2;RNF139;CDK5R1;ELK3;ZBTB18;HES1;NPAS1;NR2F2;NANOS3;CPEB3;FOXP2;SYNCRIP
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),-0.5511386034726752,-0.9102092873640211,0.6136363636363636,0.9979196600971587,1.0,1/6,6.77%,SMYD1
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.5138334889683019,-0.9101245906291379,0.5818181818181818,0.9974262239016374,1.0,2/19,5.00%,DPEP1;ENPEP
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.44200346269608903,-0.9094559836294887,0.5192307692307693,0.9982029574682929,1.0,7/26,26.01%,NUTF2;RAN;CALR;RANBP17;TPR;CSE1L;NUP42
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.6214230700894555,-0.9094303712837231,0.625,0.9968380290896157,1.0,4/5,36.68%,MSN;SPP1;NCOA4;ROCK2
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.6214230700894555,-0.9094303712837231,0.625,0.9968380290896157,1.0,4/5,36.68%,MSN;SPP1;NCOA4;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.44238837040538603,-0.9088981550388194,0.5555555555555556,0.9973625177817014,1.0,5/38,11.46%,OOEP;MGMT;PARP1;RAD51AP1;PNKP
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5261692001717689,0.9088418030467764,0.5686274509803921,0.8525848524113561,1.0,6/10,25.34%,STAT6;GHR;LYN;STAT5A;STAT3;STAT5B
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.34294781691706405,0.9086298817085074,0.6153846153846154,0.8526792925781244,1.0,22/116,14.52%,FKBP5;EGFR;PPP1R3C;GPC6;LRIG3;KIAA1217;TMEM47;DDAH1;MYO1B;CHST3;ADGRL2;TEAD1;KCTD3;EPB41L1;SYT7;FNDC4;LAMB2;CDC42EP4;GPC1;SFRP4;CPE;TMEM86A
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.4329833010578055,-0.9085209221449771,0.5714285714285714,0.9974604062389327,1.0,7/49,9.18%,ACAA2;DECR2;ECHS1;HSD17B10;CROT;ETFB;EHHADH
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.530656469546888,0.9084980090017354,0.5849056603773585,0.8525488257105112,1.0,3/8,16.25%,SLC40A1;SLC11A2;ABCC5
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),-0.5541454027381465,-0.9082247906388798,0.6,0.9974299037036438,1.0,1/6,3.05%,KIF3B
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.4705926178580515,0.9082023780554414,0.6122448979591837,0.8526378460062216,1.0,3/18,9.36%,BMP6;KIAA0319;TGFB3
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.359203798142004,0.9081827216677196,0.6,0.8522775512564155,1.0,23/92,16.16%,PDGFB;ROBO2;CSF1R;LRRK2;PID1;BMPR1B;PTPN6;TWF2;MAP2K5;LEF1;ACVR1C;NOS1;BMPR2;DPYSL3;PTPN11;GHR;PTPN5;NCOA1;ACVR2A;PTPN4;TIPARP;UCP1;PTPN20
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.5448641781865851,0.9080768491282627,0.5208333333333334,0.8521367530535259,1.0,2/6,14.65%,ITGB1BP1;MEGF10
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.3711685885548569,0.9078894432520596,0.6363636363636364,0.8521189756000466,1.0,10/62,12.50%,SLC8A1;SLC24A4;VAPB;SLC24A3;GRIN1;ATP2B3;ATP2B2;HTR2C;TRPV4;DMPK
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.5317614940621045,-0.9077566559156044,0.6744186046511628,0.9977781137044227,1.0,6/11,24.34%,MUS81;MCM4;MCM3;GINS2;MCM6;GINS4
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.5742344776610436,-0.9076824509556225,0.58,0.9972060200985172,1.0,2/7,18.24%,PNKD;SYT11
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.46668898851104695,-0.9076587404592136,0.6470588235294118,0.996564911084546,1.0,1/20,0.38%,LCK
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),0.5775529271668605,0.9074342890000446,0.627906976744186,0.8526886971596871,1.0,4/6,34.76%,PAH;SDS;CPS1;ALDH18A1
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.5367014805544724,-0.9072885097044213,0.6046511627906976,0.9967153356240699,1.0,2/8,6.89%,GBA3;GLA
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.46996992619870903,-0.9072238472334165,0.625,0.995465495458517,1.0,1/22,0.48%,ZDHHC12
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.46996992619870903,-0.9072238472334165,0.625,0.995465495458517,1.0,1/22,0.48%,ZDHHC12
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.3422334991909432,0.9067972806534174,0.6428571428571429,0.853530157451159,1.0,23/104,15.88%,TRPC4;TRPC7;ADCY8;SLC8A1;SLC24A4;VAPB;SLC24A3;ATP2B3;ATP2B2;CAMK2D;CDH23;HTR2C;MICU3;BCL2;MAIP1;TRPC3;TRPV4;DMPK;TRPC6;HCRTR2;FZD9;GPER1;CALCB
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5498399989959198,0.9066670092237914,0.5957446808510638,0.8534744216692856,1.0,3/10,16.82%,NCKAP1L;CBFB;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.5658734203653256,-0.9063333182670359,0.6511627906976745,0.9968868876958203,1.0,1/8,1.28%,SELENOS
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.47653562190959736,-0.9061492881417824,0.6046511627906976,0.9966772313029187,1.0,2/14,4.72%,WNT9A;HOXD3
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),0.5891768805895345,0.9061459992905586,0.6086956521739131,0.8541440924075357,1.0,2/6,6.76%,FAP;PTPRJ
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.45919276876871085,-0.9060087147238127,0.6382978723404256,0.9962882693403673,1.0,6/27,16.39%,SERPINE1;ACTG1;AJAP1;HRAS;EPHB2;CRK
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.45605462135886893,-0.9057647517868048,0.6,0.9960561597639394,1.0,2/19,3.81%,VPS25;CRHBP
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.40464095770937974,0.9055575835544932,0.6923076923076923,0.85495176537288,1.0,6/45,6.99%,EPHA3;DPP10;EGFR;SORBS1;STAC2;STX3
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.619584932175216,0.9053454300301067,0.6875,0.854975392384301,1.0,2/6,5.88%,ADRA1A;OXTR
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.3822144884506927,0.9047315965239772,0.5681818181818182,0.8557979380717985,1.0,17/53,17.09%,PDGFB;UTRN;PLEKHA2;CARMIL1;NPNT;FBLN2;VIT;DMTN;CX3CL1;CSPG5;RAC3;CDH13;DOCK5;ECM2;CASS4;ARHGEF7;DOCK1
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.5157766554673124,0.9046659314153418,0.6078431372549019,0.8555070536189239,1.0,2/9,16.00%,SLC22A3;SLC29A4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4207997605968534,0.9045403944895659,0.6111111111111112,0.8553601112323077,1.0,9/43,18.42%,TP73;TNFRSF1B;BCL2;DYRK2;BCL2L1;AEN;DDIT4;CIDEB;E2F1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.4641804819326616,-0.9044559567012254,0.5476190476190477,0.9983525931198761,1.0,5/22,13.78%,WNK4;ATP1B1;ACTN2;CFTR;AKAP9
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.32322296544151524,-0.9044513886711417,0.7017543859649122,0.997679990834377,1.0,44/280,16.18%,CKAP4;COPS6;ASB6;PSMB6;PSMD7;RAB8A;VWA1;LGALS1;PSME2;PSMD8;DCAF13;F5;FBXW10;BTBD6;ELOC;TF;MELTF;KNG1;ELOB;PSMB4;PSMD3;AFP;PSMB3;CCDC22;PSME1;KBTBD8;SDC2;GPS1;PSMA7;UBE2M;KLHL20;SPSB3;PSMB8;PSMD13;FEM1A;KEAP1;FBXW8;ASB5;COPS5;ERCC8;APLP2;PSMD2;MEN1;NUCB1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.4820549004950562,0.904076424319691,0.6363636363636364,0.8560271166369271,1.0,3/13,15.78%,GPLD1;SCARB1;ABHD5
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.3918009574294823,0.9039267244397885,0.6744186046511628,0.8559438720170057,1.0,9/52,15.46%,LPL;TLR2;WNT5A;NFKBIA;TNFRSF1A;CX3CL1;NFKBIZ;IL17RA;IL33
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),0.5428256424977145,0.9039149675112411,0.5925925925925926,0.855594989763979,1.0,3/6,3.38%,VSIR;NCKAP1L;IL12A
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.39809805872541215,-0.9038989822053489,0.6721311475409836,0.9982331293053847,1.0,2/71,0.51%,NGF;DDIT3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.45259545209283353,0.9036417642603525,0.5714285714285714,0.8557935435413784,1.0,9/18,25.08%,NOS1;DIP2B;TADA2A;PPARGC1A;ARRB1;RPS6KA4;PAXIP1;RUVBL2;SOX4
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.38785667755110914,0.9033501676911321,0.5660377358490566,0.8559866088960685,1.0,12/58,18.53%,PPARG;LRFN5;MAPKBP1;IRAK3;FNDC4;TNFRSF1A;AOAH;CCN3;GPER1;PRKCD;ILRUN;NLRP3
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.4549139415124961,-0.9031106743204643,0.5789473684210527,0.9991665504645327,1.0,11/35,17.59%,PRELID1;UBB;OPRD1;SOD1;PRDX3;BAX;BAK1;PYCR1;ARL6IP5;BAD;PARK7
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.41117184565519005,0.9030221824249874,0.6153846153846154,0.8562644134887216,1.0,3/29,5.60%,EGFR;NOSTRIN;DDAH1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.5940333822121222,0.9027485246038072,0.7021276595744681,0.8563350852564238,1.0,2/7,15.50%,EPHA4;THY1
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.5869033122863826,0.9022622909487398,0.6326530612244898,0.8569147138604835,1.0,3/6,29.08%,ADARB2;NUDT16;ADARB1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.38109281753828583,0.9021751323194243,0.627906976744186,0.8567094341344318,1.0,7/48,6.12%,SLA;PTPRC;IKZF2;SELL;LCP2;CD53;TNFRSF1B
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.5165880965215962,0.9020936486340422,0.6727272727272727,0.8560929175062946,1.0,1/16,4.28%,CBLIF
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.5165880965215962,0.9020936486340422,0.6727272727272727,0.8560929175062946,1.0,1/16,4.28%,CBLIF
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.41928848365473154,0.9020877438966433,0.64,0.8557083294930394,1.0,7/33,13.06%,TLR2;KYNU;WNT5A;CIITA;DAPK1;CX3CL1;SYNCRIP
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.4888538582537947,-0.9019991745019628,0.6666666666666666,1.0,1.0,5/29,16.34%,GREM1;CCT2;PNKP;DKC1;PKIB
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.3368811690017666,0.9019934469619298,0.6511627906976745,0.8554351850932539,1.0,23/121,13.83%,EPHA3;ST7;HEY1;CASZ1;GCM1;BMPR1B;ID2;SCIN;DLX1;BCL6;MAFB;NOTCH4;HOPX;GNB3;CDK5R1;YWHAH;NREP;CBFB;LGALS3;CEBPD;FES;APC2;RPS6KA3
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.5756234725185372,0.9016088557090621,0.6097560975609756,0.855844440111391,1.0,3/5,38.07%,GOLPH3;SORL1;VPS13A
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5555288517922725,0.9012551564420732,0.6153846153846154,0.8562110427609642,1.0,1/8,0.91%,VSIR
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3821065364319069,0.9012405769360617,0.5306122448979592,0.8558693578177948,1.0,13/42,17.09%,CARMIL1;EFNA5;FBLN1;DMTN;CORO1C;CSPG5;KANK1;RAC3;ITGB1BP1;DOCK5;CASS4;ARHGEF7;DOCK1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.39578189572181904,-0.9007985943741139,0.6,1.0,1.0,15/83,18.37%,RPS3;NCL;GAPDH;RACK1;DHFR;RPL13A;MEX3D;BTG2;ILF3;EPRS1;EIF2AK3;CALR;PCIF1;YBX1;TYMS
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.4669460771974957,0.9004768540644781,0.6511627906976745,0.8570964084163478,1.0,3/19,10.88%,FMO5;ACADL;GNB3
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.3584565216219452,0.8997719935557489,0.5769230769230769,0.8582009530752771,1.0,24/91,13.33%,FIGN;EGFR;FSTL1;CSPG4;LOX;LAMC1;DDAH1;GPR176;CHST3;COL12A1;TENM3;MEIS3;TEAD1;COL4A1;ADAMTS15;NUAK1;ANTXR1;AMOTL1;LAMB2;PCGF2;NR2F2;GPC1;LRP4;P3H4
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.41101661401113876,0.8992798435052205,0.6888888888888889,0.8588296525444973,1.0,2/36,2.92%,LPL;ADCY8
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.3900289500470636,0.8992173330068157,0.7142857142857143,0.8585559668232019,1.0,14/73,9.99%,SSTR1;KALRN;CNTN3;RHOJ;FGF14;SORBS2;CADPS;PDGFRA;CNTN4;GABRA2;SLC4A4;GIPC2;DENND2A;EDNRB
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.5232418574388502,0.8991583392189519,0.6296296296296297,0.8582719831003713,1.0,1/8,4.94%,KYNU
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.39310284549228014,-0.8991259637001682,0.6206896551724138,1.0,1.0,7/72,9.46%,ORC1;PCNA;CDK4;TFDP1;DHFR;CDK15;ACVR1B
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.35051040242540166,0.8990669029993704,0.6590909090909091,0.8580567516580071,1.0,36/169,11.00%,SHISA6;HTR5A;ITGB4;GRM5;C1QL2;ADCY8;NRXN1;GFAP;SYNPR;ST8SIA3;RAPGEF4;EFNB3;SORBS1;SLC1A2;PRKCZ;MPPED1;RGS7BP;ADCYAP1R1;NTRK2;OPCML;TNR;ASTN1;CDH22;CA10;EPHB1;SNCB;CADM3;MAPK4;PTPRT;ARRDC2;ATP2B2;PHYHIP;NCAN;IGSF21;SPARCL1;PSD2
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),-0.6039753403534491,-0.8989838328200284,0.6862745098039216,1.0,1.0,1/5,4.98%,LPA
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.35828303243591686,0.8988021854223193,0.5777777777777777,0.8581840508912216,1.0,10/65,13.95%,ANGPT1;LRRK2;BIRC3;PRICKLE1;AMER1;LAPTM5;DCUN1D4;FANCI;CUL3;PIAS1
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.3792882071840656,-0.8987998773476943,0.6491228070175439,1.0,1.0,4/82,2.01%,NGF;CRYAB;TEAD3;NES
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.5005010298308303,0.8987365262544382,0.5428571428571428,0.857895349636963,1.0,1/13,1.98%,MDFIC
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.5152005399057203,0.8985410228623558,0.5957446808510638,0.8578436979638384,1.0,2/7,24.66%,TRIM27;SERPINB9
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),0.6442795967568714,0.8985142467880333,0.6595744680851063,0.8575185886017134,1.0,2/5,24.50%,ZNF473;LSM11
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.4678077784575626,0.8984874527801986,0.5686274509803921,0.8571832547031539,1.0,6/20,13.67%,SULT4A1;SULT2A1;PPA2;DDO;MTARC2;SULT2B1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.41757971964221574,0.8983082315047773,0.6170212765957447,0.8571582647437389,1.0,7/23,13.37%,VSIR;GRIN2B;EPHA4;GRIN1;EFNA3;CR1;LYN
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.45691674441056895,-0.898194545585938,0.6181818181818182,1.0,1.0,6/22,19.40%,NDC80;NUMA1;DYNLT1;SAPCD2;DCTN1;PKHD1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.42238398215347495,0.8980431569786078,0.6226415094339622,0.8573276452569394,1.0,9/27,17.34%,VSIR;IGF1;PTPN6;LILRB1;IRAK3;CX3CL1;HAVCR2;GAS6;ILRUN
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5210641630754336,0.8980172770586624,0.6222222222222222,0.8569875944433193,1.0,1/11,0.08%,CREB3L1
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.6036519731317237,0.8976169265329151,0.6833333333333333,0.8572985953908471,1.0,2/5,32.26%,CHD7;DRD2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.5544430339370529,0.8974269107096584,0.6428571428571429,0.8573103180477306,1.0,2/6,14.70%,HES1;VEGFA
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.3972367518193077,0.8972298611025722,0.5476190476190477,0.8573639766966835,1.0,4/36,13.03%,GFAP;SNCAIP;IRGM;PTPN11
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.5090755608370925,-0.8970849523429882,0.5614035087719298,1.0,1.0,2/12,11.87%,HLA-DRA;B2M
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.4440587456425904,0.8970447685135695,0.6346153846153846,0.8572918043065894,1.0,3/21,8.15%,COL11A1;COL12A1;COL7A1
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.42547509468772643,0.8970412242944934,0.574468085106383,0.8569158549504888,1.0,5/27,5.71%,IGF1;PID1;SORBS1;IRS1;RHOQ
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.37472561084508066,-0.8968524793319745,0.6086956521739131,1.0,1.0,11/46,18.94%,FUCA1;GBA3;GLA;SMPD2;PIGW;SCCPDH;ESYT1;GLTP;CPTP;SMPD1;NEU4
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.5541935391073044,0.8965538271467299,0.6346153846153846,0.8575822658982164,1.0,1/9,1.62%,CHST1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,0.3531078013555957,0.8959100647427874,0.7894736842105263,0.8584993160707621,1.0,18/99,8.06%,PLAC8;SLA;CX3CR1;FGL2;PTPRC;VCAN;NR4A3;LCP2;ITGAM;CD53;SEPTIN6;BTLA;TNFRSF1B;LILRB1;WDFY4;LY86;ETV6;AXL
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.4231144137210053,-0.8957404186250261,0.5932203389830508,1.0,1.0,3/34,2.23%,JUP;SFRP1;CCL28
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.4175947445630467,-0.8957029419823281,0.5192307692307693,1.0,1.0,1/36,0.24%,BMP5
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.5075429288398651,0.8955958853658562,0.6666666666666666,0.8588139107013165,1.0,5/11,14.21%,LOXL3;DMTN;BST1;PRKD1;ITGB1BP1
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.5761992475687213,-0.8955907445700961,0.6428571428571429,1.0,1.0,2/6,20.36%,SYAP1;PINK1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.391104527469721,0.8954059433519341,0.6666666666666666,0.8588196950198312,1.0,4/50,8.88%,LPL;ACSM1;ELOVL4;OSBPL3
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.42365361656494155,0.8951629740587959,0.574468085106383,0.8589091065212874,1.0,2/29,3.25%,AQP1;MAP3K5
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.3514615791286175,0.8949671143064205,0.6521739130434783,0.8589461917046195,1.0,10/102,10.43%,IFNA2;EGFR;NCKAP1L;GRM5;LDB2;KDM4D;HSPB1;CDKN2A;CORO1C;NUP43
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.40452828353176196,0.8948107187218367,0.6923076923076923,0.8588579067510512,1.0,6/50,8.57%,PPARG;CSF1R;PDE1B;PIR;LEF1;CD4
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.4897504927466082,0.8947991569235186,0.6296296296296297,0.8584930362151889,1.0,3/10,13.89%,FAP;FZD3;BCL2L1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.4560296864454362,0.894505935844531,0.5416666666666666,0.8586659181558769,1.0,3/16,4.59%,AKAP12;LRRK2;ADGRV1
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.5826253884034478,-0.8942798695757908,0.68,1.0,1.0,1/8,7.32%,GLYATL1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.459717065399649,-0.8942528517668975,0.6379310344827587,1.0,1.0,1/21,0.38%,LCK
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.4816263045027432,-0.8938810692195428,0.6590909090909091,1.0,1.0,7/23,20.36%,UBB;PSME2;PSME1;RHBDF1;PRKACA;TMF1;PINK1
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.5023842919436076,0.893861527742544,0.6170212765957447,0.8596313954956334,1.0,3/13,3.38%,VSIR;NCKAP1L;IL12A
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.5454688856641916,-0.8938179405412298,0.5686274509803921,1.0,1.0,2/6,25.01%,TRDN;RYR1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.4335035253193429,-0.89378642671722,0.5319148936170213,1.0,1.0,1/30,0.24%,BMP5
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.5009582705791102,-0.8933342543882345,0.6086956521739131,1.0,1.0,2/12,6.14%,PAX8;USH1C
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.4599126713887114,-0.8932143176903395,0.56,1.0,1.0,2/18,9.87%,CDKN1C;HEXIM1
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),-0.5066765075774555,-0.8922865750655818,0.5932203389830508,1.0,1.0,2/8,16.04%,THAP4;GSTZ1
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.534023271624376,-0.8922505300995849,0.5952380952380952,1.0,1.0,1/8,3.91%,PCNA
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.534023271624376,-0.8922505300995849,0.5952380952380952,1.0,1.0,1/8,3.91%,PCNA
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.6017071968881662,0.8922331872707547,0.6363636363636364,0.8624779629349317,1.0,1/6,8.99%,LAPTM5
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.3918510111342889,-0.8918061932428345,0.6101694915254238,1.0,1.0,6/60,9.75%,OOEP;PLK4;RACK1;EVI2B;CALM1;TXNIP
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.46287105027407643,0.8917432009212454,0.6296296296296297,0.8631074066809655,1.0,6/16,15.53%,KLF9;ZFP36;PRKD1;CDH3;ZFP36L1;PTPRK
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5507492171388313,0.891693641736747,0.6530612244897959,0.8627935493533776,1.0,3/7,19.64%,ARRB2;ADRB2;ARRB1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.4228956378263697,-0.8916025369560489,0.603448275862069,1.0,1.0,9/30,16.27%,FIS1;BAX;BAK1;IFIT2;TIMM50;THEM4;IFI6;GGCT;BAD
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.575995872943383,-0.8915430291173777,0.6326530612244898,1.0,1.0,3/7,20.07%,PARP1;PRIMPOL;MGME1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3401678378489644,0.8914863258060015,0.7021276595744681,0.8628860554834638,1.0,28/140,12.83%,ETV1;IGFBP3;CSF2RA;GUCY1A1;SNAP25;GALNT3;LAT2;AKAP12;IKZF1;PTPRR;BIRC3;ITGBL1;PRKG2;C3AR1;ID2;RELN;TNFRSF1B;SPON1;SOX9;LAPTM5;MAFB;TMEM176B;SPARCL1;NAP1L2;KCNN4;TSPAN7;PRRX1;TSPAN13
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5068570424272452,0.8913334659354032,0.5909090909090909,0.8628275658613749,1.0,1/10,3.25%,MAP3K5
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),-0.5863296584553963,-0.8912796777903629,0.7,1.0,1.0,2/5,14.99%,IDI1;PMVK
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.39503804807878645,-0.891068044807475,0.6666666666666666,1.0,1.0,12/63,15.01%,ZDHHC12;NACA;GRIN3B;MYO1C;NACAD;ZDHHC14;NPC1;GORASP1;YIF1B;SYNE3;GORASP2;RABGEF1
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.48148579132851516,0.8907610356224154,0.7105263157894737,0.8635285665417148,1.0,3/15,11.68%,MEF2C;BASP1;ZBTB18
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.5243497385946532,0.8904138589473511,0.6274509803921569,0.8638078020416785,1.0,1/9,2.85%,NHEJ1
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.5879949419861838,0.8899488709645303,0.7027027027027027,0.863804500873986,1.0,2/6,14.70%,SFTPD;VEGFA
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.5879949419861838,0.8899488709645303,0.7027027027027027,0.863804500873986,1.0,2/6,14.70%,SFTPD;VEGFA
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.4762637172158117,-0.8899438060227887,0.631578947368421,1.0,1.0,4/19,12.85%,NT5C;PRPSAP2;DNPH1;ITPA
prerank,GO_Biological_Process_2021__skin morphogenesis (GO:0043589),0.5962105340815027,0.8899384439190088,0.6862745098039216,0.8634341874777758,1.0,1/5,2.12%,ITGB4
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.5719325611255197,0.8899331532103845,0.6885245901639344,0.8630590101715904,1.0,1/5,2.30%,GRM5
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.42280461780161693,0.8896289314448074,0.6222222222222222,0.86320295245954,1.0,4/29,8.42%,DACT1;HIPK3;PER1;DUSP10
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.3249358044579964,-0.8896083181310189,0.7333333333333333,1.0,1.0,36/274,14.45%,TUBA1A;DYNLRB1;KIF3B;SSNA1;EXOC7;PLK4;RAB8A;ABLIM3;DYNLL1;TUBB4B;CNGB1;TUBG1;TUBB4A;DCTN3;CNGA4;FBF1;TMEM107;PTPDC1;IFT81;INTU;CFAP70;CEP131;TMEM138;TTC36;MKS1;SNAP29;RSPH4A;CFAP43;TTLL3;WDR90;TUBB;DYNC1H1;HAUS6;AKAP9;BBS10;ARL13B
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.5372330572384793,0.8894438810757315,0.6666666666666666,0.8632378702599254,1.0,4/8,13.98%,DDAH1;SLC2A5;BMPR2;PLCB3
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4771220505339415,0.88934704468239,0.625,0.8630135909826887,1.0,5/17,15.50%,PTPRJ;LAPTM5;SLA2;LGALS3;THY1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.2803416125282886,0.8890972435367367,1.0,0.8631366391556771,1.0,155/905,17.20%,FLI1;ETV1;PLAC8;IFNA2;PDGFB;NPAS2;ZNF423;PPARG;BMP6;PLSCR1;EGFR;TP73;FOSL2;GRHL1;IGF1;FOS;TLR2;MDFIC;MLIP;HNF4G;HEY1;MAP3K5;MEF2C;CASZ1;PLCB1;PID1;GCM1;UHRF1;LDB2;E2F3;NR4A3;MET;HGF;BMPR1B;BCL11B;NR2F1;ATF1;KAT2B;CITED2;MAFF;ID2;PPP3CA;PRDM15;KLF15;RHOQ;MACC1;PLAGL1;MAP2K5;WNT5A;LILRB1;LMO7;RARB;DLX1;PBX1;CIITA;MEIS3;NFKBIA;SOX9;GRIN1;ETS2;PER1;LEF1;TEAD1;LMO2;TAL1;ZBTB16;TESC;MEIS2;NOS1;CLOCK;CD4;PTPRN;KDM3A;EPAS1;STAT6;TP63;AGRN;ZGLP1;MAFB;GLIS3;TGFB3;NOTCH4;TBL1XR1;TASP1;NR1I3;BCL9;ARNT;CREB3L2;TNFRSF1A;SATB2;PRKD1;BMPR2;ZNF304;ELK3;YWHAH;ZBTB18;HES1;CX3CL1;ZNF516;PARP9;NCOA7;NR2F2;POU2F2;FHOD1;PIK3R1;ZXDA;CD80;SCAF8;RGMB;MRTFB;RPS6KA3;CDH13;KAT6B;RFX3;ITGB1BP1;CREB5;NCOA1;GRHL2;ONECUT2;CAMK4;MED14;VEGFA;GLIS1;RPRD1B;KCNH2;RFXANK;TOX2;CSRNP2;THRB;WWOX;GPER1;IL33;ACVR2A;KLF6;CRX;RPTOR;JUNB;NLRC5;CKAP2;SSBP4;SMARCA2;SMARCA1;NFIA;RXRG;KDM6B;PFKM;PPARGC1A;NDP;CRLF3;KAT2A;MLLT11;NCOA6;TP53INP1;DYRK1B;PCGF5
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.45798930704857793,-0.888820043468762,0.6222222222222222,1.0,1.0,3/26,4.53%,GPC4;VAMP8;GPC2
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.49162659239583084,-0.8885196117791132,0.5434782608695652,1.0,1.0,5/18,12.98%,PCNA;POLD3;MCM4;POLE3;MCM3
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.5694687030605745,-0.8884684770795027,0.7021276595744681,1.0,1.0,1/8,3.53%,VAMP8
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.3304438116362693,-0.8883013475459552,0.6923076923076923,1.0,1.0,46/350,10.98%,ABCA13;FTL;CKAP4;JUP;FUCA1;CNN2;EEF1A1;ARPC5;TRAPPC1;FTH1;DEGS1;VAMP8;PSMD7;ITGAL;CSTB;TMEM179B;DYNLL1;PPIE;TUBB4B;GSTP1;SRP14;C6ORF120;RHOG;CCT2;LILRB3;CD63;CREG1;ADGRE5;NPC2;GLA;HLA-C;PGAM1;TARM1;RHOA;DYNLT1;AGA;MMP25;PSMD3;HSPA8;CYB5R3;HLA-B;ILF2;COMMD9;RAB31;DDOST;ANXA2
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.4546048704296634,-0.888268329388532,0.6363636363636364,1.0,1.0,4/28,11.70%,NCL;RBM22;POLR2A;SF3B4
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),0.5054080003081348,0.8882106578883493,0.5471698113207547,0.8645387354190024,1.0,1/8,6.68%,OGFOD1
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.41537267592540555,-0.8881977644033507,0.6274509803921569,1.0,1.0,7/30,11.32%,NDC80;CHAMP1;TUBG1;RAN;KIFC1;SGO2;MIS12
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.3302707510042946,-0.888090244469342,0.676923076923077,1.0,1.0,46/353,10.98%,ABCA13;FTL;CKAP4;JUP;FUCA1;CNN2;EEF1A1;ARPC5;TRAPPC1;FTH1;DEGS1;VAMP8;PSMD7;ITGAL;CSTB;TMEM179B;DYNLL1;PPIE;TUBB4B;GSTP1;SRP14;C6ORF120;RHOG;CCT2;LILRB3;CD63;CREG1;ADGRE5;NPC2;GLA;HLA-C;PGAM1;TARM1;RHOA;DYNLT1;AGA;MMP25;PSMD3;HSPA8;CYB5R3;HLA-B;ILF2;COMMD9;RAB31;DDOST;ANXA2
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.3720166146800017,-0.8880867930613618,0.6140350877192983,1.0,1.0,9/85,7.17%,CXCR4;PDE6A;GUCA1C;CNGB1;LACC1;METAP2;NLRP1;FNTA;CALM1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.4909912261598065,-0.8877720059576114,0.6,1.0,1.0,1/12,5.02%,BHLHE41
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.3399243900239117,-0.8875108102594074,0.7068965517241379,1.0,1.0,31/203,16.64%,RPS27A;UBC;ARPC5;UBB;GRIN3B;MYADM;SUN3;VAMP8;AP2S1;TF;CHMP2A;ACTG1;PLEKHA3;CHMP5;CFTR;HSPA8;NPC1;SNAP29;UBA52;CLTB;SAR1B;CHMP3;TIMM50;HGS;REEP4;MTCH1;TRDN;GLTP;VAMP3;TOR1A;CPTP
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.47552170632732305,-0.8873902335379761,0.6538461538461539,1.0,1.0,4/21,11.01%,STMN1;MAP7D3;KATNB1;STMN3
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.4478154773038808,0.887356626001717,0.6136363636363636,0.8657170103302607,1.0,4/24,7.34%,TGFB2;KITLG;WNT5A;SOX9
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.5276486279848086,0.8872481276143714,0.673469387755102,0.8655799980352209,1.0,4/11,8.99%,TNFRSF1B;WNT5A;LILRB1;LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.5930471202173654,-0.8872440079306683,0.6071428571428571,1.0,1.0,2/6,6.63%,VAMP8;SPHK2
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.5261653808324038,-0.8870524826104024,0.5961538461538461,1.0,1.0,1/12,6.73%,RAN
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.4341773763936366,-0.886874067965678,0.6346153846153846,1.0,1.0,2/38,5.18%,UXT;TFDP1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.4807337499528864,0.8868415387690531,0.6444444444444445,0.8659913327475904,1.0,3/9,16.50%,KLF15;DIP2B;SETD5
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.43293492852496507,0.8866806368636191,0.6538461538461539,0.8658749990448804,1.0,1/19,1.88%,TRIM5
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.5418569217281666,-0.8864836086926503,0.7111111111111111,1.0,1.0,1/8,4.25%,GPX4
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.3986939534222669,0.8863987244368742,0.6122448979591837,0.8659861335766523,1.0,6/55,12.07%,MAP3K5;PLCB1;SH3RF3;TIRAP;ANKRD6;MTURN
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.3565903614415088,0.886251017149102,0.6222222222222222,0.8659060601911861,1.0,17/75,13.93%,TGFB2;ITGB4;LOX;COL11A1;COL5A3;COL12A1;LOXL3;COL20A1;COL4A1;COL7A1;P3H2;COL15A1;COL9A1;P4HA1;COL22A1;P3H4;COL5A1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.6013592144918043,-0.8860024218583508,0.6842105263157895,1.0,1.0,1/6,1.48%,STAC3
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3176571090741183,0.8857267072474156,0.8157894736842105,0.8665023948539129,1.0,17/183,9.68%,ROR1;CX3CR1;PPARG;TLR2;TRIM5;ADCY8;CAMK1D;PRKCZ;RELN;WNT5A;NFKBIA;LRP8;TIRAP;CLOCK;IL1RAP;NOD1;IRAK3
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.36122916989416237,-0.885696125431653,0.6153846153846154,1.0,1.0,20/68,15.45%,TAX1BP3;S100A16;BACE2;CLCA2;CD9;DUOXA1;ALKBH7;CDC42EP5;METTL5;LAMB3;MYO1C;DNPH1;ANXA2;MT1E;TMEM54;EHF;DUSP23;ILK;RRAS;SH3RF2
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.5740460865443234,0.8856256217135705,0.6122448979591837,0.8662776680375514,1.0,4/8,24.36%,CDK12;CDK13;CCNH;CDK7
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),-0.5485531288011187,-0.8855083120298289,0.5818181818181818,1.0,1.0,1/6,13.44%,EPHB2
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.406473358113925,-0.8854912182008541,0.6444444444444445,1.0,1.0,13/58,20.90%,RNF8;H2AX;DCLRE1B;BRCC3;KAT5;ABRAXAS1;ERCC8;MDC1;HMGB1;XRCC6;UBE2N;PAXX;PRKDC
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.44851513149026756,0.8854603255509509,0.574468085106383,0.8662027305488156,1.0,2/19,3.54%,CREB3L1;LRRK2
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.3726640222606777,0.8853568574735435,0.6976744186046512,0.8660350487410936,1.0,17/42,25.75%,IL12A;MAPKAPK3;TIRAP;NOS1;IRAK3;ERBIN;RPS6KA3;NOCT;NOS2;GGT5;FER;LBP;LY96;HMGB2;SRR;PELI1;LGALS9
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.31902790520207347,-0.8853220875528428,0.7704918032786885,1.0,1.0,55/346,18.01%,TEAD2;DDIT3;WWC2;THAP1;EDF1;DRAP1;SPIN2B;PPIE;LMX1B;ZNF676;ZNF22;NKX6-2;ZNF664;ZNF492;MLX;MYBBP1A;MLF1;RPL6;HES6;POLR2A;PCGF1;ZSCAN21;ACVR1B;PATZ1;SLC2A4RG;HMGA2;CDK11A;IGSF1;ZFHX3;CDK11B;ZNF117;AHR;SOX15;PRDM8;RNF6;DAXX;CTR9;SBNO1;TCF7L1;CARM1;ACTR8;ZNF221;FADS1;THAP7;SAP30;NR5A2;CALR;HMGN5;ING2;ENG;ATF4;ATXN1L;REXO4;UBE2L3;YBX1
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.4191156881637963,0.8853089596506308,0.6,0.8657386673719972,1.0,10/28,18.55%,CITED2;ODAD3;DNAH11;DNAI2;RFX3;ARL6;DNAAF1;MKKS;PKD2;CFAP53
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.5506273342596834,0.8850870149515407,0.6511627906976745,0.8658083085808385,1.0,1/6,6.63%,HOOK1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.3999294364888531,0.8850004822814002,0.6326530612244898,0.865574077531733,1.0,6/33,7.62%,P2RY12;ACTN1;MEGF11;PDGFRA;TJP2;HSPB1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.31648440121349236,0.8842966594391403,0.782608695652174,0.8666062367235725,1.0,33/230,14.46%,CD59;NCKAP1L;ADCY8;LRRK2;ADD2;LAMC1;RSPH9;GRIA1;ANO6;SOX9;LEF1;TEAD1;DMD;COL7A1;SLC7A9;AMER1;IL1RAP;VIL1;LIN7A;DMTN;BCL9;TNFRSF1A;TGFA;CSNK1D;DLG4;HES1;CX3CL1;ANKRD28;SHANK1;CUL3;ITGB1BP1;TLE3;FANCC
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.40393688641028186,0.8842426087311342,0.62,0.8663152684723499,1.0,2/39,1.80%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.48160148067753045,-0.8838889783367732,0.6111111111111112,1.0,1.0,4/11,15.28%,CFL2;CFL1;TWF1;GSN
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.3952960548457626,-0.8836018571853813,0.6111111111111112,1.0,1.0,3/53,1.44%,DDIT3;CRTAM;BTN3A1
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.4939428030041609,0.8835731945988644,0.6938775510204082,0.8672742066500304,1.0,3/18,10.15%,LPL;SLC2A5;GPLD1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.4520241699046115,0.8832952220652603,0.6122448979591837,0.8674149910040688,1.0,3/20,11.80%,DLX1;BCL9;NREP
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.3694989460737885,-0.8831952350736368,0.6349206349206349,1.0,1.0,23/96,18.95%,DDIT3;SELENOK;SELENOS;ATF3;UFC1;FICD;RASGRF1;USP19;CFTR;ATP2A3;BAX;BAK1;ERLEC1;GORASP2;UFL1;EIF2AK3;ATF6B;PDIA3;ATF4;CREB3L3;JUN;RASGRF2;P4HB
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.40561634588071016,0.8829589821528346,0.575,0.8676481386704279,1.0,3/27,8.55%,EGFR;PLCB1;CCND1
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.393024748164304,-0.8826353291893608,0.7884615384615384,1.0,1.0,7/62,7.06%,CXCR4;P2RY10;ITGAL;HSD11B1;KLRB1;EVI2B;PYHIN1
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.47883913979061365,0.8825462175042994,0.68,0.8680454311417747,1.0,1/16,0.76%,CDS1
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.40629041282078876,-0.8822740959415567,0.7166666666666667,1.0,1.0,8/47,12.90%,CELA2A;PAX8;CRHBP;PASK;ITPR2;GCK;FFAR1;HNF4A
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.4107515697501712,-0.882204485703834,0.6206896551724138,1.0,1.0,11/44,17.64%,SQLE;SOAT2;FDXR;SC5D;LIPA;CYP4V2;TM7SF2;PMVK;MSMO1;PIP4P1;CYP7B1
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.5101991814533741,0.8816868825997763,0.6666666666666666,0.8692637596937,1.0,3/13,14.12%,PGAM5;ITPK1;MLKL
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.43840467773563857,-0.8816692978536939,0.6206896551724138,1.0,1.0,2/23,0.53%,LCK;CD38
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.519291857081694,-0.8813207840085421,0.6557377049180327,1.0,1.0,1/7,1.51%,SFRP1
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.44741284038770346,0.8812141353971397,0.6875,0.8698549957567835,1.0,2/26,5.60%,CX3CR1;DDAH1
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.4539451981321303,0.8812019906325576,0.5853658536585366,0.8691133226130918,1.0,4/17,9.33%,ADD2;TWF2;SCIN;VIL1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.4539451981321303,0.8812019906325576,0.5853658536585366,0.8691133226130918,1.0,4/17,9.33%,ADD2;TWF2;SCIN;VIL1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.5515993923320138,-0.881040498972652,0.66,1.0,1.0,4/8,22.01%,PGP;GK5;TKFC;COQ3
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.37233982369836854,0.8809103508829006,0.6065573770491803,0.8693194995400902,1.0,6/41,13.15%,GRM5;CYFIP1;PER1;PARP9;NANOS3;PUM1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.42162546889758423,0.8808954783552579,0.6744186046511628,0.8689825143748526,1.0,2/23,8.60%,ANGPT1;FBLN5
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),0.4946260499593147,0.8807521209893553,0.6557377049180327,0.8689325562877483,1.0,3/14,12.18%,CD44;HEXB;LYVE1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.4475683264473287,0.8807307841623009,0.7333333333333333,0.8685806779019515,1.0,3/19,6.76%,PTPRC;LILRB1;PTPRJ
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),-0.5758323805269218,-0.8794182626765865,0.6981132075471698,1.0,1.0,1/6,4.76%,NUTF2
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.4516997421933015,-0.8793203976547623,0.5869565217391305,1.0,1.0,2/18,6.77%,BHLHE41;SMYD1
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.5584466704633666,-0.8790684971211566,0.6470588235294118,1.0,1.0,1/5,6.10%,HMGCL
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.615002698669122,-0.8789754716664346,0.6981132075471698,1.0,1.0,1/7,3.59%,NDC80
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.615002698669122,-0.8789754716664346,0.6981132075471698,1.0,1.0,1/7,3.59%,NDC80
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.3268644088569468,-0.8788412223900064,0.7230769230769231,1.0,1.0,46/352,10.98%,ABCA13;FTL;CKAP4;JUP;FUCA1;CNN2;EEF1A1;ARPC5;TRAPPC1;FTH1;DEGS1;VAMP8;PSMD7;ITGAL;CSTB;TMEM179B;DYNLL1;PPIE;TUBB4B;GSTP1;SRP14;C6ORF120;RHOG;CCT2;LILRB3;CD63;CREG1;ADGRE5;NPC2;GLA;HLA-C;PGAM1;TARM1;RHOA;DYNLT1;AGA;MMP25;PSMD3;HSPA8;CYB5R3;HLA-B;ILF2;COMMD9;RAB31;DDOST;ANXA2
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.587590124874019,0.8787462867335248,0.7111111111111111,0.871820401282254,1.0,3/6,25.34%,GHR;STAT5A;STAT5B
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.4623907234134025,0.8787166085346659,0.6,0.8714726885276263,1.0,1/12,2.66%,CAMSAP3
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.5680587627420748,0.8786457371459879,0.7555555555555555,0.8711968366231604,1.0,2/5,27.25%,AFG1L;BNIP3L
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.432566871835389,0.878584467643248,0.7272727272727273,0.8709416605701931,1.0,9/26,15.92%,PKP2;KCNJ3;CACNA1G;SCN3B;CAMK2D;KCNH2;CACNB2;SCN4B;BIN1
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.3008247303300766,0.8785176502372999,0.9459459459459459,0.870696919609111,1.0,38/393,9.75%,FLI1;IFNA2;PDGFB;NPAS2;ZNF423;PPARG;EGFR;TP73;IGF1;FOS;MDFIC;HEY1;MAP3K5;MEF2C;CASZ1;PLCB1;GCM1;CITED2;ID2;WNT5A;CIITA;SOX9;ETS2;LEF1;TEAD1;TAL1;ZBTB16;TESC;NOS1;CLOCK;CD4;KDM3A;TP63;MAFB;TGFB3;NOTCH4;TBL1XR1;TASP1
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.3301842952361889,0.8784114064236002,0.6976744186046512,0.8704779143473813,1.0,9/75,9.33%,KANK2;PPARG;BDH2;DACT1;LOXL3;SOX9;TIMELESS;NDRG4;VIL1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),-0.5718500035540032,-0.8781555376224646,0.6428571428571429,1.0,1.0,2/5,20.71%,CD81;RNF128
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),0.5667313908550795,0.8780421564118033,0.6938775510204082,0.8707693500792388,1.0,1/5,21.61%,RAD54L
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.5176518941416708,-0.878017900751865,0.6111111111111112,1.0,1.0,1/11,1.37%,MBOAT1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.3954999644540419,0.8779038104546759,0.6122448979591837,0.8705913055099538,1.0,6/45,6.99%,EPHA3;DPP10;EGFR;SORBS1;STAC2;STX3
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.48412026361601374,0.8778194428766521,0.574468085106383,0.8703777283452909,1.0,1/12,1.17%,PTPRC
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.5452136783434609,0.877742759036262,0.6190476190476191,0.870128664691559,1.0,1/8,3.54%,LRRK2
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4674051977184801,0.8777395733318933,0.6222222222222222,0.8697626615528568,1.0,2/13,3.12%,PKP2;SLC8A1
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),0.5773755827683911,0.8777228555588028,0.6041666666666666,0.869422432190499,1.0,2/5,24.87%,SLC7A8;SLC6A9
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.4474968638626448,0.8776918697063445,0.6037735849056604,0.8691079432043435,1.0,2/20,5.49%,ITGAM;ARHGAP25
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.37314859962777025,0.8774442204542323,0.6481481481481481,0.8690633416133159,1.0,5/41,10.68%,ST8SIA3;B3GALNT1;B4GALT6;HEXB;ST6GALNAC5
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.4498336225371494,0.876597008576596,0.6041666666666666,0.87015779507149,1.0,7/19,28.44%,BIRC3;MLKL;OGT;SDCBP;PELI1;CASP8;CFLAR
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.3837126608712015,-0.8765011426037634,0.6078431372549019,1.0,1.0,17/79,18.37%,RPS3;NCL;GAPDH;ORMDL2;ORMDL1;RACK1;DHFR;RPL13A;BTG2;ILF3;EPRS1;CHRNA7;EIF2AK3;CALR;PCIF1;YBX1;TYMS
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.44437167318630044,-0.8762616275694426,0.6226415094339622,1.0,1.0,3/32,10.82%,GAPDH;PGAM1;GCK
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.48797120674276695,0.8757837030304008,0.6,0.8710229377125955,1.0,6/14,20.20%,SRC;DMTN;CORO1C;ITGB1BP1;PHLDB2;PTEN
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.48797120674276695,0.8757837030304008,0.6,0.8710229377125955,1.0,6/14,20.20%,SRC;DMTN;CORO1C;ITGB1BP1;PHLDB2;PTEN
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.5664128925769814,-0.87548145947876,0.7543859649122807,1.0,1.0,2/8,23.23%,ERLIN2;ARHGEF10L
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.5664128925769814,-0.87548145947876,0.7543859649122807,1.0,1.0,2/8,23.23%,ERLIN2;ARHGEF10L
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),-0.5780312302705507,-0.8753347555133688,0.675,1.0,1.0,1/5,6.73%,RAN
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.41142906218066294,-0.8748850833440636,0.6551724137931034,1.0,1.0,4/44,8.48%,NGF;PIK3C2G;GPR143;RHOA
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.42452014945134986,-0.8748603793303714,0.5818181818181818,1.0,1.0,3/32,5.02%,CCDC78;STAC3;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.4648703900852384,-0.8747940261159309,0.6382978723404256,1.0,1.0,3/27,4.75%,PRELID1;ACAA2;SLC25A5
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.41479965788209183,0.874686109804598,0.7,0.8728971925581732,1.0,7/31,21.96%,LRRK2;KAT2B;CCP110;KAT2A;CAV3;LIMK2;MTM1
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),0.5780618674079032,0.8746756281718594,0.627906976744186,0.8725515626667738,1.0,2/5,22.49%,SLF1;IFFO1
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.49554270280880675,-0.8743658167270948,0.6904761904761905,1.0,1.0,1/11,1.54%,DPEP1
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.4121518785793488,-0.8742762937133857,0.6326530612244898,1.0,1.0,3/25,12.41%,CENPX;SMARCA5;NPM1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.4121518785793488,-0.8742762937133857,0.6326530612244898,1.0,1.0,3/25,12.41%,CENPX;SMARCA5;NPM1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.5419961367667915,-0.8740717721625326,0.6379310344827587,1.0,1.0,2/8,11.26%,ATP6V1G1;ATP6AP1
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.5235344434972247,0.8740686062931038,0.7555555555555555,0.8733174246330047,1.0,3/11,7.64%,IFNA2;PRKCZ;LEF1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),0.5553795060890112,0.8735882607420284,0.6363636363636364,0.8737478909536247,1.0,1/5,19.31%,LRP1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.38486171395662605,-0.8735843114623179,0.6557377049180327,1.0,1.0,4/83,2.35%,CXCR4;P2RY10;CCR3;JPH1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.34904500942809347,0.8734969966978356,0.6744186046511628,0.8735189415042746,1.0,7/60,11.51%,TBC1D10A;TWF2;ODAD3;DMTN;TRPM2;GAP43;TBC1D24
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.3574032679518625,-0.8725886038504863,0.6825396825396826,1.0,1.0,17/90,7.74%,TLN1;SELP;TAGLN2;SERPINE1;SELENOP;LGALS3BP;CD9;CYB5R1;F5;MAGED2;ACTN2;CD63;TF;SOD1;CALM1;KNG1;ANXA5
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.46981654673944917,-0.8723248528292836,0.5964912280701754,1.0,1.0,2/17,6.63%,PLPP2;SPHK2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.5938204814611703,0.8717387031845331,0.7333333333333333,0.8764725155083175,1.0,3/6,19.53%,DMD;DMPK;CAV3
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.5377207868900472,-0.8716351001250796,0.6349206349206349,1.0,1.0,1/11,0.38%,LCK
prerank,PanglaoDB_Augmented_2021__T Cells Naive,0.4159295477892774,0.8711433696764175,0.6666666666666666,0.8772758964852048,1.0,7/36,5.49%,SLA;PTPRC;SELL;IKZF1;LCP2;CD53;ARHGAP25
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.44184061293903687,-0.8710767934168497,0.625,1.0,1.0,2/16,8.26%,PPM1G;DUSP7
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.5491801924400668,-0.8710437394057539,0.6981132075471698,1.0,1.0,3/7,31.88%,VPS11;MSN;EZR
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.3589130081360865,0.8708651881103014,0.6818181818181818,0.877511526093436,1.0,10/64,9.41%,CX3CR1;MEF2C;TNFRSF1B;WNT5A;LILRB1;ZFP36;AXL;GIT1;VIM;IRGM
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.5548114440829702,-0.8706957505187926,0.7045454545454546,1.0,1.0,3/5,22.36%,GLYCTK;TKFC;KHK
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.5548114440829702,-0.8706957505187926,0.7045454545454546,1.0,1.0,3/5,22.36%,GLYCTK;TKFC;KHK
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.45084135832941413,0.8703548588284342,0.65,0.8780303619204122,1.0,3/19,9.79%,PKP2;FGF13;CAMK2D
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.44310988044646715,-0.8703143395868546,0.6458333333333334,1.0,1.0,3/35,1.61%,ARHGEF16;DPEP1;EFNA2
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.36729695931881484,-0.8702591895454319,0.75,1.0,1.0,11/66,15.90%,RNF8;H2AX;RAD51AP1;RFWD3;HUS1;BRCC3;BLM;KAT5;ABRAXAS1;TOPBP1;MEN1
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),-0.5075468111638733,-0.870202340033922,0.7391304347826086,1.0,1.0,5/13,29.09%,ENY2;NXF1;NUP93;NXF5;MCM3AP
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.4266137045615373,-0.8700042450287835,0.625,1.0,1.0,8/32,13.15%,ATP6V1F;ATP6V1G1;ATP6V1G2;TF;MCOLN1;ATP6V1E2;ATP6AP1;ATP6V0E1
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),0.5318343386563248,0.8699867246426802,0.7021276595744681,0.8783464043729263,1.0,6/10,19.76%,LRRK2;SRC;BCL2;FZD9;MLLT11;KDR
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.5758695600682266,0.8697623626649625,0.7291666666666666,0.8783638405899601,1.0,1/6,7.64%,LEF1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.40193573423302664,-0.8695461346233471,0.6666666666666666,1.0,1.0,4/43,2.01%,TEAD2;TEAD3;RPL10;NES
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.43662970283306907,-0.8693991780909964,0.6037735849056604,1.0,1.0,5/18,23.34%,TSPO;NFE2L1;PGRMC1;COX10;UROD
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.4380060356242197,0.8693126425840153,0.6046511627906976,0.8789119691636728,1.0,6/20,17.31%,PLSCR1;LPCAT4;PLA2G10;OSBPL5;PLA2G4A;MBOAT2
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.39318751985067707,-0.8692042082145848,0.5510204081632653,1.0,1.0,8/78,5.84%,PRELID1;PAX8;IFNLR1;DCXR;GREM1;CBR1;CHCHD2;CD63
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.3109666154134393,-0.8688998355604932,0.8253968253968254,1.0,1.0,61/383,18.01%,TEAD2;DDIT3;RPL10;WWC2;THAP1;EDF1;DRAP1;SPIN2B;PPIE;LMX1B;ZNF676;ZNF22;NKX6-2;ZNF664;ZNF492;MLX;MYBBP1A;MLF1;RPL6;HES6;POLR2A;PCGF1;ZSCAN21;ACVR1B;PATZ1;SLC2A4RG;HMGA2;CDK11A;IGSF1;GATA1;PDGFA;ZFHX3;CDK11B;ZNF117;METTL18;AHR;TCOF1;SOX15;PRDM8;RNF6;DAXX;CTR9;SBNO1;TCF7L1;CARM1;ACTR8;ZNF221;FADS1;THAP7;SAP30;NR5A2;CALR;HMGN5;ING2;ENG;ATF4;PCIF1;ATXN1L;REXO4;UBE2L3;YBX1
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.3714372862478889,0.8688007051668653,0.7272727272727273,0.8794495232682511,1.0,13/59,14.16%,MYO7A;SLC4A10;COL11A1;ADGRV1;PCDH15;ABLIM1;DRAM2;RPGR;CDH23;CRYBG3;TRPM1;BBS2;GRM8
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.3540345468516139,0.868499585567513,0.6222222222222222,0.8796482650404389,1.0,14/73,20.16%,NEDD4L;DACT1;TNFRSF1B;WNT5A;AMER1;WWP1;GPLD1;HECW1;APC2;TIPARP;CSNK2A1;SH3D19;SNX33;TRIM32
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.3129844615832013,-0.8684367692243387,0.8356164383561644,1.0,1.0,16/260,7.46%,POU3F1;NGF;RPL5;RPS3;RPL11;RPL23;RPS7;GREM1;SLC22A2;PDCL3;HOXD3;CD63;DNMT3B;ERP29;ACTG1;FAM98A
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.5798883984380105,-0.868367082176566,0.7291666666666666,1.0,1.0,2/5,11.43%,BEX4;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.5639445734512191,0.8681782811859455,0.6190476190476191,0.8799730329811669,1.0,5/7,32.51%,TFR2;BAG2;SOX4;CCBE1;RHBDD1
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.48045980142512307,0.8678319236240444,0.7045454545454546,0.8801865174146192,1.0,1/10,2.09%,NCKAP1L
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.4275786103337351,-0.8671752401164631,0.6226415094339622,1.0,1.0,5/26,14.43%,VCPKMT;ANTKMT;CSKMT;ZNF335;CTR9
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.5778907815530464,-0.867029422856451,0.7115384615384616,1.0,1.0,1/5,11.88%,ORAI1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.38589598607736675,-0.8669927629411216,0.7413793103448276,1.0,1.0,5/78,8.13%,NGF;RACK1;OPRD1;ARAF;CNKSR3
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.36504508464159646,-0.8669647546793812,0.6833333333333333,1.0,1.0,6/83,7.89%,CXCR4;CRYAB;SRL;ACTN2;SMYD1;NID2
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),-0.4667809393533917,-0.8667117643252907,0.6274509803921569,1.0,1.0,2/15,10.29%,INTS14;TOE1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.45313681292937524,-0.866478091089617,0.7307692307692307,1.0,1.0,7/19,28.22%,FIS1;PINK1;VPS35;RALA;MUL1;BNIP3;DCN
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.3206119374663697,-0.8664266342835683,0.7941176470588235,1.0,1.0,52/341,18.14%,RPS27A;UBC;SELENOS;RNF8;UBB;RNF212;ZNF598;PCNA;MARCHF2;UBE2D4;RACK1;UFC1;ELOC;RNF113A;CDC23;RRAGA;URM1;RNF181;ELOB;SDE2;TRIM60;TMEM129;CCDC22;TRIM52;KIAA1586;RFWD3;UBA52;RAE1;UBE2M;KLHL20;TRIM61;RNF6;DCAF15;MYLIP;KEAP1;CTR9;FBXW8;ASB5;UBE2Q2;UFL1;UBE2A;NUP37;VPS11;TRIM14;FBXL15;TRIM7;PEX10;TRIM28;UBE2L3;TRAF7;RNF41;ANAPC11
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.5710449749624876,0.8662970291903728,0.6666666666666666,0.8825281916851502,1.0,4/7,33.62%,SLC27A2;ALDH3A2;PHYH;HACL1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.514632761512716,0.8661965611924992,0.717391304347826,0.8823320483800734,1.0,5/11,8.24%,CLDN5;ANGPT1;DDAH1;PTPRJ;SH3GL2
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),-0.6126384458183098,-0.8657549037211946,0.75,1.0,1.0,2/5,12.24%,SLC52A2;FLAD1
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),-0.6126384458183098,-0.8657549037211946,0.75,1.0,1.0,2/5,12.24%,SLC52A2;FLAD1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.4383520654698865,-0.8657251753669719,0.6470588235294118,1.0,1.0,1/20,1.14%,CDKN1C
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.5197675651805683,-0.8657005320000537,0.6153846153846154,1.0,1.0,1/7,1.22%,CORO1B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.516828697357816,0.865531636841041,0.7017543859649122,0.8833303686182408,1.0,1/8,9.79%,CAMK2D
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),0.5400148657231755,0.865311869137103,0.6538461538461539,0.8833355327980487,1.0,1/5,13.66%,PLBD2
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.560168554553007,0.865215212025999,0.7142857142857143,0.8831644705190341,1.0,3/7,13.64%,ADGRE2;LYN;FES
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.4770805210385848,-0.8651226333035062,0.6727272727272727,1.0,1.0,1/12,0.24%,BMP5
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),0.5815443776989815,0.8646911950279798,0.68,0.8837887312257329,1.0,1/5,3.33%,CAMK1D
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.5332895891879192,-0.8646065343475282,0.6585365853658537,1.0,1.0,3/6,20.43%,MOCS1;NFS1;MOCOS
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),0.5574102206140966,0.8644861147732972,0.68,0.8838590910829658,1.0,1/7,0.81%,AQP1
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.4685647047602534,0.8644429462930694,0.6458333333333334,0.8835623126569753,1.0,1/11,2.99%,NEDD4L
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.3379484017099791,-0.864414726790908,0.7,1.0,1.0,27/189,19.22%,TPX2;BUB1;UXT;KIF3B;NDC80;KATNB1;NUMA1;CDC42EP1;CEP131;CCNB2;ARFIP2;ARHGDIA;WASF2;DYNC1H1;SHROOM1;KIF4A;LLGL1;ARL8A;KIF11;GSN;LRPPRC;KNTC1;CDC42;SMC1A;CENPF;RFC1;MAP1S
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.5335617661692886,0.8643692063630968,0.6363636363636364,0.8833110243669839,1.0,1/7,3.54%,LRRK2
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.5631361574884581,0.8643678971749459,0.7142857142857143,0.8829393700719177,1.0,3/5,25.50%,WDR48;OTUD4;TANK
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.4795046673540161,0.8641826993924685,0.6938775510204082,0.8828643328920921,1.0,3/16,8.59%,SIGLEC10;EPHA4;GIT1
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.5233180684908303,0.8641549279406879,0.6136363636363636,0.8825484045138852,1.0,2/7,15.48%,HEXB;OGN
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.4104898872773353,0.86400401341634,0.6346153846153846,0.8824986865640856,1.0,6/27,15.67%,AURKC;TAL1;KIF14;CUL3;PKP4;PRKCE
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.5333150645566715,0.863836177636698,0.6,0.8823988546983784,1.0,3/8,18.71%,PKIA;PRKAR1B;PKIG
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.46105864165929433,0.8638167393543011,0.6956521739130435,0.8820534467664303,1.0,2/16,1.41%,SSTR1;EGFR
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.40513642726101645,0.8637623724252387,0.6862745098039216,0.8817684689685119,1.0,3/23,12.03%,CYFIP1;SLIT1;SEMA5B
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.3705782964059825,0.8632959558327351,0.7380952380952381,0.8822551544915314,1.0,9/72,13.95%,RNFT1;LRRK2;PRICKLE1;RNF217;RNF144B;PLK1;CSNK1D;ARIH2;PIAS1
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.43333601591470294,-0.8631657763999628,0.68,1.0,1.0,5/26,10.89%,PARP2;PARP12;PARP1;ART3;ART4
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.4887835419175699,-0.8631033898919785,0.6326530612244898,1.0,1.0,6/14,26.70%,INTS14;TOE1;SSB;INTS5;ERI1;INTS8
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.37231320920533306,0.8630111841915976,0.7083333333333334,0.882365893965338,1.0,12/41,19.53%,LILRB1;CAMK2B;NOS1;CD4;PLPP4;BCL2;HOMER1;TRPC6;CACNB2;PKD2;IL16;CAV3
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.4421256484713244,-0.8627754666323764,0.6326530612244898,1.0,1.0,6/20,23.38%,MUS81;EXOG;HMGB1;REXO4;ENDOG;DICER1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.45080139808810527,-0.8625927663632643,0.6428571428571429,1.0,1.0,8/19,18.25%,JPH1;CALM1;CASQ2;SRI;CLIC2;TRDN;PRKACA;JPH3
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.4042706762276197,-0.862547958756869,0.6415094339622641,1.0,1.0,2/35,1.44%,CRTAM;BTN3A1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.3889834851506786,-0.8624137914792905,0.65,1.0,1.0,8/39,22.62%,LSM2;RNH1;NUDT12;NUDT16L1;DXO;ZPR1;SIDT2;ERN1
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.5102471271030711,-0.8621421906709565,0.6470588235294118,1.0,1.0,2/7,11.53%,ADH6;ADH4
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.418580824446653,0.8620180158537759,0.7333333333333333,0.8838228766322295,1.0,2/17,5.88%,LRRK2;LRCH1
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.44118351862306104,0.8617687737701022,0.5853658536585366,0.8838778250538528,1.0,4/24,7.34%,TGFB2;KITLG;WNT5A;SOX9
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.5363807968838694,-0.8615764512107955,0.6981132075471698,1.0,1.0,1/5,3.60%,MUC4
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.4426836411953674,-0.8613072834672278,0.7037037037037037,1.0,1.0,2/19,10.13%,SMDT1;FIS1
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.3762471128679323,0.8611165866647371,0.6666666666666666,0.8847078388323705,1.0,2/49,2.10%,SNX31;DENND1B
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.4343938037885683,-0.8611136969927393,0.6607142857142857,1.0,1.0,11/27,26.17%,NDC80;NUMA1;DYNLT1;SAPCD2;LLGL1;DCTN1;PKHD1;MAP4;KIF25;SPDL1;NDEL1
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.5149694349966231,0.8607389052357969,0.66,0.8850572826229889,1.0,1/10,12.70%,CPEB3
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.5845663675357173,0.8606589192794897,0.6792452830188679,0.8847868663670718,1.0,1/6,18.21%,JADE2
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),-0.415661028418369,-0.8605591334887354,0.6595744680851063,1.0,1.0,3/29,10.90%,SELENOS;BCKDK;ADIPOR1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.46024619829889346,-0.8604647130959918,0.6590909090909091,1.0,1.0,3/23,11.22%,SERPINE1;ACTG1;HRAS
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.48879430349762165,-0.8603993615962818,0.6304347826086957,1.0,1.0,2/16,4.13%,JAGN1;CDK4
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.45201526664707853,-0.8602408820755268,0.6086956521739131,1.0,1.0,3/15,17.61%,SLC25A1;FASN;HSD17B8
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.5977533693511988,0.8601711237057955,0.72,0.8854406365390051,1.0,1/5,7.89%,DMD
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.5040006726031985,0.8601329571601763,0.723404255319149,0.8851203645433544,1.0,3/9,14.41%,SHMT2;GLDC;SHMT1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.4051999567343473,-0.8599485772013146,0.5833333333333334,1.0,1.0,8/36,14.37%,H2AX;CHAF1B;ASF1B;GRWD1;SMARCA5;H2BC21;NPM1;DAXX
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.3510260085010186,-0.8598951473929336,0.7076923076923077,1.0,1.0,20/119,15.99%,DDIT3;CD38;ATF3;GPX4;BTG3;MGMT;SOD1;FEZ1;TSPO;FDXR;TXNIP;BAX;BTG2;SC5D;SQSTM1;DAP;SMAD7;GSN;DNAJA1;TIMP2
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.5093256555945171,0.8597677665843473,0.6595744680851063,0.8853442882739175,1.0,4/11,16.00%,SNAP25;SLC22A3;SLC29A2;SLC29A4
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),-0.5452197369484926,-0.859717925045001,0.660377358490566,1.0,1.0,1/6,4.11%,NOC2L
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),0.45568606236362885,0.8595450484558129,0.7,0.8853186214162942,1.0,4/16,16.25%,CD44;HEXB;LYVE1;ABCC5
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.523518346611764,0.8594845528539992,0.5892857142857143,0.8850686103877292,1.0,2/7,6.01%,KCNT2;KCNIP2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.41095638008963864,-0.8593773785461146,0.7,1.0,1.0,4/31,5.60%,TPX2;STMN1;KATNB1;TUBB4A
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.5038088862080746,0.859362865053021,0.6511627906976745,0.8849234706676362,1.0,3/9,12.58%,IL12A;TNFRSF1B;LGALS3
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.45268979368208073,0.8590191686289959,0.6923076923076923,0.885157062306794,1.0,3/20,13.66%,ACADL;AOAH;PLBD2
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.3923908200471118,0.8588070916437549,0.75,0.8851165792133668,1.0,2/21,5.56%,L1CAM;TWF2
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.37586434205414526,0.8586102645941941,0.6938775510204082,0.8851159501907806,1.0,9/41,14.44%,GPC6;HS3ST1;B3GALNT1;GPC5;AGRN;B3GALT1;B3GNT6;GPC1;HS3ST3A1
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.4719238799459254,-0.8586019939330923,0.5263157894736842,1.0,1.0,1/14,1.51%,SFRP1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.4326230101652484,-0.8585181262645942,0.6666666666666666,1.0,1.0,7/26,13.17%,SF3A3;SF3A1;SNRPC;SRSF9;PUF60;PRPF39;KHDC4
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.42606161729327263,-0.8582842108738838,0.6428571428571429,1.0,1.0,6/26,19.40%,NDC80;NUMA1;DYNLT1;SAPCD2;DCTN1;PKHD1
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.3516477422137312,-0.8582513263166228,0.7169811320754716,1.0,1.0,22/129,16.19%,SFRP1;ATP6V1F;ATP6V1G1;ATP6V1G2;LAMTOR4;RRAGA;MYBBP1A;GABARAPL2;ATP6V1E2;HSPA8;PRKAA2;CASTOR2;ATP6V0E1;MIOS;SLC38A9;MAP1LC3B;LAMTOR2;DAP;FADS1;WDR45B;EIF2AK3;ATG14
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.37026209064854915,-0.8582046936529535,0.7090909090909091,1.0,1.0,20/103,19.00%,GAPDH;EXOC7;ATP6V1G1;ATP6V1G2;NRBP2;LAMTOR4;RRAGA;UBQLN2;ATP6V1E2;CAPNS1;PRKAA2;ATP6V0E1;SCOC;SLC38A9;LAMTOR2;PRKACA;SUPT5H;IKBKG;NEDD4;LAMTOR5
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.32006070598721387,0.8580107625296365,0.8378378378378378,0.8856974412877625,1.0,14/149,7.43%,SCN9A;FGL2;PLSCR1;CD44;IKZF2;CYFIP1;SELL;BHLHE40;PIM1;MAFF;PLAGL1;TNFRSF1B;RRAGD;AHCY
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.5201157418805606,0.8579537344758558,0.6,0.8854379569968196,1.0,1/6,7.64%,LEF1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.3465071210637578,-0.8578098576001101,0.6923076923076923,1.0,1.0,17/115,14.59%,JUP;SFRP1;PSMB6;PSMD7;PSME2;PSMD8;SEMA5A;BAMBI;PSMB4;PSMD3;PSMB3;PSME1;TMEM198;PSMA7;PSMB8;PSMD13;ILK
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.41725336822576176,-0.8574534022677289,0.711864406779661,1.0,1.0,7/33,12.01%,FTH1;SLC31A2;TF;MELTF;ATP2C2;HEPH;TTYH1
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.4320177117845584,0.8573324019563918,0.6153846153846154,0.8861530434426583,1.0,6/19,19.31%,ADGRB1;XKR4;SCARB1;MEGF10;GAS6;LRP1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.4848012675015838,-0.8570910718017385,0.6363636363636364,1.0,1.0,1/13,1.66%,PARP2
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.422588544216717,-0.8570455345369759,0.6538461538461539,1.0,1.0,7/34,22.99%,TSN;BLM;HMGB1;EXO1;MSH3;ENDOG;THAP9
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.5704537952473049,0.8568419827038742,0.6808510638297872,0.8867432995494802,1.0,1/6,5.60%,DDAH1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.2943555668400599,0.8568284509441245,0.9,0.8863992636789367,1.0,12/193,4.59%,PCSK4;SRGN;ADAMTS9;MMP16;PCSK2;F3;FAP;ADAMTS7;CAPN1;HGF;TRHDE;ADGRV1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.3635561378410213,0.8567268669868789,0.7346938775510204,0.886204464700446,1.0,21/75,15.92%,NCKAP1L;SYNPO2;BAIAP2;MET;CARMIL1;FCHSD2;BAIAP2L1;TENM1;MYLK3;VIL1;CDK5R1;MAPT;CX3CL1;TRPV4;CDC42EP4;CDC42EP3;FES;SYNPO;STMN2;PRKCE;BIN1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.37885278702031633,0.8566814706286268,0.8,0.8859204993167729,1.0,9/32,24.75%,SNAP25;SLC11A2;SLC29A2;SLC7A8;SLC16A2;NEURL1B;ATP1A2;SLC7A1;LRSAM1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.43945153767583317,0.8565676533461808,0.5925925925925926,0.885726065964522,1.0,1/14,3.54%,LRRK2
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.4409399823291461,-0.8559920519015236,0.6792452830188679,1.0,1.0,7/24,18.01%,CGAS;NEK6;HMGA2;B2M;RSL1D1;ING2;YBX1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.47088257429356906,0.8559417902726147,0.6545454545454545,0.8865731083607595,1.0,2/19,13.82%,KLHL15;CUL3
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.4044027443983957,-0.8559301663120851,0.6415094339622641,1.0,1.0,3/34,5.08%,CXCR4;BTBD6;DAGLA
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.3929020345177104,0.8557342308090365,0.7027027027027027,0.8865322168819617,1.0,7/44,5.56%,L1CAM;SYT4;NEDD4L;RIMS2;PLCB1;SYT1;TWF2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3013280268959737,0.855307153890955,0.9230769230769231,0.8869917601084047,1.0,42/239,17.04%,TTC8;ABCC4;P2RY12;CYFIP1;CC2D2A;SEPTIN6;CARMIL1;SPEF1;LZTFL1;FHDC1;ANO6;DYNLL2;SSX2IP;ARHGEF6;CEP89;ABLIM1;DMTN;RPGR;TTC39C;RAB3IP;EXOC6;DZIP1;SPAG16;TEKT3;CYS1;TEKT5;TTBK2;DNAI2;PTPRO;BBS2;TNIK;CDH13;MAK;RFX3;ARL6;DNAAF1;INPP5E;TRAPPC14;ARHGEF4;MKKS;ARHGEF7;WDPCP
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.398685544236297,-0.8551359978368938,0.6909090909090909,1.0,1.0,2/50,1.51%,WNT9A;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),-0.5161501102906206,-0.8551237154174006,0.6808510638297872,1.0,1.0,1/6,8.48%,OTUB1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.4450232384156854,-0.8545694610705701,0.6862745098039216,1.0,1.0,5/18,26.04%,BACE2;NCSTN;BACE1;RBMX;APH1A
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.507566292088104,-0.8545227735909385,0.66,1.0,1.0,1/8,2.83%,RAB7B
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.33038820829750926,0.85396267825074,0.8,0.8890158678088034,1.0,7/114,8.51%,LAMP5;ZNF423;ISG15;LRRK2;OBSCN;STX1A;BANP
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.5399060098639171,0.8539489884065268,0.6785714285714286,0.8886670832055995,1.0,1/10,2.71%,DGKB
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.31992330616368364,-0.8534829824201674,0.859375,1.0,1.0,18/280,6.81%,NGF;BMP5;TNFRSF8;WNT9A;IFNLR1;CDKN1C;SFRP1;TINF2;FTH1;GREM1;PTPRU;GSTP1;COL18A1;BTG3;TFDP1;TNS2;APOD;B4GALT7
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.455420487482075,0.8532448192980572,0.58,0.8894170955407202,1.0,3/13,9.16%,CARTPT;LILRB1;MAFB
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.4239800553638743,0.8528773623457797,0.6666666666666666,0.889711433380104,1.0,5/25,7.89%,SLC8A1;SGCZ;TPM1;SCN3B;DMD
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.34131086755907664,0.8527750569468767,0.7714285714285715,0.8895061738121088,1.0,16/116,9.08%,TGFB2;SRGN;PTPRC;EGFR;TLR2;STAB1;IL12A;CARTPT;LCP2;PTPN6;FYB1;ST8SIA4;LY86;CD4;PRKCG;CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4281640415736347,-0.8527415424920426,0.660377358490566,1.0,1.0,6/25,13.89%,RPS3;KATNB1;NUMA1;ANKRD53;AKAP9;RAC1
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.48432782303183225,-0.8526430708160033,0.6140350877192983,1.0,1.0,6/13,18.14%,SYNE2;DYNC1H1;SYNE3;CEP120;TMEM201;DCTN1
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.35599697356356974,-0.8525980821036834,0.6610169491525424,1.0,1.0,9/87,8.48%,PDE3A;RPS27A;UBC;SFRP1;UBB;HYAL2;FNTA;BAMBI;RHOA
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.44893018392364026,0.8522046425323127,0.5853658536585366,0.8901708765545132,1.0,1/17,0.38%,PKP2
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.39859589557155445,0.8518951419520536,0.6888888888888889,0.8904151289352392,1.0,5/25,8.96%,NAGLU;CHI3L1;GPC6;GPC5;AGRN
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.3769482573241462,-0.8514344056161733,0.7647058823529411,1.0,1.0,5/57,7.28%,BMP5;SFRP1;GREM1;IL17RD;BAMBI
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),-0.5557827158126996,-0.8510275721685174,0.7391304347826086,1.0,1.0,2/5,25.01%,TRPV1;RYR1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.4718183376785947,-0.8509866134912042,0.6326530612244898,1.0,1.0,4/12,23.03%,ACTG1;RAC1;CDC42;ASAP3
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.4660393395936894,0.8509773040187605,0.7222222222222222,0.8916961244035356,1.0,4/17,10.21%,C5;SULF1;C3;ARNT
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.5133775211164104,-0.8508936046634163,0.64,1.0,1.0,1/9,4.60%,GOPC
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.5629252710950844,-0.8507378739518182,0.74,1.0,1.0,4/5,30.53%,BAX;CASP9;CYCS;BOK
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.34919326607976714,-0.8503753614057386,0.7857142857142857,1.0,1.0,18/64,24.20%,SRSF7;SRSF3;SRSF9;RBM8A;RAE1;DHX38;MAGOHB;ALYREF;YBX1;SLU7;RTRAF;TPR;SIDT2;CASC3;CDC40;POM121C;SRSF2;NXF1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.4741097852925376,0.8499354303727388,0.7021276595744681,0.893212963912898,1.0,1/11,1.51%,CD44
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.5265809236712571,0.8497523833791422,0.6428571428571429,0.8931152094625385,1.0,3/7,15.50%,FUT9;BST1;THY1
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.5162938218725603,0.8496413801380235,0.66,0.8929090406359939,1.0,5/11,17.00%,PARP14;PARP8;PARP9;TIPARP;PARP16
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.538917254444074,-0.8491441614197609,0.6808510638297872,1.0,1.0,2/7,5.15%,AK8;CMPK1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.4599188009256368,0.849092153481809,0.7192982456140351,0.8935262846314491,1.0,4/17,12.18%,ADAMTS9;SAMHD1;FBXO17;AOAH
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.44785601058539404,0.8486575667890487,0.6607142857142857,0.8940148967777433,1.0,7/19,16.93%,KCNT2;KCNIP2;SLC4A4;SLC40A1;ATP1B2;KCNH2;ATP1B3
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),-0.4290601484806192,-0.8483550767862525,0.5777777777777777,1.0,1.0,2/15,3.48%,B3GALT4;B4GALNT2
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.3899744757807329,0.8477383224297917,0.7636363636363637,0.895232068596419,1.0,5/50,6.57%,PPARG;SLC4A10;NEDD4L;ABCB4;SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.5574044403179561,0.8475808918048344,0.6875,0.8952272192918452,1.0,4/5,39.97%,FGF1;SCAP;PRKAA1;ABCG1
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.561770996345548,-0.8474098416748095,0.7777777777777778,1.0,1.0,3/9,12.30%,NLRP9;NLRP1;APIP
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.2828505047487416,0.8473071081725294,0.9736842105263158,0.8954635199947933,1.0,74/377,17.89%,ARHGAP31;EGFR;TP73;ARHGAP10;KALRN;AKAP12;RHOJ;LRRK2;ARHGAP18;PAK3;BIRC3;OBSCN;RIT2;PIP5K1B;FAM13B;ARHGAP25;NTRK2;RHOQ;SRGAP1;WNT5A;TIAM2;RHOF;NFKBIA;HSPB1;GRM2;BANP;ARHGEF6;TP63;SMYD2;FAM13A;ARHGAP17;NUAK1;RFC3;PRKAB2;ZFAND6;NGEF;BST1;DYRK2;SLC15A2;MAPK11;CDK5R1;MCF2;MAPT;TPTE2;GPAT3;PRKAR1B;ARAP1;ARHGAP28;LYN;PIP4K2A;RAC3;TNIK;VEGFA;NTRK3;PAK5;ARAP2;A2M;CHN1;TRIP10;RHOT1;NLGN1;ARAP3;RAD9A;SLC15A4;DDIT4;ARHGEF4;ARHGEF7;TP53INP1;RBBP8;MBD3;TAF10;ARHGEF26;PRKAG2;CSNK2A1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.47844576505206654,0.8470690206844323,0.6538461538461539,0.8955815603804609,1.0,3/11,10.88%,MET;HSPB1;PRKD1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.35648336411639314,-0.8469607258654107,0.6904761904761905,1.0,1.0,16/80,20.99%,RAB7B;STX10;TMED9;WASHC2A;LMAN1;VPS29;STX6;RNF126;VAMP3;SURF4;GBF1;DCTN1;SNX3;ARL1;CLTCL1;VPS35
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.37828036076125743,0.8467932943665556,0.8333333333333334,0.8956995022349218,1.0,5/36,11.54%,NPAS2;RADX;SMYD2;FEM1B;MAPT
prerank,GO_Biological_Process_2021__monoacylglycerol biosynthetic process (GO:0006640),-0.5553771599810264,-0.846741966989941,0.7254901960784313,1.0,1.0,1/5,5.46%,AWAT2
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),-0.4422284267315989,-0.8466691813360921,0.7317073170731707,1.0,1.0,2/14,10.90%,BCKDK;ADIPOR1
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.33370311098398137,0.8466515490691331,0.8297872340425532,0.8956207382148828,1.0,18/92,16.27%,TM4SF20;ITGB4;SLC25A48;PROM1;BAIAP2L1;SCEL;FMO5;TP63;CDKN2A;TRIM29;FZD6;CDH3;ST6GAL1;GRHL2;MUC16;PLA2G4A;FERMT1;CKAP2
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.37913429782646735,-0.8464793917653237,0.7727272727272727,1.0,1.0,17/49,19.60%,PDE6A;PCNA;NOC2L;CNGB1;PARP1;SDE2;TRIAP1;BAK1;NPM1;OPN4;COPS9;ATF4;ATR;TMEM161A;SMPD1;NEDD4;CASP9
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.3591301023248446,-0.846154595302526,0.7058823529411765,1.0,1.0,21/88,24.60%,PARP1;TONSL;MUS81;RAD51AP1;ZSWIM7;MCM4;RFWD3;HUS1;BLM;MCM3;SFR1;SMC6;REC8;EXD2;UBE2N;GINS2;YY1;MCM6;GINS4;AP5Z1;SPIDR
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.36774085385213573,0.8460454902099636,0.6444444444444445,0.8963134023894225,1.0,8/45,11.81%,CHI3L1;ADAMTS7;SRC;SOX9;MYLK3;IRAK3;MAPK11;CX3CL1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.37061429939250895,-0.8460143663383702,0.7068965517241379,1.0,1.0,23/77,24.94%,KIF3B;AP2S1;DYNLL1;DCTN3;HLA-DRA;AP1B1;SAR1B;DYNC1H1;KIF4A;HLA-DPA1;KIF11;DYNC1I2;DCTN1;AP1S1;DCTN2;AP2A1;AP2B1;CTSF;DCTN6;KIF18A;CTSL;RILP;CLTA
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.4285653512979667,0.8459703743282118,0.7727272727272727,0.8960478267542485,1.0,7/21,18.19%,SLC43A1;SLC7A9;SLC6A15;SLC7A8;SLC6A7;SLC38A6;SLC1A1
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.571334094261185,0.8457781681901054,0.7192982456140351,0.8960671969076572,1.0,3/5,21.69%,DMTN;ANK3;JAK1
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.45944061671387804,0.8457405061937568,0.7391304347826086,0.8957430610590355,1.0,4/17,16.00%,SLC22A3;SLC22A16;SLC25A19;SLC29A4
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.4211410296373228,-0.845508089982054,0.7272727272727273,1.0,1.0,5/34,12.20%,H1-4;H1-2;BANF1;KMT5A;PHF13
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.4201282695620525,0.8455015987365283,0.6,0.8957821617849401,1.0,3/17,12.94%,KLHL15;RADX;UBQLN4
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.34572896313029616,0.8454296937140418,0.8297872340425532,0.8955172492971424,1.0,25/53,30.49%,IGF1;SRC;TNFRSF10B;FEM1B;LGALS3;WWOX;GPER1;TMC8;SIAH2;PAK2;PHIP;TNFRSF10A;RELA;SCG2;MADD;TRAF1;CASP8;TRAF2;PML;CFLAR;BID;BCL2L14;FGFR1;STX4;CAV1
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.4992377830124559,0.8453235505667132,0.74,0.8953456738190254,1.0,1/9,1.15%,BMP6
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.4178495496135257,-0.8449129747175244,0.7674418604651163,1.0,1.0,9/32,23.26%,UFC1;TEX264;GOLGA2;UFL1;PLK3;GBF1;ATG2A;MTIF2;ZFAND1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.5112925738810685,-0.8444264931922534,0.660377358490566,1.0,1.0,3/11,8.69%,DDX5;PYHIN1;PLA2R1
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.4201497245163278,0.844262000114559,0.66,0.8968349466889308,1.0,2/18,4.94%,NMNAT2;KYNU
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.4416757120245947,-0.8441657812797769,0.7254901960784313,1.0,1.0,8/26,24.69%,LSM10;SNRPB;SNRPE;SNRPG;SSB;LSM1;ERI1;EXOSC4
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.3489859248077831,0.8440460648918836,0.74,0.8968294573855488,1.0,24/61,25.54%,PPARG;ADCY8;CARTPT;PYGL;IRS1;KCNB1;NGFR;PIK3R1;PDK4;ADIPOR2;PPARGC1A;LEPR;CAV3;MLXIPL;PAX6;KLF7;CRY2;HK2;CRY1;FOXK1;STAT3;SOX4;SIRT1;CYB5R4
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.4179756089904184,0.8438938737512133,0.7291666666666666,0.8967064982525556,1.0,5/21,16.52%,ADCY8;SLC2A5;KCNB1;GPER1;GAS6
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),-0.5077406260736196,-0.8436743470976307,0.673469387755102,1.0,1.0,5/11,33.96%,TOR1A;VCP;AUP1;BAG6;UGGT2
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.327082095829416,0.8436295949484615,0.8378378378378378,0.896847848857871,1.0,19/96,17.11%,TGFB2;OSGIN1;TSPYL2;MT1M;PTPRJ;BCL6;CDKN2A;RERG;BMPR2;APBB2;FRZB;GNG4;OSGIN2;CCN3;FHL1;SESN2;SMARCA2;CRLF3;CDKN1A
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.3420569402002984,-0.843434832074663,0.76,1.0,1.0,14/124,15.29%,TAX1BP3;ERAS;CFL1;RHOG;CDC42EP5;CDC42EP1;RHOA;PLCE1;ARHGDIA;HRAS;RAC1;BRK1;RRAS;ARHGEF1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),0.3909564300882206,0.8434241519943754,0.7692307692307693,0.8968863773575905,1.0,9/39,14.70%,NCKAP1L;IKZF1;ID2;TAL1;DMTN;ALAS1;LYN;DYRK3;VEGFA
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.5168377711399497,-0.843344759472483,0.7021276595744681,1.0,1.0,2/8,4.51%,CYP2E1;AADAT
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.5194815214503471,-0.8433069635090459,0.6896551724137931,1.0,1.0,2/10,4.27%,SLC22A6;SLC22A2
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.4222910206503029,0.8433042092856909,0.711864406779661,0.8967097722622004,1.0,2/23,8.11%,PEX11A;ABCD2
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.255874027945769,0.8432623421857818,1.0,0.8964111475273551,1.0,275/1673,18.10%,ZNF366;CREB3L1;FLI1;ETV1;IFNA2;PDGFB;NPAS2;ZNF423;PPARG;MYT1;EGFR;TP73;FOSL2;GRHL1;IGF1;IKZF2;FOS;MDFIC;HNF4G;HEY1;WTIP;KLF9;MIDEAS;BHLHE40;SCRT1;ZIM2;MAP3K5;MEF2C;CASZ1;ZNF93;PLCB1;IKZF1;ZNF157;GCM1;ZSCAN22;RUNX1T1;E2F3;NR4A3;ELAVL2;DACH1;NRG1;NFATC4;ZNF20;BCL11B;NR2F1;ZEB1;ATF1;TOX;PRICKLE1;CITED2;MAFF;EBF1;PURG;TBX6;ID2;PRDM15;KLF15;MAEL;BASP1;ZNF652;HIVEP2;ZNF608;ZNF239;TBX19;PLAGL1;WNT5A;DLX1;PBX1;CIITA;LOXL3;AEBP2;ZNF215;MEIS3;TSHZ3;ZNF442;SOX9;ZBTB7C;ETS2;PER1;LEF1;HIRA;TEAD1;ETV6;ZNF600;ATXN1;TENM1;TAL1;ZBTB16;TESC;MEIS2;TIMELESS;SPINDOC;NR3C2;NOS1;CLOCK;HES4;CD4;BCL6;KDM3A;ZNF343;EPAS1;WWP1;STAT6;TP63;NEUROD6;EMX1;ZGLP1;CDKN2A;MAFB;GLIS3;ZNF697;TGFB3;L3MBTL4;BRWD3;NOTCH4;ZNF764;GTF2IRD1;TBL1XR1;TASP1;CAMK2D;ZNF768;ARNT;ZNF540;ZNF568;ZHX2;CREB3L2;ZNF615;SOX5;HOPX;TGFA;SATB2;ZNF644;ZNF304;BNC2;ZNF587;CDK5R1;ZSCAN1;ELK3;ZNF616;MYT1L;ZNF550;YWHAH;ZNF473;ZBTB18;HES1;PHF19;ZNF516;PARP9;ZNF433;CBFB;TGIF1;TULP3;NPAS1;NCOA7;PROX2;NR2F2;ZFP30;IFNK;POU2F2;ZNF467;ZNF486;ACTL6B;MED12L;PRRX1;ZNF571;ZXDA;CD80;FOXP2;ARID3A;BACH1;CEBPD;ZNF384;RGMB;APBB2;ZNF584;SRA1;ZNF775;TAF5L;CHMP1A;ZNF730;ZNF493;RPS6KA3;PIAS1;ZNF536;ZNF235;KAT6B;ZKSCAN7;RFX3;CREB5;NCOA1;ZNF549;ZNF33B;ZNF383;KLF3;GRHL2;ONECUT2;CAMK4;ZNF148;MED14;ZNF248;VEGFA;GLIS1;MAFK;ZBTB34;KCNH2;CCNQ;TRIM22;RFXANK;ZNF654;TOX2;CSRNP2;SFMBT2;FOXN2;ZNF438;ZNF98;PCGF3;ZNF648;ZNF577;BCL11A;ZNF439;ZFAT;PTPRK;ZNF415;KLF6;CRX;ALX3;ETV3;JUNB;SMARCA2;SMARCA1;NFIA;RXRG;MYNN;SETD5;GAS6;ZNF274;ZBTB1;TADA2A;PPARGC1A;NDP;TNFSF4;ZNF483;CRLF3;SNAI3;KAT2A;EBF2;SAMD13;MLLT11;POU6F2;NCOA6;CDKN1A;TP53INP1;RBBP8;DYRK1B;PCGF5;FOXN3;CSRNP1;LHX6;ZNF610;HIC2;GLIS2;HIF3A;PRMT6;HMBOX1;RLIM;ZIC4;CHD7;ZNF543;HCLS1;WWTR1;ZNF736;ZNF227;WAC;KLF16;RXRA
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.5647340681808392,0.8431891277011511,0.7058823529411765,0.8961567319846325,1.0,2/5,14.65%,MEF2C;MEGF10
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.4153421879692929,-0.8430616421402853,0.631578947368421,1.0,1.0,2/22,13.18%,KIF3B;DYNC1H1
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.49310473344100897,0.8429134484671902,0.6585365853658537,0.8963614912699805,1.0,3/8,26.82%,FZD3;ASCL1;NRP2
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.4911177974454099,-0.8428831488288051,0.6440677966101694,1.0,1.0,1/8,1.51%,SFRP1
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.5337151032570256,0.8428183993584728,0.55,0.896204918534249,1.0,4/6,29.00%,LRP1;ATP13A2;MGAT3;LRP2
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.5251698681566538,0.8425701071024048,0.75,0.8963363100176628,1.0,2/6,15.78%,GPLD1;ABHD5
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.5204345818621581,-0.8425685021200181,0.6440677966101694,1.0,1.0,2/6,15.99%,SVBP;TIMP2
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.5318079889678671,-0.8424562063881533,0.6181818181818182,1.0,1.0,3/8,22.62%,PINK1;MAP2K2;ERN1
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.35103133961530303,0.8424390462614451,0.6666666666666666,0.8961554946554996,1.0,14/57,15.92%,NCKAP1L;BAIAP2;MET;CARMIL1;FCHSD2;BAIAP2L1;TENM1;CDK5R1;MAPT;CDC42EP4;CDC42EP3;FES;PRKCE;BIN1
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.4856747395079176,-0.8418939211134978,0.6451612903225806,1.0,1.0,2/12,6.95%,AGBL1;FOLH1B
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.4552074122692068,0.8412497213018156,0.6458333333333334,0.8979148858305831,1.0,1/9,5.56%,TSPYL2
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.4345853111274446,-0.8410555365893236,0.7954545454545454,1.0,1.0,2/18,10.83%,CDK4;DBF4B
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.4303235357518719,0.8410079106255977,0.7555555555555555,0.8980015546243043,1.0,2/18,4.09%,TGFB2;ITGAM
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.40621131850089764,-0.8409898599960317,0.6666666666666666,1.0,1.0,10/36,19.28%,PRMT2;FAM98A;TRMT112;VCPKMT;CSKMT;BHMT;SNRPB;CARM1;FAM98B;ETF1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.32522197633776084,-0.8407896578160856,0.8035714285714286,1.0,1.0,14/129,10.42%,DDIT3;SFRP1;GREM1;PTPRU;PSMB6;PSMD7;PSME2;PSMD8;LZTS2;PSMB4;PSMD3;PSMB3;DACT3;PSME1
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.3404010349070946,-0.8405927561285317,0.803921568627451,1.0,1.0,13/90,10.28%,TSKS;PLAAT5;COX7B2;GSG1;SPAG6;LDHC;DDX4;MLF1;CREB3L4;MRPL14;DYNLT1;SPATA16;SPATA33
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.40649630089012223,-0.8403900282561465,0.6296296296296297,1.0,1.0,2/33,2.75%,BMP5;GREM1
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.5170502474079017,-0.8403649517405393,0.6666666666666666,1.0,1.0,3/11,20.85%,FNTA;ING2;AKAP8
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.5387367998943806,-0.8401375246295556,0.7045454545454546,1.0,1.0,1/8,7.34%,NUMA1
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.5518639898537524,-0.8400986099571606,0.65,1.0,1.0,2/5,25.94%,PINK1;HAX1
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.5519638518918571,0.8397737690244157,0.7083333333333334,0.8999145835156571,1.0,2/5,25.21%,RPS6KA4;FMR1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.4455579333656564,-0.8397239282900726,0.6923076923076923,1.0,1.0,3/17,13.14%,CHMP2A;CHMP5;CHMP3
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.3939611385276942,-0.8393505621467375,0.6481481481481481,1.0,1.0,8/39,18.53%,TNFAIP2;VAMP8;LAMB3;ADIPOR1;EHF;B3GNT3;EXO1;FBP1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.3986872537948482,-0.8393104279596273,0.6595744680851063,1.0,1.0,3/20,10.17%,WNK4;ACTN2;CASQ2
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.513478838800811,-0.8391334544691554,0.7959183673469388,1.0,1.0,2/10,9.57%,JUP;SERPINB8
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.45369203747537684,0.8386752338985495,0.6904761904761905,0.9014414220969763,1.0,2/11,21.05%,ZFP36L1;PAPOLA
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.4825985342802498,-0.8384151652144666,0.66,1.0,1.0,1/9,2.83%,RAB7B
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.40988180302336324,-0.8383771928910172,0.7592592592592593,1.0,1.0,4/51,7.07%,LSM7;LSM2;EXOSC8;NT5C3B
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.38532911606037545,-0.8382345874399975,0.7307692307692307,1.0,1.0,4/31,12.41%,CENPX;SMARCA5;MIS12;NPM1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.2848079370231101,0.8381546948781249,0.95,0.9021007692652873,1.0,38/248,16.11%,TGFB2;PTPRC;TRNP1;TP73;FAP;IL12A;BIRC3;KAT2B;CITED2;ID2;TSPYL2;PLAGL1;CDKN3;LILRB1;SOX9;FIGNL1;CCND1;PLK1;UHRF2;CDKN2A;BRINP1;MAPK12;SETMAR;PCLAF;WDR6;SMIM22;NANOS3;PUM1;APBB2;SRA1;CHMP1A;FZD9;RPRD1B;TTLL12;GPER1;PTPRK;BIN1;JUNB
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.444594605669009,-0.837654383332325,0.5925925925925926,1.0,1.0,2/21,10.98%,UBQLN2;ANXA2
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.4697144356349113,-0.8375721226835389,0.66,1.0,1.0,3/16,11.91%,POLD3;POLD4;PPIA
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.38408600202741755,-0.8375462678882506,0.6296296296296297,1.0,1.0,10/33,23.63%,ACTN2;NUMA1;CEP131;CAPN10;DYNC1H1;PLK3;NEDD4;TPR;ZFAND1;B3GAT3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.47613632790980565,0.8372483206712433,0.6111111111111112,0.9034892397495218,1.0,2/7,9.79%,FGF13;CAMK2D
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.353796448677052,-0.8372458944714328,0.7272727272727273,1.0,1.0,3/75,3.81%,CFAP61;RGS22;SLC22A6
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.34588467851506843,0.8371869344679134,0.7115384615384616,0.9032525077761324,1.0,20/72,19.24%,CBS;SHMT2;KYNU;GAD1;DDAH1;ABAT;CRYM;FTCD;NOS1;DDO;GLDC;SHMT1;BCAT2;MCCC1;NOS2;ALDH5A1;SLC25A21;TDO2;KMO;ARG1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.5525823896471449,0.8371219199065096,0.7391304347826086,0.9030159711261535,1.0,1/5,5.60%,DDAH1
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.44160927061625355,-0.8368551018907067,0.72,1.0,1.0,1/23,0.29%,CXCR4
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.41093995779143555,-0.8367241928964557,0.6545454545454545,1.0,1.0,1/26,0.24%,BMP5
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.4026443079056342,0.8365810301229687,0.6956521739130435,0.9036930151489158,1.0,5/28,11.50%,PDGFRA;OBSCN;TPM1;MYLK3;CSRP2
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.2979403203622487,-0.8365002918488655,0.9027777777777778,1.0,1.0,34/303,13.15%,RAB32;VAMP5;ATP6V1F;KIF3B;RAB8A;ARCN1;ATP6V1G1;ATP6V1G2;TF;ARL17A;CHMP2A;STX10;TMED4;TMED9;TBC1D16;ERP29;MCOLN1;SCAMP2;SNX17;ARFIP2;TXNIP;ATP6V1E2;DNAJC27;TMED2;RAB31;ATP6AP1;TMED1;VPS29;NPM1;SVBP;SAR1B;USP6NL;CHMP3;ATP6V0E1
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.38483954284001065,-0.8362909131595516,0.7358490566037735,1.0,1.0,3/24,4.24%,PPIL1;PPIB;PPIE
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.48221872272310673,-0.8361597444606333,0.6818181818181818,1.0,1.0,1/17,0.51%,DDIT3
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.4491851864713464,-0.8360139981634791,0.6923076923076923,1.0,1.0,4/19,13.14%,LGALS1;CHMP2A;KPNA2;CHMP3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.46082466059028193,-0.8358844512904902,0.6785714285714286,1.0,1.0,6/18,29.63%,PARP1;GTF2H2;DDB2;GTF2H5;DDB1;CUL4B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.46082466059028193,-0.8358844512904902,0.6785714285714286,1.0,1.0,6/18,29.63%,PARP1;GTF2H2;DDB2;GTF2H5;DDB1;CUL4B
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.4780231222150549,0.8358737204761748,0.6666666666666666,0.9045783275627465,1.0,4/13,15.62%,PYGL;PGM2L1;PHKA2;AGL
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.508364636453682,0.834740674402039,0.7058823529411765,0.9060842775073018,1.0,2/9,24.75%,PIP4K2A;LRSAM1
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.5095826896885344,-0.8342842028662516,0.6666666666666666,1.0,1.0,2/6,22.57%,WRAP73;MAP4
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4377605927974,0.8341855175278864,0.7090909090909091,0.9067009920952659,1.0,3/20,8.11%,ADGRB1;GRIN1;ABCD2
prerank,GO_Biological_Process_2021__water transport (GO:0006833),0.5103687018587806,0.8340039265983923,0.7291666666666666,0.9066623903974627,1.0,1/7,0.81%,AQP1
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.4723603192256237,0.8338373653087554,0.6470588235294118,0.9065559423495698,1.0,2/11,10.56%,WNT5A;DOCK8
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.523809630783213,0.8335126904812455,0.6956521739130435,0.9067452148877461,1.0,3/6,26.90%,CNOT2;CNOT6L;ATXN2
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),-0.5353304283023359,-0.8330149919574573,0.673469387755102,1.0,1.0,1/5,17.17%,MGLL
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.4197912387043399,-0.832888235403002,0.6666666666666666,1.0,1.0,1/21,1.51%,SFRP1
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.5404073296125254,-0.8328112874525835,0.7192982456140351,1.0,1.0,1/5,14.85%,ETS1
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.5592667394064442,-0.8327308517144411,0.7307692307692307,1.0,1.0,1/5,8.48%,RHOA
prerank,GO_Biological_Process_2021__regulation of dendritic cell cytokine production (GO:0002730),0.5121021536767771,0.8326474524500628,0.6981132075471698,0.9080485552776333,1.0,2/5,23.42%,CLEC7A;SCIMP
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.5601660300670793,0.8325226213604561,0.6744186046511628,0.9079900933389188,1.0,2/5,14.97%,SLC6A15;SLC6A7
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.383043018839127,-0.83251373015131,0.7241379310344828,1.0,1.0,10/47,15.33%,RPS3;RNF8;H2AX;PCNA;DDX5;PLA2R1;HMGA2;BRCC3;ABRAXAS1;ERCC8
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.4592165684802265,0.8324625233940851,0.8301886792452831,0.907747741602046,1.0,2/12,16.50%,SETD1A;SETD5
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.501041145487902,-0.832071824878941,0.6896551724137931,1.0,1.0,1/10,2.89%,SMDT1
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.3968707590119041,0.8319795423877847,0.7291666666666666,0.9081636224051581,1.0,9/27,13.37%,PTPRC;NCKAP1L;MEF2C;TNFSF13B;TIRAP;BCL2;BST1;SASH3;LYN
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.35900068074032554,0.8319714888278134,0.75,0.907800486026861,1.0,6/65,10.43%,IGF1;SLC4A4;GIT1;PFKFB3;ARNT;NUP43
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.48575722054066267,-0.8319210510885747,0.6545454545454545,1.0,1.0,3/10,31.88%,VPS11;MSN;EZR
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.5467385531446722,-0.8317044680905765,0.782608695652174,1.0,1.0,3/5,22.35%,IKBKG;SYT11;TESK1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.3702208409687209,-0.8316491133529815,0.7258064516129032,1.0,1.0,13/73,15.34%,LCK;SLC39A6;ATP1B1;TPT1;RMDN3;ATP2C2;RGN;ATP2A3;MT1E;MT2A;SLC39A7;CHRNA7;TRDN
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.4833509987893108,0.8315943948220081,0.7291666666666666,0.9080806375832523,1.0,3/10,14.70%,CSF1R;CD4;VEGFA
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.42138444115121293,0.8314246732926094,0.64,0.9079981197442936,1.0,3/15,7.57%,NFATC4;PPP3CA;NMUR2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.4813084910384142,-0.831120301269671,0.6666666666666666,1.0,1.0,1/9,6.73%,DNMT3B
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.49125021704130756,-0.8308731539956183,0.6875,1.0,1.0,2/11,8.78%,NEK6;CCNB2
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.5312200331745033,0.83030716190924,0.6981132075471698,0.9096256829624338,1.0,1/5,4.07%,NR4A3
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.49335354558317224,-0.8302568164890476,0.6981132075471698,1.0,1.0,2/7,10.09%,MEOX1;MEOX2
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.3671553307289688,0.8302046075182077,0.6585365853658537,0.909479828180287,1.0,10/52,13.39%,IFNA2;PTPRC;CD44;NHEJ1;PPP3CA;CD4;SLA2;IFNK;RAB29;ZAP70
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.4967347676836238,0.8301977870663659,0.6595744680851063,0.9091313761868431,1.0,2/10,10.56%,LRCH1;DOCK8
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.42553189139026076,-0.8301798364680489,0.6440677966101694,1.0,1.0,6/25,16.50%,SDF2L1;DNAJB4;HSPE1;HSPA8;HSPA2;HSPA14
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.4588533148513356,0.8299031287449425,0.7307692307692307,0.9093525137886144,1.0,4/13,18.71%,PKIA;PRKAR1B;ADRB2;PKIG
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.4864253983743007,0.8298315213312768,0.6981132075471698,0.9091297877393917,1.0,6/9,39.88%,PARD6A;GSK3B;CEP250;APC;BICD1;NSFL1C
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.5289533390860731,0.829794686272878,0.68,0.9088156513406606,1.0,4/6,36.22%,EID2;SMAD4;SMAD2;SMAD3
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.3998261132613009,0.8294977807771116,0.6875,0.9090366467387675,1.0,7/32,7.61%,CX3CR1;GRIK2;NRG3;GRIK1;RELN;CACNA1B;LRP8
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),-0.3542511780298558,-0.8293525760352125,0.8333333333333334,1.0,1.0,14/107,11.26%,SELENOS;ATP6V1F;TRARG1;RAB8A;ATP6V1G1;ATP6V1G2;PARP1;SYAP1;ATP6V1E2;USF1;CAPN10;RAB31;GCK;ATP6AP1
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.3525105629357841,-0.8292855158801836,0.7678571428571429,1.0,1.0,5/48,13.96%,PRELID1;NPC2;TRIAP1;PRELID2;ABCC1
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),-0.5533066019442041,-0.8291911717633922,0.7755102040816326,1.0,1.0,2/5,9.28%,DSCAM;SDK2
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.4418731247990387,-0.8291256807821845,0.6511627906976745,1.0,1.0,6/17,24.32%,ACOX1;CYP4F12;NUDT19;ACAA1;LDHD;ACBD5
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.5067613456413793,0.8285749156733567,0.6833333333333333,0.9102930567047781,1.0,2/6,21.82%,PAH;KYAT1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.4568191595726123,0.8285511088487838,0.6326530612244898,0.9099643857874202,1.0,4/12,14.70%,MET;HSPB1;PRKD1;VEGFA
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.45605263497051873,-0.8285465245221869,0.7169811320754716,1.0,1.0,1/19,6.73%,RAN
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.4849941259044793,-0.8285252910341235,0.7142857142857143,1.0,1.0,1/9,4.75%,PTGIS
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.47878985449424427,0.8283774695121376,0.6521739130434783,0.9098910611000375,1.0,2/11,6.97%,NMNAT2;AK4
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.45912690038681747,0.8282837570219573,0.675,0.9097071473940068,1.0,3/13,9.98%,CYB561;ENOX2;PDIA5
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.6063462964398004,-0.8281427198184989,0.7719298245614035,1.0,1.0,1/5,3.82%,AGBL1
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.4376702217950869,0.8281190970637818,0.6530612244897959,0.9095907078355377,1.0,1/12,2.66%,CAMSAP3
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.5268653196294493,0.8279706556955975,0.72,0.909541659836934,1.0,1/7,3.77%,PID1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.5404647070052242,-0.8276223982573105,0.7045454545454546,1.0,1.0,2/7,22.05%,CTTNBP2NL;INPP5K
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.37914523792034927,0.8274703599934794,0.7291666666666666,0.9101365132341352,1.0,7/25,16.91%,IL12A;IRGM;MAPK11;POU2F2;GSDME;LGALS8;VWCE
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.34795522278319596,-0.8274352430043568,0.7,1.0,1.0,12/63,14.13%,PSMB6;PSMD7;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PSME1;GATA1;PSMA7;PSMB8;PSMD13
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.4565193488915783,-0.8274220885018527,0.7037037037037037,1.0,1.0,1/12,0.32%,PDE3A
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.3488018771154324,-0.8267931942272478,0.7142857142857143,1.0,1.0,12/84,12.29%,CRYAB;GJC1;TLN1;MYL12B;ACTN2;MYL12A;CALM1;MYL6;CASQ2;TPM4;UTS2;CLCN1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.4152730060122747,-0.8267736710116556,0.6444444444444445,1.0,1.0,4/26,11.17%,CRTAM;PVR;HLA-B;HLA-DRA
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.36380006311275026,0.8266184290626035,0.6730769230769231,0.9115089638950743,1.0,7/49,7.34%,TGFB2;BMP6;ADAMTS7;BMPR1B;VSTM2A;DLX1;SOX9
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.3806370955457554,-0.826098455859475,0.7090909090909091,1.0,1.0,8/34,15.59%,DPM3;PGAP2;PIGO;PGAP4;PIGF;PIGW;DPM2;SCCPDH
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),-0.5391046938662495,-0.8260651446849756,0.7446808510638298,1.0,1.0,1/5,12.17%,PTPN12
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.39690970852381796,-0.8259299447705479,0.8076923076923077,1.0,1.0,10/39,19.34%,SQLE;HSD17B10;AKR1D1;SC5D;TM7SF2;PMVK;MSMO1;PARK7;CYP7B1;PSAT1
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.46830016168296096,-0.8257833356818037,0.6530612244897959,1.0,1.0,1/11,0.24%,BMP5
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.512143086261637,-0.8256178425610345,0.7,1.0,1.0,3/6,30.10%,GRN;CLN3;ATP6AP2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.45187875240911946,0.8255575500450192,0.7692307692307693,0.9129331072314338,1.0,6/13,32.51%,SEMA6A;NSMF;SRGAP2C;DAB2IP;PLAA;ZNF609
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3117725877263647,0.8255167231839343,0.8695652173913043,0.9126380254113751,1.0,17/106,12.26%,NFKBIE;BHLHE40;PIM1;TMIGD3;TBX6;ID2;MAP2K5;ARRB2;NFKBIA;CDKN2A;IRAK3;PLA2G10;ERBIN;CD200;HES1;MTURN;FZD6
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.5232673498470831,0.8251442235759445,0.6956521739130435,0.9129955908612793,1.0,3/7,23.34%,HES1;DAAM2;NF1
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),0.5617065866273133,0.8251365229247578,0.75,0.9126431819149569,1.0,4/5,40.88%,CAV3;CAV1;PACSIN2;CAV2
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.5032023285048813,0.8249755712592839,0.7021276595744681,0.9125019608144874,1.0,4/9,17.87%,PRKAB2;SLC25A20;ACACB;PRKAG2
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.38032834568121016,-0.8249217497367691,0.76,1.0,1.0,3/27,12.41%,CENPX;SMARCA5;NPM1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.540539941337252,-0.8248796784973513,0.7678571428571429,1.0,1.0,3/5,17.45%,MYADM;MAPK7;MBP
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.540539941337252,-0.8248796784973513,0.7678571428571429,1.0,1.0,3/5,17.45%,MYADM;MAPK7;MBP
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.37223663870468376,0.8247781442168554,0.7547169811320755,0.9124902185297932,1.0,2/40,5.56%,EGFR;TSPYL2
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.3712254821846355,-0.824747281616546,0.6274509803921569,1.0,1.0,21/61,27.54%,URM1;AARS1;TRMT112;PUSL1;METTL2A;TRMT10A;QTRT2;METTL6;TRMT1;PUS1;SSB;TRMT6;CTU2;TRMT13;AARS2;TRDMT1;ALKBH8;FTSJ1;ELP5;CTU1;OSGEP
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.27031467614230176,0.824531823193501,1.0,0.9125168002711409,1.0,106/791,15.64%,CREB3L1;CLDN5;TGFB2;IFNA2;PDGFB;VSIR;ZNF423;ANGPT1;MYT1;BMP6;PTPRC;PLSCR1;TP73;IGF1;TLR2;TRIM5;HEY1;PARP14;F3;WTIP;BHLHE40;SLC8A1;SCRT1;ZIM2;MEF2C;CASZ1;RIMS2;PID1;ZNF804A;GCM1;ELAVL2;NELL1;CITED2;ID2;VSTM2A;NTRK2;SLC24A3;NFKBID;WNT5A;SLC26A9;LILRB1;YBX3;KDM6A;SOX9;PER1;LEF1;ATXN1;SFTPD;TESC;SH3GL2;CLOCK;BCL6;IGF2BP2;MAFB;GTF2IRD1;FUBP1;MOV10;GNB3;ROBO1;MAPK11;RNF207;BNC2;ALPK2;MAPT;PHF19;ZNF516;PARP9;FGF17;TULP3;IFNK;SRRM4;ZNF486;RBM38;EOLA1;BACH1;PUM1;NFKBIZ;LYN;APBB2;CDH3;TAF5L;ZNF730;OLFM1;ZNF536;HAVCR2;KAT6B;ANK3;RFX3;SFRP4;RBMS3;ZNF148;VEGFA;NTRK3;TRIM22;RFXANK;SFMBT2;FOXN2;ZNF98;ZNF648;ZFP36L1;GPER1;NOCT;IL33;ZFAT;TCEAL1;CRX
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.45416473850005934,0.8239705582021292,0.72,0.913113056708337,1.0,5/11,18.38%,KDM4D;ZNF304;PARP9;HMBOX1;GMNN
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),-0.5465803928157699,-0.8237008312503785,0.7358490566037735,1.0,1.0,2/5,15.37%,HMGA2;MST1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.4315219137852485,-0.8234569672013725,0.7272727272727273,1.0,1.0,2/25,8.93%,PLAAT5;PLAAT4
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.38404386393728956,-0.8234377843882116,0.7903225806451613,1.0,1.0,1/59,0.14%,NGF
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.37327403288526534,0.823389408854465,0.7450980392156863,0.9136514037458116,1.0,14/52,15.92%,PLSCR4;PLSCR1;DMKN;PACSIN1;ANO6;ABCD2;SYT7;DYSF;RAB3A;CR1;COL5A1;ANK3;SYTL4;BIN1
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.49741600619616255,0.8231180454352895,0.7450980392156863,0.9137253164225743,1.0,2/9,16.90%,KAT2B;KAT2A
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.3583828441459097,-0.8230570545590136,0.8,1.0,1.0,15/93,12.59%,BUB1;GSG1;PARP2;LDHC;ART3;DDX4;MLF1;SEPTIN4;CCNB2;TSN;CFTR;RPL39L;TALDO1;GSTM3;PEBP1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.42406305090158275,0.8225791467058056,0.6,0.9141338765608686,1.0,8/18,18.55%,CITED2;ODAD3;DNAH11;DNAI2;ARL6;MKKS;PKD2;CFAP53
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.5123181267009784,-0.8225772609335272,0.7058823529411765,1.0,1.0,2/8,16.04%,PDPR;GSTZ1
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.5123181267009784,-0.8225772609335272,0.7058823529411765,1.0,1.0,2/8,16.04%,PDPR;GSTZ1
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),0.5517691079478317,0.8225336061757432,0.8,0.9138347251044749,1.0,1/6,0.81%,AQP1
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.3898451295127573,0.822491564303639,0.8076923076923077,0.913531038611778,1.0,5/27,18.42%,RUNX1T1;WNT5A;GPER1;WWTR1;E2F1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.3456167941506113,-0.822468454211389,0.8085106382978723,1.0,1.0,12/76,14.13%,PSMB6;PSMD7;PSME2;PSMD8;PSMB4;PSMD3;PSMB3;PSME1;GATA1;PSMA7;PSMB8;PSMD13
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.3315183189803997,-0.8223220828379858,0.8113207547169812,1.0,1.0,12/118,8.71%,CRYAB;GPRC5C;FSHR;S100A16;BCAM;ABLIM3;VWA1;COL18A1;TNS2;TF;CDC42EP1;SOD3
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.5450409570926091,-0.8220670369317524,0.7551020408163265,1.0,1.0,1/5,27.19%,PODXL
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.38138638242715545,0.8220112127693233,0.725,0.9140585736825058,1.0,10/33,18.97%,LRRK2;KYNU;ABCB4;WNT8B;TRPM2;GLDC;ALPL;TIPARP;SLC1A1;GGT5
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.46736394367102213,-0.821875820162222,0.6551724137931034,1.0,1.0,1/15,0.51%,DDIT3
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.4027288068320593,0.8217610843273273,0.6,0.9140892075686481,1.0,4/21,5.29%,IGF1;PPP1R3C;SORBS1;IRS1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.32424476141489145,0.8217388017764572,0.8260869565217391,0.9137523840406967,1.0,21/82,21.64%,GALNT8;POGLUT2;GALNT3;GALNT14;GALNTL6;GCNT4;ST8SIA6;B3GNT6;MUCL1;FKRP;ST6GAL1;MUC16;SLC35C1;GCNT1;POMGNT2;GCNT3;GXYLT1;GALNT9;PLOD1;OGT;GALNT6
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.5217458141753246,-0.8214739378730357,0.7115384615384616,1.0,1.0,4/9,39.93%,DICER1;CLP1;AGO4;ADAR
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.42037796606671335,-0.8213415183702774,0.6833333333333333,1.0,1.0,2/26,4.59%,RPS3;GSTP1
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.32279485780215683,0.8212882687178741,0.8695652173913043,0.9140597724463522,1.0,32/129,17.71%,TLR2;STAB1;F3;SELL;CLEC5A;LCP2;MET;CSF3R;SLC1A2;C3AR1;TNFRSF1B;SLC4A4;NFKBIA;RNF144B;AXL;OLR1;ADORA2B;RGS1;CX3CL1;SLC11A2;GABBR1;CD70;LYN;KCNMB2;ABCA1;ACVR2A;KLF6;NDP;SLC28A2;CDKN1A;PIK3R5;EDN1
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.4282215456757025,-0.8212098131360396,0.7446808510638298,1.0,1.0,6/18,17.39%,PARP1;VKORC1L1;TTLL9;TTLL3;NAA11;TPGS1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.48414409373637834,-0.8211713985520708,0.6226415094339622,1.0,1.0,1/8,2.75%,GREM1
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.42694138148205607,0.8209262748033457,0.7894736842105263,0.9143049281897299,1.0,4/13,9.27%,SAMHD1;NUDT3;GDA;NT5C1A
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.47116374908256786,0.8208487847958342,0.7,0.9140303849537039,1.0,1/11,4.57%,NRG1
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.41809747329918484,-0.8206255038160783,0.68,1.0,1.0,2/21,2.75%,WNT9A;GREM1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.38016307947178235,-0.8204261593302993,0.7169811320754716,1.0,1.0,7/31,18.14%,KIF3B;SOD1;BLOC1S4;DYNC1H1;KIF4A;AP3S2;DCTN1
prerank,PanglaoDB_Augmented_2021__Platelets,-0.33588447922451004,-0.8203613279944256,0.875,1.0,1.0,12/110,6.91%,CXCR4;OST4;CCR3;PPDPF;SELP;AQP9;SERPINE1;CD9;F5;ADGRE5;TLR1;EVI2B
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.4911259241618735,-0.8203441723542345,0.7307692307692307,1.0,1.0,1/8,2.83%,RAB7B
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.44966633537233996,-0.820297031264434,0.68,1.0,1.0,5/14,18.53%,PGP;GCK;MST1;CBFA2T3;FBP1
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.5486672804906046,0.8201749797159028,0.7380952380952381,0.9149137482193308,1.0,3/6,23.34%,HES1;DAAM2;NF1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.32426957968415004,0.8200352706563473,0.84,0.9147772848689584,1.0,10/69,11.21%,AQP1;FLT1;CHI3L1;F3;WNT5A;ADAM12;HSPB1;VEGFD;PRKD1;ZNF304
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.4809388819522238,0.8198048355900563,0.6521739130434783,0.9147599388873203,1.0,4/8,19.76%,HSPB1;PRKD1;VEGFA;KDR
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.46963833789705245,-0.8197383856281001,0.7241379310344828,1.0,1.0,2/9,5.89%,PARP2;PARP1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.432697533996227,-0.8197333679756311,0.6326530612244898,1.0,1.0,4/22,8.58%,DDIT3;HOXD3;BHLHE41;HES6
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.45167645333478734,-0.8196112953855544,0.660377358490566,1.0,1.0,3/11,15.37%,STMN1;RAC1;MST1
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.4088889199187348,-0.8194011607756669,0.7291666666666666,1.0,1.0,7/39,16.34%,GREM1;CCT2;PNKP;PINX1;DKC1;MEN1;PKIB
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.533813878197484,0.8193134117715019,0.7272727272727273,0.9152041679575086,1.0,2/7,15.31%,ARNT;SESN2
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.353806848194258,-0.8192839384706734,0.75,1.0,1.0,12/88,10.47%,LCK;AQP9;PRDX5;CROT;SOD1;AKR1D1;SOAT2;ABCA8;DHCR24;FDXR;ABCA9;NPC1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.44047859243305765,-0.8190730644373603,0.7037037037037037,1.0,1.0,2/15,11.40%,POLR2G;BTG2
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.3406472852927504,0.8182839222127438,0.8205128205128205,0.9166944551939994,1.0,9/61,13.84%,BAIAP2;SORBS1;IRS1;RHOQ;ATP6V0D2;GPLD1;PIK3R1;GRB14;PDK4
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.5443588368960519,-0.8180853511732269,0.72,1.0,1.0,1/5,2.65%,STMN1
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.49439710500688655,0.8180379007730003,0.6666666666666666,0.9168142376378189,1.0,1/7,2.75%,C1QB
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),-0.5404293122028008,-0.8174644294413502,0.7872340425531915,1.0,1.0,1/6,2.32%,TNFRSF21
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.49952724442386176,-0.8173744470777986,0.66,1.0,1.0,2/11,12.94%,EXOSC5;DKC1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.33392006916353645,-0.8173462178935416,0.8490566037735849,1.0,1.0,13/140,11.44%,TYRP1;RPL5;EIF3D;PTH;PCNA;PASK;DUOXA1;METTL5;RPS4X;PYM1;GCK;DDAH2;RPS27L
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.40550237636826936,-0.8163528031531209,0.82,1.0,1.0,6/22,20.75%,PTPA;CALM1;PPIA;PTBP1;SMPD1;DLC1
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.35649088465118056,0.8152143822993861,0.8043478260869565,0.9211827503815623,1.0,17/72,15.38%,CORIN;CGNL1;NPY1R;KALRN;SORBS2;SORBS1;COL12A1;ADAMTS6;CHRD;SLC7A9;MAOB;COL22A1;FRZB;HRH2;GHRLOS;ACSS3;A2M
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.36734897332248123,-0.8150470657629607,0.7777777777777778,1.0,1.0,1/53,0.14%,NGF
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4840076956832549,0.8150351049419865,0.7254901960784313,0.9211533551497317,1.0,1/9,8.11%,ABCD2
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.5279908920054451,-0.814649983105578,0.6923076923076923,1.0,1.0,1/5,11.91%,PPIA
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),-0.4896151783664568,-0.8144406286564221,0.76,1.0,1.0,2/7,8.36%,CD274;TARM1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3600533371177365,0.813810774847581,0.7111111111111111,0.9228572852624616,1.0,4/35,10.74%,EGFR;PTPRJ;SH3GL2;TGFA
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.4628976332502083,-0.813738255892451,0.6458333333333334,1.0,1.0,2/11,5.60%,STMN1;TUBB4A
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),-0.4740147808317805,-0.8135539954747888,0.6666666666666666,1.0,1.0,4/12,14.09%,AK8;CMPK1;ITPA;SMPDL3A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.4187905017570984,0.8134177295180056,0.7142857142857143,0.9231974939974499,1.0,4/17,15.50%,NCKAP1L;LGALS3;VEGFA;THY1
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.43122718255699327,0.813234612380104,0.6,0.9231246183468311,1.0,5/12,29.49%,LYN;PRKCE;LBP;TICAM1;IL18
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.3958443102776832,0.8130771809786035,0.8181818181818182,0.9230328292266289,1.0,9/29,12.42%,AQP1;RIMS2;PDE7A;NUDT4;IRAG1;SOX9;ADCY2;HTR2C;ADCY1
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.5091131487307132,0.8130075630185041,0.6785714285714286,0.9227751745100309,1.0,2/5,18.73%,PGAP1;PIGK
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.4113362118540991,0.8123435988142504,0.8333333333333334,0.9236030085977107,1.0,1/18,4.94%,RGPD3
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.5259247959165684,0.8120963253140906,0.7678571428571429,0.9237101050743924,1.0,1/7,6.10%,PEX11A
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.34405470537992755,-0.8120313047384553,0.8214285714285714,1.0,1.0,11/91,13.52%,COPE;ARCN1;AP2S1;CD63;GLA;SOD1;LMAN1;TMED2;ERGIC3;SSPN;COG2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.3288063785617542,0.811993079314428,0.86,0.9235329908038257,1.0,8/71,8.09%,DOK3;CD44;ADGRE2;PIM1;LRP8;MFSD2B;LMO2;TAL1
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.3966403282396339,0.8117475156664197,0.7916666666666666,0.9234838235779884,1.0,5/29,12.13%,VCAN;CSPG4;HEXB;NCAN;CSPG5
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.5169529787940507,-0.811691343278531,0.7307692307692307,1.0,1.0,3/8,32.93%,CDC42;CCNB1;ECT2
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.305008047120437,-0.8114620394300321,0.8596491228070176,1.0,1.0,38/283,18.14%,RPS27A;UBC;RNF8;UBB;PSMB6;PSMD7;PSME2;PSMD8;UBE2D4;FBXW10;RNF167;CDC23;CDC26;PSMB4;TMEM129;PSMD3;PSMB3;PSME1;UBA52;PSMA7;KLHL20;PSMB8;RNF6;DCAF15;PSMD13;MYLIP;FBXW8;UBE2Q2;ERCC8;UBE2A;PSMD2;RNF126;TRIM14;FBXL15;PSMC5;UBE2L3;RNF41;ANAPC11
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.4466361385963674,-0.8112338879722911,0.6851851851851852,1.0,1.0,7/17,16.27%,FIS1;BAX;BAK1;TIMM50;IFI6;GGCT;BAD
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.4504745697303277,-0.8111641731456329,0.82,1.0,1.0,1/26,0.29%,CXCR4
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.41605110819646635,-0.8108767349542086,0.6666666666666666,1.0,1.0,3/26,4.89%,CA6;CA5A;CYB5R1
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.4471462314930448,-0.810751330890004,0.6274509803921569,1.0,1.0,1/8,5.44%,CHAMP1
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4438300378647504,-0.8107263886539865,0.7115384615384616,1.0,1.0,2/13,11.40%,POLR2G;BTG2
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.46465073831726267,-0.8105445221524928,0.6808510638297872,1.0,1.0,2/9,4.75%,SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.3671757411842498,-0.810478986079595,0.7636363636363637,1.0,1.0,8/62,10.78%,RPS3;SFRP1;TNFRSF21;CRHBP;HYAL2;ADAMTS12;CHUK;GBP3
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.34183251877925813,-0.810454443915011,0.7777777777777778,1.0,1.0,22/115,19.21%,DAD1;DPM3;B3GALT4;PMM1;B3GALT9;B4GALT7;C1GALT1C1;MOGS;NPC1;DDOST;GALNT1;GOLGA2;B3GNT9;MAGT1;DPAGT1;ST3GAL1;B3GNT3;MGAT4B;ALG5;ALG3;DOLPP1;ALG12
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.3938225266784476,-0.810433583635844,0.6964285714285714,1.0,1.0,3/31,8.41%,LCK;GPR89A;RAG2
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),-0.46731077619539285,-0.8103681003277192,0.6415094339622641,1.0,1.0,1/8,6.43%,GBA3
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.40388108980252885,0.8102060552628941,0.7916666666666666,0.9255544559610218,1.0,3/29,6.61%,CERS3;WNT5A;SCEL
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.473014337521306,0.8101928129111445,0.7115384615384616,0.9251923559806574,1.0,4/14,16.82%,PTPRC;SASH3;CR1;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),0.5459448186152385,0.8100151877487145,0.7692307692307693,0.9252087714075544,1.0,2/5,18.95%,ACVR1C;GJA1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.42337489436404974,0.809718807058041,0.68,0.9254236620336042,1.0,2/14,6.15%,PDGFB;MAP2K5
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4170207622524813,-0.8094377317201114,0.7543859649122807,1.0,1.0,6/24,19.65%,TCEA2;ALYREF;EAF2;CCNT1;SUPT5H;CCNK
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.41054426193797317,0.8093881096193277,0.7843137254901961,0.9255533479984219,1.0,5/25,14.21%,ITGAM;KCNB1;DMTN;ANK3;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.4038060427369055,0.8093870095868969,0.7678571428571429,0.9251871068579162,1.0,3/22,4.37%,PDGFB;F3;PDGFRA
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.3399279306748384,-0.8091537760707155,0.8363636363636363,1.0,1.0,9/99,8.04%,CXCR4;CRYAB;TXLNB;SRL;SLC25A4;ACTN2;ART3;SMYD1;NPPC
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),-0.5435987012837267,-0.8090539132371308,0.7391304347826086,1.0,1.0,1/5,1.28%,SELENOS
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.4052639029276929,-0.8089595146524317,0.7592592592592593,1.0,1.0,4/28,10.98%,PFDN2;TMED9;LMAN1;ANXA2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.5172134764588828,0.8089134382389165,0.6521739130434783,0.9256566404824644,1.0,2/5,10.56%,JAM2;DOCK8
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.5195509863698107,-0.808806884657018,0.75,1.0,1.0,2/6,15.05%,GALT;GALK1
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.4812532676117086,0.8085600010964504,0.6956521739130435,0.9259370643093688,1.0,1/8,11.37%,HOMER1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.3503392288580608,-0.8078799191441525,0.673469387755102,1.0,1.0,3/62,3.83%,NGF;DPEP1;BEX3
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),-0.4854354094520145,-0.8078505682985393,0.8,1.0,1.0,1/5,9.46%,ACVR1B
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.5481121158147274,0.8075580133177688,0.803921568627451,0.9272407341655398,1.0,1/5,6.98%,SLC43A1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.44217846509469716,0.8074680729614562,0.7142857142857143,0.9269592662232155,1.0,1/15,1.51%,CD44
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.37959837806216046,-0.8074348786755511,0.8035714285714286,1.0,1.0,1/42,0.14%,NGF
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.4196279974037055,-0.807377208905432,0.7592592592592593,1.0,1.0,6/20,23.18%,NCL;SF3B4;CIRBP;PRDX6;RBMX;PAF1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.4331621964164777,0.807094992120483,0.75,0.9271540042336872,1.0,1/13,1.88%,TRIM5
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.38422966114672946,-0.806706593053987,0.75,1.0,1.0,13/43,20.16%,SQLE;HSD11B1;HSD17B10;AKR1D1;FDXR;SC5D;SRD5A1;TM7SF2;PMVK;MSMO1;CYP7B1;PRLR;STAR
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.4742453752639456,-0.8062218107677627,0.6851851851851852,1.0,1.0,1/10,2.04%,PTH
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.34970337134584634,-0.8060303480768125,0.85,1.0,1.0,6/78,9.35%,CRYAB;PRR7;UBB;CHMP2A;DHCR24;TMEM109
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.35999744448183046,-0.8056534980390161,0.7586206896551724,1.0,1.0,20/67,21.43%,GEMIN6;PTTG1IP;NUTF2;PHB2;RAN;SNUPN;SMN1;SNRPD1;NXT2;SNRPD2;SNRPB;SNRPE;SNRPG;NXT1;APPL2;EIF4ENIF1;IPO5;RANBP17;TPR;IPO7
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.4370682041597442,0.8054582763526332,0.7619047619047619,0.9296144797075839,1.0,3/19,9.79%,PKP2;FGF13;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.4139774261298304,0.805310453699401,0.803921568627451,0.9294783768467234,1.0,3/14,20.80%,SRC;GPER1;ATP1A2
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.4120129455850813,-0.8052518997983117,0.75,1.0,1.0,2/22,5.17%,DSCAM;SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),-0.485543963393532,-0.8051317038536455,0.7321428571428571,1.0,1.0,3/9,16.86%,ANXA2;VAMP3;SCRIB
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),0.4747022023101214,0.8039230238569283,0.6666666666666666,0.9313193364026149,1.0,3/13,5.26%,NCKAP1L;SYK;ID2
prerank,GO_Biological_Process_2021__caveolin-mediated endocytosis (GO:0072584),0.5116779023478957,0.8038274346536441,0.72,0.9310509171203484,1.0,2/5,30.49%,MLC1;CAV1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.4981434136999299,0.8036527512594868,0.7090909090909091,0.930966139847501,1.0,4/7,16.73%,ACSM1;ALOX12;ADIPOR2;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),0.4757310768907494,0.8036101756214868,0.7659574468085106,0.9306369575578293,1.0,2/8,10.72%,NCKAP1L;BST1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.4329563338747496,-0.8035088085952911,0.7291666666666666,1.0,1.0,1/12,6.73%,DNMT3B
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.419051575881518,0.8034578060334354,0.7115384615384616,0.930472521159607,1.0,4/11,19.72%,MT1M;GLRA2;GLRA1;ATP13A2
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.33040891905682107,0.8030511565365581,0.84,0.9307497948498394,1.0,9/77,11.54%,IGFBP3;LRRK2;PID1;FBLN1;SH3GL2;GIT1;CDKN2A;CORO1C;MAPT
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.5020068068293153,-0.8030259496556278,0.7307692307692307,1.0,1.0,3/7,39.93%,DICER1;AGO4;ADAR
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.51598003666695,0.8029566077441247,0.723404255319149,0.930524399465498,1.0,1/5,3.46%,ABHD3
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.49400272209612694,-0.802951165464068,0.6938775510204082,1.0,1.0,1/8,4.59%,GSTP1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.48300420700540947,0.8027306554942105,0.7,0.9304963277039096,1.0,3/7,30.20%,FERMT3;CXCL13;SKAP1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.41411323550902746,0.8023447958959466,0.6666666666666666,0.9308061048945171,1.0,2/23,3.85%,NTNG1;ZNF804A
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.36631766352544376,-0.8023035862830262,0.7735849056603774,1.0,1.0,2/47,2.40%,TLN1;SRPRA
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.46201930910299643,-0.8022769341213397,0.6808510638297872,1.0,1.0,2/8,14.96%,TAF7;PIH1D1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.45837333755656684,-0.8021694316923806,0.7843137254901961,1.0,1.0,1/12,0.48%,ZDHHC12
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.32507235767666176,-0.801836811631342,0.8548387096774194,1.0,1.0,16/160,11.57%,PDE3A;DDIT3;WWC2;MYADM;NOC2L;GSTP1;HYAL2;RACK1;OTUD3;NOP53;CCDC22;SPRY3;ADIPOR1;TRIM59;PRKAA2;TMSB4X
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),-0.42865653188548,-0.8017835526334148,0.7037037037037037,1.0,1.0,5/18,21.28%,NELFE;CTR9;CCNT1;SUPT5H;VIRMA
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.48411035290526355,0.8016161786122072,0.775,0.9315612014231441,1.0,2/11,10.61%,NTNG1;MOV10
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),-0.509153497328567,-0.8014531037314807,0.7916666666666666,1.0,1.0,2/5,18.57%,ADIPOR1;APPL2
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.3744358107315871,-0.801396738456545,0.7547169811320755,1.0,1.0,9/59,11.57%,DDIT3;PTGIS;PRMT2;COMMD6;TCEAL7;NLRP2;CCDC22;CHUK;TMSB4X
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.42807756275157305,0.8010755092013447,0.775,0.9319968924767401,1.0,1/13,3.54%,TBC1D10A
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.550674291161142,-0.800900323794057,0.7636363636363637,1.0,1.0,2/5,15.75%,CHMP2A;CEP120
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.35501835268318604,0.8007866747952838,0.8604651162790697,0.9320854405858566,1.0,5/45,10.54%,BIRC3;SYK;H2BC11;LAPTM5;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.3590463730815645,-0.8005940400556802,0.8333333333333334,1.0,1.0,16/61,22.35%,NDC80;PYHIN1;NUMA1;RIC3;VPS28;RANGRF;PRKAA2;EIF2AK3;MAP1A;CROCC;PARK7;SYT11;LAMTOR5;MEAK7;GPR137B;TESK1
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.4653738642235625,0.8005235147031212,0.7115384615384616,0.9321645491319147,1.0,4/9,16.00%,SLC22A3;ANTXR1;RAB29;SLC29A4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.47866597165771335,0.800073367327286,0.717391304347826,0.9325245574908143,1.0,2/10,6.32%,VSIR;LILRB1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.34538137806442093,0.8000160525821859,0.7619047619047619,0.9322195989197466,1.0,2/43,2.48%,CERS3;CERS6
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.4519102907211655,0.7998640552229358,0.7169811320754716,0.9321301162141398,1.0,2/11,5.61%,ADGRB1;XKR4
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.5028992955387372,0.7998060444685561,0.7555555555555555,0.9318489420299726,1.0,3/5,20.37%,LILRB1;FBN1;NOTCH2
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.3575048633487572,0.7993086481356282,0.7647058823529411,0.9321524008430093,1.0,2/29,2.50%,GRM5;CYFIP1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.4527720480266815,-0.7991468197270668,0.7547169811320755,1.0,1.0,2/14,8.93%,MBOAT1;PLAAT4
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.3399595401594736,-0.7990846225072189,0.8909090909090909,1.0,1.0,10/88,10.40%,PDE3A;JUP;SFRP1;AQP9;CRHBP;LAMTOR4;RRAGA;P2RY6;CFTR;HCN2
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.35205020777476753,0.7990315787634245,0.7659574468085106,0.9322406413975325,1.0,9/40,14.21%,SYNPO2;CARMIL1;TPM1;VIL1;TGFB3;CX3CL1;FHOD1;SYNPO;ITGB1BP1
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),-0.5075007885480145,-0.7989706509796869,0.72,1.0,1.0,1/6,8.48%,RHOA
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.35690744673348784,-0.7988348827376811,0.7547169811320755,1.0,1.0,11/72,14.96%,TRABD2B;RPS3;PFN1;RACK1;CHMP2A;BAX;BAK1;SNF8;HGS;BRK1;PIH1D1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3314139236317252,0.7987879681896336,0.8823529411764706,0.9322634099793263,1.0,11/72,12.35%,PDGFB;EGFR;CDK5R2;CDKN3;CCNF;CCND1;PLK1;CDKN2A;SPDYA;CDK5R1;NR2F2
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),-0.4821004934486385,-0.7986863083302278,0.7142857142857143,1.0,1.0,2/9,11.02%,MEOX1;HMGA2
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.480622250539995,0.7985212434099466,0.7608695652173914,0.9322861605123041,1.0,1/7,3.11%,FAP
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.43699162079382403,0.7983799112033814,0.7115384615384616,0.9321175103713631,1.0,1/10,7.14%,ACADL
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.4527458455961339,0.7982454033648699,0.7551020408163265,0.9319163316693232,1.0,1/12,2.66%,CAMSAP3
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.4167267650022233,-0.7981580292196311,0.75,1.0,1.0,6/13,19.32%,RPS3;AGER;ICOSLG;FADD;HMGB1;TNFSF9
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.335879256462991,0.7978283003121053,0.8461538461538461,0.9322423638670261,1.0,3/43,9.72%,MIDEAS;PER1;TBL1XR1
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.38040703229187295,0.7978035523627574,0.7142857142857143,0.9319154121290217,1.0,6/23,19.19%,KASH5;P3H4;SYCP2;TERB1;IHO1;SYCP1
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.42949577016324,0.7977725226898762,0.7380952380952381,0.9315840585718083,1.0,6/14,25.26%,ADCY7;SASH3;SAMSN1;TNFSF4;TRIM27;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.39291710443699607,-0.7976143317349588,0.6976744186046512,1.0,1.0,3/21,12.41%,CDK4;DBF4B;NPM1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.3863848031324389,0.7973138235079952,0.7450980392156863,0.9319238113245979,1.0,2/25,11.54%,LRRK2;MAPT
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.46601777536546274,0.796738290105788,0.7586206896551724,0.9325007922666227,1.0,2/8,9.07%,SOCS3;PTPRT
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.4675684187318094,0.7967347203363905,0.75,0.9321463253820094,1.0,3/11,27.74%,CDK12;CDK13;EAPP
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.5338095418350973,-0.7967228831549295,0.7647058823529411,1.0,1.0,1/5,1.52%,KCND3
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),-0.4904115317979399,-0.7961791166166449,0.6981132075471698,1.0,1.0,2/6,11.79%,HDC;CARNS1
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),-0.4904115317979399,-0.7961791166166449,0.6981132075471698,1.0,1.0,2/6,11.79%,HDC;CARNS1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4281929598128247,0.7959764294090169,0.7560975609756098,0.9329228468962445,1.0,4/15,16.84%,SPRED3;DMTN;PARD3;DDIT4
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.540291220053019,0.795920700354763,0.7272727272727273,0.9327080317890649,1.0,1/6,9.99%,EDNRB
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.4207088285273459,-0.795319628912226,0.6862745098039216,1.0,1.0,2/14,6.89%,GBA3;GLA
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.332696340406591,-0.7952729515719931,0.819672131147541,1.0,1.0,16/98,15.56%,RPS3;PRR7;CENPX;UBB;UBXN1;PTTG1IP;VPS28;SEPTIN4;PINX1;SVBP;SQSTM1;DAXX;UFL1;SMAD7;SH3RF2;DNAJA1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.35129992700215,0.7950281746275504,0.8703703703703703,0.9337394384195519,1.0,8/42,14.70%,ANGPT1;BMPER;VEGFD;GPLD1;ROBO1;CDH13;ITGB1BP1;VEGFA
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.3714883496523177,-0.7948423674139534,0.7547169811320755,1.0,1.0,11/41,26.08%,PGAM1;GCK;RAE1;NUP37;NUP210;TPR;POM121C;SLC2A6;NUP93;NUP42;NUP85
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.47389342427624515,0.7947973535867998,0.72,0.9336267181811292,1.0,5/10,13.27%,CD44;SRC;VIL1;CORO1C;KANK1
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.4824702212424963,-0.7945972468900907,0.6862745098039216,1.0,1.0,1/6,5.54%,RACK1
prerank,GO_Biological_Process_2021__hydrogen peroxide biosynthetic process (GO:0050665),-0.49852226466636673,-0.7945215085339581,0.7346938775510204,1.0,1.0,3/5,19.46%,SOD1;CYBA;ACOX1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.3252990276162554,0.79441869725917,0.7916666666666666,0.933839291559049,1.0,14/57,16.14%,ROBO2;KLF9;MEF2C;NR4A3;SRC;LMO2;GHR;SRA1;NCOA1;THRB;ZFP36L1;GPER1;NSMF;UCP1
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.420512890912941,0.7942859961743832,0.7560975609756098,0.9337266208229272,1.0,2/16,5.19%,CSF1R;SRC
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.3263791929905657,-0.7942787943952904,0.8431372549019608,1.0,1.0,21/119,18.06%,TEAD2;POLR2L;TEAD3;POLR2G;POLR2K;POLR2I;GTF2F1;NR2C2AP;POLR2A;TAF13;TAF7;POLR2E;HNF4A;POLR2C;POLR2D;TAF11;NR5A2;RXRB;GTF2H2;TAF9B;POLR2J
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.355358627511995,-0.7940191244611493,0.8,1.0,1.0,1/64,0.14%,NGF
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.3781956189735859,0.7935153084851021,0.8431372549019608,0.934621379074289,1.0,2/32,6.25%,TGFB2;SULF1
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.3660559466427203,0.7934371188535014,0.72,0.9343507191184386,1.0,3/27,9.79%,SLC8A1;TSPYL2;CAMK2D
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.3493371326692535,-0.7931506125180159,0.7761194029850746,1.0,1.0,7/66,10.34%,RPS27A;UBC;UBB;CNPY3;TLR1;S100A1;CHUK
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.4747961168967372,-0.7928750196709844,0.6964285714285714,1.0,1.0,2/10,9.68%,CORO1B;ARFIP2
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.49832639871525153,-0.7927189227882939,0.7111111111111111,1.0,1.0,1/5,15.43%,WRAP73
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),-0.483591434610693,-0.7927050629167443,0.74,1.0,1.0,1/8,8.64%,OTUD3
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.4247614142825285,0.7926749619383037,0.76,0.9351053731619662,1.0,6/19,21.01%,PTPRR;TGFB3;ZNF568;VEGFA;CHD7;MBNL1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3714349806505718,0.7926457997128474,0.7954545454545454,0.9347976426458366,1.0,5/33,13.46%,SOCS3;SLA2;IP6K3;PIK3R1;PIP4K2A
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.49340073177339694,0.7926432723596042,0.7254901960784313,0.9340624498478455,1.0,2/6,21.11%,PIK3R1;DUSP3
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.49340073177339694,0.7926432723596042,0.7254901960784313,0.9340624498478455,1.0,2/6,21.11%,PIK3R1;DUSP3
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.4046746868634966,0.7921286535860842,0.74,0.9345427914736576,1.0,3/18,12.16%,SMYD2;SETMAR;SETD1A
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.44972369148257946,0.7918793363993512,0.7446808510638298,0.9345227855370282,1.0,2/8,23.11%,CRY2;CRY1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.4315893295014893,0.7913293099148945,0.7407407407407407,0.934947038612887,1.0,5/12,19.53%,NEDD4L;NOS1;KCNH2;BIN1;CAV3
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),-0.4982515627571683,-0.7911828945074934,0.6808510638297872,1.0,1.0,1/5,17.00%,ENG
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3464677030179122,-0.7904989715417007,0.7692307692307693,1.0,1.0,14/87,18.33%,RPL11;RAD23A;UBXN1;RACK1;ARAF;ELOB;NOP53;KEAP1;UFL1;SMAD7;SH3RF2;MAP1A;PARK7;CBFA2T3
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.3491750385344462,-0.790409396587375,0.7894736842105263,1.0,1.0,3/69,1.12%,ARHGEF16;GPRC5C;FXYD4
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.5029580341827304,-0.7904092333829877,0.7358490566037735,1.0,1.0,1/7,4.11%,NOC2L
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.3564653605275261,-0.7903501001029665,0.8301886792452831,1.0,1.0,3/42,6.84%,C1GALT1C1L;MUC4;C1GALT1C1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.5245760390604393,-0.7903050692526946,0.7291666666666666,1.0,1.0,2/6,20.36%,TOMM7;PINK1
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.4462741569418053,0.7902679374823633,0.7407407407407407,0.9363469849388397,1.0,6/11,29.08%,NOS1;NOS2;CACNA1C;NF1;STIM1;MAPK14
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.33755089623971685,0.7900814232783488,0.7735849056603774,0.9362338164337688,1.0,10/46,24.17%,MSL2;PER1;LEF1;ACTL6B;JADE2;OGT;CHD5;KANSL1;ING5;RUVBL2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.3108526013104656,0.7900344400916434,0.8333333333333334,0.9359219869370274,1.0,21/78,21.11%,PTPRC;SLC8A1;PTPRB;HSPB1;DUSP10;PTPRT;CORO1C;UBASH3B;PTPRO;CAMK2N2;ITGB1BP1;THY1;CDKN1A;MACROH2A1;PRKAG2;WWTR1;YWHAG;CAV3;PAK2;CEP85;DUSP3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.400735383801445,0.7895198851856156,0.7317073170731707,0.9363265447095724,1.0,3/14,9.79%,SLC8A1;DMD;CAMK2D
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.48018286680854205,-0.7884339564754419,0.7090909090909091,1.0,1.0,1/10,5.54%,RACK1
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.4452091796322139,-0.787760229167806,0.6530612244897959,1.0,1.0,3/10,23.66%,PHB2;DNAJC19;MFSD2A
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.44771620755749314,-0.7876600857174935,0.7592592592592593,1.0,1.0,1/16,3.53%,VAMP8
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.459431687219196,-0.7874809015608367,0.7222222222222222,1.0,1.0,2/7,16.98%,CD81;FADD
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.32444582356070945,-0.78746599586945,0.9298245614035088,1.0,1.0,43/180,17.83%,UBC;JAGN1;CYC1;ACAA2;GRPEL1;GPX4;ECHS1;CMPK1;SOWAHC;SLC25A1;SAMM50;COX7B;SOD1;ARAF;RMDN3;NDUFAB1;ETFB;CAVIN1;PRDX3;ECH1;UCK1;COX6A1;UQCRQ;CHUK;TALDO1;UCP2;ABCB8;CDKN2C;MRPL15;TKT;SSPN;HSPB8;MGST3;UQCR10;SLC25A10;APLP2;ESYT1;GPAM;MGLL;NDUFA5;ACADS;DHRS7;PTCD3
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.48596034671394095,0.7874045540543417,0.74,0.9391647159939128,1.0,4/8,19.24%,DDAH1;NOS1;NOS2;ARG1
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.5175939879825747,0.7872615832919765,0.7083333333333334,0.9390229208149957,1.0,2/6,11.81%,NECAB2;CX3CL1
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.43117447079754123,-0.7870106727983637,0.7307692307692307,1.0,1.0,2/11,5.17%,THAP1;SEMA5A
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.48472657347307135,0.7867898498182018,0.6909090909090909,0.9393934846493298,1.0,2/8,22.88%,ZFAND6;LONP2
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.32145041208388797,0.7865303183843008,0.8636363636363636,0.9395653976095659,1.0,11/79,11.21%,AQP1;FLT1;CHI3L1;F3;WNT5A;BMPER;ADAM12;HSPB1;VEGFD;PRKD1;ZNF304
prerank,GO_Biological_Process_2021__regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),0.5150896650889052,0.7861211946967261,0.8235294117647058,0.9398432343780696,1.0,3/5,14.00%,LILRB1;LGALS3;HAVCR2
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.37436197156264783,-0.7860691610149769,0.7818181818181819,1.0,1.0,5/35,14.15%,SLC22A2;SLC3A2;SLC38A7;SLC7A11;SLC38A9
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.4242309167223336,0.7854716026351465,0.8,0.9404481232590411,1.0,4/13,22.37%,TNK2;PROM2;DGKD;WASL
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.3427222005221134,0.7853339797670383,0.8095238095238095,0.9402876729212983,1.0,4/38,8.45%,MAP2;LRRK2;LRCH1;NOS1
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.42496861639293787,-0.7851814331859454,0.8333333333333334,1.0,1.0,3/16,7.17%,PLPP2;SPHK2;CALM1
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.4001440988283632,0.7850994861095598,0.717391304347826,0.9402655228078621,1.0,2/19,8.64%,HOOK1;KIF16B
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),-0.5228980135710857,-0.7848920584679072,0.7446808510638298,1.0,1.0,2/5,20.54%,URM1;CTU2
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.47245490571359977,0.7846492498965933,0.7,0.9405518597454167,1.0,3/7,30.23%,SASH1;PARP10;PLAA
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.4802704885205715,0.7843884565526111,0.8,0.9406170660615507,1.0,3/5,25.79%,SFXN3;SFXN1;SLC1A4
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.3140680323501873,0.7840574260210877,0.9285714285714286,0.9407006231770266,1.0,5/68,8.16%,CHRM3;LOX;ST8SIA4;UBA7;ST3GAL6
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.32692409875707273,-0.7838757507217156,0.9137931034482759,1.0,1.0,29/127,21.15%,JUP;RBM22;UBL5;ABLIM3;TFDP1;HYAL2;RAN;CD81;MYO1C;CEP131;FIS1;YWHAB;HRAS;SAR1B;TOMM7;YWHAQ;VPS11;BAD;PLK3;ANP32B;EMD;TRIM28;UBE2L3;ZPR1;IPO5;PINK1;TPR;FLNA;DMAP1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.30848147166813744,0.7837392289403006,0.8936170212765957,0.9409128768397299,1.0,7/80,8.11%,E2F3;SYK;PRICKLE1;NUP62CL;SPRN;HEATR3;ABCD2
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.3375029055169205,0.7836199689574251,0.8666666666666667,0.9407572176260146,1.0,14/53,18.36%,ABHD3;LPCAT4;SLC44A5;PLAAT1;GPLD1;PLAAT2;PLA2G10;GPAT4;CHPT1;PLA2G4A;ACHE;MBOAT2;CSNK2A1;CHKA
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.5011647520405925,-0.7835166922355976,0.7647058823529411,1.0,1.0,1/5,2.75%,GREM1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.450684825642672,-0.78334374970558,0.8125,1.0,1.0,2/14,15.28%,RACK1;GSN
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),0.44383239467596036,0.7830643308118969,0.6981132075471698,0.9411117301318391,1.0,1/8,3.38%,IL12A
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.43039430773228615,-0.7829941341942153,0.7368421052631579,1.0,1.0,3/9,5.41%,CFL2;SEMA5A;ACTN2
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.4598104686910048,-0.7829149540399708,0.84,1.0,1.0,2/9,5.08%,SLC22A2;DAGLA
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.3102566269133137,-0.7822448278607289,0.9152542372881356,1.0,1.0,8/98,8.48%,RPS3;SFRP1;RACK1;GBA3;FNTA;CALM1;RASGRF1;RHOA
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.49466399829428775,-0.782128194956875,0.7608695652173914,1.0,1.0,2/7,13.17%,NUMA1;SAPCD2
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.3664216902057283,-0.7813988030424578,0.8,1.0,1.0,11/46,15.99%,PRELID1;GAPDH;SERPINE1;PSME2;KNG1;SERPINB8;PSME1;SERPINH1;PSMB8;NCSTN;TIMP2
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.34288105070528035,-0.7811575814925432,0.8571428571428571,1.0,1.0,2/76,1.51%,CELA2A;SFRP1
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.4853071048130436,0.7809655271037005,0.7083333333333334,0.9441668009252896,1.0,2/7,15.03%,MAP2K5;ABCA1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.36906273175452187,-0.7807746764906713,0.8,1.0,1.0,1/32,1.56%,TINF2
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.4407831734913112,0.7807147553186217,0.8,0.9441615739929331,1.0,4/14,6.75%,CSF1R;CYFIP1;CARMIL1;TPM1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4685814619940027,-0.7805264838105562,0.7368421052631579,1.0,1.0,2/13,5.02%,WNK4;ATP1B1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.38477164114625567,0.7804838884238952,0.8163265306122449,0.9441655304882112,1.0,1/21,1.31%,PRR16
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.4578416334899388,-0.780471095988742,0.765625,1.0,1.0,3/10,12.85%,NT5C;DNPH1;ITPA
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.404070942770233,0.7803392097050197,0.6888888888888889,0.9440639624238963,1.0,10/18,27.71%,STAT6;GHR;PIAS1;PKD2;STAT5A;SOCS6;STAT3;STAT5B;PKD1;STAT4
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.3549390720563847,-0.7802464026948246,0.82,1.0,1.0,9/64,17.45%,CYB5A;SEC61B;BNIP1;LMAN1;REEP4;TRDN;EIF2AK3;LMAN2;EMD
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.4124072303006282,-0.7800125138572875,0.7407407407407407,1.0,1.0,3/17,11.22%,ACTG1;SCARF1;HRAS
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.43185454284035424,-0.779774076996332,0.6956521739130435,1.0,1.0,6/9,31.54%,YBX1;RTRAF;SIDT2;NXF5;HNRNPA2B1;RBFOX1
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.3395705471813257,0.7795611466757738,0.7333333333333333,0.9448796943297904,1.0,8/40,11.80%,MET;NRG1;CITED2;SOX9;EPHB3;TGFB3;NOTCH4;HES1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.42834885058149635,0.7795263596019695,0.8,0.9445624643813366,1.0,3/15,7.34%,SRGN;MEF2C;SOX9
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.4480346550107459,-0.7790437345680938,0.7291666666666666,1.0,1.0,1/11,1.46%,SEPHS2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.4313478179154149,0.7785672822475546,0.75,0.9455606693061719,1.0,1/22,1.17%,PTPRC
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),-0.4852328416506868,-0.778388711320955,0.8,1.0,1.0,1/6,16.50%,TOR1A
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.4379997820902669,0.7782638809484297,0.76,0.9456419469770464,1.0,4/12,12.44%,ADGRV1;GRM2;EDNRB;GABBR2
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.4709272459362854,-0.7777017559928738,0.851063829787234,1.0,1.0,2/11,5.02%,KCND3;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.44570105612606065,-0.777229345958345,0.7659574468085106,1.0,1.0,2/12,13.19%,PRKAA2;KAT5
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.4105238800184378,-0.7770790744837442,0.84,1.0,1.0,4/23,4.14%,SELP;SERPINE1;RPL30;RPS19
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.3331694898145762,-0.7770337514228948,0.8548387096774194,1.0,1.0,4/67,4.69%,RPS2;CENPX;UBB;PTTG1IP
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.34488609224337485,0.7765620264147804,0.7843137254901961,0.9477333314549027,1.0,6/34,16.89%,RAB3C;RAB15;RAB3A;OLFM2;ABCA1;TVP23A
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.35936173090925466,-0.7765376398231888,0.8928571428571429,1.0,1.0,7/40,12.79%,JUP;SFRP1;ADAM15;SPHK2;CFTR;BLM;AHR
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.43486300301908576,-0.7763187699468791,0.8181818181818182,1.0,1.0,4/17,12.98%,POLD3;DCLRE1B;MCM4;MCM3
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.49313496793067296,0.7762531752535441,0.7105263157894737,0.9477999703049534,1.0,3/7,26.82%,FZD3;ASCL1;NRP2
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.33841781398748816,-0.7761653644152706,0.864406779661017,1.0,1.0,5/68,5.78%,CXCR4;SELP;AQP9;CD9;LILRB3
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.4840019008840453,-0.7760509153814948,0.84,1.0,1.0,2/10,5.02%,KCND3;ATP1B1
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.33682015618768246,0.7759332867543371,0.8913043478260869,0.9478482557229858,1.0,11/43,18.33%,SLC23A1;SLC6A11;SLC16A14;SLC6A15;SLC7A8;SLC6A7;SLC38A6;SLC17A5;SLC15A4;SLC1A1;SLC16A2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.3537400787240256,-0.7758867754326902,0.8771929824561403,1.0,1.0,1/62,0.14%,NGF
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.352113753351559,-0.7758255309258373,0.7321428571428571,1.0,1.0,7/49,10.83%,CDK4;TFDP1;PHB2;CDC23;LSM10;ADAMTS1;DBF4B
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.4736175572650702,0.7757809069124715,0.78,0.9477089843200788,1.0,3/10,8.45%,GAD1;DDAH1;NOS1
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),0.43875107549062986,0.7756139172722528,0.7142857142857143,0.9476338271495813,1.0,1/10,3.39%,EPHA4
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.47019248153617227,0.7755374124976625,0.7666666666666667,0.9473667843359497,1.0,3/9,9.63%,F3;ANO6;DMTN
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.42082348708661604,-0.7754844934307451,0.7407407407407407,1.0,1.0,1/18,2.01%,NES
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.4638610985817265,-0.7754455941346097,0.8653846153846154,1.0,1.0,3/8,13.78%,ATP1B1;ACTN2;AKAP9
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.3530374097214383,-0.7754411911150921,0.8163265306122449,1.0,1.0,18/57,22.32%,PCNA;NOC2L;HYAL2;PARP1;SDE2;TRIAP1;BAK1;NPM1;COPS9;ATF4;ATR;TMEM161A;SMPD1;NEDD4;CASP9;XPC;YY1;HYAL1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.35003315053302964,-0.7754309745117706,0.7777777777777778,1.0,1.0,2/53,2.65%,P2RY10;STMN1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.3255556058185504,-0.7748264889556495,0.8813559322033898,1.0,1.0,18/82,18.37%,RPS3;NCL;GAPDH;CSTB;RACK1;KNG1;ATRAID;DHFR;RPL13A;BTG2;ILF3;EPRS1;EIF2AK3;CALR;PCIF1;DNAJC1;YBX1;TYMS
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.4626989415791021,-0.7746329998295798,0.7111111111111111,1.0,1.0,2/10,15.71%,ATG9A;WDR45B
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.43117628762634863,-0.7742908366596696,0.8269230769230769,1.0,1.0,6/11,20.69%,PYHIN1;KLHL20;RO60;IFNAR1;PDE12;TPR
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.4633327387781653,0.7742192844385616,0.7804878048780488,0.9488770258703206,1.0,2/7,12.83%,MEF2C;GPC1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.4492872457681687,-0.7741919968601038,0.7666666666666667,1.0,1.0,3/12,24.32%,MAP1LC3B;SQSTM1;ACBD5
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.42691375564049516,-0.7736776974365573,0.74,1.0,1.0,2/13,5.54%,CFL1;RACK1
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.45616946002001324,-0.7736448281494707,0.7857142857142857,1.0,1.0,2/10,15.50%,NPL;ST3GAL1
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.47142131164781487,0.773163363112136,0.75,0.9501623356595496,1.0,2/7,16.29%,TDP1;APLF
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.4847485480391086,0.7729791511499365,0.7678571428571429,0.9500406966033395,1.0,2/7,22.88%,ZFAND6;LONP2
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.36157466610398453,0.7729347724170306,0.8235294117647058,0.9497548832599069,1.0,9/26,16.02%,BAIAP2;ADD2;MYO1B;BAIAP2L1;DMTN;PAWR;DPYSL3;SHROOM2;ADD1
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.515938613555042,-0.7728075039866086,0.8113207547169812,1.0,1.0,1/6,2.32%,TNFRSF21
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.44390697574829713,0.7728066939142152,0.7777777777777778,0.9495878836563273,1.0,5/9,20.56%,MAPKBP1;MAP2K5;OTUD7B;ARRB1;ANXA4
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.4999506676529729,-0.7722925574493694,0.76,1.0,1.0,2/5,38.01%,SRF;IFNGR1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.35011685226088274,-0.7714589638881306,0.7636363636363637,1.0,1.0,12/59,17.67%,PCNA;TFDP1;SDE2;BAX;TRIAP1;BTG2;RPS27L;RFWD3;GML;CARM1;PLK3;CNOT3
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.45131652318592375,-0.7714052500195179,0.7735849056603774,1.0,1.0,4/14,22.80%,HMGA2;POLE3;EZH1;SETDB1
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4180625806536447,-0.7713980330034722,0.74,1.0,1.0,1/14,0.93%,PRELID1
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.50396353125343,-0.7708707708983713,0.7272727272727273,1.0,1.0,1/5,4.20%,KRT10
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.3646403481803423,0.7708235851768052,0.7708333333333334,0.952101988941285,1.0,2/24,3.43%,CAMSAP3;MAP2
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.3324092371711928,-0.7705068094618664,0.828125,1.0,1.0,6/62,4.98%,TAGLN2;CBR1;EDF1;PCNA;ACTL8;CDHR2
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.42908623976544424,-0.7702078585834519,0.7586206896551724,1.0,1.0,1/12,1.68%,WWC2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.3594207897949771,0.7699024250637984,0.84,0.9530007167124485,1.0,9/26,16.02%,BAIAP2;ADD2;MYO1B;BAIAP2L1;DMTN;PAWR;DPYSL3;SHROOM2;ADD1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),-0.5122190611378117,-0.7698472458682646,0.7454545454545455,1.0,1.0,1/7,7.05%,MDGA2
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.3536799556756413,-0.7695013012443006,0.7368421052631579,1.0,1.0,10/45,16.38%,MUC4;TMEM125;ATP2C2;EPCAM;C6ORF132;EHF;BPIFB1;TSPAN8;LIPH;B3GNT3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.3729258219676115,0.7694679696066213,0.8043478260869565,0.9532335798234037,1.0,4/23,11.15%,SLC8A1;ADRA1A;NOS1;RNF207
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.43080194971616503,-0.7693700211484411,0.7916666666666666,1.0,1.0,2/13,8.78%,NEK6;CCNB2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),0.47814233828692654,0.7691931398227202,0.7450980392156863,0.9532567699392647,1.0,3/5,19.00%,IL12RB1;PRKCQ;CLEC7A
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.46716381149535746,0.7690825695698882,0.7959183673469388,0.9530341106301591,1.0,1/6,29.54%,GPX1
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.37869123869131427,0.7690423962468691,0.6888888888888889,0.9527433631719874,1.0,2/19,14.22%,EPAS1;WASHC1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.4885475853926571,0.7683482294618549,0.7560975609756098,0.9533808198806113,1.0,2/8,9.57%,VIM;NOD1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.4064814333612415,0.768166677598261,0.75,0.9532493137852145,1.0,6/23,14.10%,SYNPO2;VIL1;CX3CL1;FHOD1;SHANK1;SYNPO
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.3447368070308,0.7681037413577931,0.8727272727272727,0.952990637683631,1.0,6/44,11.18%,TGFB2;BMP6;BMPR1B;CHRD;TGFB3;BMPR2
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.4740923678234764,-0.7679700063789767,0.8,1.0,1.0,1/7,17.03%,PRKACA
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.4553403448464669,-0.7676477017901477,0.74,1.0,1.0,2/10,17.17%,AWAT2;MGLL
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.3566784589200568,-0.7673114137292818,0.8620689655172413,1.0,1.0,11/58,19.40%,LAMTOR4;RRAGA;ARAF;PRKAA2;MIOS;SLC38A9;PIH1D1;LAMTOR2;TELO2;LAMTOR5;PKHD1
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.4717949370125682,-0.7672977107472037,0.6481481481481481,1.0,1.0,1/8,5.49%,HYAL2
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.5207640500710973,0.7669213495132757,0.8205128205128205,0.9543315283425245,1.0,2/5,16.02%,UBQLN4;RUBCN
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.45435150501736365,-0.7666499240896428,0.7547169811320755,1.0,1.0,1/11,1.43%,AMPD1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.41543613189702044,0.7663400377586584,0.78,0.9549174288758174,1.0,5/16,11.81%,NCKAP1L;PTPN6;IRAK3;CD200;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.3168388525284471,0.7663066655056336,0.8571428571428571,0.9546039271418539,1.0,17/62,15.92%,NCKAP1L;SYNPO2;BAIAP2;CARMIL1;FCHSD2;BAIAP2L1;TENM1;MYLK3;VIL1;CX3CL1;CDC42EP4;CDC42EP3;FES;SYNPO;NTRK3;PRKCE;BIN1
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.4013688567174139,-0.7660031830803813,0.7586206896551724,1.0,1.0,4/20,18.84%,HSPA8;ZFYVE16;HGS;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.45588884706310906,-0.7644754328249767,0.78,1.0,1.0,4/9,19.80%,NOC2L;TAF7;THAP7;SET
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),0.4329469414174495,0.7642414043446698,0.7959183673469388,0.9570500178905459,1.0,3/9,15.76%,NOS1;BMPR2;NOS2
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.39789189071342024,-0.7641970087955487,0.7659574468085106,1.0,1.0,5/19,19.84%,CHMP2A;TOR1A;EMD;DCTN1;CHMP7
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.4147887113557691,-0.7641952951819778,0.8135593220338984,1.0,1.0,4/14,16.86%,TBC1D16;ANXA2;VAMP3;SCRIB
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.40931948082315184,0.7636810694520242,0.7872340425531915,0.957380141940357,1.0,5/18,24.12%,HES1;GHR;CRLF3;ERBB4;CYP1B1
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),-0.5344314622170118,-0.7636755428849137,0.875,1.0,1.0,1/5,5.51%,LACC1
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.4520476540311897,-0.7636444188314367,0.7868852459016393,1.0,1.0,3/6,24.57%,SAT2;AMD1;SRM
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.49148657691019937,-0.7635806257579604,0.8032786885245902,1.0,1.0,2/6,6.18%,GSTP1;APOD
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.4065911306275041,0.7635356772527108,0.7777777777777778,0.9571748921889254,1.0,3/21,6.61%,CERS3;WNT5A;SCEL
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),-0.47743043949617314,-0.7634329132782054,0.7209302325581395,1.0,1.0,3/5,7.35%,SPX;TAC3;TBXA2R
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),-0.448942936332211,-0.7633454968839656,0.7045454545454546,1.0,1.0,1/5,4.27%,SLC22A2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.35929714186669887,0.7633017484098642,0.8529411764705882,0.9570876627387082,1.0,9/29,21.00%,TP73;TP63;BCL2;YWHAH;BBC3;E2F1;YWHAG;TFDP2;NMT1
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.48326158228177385,0.7630982708542349,0.7916666666666666,0.9570322203561671,1.0,3/8,13.85%,TWF2;SCIN;TMSB15B
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.3724055103978486,-0.7630744411907618,0.8461538461538461,1.0,1.0,5/28,14.38%,USP51;TFIP11;HMGA2;PNKP;NUDT16L1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.3449268569728909,-0.7629951514809341,0.7872340425531915,1.0,1.0,3/55,1.56%,CDKN1C;SFRP1;TINF2
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.5171933306262069,0.762840512024824,0.7659574468085106,0.9570810032872777,1.0,1/6,14.48%,SLC25A22
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.3670936528392039,-0.7626815438772864,0.8448275862068966,1.0,1.0,4/33,6.75%,DDIT3;SERPINE1;HYAL2;TLR1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.3192460690175214,-0.7626752199119747,0.8771929824561403,1.0,1.0,15/76,16.76%,HELZ2;EDF1;SQLE;NPC2;OPA3;ADIPOR1;CERS2;SC5D;IDI1;TM7SF2;HNF4A;CARM1;PMVK;FASN;GPAM
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.357246031187368,-0.7626303192826167,0.8431372549019608,1.0,1.0,8/50,10.34%,RPS3;PRDX5;GSTP1;HYAL2;APOD;SOD1;PRDX3;CHUK
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.33546888895288945,-0.76260447068828,0.859375,1.0,1.0,10/62,16.14%,POLR2L;POLR2G;POLR2K;POLR2I;POLR2A;POLR2E;RAE1;POLR2C;NUP37;POLR2D
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.42259643845886696,-0.7624636715654364,0.7551020408163265,1.0,1.0,1/13,1.78%,SELP
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.38441427592012156,-0.7624374354437052,0.74,1.0,1.0,5/27,13.89%,RPS3;NUMA1;ANKRD53;AKAP9;RAC1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.47745270273947044,0.7620161379224072,0.7142857142857143,0.9580217530954698,1.0,1/6,11.98%,P4HA1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.4224922859250579,-0.7618982493355322,0.7254901960784313,1.0,1.0,1/10,8.50%,INTU
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.4527168056350611,-0.7618056012506452,0.7924528301886793,1.0,1.0,2/10,6.76%,AADAT;AFMID
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.38754717837517033,0.7616747529027053,0.8125,0.9580927494009877,1.0,5/18,14.70%,ANGPT1;ARRB2;PICK1;SFRP4;VEGFA
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.3621053115001435,-0.7616284696816494,0.835820895522388,1.0,1.0,10/30,18.16%,DPEP1;GSTP1;SOD1;GSTM4;GSTM3;GGCT;GSTZ1;CTNS;PARK7;ETHE1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.4262766517928448,0.7613569328898364,0.8181818181818182,0.9581817890310584,1.0,1/12,3.54%,LRRK2
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.37945952945019057,0.76124603867906,0.8679245283018868,0.9579722603539963,1.0,2/19,11.53%,ZMYND10;CCP110
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.3319606111200343,-0.7611237787374635,0.9491525423728814,1.0,1.0,6/53,15.96%,RNF8;UBE2D4;RNF6;UBE2Q2;UBE2A;RNF126
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.38592018971584524,0.7609522932995625,0.8333333333333334,0.9580703198668992,1.0,8/23,16.25%,NRXN1;AGRN;PICK1;DLG4;LRP4;ITGB1BP1;THY1;NLGN1
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.438530445799594,-0.7608969461911052,0.8333333333333334,1.0,1.0,1/9,3.22%,NOX1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.31464722454251637,0.7608167734823255,0.94,0.9578519561770426,1.0,3/70,1.80%,TGFB2;KANK2;IGF1
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.44782040071237705,-0.7605907911158275,0.78,1.0,1.0,2/11,18.14%,CDC23;ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.44782040071237705,-0.7605907911158275,0.78,1.0,1.0,2/11,18.14%,CDC23;ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.44782040071237705,-0.7605907911158275,0.78,1.0,1.0,2/11,18.14%,CDC23;ANAPC11
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.4102083469580277,0.7602967586308164,0.7843137254901961,0.9578853733874231,1.0,4/11,30.72%,TNIK;MINK1;RAP2C;RAP1A
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.4102083469580277,0.7602967586308164,0.7843137254901961,0.9578853733874231,1.0,4/11,30.72%,TNIK;MINK1;RAP2C;RAP1A
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.3873774103482622,0.7601886006468719,0.7954545454545454,0.9576673315510335,1.0,6/25,15.36%,EGFR;ZFP36;SOX9;VIL1;PTPN11;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.4339088294828721,-0.7601643096997169,0.78,1.0,1.0,2/16,13.92%,RACK1;LLGL1
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.5344087235849857,0.760159746134348,0.8181818181818182,0.9573321360648236,1.0,1/5,7.71%,SLC2A5
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.3772458476351661,0.7600424597156893,0.9137931034482759,0.9571144729883864,1.0,6/21,12.91%,POSTN;MYH11;SCEL;TP63;TRIM29;MUCL1
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),-0.49654748490405054,-0.7600070665987338,0.7758620689655172,1.0,1.0,2/5,23.71%,ACAA1;EPHX2
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.3584182376204151,0.7597225984447908,0.9090909090909091,0.9571494737705818,1.0,2/39,3.25%,AQP1;MAP3K5
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.42646345360980387,-0.7595161766412635,0.78,1.0,1.0,4/15,18.95%,SOD1;PPIA;MAPK7;P4HB
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.4859382810715809,0.7591070237617521,0.8181818181818182,0.9575855845433286,1.0,1/8,8.11%,ABCD2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.4111077682664962,0.7590304064209812,0.7727272727272727,0.9572869764943829,1.0,1/14,1.51%,CD44
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.34399731203060424,-0.7589106383446377,0.76,1.0,1.0,1/51,0.14%,NGF
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.3663675385681884,-0.7583681398440419,0.7843137254901961,1.0,1.0,4/29,13.89%,SERPINE1;TF;B2M;RAC1
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.43400477726583275,-0.75766111873364,0.7358490566037735,1.0,1.0,6/13,22.80%,SIRT6;RESF1;TRIM28;DNMT1;TPR;SETDB1
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.43587184994196004,-0.7575387583095251,0.7254901960784313,1.0,1.0,3/13,14.09%,ENTPD2;ITPA;SMPDL3A
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.4299159277485307,0.7574027786027624,0.7777777777777778,0.9591143473316047,1.0,2/10,8.68%,KDM4D;KDM3A
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.42119868769118185,0.7573506208663237,0.7291666666666666,0.9588018773590823,1.0,2/11,9.79%,SLC8A1;CAMK2D
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.5011346448614321,0.7572777636027243,0.7735849056603774,0.9585526498518228,1.0,3/5,12.81%,MET;COL15A1;COL22A1
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.4609184595973843,-0.7572730546559815,0.8372093023255814,1.0,1.0,1/8,5.44%,CHAMP1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.3945983683379066,0.7571217202832992,0.851063829787234,0.9583440996171654,1.0,4/21,14.21%,ITGAM;KCNB1;ANK3;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.349173294971591,0.7569013588768652,0.9,0.958243632572947,1.0,2/35,6.15%,NEDD4L;MAP2K5
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.4356336182668209,0.7566825699902382,0.7333333333333333,0.9578407252551484,1.0,4/7,29.94%,SLIT1;SLIT3;NRP2;ALCAM
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.4356336182668209,0.7566825699902382,0.7333333333333333,0.9578407252551484,1.0,4/7,29.94%,SLIT1;SLIT3;NRP2;ALCAM
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.3930627679938218,-0.7561046297881738,0.8,1.0,1.0,3/24,6.90%,TPX2;KATNB1;LIMA1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.4579551183644441,-0.7559532450637598,0.7777777777777778,1.0,1.0,1/8,1.95%,EEF1A1
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.34399106222305686,-0.7555855314088787,0.8235294117647058,1.0,1.0,9/51,13.99%,ACAA2;ECHS1;HSD17B10;CROT;EHHADH;ADIPOR1;ADH4;CYP4V2;HADHA
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.47261918347473575,0.7553985289257809,0.7777777777777778,0.9593261315375198,1.0,2/5,11.28%,LRCH1;CD200
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.38284165978662626,0.7553068057589875,0.7692307692307693,0.959086254074368,1.0,6/24,13.48%,CGNL1;MET;PIK3R1;ARAP1;ARHGAP28;SHANK1
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.49312915823011705,0.7551341286127669,0.7903225806451613,0.9589453012620862,1.0,1/5,2.30%,GRM5
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.46770374341692694,0.7548778743028058,0.78125,0.9589569987881409,1.0,1/8,0.92%,CX3CR1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.314322055185682,-0.7547797536727123,0.9393939393939394,1.0,1.0,12/112,14.13%,CRYAB;ATF3;CRHBP;CHCHD2;USP51;USP19;NEK6;HSPA8;NPM1;RAE1;HSPB8;RSL1D1
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.42300486462590214,0.754731047505671,0.813953488372093,0.9587937782365088,1.0,1/11,2.87%,SHMT2
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.45627619481646864,0.7546880088583849,0.8043478260869565,0.9584917044373754,1.0,2/7,26.48%,PRKCD;RELA
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.4299608386558185,0.7546717304356269,0.8636363636363636,0.9581808975620626,1.0,2/16,9.45%,BMP6;NOTCH4
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.29574383469905285,-0.754573216876325,0.9682539682539683,1.0,1.0,27/137,19.16%,VAMP8;PSMG2;AP2S1;GPX4;ADRM1;CCT2;USH1C;CHMP2A;SAMM50;VBP1;CASQ2;RPL38;MIS12;PSMG3;PFDN6;CLTB;CHMP3;BBS10;PSMD13;EIF4B;BBS12;VAMP3;DNAI4;CENPF;CYBA;PRLR;RAB5IF
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.43487839991627886,0.7543000151851389,0.8292682926829268,0.9583183005184683,1.0,4/10,15.95%,FSTL1;LTBP1;CHRDL1;NBL1
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.49392147700855726,-0.7542246526849765,0.8043478260869565,1.0,1.0,1/6,16.79%,FUZ
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.33849408621596877,-0.7540251822693285,0.8392857142857143,1.0,1.0,10/43,16.38%,CYP2E1;MUC4;TMEM125;DUOXA1;ATP2C2;AHR;EHF;BPIFB1;CARM1;B3GNT3
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.36822306926367054,0.7536853693593534,0.8727272727272727,0.9588451878177395,1.0,5/21,13.12%,CGNL1;MET;PIK3R1;ARAP1;ARHGAP28
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),-0.4380825666839162,-0.7535846855525031,0.7254901960784313,1.0,1.0,7/11,34.79%,ELOF1;PADI2;ZMIZ2;SMARCD1;CHEK1;SERTAD1;ZMIZ1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.4056212451707408,0.7535635460899989,0.7446808510638298,0.958642032840499,1.0,1/12,4.85%,KAT2B
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.4109171906051805,0.7531205780127948,0.7450980392156863,0.9588999191321281,1.0,6/17,19.40%,ADGRV1;GRM2;EDNRB;GABBR2;CAP2;CACNA1C
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.35493826832000785,0.7523927629121591,0.926829268292683,0.9594930794974732,1.0,8/28,26.89%,PER1;DUSP10;VEGFA;SASH1;MINK1;SPI1;LGALS9;DAB2IP
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.3544288783742899,0.7523714910048629,0.8363636363636363,0.9591423592044229,1.0,3/36,5.55%,TDRD1;EXD1;MAEL
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.42113417367162853,0.7523509310035387,0.7804878048780488,0.9588142527022564,1.0,1/11,4.71%,SYK
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.3619132580659133,-0.7523280158247676,0.8372093023255814,1.0,1.0,6/29,15.90%,SMYD1;TRMT112;PRDM5;KMT2B;DPY30;MEN1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.29521940377715405,-0.7520060535038845,0.9272727272727272,1.0,1.0,17/135,14.59%,JUP;SFRP1;PSMB6;PSMD7;PSME2;PSMD8;SEMA5A;BAMBI;PSMB4;PSMD3;PSMB3;PSME1;TMEM198;PSMA7;PSMB8;PSMD13;ILK
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.46887952533331506,0.7516557112098762,0.8043478260869565,0.9593620923095306,1.0,3/5,20.48%,TIMP3;LRP1;RECK
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.29836857536413275,-0.7516085784952176,0.9642857142857143,1.0,1.0,20/111,17.62%,TMED4;TMED9;GOLGA8M;LMAN1;GOLGA8H;TMED2;TMED1;GORASP1;USP6NL;GOLGA2;COG2;GORASP2;STX6;FBXW8;TMED5;LMAN2;PLK3;SURF4;CDC42;GBF1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.36096075112115084,0.7515488346457374,0.7659574468085106,0.9591190081069078,1.0,3/23,11.54%,KAT2B;CLOCK;MAPT
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.4208110129798054,0.7512404132691853,0.7708333333333334,0.9592198713298363,1.0,5/12,21.10%,SLC8A1;CAMK2D;RGS2;ATP1A2;CHGA
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),-0.4594518369738073,-0.7509689926401272,0.8,1.0,1.0,2/8,6.76%,AADAT;AFMID
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.32525247452612427,-0.7509041361746879,0.8888888888888888,1.0,1.0,10/97,10.17%,BMP5;RPS27A;UBC;UBB;DDX5;FNTA;BAMBI;RHOA;ACVR1B;DUSP15
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.37846845956382913,-0.7508942314889689,0.7540983606557377,1.0,1.0,9/16,27.83%,ZNF639;RRP1B;TAF11;CCNT1;JUN;CTDP1;SMARCB1;SNW1;SMARCA4
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.36987468451075034,0.7507199781822179,0.8936170212765957,0.959521482614585,1.0,7/22,20.81%,ACADL;PRKAB2;PDK4;ADIPOR2;PRKAG2;MLXIPL;LPGAT1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.39170162316414636,0.7506773336240363,0.7916666666666666,0.9592384645007062,1.0,2/9,11.28%,LRCH1;CD200
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.400801516815277,-0.750646192354775,0.6851851851851852,1.0,1.0,3/15,11.88%,GRIN3B;SRI;ORAI1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.4499210858958712,-0.7505864335294922,0.8043478260869565,1.0,1.0,3/11,17.58%,APLN;SIRT6;HMGB1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.37249045270332765,0.7504670316329142,0.8490566037735849,0.9590849828769452,1.0,12/23,29.08%,ID2;CDKN2A;PRKCD;CDKN1A;HMGA1;MAPKAPK5;SPI1;SMC5;SIRT1;NSMCE2;PML;MAPK14
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.3431692820002376,-0.7503594384730221,0.86,1.0,1.0,5/45,6.81%,FUCA1;GPC4;GPC2;HYAL2;B4GALT7
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.47645409521671483,-0.7500175660556778,0.8148148148148148,1.0,1.0,1/9,0.97%,GJC1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.3241359303422231,-0.749990309705888,0.8333333333333334,1.0,1.0,7/68,10.24%,RPL23;PTTG1IP;NUTF2;PHB2;RAN;KPNA2;NXT2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.35331697014446967,-0.7499701317124696,0.8095238095238095,1.0,1.0,7/38,13.89%,RPS3;STMN1;TUBB4A;NUMA1;ANKRD53;AKAP9;RAC1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.36726389779560314,0.7497155607276432,0.8490566037735849,0.9597652073897368,1.0,4/25,10.97%,IRS1;CACNA1B;STAT6;ERBIN
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.37954494075948364,-0.749646795366859,0.8823529411764706,1.0,1.0,4/22,12.11%,MYADM;COL18A1;ICAM1;GSTM3
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.3218416078754819,0.7496326716993925,0.9387755102040817,0.9594779622059373,1.0,4/62,4.28%,ALDH1L1;SLC23A1;SHMT2;CBLIF
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.4196795411705443,-0.7493802468164384,0.8653846153846154,1.0,1.0,2/14,7.17%,PTPA;CALM1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.3543545215939479,0.7491713344955946,0.82,0.9596675475140444,1.0,5/27,16.52%,ADCY8;PTPRN;KCNB1;GPER1;GAS6
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.4318333814227897,0.74890030100906,0.8095238095238095,0.9596031886764571,1.0,4/12,12.42%,ADCY8;ADCY2;ADCY7;ADCY1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.32576295224688645,0.7488403127902322,0.8775510204081632,0.959325232181414,1.0,4/49,5.29%,PPARG;ADCY8;PYGL;IRS1
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.3885781283168043,0.7487600572208993,0.8108108108108109,0.9590608334734931,1.0,2/18,11.68%,MEF2C;ZBTB18
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.3281510915540474,-0.7487115993800908,0.9038461538461539,1.0,1.0,22/61,23.00%,DPEP1;BACE2;GSTP1;ENPEP;SOD1;SPCS1;GSTM4;SEC11C;SPCS2;GSTM3;SPCS3;CPXM2;GSTZ1;CTNS;ETHE1;G6PD;ADAMTS13;BACE1;NLN;RHCE;ERAP2;OPLAH
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),0.49350167356040253,0.7485480090981268,0.813953488372093,0.9590190145765387,1.0,1/5,27.16%,SLC6A6
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.3844497339670349,0.7479370068819675,0.803921568627451,0.9593862523822143,1.0,5/16,17.06%,MET;RASIP1;KANK1;CUL3;KCTD13
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.45572597175675966,0.7478487407814263,0.803921568627451,0.9591265741112455,1.0,1/8,3.43%,BDH2
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.3071120655410286,0.7474837378850672,1.0,0.9592224974811051,1.0,14/97,17.32%,LPL;PPARG;ACSM1;ABCD2;ELOVL4;AOAH;ALOX12;ACSL5;ADIPOR2;LTC4S;PPARGC1A;SLC27A2;ACOX2;CBR4
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.38785863763033446,0.7472714021722034,0.7346938775510204,0.9591185081271084,1.0,2/11,14.50%,VAPB;ATL2
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.4145398766315211,-0.7470799516544048,0.7954545454545454,1.0,1.0,1/17,0.74%,CRTAM
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.4641715892024686,-0.7469721040312597,0.7735849056603774,1.0,1.0,1/8,1.28%,SELENOS
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.39607116419885624,0.7465252789406961,0.7837837837837838,0.9596094532513424,1.0,2/19,7.34%,PTPRZ1;SOX9
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.4990087166489265,-0.7463160932531959,0.8367346938775511,1.0,1.0,2/5,27.59%,CALR;SEC22B
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.4552344825291079,0.7461053904989386,0.7818181818181819,0.9597139614632447,1.0,1/7,6.58%,CIITA
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.4631974567507797,-0.7460938024053808,0.7708333333333334,1.0,1.0,1/11,0.32%,PDE3A
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.5339395981814492,-0.7460249155247993,0.8448275862068966,1.0,1.0,2/5,24.69%,EXOSC5;EXOSC4
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.49081856451503797,-0.7458749651507294,0.6862745098039216,1.0,1.0,1/5,19.01%,TMBIM1
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.3850878692995039,-0.7454568134339203,0.8653846153846154,1.0,1.0,3/18,17.59%,DHFR;S100A1;PARK7
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.3813324690470542,-0.7451594064550056,0.8536585365853658,1.0,1.0,6/28,14.88%,NOP53;HMGA2;BRCC3;BLM;ABRAXAS1;TOPBP1
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.4600345030088753,-0.7448186217514998,0.8596491228070176,1.0,1.0,3/10,16.99%,NEK6;RSL1D1;ING2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.43152718629197295,-0.7445497971530993,0.7551020408163265,1.0,1.0,3/11,16.53%,RIC3;RANGRF;MAP1A
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.3418597095934178,0.7439567348161547,0.875,0.9620230243041419,1.0,4/28,9.73%,GUCY1A1;C3AR1;SGCZ;OLR1
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.523344427342968,0.7439380773264909,0.8125,0.9617097294989101,1.0,1/5,14.19%,ANK3
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),0.4632204549885328,0.7439348670864513,0.8333333333333334,0.9613479124449227,1.0,2/6,9.33%,SCIN;VIL1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.3372514975844678,-0.7434028644484455,0.9230769230769231,1.0,1.0,6/59,7.51%,RS1;EYS;COL18A1;CNGB1;CACNA2D4;GPR143
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.45078302702525974,-0.7433817872725228,0.8333333333333334,1.0,1.0,1/11,6.63%,SPHK2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.45078302702525974,-0.7433817872725228,0.8333333333333334,1.0,1.0,1/11,6.63%,SPHK2
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),0.4414175193152611,0.7431579876891656,0.8857142857142857,0.9616792467889232,1.0,3/11,19.19%,P3H4;SYCP2;SYCP1
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),0.4414175193152611,0.7431579876891656,0.8857142857142857,0.9616792467889232,1.0,3/11,19.19%,P3H4;SYCP2;SYCP1
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.47078002340282754,0.7430612965266861,0.8032786885245902,0.961415255134214,1.0,4/5,37.71%,OTUD7B;USP9X;ZRANB1;OTUD7A
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.3670189218434301,0.7430388344365756,0.8958333333333334,0.961062944146137,1.0,8/33,18.41%,KDM4D;FIGNL1;CLOCK;OPN3;TRPM1;RAD9A;CDKN1A;RRH
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.4589422344197541,0.7430130457294755,0.7441860465116279,0.9607418673071524,1.0,2/6,8.20%,LEF1;TESC
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.3600614464450682,0.7429291248458308,0.6956521739130435,0.960500637614391,1.0,5/26,9.45%,MET;NPNT;COL4A1;RASIP1;NOTCH4
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.381481913112725,0.7425199668648426,0.9285714285714286,0.9606309446811293,1.0,3/17,8.69%,NELL1;DACT1;AMER1
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.44678530729902727,-0.7423740849426821,0.82,1.0,1.0,2/7,20.01%,LSM1;DCPS
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.4556353236436089,0.7423674763032054,0.86,0.9604650646970833,1.0,1/9,3.43%,BDH2
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.27050423368766296,-0.741939684814356,1.0,1.0,1.0,53/447,15.98%,RPS27A;UBC;SELENOS;RNF8;UBB;ZNF598;PSMB6;PSMD7;PCNA;PSME2;PSMD8;MARCHF2;UBE2D4;FBXW10;RNF167;RACK1;ELOC;RNF113A;CDC23;RRAGA;RNF181;ELOB;SDE2;TRIM60;PSMB4;TMEM129;PSMD3;PSMB3;CCDC22;TRIM52;PSME1;RFWD3;KBTBD8;UBA52;PSMA7;KLHL20;TRIM61;PSMB8;RNF6;DCAF15;PSMD13;MYLIP;KEAP1;CTR9;FBXW8;ASB5;UBE2Q2;ERCC8;SH3RF2;UBE2A;PSMD2;RNF126;VPS11
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.33815450920267776,-0.7418315343551123,0.8888888888888888,1.0,1.0,4/62,8.48%,NGF;PIK3C2G;GPR143;RHOA
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.4642356588294398,-0.7417595489834733,0.7872340425531915,1.0,1.0,1/5,5.56%,PMP22
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.4126908948944741,-0.7412794090571464,0.8297872340425532,1.0,1.0,6/11,30.48%,PFAS;IMPDH2;ATIC;ADSS1;LHPP;GART
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.37840022804716944,0.7412693916601973,0.851063829787234,0.9613816177302688,1.0,2/20,3.47%,CX3CR1;CLEC5A
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.41218728805144234,-0.7410878055131411,0.8113207547169812,1.0,1.0,5/15,22.87%,NCL;SF3B4;CIRBP;PRDX6;RBMX
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.3939032599619356,0.7408116850121697,0.7959183673469388,0.9612350677419993,1.0,4/11,15.07%,MET;TP63;TMEM79;ALOX12
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.3939032599619356,0.7408116850121697,0.7959183673469388,0.9612350677419993,1.0,4/11,15.07%,MET;TP63;TMEM79;ALOX12
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.47861297747771714,0.7407393752335822,0.7804878048780488,0.9609588944380875,1.0,3/8,16.02%,PIP4K2A;WASHC1;RUBCN
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.44189233071661316,-0.7405214186292127,0.8307692307692308,1.0,1.0,3/10,12.85%,NT5C;DNPH1;ITPA
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.32231448096815823,-0.7404846555324031,0.8620689655172413,1.0,1.0,5/65,4.75%,PRELID1;ACAA2;NOC2L;GSTP1;SLC25A5
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.3640100426227422,0.7402073743586007,0.8688524590163934,0.9613842722513753,1.0,5/22,15.67%,AURKC;KIF14;CUL3;PKP4;PRKCE
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.3193263067335106,0.7399532181957575,0.8775510204081632,0.9613463530918047,1.0,4/53,5.95%,TRIM5;TRIM46;MAP2;SLC26A4
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.4063277004677498,-0.7397879765627422,0.851063829787234,1.0,1.0,3/13,14.96%,ZNF335;CTR9;PIH1D1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.368526630965536,-0.739380750136796,0.8103448275862069,1.0,1.0,4/37,16.18%,USP1;KPNA2;PDGFA;ALYREF
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.30382530230851196,-0.7393556797954309,0.9423076923076923,1.0,1.0,23/89,23.18%,RPL11;PTTG1IP;NUTF2;PHB2;RAN;NOP53;NXT2;PINX1;RPF2;TOR1A;CALR;NOL8;MORC3;NXT1;APPL2;EIF4ENIF1;IPO5;RANBP17;TPR;IPO7;SKP1;POM121C;PAF1
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.34488521499356517,-0.7387542193863653,0.8181818181818182,1.0,1.0,3/41,7.70%,LCK;CD274;CD81
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.29834100843619515,0.7387264589065778,1.0,0.9625734636507706,1.0,17/67,24.17%,KAT2B;PER1;LEF1;ACTL6B;TAF5L;KAT6B;TADA2A;KAT2A;TAF10;JADE2;DR1;SUPT3H;CHD5;SPI1;MBIP;ING5;RUVBL2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.3042974666784912,-0.738050020604947,0.9206349206349206,1.0,1.0,11/89,12.41%,RPL5;EIF3D;PTTG1IP;PASK;METTL5;RPS4X;PYM1;BAK1;RPS27L;AURKAIP1;NPM1
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.48961036527901336,-0.7377387737939222,0.8,1.0,1.0,1/6,4.11%,NOC2L
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.39691113352542545,-0.7375860631588022,0.8,1.0,1.0,6/21,12.58%,PRMT2;FAM98A;VCPKMT;CSKMT;BHMT;SNRPB
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.3281308808020155,-0.7375302744976584,0.8518518518518519,1.0,1.0,13/46,26.08%,PGAM1;GCK;RAE1;NUP37;NOA1;NUP210;TPR;KHK;POM121C;SLC2A6;NUP93;NUP42;NUP85
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.41256498171729883,-0.7372823994152404,0.8333333333333334,1.0,1.0,2/16,8.66%,WWC2;NEK8
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),0.45494397373746487,0.7372655014534102,0.8367346938775511,0.9639891153404991,1.0,1/7,1.76%,FSTL1
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.44211813335247924,0.737133729882023,0.8431372549019608,0.9634711706773477,1.0,1/7,9.51%,DIO2
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.44211813335247924,0.737133729882023,0.8431372549019608,0.9634711706773477,1.0,1/7,9.51%,DIO2
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.30605671813849117,-0.7358036152875285,0.8867924528301887,1.0,1.0,20/98,18.62%,PSMB6;PSMD7;PSME2;PSMD8;CALM1;PSMB4;PSMD3;PSMB3;CHUK;PSME1;VAV1;PSMA7;RAC1;PSMB8;PSMD13;PSMD2;PSMC5;IKBKG;NFATC1;JUN
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.4197785908698005,0.7357913028110373,0.8409090909090909,0.964818884302584,1.0,3/9,11.28%,LRCH1;DOCK8;CD200
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.3589881413413626,0.7357106982043055,0.8367346938775511,0.964559795531763,1.0,7/25,14.74%,CAMSAP3;SPEF1;FGF13;TRPV4;TTBK2;APC2;STMN2
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.32047206909829634,-0.7355525088247185,0.8703703703703703,1.0,1.0,11/64,12.18%,HELZ2;B3GALT4;VAMP8;SIGIRR;PARP12;ADGRE5;HLA-C;MMP25;LITAF;ADIPOR1;CDC42SE1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4268763584287985,0.7349595355939493,0.8235294117647058,0.965264018075304,1.0,6/12,23.99%,KCNH2;SCN4B;CAV3;SCN1B;CACNA2D1;KCNE4
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.42133529608977893,0.7349005008747599,0.7222222222222222,0.9649741834562413,1.0,4/12,22.51%,BMPER;VEGFA;JAK1;FGF1
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),-0.4694479578592382,-0.7344596086280847,0.7924528301886793,1.0,1.0,2/6,21.64%,DPY30;EZH1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.39624734446747467,-0.7344282032436805,0.8571428571428571,1.0,1.0,2/14,12.41%,PHB2;NPM1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.42115513791347003,-0.7342343752524263,0.88,1.0,1.0,1/16,2.83%,RAB7B
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.444079162678341,0.7341866467190157,0.8222222222222222,0.9654623947157804,1.0,5/8,37.94%,AGK;CPNE7;CPNE3;CPNE6;CPNE1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.4128668344224756,-0.7336624214725068,0.8666666666666667,1.0,1.0,7/18,28.76%,PARK7;VDAC1;PINK1;CSNK2A2;HAX1;HDAC6;HTRA2
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.4528824453637972,0.7329642635094537,0.8461538461538461,0.9666531026074415,1.0,4/9,13.84%,SLC26A4;SLC9A7;CLCN3;PDK4
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.42811782715445157,-0.7327232285662476,0.8214285714285714,1.0,1.0,1/13,1.48%,STAC3
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.467881015012249,0.7323683399334872,0.8222222222222222,0.9671315416916011,1.0,1/6,27.16%,SLC6A6
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.4095691829751402,-0.7323610338966481,0.7586206896551724,1.0,1.0,5/11,33.34%,NEDD4;TPR;IFI27;SIRT7;NUP214
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.38266296202421396,-0.7321429829517659,0.8301886792452831,1.0,1.0,2/19,7.04%,TNFRSF21;CD274
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.42708359744145397,-0.7320076533970123,0.7962962962962963,1.0,1.0,5/10,28.74%,SAT2;AMD1;SRM;ODC1;HDAC6
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.38427377729441836,-0.7320024625362399,0.7959183673469388,1.0,1.0,1/20,2.11%,RNF8
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.38303745783574655,-0.7319535453733753,0.8222222222222222,1.0,1.0,3/18,17.61%,SLC25A1;FASN;HSD17B8
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.43314350401120955,0.73169444777571,0.8235294117647058,0.9675920658398756,1.0,2/11,5.74%,ROBO2;BASP1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.3195721689661703,-0.7315498834874047,0.8431372549019608,1.0,1.0,6/64,9.18%,ACAA2;ECHS1;HSD17B10;CROT;ABHD1;EHHADH
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.3071874247952551,-0.7315266784795871,0.9272727272727272,1.0,1.0,12/95,11.93%,PRDX1;SLC25A4;PRDX5;HMGCL;SOD1;TSPO;ECH1;DHCR24;EHHADH;FIS1;HRAS;IDI1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.4529310168940759,0.7313161200012033,0.7692307692307693,0.967701209264414,1.0,2/6,16.59%,TNFRSF1B;ZBTB1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.35669675206385115,0.7312754060333617,0.875,0.9673672513364006,1.0,4/27,7.62%,P2RY12;ACTN1;PDGFRA;HSPB1
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.44318512909133945,0.7311560327818943,0.7647058823529411,0.9671519290174851,1.0,4/7,17.86%,CARTPT;BBS2;MKKS;BBS4
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.4154991660565643,-0.7307101718636035,0.7843137254901961,1.0,1.0,4/14,13.44%,SERPINE1;KNG1;TFPI;EPHB2
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.3677513607226448,0.7306196877157781,0.8979591836734694,0.9673926065862384,1.0,6/21,14.74%,CAMSAP3;SPEF1;FGF13;TTBK2;APC2;STMN2
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.3611417680438004,0.7304086230174113,0.94,0.9672606824211665,1.0,11/24,23.73%,PLSCR1;WNT5A;IFNK;NLRC5;SLC15A4;TRIM62;POLR3G;SPI1;POLR3C;LBP;UBE2K
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.44072737345775786,-0.730107529905229,0.8,1.0,1.0,1/7,7.02%,CDSN
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.45143977848811395,-0.7300664243274503,0.7872340425531915,1.0,1.0,1/7,6.10%,HMGCL
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),-0.45386709441895245,-0.7296731873651437,0.74,1.0,1.0,2/8,16.04%,DPH1;DPH2
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.4567849307678779,0.7296121605669776,0.7884615384615384,0.9677507900755516,1.0,1/6,1.76%,FSTL1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.4014233870885138,-0.7292913837204525,0.8666666666666667,1.0,1.0,7/15,32.60%,ATG9A;WDR45B;ATG2A;ATG3;ULK2;WIPI2;ATG12
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.4720970766105129,0.7290257541124445,0.8260869565217391,0.9681048096619898,1.0,4/6,28.09%,TNFRSF10B;SPI1;TNFRSF10A;CASP8
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.3488629846329575,-0.7287960584308918,0.8571428571428571,1.0,1.0,6/31,22.87%,BACE2;NCSTN;CTSH;BACE1;AFG3L2;RBMX
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.4073168159826992,0.7287391855029904,0.88,0.9680690522959617,1.0,2/15,13.15%,BIRC3;PUM1
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.4802130824294457,-0.7286218660796606,0.8333333333333334,1.0,1.0,3/6,31.12%,EXOSC5;EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.4065343751740078,-0.7284239887303433,0.8867924528301887,1.0,1.0,4/21,13.14%,CHMP2A;CHMP5;TMEM50A;CHMP3
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.35466976685980833,-0.7281800852443243,0.8979591836734694,1.0,1.0,1/22,1.54%,DPEP1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.41778104509590513,-0.7280919706770383,0.8085106382978723,1.0,1.0,1/11,3.68%,BACE2
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.471487385994529,0.7276646070501275,0.7916666666666666,0.9690920559787309,1.0,3/7,14.70%,OXTR;GPAT4;VEGFA
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),0.4551697317956439,0.7275455312338722,0.82,0.9688810262188455,1.0,4/6,30.49%,EPS15;PIKFYVE;TPCN2;CAV1
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.4616523058732116,-0.7275261853447704,0.82,1.0,1.0,1/5,9.46%,ACVR1B
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.43687803253801416,0.7272251251441968,0.88,0.9689936580692883,1.0,3/10,6.15%,ADGRV1;ADRA1A;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.43272894069364115,0.7270758581823988,0.8863636363636364,0.9688265220341047,1.0,4/8,18.38%,KDM4D;PARP9;HMBOX1;GMNN
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.35072123909671604,0.726970587238812,0.8666666666666667,0.9686070885732,1.0,1/24,3.88%,UHRF1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.3864779322101751,0.7268873612623441,0.9473684210526315,0.9683659836351782,1.0,3/18,17.65%,PLK1;MCM9;MACROH2A1
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.4195491456126052,0.7267281992906172,0.8666666666666667,0.9681818050926929,1.0,6/15,20.81%,GPAT4;GPAT3;DGAT1;GK;AGMO;LPGAT1
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.3990071013849935,0.726167943977137,0.75,0.9684864854502055,1.0,4/13,14.00%,LILRB1;LGALS3;CR1;HAVCR2
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.4809806891210817,-0.725684030624688,0.8253968253968254,1.0,1.0,1/7,4.29%,LGALS1
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.4809806891210817,-0.725684030624688,0.8253968253968254,1.0,1.0,1/7,4.29%,LGALS1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.35590969063204553,0.7251617814294452,0.8571428571428571,0.9694147030486404,1.0,3/20,13.89%,CD44;BCL2;BCL2L1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.38588581427378765,-0.7248349166341623,0.8113207547169812,1.0,1.0,6/15,16.04%,GSTP1;GSTM4;GSTO2;GSTM3;MGST3;GSTZ1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.38588581427378765,-0.7248349166341623,0.8113207547169812,1.0,1.0,6/15,16.04%,GSTP1;GSTM4;GSTO2;GSTM3;MGST3;GSTZ1
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.48124908087277407,0.7247288911933911,0.86,0.9694832419589835,1.0,2/5,27.93%,IMMP2L;PMPCB
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.38576968904267217,0.7245897499712253,0.8627450980392157,0.9693250751332819,1.0,4/13,17.79%,CIITA;ABCD2;GPER1;ASXL3
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.4271836564166289,0.7240500483469883,0.8723404255319149,0.9694981678189856,1.0,2/10,6.56%,BIRC3;YBX3
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.28177958352052074,-0.7236171541408097,1.0,1.0,1.0,19/168,14.52%,H4C3;RAD23A;UBAC1;BCAM;MARCHF2;SLC10A3;EIF2AK1;BLVRA;SLC7A11;CLIC2;ADIPOR1;UCP2;NFE2L1;BTG2;GATA1;EPOR;MGST3;MPP1;CROCCP2
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.36500431477875994,0.7234211684087525,0.8863636363636364,0.9698322870498965,1.0,3/22,9.58%,CD44;SPRED3;SMYD2
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.42950776521974454,-0.7229144196710661,0.7659574468085106,1.0,1.0,1/8,12.77%,BLM
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.386441812102834,0.7228227765720904,0.8431372549019608,0.9701966367607022,1.0,3/11,14.15%,DLG4;NECAB2;RIN3
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.34890384291404447,-0.7226684045440608,0.8846153846153846,1.0,1.0,5/44,13.92%,VAMP5;GOPC;CCDC22;RAB31;LLGL1
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.3998478986227137,-0.7222814154870321,0.9122807017543859,1.0,1.0,2/17,4.40%,PRELID1;PSME2
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.40108606579212946,-0.7221175113648076,0.7666666666666667,1.0,1.0,1/18,4.27%,SLC22A2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3384123950678881,0.721772554193826,0.9622641509433962,0.9711874498817265,1.0,5/31,16.84%,TP73;ZNF385B;DYRK2;AEN;DDIT4
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.4623797612701174,0.7214130354010185,0.8,0.9712812865152324,1.0,1/6,2.24%,CSF1R
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),0.4550882363745842,0.7212206571928481,0.8125,0.9711141080806435,1.0,2/7,5.92%,SLC25A48;SLC22A3
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.4094450134203927,-0.7211401917191526,0.782608695652174,1.0,1.0,2/13,11.01%,RASGRF1;STMN3
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.4459885365521457,-0.7204794705765887,0.82,1.0,1.0,1/7,6.02%,PHB2
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.445712840507776,-0.7204580515682301,0.92,1.0,1.0,2/10,7.53%,ERH;MACROD2
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.38505240836898413,-0.7204319974864852,0.76,1.0,1.0,1/12,6.97%,RBM15B
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.41223267861032914,-0.720335559706444,0.8,1.0,1.0,7/14,32.99%,SSB;LSM1;ERI1;EXOSC4;TUT4;EXOSC10;ATM
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.4243926969513475,0.7203263946647569,0.8444444444444444,0.9716904741012365,1.0,2/9,8.20%,LEF1;TESC
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.3411708872224325,-0.7195236669965155,0.8235294117647058,1.0,1.0,6/43,11.82%,RPS14;RPS19;SLC25A5;EVI2B;PRDX3;GATA1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.3467245556538019,-0.7194526583016905,0.9107142857142857,1.0,1.0,7/31,23.62%,PHAX;DKC1;YBX1;CIRBP;EIF4ENIF1;TRDMT1;VIP
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.31561542342180704,0.7190761979626356,0.9583333333333334,0.9727792297033451,1.0,13/56,21.43%,CSF1R;SOX9;LEF1;CCND1;CDKN2A;MOV10;CBFB;MED14;CDKN1A;RUNX2;PTEN;TNRC6A;PAXIP1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.392830073722903,-0.7187896407739174,0.8333333333333334,1.0,1.0,1/18,1.27%,JUP
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.4737314215302799,0.7185693685422428,0.8181818181818182,0.9731025881299146,1.0,1/5,21.48%,TMEM33
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.4532624440244425,0.7185677166607163,0.8076923076923077,0.9727439067483703,1.0,2/7,16.65%,CLCN2;SIRT5
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),-0.4667776894707719,-0.7183295980340084,0.7777777777777778,1.0,1.0,3/6,29.02%,PSAT1;PHGDH;SERINC3
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.34114907248494303,-0.718302179103789,0.8367346938775511,1.0,1.0,2/37,4.79%,RNF8;UBE2D4
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.2876014778556164,-0.7180544876126322,0.9814814814814815,1.0,1.0,10/98,7.90%,DEGS1;ORMDL2;ORMDL1;PLPP2;KDSR;GBA3;SPHK2;GLA;ELOVL1;SMPD2
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),-0.4344529094770899,-0.7179786828508515,0.8113207547169812,1.0,1.0,2/9,4.77%,VAMP8;SPX
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.3220586321048382,-0.7177653601159978,0.9545454545454546,1.0,1.0,11/70,20.26%,PARP1;TONSL;RAD51AP1;ZSWIM7;RFWD3;HUS1;BLM;SFR1;SMC6;EXD2;UBE2N
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.3645237188941395,-0.717162954363586,0.8524590163934426,1.0,1.0,1/19,1.20%,RPS3
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.32767738595105256,0.716600897419973,0.9411764705882353,0.9746298302019513,1.0,6/44,12.83%,TRIM46;GPC6;MAP2;GPC5;MAPT;GPC1
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.3786747620531353,0.7153592500750292,0.7948717948717948,0.9758374046953002,1.0,4/19,14.59%,CARTPT;MAFB;UBASH3B;CAMK4
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.4215967239697075,-0.7153270393599342,0.7777777777777778,1.0,1.0,4/10,18.14%,SYNE2;DYNC1H1;SYNE3;DCTN1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.3662386121560277,-0.7148739375076499,0.8653846153846154,1.0,1.0,3/21,16.64%,ELOVL1;HSD17B12;ACSF3
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),-0.4378588385237517,-0.7147880441983951,0.7843137254901961,1.0,1.0,1/6,8.69%,PLA2R1
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.3447986401196384,0.7143589941309662,0.9298245614035088,0.9766103012090265,1.0,4/24,13.84%,FMO5;ACADL;GNB3;PDK4
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.35276228474191423,0.7142408119070996,0.875,0.9763809455858727,1.0,1/22,0.97%,ANGPT1
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.40917215346061286,0.7141538846559142,0.8867924528301887,0.9761170811664546,1.0,5/10,20.39%,FSTL1;BMPR2;KDM6B;KDR;TIE1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.39099161040008007,0.7141366840762344,0.8148148148148148,0.9757624157090329,1.0,4/18,10.21%,C5;SULF1;C3;ARNT
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),0.4735936574145608,0.7138718310284543,0.8571428571428571,0.9753396413372124,1.0,1/5,14.41%,SHMT1
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),0.4735936574145608,0.7138718310284543,0.8571428571428571,0.9753396413372124,1.0,1/5,14.41%,SHMT1
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),0.45500150199506173,0.7137897635512966,0.8392857142857143,0.9750722188940946,1.0,5/6,36.58%,ANK3;KCNE4;CAV1;KCNE1;KCNAB1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.3449933314632082,-0.7128762117345362,0.8775510204081632,1.0,1.0,9/51,17.67%,PCNA;TFDP1;BAX;TRIAP1;BTG2;GML;CARM1;PLK3;CNOT3
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),-0.46101589677436433,-0.7126195354329191,0.8135593220338984,1.0,1.0,2/7,29.30%,ALYREF;THOC5
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),-0.46101589677436433,-0.7126195354329191,0.8135593220338984,1.0,1.0,2/7,29.30%,ALYREF;THOC5
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.35320087680174295,0.7120337376785718,0.9333333333333333,0.9766611626611219,1.0,2/24,7.62%,LRRK2;HSPB1
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.493510284739629,0.7120260723662288,0.9056603773584906,0.9763069484686754,1.0,1/5,13.17%,GHR
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.30355386884902336,0.7113642306151483,0.9302325581395349,0.9766923231001035,1.0,7/40,15.08%,PID1;KIF16B;MKLN1;GNB3;PDK4;ACACB;STK17A
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),-0.43901479161295665,-0.7112731224388332,0.8409090909090909,1.0,1.0,1/8,17.03%,PRKACA
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),-0.43901479161295665,-0.7112731224388332,0.8409090909090909,1.0,1.0,1/8,17.03%,PRKACA
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.45843339972745395,0.7111272830305087,0.7857142857142857,0.9766063197730349,1.0,1/6,7.25%,NFKBIA
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.3978154428685234,0.7108559406850801,0.8888888888888888,0.9765592630277723,1.0,5/13,28.34%,SLC15A4;MAD2L2;PAXIP1;HMCES;TFRC
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.3737605567083703,-0.7104702511952468,0.8392857142857143,1.0,1.0,3/20,5.15%,DCTD;AK8;CMPK1
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),-0.46800312950283096,-0.7102393669511303,0.8043478260869565,1.0,1.0,1/5,9.77%,ALKBH2
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.3848798733079673,0.7101503124931752,0.8775510204081632,0.9769873094282303,1.0,4/19,24.06%,MSL2;JADE2;OGT;KANSL1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.2915555031955999,-0.7101313766886432,0.9464285714285714,1.0,1.0,6/62,11.40%,CDKN1C;BTG3;RNF167;NPPC;HEXIM1;BTG2
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.47466184867344935,-0.7096086665996654,0.9130434782608695,1.0,1.0,2/6,18.17%,DDR1;AAMP
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.3220991677632799,0.7094294342159045,0.9,0.9774366282432658,1.0,8/41,15.36%,ZFP36;MOV10;GTPBP1;NANOS3;CPEB3;PUM1;RBM24;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.329196155018055,-0.7094005414236292,0.92,1.0,1.0,8/34,18.95%,SRSF3;C9ORF78;CDK11A;CDK11B;RBM23;PTCD2;JMJD6;SRPK3
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.2647674914927928,-0.7093197681858004,1.0,1.0,1.0,36/271,15.71%,RAB32;CORO1B;GRIN3B;PTPRU;ARCN1;ABHD17A;CD63;ARL17A;STX10;TMED4;RRAGA;TMED9;TBC1D16;ERP29;DUOXA1;RIC3;SEPTIN4;SNX17;ARFIP2;DNAJC27;TMED2;RAB31;ATG9A;TMED1;VPS29;NPM1;SAR1B;USP6NL;ESAM;STX6;HGS;SEPTIN10;LAMTOR2;UNC93B1;TMED5;WDR45B
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.34475499159265166,-0.7091150973076,0.8679245283018868,1.0,1.0,5/29,14.38%,CGAS;OTUB1;TFIP11;HMGA2;NUDT16L1
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.4782699585841601,-0.7088200029446394,0.88,1.0,1.0,3/5,21.96%,HADHA;LCLAT1;HADHB
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.39608125779535996,0.7087462963795575,0.8909090909090909,0.9777561486294625,1.0,4/19,12.40%,PTPRC;WNT5A;LAPTM5;SASH3
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3868812432450408,0.7084827495332826,0.8958333333333334,0.9777087397780572,1.0,6/17,31.10%,MED14;PAXIP1;MED30;MITF;MED13;BCLAF1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.3646313472552436,0.7081255142659176,0.9423076923076923,0.9777131154240687,1.0,6/20,20.66%,DGKB;DGKI;DGAT1;DGKD;DGKE;DGKA
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.4009277956192026,-0.7080424481709394,0.9166666666666666,1.0,1.0,2/11,14.01%,PTGIS;NUDT12
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.4325763412772975,0.7080066199815801,0.8181818181818182,0.9774803881116795,1.0,5/9,19.00%,ITGAM;SYK;MAPT;PRKCD;CLEC7A
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.3813150382564903,-0.7076767438069302,0.8421052631578947,1.0,1.0,4/27,9.30%,SERPINE1;ADAM15;APOD;AJAP1
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.4286573833578975,0.7072515930005423,0.8292682926829268,0.977859755605667,1.0,1/9,2.10%,CSGALNACT1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.2810693712225626,0.7069519136438839,0.9743589743589743,0.9777994549521115,1.0,3/81,3.38%,AQP1;EGFR;IL12A
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.39578999656035846,0.706693218864677,0.926829268292683,0.9777521169113548,1.0,5/11,29.92%,CCP110;LIMK2;YAP1;CEP97;ODF2L
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.3656752087121244,-0.7066576263476859,0.8813559322033898,1.0,1.0,1/22,2.83%,RAB7B
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.3832253206288676,0.7062930636711445,0.8448275862068966,0.9778038193646151,1.0,3/11,12.58%,MAFB;CBFB;LGALS3
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.3747921516171572,-0.7058710577376552,0.9019607843137255,1.0,1.0,3/22,20.13%,ABHD17A;SIRT6;ABHD10
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.3988262850221094,0.7058323149947214,0.88,0.9779286356003876,1.0,3/7,14.70%,CAMK2D;PRKD1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.2910236464586778,0.7054161193262836,1.0,0.9780748680025386,1.0,22/75,27.25%,TRIM5;LRRK2;DAPK1;IRGM;PRKD1;TRIM22;SESN2;TP53INP1;WAC;KDR;ULK1;DHRSX;GSK3B;TRIM27;TPCN1;FOXO3;TICAM1;SIRT1;STK11;ATF6;FBXO7;BNIP3L
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.4305466125042965,0.7051187387586184,0.8695652173913043,0.9779673000730952,1.0,2/9,6.56%,BIRC3;YBX3
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.3480163236886686,-0.7049934339063393,0.9019607843137255,1.0,1.0,2/25,9.32%,MYADM;ICAM1
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.46165567566158594,0.7046388703829195,0.8125,0.9781005167012272,1.0,4/7,16.00%,SLC22A3;SLC6A4;SLC29A2;SLC29A4
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.2855494487937148,0.7046141558523704,1.0,0.9777609931027754,1.0,12/78,17.34%,PPARG;EPHA4;LRFN5;MAPKBP1;IRAK3;FNDC4;TNFRSF1A;AOAH;CCN3;GPER1;PRKCD;ILRUN
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.3693923341850971,0.7045026237124478,0.8163265306122449,0.9774732593243883,1.0,4/13,24.32%,TOP2A;MTERF1;TOP1MT;HMGB2
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.4133210792905334,-0.7044859349047871,0.8269230769230769,1.0,1.0,1/10,0.89%,DSCAM
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.41406857265018865,-0.7044196664126742,0.8260869565217391,1.0,1.0,4/12,23.42%,DPAGT1;ALG3;ALG12;ALG1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4129365248841085,-0.7043874765937674,0.8297872340425532,1.0,1.0,2/11,5.02%,WNK4;ATP1B1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.3525883663417236,0.7035246166258857,0.8863636363636364,0.9781303323986354,1.0,9/23,25.79%,SLC1A2;SLC7A9;SLC7A8;SLC25A22;SLC1A1;SLC7A1;SLC7A2;SFXN1;SLC1A4
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),-0.4426388038438497,-0.7034164412464458,0.8163265306122449,1.0,1.0,2/6,18.54%,CHRNA7;SEMA3A
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.3152191999826308,0.7033489648090645,0.9375,0.9779800196061263,1.0,11/54,14.76%,RHBDF2;CAPN1;GDPD3;NBEAL2;SLC14A1;ANXA11;SULT2B1;TMEM79;PRICKLE3;DTX2;AP1G2
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.2897923219494167,0.7031458945942085,1.0,0.977808363810486,1.0,8/75,11.54%,IGFBP3;LRRK2;PID1;FBLN1;DMD;SH3GL2;CORO1C;MAPT
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.4626103665154586,-0.7027761520004124,0.85,1.0,1.0,3/8,22.37%,SLC66A1;SLC38A3;SLC3A1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.3498053953625343,-0.7025870747850614,0.9672131147540983,1.0,1.0,5/34,11.43%,GAPDH;SERPINE1;KNG1;SERPINB8;SERPINH1
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.4367036767541065,0.7022431291634503,0.8723404255319149,0.9783831075545525,1.0,5/8,19.00%,ITGAM;SYK;MAPT;PRKCD;CLEC7A
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.431486566374267,0.7018220484128918,0.7959183673469388,0.9784257986823025,1.0,1/7,8.77%,JAM2
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.47683438210720364,0.701410482124725,0.8301886792452831,0.9784941736341214,1.0,4/5,25.67%,CIITA;NLRC5;NLRP12;HSPH1
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.37632974810243564,-0.7013188261208025,0.819672131147541,1.0,1.0,3/14,11.01%,STMN1;KATNB1;STMN3
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.41303171170039465,-0.7012401691063032,0.9148936170212766,1.0,1.0,5/11,20.90%,SDE2;RPS27L;RFWD3;PLK3;PRKDC
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.3474768048179798,0.7009796470755231,0.8269230769230769,0.9786696052444904,1.0,7/26,19.00%,PER1;ABCD2;ADCY7;IL17RA;NOS2;NLRP7;CLEC7A
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),0.466957757145199,0.7005210161850626,0.8983050847457628,0.9787421245605299,1.0,2/5,23.99%,ANK3;KCNE4
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.36580412520002203,-0.7004769575943645,0.8571428571428571,1.0,1.0,8/21,24.94%,AP2S1;MYLIP;NEDD4;BECN1;ZNRF3;AP2A1;AP2B1;CLTA
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.3483363474827346,-0.7002582472982736,0.84,1.0,1.0,7/24,23.72%,HSD17B10;AKR1D1;NPC1;CYP7B1;ACAA1;OSBPL7;OSBP
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.3551773095338608,-0.6991747426733794,0.9591836734693877,1.0,1.0,3/29,7.86%,SQLE;IDH3B;SOAT2
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.40732358612363406,-0.6989205657162676,0.864406779661017,1.0,1.0,1/8,2.83%,RAB7B
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),-0.4405758216943343,-0.6986814651415267,0.9215686274509803,1.0,1.0,1/7,5.65%,MGMT
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.44543985517117524,-0.6984966205538435,0.8813559322033898,1.0,1.0,1/7,3.80%,PNRC2
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.37101247825375083,-0.698203774896093,0.8490566037735849,1.0,1.0,3/24,8.14%,SMYD1;PRMT2;TRMT112
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.3398439753602891,0.6981442788908081,0.9574468085106383,0.9807839164355244,1.0,2/29,3.92%,SHMT2;STAMBPL1
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.44848330019346433,-0.6977433503147533,0.782608695652174,1.0,1.0,1/5,4.27%,SLC22A2
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.33775569420880974,0.697047544517333,0.9565217391304348,0.9815959835800141,1.0,1/25,1.42%,TP73
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.3102447385807653,0.6969440285709443,1.0,0.9813935672053374,1.0,2/51,3.28%,FAP;ADAMTS7
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.38507311535385336,-0.6966938604454557,0.7818181818181819,1.0,1.0,1/21,0.38%,LCK
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.34641625726435316,0.6964703734973102,0.9090909090909091,0.9815077572963831,1.0,2/22,9.68%,MAPKBP1;IRAK3
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.3954496627352349,-0.6959516069526446,0.8076923076923077,1.0,1.0,2/8,29.66%,MAPRE2;IQSEC1
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.4465895219861528,0.6959413577038828,0.8333333333333334,0.9816475140907804,1.0,1/7,5.36%,PRDM15
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.30840058181530894,-0.6958885923448745,0.9444444444444444,1.0,1.0,8/62,18.29%,STMN1;DCTN3;RHOA;SEPTIN4;KIF4A;SEPTIN10;STAMBP;RAB35
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.4246316740285192,0.6956673300347594,0.8727272727272727,0.9815478603483468,1.0,1/8,5.19%,SRC
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.385356063204239,0.695452481406986,0.8947368421052632,0.9814525506994308,1.0,4/14,28.72%,SAR1A;SEC23A;SCAP;RAB1A
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.32689361671386735,0.6953135569807823,0.9318181818181818,0.9812292017414163,1.0,4/29,15.39%,ADCY8;GPLD1;BAIAP3;GPER1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.37122576722370587,0.6950283595988598,0.8695652173913043,0.981146882811781,1.0,1/14,0.97%,ANGPT1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.40927142907924385,-0.6948244960765905,0.8070175438596491,1.0,1.0,1/14,2.86%,RBM22
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.46844934023412244,-0.6944825647287292,0.8936170212765957,1.0,1.0,2/6,25.42%,PYCR1;GLUL
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.4211337150435137,-0.6943145393555353,0.8269230769230769,1.0,1.0,1/9,10.18%,ROGDI
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.283128233371268,-0.6940413589113312,1.0,1.0,1.0,17/92,16.22%,PKMYT1;CCNG1;CNPPD1;BCCIP;CCNB3;CALM1;SYAP1;RHOA;CCNB2;HMGA2;CDKN2C;SNF8;BLM;HGS;PIH1D1;MST1;CDC37
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.4102044782648469,0.6939496423110887,0.8928571428571429,0.9817985796217217,1.0,2/12,7.35%,GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.41889297763185435,0.6930376968398092,0.7884615384615384,0.9822834445023899,1.0,3/8,14.93%,NEDD4L;CAMK2D;WNK2
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.29986624275349666,0.6926295762006044,0.851063829787234,0.9823713973105381,1.0,1/30,0.92%,CX3CR1
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.4115903232472269,-0.6923023330111306,0.8363636363636363,1.0,1.0,2/9,14.85%,RHOA;ETS1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.32811885865521473,0.6921484502263147,0.8421052631578947,0.9825189622491121,1.0,3/18,9.79%,SLC8A1;DMD;CAMK2D
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.4237950786585337,-0.6908696078866285,0.8,1.0,1.0,2/8,8.30%,CDC42EP5;CDC42EP1
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.4237950786585337,-0.6908696078866285,0.8,1.0,1.0,2/8,8.30%,CDC42EP5;CDC42EP1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.3040358930306645,-0.6907114967948921,0.967741935483871,1.0,1.0,12/83,16.27%,DDIT3;SELENOK;DDX5;MYBBP1A;ATP2A3;BAX;BAK1;ZNF622;ARL6IP5;BCL2A1;IFI6;BAD
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.3675723770428482,0.690116555136495,0.8269230769230769,0.9842472564730873,1.0,5/19,17.87%,ABCD2;PRKAB2;SLC25A20;ACACB;PRKAG2
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.4045158205576613,-0.6900749060562842,0.8805970149253731,1.0,1.0,1/9,12.97%,ERLEC1
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),0.4428559605612545,0.689093173936102,0.92,0.984960546442406,1.0,3/5,25.15%,BMPR2;ACVR2B;CCBE1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),-0.31260585640997174,-0.6879515423977881,0.9666666666666667,1.0,1.0,1/76,0.43%,CRYAB
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.42665165903098,0.6878706498489554,0.7916666666666666,0.9857840271176933,1.0,2/6,16.25%,PHACTR1;NLGN1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3064115956367787,-0.6875057203062067,0.9827586206896551,1.0,1.0,7/47,13.11%,SAP18;DDX5;RBM15B;RBM11;PUF60;RBM8A;MBNL3
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.41232071423551686,0.6870744417837112,0.85,0.9863132215106534,1.0,2/7,20.83%,CAMK2D;EPDR1
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.3942185892034628,-0.6870699303657618,0.9230769230769231,1.0,1.0,6/15,22.27%,RRAGA;PIH1D1;PIP4P1;TELO2;LAMTOR5;GPR137B
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.40844582215549996,-0.6868538185738372,0.9259259259259259,1.0,1.0,5/11,22.62%,BAX;BAK1;PTPN1;XBP1;ERN1
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.42593061417675193,-0.6867884340695841,0.78,1.0,1.0,2/5,19.39%,SSU72;CTDP1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.308151834434631,0.6865102511944856,0.9347826086956522,0.9864761158680985,1.0,3/33,8.42%,DACT1;PER1;DUSP10
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.3862371417748352,-0.6865039586453392,0.8301886792452831,1.0,1.0,1/20,0.38%,LCK
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.3909929533656467,-0.6862891083413962,0.8837209302325582,1.0,1.0,1/13,1.51%,SFRP1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.32618914507899205,0.686223372941478,0.875,0.9864304798255027,1.0,3/31,9.45%,BMP6;MAP2K5;NOTCH4
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.32727670573413314,0.6862167127469683,0.9433962264150944,0.9860787480400864,1.0,4/29,10.97%,CAMSAP3;ANK1;LIN7A;ERBIN
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.34622940329676255,-0.6858889870602504,0.8596491228070176,1.0,1.0,3/21,8.76%,RPS19;PHPT1;CAVIN1
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.3723144477013039,0.6858723298898809,0.813953488372093,0.9860162872608986,1.0,4/11,21.27%,ADCY8;DYRK3;MACROH2A1;MLC1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3382257197855506,-0.6854085498995977,0.9411764705882353,1.0,1.0,6/34,11.87%,GREM1;SERPINE1;CD63;TF;ANXA2;B2M
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.4369271613964418,0.6850912845846189,0.851063829787234,0.9864594692914922,1.0,1/7,2.99%,NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.38858835904406325,0.684399070660983,0.8301886792452831,0.9867536801795679,1.0,5/12,21.23%,ANO6;SFRP4;GPER1;PLCG1;RGCC
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.40141681066038015,-0.6841187144782823,0.8392857142857143,1.0,1.0,3/9,21.96%,HADHA;LCLAT1;HADHB
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.3430807981015437,-0.6836720820318676,0.9090909090909091,1.0,1.0,7/28,21.47%,ACOT1;ELOVL1;ACOT2;ACOX1;CYP4F12;SLC27A6;ACAA1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.333006760880458,0.6834368715189895,0.926829268292683,0.987166557462761,1.0,10/24,32.95%,CSNK1D;RIPOR1;GAK;GOLPH3;OBSL1;ZDHHC15;PAQR3;RAB33B;TMED10;ARL5B
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.393039706158763,-0.682999140363252,0.86,1.0,1.0,3/11,19.42%,ZNF335;CTR9;BEND3
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.28976151393150723,0.682962025460699,0.9523809523809523,0.9872311186961074,1.0,10/67,13.95%,LRRK2;PRICKLE1;RNF217;RNF144B;PLK1;LAPTM5;CSNK1D;RNF139;ARIH2;PIAS1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.3890335451298508,0.682945032010608,0.8958333333333334,0.9869010715574412,1.0,2/14,9.28%,ABCD2;PICK1
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.2929101193994707,0.6824511331517208,0.9534883720930233,0.9870335390551596,1.0,10/59,13.46%,DEPP1;LRRK2;ITPR1;RRAGD;HSPB1;DAPK1;DRAM2;MAPT;ACER2;PIP4K2A
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.3719202599424081,-0.6816124314185247,0.9130434782608695,1.0,1.0,2/13,19.96%,SIRT6;DDX11
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.3062105412221116,0.6813826757393029,0.9615384615384616,0.9874796377314744,1.0,7/53,11.93%,CSF1R;SOX9;LEF1;CCND1;CDKN2A;MOV10;CBFB
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),-0.466503336023553,-0.6810570664192743,0.8269230769230769,1.0,1.0,1/5,21.12%,NAPA
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.325965300931345,-0.6809299595741293,0.8636363636363636,1.0,1.0,1/24,1.56%,TINF2
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.3457767363453731,0.6809165639973284,0.875,0.9875736596093728,1.0,5/19,16.97%,DMTN;CORO1C;ITGB1BP1;PRKCE;ARHGEF7
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.3939528206065314,0.6809036647939248,0.8679245283018868,0.9872185450248314,1.0,4/8,28.61%,KIF14;AKNA;NUMBL;DOCK7
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.4501259669171776,0.6806063219450579,0.8571428571428571,0.9871135493018767,1.0,1/6,16.25%,NLGN1
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),0.4081901473902025,0.6805618139950478,0.7959183673469388,0.9864171118050038,1.0,1/5,12.11%,SCARB1
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),0.4081901473902025,0.6805618139950478,0.7959183673469388,0.9864171118050038,1.0,1/5,12.11%,SCARB1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.3217108854425265,0.6803129291471476,0.8775510204081632,0.9862913648821228,1.0,3/24,8.68%,KDM6A;KDM4D;KDM3A
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,0.3104398791183301,0.6802040226453956,0.9375,0.9860303835787219,1.0,8/38,19.54%,AQP1;ZBTB7C;TRIM29;GRHL2;IL33;EXPH5;PROM2;FUT2
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.43353953278852275,0.6797274596356434,0.8656716417910447,0.9861204619326054,1.0,3/6,26.91%,ATP10A;WASL;DNM2
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.26572188120890394,-0.6793823812113481,1.0,1.0,1.0,32/203,17.86%,DDIT3;EEF1A1;GAPDH;EXOC7;RAB8A;ATP6V1G1;ATP6V1G2;LAMTOR4;RRAGA;UBQLN2;ATP6V1E2;CAPNS1;EIF4G2;PRKAA2;VPS29;CISD2;ATP6V0E1;KAT5;GOLGA2;SLC38A9;KEAP1;UFL1;LAMTOR2;DAP;TMEM59;BAD;TRIM14;CPTP;PRKACA;RAB39B;HMGB1;VDAC1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.2960868348993098,0.6792892419313129,0.9772727272727273,0.9861006032635113,1.0,12/62,17.86%,DCDC1;AURKC;GIT1;PLK1;KIF14;CCP110;CUL3;BCL2L1;PKP4;PRKCE;KLHL9;BBS4
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.338967293926015,0.6792100614447157,0.8958333333333334,0.9858272980440899,1.0,2/27,4.50%,AQP1;HCN1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.40005142149950723,0.679197276769498,0.8367346938775511,0.9854908462561697,1.0,1/11,2.10%,CSGALNACT1
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),-0.3812235821835903,-0.679153489708669,0.8709677419354839,1.0,1.0,2/11,8.31%,SLC22A2;APLN
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.4244284654567164,-0.6790067968557082,0.8695652173913043,1.0,1.0,1/7,17.34%,ACADS
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.33216929058661493,0.6782227989046005,0.9629629629629629,0.9858595959051907,1.0,5/22,18.95%,SLC1A2;SLC26A7;SLC25A22;SLC1A1;GJA1
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.39233033340022333,0.6781945916020744,0.8723404255319149,0.9852042651631319,1.0,1/8,8.59%,GIT1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.39233033340022333,0.6781945916020744,0.8723404255319149,0.9852042651631319,1.0,1/8,8.59%,GIT1
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.44299106377656045,0.6776318231275508,0.8666666666666667,0.9853576653160451,1.0,1/6,10.54%,TNFRSF1A
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.43396171860540805,-0.6772310086485142,0.8703703703703703,1.0,1.0,5/7,20.69%,PYHIN1;RO60;IFNAR1;PDE12;TPR
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.3023788667692444,-0.6770864319519867,0.9508196721311475,1.0,1.0,13/94,17.69%,TRABD2B;RPS3;RACK1;PARP1;DHX33;BAX;BAK1;BRK1;PIH1D1;TPPP3;PSMC5;PARK7;GTF2H2
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),-0.4320321539194193,-0.6770366090748549,0.8958333333333334,1.0,1.0,2/5,27.17%,PIH1D1;SMARCB1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),0.44193329052890445,0.6766584312018676,0.9333333333333333,0.9859493446292836,1.0,1/8,12.11%,SCARB1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.3473861978255044,-0.676596726715354,0.8983050847457628,1.0,1.0,4/20,21.33%,PRDX5;MAF1;BRF2;ZC3H8
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.39974019876769773,0.6760289983194235,0.9090909090909091,0.9860897272617812,1.0,3/10,24.24%,PIK3R1;EEF1A2;RBL2
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),0.4375144396916577,0.6759965203178565,0.8363636363636363,0.9857708727363009,1.0,2/6,23.34%,DKK3;NF1
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.4298672969154327,-0.6759946824799867,0.9230769230769231,1.0,1.0,1/7,8.50%,INTU
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.36073543215954706,-0.6755858822059607,0.8823529411764706,1.0,1.0,2/26,10.74%,VAMP5;RAB31
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.308782902503941,0.6753852426773729,0.9615384615384616,0.9859280618435572,1.0,4/25,16.02%,LRRK2;LZTS1;UBQLN4;RUBCN
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.384857223728892,-0.6753377059599103,0.9,1.0,1.0,3/11,7.70%,MADCAM1;RHOG;CD81
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.426972127593342,0.6753117581859229,0.8936170212765957,0.9856305391818329,1.0,1/7,8.09%,TAL1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.38548681950989716,0.674559684655122,0.7560975609756098,0.9859517684142215,1.0,3/10,10.97%,VIM;NOD1;ERBIN
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.32651263938454456,0.6745131268744653,0.9574468085106383,0.9856376247346486,1.0,2/32,4.50%,AQP1;HCN1
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.3584286799226363,0.6744245200664718,0.9230769230769231,0.9853405242731718,1.0,5/14,24.26%,ACACB;MVD;TDO2;ACSS1;MLYCD
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.40537224918971954,-0.6736440899818972,0.8823529411764706,1.0,1.0,3/11,20.31%,DDX5;DAXX;TMF1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.43659917480649835,-0.6736427211183761,0.9333333333333333,1.0,1.0,1/8,11.93%,IDI1
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.3880051889511581,-0.6732801561774275,0.9230769230769231,1.0,1.0,4/10,27.42%,BAX;BAD;BLOC1S2;BNIP3
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.43011194886926146,-0.6726534812628708,0.8333333333333334,1.0,1.0,2/6,15.05%,GALT;GALK1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.36917494335167667,0.6723899040283755,0.85,0.9867963899611855,1.0,3/10,14.19%,SLC8A1;CAMK2D;ANK3
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.24701961932145106,0.6720624723123911,1.0,0.9867175790726062,1.0,16/167,14.50%,SRGN;LRRK2;VAPB;GOLGA8O;HOOK1;DNM1;DYSF;PRKD1;ALS2CL;CSNK1D;DMPK;STX17;CR1;RAB29;ANK3;ATL2
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.39085171612783626,-0.671853728412206,0.8301886792452831,1.0,1.0,2/11,21.48%,PEX10;PEX16
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.3612375013485962,-0.6716870388738684,0.9016393442622951,1.0,1.0,2/18,7.71%,SLC22A2;SLC3A2
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.3546473787202753,-0.6713832104232388,0.8936170212765957,1.0,1.0,5/17,17.12%,CORO1B;ARFIP2;WASF2;BRK1;WASF3
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.3172528020956459,0.6709967526067883,0.9444444444444444,0.9872856629423252,1.0,3/27,14.35%,LEF1;BCL9;TLE3
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.41085860906732274,0.6708012721734214,0.9210526315789473,0.9870807712539225,1.0,2/8,14.25%,DCUN1D4;UBA3
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.271202672565509,0.6707384437423075,1.0,0.9867710941086119,1.0,14/98,14.46%,NCKAP1L;ADD2;LAMC1;SOX9;TEAD1;SLC7A9;IL1RAP;VIL1;LIN7A;DMTN;DLG4;HES1;SHANK1;FANCC
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.3971031830674347,0.6703350185394129,0.88,0.9867595367023665,1.0,1/8,6.75%,TPM1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.29604724410013206,-0.6703303286531724,0.9122807017543859,1.0,1.0,7/52,12.94%,GREM1;PCNA;CCT7;CCT2;CCT6A;PNKP;DKC1
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.40170648691413047,0.669944174273479,0.851063829787234,0.9867815416792844,1.0,2/11,17.18%,ZNF516;DYRK1B
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.34032609163048305,0.6698980384785466,0.9,0.9864429522008613,1.0,1/17,2.50%,CYFIP1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.3857087055966655,0.6698565018976502,0.92,0.986129751336304,1.0,2/10,8.42%,HIPK3;DUSP10
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.32749576718121926,0.669546609325977,0.9130434782608695,0.9860514017299913,1.0,4/18,17.31%,LPCAT4;PLA2G10;PLA2G4A;MBOAT2
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.30737973652688066,-0.6685906963047009,0.96,1.0,1.0,6/54,7.71%,SLC25A4;SLC35B1;SLC25A11;SLC25A5;SLC25A1;SLC3A2
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.41330377005216146,0.6682516779307305,0.8888888888888888,0.9867646975057426,1.0,1/7,4.59%,ADGRV1
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.33355867438700304,0.6680824201243726,0.9545454545454546,0.9865647602599057,1.0,2/22,6.94%,ANGPT1;ANO6
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.3725682696451501,-0.6680655553691056,0.8541666666666666,1.0,1.0,4/12,20.65%,AADAT;HYKK;ALDH7A1;PHYKPL
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.3725682696451501,-0.6680655553691056,0.8541666666666666,1.0,1.0,4/12,20.65%,AADAT;HYKK;ALDH7A1;PHYKPL
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.2969301699166603,0.6679178747465081,0.96,0.9863900770421725,1.0,2/44,3.77%,PDGFB;PID1
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.39700174615391315,-0.6677169425710053,0.8867924528301887,1.0,1.0,2/9,9.04%,CALM1;DHFR
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.3234988290592466,0.6676669749457153,0.9661016949152542,0.9862991947531216,1.0,1/29,2.85%,NHEJ1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.4245861678055634,0.6674523054941037,0.9245283018867925,0.986137276902535,1.0,2/5,16.55%,ZNF304;ZNF274
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.37230990830154004,0.6672636998350554,0.9056603773584906,0.9859712930949807,1.0,5/11,34.59%,IP6K3;IPMK;ITPKC;PPIP5K2;ITPKA
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.327578005404358,0.6671236449253252,0.9583333333333334,0.9857761713131652,1.0,8/25,24.48%,ST8SIA6;B3GNT6;GK;ALG6;GCNT1;B4GALT5;GAL3ST2;GOLPH3
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.39257082957180767,0.6671149377161736,0.7959183673469388,0.9854307832036345,1.0,1/7,24.89%,STAT3
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.281656701126275,-0.666905577925411,1.0,1.0,1.0,20/98,18.62%,PSMB6;PSMD7;PSME2;PSMD8;CALM1;PSMB4;PSMD3;PSMB3;CHUK;PSME1;VAV1;PSMA7;RAC1;PSMB8;PSMD13;PSMD2;PSMC5;IKBKG;NFATC1;JUN
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),-0.45090817058650423,-0.6662418631035799,0.8936170212765957,1.0,1.0,2/5,31.97%,BECN1;CCNB1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.3349362041595215,-0.6661431411256263,0.92,1.0,1.0,6/29,19.80%,NOC2L;TAF7;BRD7;THAP7;PARK7;SET
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.3776376806582565,0.6660816167562128,0.8979591836734694,0.9858875140746297,1.0,2/12,9.92%,TUSC3;NIPAL2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3503564443441024,0.6656607516030398,0.9230769230769231,0.9858972018476561,1.0,6/22,16.93%,NEDD4L;NETO1;KCNS1;ATP1B2;FHL1;ATP1B3
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.4424531200314913,-0.665549695592134,0.8444444444444444,1.0,1.0,3/5,19.63%,SQSTM1;ATG14;BECN1
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),-0.4253091490796542,-0.6653136337939366,0.88,1.0,1.0,3/5,23.22%,SLC3A2;SLC36A4;SLC25A29
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),0.4526390207139338,0.6650124736737586,0.8909090909090909,0.9860779949782306,1.0,2/5,17.71%,NMB;EDN1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.34608055845087127,-0.6648019580155252,0.9148936170212766,1.0,1.0,5/23,15.28%,MYADM;PFN1;TWF1;TMSB4X;GSN
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.3333529296040852,0.6646923958248758,0.975,0.9859999966295785,1.0,3/22,15.36%,PDGFRA;SFRP4;WWOX
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3357976679087012,0.6644846530858145,0.9574468085106383,0.9857802560203422,1.0,9/21,19.67%,CACNB1;DMD;NOS1;CAMK2D;JPH4;CACNB2;FKBP1B;CAV3;HPCA
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.3801047949927272,0.6644473158478609,0.9555555555555556,0.9854522759269818,1.0,2/17,16.65%,ABCD2;SIRT5
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.30464482451345004,-0.6641515261439674,0.9666666666666667,1.0,1.0,8/49,17.95%,SLC25A4;SLC25A5;PRKAA2;SCOC;HSPB8;SUPT5H;VDAC1;IKBKG
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.41452069525137125,-0.6640449866692544,0.8888888888888888,1.0,1.0,1/10,7.06%,PYHIN1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.3598916898432061,0.66359678382149,0.9555555555555556,0.985849683942631,1.0,3/15,18.00%,DACT1;GRHL2;PKD2
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.31721913370982024,0.6635106189746558,0.9555555555555556,0.985559406060796,1.0,8/29,25.21%,NOS1;TADA2A;PPARGC1A;ARRB1;RPS6KA4;PAXIP1;RUVBL2;FMR1
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.3278001389320174,0.6633081535582532,0.9574468085106383,0.9853609549761937,1.0,6/18,21.87%,CAMSAP3;FERMT1;PARD3;CLASP1;OPHN1;SYNE4
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),-0.41806909439686424,-0.6628680639412974,0.9056603773584906,1.0,1.0,1/6,6.19%,RNF113A
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.3206787809724878,-0.6627205820185789,0.9230769230769231,1.0,1.0,2/16,12.77%,MCM4;BLM
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.32655929727540733,-0.6627023214362792,0.8727272727272727,1.0,1.0,2/21,7.65%,HSD17B10;AKR1D1
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.3957643797879561,-0.662670193994207,0.9166666666666666,1.0,1.0,1/10,12.97%,ERLEC1
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),-0.4142893637849446,-0.6625205961533903,0.84,1.0,1.0,2/5,23.84%,PTPN1;NCK1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.3926169186474112,0.6622064015022617,0.8222222222222222,0.9858828683522685,1.0,1/8,2.09%,NCKAP1L
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.38209943583481076,0.6617887928488851,0.8541666666666666,0.9859008503183849,1.0,3/10,15.51%,EPHA4;SLIT1;CHN1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.2951486222530097,-0.6609822721954254,0.9803921568627451,1.0,1.0,8/71,8.65%,OOEP;NDC80;PLK4;RANBP1;NUMA1;USP19;RHOA;MAP10
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.38325915245044595,-0.6604465106607849,0.926829268292683,1.0,1.0,3/13,17.75%,PLK4;NPM1;STIL
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.41184885108365166,0.6600379258376601,0.88,0.9870379149086319,1.0,2/6,9.63%,LOXL3;DMTN
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.35417004980024963,-0.6595233662442255,0.9019607843137255,1.0,1.0,1/20,3.79%,PTK6
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.35854832076728893,-0.6593155400688862,0.9193548387096774,1.0,1.0,7/22,23.57%,RBM22;ANP32B;EMD;PARK7;TPR;IFI27;SP100
prerank,GO_Biological_Process_2021__negative regulation of pinocytosis (GO:0048550),0.43319173267410893,0.6589860812349678,0.9069767441860465,0.9875129375586692,1.0,2/5,30.49%,PROM2;CAV1
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.3072181023136849,-0.6587298671878243,0.9333333333333333,1.0,1.0,13/50,26.08%,RNF212;KIAA1586;RAE1;NUP37;TRIM28;NUP210;TPR;POM121C;PIAS3;SUMO1;NUP93;NUP42;NUP85
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.3121831512524726,0.6585631918808845,0.9636363636363636,0.9875344825760676,1.0,3/32,11.77%,RAB27B;HSPB1;NEFL
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.38299897453053444,-0.6580831825102256,0.8727272727272727,1.0,1.0,1/12,7.36%,ELOVL1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.3585705994182871,0.6580482563544308,0.9230769230769231,0.9875684798041447,1.0,1/17,5.19%,SRC
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.35479782537073623,-0.6575856370000278,0.8867924528301887,1.0,1.0,2/12,9.08%,MSTO1;CLUH
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.31454499705334293,-0.657211077440882,0.9787234042553191,1.0,1.0,8/47,12.90%,F11;PIK3C2G;SLC28A1;KNG1;ADH4;TTF1;BHMT;HNF4A
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.3938134752307949,0.6571884118779653,0.9183673469387755,0.9879929608243915,1.0,1/10,4.37%,PDGFRA
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.4166620444465806,-0.6569701062701534,0.9074074074074074,1.0,1.0,3/7,15.47%,USH1C;SOD1;PLS1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.4083059391125695,-0.6566373789803597,0.9361702127659575,1.0,1.0,3/10,22.66%,BLM;EXO1;TERF1
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.4083059391125695,-0.6566373789803597,0.9361702127659575,1.0,1.0,3/10,22.66%,BLM;EXO1;TERF1
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.4083059391125695,-0.6566373789803597,0.9361702127659575,1.0,1.0,3/10,22.66%,BLM;EXO1;TERF1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.3316293572862182,-0.6565522295353279,0.9166666666666666,1.0,1.0,4/17,10.84%,ATP1B1;CALM1;CASQ2;CLIC2
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.42089845194082176,-0.6564835608373668,0.8627450980392157,1.0,1.0,1/6,6.06%,METAP2
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.37494440253949124,-0.6563632855161577,0.9019607843137255,1.0,1.0,5/13,16.00%,PARP1;SPHK2;ANTKMT;TMSB4X;DNAJC30
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.366068397275686,0.6562980920343334,0.86,0.988246874780153,1.0,3/12,13.41%,IGF1;GHR;BBS2
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.35056725820004137,0.6555415550288614,0.9,0.9884964583869545,1.0,7/18,24.12%,ST3GAL6;AGK;CERKL;AGMO;FUT2;ACER1;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.34010863993360424,-0.6555260883186387,0.9019607843137255,1.0,1.0,3/23,11.87%,LACC1;SPHK2;B2M
prerank,GO_Biological_Process_2021__CRD-mediated mRNA stabilization (GO:0070934),0.439277771596037,0.6547163045902636,0.88,0.9887873656489704,1.0,1/5,13.06%,SYNCRIP
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.3180381086134108,0.6545218914204043,0.8571428571428571,0.9885470617397116,1.0,3/19,13.89%,MAP2K5;BCL2;BCL2L1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.32302190456526964,-0.6538024830955549,1.0,1.0,1.0,5/23,20.85%,GREM1;EPHB2;PARK7;EGF;HFE
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.3724087332586232,0.6526472385830671,0.9245283018867925,0.989667151708331,1.0,1/9,8.09%,TAL1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.3138527571733856,-0.6525208212824359,0.9629629629629629,1.0,1.0,10/32,22.00%,LAMTOR4;RRAGA;CASTOR2;SLC38A9;LAMTOR2;NEURL1;LAMTOR5;IPO5;CAPN2;XBP1
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),-0.41274517216256157,-0.6522923830977215,0.8913043478260869,1.0,1.0,1/6,20.56%,CTTNBP2NL
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.4032218778800841,-0.6517132848088224,0.9230769230769231,1.0,1.0,1/6,7.71%,SLC3A2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.3714380323967006,0.6516187841974318,0.8846153846153846,0.989965631099047,1.0,4/10,27.07%,PORCN;UGCG;PIK3C3;ATG7
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.2682165265931966,0.6512289890612467,1.0,0.9899448041069259,1.0,13/56,25.23%,TBC1D10A;ODAD3;TBC1D24;CCP110;CDKL1;BBS4;LIMK2;IFT140;RABGAP1;IFT88;TBC1D5;DCDC2;TBC1D8
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.3803384415661847,0.6505734051216702,0.8363636363636363,0.9901394096677906,1.0,2/11,17.71%,RFK;EDN1
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.3157106471831972,0.6503040644666981,0.9565217391304348,0.9900025827484947,1.0,8/30,18.97%,PAM;BDH2;ACSS3;ALOX12;LTC4S;FAR2;CBR4;GGT5
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.3720290666126628,-0.6501920035329335,0.8923076923076924,1.0,1.0,1/16,10.34%,CHUK
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.35837004141600565,-0.6498483047450244,0.9803921568627451,1.0,1.0,2/18,7.04%,DDIT3;CD274
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.31168893249495133,-0.6494879415439078,0.9122807017543859,1.0,1.0,10/30,25.21%,RRAGA;CASTOR2;PIH1D1;PIP4P1;TELO2;LAMTOR5;DGKQ;GPR137B;RNF152;ITFG2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.2983812652545951,-0.6494107788240766,0.9830508474576272,1.0,1.0,8/33,18.25%,JPH1;CALM1;CASQ2;SRI;CLIC2;TRDN;PRKACA;JPH3
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.3225189210846351,-0.6492496995246779,0.9259259259259259,1.0,1.0,1/17,3.49%,MSTO1
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.4067304033247765,-0.6492449340065382,0.859375,1.0,1.0,2/6,18.14%,HSPA8;DCTN1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.4304286735141579,-0.649242452693474,0.8541666666666666,1.0,1.0,2/8,15.50%,PARP1;ST3GAL1
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.40615432728411366,0.64919800490967,0.8983050847457628,0.990519931036098,1.0,1/7,8.50%,ATP2B3
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.3383019657075961,0.6481096875016659,0.9230769230769231,0.9906765289433612,1.0,3/16,13.89%,MAP2K5;BCL2;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.3383019657075961,0.6481096875016659,0.9230769230769231,0.9906765289433612,1.0,3/16,13.89%,MAP2K5;BCL2;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.3933894949079659,0.6480273073067672,0.92,0.9903991026227155,1.0,4/9,19.53%,NEDD4L;KCNH2;BIN1;CAV3
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.36410086146863396,0.6478453382239054,0.875,0.9901466745712842,1.0,4/12,25.08%,EDNRB;NF1;ASCL1;SOX4
prerank,GO_Biological_Process_2021__positive regulation of respiratory burst (GO:0060267),0.44865589052658994,0.6472270048258727,0.9318181818181818,0.990287009265412,1.0,1/5,3.33%,CAMK1D
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.3995464192258748,0.6471003309712873,0.8958333333333334,0.9900182734088312,1.0,4/9,16.20%,GRIN3A;GRIN1;CDK5R1;GRIA2
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.4132511422027377,0.6467397110474499,0.8444444444444444,0.9899066501229854,1.0,4/6,33.85%,PLOD2;MTHFR;GOT1;MTR
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.3399091126799928,0.6461134551142923,0.9090909090909091,0.9900882027725206,1.0,4/21,14.64%,BIRC3;YBX3;MLKL;FZD9
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.2860561229976313,0.645868949415435,0.9761904761904762,0.9899229862066508,1.0,3/33,8.68%,SRC;NR3C2;KDM3A
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.3900902052126083,0.6458192853027701,0.8846153846153846,0.9896135017303636,1.0,3/8,11.80%,RTN4RL2;GAP43;NREP
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.3007531282140049,0.6458134740574235,0.9622641509433962,0.9892712434876986,1.0,4/28,11.47%,ID2;PTPN6;KIF14;MN1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.3161081763090472,0.645654512474255,0.9767441860465116,0.9890364060917234,1.0,4/24,21.96%,TPTE2;PTEN;PIP4P2;MTM1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.3168263428092908,0.6448725700302426,0.95,0.9892220665353195,1.0,2/33,3.54%,SIAH3;LRRK2
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.2569881795914365,0.6447408319350062,1.0,0.9889668131741557,1.0,15/57,24.35%,TNFRSF1B;IGF2BP2;SRRM4;RBM38;RBM20;PRX;HNRNPLL;CLK1;SNRNP70;MBNL1;NOVA1;AHNAK;RASA1;PTBP2;MBNL2
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),0.42829939925989724,0.6447172964492394,0.8627450980392157,0.9886252594828808,1.0,1/5,4.93%,CITED2
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.3019031396889558,0.644624344859996,0.9824561403508771,0.9883004108639781,1.0,6/30,20.17%,LRRK2;ICA1;FES;LEPR;WWC1;GAPVD1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.33167691434032964,-0.6443790047641161,0.9672131147540983,1.0,1.0,2/19,4.88%,PTPA;PPP1R1B
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.3220555773608537,0.6441119416827874,0.975609756097561,0.9883214625950298,1.0,1/17,7.73%,ATP6V0D2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),0.4235695376227764,0.6436668574437913,0.9423076923076923,0.9882643388897132,1.0,2/7,26.05%,TPK1;CTPS2
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.3741200306292698,-0.6433758845227604,0.8431372549019608,1.0,1.0,3/10,20.85%,SPHK2;ING2;AKAP8
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.38300619628007765,-0.6430159802189982,0.8518518518518519,1.0,1.0,1/11,7.36%,ELOVL1
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.34393291086002004,-0.642497911719942,0.9111111111111111,1.0,1.0,3/15,14.83%,PIGF;PIGW;DPM2
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.3958335106056452,-0.6422303308801448,0.8846153846153846,1.0,1.0,1/7,4.59%,HDC
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.32051248552987904,0.6421010772373951,0.9333333333333333,0.9890173756128218,1.0,10/27,19.40%,SLC8A1;ADRA1A;ATP2B3;MICU3;MAIP1;TRPM1;JPH4;ITPR3;MCUB;CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2829269414520015,-0.6419889300152104,0.9642857142857143,1.0,1.0,6/66,10.05%,CDKN1C;GSTP1;HYAL2;DUSP7;HEXIM1;SPRY3
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.39663610419930473,-0.6419764686867615,0.873015873015873,1.0,1.0,4/8,23.66%,SOAT2;P4HB;MTTP;MFSD2A
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.3035239789764375,-0.6419743772956891,0.9622641509433962,1.0,1.0,1/32,0.93%,PRELID1
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.3707291404646024,-0.6417094538339019,0.8888888888888888,1.0,1.0,3/10,23.75%,DYNC1I2;SPA17;SPAG17
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.29363579680396484,0.6415101708984361,0.9607843137254902,0.9890628202589741,1.0,6/33,17.43%,SLC23A1;SLC7A9;SLC7A8;SLC38A6;ABCC5;SLC25A21
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),-0.4362388704104298,-0.6414964354427626,0.9038461538461539,1.0,1.0,3/5,21.03%,TLR1;CYBA;PJA2
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.3492753283013039,0.6400917668872004,0.9130434782608695,0.9896588952634187,1.0,1/14,7.64%,PER1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),-0.2800762737657235,-0.6395658161962838,1.0,1.0,1.0,13/102,15.69%,PARP2;USP51;ENY2;PRMT2;USP16;PRDM5;RCOR2;ZNF541;KAT5;MRGBP;UFL1;CARM1;UBE2A
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.3551120434956333,-0.6392644493319805,0.9074074074074074,1.0,1.0,5/13,28.93%,GRWD1;SET;SMARCB1;SMARCA4;SMARCD1
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.3551120434956333,-0.6392644493319805,0.9074074074074074,1.0,1.0,5/13,28.93%,GRWD1;SET;SMARCB1;SMARCA4;SMARCD1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.35604403152815245,-0.63925001866345,0.8867924528301887,1.0,1.0,4/10,22.80%,HMGA2;RESF1;INPP5K;SETDB1
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.3919314967553415,-0.6391679200672487,0.8070175438596491,1.0,1.0,2/6,29.22%,RYR1;MYORG
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.39579709519461115,0.6389948173148521,0.9148936170212766,0.9900573712905375,1.0,2/9,18.69%,AXL;PROM2
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.42988198758861484,-0.6388365063861632,0.88,1.0,1.0,1/6,9.06%,NOP53
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.36383928031437573,0.6379080811305177,0.9423076923076923,0.9903980777860538,1.0,6/14,23.99%,KCNH2;SCN4B;CAV3;SCN1B;CACNA2D1;KCNE4
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.3554582715232306,-0.6376695453765804,0.9818181818181818,1.0,1.0,3/12,12.02%,CYB5R3;DDAH2;NQO1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.36453958929067903,0.6369926083864719,0.9,0.9906236034170343,1.0,3/10,18.29%,DIAPH1;UBASH3B;FKBP1B
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.3530545931849447,-0.6365327125595157,0.9024390243902439,1.0,1.0,1/10,4.83%,DDX5
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.40083642140059617,-0.6360721638099115,0.96,1.0,1.0,1/6,7.36%,ELOVL1
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.40083642140059617,-0.6360721638099115,0.96,1.0,1.0,1/6,7.36%,ELOVL1
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.40083642140059617,-0.6360721638099115,0.96,1.0,1.0,1/6,7.36%,ELOVL1
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.40083642140059617,-0.6360721638099115,0.96,1.0,1.0,1/6,7.36%,ELOVL1
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),0.4091711906838953,0.6357772492487577,0.8421052631578947,0.9911690599915185,1.0,2/5,15.76%,H2BC11;NOS2
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.2836291883931656,-0.6357537018353379,1.0,1.0,1.0,13/82,13.14%,TNFAIP2;HELZ2;MARCKSL1;PARP12;ANXA5;HLA-C;LAMB3;NFIC;SCAMP2;ICAM1;GBP3;AHR;EHF
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.4149482794294166,-0.6355527344705029,0.8936170212765957,1.0,1.0,1/6,18.82%,REC8
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.36895881093363114,-0.6355512684101124,0.8780487804878049,1.0,1.0,3/10,15.91%,SERPINE1;GAS1;TMEM59
prerank,GO_Biological_Process_2021__detection of molecule of bacterial origin (GO:0032490),-0.37352980288631055,-0.6350641401083321,0.88,1.0,1.0,1/5,6.58%,SSC5D
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.3442282669977756,0.633499688035041,0.8431372549019608,0.9922105106752263,1.0,2/10,17.86%,CCDC120;BBS4
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.3124313288895033,-0.6331686395668513,0.9583333333333334,1.0,1.0,7/29,12.51%,RHOA;DYNLT1;ARHGDIA;B2M;MAG;GORASP1;LINGO1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.3794281073922412,-0.6329233537226362,0.8958333333333334,1.0,1.0,1/9,2.75%,GREM1
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.33309206145610437,0.632174039850976,0.9464285714285714,0.9927509343493125,1.0,3/11,18.95%,ACVR1C;VEGFA;GJA1
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.3961138404159317,-0.6320290178636765,0.9215686274509803,1.0,1.0,1/7,10.14%,KMT2B
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.4118252347217507,0.6319384018817807,0.8958333333333334,0.9925325912182018,1.0,1/7,8.06%,AXL
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.3471748665480763,-0.6316917616504035,0.9454545454545454,1.0,1.0,3/13,12.02%,CYB5R3;DDAH2;NQO1
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.28234963051636885,-0.6315996024907873,0.9607843137254902,1.0,1.0,17/53,26.08%,SPHK2;PGAM1;FIS1;GCK;RAE1;NUP37;BEND3;NUP210;COX7A2;PINK1;TPR;POM121C;UQCC2;SLC2A6;NUP93;NUP42;NUP85
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.3157245991325953,-0.6306726507216206,0.9230769230769231,1.0,1.0,6/19,15.34%,CALM1;CASQ2;SRI;CLIC2;EPHB2;TRDN
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.40815384776837654,-0.6305389960303686,0.8913043478260869,1.0,1.0,1/6,10.14%,KMT2B
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.3490351129702543,-0.6304427717957248,0.9038461538461539,1.0,1.0,4/14,18.58%,APOD;CHID1;APPL2;CUEDC2
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.3843233575799513,-0.6302515747129505,0.8292682926829268,1.0,1.0,3/6,34.93%,TKFC;C1QBP;RIOK3
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.3350316127544932,0.6301269549592826,0.9459459459459459,0.993379875676587,1.0,2/16,8.90%,B4GALT6;CNTNAP1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.3972249209162557,-0.6301141496896415,0.8958333333333334,1.0,1.0,1/7,17.26%,ADI1
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3439517753167744,-0.6295957129018996,0.9347826086956522,1.0,1.0,3/14,10.17%,GOPC;ACTN2;CASQ2
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.378446668591555,0.6286638848576682,0.8541666666666666,0.9936434755780105,1.0,5/9,21.82%,KYNU;TDO2;KMO;IDO1;KYAT1
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.378446668591555,0.6286638848576682,0.8541666666666666,0.9936434755780105,1.0,5/9,21.82%,KYNU;TDO2;KMO;IDO1;KYAT1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.4570243454042281,0.6284309220475623,0.98,0.9934947188863438,1.0,1/5,11.93%,CBFB
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.38519811456265196,-0.6283386210385838,0.9473684210526315,1.0,1.0,3/9,27.54%,GGCT;OPLAH;HAGH
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.37140256888604817,0.6282135684860641,0.8888888888888888,0.9932887734761184,1.0,2/8,16.49%,ANK3;GLRX
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.2802597061318691,-0.6281980291686111,0.9827586206896551,1.0,1.0,14/67,21.16%,RAD23A;RACK1;ELOB;UBQLN2;NOP53;KEAP1;SIRT6;SMAD7;SH3RF2;PLK3;CBFA2T3;DDA1;RNF180;CDC20
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.39666015456710774,-0.6280874026940262,0.8936170212765957,1.0,1.0,3/9,28.08%,ENG;TESK1;ENPP1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.3014129401470583,-0.6280663753484051,0.971830985915493,1.0,1.0,5/43,10.82%,GAPDH;LDHC;PGAM1;PDHB;GCK
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.3927874779960987,0.6279607026860003,0.9130434782608695,0.9931320615103585,1.0,5/5,60.73%,ATP8A1;ATP11B;TMEM30A;SCARB2;ATP8A2
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.3331659527179721,0.6279539294743482,0.9545454545454546,0.992791433131645,1.0,4/16,12.58%,IL12A;ANO6;JAM2;LGALS3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.42062731409204523,-0.627839516543376,0.875,1.0,1.0,4/7,27.59%,TFIP11;DHX8;ZFAND1;VCP
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",-0.3510156801837782,-0.62759364586514,0.92,1.0,1.0,7/14,25.40%,RIC3;NQO1;CHRNA7;CHRNA10;CHRNB4;CHRNA4;CHRNB1
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.3492421621737376,0.6275612234925941,0.9818181818181818,0.9926677067258328,1.0,2/14,8.59%,PID1;GIT1
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.42385337930901895,-0.6267509125143974,0.9056603773584906,1.0,1.0,2/7,15.28%,CAPN10;GSN
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.3589168637638332,-0.6267402362965576,0.9056603773584906,1.0,1.0,2/7,22.66%,BLM;TERF1
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.3861387770137373,0.6261656728511791,0.8936170212765957,0.9933000893743387,1.0,1/6,4.39%,DACH1
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.38563707878793685,-0.6249567987719546,0.9107142857142857,1.0,1.0,2/8,12.77%,ZNF830;BLM
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.36310812561525196,-0.6247712061342594,0.8823529411764706,1.0,1.0,1/8,6.19%,RNF113A
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.3424923415537245,-0.6247454358278487,0.9038461538461539,1.0,1.0,4/11,23.43%,TAF7;TAF11;BDP1;GTF2A2
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),0.4199479512699141,0.6246085315114851,0.9,0.9935344271809047,1.0,3/5,16.00%,SLC22A3;SLC6A4;SLC29A4
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),0.4199479512699141,0.6246085315114851,0.9,0.9935344271809047,1.0,3/5,16.00%,SLC22A3;SLC6A4;SLC29A4
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.279671730684032,0.6245882114786618,1.0,0.9932064966135331,1.0,9/47,20.03%,PPARG;ABCB4;PNPLA1;ABCA1;ABHD5;ACOX2;MLXIPL;ATP13A2;ABHD8
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.24424833466225074,0.6235515607475359,1.0,0.9934623690629892,1.0,29/118,26.99%,KAT2B;KDM6A;KDM4D;SOX9;SATB2;PHF19;ACTL6B;SMARCA2;SMARCA1;KDM6B;SETD5;ZBTB1;TADA2A;KAT2A;DR1;SPI1;SMARCD2;HDAC4;CHD1;RUVBL2;SETDB2;HMGB2;SNAI1;SIRT1;PRDM16;TAF6L;ATRX;BAZ2B;MTF2
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.4102253162250591,0.623405035297385,0.8571428571428571,0.993208122208607,1.0,1/5,7.58%,CHDH
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.32645311285302037,-0.623283359241208,0.8823529411764706,1.0,1.0,6/25,24.32%,FIS1;PXMP4;PEX10;ATAD1;PEX16;ACBD5
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.38107155720691943,-0.6231643804070761,0.96,1.0,1.0,4/9,23.36%,ETFB;ACADS;ETFA;IVD
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),-0.3807763386942402,-0.6227109493538991,0.8823529411764706,1.0,1.0,4/8,17.58%,LGALS1;HLA-B;AGER;HMGB1
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.39752280237809406,0.6224826064256997,0.8490566037735849,0.9934515825854414,1.0,2/5,25.48%,DYRK3;KLC1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.4018303959114641,-0.6222179100072905,0.9230769230769231,1.0,1.0,1/6,15.34%,TRDN
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.33866087271724865,-0.6216202427057815,0.9019607843137255,1.0,1.0,5/17,20.99%,PTTG1IP;CD81;VPS11;RNF128;VPS35
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.4153525722664124,0.6211671512197189,0.9285714285714286,0.9938171758869633,1.0,2/6,22.88%,PDE3B;LONP2
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.28531521516316016,-0.6209063365989841,1.0,1.0,1.0,5/55,11.91%,CDKN1C;GSTP1;PRDX3;TAF7;PPIA
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.3281877504079498,0.6206164117309257,0.9230769230769231,0.9937546094020945,1.0,6/15,34.59%,IP6K3;IPMK;ISYNA1;ITPKC;PPIP5K2;ITPKA
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.32356213579290527,0.6205589091163796,0.9565217391304348,0.9934435786310335,1.0,1/16,3.38%,IL12A
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.4102267595526541,0.6204977566095189,0.9375,0.9931205454245186,1.0,1/6,5.19%,SRC
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.289227936979637,-0.6196599909570027,0.9803921568627451,1.0,1.0,5/62,8.48%,SFRP1;STMN1;PFN1;ACTG1;RHOA
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),0.3543513690768174,0.6194902558962191,0.98,0.9933473311175772,1.0,3/13,12.48%,H2BC11;SFTPD;DMBT1
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.3856595890665869,0.6186790865718939,0.8823529411764706,0.9935088453735467,1.0,3/8,25.21%,MACROH2A1;RPS6KA4;FMR1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3144246561326781,0.6185494589144886,0.875,0.9932186704033475,1.0,6/20,20.80%,CBARP;GPR35;GNB5;PKD2;FKBP1B;ATP1A2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.33455684642504735,-0.6184792545291499,0.9047619047619048,1.0,1.0,5/11,21.92%,GORASP1;GOLGA2;UBE2S;CDC20;SKP1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.27463263769828716,-0.6184332657036528,1.0,1.0,1.0,9/47,17.96%,UBL5;ABLIM3;TFDP1;YWHAB;TOMM7;YWHAQ;VPS11;BAD;UBE2L3
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.3502038429665756,-0.6183555792176108,0.9107142857142857,1.0,1.0,2/10,10.22%,SSC5D;HLA-B
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.30616017581913013,-0.6183499116406895,0.9433962264150944,1.0,1.0,1/25,2.11%,RNF8
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3743231550881937,0.6182830965537668,0.9361702127659575,0.9930629022437633,1.0,1/10,4.07%,NR4A3
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),-0.3614984852749947,-0.6182387972277955,0.8301886792452831,1.0,1.0,1/11,15.33%,CHRNA7
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.3631149358261264,-0.6181913250792465,0.8979591836734694,1.0,1.0,5/12,27.43%,IDH3B;IDH3G;ACLY;IDH2;IDH1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.30436302658448444,-0.6181450460193233,0.9245283018867925,1.0,1.0,4/22,23.18%,DNMT3B;CTR9;DNMT1;PAF1
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),-0.37279818204128057,-0.6177882849638677,0.8913043478260869,1.0,1.0,3/8,30.72%,IKBKG;DAPK2;MAP3K7
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.41690101626516396,0.6166962352529215,0.9565217391304348,0.9936715480229011,1.0,2/7,19.10%,MVB12A;LYST
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.34660911881413925,-0.616564358127246,0.9361702127659575,1.0,1.0,1/11,20.91%,UAP1
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),-0.4271953018815303,-0.6163634673465348,0.8688524590163934,1.0,1.0,3/6,27.11%,SLC36A4;SLC38A3;SLC36A1
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.3640186907380574,-0.616099624909586,0.9090909090909091,1.0,1.0,1/10,4.41%,CD9
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.35407197016252234,0.6155438291666735,0.94,0.9939221368493011,1.0,3/8,15.02%,ITGB1BP1;MEGF10;CCN3
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3363396609147539,0.6148448053100136,0.9791666666666666,0.9939897333352515,1.0,7/18,23.60%,CARTPT;MAFB;FBN1;CDK6;C1QC;GPR137;ZNF675
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.3184454126603668,-0.6146732191754691,1.0,1.0,1.0,3/29,11.99%,H2AX;ZNF830;HUS1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.4099967294320437,-0.6144606755770011,0.9555555555555556,1.0,1.0,2/5,18.87%,SLC35B3;SLC35B2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.4099967294320437,-0.6144606755770011,0.9555555555555556,1.0,1.0,2/5,18.87%,SLC35B3;SLC35B2
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.36529708933158866,-0.6142611401942744,0.8867924528301887,1.0,1.0,2/11,17.59%,KAT5;PARK7
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.39196840652804876,-0.6141922210227811,0.9365079365079365,1.0,1.0,7/7,60.82%,AGO4;DDX3X;DHX36;DHX9;AGO1;AGO3;AGO2
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.32507425220624037,-0.6129345880495999,0.9387755102040817,1.0,1.0,3/23,5.76%,DAO;AADAT;HSD17B10
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.3084370177271921,-0.6123451703502526,0.9574468085106383,1.0,1.0,3/23,11.06%,NUMA1;PLAAT4;ETV4
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.3186006196717152,-0.6123220883125204,0.9454545454545454,1.0,1.0,3/16,21.03%,RELL1;AGER;PJA2
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.3612941576275487,0.6114745294735701,0.9069767441860465,0.9955396415055932,1.0,2/11,14.70%,PRKD1;VEGFA
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),-0.36782487563437655,-0.6112421628773814,0.9473684210526315,1.0,1.0,4/14,22.01%,FDXR;COQ7;COQ10B;COQ3
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.3345995997186453,0.6111999128769717,0.9215686274509803,0.9953508630945278,1.0,1/10,5.83%,SGCZ
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.27276613941388284,0.6109039494336026,0.9210526315789473,0.9951581562833198,1.0,4/25,17.15%,IL12A;ZBTB1;TNFSF4;IL12RB1
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.3105934647152284,-0.6106597228296322,0.9183673469387755,1.0,1.0,4/31,13.63%,GSTP1;CCDC22;TRIM59;NLRX1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.30437854336026376,-0.6103726815914408,0.9814814814814815,1.0,1.0,2/23,7.71%,SLC22A2;SLC3A2
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),0.33146112675523615,0.6103205097039368,0.9347826086956522,0.9951278645930104,1.0,2/10,12.05%,PRMT8;NDUFAF5
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.3853729363571754,-0.6086485966941949,0.9215686274509803,1.0,1.0,1/6,6.63%,FNTA
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),-0.3505815529923222,-0.6084982055356436,0.9411764705882353,1.0,1.0,5/13,29.89%,ELOF1;PADI2;ZMIZ2;SMARCD1;CHEK1
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.34671097510917276,-0.6083943529270399,0.9019607843137255,1.0,1.0,5/14,33.96%,SMC6;MSH3;GEN1;RAD52;XRCC3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.38749031754705676,-0.6074535278241634,0.9454545454545454,1.0,1.0,2/7,11.57%,CCDC22;TMSB4X
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.36968971526923666,-0.6069567393987159,0.9482758620689655,1.0,1.0,4/13,22.01%,FDXR;COQ7;COQ10B;COQ3
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.36968971526923666,-0.6069567393987159,0.9482758620689655,1.0,1.0,4/13,22.01%,FDXR;COQ7;COQ10B;COQ3
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.3238276955643621,-0.6069092319936015,0.896551724137931,1.0,1.0,3/18,13.96%,SLC22A2;ABCA8;ABCC1
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),0.39844415998833504,0.606880188994883,0.9787234042553191,0.9966590242009817,1.0,2/6,19.10%,CLEC7A;LYST
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.34790580764921697,-0.6066995563484116,0.9672131147540983,1.0,1.0,4/18,19.60%,BAX;BAK1;BCL2A1;CASP9
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.2614749013552855,0.6066907926149069,1.0,0.9964498490998839,1.0,7/42,20.06%,SEPTIN6;PLK1;CENPA;ANK3;CKAP2;BBS4;SNX33
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.3669713957000664,-0.6064244363278495,0.92,1.0,1.0,3/6,30.71%,TPR;SUPT6H;NSUN2
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.3669713957000664,-0.6064244363278495,0.92,1.0,1.0,3/6,30.71%,TPR;SUPT6H;NSUN2
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.34557248416882896,-0.6062096958353259,0.9454545454545454,1.0,1.0,1/16,4.31%,SLC39A6
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.35590061712222326,0.6051147580223032,0.9215686274509803,0.9968892776245419,1.0,3/8,30.91%,RPTOR;CLEC16A;CARD11
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.3711073832967481,0.6049610607922103,0.9583333333333334,0.9966518068493457,1.0,2/8,25.26%,HDAC4;SIRT1
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.4367577351109475,0.6048629207856934,0.9166666666666666,0.9963577981255201,1.0,1/6,5.27%,MACROD1
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.38408742565988063,-0.6046744658776644,0.9629629629629629,1.0,1.0,2/6,16.45%,HLA-DRA;CD46
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.38408742565988063,-0.6046744658776644,0.9629629629629629,1.0,1.0,2/6,16.45%,HLA-DRA;CD46
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.35572373105584976,-0.6042521945987003,0.975609756097561,1.0,1.0,1/11,6.98%,ASF1B
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.37181867078074715,-0.6040925233741137,0.9090909090909091,1.0,1.0,1/8,4.41%,CD9
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.3902515608009394,-0.6039946002423009,0.8363636363636363,1.0,1.0,1/5,8.48%,RHOA
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.31557829839178075,-0.6039673670361486,0.9814814814814815,1.0,1.0,4/17,20.36%,PPIA;MAPK7;PARK7;PINK1
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.37591772488055053,0.6031878710407587,0.8478260869565217,0.9970113860984752,1.0,2/9,15.52%,ACVR1C;ACVR2A
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.3315803439026811,0.6031455112086311,0.9215686274509803,0.9966972193279354,1.0,2/12,17.86%,CCDC120;BBS4
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.3154431212604403,-0.603112575051583,0.9803921568627451,1.0,1.0,3/20,15.34%,CALM1;P2RY6;TRDN
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.3209007329443738,-0.6030883945789612,0.9183673469387755,1.0,1.0,5/17,24.40%,TOR1A;IKBKG;SYT11;TESK1;SNAPIN
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.38713953013343544,-0.602575005265158,0.8723404255319149,1.0,1.0,2/6,20.29%,ATG9A;ATG2A
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.3352662915774131,-0.6024952982507649,0.9272727272727272,1.0,1.0,3/15,16.53%,SOD1;DYNC1H1;MAP1A
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.2898154482613147,-0.6023372995921107,1.0,1.0,1.0,13/42,22.35%,MYADM;SS18L2;RAC1;FBXW8;ILK;CRK;CALR;CDC42;LIMS2;P4HB;PRKDC;FLNA;TESK1
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.37893146362902175,0.6023102387244921,0.9411764705882353,0.9967999975040025,1.0,4/8,20.80%,SLC4A4;ATP1B2;ATP1B3;ATP1A2
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.30577224330469965,-0.6021191095612674,0.9629629629629629,1.0,1.0,5/20,17.78%,AWAT2;PLCE1;PNPLA3;GPAM;GPAT2
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.24874230964350005,0.6015632999341223,1.0,0.996866304386461,1.0,14/91,18.54%,KAT2B;KDM6A;KDM4D;SOX9;SATB2;ACTL6B;SMARCA2;SMARCA1;KDM6B;ZBTB1;TADA2A;KAT2A;MBD3;DR1
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.4080420767689588,-0.6012488430977293,0.9019607843137255,1.0,1.0,2/5,18.10%,COMT;MOXD1
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.3875194113534355,-0.5990057892169696,0.8695652173913043,1.0,1.0,1/7,4.20%,KRT10
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.39713384956840836,0.5989505914379054,0.9230769230769231,0.9977694952053057,1.0,1/5,8.60%,FBLN5
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.34801697264795317,-0.5988310278217616,0.9333333333333333,1.0,1.0,1/11,4.59%,GSTP1
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.3187527343607496,0.5986289338690176,0.9245283018867925,0.9975929189805026,1.0,2/10,12.96%,SLA2;CD70
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.3525354069518506,0.597492639621315,0.9215686274509803,0.9970962172197981,1.0,2/8,16.60%,CR1;SUSD4
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.3525354069518506,0.597492639621315,0.9215686274509803,0.9970962172197981,1.0,2/8,16.60%,CR1;SUSD4
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",0.3525354069518506,0.597492639621315,0.9215686274509803,0.9970962172197981,1.0,2/8,16.60%,CR1;SUSD4
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.3750495434437978,-0.5966900125293938,0.9259259259259259,1.0,1.0,1/10,6.18%,APOD
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.3411550433204765,0.5966894979795384,0.9591836734693877,0.997121924210041,1.0,2/9,21.39%,SHANK1;SLC6A1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.2832181855766876,-0.5952041005993265,1.0,1.0,1.0,10/34,25.83%,MYBBP1A;PRKAA2;EIF2AK3;ATG14;ATF4;TBL2;BECN1;XBP1;ITFG2;HSPA5
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.3891241257909511,0.5947899020297904,0.9,0.9976681066113634,1.0,5/5,61.10%,GLI3;LMBR1L;FAS;RIPK1;AKT1
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.3742433659022476,0.5946120038623072,0.851063829787234,0.9973991584899149,1.0,2/6,23.53%,PARD3;MAD2L1
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.29628512442217275,-0.59447187788648,0.9259259259259259,1.0,1.0,2/15,12.86%,AP2S1;CLTB
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.40141783233418976,-0.5942871254875977,0.9454545454545454,1.0,1.0,6/6,59.87%,DDX3X;PRKN;PTPN22;BIRC2;MARCHF7;XIAP
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.3520448858785886,-0.5938308074594618,0.9615384615384616,1.0,1.0,1/16,4.31%,SLC39A6
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.3435373371659814,0.5935782161711802,0.9565217391304348,0.9975698898557497,1.0,3/11,19.76%,VEGFD;VEGFA;KDR
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.33910104334459035,0.5926151522816954,0.8666666666666667,0.9976840747635465,1.0,5/10,25.63%,NOS1;NOS2;CACNA1C;NF1;STIM1
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.2857975768348456,-0.5925854952252725,1.0,1.0,1.0,4/36,10.14%,SLC25A45;SLC3A2;SLC38A7;SLC7A11
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.33933408633773743,0.5924716839628191,0.9464285714285714,0.9974476315995896,1.0,5/12,24.09%,ZFP36;TRIM62;TRIM32;IFITM3;TRIM27
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.2533957077673602,0.5922269186894913,1.0,0.9972274618360003,1.0,2/42,9.72%,MIDEAS;TBL1XR1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.30764344490099615,0.5909932526014327,0.9047619047619048,0.9974704964879086,1.0,3/8,23.37%,PFKM;HK2;PFKP
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.3606917590381971,0.5894764072906254,0.9375,0.9977616672381895,1.0,2/7,14.65%,MRTFB;MEGF10
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.284842023804218,0.5876322708711245,1.0,0.9983222340683056,1.0,10/32,22.50%,TIMELESS;CLOCK;SETMAR;RAD9A;PRPF19;E2F1;DNA2;DOT1L;BRIP1;MAP3K20
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.3515120050658662,0.5866954234846247,0.8536585365853658,0.9983957038931299,1.0,1/5,19.13%,WRN
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.31713037214020023,0.5866498347259984,0.9583333333333334,0.9980831019181003,1.0,4/16,16.82%,LAPTM5;SAMSN1;ZFP36L1;TNFSF4
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.2999806856536863,0.5856331346964587,0.9629629629629629,0.9982128788144411,1.0,2/21,4.85%,BMPR1B;KAT2B
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.3806652123750043,0.5854149371463273,0.9090909090909091,0.9979527905367873,1.0,3/6,16.59%,EPHB3;HES1;ZBTB1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),-0.3945953660973405,-0.585310548926653,0.9137931034482759,1.0,1.0,5/5,60.55%,MTMR4;MTMR1;MTMR9;MTMR2;MTMR3
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.315271239715575,0.584812564202492,0.9555555555555556,0.9978816760712984,1.0,6/17,16.81%,PLA2G10;SLC15A2;SCARB1;SLC25A19;SLC29A2;SLC15A4
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3632571572699315,0.5844703985232418,0.875,0.997718251814701,1.0,5/9,28.18%,PIH1D2;RUVBL2;NAF1;NUFIP1;SHQ1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.2985532218412984,0.5843936307917131,1.0,0.9973983847824587,1.0,5/14,24.89%,SLA2;CD70;BACH2;HLA-DRB1;STAT3
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.37947902436300773,-0.584315980792461,0.9166666666666666,1.0,1.0,1/5,12.90%,HNF4A
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.32517077299801744,-0.5841931912037573,1.0,1.0,1.0,3/19,10.60%,ACTN2;MYL6;TPM4
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.32517077299801744,-0.5841931912037573,1.0,1.0,1.0,3/19,10.60%,ACTN2;MYL6;TPM4
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.3709128185834225,0.5826189679161619,0.9111111111111111,0.9977970342591509,1.0,2/8,16.40%,DMTN;CASS4
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.3287019639070556,0.5824385285262619,0.8979591836734694,0.9975134614977802,1.0,4/10,36.22%,DROSHA;SMAD2;PUS10;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of protein sumoylation (GO:0033234),-0.3931505403744919,-0.5823224040971785,0.9444444444444444,1.0,1.0,2/5,23.40%,PARK7;PIAS3
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.33424597716411264,-0.5818876091585616,0.9423076923076923,1.0,1.0,1/11,7.37%,PCBP3
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.34942088383378805,-0.5817669368020214,0.9387755102040817,1.0,1.0,3/9,23.74%,STIL;RIPPLY2;MESP1
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.29114263284937486,-0.580617305594116,0.9818181818181818,1.0,1.0,2/35,8.48%,SFRP1;RHOA
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.31862608070380394,-0.5803578349551436,0.9491525423728814,1.0,1.0,4/12,22.80%,RESF1;TRIM28;DNMT1;SETDB1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.3472514957019035,0.5802110059290316,0.9574468085106383,0.9981644373454195,1.0,3/8,30.07%,RHOT1;BNIP3L;ATF2
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.2874445040963948,0.5790600644278091,0.9803921568627451,0.9982497371143693,1.0,5/23,20.08%,PLK1;NCAPG;CHMP1A;CSNK2A1;MCPH1
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.3429918635232734,-0.5787133985630399,0.95,1.0,1.0,3/9,18.43%,COMT;BHMT;ALDH7A1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.2909101610289583,-0.5784724842179855,0.9782608695652174,1.0,1.0,3/20,22.00%,CREB3;ATF4;XBP1
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.36793331592253653,0.5780236696364233,0.9107142857142857,0.9982908976566723,1.0,2/5,22.69%,SLC11A2;TFR2
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.33797035444762485,-0.5780016031507783,0.9215686274509803,1.0,1.0,2/8,22.66%,BLM;TERF1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.29928324688036395,0.5776084799385488,1.0,0.9981998315748695,1.0,9/22,28.02%,MTERF1;MCM9;WRN;DNA2;MRE11;HMGB2;RECQL4;ZRANB3;POT1
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.35973377493286324,0.5775538753309576,0.9137931034482759,0.9978725526067306,1.0,3/8,17.20%,PCGF2;PCGF3;PCGF5
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.2752403498027706,0.577498670540363,1.0,0.997557505940748,1.0,8/29,17.09%,CARMIL1;DMTN;CSPG5;RAC3;DOCK5;CASS4;ARHGEF7;DOCK1
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.34368530048951224,0.5773383442923525,0.9230769230769231,0.9972826926707229,1.0,2/10,6.15%,SYK;WNT5A
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.27455425884988943,-0.5762967932160602,0.9772727272727273,1.0,1.0,5/35,18.66%,ZNF598;KBTBD8;CTR9;RNF126;NEURL1
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),0.34001399214607575,0.5759116134055006,0.8780487804878049,0.9975361423372626,1.0,3/7,20.18%,DNAH11;DNAAF1;DRC1
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.31368928016056485,-0.575480056349956,0.9607843137254902,1.0,1.0,3/18,19.77%,UBQLN2;RAC1;ANKRD13D
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.30649345579359666,-0.5751794874669882,0.9411764705882353,1.0,1.0,5/20,24.32%,FIS1;PXMP4;ATAD1;PEX16;ACBD5
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.2588929066951017,0.5746899665423696,1.0,0.9977254324184932,1.0,1/33,3.54%,LRRK2
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.36257567876799146,0.5733089471611644,0.9230769230769231,0.9979545726674214,1.0,1/5,7.96%,DCTPP1
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.3201473602786856,-0.573262613624295,0.9454545454545454,1.0,1.0,2/9,12.98%,MCM4;MCM3
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.29239349207797616,0.5732175251662806,0.9777777777777777,0.99764003251883,1.0,3/25,16.90%,KAT2B;KAT6B;KAT2A
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.3061024087341959,0.5730714982986113,0.9811320754716981,0.9973616620556328,1.0,3/12,18.19%,SLC1A2;SLC25A22;SLC1A1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),0.3850366631036837,0.572422272113898,0.9423076923076923,0.9972312508233115,1.0,1/5,11.80%,HES1
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.22965653091065671,0.5719490247035588,1.0,0.9970729808669672,1.0,13/68,22.30%,CAMSAP3;SPEF1;DIAPH1;MAPT;RHOT1;PRMT6;TBC1D25;ATP13A2;SAR1A;PAK2;TMEM33;MTM1;EHD3
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),-0.32863475032412565,-0.5718386162524202,0.9772727272727273,1.0,1.0,4/9,24.37%,ENG;CSRP1;SRPK3;POGLUT1
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.3676084340207427,-0.5716031026226108,0.9615384615384616,1.0,1.0,1/7,13.39%,GOLGA2
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.3633981837470385,0.5706490518557503,0.9230769230769231,0.9972021767356071,1.0,3/7,27.71%,IL12RB1;STAT3;STAT4
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.34567186969593294,-0.5703366830530266,0.9444444444444444,1.0,1.0,2/9,25.33%,TPR;NUP93
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.3765056736461151,-0.569726999680187,1.0,1.0,1.0,2/7,19.96%,BLM;DDX11
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),-0.3453140741147258,-0.5696121295666627,0.9615384615384616,1.0,1.0,3/5,30.85%,TMEM126A;ERBB3;SALL1
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.36778617263053737,-0.5685384940377918,0.9148936170212766,1.0,1.0,2/5,16.58%,HLA-DRA;CALR
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.37951128331341344,-0.5682652319031936,0.8974358974358975,1.0,1.0,1/5,13.31%,CAP1
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),-0.3801322612874066,-0.5675430441684471,0.9347826086956522,1.0,1.0,5/5,62.00%,C17ORF75;TRIP11;TBC1D23;FAM91A1;WDR11
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.25052013012780505,-0.5668834745657402,1.0,1.0,1.0,15/49,29.16%,FIS1;BAX;BAK1;BAD;PLAUR;PARK7;PINK1;VPS35;RALA;MUL1;PDCD5;BNIP3;DCN;HTRA2;HRK
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.30464946328309994,-0.5662517722022483,0.9444444444444444,1.0,1.0,3/12,16.64%,QPRT;PM20D2;ACSF3
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.3845225154006758,-0.5658619562551794,0.9148936170212766,1.0,1.0,1/6,11.88%,ORAI1
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.30309014104727977,0.565486710299634,0.9827586206896551,0.9988274376303296,1.0,5/13,27.17%,NLGN1;RAB27A;KIF5A;DNM2;KIF5C
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.3021762728841454,-0.5650422525941392,0.9807692307692307,1.0,1.0,2/25,12.86%,AP2S1;CLTB
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.3517245458773568,-0.5650130348922912,0.9375,1.0,1.0,3/9,23.28%,DHFR;PINK1;ALOX5
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.31544485217557355,0.564764930854839,0.9411764705882353,0.9987286139026961,1.0,7/17,28.33%,TAF5L;KAT2A;ZC3H13;CNOT2;ZNF706;TAF6L;ESRRB
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.3125586933595438,0.5644290276742909,0.9615384615384616,0.9985381551467755,1.0,2/10,16.97%,GIT1;ARHGEF7
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.3532887438612151,-0.5641941871185776,0.9361702127659575,1.0,1.0,1/6,16.76%,GPAM
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.29609909439448756,-0.5640252950102327,1.0,1.0,1.0,5/13,28.21%,PNKP;PKIB;MAP2K7;TNKS2;NABP2
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.2960180016876443,0.5632882724408999,1.0,0.9986108808557851,1.0,1/14,6.12%,TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.3492112393335486,0.563153591185991,0.9622641509433962,0.9983249665002967,1.0,6/8,34.92%,ROBO1;DEAF1;GPX1;ZNF703;RREB1;BRCA2
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.3471770349829525,0.5627557126336986,0.9772727272727273,0.998126871374801,1.0,2/8,14.59%,TOX;CAMK4
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.32551568708814244,0.5626576563549465,0.9782608695652174,0.9978373321919235,1.0,5/13,21.82%,KYNU;TDO2;KMO;IDO1;KYAT1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.35631126158443455,-0.5625705948233336,0.9807692307692307,1.0,1.0,3/8,31.88%,EGF;MSN;EZR
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.35631126158443455,-0.5625705948233336,0.9807692307692307,1.0,1.0,3/8,31.88%,EGF;MSN;EZR
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.35631126158443455,-0.5625705948233336,0.9807692307692307,1.0,1.0,3/8,31.88%,EGF;MSN;EZR
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.22391239686418762,0.5621679915241838,1.0,0.9976435159606832,1.0,20/106,24.09%,TBC1D10A;HOOK1;KIF16B;DENND2A;LAPTM5;RAB29;WASHC1;BAIAP3;RIC1;AP1G1;CCDC91;EPS15;RAB6B;PIK3C3;SORT1;EHD3;TBC1D5;DOP1B;GAK;TRIM27
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.3194505959209417,-0.5618660485451686,0.98,1.0,1.0,2/23,6.16%,TNFRSF21;NKX6-2
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.28588093288097116,0.5618546097296329,0.9767441860465116,0.9974219779176922,1.0,3/23,17.59%,GPR161;TULP3;GLIS2
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.31943969567231517,-0.5617694567166911,0.9629629629629629,1.0,1.0,4/11,22.80%,RESF1;TRIM28;DNMT1;SETDB1
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.3347857711090739,0.5615893177616433,0.8936170212765957,0.9971687685231116,1.0,2/9,11.81%,C3;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),0.3586148913854739,0.5602970182455259,0.9148936170212766,0.9972735947809414,1.0,1/8,5.14%,PRKCZ
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.3827362862435974,-0.5598468622385103,0.9215686274509803,1.0,1.0,1/5,13.39%,GOLGA2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.36051080731336865,0.5592478327269619,0.9473684210526315,0.9972710271054693,1.0,1/6,10.17%,CORO1C
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.38761654049888306,-0.5588973061150103,0.95,1.0,1.0,1/5,10.27%,DDR1
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.28030883024262887,-0.5583933138462313,1.0,1.0,1.0,9/26,22.00%,LAMTOR4;RRAGA;SLC38A9;LAMTOR2;NEURL1;LAMTOR5;IPO5;CAPN2;XBP1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),0.3053551877114856,0.5577937154876176,1.0,0.997399589721991,1.0,1/11,19.31%,LRP1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.33164669946320074,0.5574393288283747,0.9795918367346939,0.9971904241414961,1.0,3/10,17.13%,CNTNAP1;PARD3;PRX
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),0.3623244889718401,0.5563380573828236,0.9111111111111111,0.9972077416651643,1.0,3/5,22.51%,RNF207;GJA1;FGF1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.3304450138832852,0.5559395065268807,1.0,0.9970027512469519,1.0,1/13,6.59%,FHDC1
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.30747388965121614,-0.5558930570104734,0.9803921568627451,1.0,1.0,3/18,19.92%,ADIPOR1;TMSB4X;UACA
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.29631027532869925,0.5547928163505618,0.9821428571428571,0.9970042473587308,1.0,4/18,23.88%,PUM1;RBM24;FTO;GIGYF2
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.33166391624741076,-0.5528088310585987,0.9777777777777777,1.0,1.0,2/9,22.00%,PRKAA2;XBP1
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.3213651268058658,-0.5527450569848906,0.98,1.0,1.0,3/10,25.21%,CASTOR2;RNF152;ITFG2
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.31488805370714945,0.5526142929062847,0.9795918367346939,0.9972834256854406,1.0,3/9,24.32%,TOP2A;TOP1MT;HMGB2
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.36241126571124616,0.5524031054918946,0.9183673469387755,0.9970072365608579,1.0,3/5,29.83%,GAS6;CXCL13;HSD3B7
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.31629046745839484,-0.5520485077661471,1.0,1.0,1.0,2/14,9.42%,DDX4;ZSCAN21
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),-0.3741415029938243,-0.5517549101362283,0.9310344827586207,1.0,1.0,1/5,10.98%,ANXA2
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.24862604536238953,0.5514317311412635,0.9803921568627451,0.9970999070274129,1.0,9/25,31.62%,RBM24;NOCT;E2F1;TAF15;NBAS;FMR1;DND1;FUS;HNRNPU
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.3767051870496024,0.5513934828955,0.9215686274509803,0.9967803735268139,1.0,1/5,10.99%,AEBP1
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),0.3347182623002115,0.5508952201252089,0.9722222222222222,0.996587825078325,1.0,2/6,15.43%,DNAH11;DNAAF1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.2795784849754165,-0.550591675251938,0.9807692307692307,1.0,1.0,5/19,28.21%,PNKP;PKIB;MAP2K7;TNKS2;NABP2
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.3050553457005801,0.5505562269973162,0.9821428571428571,0.9963478832408132,1.0,2/10,15.14%,TTLL4;TTLL6
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.23145559106290825,-0.5503939778161293,1.0,1.0,1.0,8/65,17.75%,TBC1D16;UBQLN2;TBC1D19;NPM1;USP6NL;GSN;VPS11;STIL
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.30694197167245696,-0.5497544656805473,0.9444444444444444,1.0,1.0,2/11,18.01%,HMGA2;YBX1
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.35062092591711475,-0.5494066895026014,0.9622641509433962,1.0,1.0,7/7,64.95%,ATM;TERF2;NBN;ERCC1;SMG6;RAD50;ERCC4
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.31993235074480025,-0.5477943024172703,0.9649122807017544,1.0,1.0,3/12,26.68%,DYNC1H1;EIF4ENIF1;LSM3
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.35097782359126595,0.5477333983027326,0.9,0.9969671851238779,1.0,1/6,14.59%,CAMK4
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.3097031895797475,0.5454705882252885,0.95,0.9973842345957781,1.0,2/8,19.91%,VEGFA;NCAM1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.3373725868679939,0.5451298435694665,0.9423076923076923,0.9971561357815387,1.0,1/6,11.28%,CD200
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.2494555323283592,-0.544460273926729,1.0,1.0,1.0,9/45,18.87%,USP1;USF1;OPN4;ERCC8;UBE2A;MEN1;GTF2H2;PRIMPOL;CIRBP
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.3106830822298735,-0.543420128986296,1.0,1.0,1.0,6/13,30.48%,PFAS;IMPDH2;ATIC;ADSS1;LHPP;GART
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.27845063066469067,0.5428910063454911,0.9534883720930233,0.9975847065886885,1.0,3/17,11.15%,DMD;NOS1;RNF207
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.33075916138604966,-0.5428731194943222,0.9491525423728814,1.0,1.0,1/12,8.06%,PGAM1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.23938116052858216,-0.5427768199140114,1.0,1.0,1.0,11/67,17.67%,PCNA;TFDP1;BAX;TRIAP1;BTG2;RPS27L;KAT5;GML;CARM1;PLK3;CNOT3
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.3307019206425801,-0.5426052234097661,0.9375,1.0,1.0,2/10,17.85%,MUS81;REXO4
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.3443122191101686,-0.5419163851345575,0.8846153846153846,1.0,1.0,2/7,18.51%,MIS12;CENPF
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.2872785143752675,0.541419058546073,0.9777777777777777,0.997756006322013,1.0,1/12,5.06%,DACT1
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.3522527237261525,0.5405384851180497,0.9245283018867925,0.9973949938395911,1.0,5/5,64.78%,PEX7;FAR1;AGPS;DHRS7B;GNPAT
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.3522527237261525,0.5405384851180497,0.9245283018867925,0.9973949938395911,1.0,5/5,64.78%,PEX7;FAR1;AGPS;DHRS7B;GNPAT
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.28772508688175824,0.5405085861775114,1.0,0.9970685333672592,1.0,5/21,22.64%,ABCB4;ABCA1;ATP10A;ATP9A;ATP8B4
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.3495333742434826,-0.5399619035431447,0.9811320754716981,1.0,1.0,3/8,14.37%,APOD;PTPN12;HGS
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.29942155057620157,-0.5398192547619844,0.9259259259259259,1.0,1.0,1/15,5.21%,PDCD7
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),0.3306406676450006,0.5383831754106069,0.9607843137254902,0.9972437247482796,1.0,2/6,14.06%,CDC7;DBF4
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.3272369974015751,-0.5374663193337842,0.98,1.0,1.0,2/11,19.70%,ANXA2;GRN
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.31581665515668994,-0.5371188239974108,0.9583333333333334,1.0,1.0,1/8,12.90%,HNF4A
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.2881038015296611,-0.5368541020908869,1.0,1.0,1.0,2/19,8.13%,RACK1;CNKSR3
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.3037354270758982,-0.5365553309845448,0.9230769230769231,1.0,1.0,9/9,69.64%,RAP2B;RAPGEF1;RAPGEF3;RAP1B;RAPGEF2;PLK2;RAP2A;RAP1A;RAP2C
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.3291328733765632,0.5352824475715927,0.9183673469387755,0.99779770777123,1.0,2/5,25.79%,SLC38A6;SLC1A4
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.3138925009262096,0.5349885126627729,0.9772727272727273,0.9975858641904417,1.0,2/11,14.41%,ACADL;SHMT1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.26149027059023044,-0.5349810605051368,1.0,1.0,1.0,2/28,11.93%,PRKAA2;CASTOR2
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.2753214852330394,0.5349325463110057,1.0,0.9972755542977164,1.0,3/19,15.39%,ACVR1C;TOP2A;GPER1
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),0.32387362304044043,0.5344241118918713,0.9565217391304348,0.997075856281836,1.0,2/7,14.06%,CDC7;DBF4
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.28261963164941484,0.5339797257410714,0.9814814814814815,0.9968723502009157,1.0,6/18,32.51%,NGFR;SPPL2B;RELA;ADAM9;TRAF6;RHBDD1
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.3390407022405604,0.5332653198551265,0.9555555555555556,0.996720205037667,1.0,2/6,24.89%,CDK6;STAT3
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.3259331163640694,0.5318079091023976,0.9607843137254902,0.996796626585102,1.0,1/8,8.26%,TIMELESS
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.31471341319259405,0.531765302476272,1.0,0.9964792235714529,1.0,1/9,16.08%,RPTOR
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.258689384614632,-0.5315054910548073,1.0,1.0,1.0,19/32,30.58%,DAXX;POLR2D;PRKACA;IER5;SLU7;TRPV1;TPR;ZFAND1;SUMO1;HMOX1;HIKESHI;ANO1;HSP90AA1;HSBP1L1;VCP;YWHAE;HTRA2;HSBP1;HSF1
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.3066193906279425,-0.5304962920325796,1.0,1.0,1.0,1/7,17.00%,ENG
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.291035951775369,-0.5303639113485985,0.9803921568627451,1.0,1.0,3/11,28.35%,CALR;SNW1;AKR1C3
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.3483394704383743,-0.5302390344274006,0.9565217391304348,1.0,1.0,3/8,23.28%,MGST3;FADS1;ALOX5
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.2569452921928527,-0.530189964971376,1.0,1.0,1.0,6/24,19.42%,KMT2B;ZNF335;CTR9;DPY30;MEN1;BEND3
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.33670579334658396,0.5301008574380651,0.9111111111111111,0.996622593692157,1.0,3/6,32.81%,SENP7;USPL1;SENP6
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.28308501231276006,-0.5292515617490317,1.0,1.0,1.0,1/22,3.79%,PTK6
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.33367123919616226,-0.5286981133773837,0.9512195121951219,1.0,1.0,2/6,27.17%,PIH1D1;SMARCB1
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.26124683079669164,-0.528465357276507,1.0,1.0,1.0,9/35,19.00%,LAMTOR4;RRAGA;MIOS;SLC38A9;PIH1D1;LAMTOR2;PIP4P1;TELO2;LAMTOR5
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.3389490790796748,0.5265672013052798,0.9245283018867925,0.9971672486853732,1.0,2/5,19.61%,FTO;ALKBH1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),-0.34637322363085493,-0.5260008409033466,0.9642857142857143,1.0,1.0,1/5,23.84%,NCK1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.2944304997678898,-0.5258625190489871,0.9777777777777777,1.0,1.0,4/10,25.58%,DNAJA1;SNX3;TERF1;PPM1F
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.28362937856034753,-0.5249323457270623,1.0,1.0,1.0,1/15,7.70%,CD81
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.333216007584199,0.5247380782345799,0.9545454545454546,0.997408638103427,1.0,2/6,19.72%,NDP;ATP13A2
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),0.337870173016274,0.5232740547531745,0.9056603773584906,0.9975240271019847,1.0,1/5,20.83%,NAB2
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.27917196197616456,-0.5219471309897005,1.0,1.0,1.0,3/19,14.96%,SPHK2;BRD7;PIH1D1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.28200603659934154,0.5218342372412055,1.0,0.9976118209403644,1.0,4/13,20.91%,KCNB1;RPTOR;UCP1;ULK1
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.3147639750535032,0.5199588660868093,1.0,0.9976838367942797,1.0,4/10,36.72%,TCAP;EFEMP2;PROX1;MYLK
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.2745615498495929,-0.5189614490891274,0.9807692307692307,1.0,1.0,5/21,21.37%,PTK6;CTR9;STAMBP;IFNAR1;IL31RA
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.3131673157690486,0.5180649604994416,0.9807692307692307,0.9978147327765188,1.0,3/9,28.19%,ADCY10;TSG101;CABYR
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),0.30405038112718524,0.5161403013314324,0.9767441860465116,0.997996595538662,1.0,2/9,14.06%,CDC7;DBF4
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.3269363126282931,0.5154476523390812,0.9024390243902439,0.9978367815805399,1.0,3/7,26.66%,PIH1D2;RUVBL2;NUFIP1
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.34507382701353184,-0.5140818170975058,0.9795918367346939,1.0,1.0,2/5,22.43%,ATF4;BFSP1
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.26482530455426123,-0.5134282598572026,1.0,1.0,1.0,4/37,10.05%,GSTP1;HYAL2;DUSP7;SPRY3
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),0.29573928223149537,0.5123311495819869,0.9615384615384616,0.9983403344910776,1.0,1/7,11.54%,MAPT
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.25723961385136485,-0.5119700022919167,1.0,1.0,1.0,2/26,10.04%,PYHIN1;CCDC22
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.2911535937110695,-0.5092002707608184,0.9777777777777777,1.0,1.0,5/16,24.60%,BLM;DAXX;PDE12;DDX11;SPIDR
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.32296502774640584,0.508810319138369,1.0,0.9988239354808678,1.0,1/9,8.26%,TIMELESS
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.33751299032328347,0.5087883566655145,1.0,0.9984914374996823,1.0,2/7,15.76%,NOS1;NOS2
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.3105286547177796,-0.5081196017050797,1.0,1.0,1.0,2/8,21.01%,PRKACA;ZDHHC8
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.28206012846974093,-0.5075778806000557,0.9803921568627451,1.0,1.0,2/13,18.01%,HMGA2;YBX1
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.32103969900533186,-0.5068850618870935,0.9777777777777777,1.0,1.0,2/8,22.32%,VPS11;ANKFY1
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.2701950252004591,0.5067130171648299,1.0,0.9985551514792518,1.0,3/13,19.61%,TRMT9B;MOCS3;ALKBH1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.28463984624601274,-0.5060864143852204,1.0,1.0,1.0,4/13,35.13%,TPR;NUP93;SEH1L;NUP54
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.262600157015795,-0.505429990317858,0.98,1.0,1.0,5/20,21.64%,HMGA2;POLE3;ZNFX1;BEND3;EZH1
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.2601001382893236,-0.5050948598838435,1.0,1.0,1.0,4/18,20.26%,BLM;KAT5;EXD2;UBE2N
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.3288609763060234,-0.5043358118537786,0.9344262295081968,1.0,1.0,6/6,67.13%,TUT4;LIN28B;TENT4B;SND1;DIS3L2;PARN
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.3169465987998158,-0.5038644270381065,0.9821428571428571,1.0,1.0,2/7,27.42%,MUL1;BNIP3
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.3440533938693993,-0.5035101208297461,0.9818181818181818,1.0,1.0,1/6,7.42%,VBP1
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.30461610775099346,-0.5033578398489443,1.0,1.0,1.0,1/15,4.51%,AADAT
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.2552847204402644,0.5030979763454135,0.9818181818181818,0.9990577953473606,1.0,2/17,9.41%,CRYM;DDO
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),-0.318974655220407,-0.5024781634376979,1.0,1.0,1.0,3/6,27.01%,ATF4;TFCP2;SUPT6H
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.3295014317074191,-0.5022881435164289,0.9682539682539683,1.0,1.0,2/5,18.46%,ABT1;NOP14
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.3295014317074191,-0.5022881435164289,0.9682539682539683,1.0,1.0,2/5,18.46%,ABT1;NOP14
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.3295014317074191,-0.5022881435164289,0.9682539682539683,1.0,1.0,2/5,18.46%,ABT1;NOP14
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),-0.3169234793705803,-0.5022337793959271,0.95,1.0,1.0,1/5,15.24%,SMAD7
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.2726078226038848,0.4999337249674894,1.0,0.9994190535901096,1.0,4/20,29.95%,MED14;PAXIP1;MED30;MED13
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.3214654771353732,-0.4988988480463106,0.9565217391304348,1.0,1.0,1/7,14.83%,CARM1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.2511266585494666,0.49882071963517083,1.0,0.9993453080140562,1.0,8/27,28.87%,AEBP2;PHF19;MACROH2A1;SPI1;TRIM27;CREBZF;MTF2;TASOR
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.30082986731884537,-0.49874397618526495,0.9038461538461539,1.0,1.0,2/7,16.52%,P3H3;JMJD6
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.31121151070759445,0.4987085347901008,1.0,0.9990249357306716,1.0,1/5,23.84%,EFHD1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.3182581652076474,-0.49715897461896347,0.9824561403508771,1.0,1.0,3/7,21.03%,TLR1;CYBA;PJA2
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),-0.3003240230397397,-0.49601404232926094,0.9166666666666666,1.0,1.0,1/6,14.96%,PIH1D1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.2855617984523216,-0.49542718742323755,0.9622641509433962,1.0,1.0,3/12,19.50%,ZNF830;BLM;MSH3
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.3458538424239114,-0.49425419337644727,0.9761904761904762,1.0,1.0,1/6,24.26%,ZFP57
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),0.30504955176111653,0.49363723769442036,0.9534883720930233,0.9996559237252545,1.0,1/8,7.58%,SNCAIP
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.2748694277612418,-0.4931857777240297,0.9807692307692307,1.0,1.0,6/17,29.43%,CEP131;STIL;DCTN2;CCDC14;HOOK3;CEP192
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),0.3179729451745319,0.4911161944717404,0.9591836734693877,0.9998169461707204,1.0,2/5,25.15%,VEGFA;CCBE1
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.24051373293726938,0.49108850786230257,1.0,0.9994889132212734,1.0,6/30,20.20%,PEX11A;RIN3;RPTOR;RARG;ATP13A2;PTEN
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.2420551754540325,0.4905311827333255,1.0,0.9992314832289323,1.0,2/27,10.55%,ABCD2;ZFAND6
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.21245585103898004,-0.49014932321178206,1.0,1.0,1.0,11/92,17.68%,RNF212;RNF113A;NDUFAB1;VCPKMT;KIAA1586;RAE1;KAT5;NUP37;P3H3;PARK7;TRIM28
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.274463016585463,-0.4878570901374874,0.9666666666666667,1.0,1.0,1/13,12.97%,ERLEC1
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.3094038485862689,-0.4870083199441229,1.0,1.0,1.0,1/6,22.00%,XBP1
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.28121553942390287,0.48559514711589424,0.9811320754716981,0.9997755674567322,1.0,3/9,20.57%,SULT2A1;ALDH1A1;ACSS1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.26268289595092414,0.4852789779792491,0.9642857142857143,0.9995103977631888,1.0,1/11,11.80%,HES1
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.3119005458497892,-0.484979018723758,0.9347826086956522,1.0,1.0,1/5,19.65%,CCNK
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.29475373052696174,-0.48438486979053136,0.9615384615384616,1.0,1.0,3/7,30.42%,CYP3A4;CYP2R1;CUBN
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.2765189591665065,0.48221366849780084,0.98,0.9997337039131381,1.0,3/9,27.34%,PIAS1;HDAC4;PIAS4
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),-0.2738126100908052,-0.48071363526697636,1.0,1.0,1.0,1/13,7.62%,URM1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.27986343988440865,-0.4800825476281084,0.9795918367346939,1.0,1.0,2/8,18.88%,GNPTG;TKFC
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.3084675549888914,-0.47955183008961194,0.9787234042553191,1.0,1.0,2/9,13.69%,MGST3;GGTA1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.2461623922361324,-0.4778270607620031,0.9782608695652174,1.0,1.0,3/27,16.34%,PNKP;SIRT6;PKIB
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.2908346753583689,-0.47779241232139014,0.9811320754716981,1.0,1.0,4/8,30.53%,PTPN1;NCK1;HSPA5;BOK
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.27574190482364036,-0.47689906443405194,1.0,1.0,1.0,6/15,29.43%,CEP131;STIL;DCTN2;CCDC14;HOOK3;CEP192
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.2825693311830556,0.4765828925487715,1.0,1.0,1.0,1/9,17.34%,ILRUN
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.21476267050137446,-0.4712704215882064,1.0,1.0,1.0,3/46,11.99%,H2AX;TRIAP1;HUS1
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.2521415571920269,-0.4661818847963868,1.0,1.0,1.0,4/17,23.57%,MORC3;PARK7;SKP1;SP100
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),-0.3049621770778819,-0.4655636226355454,0.9791666666666666,1.0,1.0,5/5,69.52%,SOD2;CIAO3;HIF1A;ALAS2;CAV1
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),0.26370384468976027,0.46435785362953685,0.9821428571428571,1.0,1.0,8/8,73.64%,NAB2;SORL1;CLU;EGR1;C5AR1;RB1;HSP90AB1;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),-0.30391440262643915,-0.46416859433821234,0.9615384615384616,1.0,1.0,2/5,20.68%,HMGB1;PARP3
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.30755539805029436,0.4637059346301208,0.96,1.0,1.0,3/7,27.07%,ULK1;ATG2B;ATG7
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.30755539805029436,0.4637059346301208,0.96,1.0,1.0,3/7,27.07%,ULK1;ATG2B;ATG7
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.25096221901746285,-0.46369176030222903,1.0,1.0,1.0,8/16,35.51%,MORC3;PINK1;SKP1;HSPA5;ARL2BP;CHCHD10;HK1;SUPT7L
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.2699062737569485,-0.46023793666916296,1.0,1.0,1.0,3/11,20.85%,PARK7;UBE2N;AKAP8
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),-0.26831259525490986,-0.4599124680299208,0.9818181818181818,1.0,1.0,1/8,19.42%,BEND3
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.2258263341834806,-0.4590477999131945,1.0,1.0,1.0,8/37,23.22%,BYSL;PYHIN1;EIF2AK3;PARK7;LAMTOR5;TPR;TESK1;NVL
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.30024328920524185,-0.45814571628954953,1.0,1.0,1.0,2/5,22.36%,FBP1;KHK
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.2807797711654809,0.457286848665688,0.9574468085106383,1.0,1.0,1/8,19.30%,UGDH
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2299826517058473,0.45555543287982037,1.0,1.0,1.0,4/19,18.00%,BBC3;GPER1;MLLT11;CIDEB
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.3035493386620991,0.4555189204738723,1.0,1.0,1.0,6/6,69.65%,STARD4;AGT;ABCG1;APOE;ABCA2;LAMTOR1
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.2715162472049097,0.4549154109569735,0.98,1.0,1.0,5/5,72.85%,SLC6A9;LDB1;ABCB10;PRMT1;SLC25A37
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.30721760928190295,0.4544756674352107,1.0,1.0,1.0,2/6,23.11%,FEM1B;CRY1
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.2847965738758028,0.45241863876761973,1.0,1.0,1.0,9/9,71.53%,HDAC4;SMARCAD1;RCOR1;HDAC2;HDAC3;HDAC9;SIRT2;REST;HDAC1
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.3015986297459321,-0.45214419793919297,0.9791666666666666,1.0,1.0,6/6,69.85%,HDAC6;ETFBKMT;PRKN;MT3;OXA1L;SNCA
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.3076008282964835,-0.45206322761789636,0.9782608695652174,1.0,1.0,3/5,32.41%,BDP1;GTF3C1;CRCP
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),0.26306033647023674,0.44678044749594414,0.9803921568627451,1.0,1.0,4/7,33.58%,ARG1;ASL;CPS1;ARG2
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.26216872055954704,-0.4434559998653041,0.9636363636363636,1.0,1.0,7/7,73.80%,MTIF2;MTIF3;MRRF;DENR;MCTS1;EIF2D;GFM2
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.2759063659720241,0.44266917804370043,0.98,1.0,1.0,6/6,72.42%,SPI1;SETD2;WAPL;RB1;VCPIP1;VCP
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.23228881140968458,-0.44210328841988483,1.0,1.0,1.0,4/22,19.65%,ALYREF;CCNT1;SUPT5H;CCNK
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.2849729335127768,-0.43853659011505686,0.9787234042553191,1.0,1.0,3/5,33.54%,DHODH;CTPS1;UMPS
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.2591912909712958,-0.437135653769237,1.0,1.0,1.0,3/10,19.86%,UNC93B1;FADD;TNIP2
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.24595250867434604,0.4362041843928845,1.0,1.0,1.0,2/9,20.39%,TBCD;PAK2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.27051843783286544,0.43616392862484543,1.0,1.0,1.0,1/7,15.39%,GPER1
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.26888581988476934,0.43514724857057696,0.9387755102040817,1.0,1.0,1/9,11.35%,FEM1B
prerank,GO_Biological_Process_2021__leukocyte chemotaxis involved in inflammatory response (GO:0002232),-0.27505604713548304,-0.42853972913214955,0.9811320754716981,1.0,1.0,1/5,23.28%,ALOX5
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.2526290744706162,-0.4224607396985031,1.0,1.0,1.0,9/9,74.75%,MSH3;CHTOP;SSBP1;MSH2;MSH6;TP53;IFIT1;POT1;SIRT1
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.23364220089466572,0.4215265157768071,1.0,1.0,1.0,1/15,12.54%,INTS6
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.23382989862453002,0.420669142088169,1.0,1.0,1.0,13/13,76.63%,DROSHA;TUT7;AGO2;PRKRA;AGO3;AGO1;TARBP2;ADAR;LIN28B;MRPL44;AGO4;TUT4;DICER1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.2328441288989193,0.4198612951206323,1.0,1.0,1.0,3/17,17.20%,PCGF2;PCGF3;PCGF5
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.22767942128307628,0.4195753887467306,1.0,1.0,1.0,12/12,77.25%,IFT140;DYNC2I2;TTC21B;DYNC2H1;IFT43;WDR35;DYNC2LI1;WDR19;IFT122;DYNC2I1;CILK1;TTC21A
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.24894133320645193,-0.41926176129612797,0.9811320754716981,1.0,1.0,7/7,75.12%,EIF4ENIF1;EIF4E2;DDX6;AGO2;EIF4G1;TNRC6B;STAT3
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.24894133320645193,-0.41926176129612797,0.9811320754716981,1.0,1.0,7/7,75.12%,EIF4ENIF1;EIF4E2;DDX6;AGO2;EIF4G1;TNRC6B;STAT3
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.29257399655204364,0.41677372195949425,1.0,1.0,1.0,1/5,21.06%,VRK1
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.27986651219285097,0.41501149472568766,1.0,1.0,1.0,3/5,37.66%,SIRT1;MTHFR;SUPV3L1
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),-0.2757290222481322,-0.4150090380572798,1.0,1.0,1.0,1/5,16.24%,NAA20
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.2472286390420237,0.4135668979079676,1.0,1.0,1.0,2/8,22.46%,GAS6;NLRP12
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.24833428517037884,-0.40447052280624807,1.0,1.0,1.0,12/12,75.19%,TPR;SUPT6H;NSUN2;NRDE2;KHDRBS1;NCBP2;DHX9;NUP153;SETD2;AKAP8L;IWS1;CPSF6
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.23449416400149778,0.4033462000332138,1.0,1.0,1.0,1/10,15.03%,IMMP2L
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),-0.2525809981445359,-0.4020156334608001,1.0,1.0,1.0,5/5,74.75%,STAR;NR1D1;PROX1;STARD4;SIRT1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.2302486772978751,0.39779840498742486,1.0,1.0,1.0,5/15,26.80%,KIF16B;EPS15;SORT1;DOP1B;AP1AR
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.22213657016806523,0.39737463020824393,1.0,1.0,1.0,4/15,27.34%,PIAS1;CAPN3;HDAC4;PIAS4
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",-0.2776089157868291,-0.3972662591629155,1.0,1.0,1.0,2/5,20.97%,FBP1;PFKL
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.24335778003714326,-0.396763161355086,1.0,1.0,1.0,1/8,16.04%,GSTZ1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.23792673718218965,-0.3947339269313485,1.0,1.0,1.0,1/7,17.48%,CDC42
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.2578143584376041,-0.3915742996182144,0.9795918367346939,1.0,1.0,5/5,74.23%,CA2;RAB11B;ATP8B1;PDZK1;ABCB1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.21925566343042072,-0.38633655000515205,1.0,1.0,1.0,12/12,78.09%,UAP1;RENBP;GFPT2;GNPDA1;GNPNAT1;GFPT1;PGM3;NAGK;GNPDA2;AMDHD2;UAP1L1;NANP
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.2154008439554032,-0.3848484394542466,1.0,0.9999063644174436,1.0,2/12,19.73%,ETS1;ZPR1
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.2349861996764062,-0.38174145366051865,1.0,0.9996243472275117,1.0,10/10,76.52%,SMC6;XRCC3;TEP1;ERCC1;RAD50;RAD51;TPRKB;ERCC4;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.20654259888161033,0.37732466218656013,1.0,1.0,1.0,4/15,29.10%,JADE2;OGT;KANSL1;WDR5
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.20654259888161033,0.37732466218656013,1.0,1.0,1.0,4/15,29.10%,JADE2;OGT;KANSL1;WDR5
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.20372812919511837,0.3765386178902685,1.0,1.0,1.0,5/10,34.92%,MACROH2A1;RUVBL2;POT1;MACROH2A2;BRCA2
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.21587852770347485,0.3760861538390323,1.0,1.0,1.0,4/11,27.17%,RAB27A;KIF5A;DNM2;KIF5C
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.2247512465215642,-0.37038711619846854,1.0,0.9996651445756274,1.0,2/7,27.34%,DISP3;NR1H2
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.19043096543194188,0.3643798204586594,1.0,1.0,1.0,7/28,25.82%,TENM1;RAB29;RUFY3;ATP13A2;RIPOR1;PTPN14;BCAS3
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.1848032007996919,0.36369656670127704,1.0,1.0,1.0,3/24,21.57%,SCAF8;PAPOLA;CSTF3
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.1848032007996919,0.36369656670127704,1.0,1.0,1.0,3/24,21.57%,SCAF8;PAPOLA;CSTF3
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.21855589606386489,0.3617943519272223,1.0,0.9998295048821474,1.0,3/8,30.92%,RIOX1;RIOX2;KDM1A
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.2119438496312156,0.35054486584581596,1.0,0.9997527773914925,1.0,9/9,78.81%,PTEN;ADAM9;FGF7;EPB41L4B;MAP4K4;ARF6;MTOR;IQSEC1;MAPRE2
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.16489906439376523,-0.3438542152535578,1.0,0.9998582686093316,1.0,1/27,11.34%,SNIP1
